Deals

This transaction is a prepackaged Chapter 11 restructuring combined with an equity investment, involving Getty Images Holdings, Inc., trading under the ticker GETY, as the company, with members of the Getty Family and affiliates of Koch Equity Development (KED) participating as investors. The deal is classified within the business services sector, falls under the restructuring product group, and carries a disclosed value of 533,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on October 21, 2026. Based on the facts provided, the deal's status is pending regulatory approval. The financial advisory structure on this deal spans multiple constituencies. For the Company itself, Guggenheim Securities, LLC is serving as investment banker and is identified as holding lead status, while Alvarez & Marsal North America, LLC is serving as financial advisor to the Company in a supporting capacity. For the ad hoc group of secured creditors, Houlihan Lokey Capital, Inc. is serving as investment banker and is identified as holding lead status. For the ad hoc committee of unsecured creditors, Perella Weinberg Partners LP is serving as investment banker, also identified as holding lead status. On the investor side, Moelis & Company LLC is serving as financial advisor to members of the Getty Family, through certain of their affiliated entities, and is identified as holding lead status, while Rothschild & Co is serving as financial advisor to KED and is likewise identified as holding lead status. Legal advisors are similarly distributed across constituencies. Simpson Thacher & Bartlett and Cole Schotz P.C. are both serving as counsel to the Company. Gibson, Dunn & Crutcher LLP is serving as legal counsel to the ad hoc group of secured creditors, and Akin Gump Strauss Hauer & Feld LLP is serving as legal counsel to the ad hoc committee of unsecured creditors. Separately, Milbank LLP is serving as legal advisor to the agent for the revolving lenders. On the investor side, Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor to the Getty Family affiliates, and Jones Day is serving as legal advisor to KED. The source material also notes that Kekst CNC is serving as strategic communications advisor to the Company. Beyond confirming that this is a prepackaged Chapter 11 process combined with an equity investment, with a disclosed value of 533,000,000 dollars, no further detail on the specific equity stakes to be received by the Getty Family or KED, or on the treatment of specific creditor classes, is included in the facts available. A number of elements of this deal remain undisclosed. No specific breakdown is given of how the 533,000,000 dollar disclosed value is allocated between the Getty Family and KED equity investments or among creditor recoveries, and no expected date for court confirmation or emergence from Chapter 11 is provided in the facts available.

Myriad Genetics, Inc. and Labcorp announced on October 20, 2026 a definitive agreement under which Myriad will sell its Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests, to Labcorp for $210 million in cash plus the value of related inventory at closing. The divestiture is part of Myriad's disclosed strategic portfolio review and is intended to sharpen its focus on its cancer care continuum business, while Labcorp expects the acquired prenatal testing portfolio to add approximately $160 million in revenue in its first year. This extraction is sourced from Myriad Genetics' 8-K exhibit (Exhibit 99.1) filed with the SEC on October 20, 2026, carrying the joint press release announcing the signed agreement. The deal remained subject to regulatory clearance and customary closing conditions as of this filing, with Myriad stating it would provide further commentary on its third-quarter earnings call scheduled for November 4, 2026. Barclays acted as financial advisor to Labcorp, the acquirer, while Guggenheim Securities, LLC acted as exclusive financial advisor to Myriad Genetics, the seller. Guggenheim's engagement was explicitly described as exclusive, while Barclays' role for Labcorp was not qualified as exclusive or lead in the release. On the legal side, Covington & Burling LLP served as legal advisor to Myriad Genetics, while Polsinelli served as legal advisor to Labcorp. The transaction is an all-cash divestiture of a discrete business unit rather than a sale of Myriad as a whole. Over the trailing twelve months, Myriad's Prenatal Health portfolio had been used by thousands of providers and over 600,000 patients. Labcorp expects the deal to be slightly accretive to adjusted earnings in its first year and to reach average diagnostics segment margins by the end of year two once integrated. The transaction is expected to close by early 2027. The press release does not disclose the value of the inventory component being added to the $210 million cash price, nor does it disclose advisory fees paid to either Barclays or Guggenheim Securities, or any termination fee terms in the definitive agreement.

CBRE Group, Inc. (NYSE: CBRE), the Dallas-headquartered global commercial real estate services and investment firm, announced on October 20, 2026 a definitive agreement to acquire Onnec Group Limited, a London-based, independent provider of data center infrastructure services serving hyperscale technology companies across the United Kingdom, Continental Europe, and Asia Pacific. The acquisition is intended to expand CBRE's critical infrastructure services capabilities in Europe and Asia Pacific, complementing its existing data center infrastructure services business in the United States. This entry is sourced from CBRE's Exhibit 99.1 press release filed as part of an 8-K on October 20, 2026. The agreement is a signed definitive agreement that had not yet closed as of this filing; the transaction is subject to customary regulatory approvals and was expected to be completed around the end of the year (2026). J.P. Morgan Securities, LLC is acting as financial advisor to CBRE. Goldman Sachs International is acting as financial advisor to Onnec. Simpson, Thacher & Bartlett LLP is acting as legal advisor to CBRE. Freshfields LLP is acting as legal advisor to Onnec. The initial purchase price is £460 million (approximately $610 million) in cash. In addition, the parties agreed to a multi-year earnout of up to £300 million (approximately $400 million), contingent on Onnec meeting certain growth thresholds. Onnec, founded in 1986 with approximately 800 employees, is expected to generate approximately £370 million ($498 million) in revenue and more than £50 million ($67 million) of core EBITDA in 2027, and the acquisition is expected to be immediately accretive to CBRE's core earnings per share. CBRE expects its Critical Infrastructure Services business line to generate nearly $4.5 billion of total revenue in 2027 including Onnec's contribution. The release does not disclose the specific earnout performance metrics or growth thresholds that would trigger the full £300 million contingent payment, Onnec's current or historical EBITDA or revenue figures prior to the 2027 projection, or the fee arrangements for J.P. Morgan, Goldman Sachs International, Simpson Thacher, or Freshfields. The exact GBP-to-USD exchange rate used to convert the headline purchase price figures is also not specified in this release.

Hess Midstream LP (NYSE: HESM), a fee-based, growth-oriented midstream company primarily operating in the Bakken and Three Forks Shale plays, announced on October 6, 2026 that it has executed a definitive agreement with Chevron to acquire Chevron's crude oil and natural gas gathering and storage assets in the Denver Julesburg (DJ) Basin, including a minority interest in the Saddlehorn long-haul pipeline. As part of the same transaction, Chevron will contribute 100% of its consolidated ownership interests in Hess Midstream and 100% of its ownership interests in Hess Midstream's general partner, which will decrease Hess Midstream's outstanding shares by nearly 40% upon closing and establish Hess Midstream as an independent, multi-basin midstream company with a new independent board. This entry is sourced from Hess Midstream's Exhibit 99.1 press release filed as part of an 8-K on October 6, 2026. The terms of the proposed transaction have been unanimously approved by the Hess Midstream board and by a conflicts committee of the board consisting entirely of independent directors, which engaged legal advisors and an independent financial advisor to render a fairness opinion. The transaction has not yet closed; it is expected to close by year-end 2026, subject to customary closing conditions. Evercore is acting as financial advisor to the conflicts committee of the Hess Midstream board, and BofA Securities is acting as financial advisor to Chevron. No financial advisor is separately named for Hess Midstream as a corporate entity outside of the conflicts committee's advisor. Gibson, Dunn & Crutcher LLP is acting as legal advisor to the conflicts committee, and Latham & Watkins LLP is acting as legal advisor to Chevron. Under the disclosed terms, Hess Midstream will pay Chevron $200 million in cash, and Chevron will contribute to Hess Midstream 100% of its consolidated ownership interests, including 77,827,485 Class B units of Hess Midstream Operations LP and 449,000 Class A shares of Hess Midstream, all of which will be canceled. Chevron will also contribute its ownership interests in the general partner. Hess Midstream and Chevron will separately amend their existing Bakken commercial agreements, reducing crude oil and gas gathering and processing tariffs payable by Chevron while extending those agreements from 2033 through 2045. Hess Midstream does not expect to pay any material taxes associated with the transaction, and all Chevron-affiliated board members will depart, with shareholders gaining the right to elect board members beginning in 2028. The release does not disclose an aggregate enterprise or equity value assigned to the DJ Basin assets or to Chevron's contributed Hess Midstream and general partner interests; the only explicit cash figure is the $200 million payment from Hess Midstream to Chevron. No termination fee, regulatory approval requirements, or fee arrangements for the named advisors are disclosed in this release.

This deal is a cash and stock acquisition classified as an M&A transaction in the healthcare sector, involving BioLife Solutions Inc (ticker BLFS) as target and Repligen Corp (ticker RGEN) as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on October 6, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners LP and Goldman Sachs & Co. LLC served as financial advisors to Repligen, the acquirer, with no lead designation specified for either firm. Centerview Partners, LLC served as financial advisor to BioLife, the target, also without a specified lead designation. On the legal side, Goodwin Procter LLP served as legal counsel to Repligen, the acquirer, while K&L Gates LLP served as legal counsel to BioLife, the target. Beyond the cash and stock consideration mix noted in the deal subtype, no further detail on the specific split between cash and stock components is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document, no lead designation is specified for any of the financial advisors named, the precise cash-versus-stock consideration split is not broken out beyond the general subtype classification, and no expected closing date or further timeline detail beyond the October 2026 filing date and pending-regulatory status is given.

HighPeak Energy, Inc. (NASDAQ: HPK), a Fort Worth-based independent crude oil and natural gas company operating in the Midland Basin, announced on October 6, 2026 a comprehensive refinancing consisting of a $450 million preferred equity investment and a new $800 million reserve-based credit facility. The preferred equity investors are PT Danantara Investment Management, a sovereign fund of the Republic of Indonesia, and PT Energi Mega Persada Tbk, an Indonesia-based upstream oil and gas company listed on the Indonesia Stock Exchange. This entry is sourced directly from HighPeak's Exhibit 99.1 press release filed with the SEC as an 8-K exhibit on October 6, 2026. The release states the transaction is not yet closed; it is expected to close during the fourth quarter of 2026, subject to customary closing conditions, and is being recorded here based on the announcement terms as disclosed. On the financial advisory side, Barclays Bank PLC is acting as financial advisor to PT Danantara Investment Management, and Citigroup Global Markets Singapore Pte. Ltd. is acting as financial advisor to PT Energi Mega Persada Tbk. No financial advisor is named for HighPeak itself in this release; Citibank, N.A. and Fifth Third Bank, N.A. are named as providers of committed financing for the new $800 million reserve-based credit facility, in a lending rather than advisory capacity. On the legal side, Vinson & Elkins LLP is acting as legal counsel to HighPeak, Milbank LLP is acting as legal counsel to the investors, and Bracewell LLP is acting as legal counsel to Citibank, N.A. Under the terms disclosed, the Investors have committed to purchase 450,000 shares of newly created Series A 6% Perpetual Convertible Preferred Stock for total gross proceeds of approximately $450 million. Each preferred share is convertible at a conversion price of $9.50 per common share. The preferred stock may be redeemed by HighPeak after the third anniversary of closing at a price providing a 10.0% IRR, and is mandatorily convertible under specified stock-price conditions. Proceeds from the preferred investment, together with initial borrowings under the new $800 million reserve-based credit facility (arranged with Citibank and Fifth Third Bank) and available cash, are expected to allow HighPeak to repay its existing $1.17 billion term loan in full. DIM and EMP will each appoint one director to HighPeak's board. The release does not disclose the specific pricing or fee terms of the new $800 million credit facility beyond stating it is a reserve-based lending facility, nor does it disclose transaction expenses, underwriting fees paid to the financial advisors, or the ownership percentage the preferred stock would represent on an as-converted basis. No aggregate enterprise or equity valuation for HighPeak was stated in connection with this transaction.

CareTrust REIT, Inc. (NYSE: CTRE), a Dana Point, California-based, self-administered REIT engaged in ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties in the US and UK, announced on October 2, 2026 a strategic SHOP (senior housing operating portfolio) pipeline agreement with LNT Care Developments Holdings Limited, a UK-based care home developer, to acquire 45 new care homes for approximately £1.1 billion. The deal is designed to build a significant senior housing operating portfolio platform for CareTrust in the UK. This entry is sourced from CareTrust's Exhibit 99.1 press release filed as part of an 8-K on October 2, 2026. The transaction is structured with staggered closings: the first closing occurred October 1, 2026, covering 24 completed homes for approximately £576 million (approximately $764 million), funded through settlement of outstanding forward equity agreements and a draw on CareTrust's revolving credit facility. The remaining 21 homes are currently under development and will be acquired for approximately £504 million upon completion, with closings anticipated on a rolling basis throughout 2027 subject to regulatory approval. J.P. Morgan served as financial advisor to CareTrust. Lazard served as financial advisor to LNT. Jones Day acted as legal advisor to CareTrust. Slaughter and May and Freeths served as legal advisors to LNT. All homes are, or will be upon closing, leased to subsidiaries of Crystal Care, LNT's care home operating portfolio company, under triple-net leases with fixed annual escalators during an initial "Lease-up Phase." Following lease-up, both parties intend to transfer all 45 homes to a RIDEA structure with Crystal Care, beginning the "SHOP Phase," expected to start between years two and four following each home's completion, with the first transition anticipated by the fourth quarter of 2027. CareTrust underwrites an all-in yield in the mid-to-high-7% range on a pre-tax basis in year one of the SHOP Phase. LNT also granted CareTrust an option to acquire the LNT platform in its entirety in the future. The release does not disclose the specific GBP-to-USD conversion rate used for the £1.1 billion aggregate figure beyond the 1.327 rate cited for the first tranche, nor does it disclose a termination fee, the purchase price allocation methodology across the 45 individual homes, or fee arrangements for J.P. Morgan, Lazard, Jones Day, Slaughter and May, or Freeths. The timing and regulatory approval requirements for each of the remaining 21 homes are described only in aggregate, not property-by-property.

This transaction is a cash acquisition in which Flowco Holdings Inc. (ticker FLOC), classified here under the tech sector, is acquiring Lifting Solutions Energy Services Inc. The deal falls under the M&A product group and carries a disclosed value of $113,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on October 2, 2026. On the financial advisory side, only one advisor is named: TPH&Co, described as the energy business of Perella Weinberg Partners, is serving as exclusive financial advisor to Lifting Solutions, the target, in a lead capacity. No financial advisor is named for Flowco, the acquirer, in the facts block. Legal counsel, by contrast, is documented on both sides. For Flowco, the acquirer, three firms are named: Troutman Pepper Locke LLP, Blake, Cassels & Graydon LLP, and Vinson & Elkins LLP are all serving as legal advisors, the mix of U.S. and Canadian firms, including Blake, Cassels & Graydon LLP, suggesting a cross-border element to the transaction. For Lifting Solutions, the target, Dentons Canada LLP is serving as exclusive legal counsel, also pointing to a Canadian dimension of the deal. The facts block confirms this is a cash acquisition with a disclosed value of $113,000,000, but provides no further detail on the per-unit or per-share price, financing sources for Flowco, or any specific terms of the purchase agreement. Several material facts are not disclosed. No financial advisor is named for Flowco, the acquirer. No expected closing date is given, and no detail on the cross-border structure implied by the Canadian legal counsel on both sides is explained beyond the firms' names themselves.

Artemis Gold Inc. (TSXV: ARTG), a Vancouver-based gold and silver producer that owns and operates the Blackwater mine in British Columbia, and Vista Gold Corp. (NYSE American and TSX: VGZ), owner of the Mt Todd gold development project in the Northern Territory, Australia, announced on September 21, 2026 that they entered into a definitive arrangement agreement dated September 20, 2026 under which Artemis Gold will acquire all issued and outstanding shares of Vista Gold pursuant to a court-approved plan of arrangement under the Business Corporations Act (British Columbia). Artemis Gold already held a 4.95% stake in Vista Gold prior to the announcement. This entry is sourced from Vista Gold's Exhibit 99.1 press release filed as part of an 8-K on September 21, 2026. The transaction is a signed definitive agreement that had not yet closed; full details were expected in Vista Gold's definitive proxy statement, to be mailed to shareholders in November 2026, with a shareholder meeting expected in December 2026 and closing expected in January 2027, contingent on shareholder and court approval. BMO Capital Markets is acting as financial advisor to Artemis Gold. CIBC Capital Markets is acting as financial advisor to Vista Gold and has provided a fairness opinion to the Vista Gold board of directors; ATB Cormark separately provided an independent fairness opinion to the Vista Gold board. Blake, Cassels & Graydon LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP are acting as Artemis Gold's legal advisors. Stikeman Elliott LLP and Davis Graham & Stubbs LLP are acting as Vista Gold's legal advisors. Under the terms disclosed, Vista Gold shareholders will receive 0.0966 common shares of Artemis Gold for each Vista Gold common share held, implying consideration of US$2.83 per Vista Gold share and a total transaction value of approximately US$427 million on a 100% basis, a 29% premium to the 20-day volume-weighted average price and a 25% premium to the last closing price as of September 18, 2026. The consideration is payable entirely in Artemis Gold common shares, with no cash consideration and no new debt incurred. Upon completion, existing Artemis Gold and Vista Gold shareholders are expected to own approximately 95% and 5% of the combined company, respectively. The agreement includes a termination fee of US$18 million payable by Vista Gold under certain customary circumstances, including termination in connection with Vista Gold pursuing a superior proposal, and requires approval by 66 2/3% of Vista Gold shareholder votes cast. The release does not disclose the specific fee arrangements for BMO Capital Markets, CIBC Capital Markets, ATB Cormark, or any of the four named law firms. The transaction also remains subject to Australia's Foreign Investment Review Board approval, Northern Territory Ministerial Consent, and SEC, TSX, and TSX Venture Exchange approvals, none of which had been obtained as of this release.

RREEF Property Trust, Inc. (NASDAQ: ZRPTAX, ZRPTIX, ZRPTTX, ZRPTMX, ZRPTUX, ZRPTNX), a publicly registered, non-listed, daily net asset value real estate investment trust advised by an affiliate of DWS Group, announced on September 18, 2026 that its Board of Directors approved a plan of complete liquidation and dissolution, providing for the voluntary sale of all of the Company's assets followed by dissolution. The Company's current portfolio includes seven real estate investments spread across five states in the industrial, retail, residential, and office sectors. This entry is sourced from RREEF's Exhibit 99.1 press release filed as part of an 8-K on September 18, 2026. The plan is a board-approved action that is subject to stockholder approval at a special meeting the Company plans to convene; it has not yet been approved by stockholders or executed as of this filing. The Company intends to file a proxy statement with the SEC in connection with the plan. Jones Lang LaSalle Securities, LLC is acting as financial advisor to the Company in connection with the evaluation of strategic alternatives that led to the liquidation decision. No financial advisor is or could be named for a counterparty, since this announcement reflects a unilateral decision to liquidate rather than a sale to an identified acquirer. Alston & Bird LLP acted as counsel to the Company, and Venable LLP acted as Maryland counsel to the Company. The release states the Company's Board, effective immediately, suspended the sale of shares of common stock in its public and private offerings, its share redemption plan, and its distribution reinvestment plan, while intending to continue paying monthly distributions to stockholders subject to Board discretion. The Company reported since-inception annualized total returns as of August 31, 2026 of 6.35% for Class I shares (its largest and longest-running share class) and annualized monthly distributions between 5.1% and 6.9% over the past two years across all share classes. The Company stated it will endeavor to complete the sale of its assets within 24 months of stockholder adoption of the plan. Because this is a liquidation announcement rather than a sale to a specific acquirer, no aggregate transaction value, consideration structure, or counterparty exists to disclose. The release does not name any specific buyers for the seven underlying properties, disclose expected net proceeds per share from the liquidation, or specify fee arrangements for Jones Lang LaSalle Securities, Alston & Bird, or Venable.

This transaction is a cash tender offer in which Copart, Inc., trading under the ticker CPRT, is seeking to acquire ACV Auctions Inc., trading under the ticker ACVA. The deal falls within the business services sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form SC 14D9 filing published on September 17, 2026. Based on the facts provided, the deal's current status is pending regulatory approval. No financial advisors were extracted for this deal in the facts provided, meaning that neither ACV Auctions nor Copart has a financial advisor identified in the available material. On the legal side, Davis Polk & Wardwell LLP is identified as legal advisor to ACV Auctions, the target in this transaction. The source material lists the firm's address as 450 Lexington Ave., New York, NY 10017, consistent with its role as counsel of record on the Schedule 14D-9. No legal advisor to Copart, the acquirer, is identified in the facts provided. Beyond confirming that the transaction is structured as a cash tender offer, no further detail on the offer price per share or other specific terms of the tender is included in the facts available. This deal's facts block is notably thin: no financial advisor is identified for either side, the deal value is explicitly noted as not stated in the source document, and no legal advisor to Copart is named. No expected closing date, offer price, or detail on the conditions of the tender offer is provided in the available material.

Hallador Energy Company (Nasdaq: HNRG), a Terre Haute, Indiana-based vertically integrated independent power producer, announced on September 17, 2026 that it closed a $600 million senior secured term loan facility on September 15, 2026, with a three-year term and a lender-approval-contingent two-year extension option. Combined with the ability to establish an additional super-priority revolving credit facility of up to $75 million, the overall financing package totals up to $675 million. Kennedy Lewis Investment Management LLC provided the Term Loan Facility. This entry is sourced from Hallador's Exhibit 99.1 press release filed as part of an 8-K on September 17, 2026. The transaction described is a completed financing, not a pending announcement; the term loan facility closed on September 15, 2026, two days before the filing date. PEI Global Partners acted as the exclusive financial advisor to Hallador in connection with this transaction. Kennedy Lewis Investment Management LLC is named as the lender providing the Term Loan Facility, functioning as the financing counterparty rather than an advisor. No legal advisors are named in this release for either Hallador or Kennedy Lewis. No legal advisors were disclosed in this press release. Proceeds from the Term Loan Facility, together with a potential additional $50 million delayed draw term loan commitment available for up to 12 months, are expected to fund Hallador's turbine asset purchase agreement obligations, transportation and refurbishment costs, and construction of the Company's proposed 460-megawatt natural gas-fired Turtle Creek Gas project, which has an expected total project cost of less than $800 million. Approximately $120 million of proceeds will be used to repay Hallador's existing $45 million term loan and $75 million revolving credit facility, with the balance for general corporate purposes. As of June 30, 2026, Hallador had approximately $2.4 billion of contracted forward sales under multi-year agreements with utilities and other counterparties. The release does not disclose the interest rate or pricing terms of the Term Loan Facility, the specific fee paid to PEI Global Partners, or the identity of legal counsel to either party. No final investment decision (FID) on the Turtle Creek project itself has been made as of this release; the company states a long-term power purchase agreement is not expected to be a condition to FID, but the generator interconnection agreement had not yet been executed as of the filing date.

Surgery Partners, Inc., a Brentwood, Tennessee-based owner and operator of short-stay surgical facilities, announced on September 17, 2026 the completion of its previously announced sale of its ownership interests in Idaho's Mountain View Hospital and Idaho Falls Community Hospital (together, the Idaho Falls Facilities) to Intermountain Health, a nonprofit health system based in Utah. The transaction valued the combined Idaho Falls Facilities at approximately $1.15 billion, with Surgery Partners receiving $797 million in gross proceeds and $587 million in net cash proceeds at closing. This extraction is sourced from Surgery Partners' 8-K press release exhibit (Exhibit 99.2) filed with the SEC on September 17, 2026, announcing deal completion. The transaction had been previously announced and was disclosed here as fully closed, with Surgery Partners updating its full-year 2026 financial guidance to reflect the divestiture. Barclays served as the lead financial advisor to Surgery Partners, the seller, while RBC Capital Markets, LLC served as the lead financial advisor to Intermountain Health, the buyer. Both banks held lead advisory roles for their respective sides. On the legal side, McDermott Will & Schulte LLP served as legal counsel to Surgery Partners, while Hall, Render, Killian, Heath & Lyman, P.C. served as legal counsel to Intermountain Health. The divestiture was structured as a sale of ownership interests under Securities Purchase Agreements, representing an approximately 7x multiple of the Idaho Falls Facilities' last-twelve-months adjusted EBITDA (through June 30, 2026). Physician ownership of Mountain View Hospital was to remain unchanged under Intermountain Health's leadership. Surgery Partners stated the proceeds would be used primarily to pay down debt, improving balance sheet leverage by 30 basis points from 4.4x at the end of the second quarter of 2026, and described the deal as part of a broader portfolio optimization that included reducing Medicaid payor mix and eliminating several lower-margin service lines across its remaining business. The press release does not disclose the specific advisory fees paid to Barclays or RBC Capital Markets, nor does it break out how the $797 million gross proceeds figure splits between the two individual hospital facilities within the combined Idaho Falls transaction.

Sysco Corporation, a food-service distribution company trading under ticker SYY, priced an underwritten public offering of 12,345,679 shares of its common stock, par value $1.00 per share, at $81.00 per share on September 14, 2026. The offering generated gross proceeds of $999,999,999 and net proceeds of approximately $967.4 million after underwriting discounts of $2.43 per share ($29,999,999.97 in aggregate) and estimated offering expenses of approximately $2.6 million. The offering closed and shares were delivered through The Depository Trust Company on September 16, 2026. The $81.00 offering price represented a discount of approximately 2.7 percent to Sysco's last reported NYSE closing price of $83.21 per share on September 11, 2026, the trading day before the prospectus supplement was dated. Sysco granted the underwriters a 30-day option to purchase up to 1,851,851 additional shares solely to cover overallotments; if exercised in full, the shares offered would rise to 14,197,530 and net proceeds to approximately $1.1 billion. The filings reviewed do not state whether the overallotment option was ultimately exercised. Goldman Sachs & Co. LLC, TD Securities (USA) LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC acted as joint book-running managers and representatives of a 15-firm underwriting syndicate. The prospectus supplement's underwriting table shows Goldman Sachs with the largest allocation (4,444,444 shares), followed by TD Securities (2,962,962 shares), and BofA Securities, J.P. Morgan and Wells Fargo Securities with 777,778 shares each. BNP Paribas Securities Corp., BTIG, LLC, PNC Capital Markets LLC and Truist Securities, Inc. served as additional bookrunners with 489,198 shares each, and Barclays Capital Inc., Rabo Securities USA, Inc., Scotia Capital (USA) Inc., BMO Capital Markets Corp., Lloyds Securities Inc. and Siebert Williams Shank & Co., LLC served as co-managers with smaller allocations. The offering was conducted under Sysco's shelf registration statement on Form S-3ASR (Registration No. 333-298926) filed September 14, 2026, and priced the same day under a prospectus supplement dated September 14, 2026 (filed as a 424B5). A Form 8-K filed September 16, 2026, disclosed the final terms and attached the underwriting agreement (dated September 14, 2026) and a legal opinion as Exhibit 5.1. This chain indicates the equity offering was launched and priced on an accelerated basis between approximately September 11 and 14, 2026. Sysco intends to use the net proceeds, together with proceeds from other financing transactions (a Term Loan Credit Agreement, a Revolving Credit Agreement, a $750 million CoBank delayed-draw term loan facility, and additional securities offerings including a multi-tranche senior notes offering) and cash on hand, to pay a portion of the cash consideration for its pending acquisition of JRD Unico, Inc. and Warehouse Realty, LLC (together, "Jetro Restaurant Depot"), plus related fees, costs and expenses. The equity offering itself is not contingent on completion of the JRD acquisition; if that acquisition is not consummated, Sysco said it would use the net proceeds for general corporate purposes. As of June 27, 2026, Jetro Restaurant Depot had approximately $4.6 billion of total third-party indebtedness, including about $3.7 billion of private placement notes and roughly $0.9 billion across six mortgage facilities, which Sysco expects to redeem, purchase, refinance or amend using proceeds of the financing transactions. Sysco had 479,568,281 shares of common stock outstanding as of September 9, 2026. The new issuance of 12,345,679 shares (before any overallotment exercise) represents dilution of approximately 2.6 percent, bringing shares outstanding to 491,913,960 (or 493,765,811 if the overallotment option is exercised in full). The filings reviewed do not disclose any concurrent share repurchase program tied to this offering. Sysco's directors and executive officers, and Sysco itself (with certain exceptions), agreed to 45-day lock-up restrictions on share sales following the prospectus supplement date, subject to the consent of Goldman Sachs & Co. LLC and TD Securities (USA) LLC. The validity of the shares was passed upon for Sysco by Paul, Weiss, Rifkind, Wharton & Garrison LLP of New York, and certain legal matters for the underwriters were passed upon by Davis Polk & Wardwell LLP of New York. The underlying JRD acquisition, as referenced in these filings, stems from an Agreement and Plan of Merger dated March 30, 2026, among Sysco, Sysco Holdings Corporation (formerly New Slider Holdco, Inc.), JRD Unico, Inc., Warehouse Realty, LLC and certain merger subsidiaries, under which Sysco will acquire Jetro Restaurant Depot in a cash-and-stock transaction and Sysco will become a wholly owned subsidiary of Sysco Holdings. A September 1, 2026 8-K noted the JRD acquisition was then anticipated to close by the third quarter of calendar 2027, and the equity offering's prospectus supplement describes that deal as still pending. No closing confirmation for the JRD acquisition itself was found in the filings reviewed, so that underlying transaction's status remains pending as previously disclosed; this equity offering's own structure, pricing and settlement, however, are confirmed complete as of September 16, 2026.

This transaction is a go-private cash merger involving The Baldwin Group, Inc., with Sequence Holdings and DFO Management as the acquiring parties. The disclosed value of the transaction is 7,700,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on September 14, 2026. Based on the facts provided, the deal's status is pending regulatory approval. The financial advisory arrangement on this deal is layered by committee and company. Perella Weinberg Partners LP is serving as independent financial advisor to the Special Committee of the Board of Directors of Baldwin and is identified as the lead advisor in that specific capacity. Separately, Ardea Partners LP is serving as lead financial advisor to The Baldwin Group as a whole, with MarshBerry also acting as a financial advisor to The Baldwin Group in connection with the transaction, indicating more than one advisor supporting the company-level mandate alongside the Special Committee's independent advisor. On the legal side, Potter Anderson & Corroon LLP is serving as independent legal advisor to the Special Committee, paired with Perella Weinberg Partners in that mandate. Davis Polk & Wardwell LLP is serving as legal advisor to The Baldwin Group, paired with Ardea Partners, and Troutman Pepper Locke LLP is serving as insurance regulatory counsel to The Baldwin Group as well. On the acquirer side, Latham & Watkins LLP is acting as legal counsel to Sequence, and Sullivan & Cromwell LLP is acting as legal counsel to DFO. Beyond confirming that this is a go-private cash merger with a disclosed value of 7,700,000,000 dollars, no further detail on the specific per-share price or other terms of the cash consideration is included in the facts available. A number of elements of this deal are not disclosed. No financial advisor to Sequence or DFO, the acquiring parties, is identified, only their legal counsel. No expected closing date is given, and no detail on the specific per-share cash price or regulatory approvals required to close is provided in the available material.

Crane Company (NYSE: CR) announced on September 14, 2026 that it has entered into a definitive agreement to acquire the U.S. pump business of First Reserve-backed Trillium Flow Technologies for approximately $240 million, a price representing roughly 14.6 times the business's estimated 2026 adjusted EBITDA. The acquired business includes the Floway, Wemco, Roto-Jet and WSP brands, which make pumping equipment primarily for U.S. municipal water and wastewater customers, and is expected to generate approximately $115 million of revenue in its current fiscal year. This record is sourced from Crane's own 8-K press release (Exhibit 99.1) furnished to the SEC on September 14, 2026, which is the company's original announcement of the transaction. The filing is a standard acquisition press release and does not reference a separate definitive merger or purchase agreement filed as an exhibit, so deal mechanics beyond what is stated below are not available from this document. The press release does not name any financial advisor to either Crane or Trillium Flow Technologies in connection with this transaction, so no advisor fields can be populated with confidence; any financial advisor relationship, if one exists, is not disclosed in the source document reviewed. Likewise, the release does not identify legal counsel to either party. No legal advisor information can be extracted from this filing. Crane describes the purchase price as approximately $240 million, equal to about 14.6 times the target business's estimated 2026 adjusted EBITDA, which implies the figure is being presented on an enterprise value basis. The acquired brands and installed base are expected to support recurring service, repair, retrofit and replacement revenue going forward, and the deal is expected to close in the fourth quarter of 2026, subject to customary closing conditions including applicable regulatory approvals. Not disclosed in this filing: any financial or legal advisors to either party, the structure of consideration (cash versus other forms), financing sources, specific closing date, any termination fee, and the identity of specific Trillium Flow Technologies personnel or board approvals related to the sale.

Analog Devices, Inc. (NASDAQ: ADI), a technology sector company, and Alif Semiconductor, Inc., a Pleasanton, California-based provider of low-power microcontroller and fusion processor semiconductor products with integrated AI/ML acceleration, announced on September 9, 2026 that they entered into a definitive agreement under which ADI will acquire Alif in an all-cash transaction. The announcement was disclosed in a Form 8-K (Item 7.01, Regulation FD Disclosure) furnishing a joint press release as Exhibit 99.1. Under the terms of the agreement, which has been approved by the boards of directors of both companies, ADI will pay Alif's stockholders $1.35 billion of upfront cash consideration, subject to the terms of the definitive agreement. In addition, ADI may pay incremental contingent consideration of up to $200 million, the terms and triggers of which were not detailed in the disclosed materials. No equity, exchange ratio, or stock component is involved; Alif is a private company, so no proxy statement, S-4, or tender offer filing applies to this transaction. Strategically, ADI describes the deal as accelerating its delivery of what it calls "Physical Intelligence," enabling systems to sense, reason, and act locally in real time within the constraints of the physical world. Vincent Roche, CEO and Chair of ADI, said: "AI is moving out of the data center and into the physical world, where latency, power, and trust cannot be compromised... By combining Alif's digital processing capabilities with our leadership in multi-modal sensing, signal processing, power, connectivity, and software, we can empower customers to create entirely new classes of secure, intelligent systems that sense, reason, and act locally in real time." Reza Kazerounian, Co-Founder and President of Alif, said the company was "founded to reimagine what a microcontroller can be in the AI era," engineering "a heterogeneous architecture from the start, integrating dedicated low-power neural processing with connectivity, security, and intelligent power management." ADI says the combination will expand its addressable market across industrial, data center infrastructure, defense, energy, robotics, digital health, and wearable applications, and notes that Alif's silicon is already shipping in production with design wins across leading consumer and industrial customers. On financing, ADI separately raised $3.0 billion through an underwritten public offering of senior notes across four tranches ($500 million of 5.100% notes due 2029, $500 million of 5.350% notes due 2031, $1.0 billion of 5.600% notes due 2033, and $1.0 billion of 5.750% notes due 2036), priced September 15, 2026 and issued September 17, 2026, with J.P. Morgan Securities LLC acting as representative of the underwriters. In the related 424B2 prospectus supplement filed September 16, 2026, ADI disclosed estimated net proceeds of approximately $2.969 billion and stated it intends to use the net proceeds for general corporate purposes, "which may include funding the upfront cash purchase price of the Alif Acquisition, capital expenditures, repurchases of our common stock under our stock repurchase program, repayment or refinancing of existing indebtedness, dividend payments and other acquisitions." The prospectus supplement also states there will be no special mandatory redemption of the notes if the Alif acquisition is not consummated, meaning the notes are not strictly conditioned on deal completion. On the financial advisory side, PJT Partners is acting as financial advisor to ADI, the acquirer. For Alif, the target company, Qatalyst Partners is serving as financial advisor. Legal counsel is divided accordingly: Wachtell, Lipton, Rosen & Katz is serving as legal counsel to ADI, and DLA Piper is acting as legal counsel to Alif. The transaction is expected to close before the end of calendar year 2026 (the fourth quarter of ADI's 2026 calendar year), subject to customary closing conditions, including the expiration (or termination) of the applicable waiting period, and any extension thereof, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. No other specific closing conditions, termination fee, EPS accretion/dilution guidance, synergy targets, or pro forma financial detail for the combined company have been disclosed in the available filing materials. No merger/purchase agreement exhibit, investor presentation deck, merger proxy, or closing 8-K has been filed or located as of this writing.

This is an all-stock merger in the real-estate sector in which Independence Realty Trust, Inc. (ticker IRT) is acquiring Centerspace (ticker CSR). The product group is M&A, and the disclosed transaction value is $8,100,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on September 9, 2026. The deal's current status is pending regulatory review. Financial advisory roles are disclosed for both sides, without a lead designation specified for any individual advisor. BMO Capital Markets Corp. is acting as financial advisor to Centerspace, the target, per the statement "BMO Capital Markets Corp. is acting as financial advisor, and Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Centerspace." On the acquirer side, RBC Capital Markets and Rothschild & Co. are both acting as financial advisors to IRT, consistent with the language "RBC Capital Markets and Rothschild & Co. are acting as financial advisors and Troutman Pepper Locke LLP is acting as legal advisor to IRT." Legal advisors are disclosed for both sides: Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Centerspace, the target, while Troutman Pepper Locke LLP is acting as legal advisor to IRT, the acquirer. Beyond the classification of this transaction as an all-stock merger with a disclosed value of $8,100,000,000, no further detail on the specific exchange ratio or other consideration terms is included in the facts provided. Several items are not disclosed in this record: the specific stock exchange ratio is not given, and no expected closing date is given beyond the pending-regulatory status.

Franklin Electric Co Inc, a company in the industrials sector trading under the ticker FELE, is acquiring an undisclosed target in a merger and acquisition transaction valued at $350 million in USD. The transaction was announced on September 8, 2026, as disclosed in a Form 8-K filing submitted to the SEC and available on SEC EDGAR. This represents a significant capital deployment for the acquirer and falls within the standard M&A product group. The transaction details derive from a Form 8-K current report filed with the Securities and Exchange Commission on September 8, 2026, and published on SEC EDGAR. The deal is currently in announced status as of the filing date, meaning the transaction has been publicly disclosed but has not yet closed. No expected closing date or timeline to completion has been disclosed in the available filing materials. Houlihan Lokey has been retained as the lead financial advisor to the target, while Rothschild & Co serves as the lead financial advisor to the acquirer Franklin Electric. Both firms are advising their respective clients on the transaction, though the specific roles beyond lead advisory status (such as whether either advisor is arranging financing, acting as sole advisor, or sharing advisory duties with co-advisors) have not been detailed in the disclosed materials. No legal advisors have been identified in the source materials provided for this transaction, though legal representation on both sides would typically be standard in a transaction of this size and complexity. The transaction structure and consideration framework remain substantially undisclosed beyond the aggregate value. The $350 million disclosed value does not specify the composition of consideration, such as whether payment will be made in cash, stock, debt, or some combination thereof. No information regarding earnouts, contingent payments, working capital adjustments, or any other structural features of the purchase price has been disclosed. The target company's identity, the specific terms of the transaction, the expected closing date, the consideration structure and mix, financing arrangements for the acquirer, representations and warranties, conditions precedent, and any regulatory approvals required remain unknown or undisclosed. The filing provides only the announcement of the transaction and the headline purchase price without elaboration on the substantive deal terms or mechanics.

John Marshall Bancorp, Inc. (Nasdaq: JMSB), the parent company of John Marshall Bank, and Eagle Financial Services, Inc. (Nasdaq: EFSI), the parent company of Bank of Clarke, jointly announced on September 8, 2026 a definitive merger agreement under which EFSI will merge with and into John Marshall in an all-stock transaction. The deal was disclosed in Form 8-K filings by both companies that attached a joint press release and a joint investor presentation. Chris Bergstrom, President and CEO of John Marshall, said "Bank of Clarke has spent nearly a century and a half earning the trust of the Shenandoah Valley. Together we will have the scale to do more for our clients, more for our employees and more for the communities we serve, without giving up the local decision-making that has defined both of our banks." Brandon Lorey, President and CEO of EFSI, added, "At its core, this is about bringing together two organizations that think alike, serve customers the same way, and believe in the future of community banking. By combining our strengths, we're creating a stronger franchise with greater lending capacity, more opportunities for employees, and the scale to continue investing in our customers and communities for years to come." Under the terms of the agreement, each share of EFSI common stock will be converted into the right to receive 2.0 shares of John Marshall common stock, a fixed exchange ratio with no collar disclosed. Based on John Marshall's closing stock price of $23.36 on September 4, 2026, the implied consideration is $46.72 per EFSI share, representing an aggregate transaction value of approximately $252.8 million (rounded to $253 million) and a premium of approximately 11.5% to EFSI's September 4, 2026 closing price of $41.90. The investor presentation discloses implied multiples of 1.30 times EFSI's tangible book value and 11.5 times EFSI's 2027 estimated earnings per share (based on management estimates). The transaction is structured as 100% stock consideration; no cash component, contingent value right, or earn-out was disclosed. At closing, legacy John Marshall shareholders are expected to own approximately 56.6% of the combined company and legacy EFSI shareholders approximately 43.4%, assuming roughly 10.8 million new JMSB shares issued against 5,411,615 EFSI shares outstanding. The combined company, to be named John Marshall Bancorp, Inc. and headquartered in Reston, Virginia (with the banking subsidiary headquartered in Berryville, Virginia), is expected to have approximately $4.4 billion in assets, $3.7 billion in deposits, and $3.6 billion in loans across 23 banking offices, based on modeled figures as of a 12/31/2026 transaction close. The investor presentation describes expected cost savings equal to 15% of the combined company's annual noninterest expense base, with 75% phased in during 2027 and 100% realized thereafter. One-time pre-tax merger expenses are estimated at $24.0 million. Other purchase-accounting assumptions disclosed include a gross credit mark on EFSI loans held for investment of $19.0 million (1.2% of EFSI's total loans), a loan portfolio interest-rate write-down of $40.7 million accreted over 3 years, a $29.6 million core deposit intangible (2.50% of core deposits) amortized over 10 years, and a resulting goodwill of $56.7 million at close. On a pro forma basis, the companies disclosed approximately 14% tangible book value dilution at close (TBV per share dilution of $2.91, or 14.4%, taking pro forma TBV per share to $17.32 from JMSB's standalone $20.23), with an estimated TBV earnback period of approximately 3.1 years under the crossover method. Fully phased-in 2027 estimated EPS accretion is approximately 38%, assuming cost savings are fully realized. Pro forma 2027 estimated profitability metrics disclosed include approximately 1.6% ROAA, approximately 16.2% ROATCE, and an approximately 47% efficiency ratio, which the presentation compares favorably to top-quartile and median peer banks (12 exchange-traded banks headquartered in MD, DC, VA, NC, SC, TN, GA, and FL with $3-8 billion in assets). Estimated pro forma capital ratios at close are approximately 10.0% TCE/TA, approximately 12.2% CET1, and approximately 14.3% total risk-based capital. Following closing, John Marshall expects to raise its quarterly cash dividend to $0.155 per share, equivalent on a post-exchange basis to EFSI's current quarterly dividend of $0.31 per EFSI share. On the target side, Eagle Financial Services retained Piper Sandler & Co. as financial advisor, which delivered a fairness opinion to the EFSI board, and Troutman Pepper Locke LLP served as EFSI's legal counsel. On the acquirer side, John Marshall retained Keefe, Bruyette & Woods, A Stifel Company, as financial advisor, which delivered a fairness opinion to the John Marshall board, and Skadden, Arps, Slate, Meagher & Flom LLP served as John Marshall's legal counsel. The merger agreement (filed as Exhibit 2.1 to both companies' 8-Ks) specifies a termination fee of $10,100,000 payable by EFSI to John Marshall under specified termination circumstances, including a change in EFSI board recommendation or termination to accept a superior proposal. The merger agreement was unanimously approved by the John Marshall board and unanimously approved by all present directors of the EFSI board. Concurrently with signing, directors and certain executive officers of both EFSI and John Marshall entered into voting agreements committing to vote their shares in favor of the merger, subject to customary exceptions. The combined company's board will have 12 directors, split evenly 6-6 between legacy John Marshall and legacy EFSI designees; Christopher W. Bergstrom will serve as Executive Chairman and Brandon C. Lorey, current EFSI President and CEO, will become CEO of the combined company. The transaction is expected to close early in the first quarter of 2027, subject to approval by the shareholders of both John Marshall and EFSI and receipt of customary regulatory approvals. John Marshall will file a Form S-4 registration statement to register the shares to be issued, which will include a joint proxy statement/prospectus; this S-4 had not yet been identified as filed as of the date of this summary. No closing date, vote date, or regulatory approval has yet been disclosed as obtained, and the deal has not closed.

Indaptus Therapeutics, Inc., a healthcare company trading under ticker INDP on the Nasdaq Capital Market, has established an at-the-market (ATM) equity offering program for shares of its common stock with an aggregate offering price of up to $100,000,000. On August 28, 2026, the Company entered into an Amended and Restated At the Market Offering Agreement with H.C. Wainwright & Co., LLC, which amends, restates in its entirety, and supersedes the original At the Market Offering Agreement dated June 1, 2022 between the Company and Wainwright. The $100,000,000 maximum applies only to shares sold on or after the execution date of the new agreement; shares previously sold under the original 2022 agreement do not count toward the new limit. The Company filed a prospectus supplement dated August 31, 2026, together with an accompanying base prospectus dated August 20, 2025, as part of its shelf registration statement on Form S-3 (File No. 333-289573), which was declared effective on August 20, 2025. On September 4, 2026, the Company filed Amendment No. 1 to that prospectus supplement solely to correct a clerical error in the mathematical calculations in the dilution section; it states that as of September 4, 2026, no shares of common stock had yet been sold under the Offering Agreement. No subsequent SEC filing identified in this review discloses any shares having been sold under the ATM program since that date. Under the agreement, Wainwright acts as sales agent and/or principal and will use commercially reasonable efforts, consistent with its normal trading and sales practices, to sell shares into the Nasdaq Capital Market or another existing U.S. trading market at prevailing market prices, in negotiated transactions, or directly to Wainwright as principal, as the Company directs through sales notices specifying amount and minimum price. There is no minimum offering amount required to close the program, so the actual total amount sold, commissions, and proceeds are not determinable in advance. Settlement occurs on the second trading day following each sale through The Depository Trust Company. The Company will pay Wainwright a placement fee equal to 3.0% of the gross sales price of shares sold, and Wainwright is deemed an "underwriter" within the meaning of the Securities Act, with its compensation deemed underwriting commissions or discounts. The Company also agreed to reimburse Wainwright up to $50,000 for its legal counsel's fees related to the offering, plus up to $5,000 per quarterly bringdown and $3,500 per annual bringdown for ongoing diligence-related legal costs. The prospectus supplement states the Company intends to use net proceeds for working capital, general corporate purposes, and strategic initiatives, including potential acquisitions (none identified as of the filing), investments, and research collaborations, with management retaining broad discretion over allocation; no specific debt repayment or identified acquisition use is disclosed. For illustrative dilution purposes, the prospectus supplement (as corrected by Amendment No. 1) assumed a hypothetical full draw of $100,000,000 at $1.14 per share, the last reported Nasdaq closing price on August 26, 2026, implying approximately 87,719,298 shares if the entire program were sold at that single price (actual sales would occur at varying prices over time). Based on 133,242,324 shares outstanding as of June 30, 2026, a full illustrative draw at that assumed price would represent dilution of roughly 66% of pre-offering shares outstanding. As corrected, net tangible book value as of June 30, 2026 was approximately $11.4 million, or $0.09 per share; pro forma net tangible book value after a hypothetical full $100,000,000 draw at $1.14 per share was calculated at approximately $108.3 million, or $0.49 per share, representing an immediate increase of $0.40 per share to existing stockholders and immediate dilution of $0.65 per share to new investors in the illustrative scenario. (The original August 31, 2026 prospectus supplement had understated net tangible book value, pro forma figures, and per-share dilution due to a clerical calculation error later corrected in Amendment No. 1.) No greenshoe or over-allotment option applies to this program, as ATM offerings of this type do not use such mechanisms; sales occur incrementally over time rather than in a single underwritten tranche. McCarter & English, LLP served as legal counsel to Indaptus Therapeutics and issued an opinion, filed as Exhibit 5.1 to the Form 8-K, on the validity of the shares issuable under the Sales Agreement. Haynes and Boone, LLP, of New York, New York, served as counsel to Wainwright in connection with the offering, as disclosed in the "Legal Matters" section of the prospectus supplement. Separately, on September 8, 2026, Indaptus entered into a Stock Purchase Agreement for an unregistered private placement of 20,338,974 shares of common stock for aggregate gross proceeds of approximately $24.0 million, priced at the "Nasdaq Minimum Price" plus $0.015 per share; that transaction is distinct from, and not part of, the $100,000,000 ATM program described above and is not the subject of this deal record. Several details remain undisclosed: the actual number of shares sold or proceeds raised to date under the ATM program (none confirmed as of the most recent prospectus amendment on September 4, 2026), any specific pricing of individual ATM sales, and any expected timeline for drawing down the full $100,000,000. The nature of the "pending regulatory" status and any specific conditions to further draws are not specified in the filings reviewed.

Mandel Group, Inc., a Milwaukee-based real estate developer and asset manager, and Cottonwood Communities, Inc., a Salt Lake City-based, multifamily-focused, non-traded net asset value REIT, announced on September 4, 2026 a strategic merger in which Mandel agreed to merge a portion of its multifamily portfolio, specifically 13 Mandel-owned and operated properties valued at over $600 million, with Cottonwood's portfolio in exchange for units in the Cottonwood operating partnership and cash. Both companies will also merge their property management platforms, with the combined management company managing all Mandel assets, including those not part of this transaction. This entry is sourced from Cottonwood's Exhibit 99.1 press release filed as part of an 8-K on September 4, 2026. As of the release, membership interests in one property had already been acquired (at the end of July 2026), while the merger transactions for the remaining twelve properties were expected to be completed in the coming months, subject to lender approvals, approval by members of the property-owning entities, and other closing conditions. Additional information was filed in the underlying Form 8-K referenced in the release. Jones Lang LaSalle Securities, LLC is acting as financial advisor to Mandel on both the mergers of its multifamily portfolio and its property management platform. Robert A. Stanger & Co., Inc. is acting as financial advisor to the property-owning entities (the individual entities holding the 13 properties being contributed). DLA Piper LLP (US) is acting as legal counsel to Cottonwood. Proskauer Rose LLP and Foley & Lardner LLP are acting as legal counsel to the property-owning entities and Mandel jointly. The disclosed consideration is a mix of operating partnership units and cash for the contributed properties, valued at over $600 million in aggregate for the 13 properties; the release does not break out a cash/unit split percentage. Following completion of the transactions, Cottonwood will own $3.3 billion in assets, including 13,400 apartments across 16 states and 21 markets, and will provide property management for an additional 2,346 multifamily units beyond its owned portfolio. Mandel will continue operating independently, retaining ownership and asset management of approximately $900 million of assets not included in this transaction. The release does not disclose the specific cash-versus-unit allocation of consideration, a precise aggregate purchase price beyond the "over $600 million" valuation range, or the number of Cottonwood operating partnership units to be issued. Information regarding the merger agreements and the full transaction terms was stated to be included in Cottonwood's underlying Form 8-K filed the same day, which was not independently reviewed as part of this extraction. No fee arrangements for Jones Lang LaSalle Securities or Robert A. Stanger & Co. are disclosed.

Stanley Black & Decker, Inc. (NYSE: SWK) has agreed to sell its Excel Industries, LLC subsidiary, maker of the Hustler brand of professional-grade, gas-powered, ride-on and zero-turn mowers, to Bad Boy Mowers JV Acquisition, LLC. The parties signed an Equity and Asset Purchase Agreement dated September 1, 2026, under which Bad Boy Mowers will purchase Excel Industries, LLC and certain assets related to the Hustler brand name. The transaction was publicly announced on September 4, 2026 in a Form 8-K current report filed under Item 7.01 (Regulation FD Disclosure), which attached a joint press release as Exhibit 99.1. Excel is based in Hesston, Kansas and is expected to generate FY2026 revenue of approximately $300 million. Stanley Black & Decker's President and CEO, Chris Nelson, said "the sale of Excel further refines our portfolio and unlocks greater shareholder value by concentrating resources on the areas where we see the most compelling opportunities to grow and win," adding that the company remains committed to growing its Outdoor business through brands including Cub Cadet, Dewalt, Craftsman, Troy-Bilt and Black+Decker, and that it is "excited about the high-growth opportunities presented in electric outdoor products." Bill Beck, President of Tools & Outdoor at Stanley Black & Decker, said the Outdoor business and brands "remain a strong asset, with meaningful value and opportunity ahead," and thanked the Excel team for building momentum that leaves the business "well positioned for the future." Peter Ballantyne, CEO of Bad Boy Mowers, said the company is "excited to welcome Hustler and its talented team to the Bad Boy family" and has "tremendous respect for the business and the team that has built it over many decades." No purchase price or valuation multiple has been disclosed in the public filing. Stanley Black & Decker stated that it does not expect the transaction to be dilutive to adjusted earnings per share, but no further detail on financing structure, cash versus any other consideration, or specific EPS impact in dollar or percentage terms has been disclosed. Until closing, Excel's results will remain in Stanley Black & Decker's continuing operations and will not be reclassified as discontinued operations, per the press release. BofA Securities, Inc. is acting as financial advisor to Stanley Black & Decker, and Cravath, Swaine & Moore LLP is acting as external legal counsel to Stanley Black & Decker, both per the press release. No financial or legal advisor to Bad Boy Mowers has been identified in the filing. The transaction is subject to receipt of required regulatory approvals and other customary closing conditions, per the 8-K and press release. No expected closing date, termination fee, or other transaction terms have been disclosed. A search of SEC EDGAR for subsequent filings by Stanley Black & Decker (including its most recent Form 10-Q, filed July 29, 2026, which predates this announcement, and EDGAR full-text search through October 19, 2026) found no purchase agreement exhibit, investor presentation, closing 8-K, or other filing disclosing additional deal terms; the September 4, 2026 Form 8-K and its Exhibit 99.1 press release remain the only public filings describing this transaction as of this writing.

Hawthorn Bancshares, Inc. (NASDAQ: HWBK), the Jefferson City, Missouri-based holding company for Hawthorn Bank, agreed to acquire FSC Bancshares, Inc. ("FBI"), the holding company for Farmers State Bank of Cameron, Missouri, in a cash-and-stock transaction. The deal was announced on April 29, 2026, when the companies signed an Agreement and Plan of Reorganization, and the merger closed on September 3, 2026. Hawthorn disclosed the transaction's aggregate value as approximately $28.3 million, based on its April 28, 2026 closing stock price of $34.57 per share. Under the terms of the agreement, each share of FBI common stock was converted into the right to receive a pro rata share of $14.0 million in cash and 413,101 shares of HBI common stock in the aggregate, together worth approximately $147.69 per FBI share as calculated by FBI's financial advisor at signing. FBI's financial advisor, Olsen Palmer LLC, calculated implied transaction multiples of 1.35 times FBI's tangible book value as of March 31, 2026, 9.0 times FBI's last-twelve-months net income, and 2.2% of FBI's core deposits as of March 31, 2026. The cash portion was subject to downward adjustment if FBI's closing tangible common equity, as defined in the agreement, fell below $19.0 million. The letter of intent signed August 25, 2025 had originally contemplated a consideration mix of between 45% and 55% cash and the remainder in HBI stock. Hawthorn stated in its April 29, 2026 announcement that the transaction was expected to be accretive to its earnings per share by approximately 20% on a fully phased-in basis, with tangible book value dilution at closing of approximately 9.8%, earned back in approximately 3.0 years using the crossover method. On a combined basis, using financial data as of March 31, 2026, the companies expected total assets of approximately $2.2 billion, total loans of approximately $1.7 billion, and total deposits of approximately $1.9 billion. The acquisition added approximately $384 million in total assets and nine branch locations across Farmers State Bank's northern Missouri footprint. No specific dollar amount or percentage figure for cost synergies was disclosed; HBI's board cited "the expectation of cost synergies resulting from the merger" among its reasons for approving the deal without quantifying the figure, according to the joint proxy statement/prospectus on Form S-4. "We are pleased to partner with Farmers State Bank as we continue to execute on our strategy of disciplined growth," said Brent Giles, Chief Executive Officer of Hawthorn, in the April 29, 2026 announcement. "Farmers has developed strong customer relationships and a respected community presence that align closely with Hawthorn's values. This proposed transaction expands our footprint in Northwest Missouri and positions us to deliver an expanded range of products and services while maintaining the personalized service that customers expect from a community bank." Michael Poland, President of FSC, added that the deal "represents a compelling opportunity for our customers, employees, and communities" and would allow FSC to "offer broader capabilities, enhanced technology, and additional financial solutions while preserving the local decision-making and service culture our customers value." According to the background-of-the-merger section of the Form S-4 registration statement, FBI's board began exploring a sale or merger in early 2025 and engaged Northland Capital Markets (then The Capital Corp., n/k/a Northland Securities) as exclusive financial advisor in June 2025. Northland contacted twelve potential merger partners, seven of which, including HBI, signed confidentiality agreements. On July 11, 2025, Northland received two written indications of interest, one from HBI and one from an unnamed competing bidder referred to as "Bank A." FBI's board determined HBI's combined cash-and-stock offer was superior to Bank A's all-cash offer because it represented greater total value and gave FBI shareholders a public-market liquidity option through HBI stock. The parties signed a non-binding letter of intent on August 25, 2025, and the definitive merger agreement on April 29, 2026. The merger agreement provided for a termination fee of $1,120,000 payable by FBI under certain circumstances, and for termination by either party if the merger did not close by January 31, 2027, subject to extension. Closing was conditioned on, among other things, approval by FBI shareholders, Nasdaq listing of the HBI shares to be issued, receipt of required regulatory approvals, and effectiveness of HBI's Form S-4 registration statement. FBI held its special shareholder meeting on September 1, 2026 at Farmers State Bank's Cameron, Missouri offices to vote on the merger. The transaction was structured as a two-step merger (FBI into a Hawthorn merger subsidiary, then into HBI) followed by a merger of Farmers State Bank into Hawthorn Bank, and was intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. Raymond James & Associates, Inc. served as financial advisor to Hawthorn Bancshares, and Hunton Andrews Kurth LLP served as its legal counsel. Northland Capital Markets served as financial advisor to FSC Bancshares, and Stinson LLP served as its legal counsel. Olsen Palmer LLC rendered the fairness opinion to FSC's board. Hawthorn announced completion of the merger on September 4, 2026, confirming the mergers became effective September 3, 2026, and that Farmers State Bank's customer conversion onto Hawthorn's platform was expected during the first quarter of 2027. Following the closing, Hawthorn Bank operates twenty-seven banking locations across northern, central, western and mid-Missouri, plus one location in Kansas, with the combined company's total assets at approximately $2.2 billion.

Hawthorn Bancshares, Inc. (NASDAQ: HWBK), the Missouri-based holding company of Hawthorn Bank, announced on September 4, 2026 the completion of its merger with FSC Bancshares, Inc., the holding company of Farmers State Bank in Cameron, Missouri. FSC merged with and into Hawthorn, with Hawthorn continuing as the surviving corporation, and Farmers State Bank merged with and into Hawthorn Bank, with Hawthorn Bank continuing as the surviving bank. The mergers became effective on September 3, 2026, bringing the combined company's total assets to approximately $2.2 billion. This record is sourced from Hawthorn's own 8-K press release (Exhibit 99.1), furnished to the SEC on September 4, 2026, which announces the closing of a transaction rather than its original signing; the release does not restate the original deal value or consideration terms from when the merger agreement was first announced, so those figures are not available from this document. Raymond James & Associates, Inc. served as financial advisor to Hawthorn Bancshares on the acquirer side. Northland Capital Markets served as financial advisor to FSC Bancshares on the target side, and Olsen Palmer LLC separately rendered a fairness opinion to FSC in connection with the transaction. Hunton Andrews Kurth LLP served as legal counsel to Hawthorn Bancshares. Stinson LLP served as legal counsel to FSC Bancshares. Beyond confirming that the merger has closed, the press release does not restate deal economics; it notes only that Hawthorn Bank will begin integrating Farmers State Bank into its platform, with customer conversion anticipated in the first quarter of 2027, and that the combined bank will operate twenty-seven banking locations across northern, central, western, and mid-Missouri, plus one location in Kansas. Not disclosed in this filing: the aggregate transaction value or per-share consideration, the cash/stock mix, the original announcement date and terms of the merger agreement, and any termination fee or financing details.

Intellia Therapeutics, Inc., a healthcare company trading under ticker NTLA, entered into a Credit Agreement on September 4, 2026 (the Closing Date) establishing a five-year senior secured credit facility of up to $400 million. The lenders are OrbiMed Royalty & Credit Opportunities IV, LP and OrbiMed Royalty & Credit Opportunities V, LP, with OrbiMed Royalty & Credit Opportunities V, LP acting as administrative agent. The facility was disclosed in a Form 8-K (Items 1.01, 2.03, 7.01 and 9.01) filed with the SEC on September 4, 2026, which included a press release as Exhibit 99.1. The facility is structured in multiple tranches rather than as a single draw. It includes an initial term loan of $75 million funded at closing; a potential additional $75 million draw at Intellia's option upon FDA approval of its biologics license application (BLA) for lonvoguran ziclumeran (lonvo-z) prior to a certain date; three potential additional $40 million draws at Intellia's option upon achieving certain revenue targets for lonvo-z prior to certain dates (totaling up to $120 million, consistent with the press release's reference to additional tranches totaling up to $225 million tied to the FDA-approval and revenue milestones); a potential additional $30 million draw at Intellia's option upon achieving an equity fundraising target prior to a certain date; and an uncommitted additional incremental facility of up to $100 million subject to mutual agreement among Intellia and the lenders. The press release additionally characterizes the facility as non-dilutive. The Credit Facility matures on September 4, 2031. Loans bear interest, payable monthly, at a rate per annum equal to the greater of (a) 3.00% or (b) the one-month SOFR rate applicable to the period, plus an applicable margin of 6.15%. Intellia is also required to pay customary commitment, administrative, undrawn amount and facility fees. Intellia may prepay amounts owed prior to the maturity date subject to a repayment premium or exit fee, as applicable, plus accrued interest on amounts repaid or prepaid; the facility is also subject to customary mandatory prepayments from proceeds of indebtedness and certain asset sales and casualty events. The 8-K does not specify the exact dollar amount or percentage of the repayment premium or exit fee. Proceeds of the Credit Facility are to be used for Intellia's working capital needs and general corporate purposes. The 8-K does not disclose that this facility refinances any prior specific credit facility; no prior facility is named. All obligations under the Credit Agreement are secured on a first-priority basis, subject to certain exceptions, by security interests in substantially all of Intellia's assets, including its intellectual property. The Credit Agreement is not covenant-lite: it contains customary financial covenants, including a requirement to maintain liquidity of at least $50 million in controlled accounts until FDA approval of the lonvo-z BLA, and, thereafter, a requirement to either achieve certain revenue targets, maintain certain market capitalization thresholds, or maintain outstanding loan principal in cash equivalents in controlled accounts. It also contains negative covenants that, subject to certain exceptions, restrict Intellia's ability to incur additional indebtedness, grant liens, make investments (including acquisitions), effect mergers or consolidations, engage in asset sales and licensing transactions, pay dividends, terminate or modify certain material agreements, and pay subordinated indebtedness, among other customary restrictions. Exceptions to the indebtedness and lien covenants permit Intellia to enter into synthetic royalty transactions, subject to certain restrictions in the Credit Agreement. The Credit Agreement contains customary events of default, including payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against Intellia and its subsidiaries, and change of control. TD Cowen acted as exclusive financial advisor to Intellia on the transaction. Goodwin Procter LLP acted as legal advisor to Intellia. Covington & Burling LLP acted as legal advisor to OrbiMed, confirming OrbiMed as the lender/creditor side of the transaction (via its affiliated funds OrbiMed Royalty & Credit Opportunities IV, LP and V, LP, the latter also serving as administrative agent). The 8-K states that the full Credit Agreement itself had not yet been filed as of the September 4, 2026 report; Intellia disclosed that it will be filed as an exhibit to its Quarterly Report on Form 10-Q for the quarter ending September 30, 2026. As of this update, that 10-Q has not yet been filed with the SEC (the most recent 10-Q on file is for the quarter ended June 30, 2026, filed August 6, 2026), so the complete text of the Credit Agreement, including the precise pricing grid (if any), full definitions of the revenue/market-cap thresholds, and the exact repayment premium or exit fee schedule, remains undisclosed. The deal status remains announced; no closing, draw, or termination beyond the initial $75 million funded at the Closing Date has been confirmed in subsequent filings.

Cottonwood Communities, Inc. ("CWREIT" or "Cottonwood"), a Salt Lake City-based, non-traded, NAV-based perpetual-life multifamily REIT, has agreed to merge a portfolio of multifamily properties owned by entities controlled by Barry R. Mandel and his affiliates (the "Mandel Parties," together with Mandel Group, Inc., "Mandel") into Cottonwood's operating partnership, Cottonwood Residential O.P., LP ("CROP"). The transaction was announced via a joint press release and investor presentation filed as exhibits to a Form 8-K dated September 4, 2026 (reporting events as of September 2, 2026, when the merger agreements were signed). Barry Mandel, chairman and CEO of Mandel, said the transaction "brings together two organizations with complementary cultures and core values and a shared commitment to acquiring, developing and managing exceptional multifamily communities," adding that combining the portfolio and management operations with Cottonwood creates "a platform with greater scale, enhanced operational capabilities and geographic diversity in high-growth metropolitan markets." Daniel Shaeffer, CEO of Cottonwood, said the partnership "accomplishes our objective of growth and expansion in the best possible way," noting the transaction "not only adds high-quality properties to the combined portfolio but also brings many talented and well-trained people to our team." The transaction involves 13 Mandel-owned multifamily properties with a transaction value described in the press release as "over $600 million" and specified in the investor presentation as approximately $614 million. One of the 13 properties, Park Lafayette Towers in Milwaukee (271 units), was already acquired by Cottonwood on July 31, 2026, primarily using 1031 exchange proceeds. The remaining 12 properties are subject to separate merger agreements that are cross-conditioned on a threshold number of the mergers closing, and remain subject to member approval of the property-owning entities and lender consent. Separately, Mandel's property management platform will merge with Cottonwood's, with the combined company managing all Mandel assets, including an additional approximately $700 million of Mandel assets that will continue to be owned by Mandel (not acquired) but managed by Cottonwood on a third-party basis; Cottonwood estimates this will generate roughly $2.1 million in fee income. Following the transactions, Mandel will continue to operate independently, retaining ownership and asset management of approximately $900 million of assets and pursuing new development opportunities, and Barry Mandel will join Cottonwood's advisory board. Consideration for the portfolio mergers will consist of assumed in-place mortgage debt, new financing on three of the assets, and equity consideration paid at least 50% in CROP common limited partnership interests ("CROP Units") and up to 50% in cash. Excluding Park Lafayette, Barry Mandel and Mandel Group-affiliated entities will receive at least 50% of their merger consideration in CROP Units. Cash consideration, to the extent required, is expected to be financed with new loan proceeds and capacity under a new NAV-based lending facility; Cottonwood disclosed it has agreed to a term sheet with a global financial institution for a $250 million NAV lending facility intended to close alongside the mergers. Each merger agreement also provides that cash and CROP Units equal to 1.5% of the merger consideration will be held back to secure post-closing purchase-price adjustments and seller indemnification obligations; a portion of this holdback will go into escrow and a portion will be "restricted units" subject to clawback by CROP, with any remaining balance released to the Owner Entities one year after closing, subject to pending claims. On October 15, 2026, Cottonwood and the Mandel Parties amended the merger agreements, as disclosed in a subsequent Form 8-K, to correct a scrivener's error so that the 1.5% escrow amount is calculated inclusive of debt to be assumed or repaid out of the purchase price. According to the investor presentation, the combined company is expected to hold $3.3 billion in total gross asset value (up roughly 23%) across 61 multifamily assets in 16 states, totaling approximately 13,400 units, versus Cottonwood's standalone $2.7 billion GAV and 48 assets/11,141 units as of June 30, 2026. Total net asset value is expected to rise to approximately $1.2 billion (up roughly 10%), reflecting the minimum 50% CROP Unit issuance. Secured debt-to-GAV is expected to be approximately 62.8% for the combined company versus 59.3% for Cottonwood standalone and 58.9% for the Mandel portfolio, while total debt-plus-preferred-equity-to-GAV is expected to be approximately 52.9% combined versus 50.3% for Cottonwood standalone. The Mandel portfolio has a reported average unit age of 2013 (CWREIT's standalone portfolio averages 2001) and average occupancy of 96.4% versus Cottonwood's 92.2% standalone. The presentation states that "pro forma estimates suggest funds from operations (FFO) accretion day one," and cites inherent synergies including leveraging Cottonwood's existing overhead base to enhance NOI margins and eliminating duplicative IT, audit, tax and legal costs from integrating the Mandel platform; no specific dollar synergy figure or phase-in timeline was disclosed. The deal is also expected to raise Midwest NOI concentration to approximately 31% by adding assets in Wisconsin, Minnesota and Iowa. On financial advisors, Jones Lang LaSalle Securities, LLC is acting as financial advisor to Mandel on both the property portfolio mergers and the property management platform merger, while Robert A. Stanger & Co., Inc. is acting as financial advisor to the property-owning entities. On legal advisors, the press release discloses that DLA Piper LLP (US) is acting as legal counsel to Cottonwood, while Proskauer Rose LLP and Foley & Lardner LLP are acting as legal counsel to the property-owning entities and Mandel. In a separate but related disclosure, Cottonwood reported in an October 16, 2026 Form 8-K that CROP, as borrower, together with guarantor subsidiaries Cottonwood Communities GP Subsidiary, LLC, CC RSP Manager, LLC and Cottonwood Capital Management, Inc., entered into a loan agreement on October 16, 2026 with JPMorgan Chase Bank, N.A. providing for a term loan with an initial principal amount of $75,000,000 (of which $38,000,000 was funded at closing, with the facility expandable to $150,000,000 at the lender's discretion) plus revolving credit commitments of up to $100,000,000, together the "Credit Facility." Proceeds are to be used to finance an acquisition and pay related fees and expenses, as well as to pay down $25,400,000 of an outstanding loan. The Credit Facility bears interest at Term SOFR plus 3.35% per annum, matures October 16, 2029 (extendable up to two additional twelve-month terms at the lender's discretion), and is secured by pledges of certain ownership interests in indirect subsidiaries; it requires CROP to maintain a minimum NAV of $750,000,000 along with debt yield, fixed charge coverage and pledge coverage ratios. The 8-K does not explicitly state that this credit facility is the Mandel-transaction financing referenced in the investor presentation, though the timing and stated use of proceeds for "an acquisition" are consistent with funding the cash portion of the merger consideration; this link is not confirmed in the filing text itself. The transaction had not closed as of the most recent filings. As of the October 16, 2026 8-K, 12 of the 13 property mergers remained subject to member approval of the property-owning entities and lender consent, with only Park Lafayette already closed (July 31, 2026). The investor presentation's estimated timeline anticipated definitive agreements signed September 2, 2026, asset-level member consents and lender approvals occurring October through December 2026, and transaction closings estimated in the fourth quarter of 2026. No closing 8-K, termination fee amount, or specific regulatory approval requirement beyond member/lender consents has been disclosed. The property-owning entities' approval process will proceed through a private placement memorandum and consent solicitation to be distributed to their members, rather than a public shareholder vote, consistent with the non-public nature of the Mandel-controlled Owner Entities.

USA Rare Earth, Inc., a natural resources company trading under ticker USAR on Nasdaq, acquired Serra Verde Group, the owner of the Pela Ema rare earth mine and processing plant in Goias, Brazil, in a cash-and-stock merger. The deal was announced on April 20, 2026 and closed on September 3, 2026, after USAR stockholders approved the related share issuance at a special meeting on August 28, 2026. This is a correction to the deal's prior classification as all-stock and pending: the transaction included a cash component and has closed. Under the Agreement and Plan of Merger dated April 19, 2026 (as amended by Amendment No. 1 dated July 16, 2026 and Amendment No. 2 dated September 3, 2026), the aggregate merger consideration consisted of $300,000,000 in cash and 126,849,307 newly issued shares of USAR common stock. Based on USAR's closing share price of $19.95 on April 17, 2026, the companies announced the deal implied an equity value for Serra Verde of approximately $2.8 billion (stated more precisely in the proxy statement as an Implied Equity Value Purchase Price of $2,831 million). USAR's financial advisor, Moelis & Company LLC, performed a discounted cash flow analysis of Serra Verde using discount rates of 11.25% to 14.25%, yielding an implied enterprise value range of $3,527 million to $4,335 million and an implied equity value range of $3,413 million to $4,220 million, which Moelis compared to the $2,831 million purchase price. Moelis also ran a sum-of-the-parts DCF on USAR itself (separating its Mining and Processing business from its Metal and Magnet Making business, the latter using a terminal TEV/EBITDA multiple range of 8.0x to 11.0x informed by MP Materials' and Lynas Rare Earths' 2030E EBITDA multiples), producing an implied USAR equity value range of $3,793 million to $5,771 million, or $15.24 to $22.74 per share, versus USAR's then-market equity value of approximately $5.0 billion. At closing, USAR issued 126,849,307 new shares to Serra Verde's shareholders and other recipients (including the U.S. International Development Finance Corporation, or DFC, in respect of cancelled warrants, OMF Fund III (F) Ltd., and certain SVRE employees and consultants), resulting in an implied pro forma USAR retained ownership of 66.3% for existing USAR shareholders, per the proxy statement's disclosure. The new shares were issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act and Regulation S. In connection with closing, USAR entered into a Registration Rights Agreement obligating it to file a resale shelf registration statement on the first business day after closing, and the recipients of merger shares signed lock-up agreements under which one-third of shares are unrestricted at closing, one-third are locked up for 90 days, and one-third are locked up for 180 days. As part of the transaction, Merger Sub assumed SVRE's existing Finance Agreement with the DFC (as amended, the Retained Finance Agreement), providing for up to $565,000,000 of debt consisting of a $465,000,000 Initial Loan and a $100,000,000 Incremental Loan. The Initial Loan bears interest at Term SOFR (0.00% floor) plus 4.0%, has a term of up to 15 years, and is repayable in up to 49 quarterly installments, secured by a first-priority lien on substantially all assets of Merger Sub and its subsidiaries. The Incremental Loan, which had been funded before closing, was extinguished at closing when the associated DFC warrants were cancelled and converted into merger consideration. Strategic rationale, as stated in the April 20, 2026 announcement: Barbara Humpton, then USAR's CEO, said the acquisition "represents a transformational step in delivering on our ambition to build a global champion and the partner of choice in rare earth elements, oxides, metals and magnets," noting Serra Verde's Pela Ema mine is "the only producer outside Asia capable of supplying all four magnetic rare earths at scale." Thras Moraitis, then Serra Verde's CEO, said "joining forces with USA Rare Earth accelerates the realization of our shared vision: establishing a secure, diversified global rare earth supply chain." The companies disclosed that Serra Verde was expected to achieve annualized run-rate EBITDA of $550 million to $650 million by the end of 2027 (based on roughly 4,400 metric tons per year of total rare earth oxide production after lanthanum removal, at an illustrative average basket price of approximately $190/kg), and that the combined company was expected to generate approximately $1.8 billion of annualized EBITDA by the end of 2030 with approximately 80% cash flow conversion, with pro forma liquidity of more than $3.2 billion including committed and milestone-based DFC and U.S. Department of Commerce facilities. These are company projections rather than audited results. As part of the transaction's governance terms, Sir Mick Davis (Serra Verde's Chairman and former Xstrata plc CEO) and Thras Moraitis (Serra Verde's CEO) joined the USAR board at closing; Moraitis was named President of USAR through October 1, 2026, at which point he succeeded Humpton as CEO. VB (Rare Earths) Limited, an affiliate of Vision Blue Resources, also received a contractual right under a Board Appointment Agreement to designate one USAR director for so long as it holds at least 5% of USAR's outstanding common stock. On the advisory side, Moelis & Company LLC acted as exclusive financial advisor and Latham & Watkins LLP as legal counsel to USA Rare Earth. Goldman Sachs & Co. LLC acted as exclusive financial advisor and White & Case LLP as legal counsel to Serra Verde. Allen Overy Shearman Sterling US LLP acted as legal counsel to the shareholders of Serra Verde. Moelis delivered a written fairness opinion dated April 19, 2026 to the USAR board concluding the merger consideration was fair to USAR from a financial point of view. The merger agreement provided for a bifurcated termination fee payable by USAR to Serra Verde if USAR stockholders failed to approve the share issuance: $75,000,000 if the USAR board had made an adverse recommendation change prior to termination, or $25,000,000 if it had not. Closing conditions included HSR Act antitrust clearance, USAR stockholder approval of the share issuance under Nasdaq listing rules, receipt of SVRE shareholder written consent, and various third-party consents under SVRE's and USAR's existing financing arrangements, among other customary conditions, with an agreed End Date of December 31, 2026. Stockholders holding approximately 8% of USAR's outstanding shares signed Voting and Support Agreements to vote in favor of the share issuance. At USAR's August 28, 2026 special meeting, the share issuance proposal passed with 108,248,297 votes for, 1,403,269 against, and 16,879,393 abstentions. According to the DEFM14A's background section, the transaction originated as a proposed minority investment: USAR's initial October 2025 letter of intent contemplated acquiring 49.9% of Serra Verde for $998.0 million in USAR stock, which was revised in November 2025 to $1.2475 billion (split between $247.5 million cash and $1.0 billion of stock), before the parties agreed in March 2026 to a full acquisition structure at $2.5 billion (later increased to $2.6 billion to reflect conversion of the Incremental Loan into equity, and ultimately to the final $2,831 million figure). The disclosed negotiation history does not reference any other bidders or competing offers for Serra Verde; the process appears to have been conducted bilaterally between USAR and Serra Verde's shareholder representatives. The acquisition closed on September 3, 2026, and USAR issued a press release announcing the closing on September 4, 2026. Because the transaction has closed, this deal's status should be updated from pending-regulatory to closed.

G-III Apparel Group, Ltd. (NasdaqGS: GIII), a Delaware corporation in the consumer-retail sector, and WHP Global jointly acquired the Marc Jacobs business from LVMH Moet Hennessy Louis Vuitton Inc. and its affiliates. The transaction was signed on May 14, 2026 and disclosed in a Form 8-K filed that day, and it closed on September 1, 2026, as confirmed in a subsequent Form 8-K filed September 2, 2026. Morris Goldfarb, G-III's Chairman and Chief Executive Officer, said at signing that "Marc Jacobs is one of the most influential names in fashion. This transaction underscores our long-standing commitment to building a diversified portfolio of iconic, globally relevant brands," adding that the deal "accelerates our transformation efforts and positions us to drive long-term shareholder value." At closing, Yehuda Shmidman, Founder, Chairman and CEO of WHP Global, said Marc Jacobs is "a defining name in fashion, with powerful cultural relevance and global growth potential," and thanked LVMH "for its stewardship of this brand over nearly three decades." Goldfarb called the closing "an exciting new chapter for Marc Jacobs" and said G-III "brings the scale and expertise to build and grow global brands." The transaction was structured in three linked steps. First, MJ Topco, LLC ("IPCo"), a newly formed 50/50 joint venture between a G-III subsidiary and an affiliate of WHP Global, acquired all outstanding units of Marc Jacobs Holdings, LLC through a wholly owned indirect subsidiary, Majestic AcqCo, LLC ("Purchaser"), pursuant to a Unit Purchase Agreement dated May 14, 2026. Second, immediately following that closing and a related pre-closing restructuring, G-III Leather Fashions, Inc., a G-III subsidiary, purchased the Marc Jacobs operating business (excluding the Marc Jacobs intellectual property, certain employment agreements, and certain retained assets and liabilities in China and Japan) from IPCo pursuant to an Equity Purchase and Distribution Agreement, also dated May 14, 2026. Third, IPCo retained the Marc Jacobs intellectual property and licensed it exclusively to G-III subsidiaries (G-III Leather Fashions, Inc. and G-III Apparel Canada, ULC) under a long-term License Agreement covering the United States, Canada, Mexico and Western Europe, with an initial term running from closing through December 2041 and automatic 5-year renewals. WHP Global leads the IPCo joint venture, including global brand licensing outside the licensed territories, while G-III owns and leads the Marc Jacobs operating business (wholesale, retail and e-commerce) and provides support services to the JV. G-III Investments, Inc. and WHP's MJWHP, LLC each hold 50% of IPCo's membership units under an Amended and Restated Operating Agreement, with a five-manager board split two G-III appointees and three WHP appointees, subject to change based on relative ownership. Marc Jacobs, the brand's founder, continues as Founder and Creative Director. G-III disclosed that it funded its approximately $500 million investment in the transaction using cash on hand and borrowings under its revolving credit facility. No aggregate purchase price for the overall Marc Jacobs transaction (i.e., LVMH's total proceeds, or WHP Global's share of the investment) was disclosed in the filings reviewed, nor was any EV/EBITDA or other valuation multiple. Morgan Stanley Senior Funding, Inc. provided committed debt financing to support the acquisition, though the amount and terms of that financing were not disclosed. G-III stated the transaction is expected to be dilutive to earnings during the first 12 months after closing, with accretion expected thereafter; this guidance was reiterated in G-III's September 2, 2026 second-quarter fiscal 2027 earnings release, which separately noted the company's outlook for fiscal 2027 excludes any impact from the Marc Jacobs acquisition pending more specific guidance at third-quarter results. No dollar synergy targets, phase-in timeline, or pro forma combined financial statements were disclosed. G-III did disclose a long-term ambition for the Marc Jacobs business, stating it "targets $1 billion in long-term annual revenue." UBS served as financial advisor to G-III, and Paul, Weiss, Rifkind, Wharton & Garrison served as legal advisor to G-III. Morgan Stanley & Co. LLC served as financial advisor to WHP Global, and Gibson Dunn served as legal advisor to WHP Global. Barack Ferrazzano served as legal advisor to LVMH, the seller. This corrects the prior thin summary, which had stated that both Morgan Stanley and UBS were lead financial advisors to G-III; the filings show Morgan Stanley advised WHP Global, G-III's joint-venture partner, not G-III itself. The Unit Purchase Agreement closing was subject to customary conditions, including accuracy of representations and warranties, absence of legal prohibitions, and receipt of required antitrust approvals; IPCo also obtained a buy-side representation and warranty insurance policy. The agreement allowed termination by mutual consent, by either party if closing had not occurred within six months of signing (extendable by 60 days in certain circumstances to obtain antitrust approvals), by either party for the other's uncured material breach, or if a final legal prohibition prevented consummation; no reverse termination fee applied. The agreement was governed by New York law with confidential JAMS arbitration and specific performance available to compel closing. The deal closed within this timeframe, on September 1, 2026, roughly three and a half months after signing, well within the six-month outside date and in line with G-III's original expectation of closing in its fiscal third quarter of 2027.

Vertiv Holdings Co, trading under ticker VRT, announced on September 2, 2026 that its wholly-owned subsidiary Vertiv Corporation has entered into an agreement and plan of merger to acquire Utility Innovation Holdings, Inc., which operates as UtilityInnovation Group (UIG), a privately held provider of microgrid controls, onsite generation and energy storage orchestration, and behind-the-meter power architecture for data centers. The acquisition will be effected through a merger of Vultra Merger Sub, Inc., a wholly-owned subsidiary of Vertiv Corporation, with and into UIG, with UIG surviving as an indirect wholly-owned subsidiary of Vertiv Holdings Co. The transaction was disclosed in a Form 8-K filed with the SEC that attached both the Agreement and Plan of Merger (Exhibit 2.1) and a press release (Exhibit 99.1). Under the terms of the agreement, UIG's stockholders and other equity holders will receive approximately $1.45 billion in cash at closing, subject to customary adjustments for working capital, indebtedness and transaction expenses, plus additional potential cash consideration of up to $1.15 billion, payable in two tranches if earned. The merger agreement structures this contingent consideration as a 2027 Earnout Amount and a 2028 Earnout Amount, each capped at $575,000,000, tied to UIG's Adjusted EBITDA performance over defined earnout periods running from October 1, 2026 through September 30, 2027 and September 30, 2028, respectively, measured against EBITDA targets set in a schedule to the agreement. Under the formula for both tranches, if Adjusted EBITDA for the applicable period comes in below 50 percent of that period's EBITDA target, the corresponding earnout amount is reduced to zero. At the approximately $1.45 billion upfront purchase price, Vertiv said the acquisition represents approximately 13 times UIG's expected 2027 EBITDA, a multiple the company said is anticipated to be significantly lower if the full earnout is paid. Vertiv stated it expects to fund the acquisition from existing resources, and no new debt issuance or stock consideration has been disclosed in connection with the deal. Vertiv said it expects the acquisition to be accretive to adjusted earnings per share in the first year following completion; no specific EPS accretion figure, leverage impact, or pro forma combined financial metrics were disclosed. Strategically, Vertiv said the deal is intended to extend its power and cooling portfolio upstream to the grid interconnect, adding microgrid controls, onsite generation and energy storage orchestration, and behind-the-meter power architecture to help data center operators secure power faster amid growing grid constraints on AI infrastructure deployment. Vertiv CEO Gio Albertazzi said, "For AI data center operators, competitive advantage increasingly depends on how quickly they can move from site selection to first token. Vertiv has the most complete power and cooling portfolio in the industry. With UIG, we anticipate extending that portfolio upstream to the utility interconnect and onsite power sources, creating a coordinated architecture from source to chip without tying customers to a single generation technology or supplier." He added that the combination is expected to help the companies "support grid-connected sites, bridge-to-grid deployments and islanded sites supplied by onsite generation, while reducing complexity from site planning through rack-level deployment." UIG Founder and CEO Sidney Hinton, who also serves as the Seller Representative under the merger agreement, said UIG "was founded to solve increasingly complex power challenges for data center operators through flexible, technology-agnostic architectures," and that "Vertiv's global scale, critical infrastructure portfolio and service capabilities make it a strong strategic fit for what we have built." UIG was founded in 2020 and is headquartered in Raleigh, North Carolina, with a European headquarters in Dublin, Ireland, and manufacturing operations in North Carolina and New Jersey. Per the press release, the company's technology includes a proprietary controls platform and pre-engineered microgrid switchgear designed to orchestrate multiple power sources in real time, with pre-validated reference designs for grid-connected, bridge-to-grid and islanded sites across the United States and Europe. J.P. Morgan Securities LLC is acting as financial advisor to Vertiv, and Buchanan Ingersoll & Rooney PC is serving as its legal counsel. Morgan Stanley & Co. LLC is acting as financial advisor to UIG, and Davis Polk & Wardwell LLP is serving as its legal counsel. The transaction has not yet closed. It is subject to regulatory approvals and customary closing conditions, including expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and is expected to close in the fourth quarter of 2026. The merger agreement sets an Outside Date (termination deadline) of 120 calendar days after the September 1, 2026 signing date, automatically extended to 210 days if all conditions other than regulatory-approval-related conditions have been satisfied or waived by that date. No termination fee provision was identified in the portions of the merger agreement reviewed. No closing 8-K, vote-result filing, or pro forma financial statements have been filed as of this update.

Comstock Resources, Inc. (NYSE and NYSE Texas: CRK), a Frisco, Texas-based independent natural gas producer focused on the Haynesville shale, announced on September 1, 2026 that it has entered into a letter of intent with the State Oil Company of the Azerbaijan Republic (SOCAR) under which SOCAR or a wholly owned subsidiary would acquire a 20% non-operated working interest in Comstock's Legacy Haynesville upstream assets, a 15% non-operated working interest in its Western Haynesville upstream assets (reducing to 7.5% after SOCAR achieves a 15% return on investment), and 15% of Comstock's 73% ownership interest in Pinnacle Gas Services LLC, for an aggregate purchase price of $1.65 billion in cash. The same release separately announced a $450 million Haynesville shale drilling venture with Jerry Jones, Comstock's majority stockholder. This entry is sourced from Comstock's Exhibit 99.1 press release filed as part of an 8-K on September 1, 2026. The SOCAR transaction is only at the letter-of-intent stage as of this filing; the parties are targeting execution of a definitive purchase and sale agreement by October 31, 2026, and a closing by year end 2026, subject to the progress of negotiations, customary conditions, and required government and third-party approvals. The transaction will have an effective date of July 1, 2026. On the financial advisory side, Wells Fargo is acting as financial advisor to Comstock, and J.P. Morgan Securities LLC is acting as financial advisor to SOCAR. No lead designation or additional financial advisors are disclosed for either side in this release. On the legal side, O'Melveny & Myers LLP is serving as legal counsel to Comstock, and Baker Botts LLP is serving as legal counsel to SOCAR. The disclosed terms center on the $1.65 billion aggregate purchase price, payable entirely in cash and subject to customary purchase price adjustments. Comstock states the transaction would reduce its net debt from $3.1 billion to $1.5 billion as of June 30, 2026 pro forma, and that Comstock will retain operatorship of all upstream assets and continue to manage, operate and control Pinnacle Gas Services. SOCAR will also have rights to participate in future opportunities generated by Comstock in the Legacy and Western Haynesville at the same percentages being acquired, and SOCAR will provide opportunities for Comstock to market natural gas to international customers via SOCAR's Global LNG marketing operations. Because the deal is only at the letter-of-intent stage, several items remain undisclosed: the final terms of the definitive purchase and sale agreement (which has not yet been executed), the specific valuation methodology underlying the $1.65 billion price, any termination or break-up fee, and the precise form of the development and ownership agreement that will govern future leasing and acquisition rights in the area of mutual interest. The separate $450 million Jerry Jones drilling venture is a related but distinct transaction and is not part of the SOCAR purchase price.

Comstock Resources Inc, a natural resources company trading under the ticker CRK, is the target in a merger and acquisition transaction with a disclosed deal value of $1.65 billion. The transaction has been announced and is documented in an 8-K filing published on September 1, 2026, which was filed with the SEC on the EDGAR system. This mergers and acquisitions transaction falls within the natural resources sector. The transaction was sourced from a Form 8-K current report filed with the Securities and Exchange Commission on September 1, 2026. The deal has been announced, meaning the parties have made a public disclosure of the transaction terms and their intent to proceed, though the transaction has not yet closed. The filing represents the official notification to the market and the SEC of the announced transaction. J.P. Morgan Securities LLC is serving as financial advisor to the acquirer in this transaction. Wells Fargo is serving as financial advisor to the target, Comstock Resources Inc. Both institutions are providing financial advisory services on the transaction, though their specific roles beyond general financial advisory capacity, such as whether either is serving as lead or co-advisor, or the particular scope of their engagement, are not specified in the disclosed information available. No legal advisors have been identified in the sourced information provided for this transaction. The transaction is structured as a merger and acquisition with a disclosed consideration value of $1.65 billion. However, specific details regarding the consideration mix, whether cash, stock, or a combination thereof, have not been disclosed. The structure of the transaction, including whether this is an all-cash deal, a stock transaction, or a mixed consideration structure, remains undisclosed. No information has been provided regarding any earn-outs, escrow arrangements, or other contingent consideration mechanisms that may be part of the overall consideration package. The following material information has not been disclosed: the expected closing date for the transaction, the specific composition and mix of consideration to be paid to shareholders of Comstock Resources, the identity of the acquirer, the financing sources for the transaction, any regulatory approvals or conditions precedent to closing, and any deal protections or termination provisions. Additionally, no detail has been provided regarding the acquirer's financing plans or the mechanics of how the $1.65 billion consideration will be funded.

Public Storage (NYSE: PSA), the self-storage REIT headquartered in Frisco, Texas, announced on September 1, 2026 that it had completed its acquisition of Public Storage Canada ("PS Canada"), the entity that has operated under the Public Storage brand in Canada for decades under the ownership of Tamara Hughes Gustavson and family. The transaction was disclosed via a press release (Exhibit 99.1) attached to a Form 8-K filed under Items 7.01 and 8.01, meaning the filing reports a completed, already-closed transaction rather than a newly signed agreement; no separate 8-K announcing the signing of a definitive agreement for this transaction was identified in Public Storage's EDGAR filing history. Under the terms of the transaction, Public Storage paid consideration worth approximately $1.2 billion at closing. This consisted of approximately $900 million of Public Storage OP units, comprising 2.76 million units valued at $321.98 per unit, and approximately $310 million in cash, subject to customary purchase price adjustments. The transaction also includes an opportunity for the sellers to receive earn-out consideration of up to $288 million in additional Public Storage OP units, priced at $375 per unit, contingent on PS Canada achieving certain net operating income (NOI) performance targets. All values are presented in USD per the filing. With the acquisition, Public Storage assumed direct ownership of a portfolio of 68 self-storage properties totaling approximately 5.3 million net rentable square feet, spanning the Canadian markets of Toronto, Vancouver, Montreal, Calgary, and Ottawa. The filing states these assets benefit from "robust population densities, high household income levels, and attractive self-storage supply levels," and that the deal provides "a foundation for potential platform expansion in Canada's leading markets." Following the transaction, Public Storage reported it owns and/or operates 4,647 self-storage facilities across 41 U.S. states and Puerto Rico (approximately 329 million net rentable square feet), the 68 Canadian facilities, and a 35% common equity interest in Shurgard Self Storage Limited (Euronext Brussels: SHUR), which owns 335 facilities in seven Western European countries. Public Storage disclosed that the acquisition is expected to be accretive to its long-term IRR, NOI growth, and FFO per share. The company said that by applying its "PS Next" operating model across the portfolio, realizing operating efficiencies, and strengthening the customer experience, it expects to achieve near-term compounding NOI growth in the "high single-digits," building off an acquired "high-5's" going-in yield. The filing also cites expected benefits from growth opportunities across acquisitions, development, lending, and third-party management, as well as access to lower-cost Canadian borrowing. No specific dollar synergy target, percentage of cost base, or phase-in timeline was disclosed. Tom Boyle, Chief Executive Officer of Public Storage, said: "Strategic international growth is a value creation opportunity for Public Storage. With an excellent portfolio, leadership in highly attractive markets, and alignment with our brand and culture, PS Canada is a terrific partner for us and reunites the two companies under common ownership. We are grateful for the continued support of Tamara Hughes Gustavson and family, and their thoughtful stewardship of PS Canada. We are excited to work closely with PS Canada's talented and experienced team -- bringing together their domestic expertise with the power of PS Next to deliver meaningful value for our customers and shareholders. Following the recent closing of the National Storage Affiliates Trust transaction, this acquisition marks another important value creation milestone." Scotiabank served as financial advisor, Wachtell, Lipton, Rosen & Katz and Torys LLP served as legal advisors, and Kekst CNC served as strategic communications advisor to Public Storage. Eastdil Secured served as financial advisor, and Allen Matkins Leck Gamble Mallory & Natsis LLP and Osler, Hoskin & Harcourt LLP served as legal advisors to the sellers. Because the press release characterizes the transaction as completed ("Public Storage Completes Acquisition of Public Storage Canada"), the deal is treated as closed as of the September 1, 2026 filing date. No merger agreement exhibit, investor presentation, pro forma financial statements, or closing conditions/termination fee disclosures were identified in Public Storage's EDGAR filings in connection with this transaction; it is possible some of this information was disclosed only in non-SEC materials or in a subsequent Form 8-K/A containing pro forma financials under Item 9.01, which was not located as of this review. No EV/EBITDA, cap rate on a GAAP basis beyond the stated going-in yield, or earnings accretion/dilution figures were disclosed.

Kustom Entertainment, Inc., a Nevada corporation trading on Nasdaq under ticker KUST and formerly known as Digital Ally, Inc., has agreed to acquire 100% of the equity interests of TFL, LLC, a Kansas limited liability company doing business as Tickets For Less, a wholesale ticketing distribution and live event technology platform headquartered in Overland Park, Kansas. The parties entered into a Unit Purchase Agreement on August 31, 2026, announced in a press release on September 1, 2026. Stanton E. Ross, Kustom's Chairman, President and CEO, called the deal "a transformational milestone for Kustom Entertainment as we build a fully integrated, end-to-end live entertainment ecosystem," while Dan Rouen, TFL's Founder and CEO, said the combination would provide TFL "the capital, public market platform, and strategic alignment to accelerate our expansion." The stated purchase price for TFL is $112.0 million, consisting of $89.6 million in cash (subject to adjustment) and $22.4 million in Kustom restricted common stock, 80% cash and 20% stock. The number of shares comprising the stock consideration will be set using the volume-weighted average trading price of Kustom common stock over the ten trading days ending immediately before closing, with no collar or floor. Of the $22.4 million in stock consideration, $11.2 million is structured as Holdback Shares that will be issued only if TFL achieves a specified Target EBITDA threshold (confirmed in Kustom's fairness-opinion materials as $20,870,747) measured from closing through calendar year 2027. Separately, Kustom will fund up to $35.0 million at closing to retire TFL's outstanding third-party debt, which does not reduce the stated purchase price, and TFL's own cash will be used to pay down debt first, such that Kustom expects to acquire zero cash. A Section 338(h)(10) tax election gross-up payable to sellers is capped at $845,000. Roth Capital Partners, LLC, in its fairness-opinion analysis, defined an all-in "Transaction Consideration" of $147,845,000, combining the $89.6 million cash, $22.4 million stock, $35.0 million debt payoff responsibility and the $845,000 tax gross-up at its cap. Roth's fairness opinion, dated August 31, 2026 and included in Kustom's proxy statement, valued TFL using three methodologies. A comparable-companies analysis of four publicly traded live-event-ticketing peers (Vivid Seats, StubHub Holdings, CTS Eventim and Live Nation Entertainment) produced EV/CY2026E EBITDA multiples ranging from 6.3x to 17.3x (25th to 75th percentile of 7.2x to 11.0x), implying an enterprise value range of $126.1 million to $192.0 million for TFL, which the Transaction Consideration fell within. A precedent-transactions analysis of five live-event-ticketing and entertainment deals (including Silver Lake/Endeavor Group Holdings, Bending Spoons/Eventbrite, TKO Group/WWE, Vivid Seats/Wavedash and Endeavor/On Location Events) produced wider ranges that mostly placed the Transaction Consideration below the implied values. A discounted cash flow analysis using a 14.6% WACC produced an EBITDA-exit-multiple enterprise value range of $137.4 million to $211.2 million (within which the $147.845 million Transaction Consideration fell, $10.4 million above the low end) and a perpetuity-growth-method range of $85.9 million to $145.6 million (the Transaction Consideration fell above this range). Overall, of ten reference ranges Roth calculated, the Transaction Consideration fell within three, below six and above one. TFL's own forecast, per the Adjusted EBITDA schedule furnished to Roth, projected revenue of $229.9 million in 2026E, $250.0 million in 2027E and $280.0 million in 2028E, with Adjusted EBITDA of $17.4 million, $19.7 million and $22.1 million in those years (a roughly 7.6% CY2026E Adjusted EBITDA margin on management's forecast), versus Kustom's own standalone forecast of just $0.9 million of Adjusted EBITDA in FY2026E and $1.5 million in FY2027E on about $21 million of revenue. TFL generated over $238 million in revenue for full-year 2025, according to the September 1, 2026 press release. Roth received a $400,000 opinion fee and is entitled to a closing-contingent advisory fee equal to 1.25% of the Aggregate Consideration, estimated at approximately $1,848,000 before a credit for the opinion fee (about $1,448,000 after). The Unit Purchase Agreement requires Kustom to obtain financing, potentially including a public securities offering, sufficient to fund the cash purchase price and debt payoff at closing; the agreement states Kustom makes no representation that such financing has been secured. Kustom's unaudited pro forma financial statements model this as a capital raise of $135.0 million used alongside other closing-date adjustments. No cost synergies, synergy dollar amounts, or expected EPS accretion/dilution figures are disclosed in the filings reviewed. At closing, one individual designated by TFL's sellers will be appointed to Kustom's board, TFL's executive leadership will enter long-term employment agreements with Kustom, and the sellers will be subject to five-year non-competition and non-solicitation covenants. Ancillary closing documents include an escrow agreement (a $500,000 purchase-price-adjustment escrow and a $1.0 million indemnification escrow), a registration rights agreement for the stock consideration, and lock-up agreements. Closing is conditioned on, among other things, required third-party consents, the stockholder approvals described below, Kustom obtaining sufficient financing, and other customary conditions; there is no working-capital adjustment, though the agreement provides for a purchase-price adjustment tied to TFL's closing net debt and transaction expenses. Either party may terminate the agreement if closing has not occurred by October 15, 2026 (the "Outside Date"), which is automatically extended once by 15 days if Kustom files a Form S-1 registration statement before that date; a party cannot exercise this termination right if its own material breach was the principal cause of the delay. No specific termination fee is disclosed in the filings reviewed. At a special/annual meeting held October 5, 2026, Kustom stockholders approved all of the Nasdaq-rule-related proposals needed to proceed with the acquisition, including the issuance of 20%-or-more of outstanding shares under Nasdaq Rule 5635(a), the change-of-control issuance under Rule 5635(b), the issuance under Rule 5635(d), and an offering of shares to fund the cash portion of the purchase price; stockholders also approved an increase in authorized shares to 1,200,000,000 and a 2026 equity incentive plan. Separately, Kustom completed a 1-for-10 reverse stock split effective October 1, 2026. As of the most recent filings reviewed (through October 5, 2026), Kustom has not filed a closing 8-K, so the transaction has not been confirmed as completed. Roth Capital Partners, LLC acted as exclusive financial advisor to Kustom and rendered the fairness opinion to its board. Sullivan & Worcester LLP served as legal counsel to Kustom, and Lewis Brisbois Bisgaard & Smith, LLP served as legal counsel to TFL, according to the background-of-the-acquisition narrative in Kustom's definitive proxy statement. The proxy's background section, which runs from an initial March 11, 2026 teleconference between the companies through the August 31, 2026 signing, does not describe any competing bidders or alternative transaction processes being run for TFL. No financial advisor to TFL is identified in the filings reviewed. The specific dollar amount of any termination fee, the pro forma post-closing ownership split between Kustom and TFL sellers, and whether the public offering financing condition has been satisfied remain undisclosed in the filings reviewed and should be monitored through subsequent SEC filings.

Helix Energy Solutions Group, Inc. (NYSE: HLX), an energy-sector offshore services company, and Hornbeck Offshore Services, Inc., also in the energy sector, completed an all-stock merger of equals on September 1, 2026. The combination was first announced April 22-23, 2026, when the companies entered into an Agreement and Plan of Merger, and it closed following approval by Helix shareholders at a special meeting held August 31, 2026. The combined company retained the Hornbeck Offshore Services name and began trading on the New York Stock Exchange under the ticker symbol HOS on September 2, 2026, while Helix's HLX ticker ceased trading at the close of markets on September 1, 2026. Under the terms of the merger agreement, each share of Hornbeck common stock was converted into the right to receive a fixed exchange ratio of 10.27167 shares of the combined company's common stock. On a fully diluted basis, Hornbeck shareholders were expected to own approximately 55 percent of the combined company and Helix shareholders approximately 45 percent. The transaction was structured as tax-free to shareholders of both companies. No specific aggregate deal value, enterprise value, or implied equity value figure was disclosed in the filings reviewed, and no EV/EBITDA, P/E, or similar valuation multiple for the transaction itself was provided. Structurally, the deal involved a series of mergers: Helix converted from a Minnesota corporation to a Delaware corporation, a Helix subsidiary (Odyssey Sub, Inc.) merged into Hornbeck with Hornbeck surviving as a subsidiary of the renamed Helix Delaware entity, and one minute later that surviving entity merged into another Helix subsidiary (Hercules Sub LLC). Shares issued to most Hornbeck stockholders were registered under a Form S-4 (File No. 333-296508) declared effective by the SEC; shares issued to certain "Consenting Stockholders" who approved the deal by written consent (an aggregate of 37,818,435 shares) were issued under a private-placement exemption. Legacy Hornbeck warrant and equity awards were converted or assumed using the same 10.27167 exchange ratio mechanics. The companies disclosed expected annual revenue and cost synergies of $75 million or more, to be achieved within three years of closing, driven by combined and integrated service offerings, cross-selling to existing customers, and fleet optimization that reduces reliance on third-party vessel charters. An investor presentation dated April 23, 2026 characterized the pro forma combined company as having more than $500 million of cash at closing and leverage of approximately 0.5 times net debt to the sum of Hornbeck's and Helix's 2025 Adjusted EBITDA (a non-GAAP measure), along with roughly $2.0 billion of total backlog as of year-end 2025. The same presentation stated that, before synergies, the pro forma combined company's 2025 revenue and 2025 EBITDA were approximately 106 percent and 56 percent higher, respectively, than Helix's standalone 2025 figures, though the filings reviewed did not provide the absolute dollar figures underlying those percentages. Strategically, the companies described the merger as combining Hornbeck's high-specification offshore support vessel fleet with Helix's well intervention, robotics, and subsea trenching capabilities to create what they called "a premier integrated offshore services company" serving deepwater energy, defense and renewables customers. Owen Kratz, then President and CEO of Helix, said the transaction "creates a global deepwater vessel and services company with the scale and capabilities to deliver sustainable, long-term growth." At closing, Hornbeck said the merger brought together "Hornbeck's industry-leading marine expertise with Helix's differentiated robotics, well intervention and subsea capabilities." Governance of the combined company was negotiated as part of the deal: the post-merger board was set at seven directors, four from the Hornbeck side (including Todd M. Hornbeck) and three from Helix, with William L. Transier (previously a Helix director) serving as Chairman and Todd M. Hornbeck serving as President and CEO. At the special meeting on August 31, 2026, Helix shareholders approved the share issuance (126,692,154 votes for, 644,096 against), an increase in authorized shares, the second-step merger, the plan of conversion to a Delaware corporation, and Jones Act compliance provisions in the new charter, each by wide margins. The merger agreement provided for an Outside Date of December 31, 2026 (automatically extendable by 180 days in certain circumstances solely to obtain antitrust or foreign-investment regulatory clearances). It included customary no-shop and fiduciary-out provisions, and specified termination fees of $49,500,000 payable by Hornbeck (the "Company Termination Fee") and $40,500,000 payable by Helix (the "Parent Termination Fee") under specified circumstances, with smaller expense-reimbursement amounts ($16.5 million payable by Hornbeck and $13.5 million payable by Helix in certain non-approval scenarios) credited against any later-triggered termination fee. In connection with closing, Legacy Hornbeck's credit facilities were amended to permit the merger, and a First Incremental Facility Amendment increased total revolving commitments under Hornbeck's first-lien credit agreement to $125 million from $75 million, with uncommitted incremental capacity increased to $175 million. Helix's existing $120 million asset-based credit facility was terminated at closing, with no outstanding borrowings at that time. On the financial advisory side, Hornbeck retained Barclays, J.P. Morgan and Piper Sandler & Co. as financial advisors, while Goldman Sachs & Co. LLC served as financial advisor to Helix, with Veriten LLC serving as an additional independent strategic advisor to Helix. On the legal side, Kirkland & Ellis LLP and Jones Walker LLP served as legal counsel to Hornbeck, and Baker Botts L.L.P. served as legal counsel to Helix; Joele Frank, Wilkinson Brimmer Katcher served as Helix's strategic communications advisor. The filings reviewed did not disclose a specific EPS accretion/dilution estimate, a tangible book value or earnback analysis, or a negotiation background/other-bidders narrative (such detail would typically appear in the "Background of the Merger" section of the definitive proxy statement/prospectus, which was referenced as filed July 31, 2026 but was not independently reviewed for this summary).

ARRAY Technologies (NASDAQ: ARRY), a global provider of solar tracking technology and fixed-tilt products, announced on August 31, 2026 the successful completion of its acquisition of Affordable Wire Management, LLC (AWM), a provider of wire management, cable protection, and balance-of-system solutions for utility-scale solar and energy storage projects. ARRAY said the deal broadens its balance-of-system portfolio and is expected to create growth opportunities in battery energy storage and datacenter infrastructure. AWM's products organize, secure, and protect electrical wiring to improve system reliability, safety, installation efficiency, and long-term performance, with proprietary designs engineered to provide greater durability, enhanced thermal management, and lower resistive losses than conventional solutions. This record is sourced from ARRAY's own 8-K press release (Exhibit 99.1), furnished to the SEC on August 31, 2026, announcing the transaction as already closed. The release states that additional information regarding the transaction would be included in a Current Report on Form 8-K to be filed by ARRAY, which this document already represents, though it does not attach the underlying purchase agreement, so specific deal terms beyond strategic rationale are not available here. Jefferies LLC acted as exclusive financial advisor to ARRAY on the acquirer side. First Liberties Financial acted as exclusive financial advisor to AWM on the target side. Edelman Smithfield additionally served as strategic communications advisor to ARRAY, a non-financial advisory role. Jones Day acted as legal advisor to ARRAY. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. acted as legal advisor to AWM. The press release does not disclose a purchase price or any value metric for the transaction, stating only that the acquisition is expected to be at least high single digit accretive to ARRAY's Adjusted EPS in the first year before synergies. No consideration structure (cash, stock, or earnout) is specified. AWM's co-founder and Chief Executive Officer Scott Rand and co-founder and Chief Technology Officer Dan Smith both framed the deal as a growth platform for AWM's existing product lines rather than describing any changes to deal economics. Not disclosed in this filing: the purchase price or enterprise value, the consideration mix, AWM's revenue or EBITDA, the original signing date of the purchase agreement, and any financing arrangements used to fund the acquisition.

First Financial Corporation /IN/, the Terre Haute, Indiana-based holding company for First Financial Bank, N.A. and trading under ticker THFF, has agreed to acquire First Illinois Corporation, Decatur, Illinois, the holding company for Hickory Point Bank and Trust, in a stock-and-cash transaction valued at approximately $111.3 million. The merger agreement was signed August 26, 2026 and announced August 27, 2026 via a Form 8-K that included a joint press release, an investor presentation, internal colleague communications, and a shareholder letter. Under the agreement, First Illinois will merge with and into First Financial, with First Financial as the surviving corporation, and immediately thereafter Hickory Point Bank and Trust will merge into First Financial Bank, N.A. First Illinois stockholders may elect to receive either 0.5727 shares of First Financial common stock or $44.35 in cash for each First Illinois share, subject to proration so that 70% of First Illinois shares are exchanged for stock and 30% for cash. Based on First Financial's August 26, 2026 closing price of $79.07, the implied per-share purchase price is $45.00 and the aggregate transaction value is approximately $111.3 million. The merger consideration is subject to downward adjustment, dollar for dollar, if First Illinois' adjusted consolidated shareholders' equity at closing falls below $82,437,826, subject to specified exclusions for transaction expenses, benefit-plan costs and AOCI changes on available-for-sale securities. Outstanding First Illinois stock options will be cashed out based on the $44.35 cash consideration net of exercise price, and unvested restricted stock awards will vest in full and receive the merger consideration. The investor presentation values the deal at 135% of First Illinois' tangible book value, 13.0x last-twelve-months earnings, 7.4x 2028 estimated earnings inclusive of fully phased-in cost savings, and a 5.3% premium to First Illinois' core deposits; it also discloses a "pay-to-trade" ratio (the deal's TBV multiple divided by THFF's standalone TBV multiple) of 80%. Pro forma ownership is expected to be approximately 92% First Financial and 8% former First Illinois shareholders. First Financial disclosed expected cost savings equal to 34% of First Illinois' noninterest expense base, with 75% phased in during 2027 and 100% realized thereafter. The company estimates pre-tax merger and transaction expenses of $10.8 million, fully reflected in the pro forma tangible book value estimate at closing. Purchase accounting marks disclosed include a loan credit mark of 1.39% of gross loans ($6.1 million), an interest-rate mark on loans of 2.32% of gross loans ($10.1 million) amortized over 3.0 years on a straight-line basis, a $2.4 million mark on Hickory Point's held-to-maturity securities amortized over 2.1 years, and a core deposit intangible of 3.00% amortized over 10 years using the sum-of-the-years-digits method, in addition to other fair value marks on fixed assets, AOCI, time deposits and FHLB borrowings. First Financial projects EPS accretion of approximately 6% in 2027 and approximately 7% in 2028 (fully phased in), tangible book value dilution of 3.2% at closing with an earnback period of 2.3 years, and pro forma capital ratios at closing of 9.1% tangible common equity to tangible assets, 12.9% CET1, 13.8% total risk-based capital and 10.4% Tier 1 leverage. The investor presentation also cites an estimated internal rate of return of over 20%. On a combined basis using June 30, 2026 financial data, the pro forma company is expected to have approximately $6.9 billion in total assets, $4.9 billion in total loans (gross), $5.5 billion in total deposits, and $625 million of tangible common equity at closing, operating 95 branches across Georgia, Illinois, Indiana, Kentucky and Tennessee (87 from First Financial and 8 from Hickory Point). Hickory Point Bank, founded in 1979 and previously owned by Archer-Daniels-Midland Company from 1986 to 2011 before being purchased by local business leaders and bank executives who formed First Illinois, operates 8 branches in the Decatur, Champaign-Urbana and Springfield, Illinois markets. As of June 30, 2026, Hickory Point reported approximately $717 million in total assets, $438 million in gross loans, $624-627 million in deposits, $82.4 million in tangible common equity, $8.5 million in LTM net income, 1.18% LTM ROAA, a 70% loan-to-deposit ratio, and 1.27% cost of deposits; at the bank level it reported an 11.0% leverage ratio and 17.3% total risk-based capital ratio. First Financial President and CEO Norman D. Lowery said the company is "pleased to expand our footprint in Illinois through the addition of Hickory Point Bank, an exceptional community banking franchise with strong customer relationships across central Illinois," adding that "Hickory Point Bank brings an attractive core deposit franchise and strong balance sheet liquidity that will enhance our funding profile and support continued growth." Anthony G. Nestler, President of First Illinois and President and CEO of Hickory Point Bank, said the companies are "pleased to be joining an organization that shares Hickory Point Bank's commitment to relationship-focused community banking" and that the deal "will provide our customers and employees with access to additional resources and capabilities while delivering meaningful value to our stockholders." The investor presentation frames the deal around three themes: it is "financially attractive" (approximately 7% fully phased-in EPS accretion, 2.3-year TBV earnback, and over 20% IRR), it represents an "enhanced franchise" (complementing First Financial's existing Illinois footprint with entry into Decatur and Springfield, adding experienced local management and lending teams, and improving an already low-cost deposit base), and it is "low risk" (citing shared values and credit cultures, a comprehensive due diligence process, and First Financial's track record of successfully integrating past acquisitions, including HopFed Bancorp in 2019, Hancock Bancorp in 2021, Simply Bank in 2024 and CedarStone Financial in March 2026). On the acquirer side, Raymond James & Associates, Inc. served as financial advisor to First Financial and rendered a fairness opinion to its board of directors; Amundsen Davis, LLC served as First Financial's legal counsel. On the target side, Piper Sandler & Co. served as financial advisor to First Illinois and rendered a fairness opinion to its board, while Barack Ferrazzano Kirschbaum & Nagelberg LLP served as First Illinois' legal counsel. The merger agreement separately identifies Levenfeld Pearlstein, LLC as special tax counsel to First Financial, expected to deliver a closing opinion that the merger qualifies as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. The transaction has been unanimously approved by both companies' boards of directors, and First Illinois directors have signed voting agreements committing to vote their shares in favor of the merger. The deal is expected to close in the fourth quarter of 2026, subject to First Illinois stockholder approval, the effectiveness of a Form S-4 registration statement (which First Financial has not yet filed with the SEC as of this writing), Nasdaq listing approval for the shares to be issued, and receipt of required bank regulatory approvals without the imposition of a condition deemed "unduly burdensome" by First Financial. The merger agreement sets an "Outside Date" of March 31, 2027 (automatically extended to May 31, 2027 if the SEC has not declared the Form S-4 effective by then, and otherwise extendable by up to 60 additional days in 30-day increments if regulatory approvals remain pending). The agreement provides for a termination fee of $4,400,000 payable by First Illinois to First Financial if the agreement is terminated under specified circumstances, including a change in the First Illinois board's recommendation or termination by First Illinois to accept a superior proposal. No closing 8-K, vote-result 8-K, or definitive merger proxy/S-4 has been filed as of this update; the specific terms of the proxy statement/prospectus, any other bidders considered by First Illinois, and final closing conditions satisfaction have not yet been disclosed in public filings.

First Financial Corporation, the Terre Haute, Indiana-based holding company for First Financial Bank, N.A. and a NASDAQ-listed company under ticker THFF, has agreed to acquire First Illinois Corporation, the Decatur, Illinois-based holding company for Hickory Point Bank and Trust, in a stock-and-cash merger valued at approximately $111.3 million. The deal was announced on August 27, 2026, through a joint press release and investor presentation filed as exhibits to a Form 8-K (corrected via Form 8-K/A solely to mark the Rule 425 checkbox) dated August 26, 2026, the date the parties signed the Agreement and Plan of Merger. Under the agreement, First Illinois will merge with and into First Financial, with First Financial as the surviving corporation, and immediately thereafter Hickory Point Bank and Trust will merge with and into First Financial Bank, N.A. Under the terms of the merger agreement, each share of First Illinois common stock will be converted into the right to elect either 0.5727 shares of First Financial common stock or $44.35 in cash, with the overall consideration mix fixed at 70% stock and 30% cash. Based on First Financial's closing stock price of $79.07 on August 26, 2026, the implied per-share purchase price is $45.00, and the deal values First Illinois at approximately 135% of tangible book value and 13.0 times last-twelve-months earnings, or 7.4 times 2028 estimated earnings including fully phased-in cost savings. The investor presentation also discloses a 5.3% premium to First Illinois' core deposits and a pay-to-trade ratio (the transaction TBV multiple divided by First Financial's standalone TBV multiple) of 80%. The merger consideration is subject to downward adjustment, dollar-for-dollar, if First Illinois' adjusted consolidated shareholders' equity at closing falls below $82,437,826, subject to certain exclusions for transaction expenses and other specified items. Outstanding First Illinois stock options will be cashed out based on the $44.35 per-share value less the exercise price, unvested restricted stock will vest and convert into merger consideration, and outstanding stock appreciation rights will be cashed out per their award terms. At closing, First Financial shareholders are expected to own approximately 92% of the combined company and former First Illinois shareholders approximately 8%, based on 2,424,590 First Illinois shares outstanding (inclusive of restricted stock) and 166,840 options with a weighted average strike price of $31.02. The combined company is expected to have approximately $6.9 billion in total assets, $4.9 billion in gross loans, and $5.5 billion in total deposits, operating 95 branches across Illinois, Indiana, Kentucky, Tennessee and Georgia. Hickory Point Bank, founded in 1979 and previously owned by Archer-Daniels-Midland from 1986 to 2011, operates 8 branches in Decatur, Champaign-Urbana and Springfield, Illinois, and reported approximately $717 million in total assets, $438 million in gross loans, $624 million in deposits, $82.4 million in tangible common equity, and $8.5 million in LTM net income (1.18% LTM ROAA) as of June 30, 2026, with a 1.27% cost of deposits and 70% loan-to-deposit ratio. First Financial disclosed anticipated cost savings equal to 34% of First Illinois' noninterest expense base, with 75% phased in during 2027 and 100% realized thereafter. The company estimated pre-tax transaction/merger expenses of $10.8 million, fully reflected in the pro forma tangible book value estimate at closing. Purchase accounting marks disclosed include a loan credit mark of 1.39% of gross loans ($6.1 million), an interest rate mark on loans of 2.32% of gross loans ($10.1 million) amortized over 3.0 years on a straight-line basis, a $2.4 million mark on First Illinois' held-to-maturity securities amortized over 2.1 years straight-line, and a core deposit intangible of 3.00% amortized over 10 years using the sum-of-years-digits method, along with additional marks on fixed assets, AOCI, time deposits and FHLB borrowings. On financial impact, First Financial expects the deal to be approximately 6% accretive to earnings per share in 2027 and approximately 7% accretive in 2028 (fully phased in), with tangible book value dilution of 3.2% at closing and an earnback period of 2.3 years. Pro forma capital ratios at closing are estimated at 9.1% tangible common equity to tangible assets, 12.9% common equity tier 1, 13.8% total risk-based capital, and 10.4% tier 1 leverage. The presentation also cites an estimated internal rate of return above 20% and a projected 2028 pro forma ROAA of 1.52%. First Financial characterized the deal as financially attractive, noting a short-duration balance sheet that limits purchase accounting impact, and separately cited a track record of prior bank acquisitions (HopFed Bancorp in 2019, Hancock Bancorp in 2021, Simply Bank in 2024, and CedarStone Financial in March 2026). Norman D. Lowery, First Financial's President and CEO, said: "We are pleased to expand our footprint in Illinois through the addition of Hickory Point Bank, an exceptional community banking franchise with strong customer relationships across central Illinois. Hickory Point Bank brings an attractive core deposit franchise and strong balance sheet liquidity that will enhance our funding profile and support continued growth." Anthony G. Nestler, President of First Illinois and President and CEO of Hickory Point Bank, added: "We are pleased to be joining an organization that shares Hickory Point Bank's commitment to relationship-focused community banking. This combination will provide our customers and employees with access to additional resources and capabilities while delivering meaningful value to our stockholders." Raymond James & Associates, Inc. served as financial advisor to First Financial and rendered a fairness opinion to its board of directors; Piper Sandler & Co. served as financial advisor to First Illinois and rendered a fairness opinion to its board. Amundsen Davis, LLC served as legal counsel to First Financial, and Barack Ferrazzano Kirschbaum & Nagelberg LLP served as legal counsel to First Illinois. The merger agreement was unanimously approved by both companies' boards of directors, and each director of First Illinois has signed a voting agreement to vote his or her shares in favor of the deal. Completion is subject to customary closing conditions, including approval by First Illinois shareholders and receipt of required regulatory approvals; First Financial expects the transaction to close in the fourth quarter of 2026. The agreement includes customary non-solicitation provisions limiting First Illinois from pursuing alternative acquisition proposals, and provides for a termination fee of $4.4 million payable by First Illinois under certain circumstances. First Financial has indicated it will file a Form S-4 registration statement that will include a proxy statement for First Illinois shareholders and a prospectus for First Financial shares; as of the most recent filings reviewed, that S-4 had not yet been filed with the SEC, so details such as a shareholder vote date, full merger agreement text beyond the 8-K summary, and background-of-the-merger negotiation history are not yet available. The specific regulatory approvals required (for example from the Federal Reserve, OCC, or state banking regulators) and their status are not detailed in the filings reviewed.

Velocity Financial, Inc., a Westlake Village, California-based real estate finance company, announced on August 27, 2026 a definitive agreement to acquire the operating platform of Toorak Capital LLC, a business-purpose lending and asset management platform majority owned by funds advised by affiliates of KKR. Toorak had also separately agreed to sell its approximately $3 billion portfolio of business-purpose loans to a third-party investment firm, with Velocity entering into a related agreement to manage that acquired portfolio and to sell future Toorak loan production to the same counterparties. The combined platform and portfolio transactions were valued at approximately $3.2 billion based on Toorak's consolidated balance sheet as of June 30, 2026. This extraction is sourced from Velocity Financial's 8-K press release exhibit filed with the SEC on August 27, 2026, announcing the signed definitive agreement. The deal was still pending at the time of this filing, with Velocity expecting the acquisition to close in the fourth quarter of 2026 subject to customary closing conditions. Barclays Capital Inc. served as exclusive financial advisor to Velocity, the acquirer, while Piper Sandler & Co. served as exclusive financial advisor to both Toorak and its majority owner KKR. Each bank held a sole, lead advisory mandate on its respective side of the transaction. On the legal side, Simpson Thacher & Bartlett LLP and Morgan, Lewis & Bockius LLP served as legal counsel to Velocity, while Dechert LLP served as legal counsel to both Toorak and KKR. The acquisition of Toorak's operating platform by Velocity was structured as a 100% cash purchase, encompassing Toorak's direct U.S. origination business (Merchants Mortgage & Trust Corporation) and its lending operations in both the United States and the United Kingdom. Toorak, founded in 2016 with KKR backing, had funded over $20 billion in cumulative loan volume across nearly 43,000 loans since inception; its approximately 280 employees, including Founder and CEO John Beacham, were expected to continue with the business, which will become a subsidiary of Velocity Commercial Capital, LLC. The press release does not disclose the specific cash purchase price allocated to the operating platform acquisition alone, separate from the $3.2 billion combined platform-and-portfolio valuation, nor does it name the third-party investment firm purchasing Toorak's existing loan portfolio or disclose financial advisory fees paid to Barclays or Piper Sandler.

Biohaven Ltd. (NYSE: BHVN) and SK Biopharmaceuticals Co., Ltd. announced on August 26, 2026 a strategic global licensing and collaboration agreement under which SK Biopharmaceuticals will obtain an exclusive worldwide license to Biohaven's Kv7 ion channel platform, led by opakalim (BHV-7000), a next-generation, selective Kv7.2/7.3 potassium channel activator in Phase 2/3 development for focal epilepsy. SK Biopharmaceuticals, which markets XCOPRI for partial-onset seizures through its U.S. subsidiary SK Life Science, will take over development and commercialization of opakalim following closing. This record is sourced from the companies' joint press release (Exhibit 99.1), furnished with Biohaven's 8-K on August 26, 2026. The filing describes this as a licensing and collaboration agreement rather than a sale of the company, and states that closing is contingent on completion of regulatory and antitrust review, including under the Hart-Scott-Rodino Antitrust Improvements Act. J.P. Morgan Securities LLC is serving as exclusive financial advisor to Biohaven. Nomura Securities International, Inc. is serving as exclusive financial advisor to SK Biopharmaceuticals. Sullivan & Cromwell LLP is serving as legal advisor to Biohaven. Paul Hastings LLP is serving as legal counsel to SK Biopharmaceuticals. Under the agreement, SK Biopharmaceuticals will provide upfront and milestone payments related to the Kv7 platform of up to $795 million in aggregate, along with tiered royalties to Biohaven ranging from the mid-teens to low twenties percent on U.S. net sales of opakalim. Of that total, Biohaven will receive $400 million in near-term cash consideration ($350 million at closing and $50 million in 2027), plus up to an additional $150 million in development and regulatory milestones, with ex-U.S. royalties set at a mid-single digit rate. SK Biopharmaceuticals will also assume certain Biohaven obligations to Knopp Biosciences, including up to $185 million payable upon U.S. and EU approval plus a mid-single digit worldwide royalty, separate from its payments to Biohaven. Not disclosed in this filing: a specific expected closing date beyond the regulatory contingency, the exact royalty percentages within the disclosed ranges, and financial details of SK Biopharmaceuticals' own balance sheet or funding source for the upfront payment.

Caesars Entertainment, Inc., a real estate sector company trading under the ticker CZR, is the target in a merger transaction valued at $31 million. The transaction is classified as a mergers and acquisitions product and falls within the real estate sector. The identity of the acquiring party is not disclosed in the available source documentation. This briefing is sourced from an SEC EDGAR filing published on August 26, 2026. The specific form type is not identified in the available data. The deal is currently in pending regulatory status, indicating that regulatory approvals or clearances remain outstanding and the transaction has not yet closed. Innisfree M&A Incorporated has been engaged in an advisory capacity on behalf of the target, Caesars Entertainment, serving in the role of proxy solicitor. According to the source document, Innisfree is responsible for assisting shareholders in connection with proxy submission and voting instruction matters, and can be reached toll-free at (877) 456-3442 for questions or assistance related to these proxy-related functions. No legal advisors are identified in the available source materials for either party to the transaction. The transaction structure, consideration composition, and other material deal terms have not been disclosed in the available documentation. While the deal is valued at $31 million, there is no information provided regarding the form of consideration, whether cash, stock, debt, or some combination thereof, or any other structural details that would typically characterize a merger agreement. Several material points remain unknown or undisclosed: the identity of the acquiring party, the expected closing date or anticipated timing for regulatory approval, the specific consideration structure and mix, the complete list of financial and legal advisors across both sides of the transaction, and the form type of the SEC filing itself. The $31 million valuation is disclosed, but no detail is provided on how this reflects the merger consideration or equity value.

Par Pacific Holdings, Inc. (NYSE and NYSE Texas: PARR), a Houston-based energy company providing renewable and conventional fuels across the western United States, announced on August 25, 2026 that Laramie Energy, LLC, in which Par Pacific owns a 46% non-controlling ownership interest, entered into a definitive agreement with an unnamed third-party purchaser to sell substantially all of its oil and gas assets for $485 million in cash, of which $60 million is payable on the fifth anniversary of closing, subject to working capital and other customary closing date adjustments. Laramie Energy is also eligible to receive price-contingent earn-out payments of up to an additional $65 million in the aggregate following the first through fifth anniversaries of closing. This entry is sourced from Par Pacific's Exhibit 99.1 press release filed as part of an 8-K on August 25, 2026. The transaction is a definitive agreement that had not yet closed as of this filing; it was expected to close by the end of 2026, subject to regulatory approvals and satisfaction of customary closing conditions. No financial advisor is named in this release for Laramie Energy, Par Pacific, or the unnamed third-party purchaser. No legal advisor is named in this release for any party to the transaction. Under the disclosed terms, in connection with the closing, Par Pacific (net of Laramie Energy's debt repayment and closing adjustments and fees) expects to receive approximately $146 million of the transaction consideration (of which approximately $27.5 million is payable on the fifth anniversary of closing) and is eligible to receive up to approximately $30 million of the earn-out payments. Par Pacific will exit its investment in Laramie Energy entirely as part of the transaction. The release does not disclose the identity of the third-party purchaser, the names of any financial or legal advisors involved on any side of the transaction, the specific terms of the working capital adjustment mechanism, or the methodology for calculating the price-contingent earn-out payments beyond their aggregate cap. Par Pacific's own sale of its 46% interest in Laramie Energy, as distinct from Laramie Energy's sale of its operating assets, is described only in terms of expected net proceeds and earn-out eligibility, without an explicit standalone valuation for Par Pacific's equity stake itself.

Two Harbors Investment Corp., a real estate sector company trading under ticker symbol TWOD, is the target in a merger and acquisition transaction. The acquirer's identity and the disclosed transaction value are not specified in the source materials. This is a standard M&A transaction within the real estate sector, and the deal has been announced as of the filing date. The transaction was disclosed via an SEC Form 8-K filing published on August 25, 2026, and accessed through SEC EDGAR. The form 8-K is the primary source document for this briefing, filed contemporaneously with the public announcement. The deal is currently in announced status, meaning it has been publicly disclosed but the transaction has not yet closed. Two Harbors Investment Corp. is being advised by two financial advisors. PJT Partners is serving as a strategic advisor to the target company. Houlihan Lokey Capital, Inc. is advising Two Harbors as well and is identified as a lead advisor on the transaction. On the acquirer side, Citigroup (Citi) has been retained as the exclusive financial advisor, holding a lead role in that capacity. No legal advisors are identified in the source materials provided for this transaction. The specific structure and terms of the proposed transaction are not disclosed in the Form 8-K filing. Details regarding the consideration mix, whether cash, stock, or a combination of the two, are absent from the source document. No information about earnout provisions, working capital adjustments, or other customary transaction mechanics is available. The filing provides no detail on timing or conditions to closing. Several material details remain undisclosed or unknown at this stage. The identity of the acquirer is not stated in the source materials. The total transaction value or purchase price is not disclosed. The expected closing date has not been provided. The structure of consideration, including the relative portions of cash and equity or any contingent payments, is not specified. No information regarding deal conditions, termination rights, or other closing mechanics has been disclosed in the available documentation.

CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology, agreed on May 28, 2026 to acquire Zonda, a privately held provider of new home construction data, homebuilder software, and residential real estate marketplaces, for $800 million in cash. The transaction was structured as a Stock Purchase Agreement among CoStar Group's wholly owned subsidiary CoStar Realty Information, Inc., as purchaser, Bora Holdings Group, L.P., as seller, and Bora, Inc. (together with its subsidiaries, defined in the agreement as "Zonda"). The deal was announced in a press release on May 29, 2026 and completed on August 21, 2026, per CoStar Group's Form 8-K filings. The Stock Purchase Agreement defines "Enterprise Value" as exactly $800,000,000, with the final Purchase Price calculated as Enterprise Value plus a net working capital adjustment, plus cash and cash equivalents, minus closing date indebtedness, minus unpaid transaction expenses. At closing, $5,000,000 of the estimated purchase price was deposited into an escrow account (the "Adjustment Escrow Amount") under a separate Escrow Agreement to secure post-closing purchase price adjustments. No equity or stock consideration was involved; the entire transaction was cash-funded, and the agreement explicitly states that CoStar Group's obligation to consummate the transaction was not subject to any financing condition or to CoStar Group stockholder approval. According to the companies' press releases, Zonda generated approximately $170 million of revenue in 2025 at an Adjusted EBITDA margin of approximately 23%, which implies Adjusted EBITDA of roughly $39 million and an implied purchase price of approximately 20 times trailing Adjusted EBITDA (a figure derived from these two disclosed inputs rather than a multiple stated outright in the filings). The May 29, 2026 announcement also described Zonda's revenue as majority subscription-based with 104% net customer retention. CoStar Group stated the acquisition is expected to be accretive to adjusted EPS in the first full year of ownership; no specific EPS accretion/dilution dollar or percentage figure, leverage impact, or pro forma balance sheet detail was disclosed. Strategically, CoStar Group said the acquisition extends its data, analytics, software and marketplace capabilities into new home construction, a market the company sized (citing Census data) at approximately $1 trillion in annual new residential construction value, which it noted is larger than the institutional apartment and office rent rolls CoStar has historically monetized; the August 21 completion release separately cited the U.S. new home market at approximately $400 billion in annual home sales. Zonda serves more than 3,000 customers, including many of North America's largest homebuilders, developers, suppliers and lenders, through a proprietary lot-level database covering new home communities, land development activity, construction status, home sales and builder operations. The deal also brings the NewHomeSource.com and Livabl online new-home marketplaces into CoStar Group's portfolio, and CoStar said it intends to pair Zonda's "Envision" visualization and digital merchandising tools with Matterport's spatial technology. Andy Florance, Founder and CEO of CoStar Group, said: "Zonda has built an extraordinary business with deep relationships across the homebuilding industry and one of the most valuable proprietary datasets in new home real estate... We believe the combination will deliver deeper insights, workflow efficiencies, and analytics to the homebuilding industry, while strengthening our core information offerings and significantly expanding our new home marketplace capabilities." At completion, Florance added: "Zonda gives us an outstanding foundation to bring that model more deeply into the new home market." BofA Securities served as financial advisor and Latham & Watkins LLP served as legal advisor to CoStar Group on the transaction, per the May 29, 2026 press release filed as Exhibit 99.1 to the Form 8-K. No financial or legal advisor to the seller, Bora Holdings Group, L.P., was disclosed in the filings reviewed. The Stock Purchase Agreement's closing conditions included expiration or termination of the applicable Hart-Scott-Rodino Act waiting period and certain other foreign regulatory approvals, the absence of any governmental order prohibiting the transaction, accuracy of each party's representations and warranties, compliance with covenants, and (for CoStar Group's obligation) the absence of a material adverse effect with respect to Zonda. The agreement included an outside date of May 28, 2027 (subject to extension in specified circumstances) after which either party could terminate if closing had not occurred, and a reverse termination right for either party if a governmental authority issued a final, non-appealable order permanently enjoining the transaction. Under Section 8.3 of the agreement, if the agreement is terminated under specified circumstances tied to the purchaser's failure to close after all conditions were satisfied, CoStar Group (as Purchaser) would be required to pay the seller a $40,000,000 "Purchaser Termination Fee," payable within fifteen business days of such termination; the agreement states the fee is not payable more than once. No separate seller-side termination fee amount was identified in the sections reviewed. The transaction closed on August 21, 2026, as confirmed by CoStar Group's Form 8-K filed that day (Items 7.01 and 9.01) announcing it "has completed its acquisition of Zonda... for $800 million in cash." No merger proxy, S-4, or tender offer documents apply to this transaction since it was a private stock purchase not requiring a shareholder vote or SEC registration of securities as consideration, and no pro forma financial statements for the combination were identified in the filings reviewed.

Evolution Petroleum Corporation (NYSE American: EPM), a Houston-based independent energy company focused on onshore U.S. oil and natural gas properties, priced an underwritten public offering of common stock on August 18, 2026. The company sold 3,700,000 shares at a public offering price of $3.25 per share, for gross proceeds of $12,025,000 before underwriting discounts, commissions, and estimated offering expenses. The last reported sale price of EPM common stock on the NYSE American on August 14, 2026, the day before the deal was marketed, was $3.76 per share, meaning the $3.25 offering price represented a discount of approximately 13.6 percent to that prior close. The offering was made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-292785), declared effective January 27, 2026, and a prospectus supplement dated August 18, 2026 (filed as a final Form 424B5 on August 19, 2026). Per the final pricing table in the prospectus supplement, the underwriting discount was $0.195 per share ($721,500 in total), leaving proceeds to the company, before expenses, of $3.055 per share, or $11,303,500 in aggregate. The company separately estimated approximately $10.8 million of net proceeds after underwriting discounts, commissions, and estimated offering expenses (assuming no over-allotment exercise), rising to approximately $12.4 million if the underwriters' option was exercised in full. Roth Capital Partners acted as sole book-running manager, Northland Capital Markets acted as co-manager, and A.G.P./Alliance Global Partners served as financial advisor to the company in connection with the offering. The company granted the underwriters a 30-day option to purchase up to an additional 555,000 shares at the public offering price, less the underwriting discount, to cover over-allotments. According to the Form 8-K filed August 20, 2026 (which disclosed the underwriting agreement entered into on August 18, 2026), the underwriters exercised that over-allotment option in full on August 19, 2026, bringing total shares sold to 4,255,000 and total net proceeds from the offering plus the option exercise to approximately $12.4 million. The offering closed on August 20, 2026, with shares delivered through the book-entry facilities of the Depository Trust Company. Evolution intends to use the net proceeds to fund a portion of the purchase price for its previously announced acquisition of oil and natural gas mineral, royalty, and overriding royalty interests in the Midland Basin (Reagan, Upton, Glasscock, Midland, and Martin Counties, Texas), together with borrowings under its senior secured reserve-based credit facility and cash on hand, and for general corporate purposes, which may include repayment of a portion of outstanding borrowings under that credit facility. The acquisition, structured as a Purchase and Sale Agreement signed August 18, 2026 by Evolution's subsidiary Evolution Minerals, LLC, carried a base purchase price of $16,000,000 in cash and closed on August 20, 2026, the same day as the equity offering, according to the company's Form 8-K filings dated August 18 and August 21, 2026. The prospectus supplement noted the equity offering was not conditioned on completion of the acquisition. As of June 30, 2026, the company had approximately $56.5 million outstanding under its credit facility and $0.8 million in letters of credit outstanding, at a weighted average interest rate of 6.69% for the year then ended; the facility matures June 30, 2028. The underwriting agreement included customary representations, warranties, and indemnification obligations, and the company and its executive officers and directors agreed to a lock-up restricting sales of common stock or related securities for 60 days after the date of the underwriting agreement, subject to the underwriters' written consent. Legal matters for the issuance of the common stock were passed upon for the company by Mayer Brown LLP and Fennemore Craig, P.C. (Reno, Nevada), while Porter Hedges LLP (Houston, Texas) passed upon certain matters for the underwriters, per the "Legal Matters" section of the final prospectus supplement. No free writing prospectus pricing term sheet was identified in the company's EDGAR filing history for this offering; pricing terms were instead disclosed through the final Form 424B5 prospectus supplement and the Form 8-K/press release dated August 19-20, 2026.

Beacon Financial Corp, trading under ticker BBT in the financial services sector, is issuing $175,000,000 in subordinated notes through a debt capital markets offering. This is a fixed income transaction within the subordinated notes subtype, a common capital-raising instrument for financial institutions seeking to bolster their balance sheet with instruments that rank below senior debt but above equity. The transaction is sourced from an SEC filing published on August 19, 2026, through SEC EDGAR. The specific form type has not been identified in the available documentation. The deal currently holds pending-regulatory status, indicating that it has not yet closed and remains subject to regulatory approval or other outstanding conditions before completion. Beacon Financial has retained three joint book-running managers to lead the subordinated notes offering: Keefe, Bruyette & Woods, A Stifel Company, and Piper Sandler & Co., all functioning in lead capacity. Additionally, Hovde Group has been engaged as a co-manager to the issuer, assisting in the distribution and placement effort. The participation of these four firms across lead and co-manager roles reflects a broad syndication approach typical of institutional-scale debt offerings, with the three leads bearing primary responsibility for bookbuilding and pricing while the co-manager provides supporting distribution capacity. No legal advisors have been identified in the available documentation for this transaction. The transaction involves an issuance of $175,000,000 in subordinated notes. Beyond the disclosed principal amount, no additional structural details have been disclosed regarding the specific terms of the notes, including coupon rate, maturity date, tenor, or any call features, step-up provisions, or other embedded optionality that may be present in the final security. The closing date for this offering has not been disclosed. The specific form type of the SEC filing has not been identified. The coupon rate, maturity date, and other detailed terms of the subordinated notes, including any step-up features, call protection, or other structural provisions, remain undisclosed. Consideration structure, to the extent it differs from a standard cash notes issuance, has not been specified.

Arxis, Inc., a publicly traded industrials-sector company trading under ticker ARXS and a portfolio company formed in partnership with Arcline Investment Management, agreed on May 29, 2026 to acquire Omnetics Connector Corporation, a privately held Minneapolis, Minnesota-based designer and manufacturer of proprietary high-reliability Micro-D-Sub and Nano-D-Sub connectors and interconnect assemblies used in critical defense and space, commercial aerospace, and medical applications. The transaction closed on August 17, 2026, with Arxis announcing completion in a press release filed as Exhibit 99.1 to a Form 8-K on August 18, 2026. The agreement was structured through a reverse triangular merger in which Orion Merger Sub, Inc., a wholly owned Arxis subsidiary, merged with and into Omnetics, with Omnetics surviving as a wholly owned subsidiary of Arxis; Gary Jacobs, President of Omnetics, served as shareholder representative. Kevin Perhamus, President and Chief Executive Officer of Arxis, said of the acquisition, "Omnetics is exactly the kind of business we built Arxis to own. For over 40 years, the company has been the trusted standard in Nano- and Micro-D-Sub connectors for applications where failure is not an option, earning preferred-source positions on long-tenured programs that are highly difficult to replicate." Gary Jacobs stated, "Arxis shares our deep commitment to innovation, quality, and the customers who rely on us. Joining Arxis gives us the resources and platform to accelerate investment in our products, our technology, and our people, while continuing to deliver high performance and reliability to our customers." Rajeev Amara, Chairman of Arxis and CEO of Arcline, said the Omnetics and concurrently announced MagCanica acquisitions reinforce "the power of the Arxis-Arcline partnership in creating a repeatable engine of value creation for Arxis as a next-generation industrial compounder." The aggregate consideration for the Omnetics merger was based on an agreed enterprise value of approximately $770 million, subject to customary closing adjustments, and was paid entirely in Arxis Class A common stock, reflecting what the company described as Omnetics shareholders' preference for public-company stock over cash. At closing, Arxis issued 13,351,964 shares of Class A common stock to former Omnetics shareholders, representing approximately 3.1 percent of Arxis' total common stock outstanding as of the closing date, and funded $8.0 million into cash escrow accounts to secure post-closing indemnification obligations under the merger agreement. The number of shares issuable as consideration was subject to a collar (with the collar floor set at 85 percent of the exchange-ratio calculation price), with any value shortfall below the applicable floor payable to Omnetics shareholders in cash instead of stock. The merger agreement also included a working capital adjustment mechanism (Section 2.16) under which closing consideration is trued up based on closing working capital relative to a target. Arxis disclosed that, combined with its concurrently announced acquisition of MagCanica, Inc., the aggregate purchase price across both deals (approximately $890 million at announcement) represented approximately 12 times FY27 estimated adjusted EBITDA; no Omnetics-specific EBITDA multiple was disclosed separately. Omnetics shareholders, including the company's five largest shareholders, entered into lock-up agreements restricting resale of the Arxis shares received as consideration. For the five largest shareholders, the stock will be released from transfer restrictions in four equal tranches, with the first release in October 2026 and the final release in May 2028, and those holders must give Arxis 30 days' prior written notice of any proposed sales during the lock-up period; other, smaller shareholders will be released from lock-up restrictions in October 2026. Arxis also agreed to file a registration statement with the SEC covering resale of the shares issued as merger consideration pursuant to a Registration Rights Agreement entered into at closing. The shares were issued without registration in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act of 1933. William Blair & Company, L.L.C. served as financial advisor to Arxis, and Vermillion Capital (also referred to as Vermillion Capital, LLC in the merger agreement, which established the transaction data room) served as financial advisor to Omnetics. No legal advisors to either party were identified in the Form 8-K filings, the merger agreement, or the related press releases. Upon closing, Omnetics began operating within Arxis' Electronic Components segment. The merger agreement's closing was subject to customary conditions precedent, including regulatory approval; no termination fee provision was identified in the merger agreement. The deal has closed; no post-closing 8-K beyond the August 18, 2026 completion announcement, and no proxy statement, S-4, or tender-offer filing, was identified or was applicable, since the transaction was a direct merger of a privately held target funded with registration-exempt stock rather than a stock-for-stock combination of two reporting companies.

Fulcrum Therapeutics, Inc. (Nasdaq: FULC) and Slate Medicines, Inc., a biotechnology company developing next-generation migraine therapeutics, announced on August 17, 2026 that they have entered into a definitive agreement to combine in an all-stock merger. The surviving public company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq under the ticker "SLTE," focusing on Slate's lead candidate SLTE-1009, a clinical-stage subcutaneous anti-PACAP/VIP monoclonal antibody for migraine prevention. Fulcrum's CEO said the deal follows the company's evaluation of strategic alternatives for its rare hematological disease pipeline. This record is sourced from Fulcrum's own 8-K press release (Exhibit 99.1), furnished to the SEC on August 17, 2026. The transaction has received unanimous support from both companies' boards of directors and is structured as a reverse merger paired with a concurrent private placement financing. Wedbush Securities Inc. is serving as exclusive financial advisor to Slate (the accounting acquirer in the combination). Leerink Partners is serving as exclusive financial advisor to Fulcrum. Cooley LLP is serving as legal counsel to Slate. Goodwin Procter LLP is serving as legal counsel to Fulcrum. Under the terms of the merger agreement, pre-merger Fulcrum stockholders are expected to own 5.0% of the combined company and pre-merger Slate stockholders (including investors in the concurrent financing) are expected to own 95.0%, with the split subject to adjustment based on Fulcrum's net cash at closing. Slate has secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with participation from Forbion, RA Capital Management, Deep Track Capital, Foresite Capital, OrbiMed, RTW Investments, and Mingxin Capital, expected to fund operations into 2029. Fulcrum also expects to pay a cash dividend to its pre-merger stockholders equal to the amount by which its net cash exceeds $20.3 million, estimated at approximately $270.0 million. The deal is expected to close in the fourth quarter of 2026, subject to stockholder approval at both companies, Nasdaq listing approval, effectiveness of an S-4 registration statement, and expiration of the Hart-Scott-Rodino waiting period. Not disclosed in this filing: the exact final exchange ratio or adjusted ownership split post-closing, any termination fee, and the specific use of net cash dividend proceeds beyond the stated cap.

DocGo Inc., a publicly traded technology-enabled mobile health and medical transportation company trading under ticker DCGO, has agreed to acquire 100% of Hicuity Health, Inc., a privately held virtual care provider, in a transaction announced August 17, 2026. DocGo disclosed the deal in a Form 8-K filed with the SEC that attached the Agreement and Plan of Merger (dated August 16, 2026) as Exhibit 2.1 and a press release as Exhibit 99.1. Under the agreement, HH Merger Sub, LLC, a subsidiary of DocGo's Ambulnz Holdings, LLC subsidiary, will merge into Hicuity, with Hicuity surviving as a wholly owned subsidiary of Ambulnz. The merger is intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. Hicuity delivers high-acuity virtual clinical care, including Tele-ICU, Virtual Nursing, and Telemetry Monitoring services, to health systems, hospitals, and post-acute facilities. On a trailing 12-month basis, Hicuity generated approximately $65 million in revenue and approximately $4.5 million of adjusted EBITDA, according to DocGo's press release. No single aggregate purchase price or enterprise value figure was disclosed in the filings; instead, consideration is structured as a combination of assumed debt and DocGo stock. DocGo is acquiring Hicuity in exchange for (i) the assumption of Hicuity's existing indebtedness held by Perceptive Credit Holdings IV, LP, estimated at approximately $52 million at closing and now maturing in December 2029, and (ii) equity consideration consisting of a number of DocGo common shares equal to 2.0% of DocGo's fully diluted shares outstanding at closing (the "Closing Stock Consideration"), plus additional "Earnout Shares" equal to 3.5% of DocGo's fully diluted shares outstanding, which vest only if DocGo's common stock achieves a specified market capitalization threshold (publicly described by DocGo as $250 million) within three years of closing, or fully vest automatically upon an above-threshold go-private transaction before expiration. The Earnout Shares are subject to downward-only post-closing adjustment based on final closing indebtedness and transaction expenses; no upward adjustment is permitted. Because the Merger is a "Deemed Liquidation Event" under Hicuity's charter and total consideration is insufficient to satisfy Hicuity's Series F liquidation preference in full, the entire merger consideration is payable solely to Hicuity's Series F Convertible Preferred stockholder; all other classes of Hicuity capital stock, along with all outstanding options and warrants, will be cancelled for no consideration. As part of the transaction, Perceptive Credit Holdings IV, LP (as administrative agent and lender) committed to provide up to an additional $50 million of new senior secured term loan financing to DocGo/Ambulnz, structured as a $12.5 million term loan, a second $12.5 million term loan, and a third $25 million term loan, alongside continuation of $52 million of existing Hicuity term loans. On October 1, 2026, DocGo disclosed in a subsequent Form 8-K that Hicuity and Ambulnz (as co-borrowers), together with DocGo and certain Ambulnz subsidiaries as guarantors, entered into a definitive Amended and Restated Credit Agreement and Guaranty with Perceptive implementing this financing: Term Loan A continues the existing $52 million of Hicuity term loans; Term Loan B is a new $12.5 million facility funded at signing; Term Loan C is a new $12.5 million facility to fund upon consummation of the Merger (or later at DocGo's option); and Term Loan D is a $25 million delayed-draw facility available from the Closing Date through December 31, 2027. The Term Loans bear interest at Term SOFR (with a 3.50% floor) plus a 7.50% margin, with no scheduled amortization before the December 6, 2029 maturity date. In connection with this financing, DocGo also issued Perceptive's administrative agent a warrant to purchase up to 4,000,000 shares of DocGo common stock at an exercise price of $0.5039 per share, fully vested as of the October 1, 2026 issue date and exercisable for ten years. Separately, DocGo terminated its prior undrawn revolving credit facility with Citibank, N.A. on October 1, 2026 in connection with entering into the new credit agreement. Ahead of closing, Ambulnz and Hicuity entered into a Consulting Services Agreement (also dated August 16, 2026) under which Ambulnz manages Hicuity's day-to-day non-clinical operations and funds Hicuity's operating expenses in exchange for a weekly management fee equal to Hicuity's gross revenue collections less operating expenses; this arrangement terminates upon the earlier of closing or termination of the merger agreement. DocGo's October 5, 2026 8-K confirms that the conditions to the Consulting Services Agreement were satisfied and Ambulnz began managing Hicuity's non-clinical operations effective October 1, 2026, but it explicitly describes the Merger's closing as still "pending" as of that filing date; no closing 8-K has been filed. DocGo's CEO, Lee Bienstock, said the transaction "took a major leap forward" in the company's evolution "into the premier provider of virtual, remote, and in-home healthcare at any address," adding that "Hicuity brings technology-enabled acute and critical care telemedicine capabilities, serving a diverse portfolio of health systems across the United States," and that integrating Hicuity's offering would help "create one of the most innovative healthcare delivery platforms in the industry" by matching "the right clinician with the right patient at the right time in the right setting," bridging patient care "from the hospital to the home." DocGo's CFO, Norm Rosenberg, said the pending acquisition "represents not only a significant growth opportunity with numerous cost synergies, but will also create a combined entity with much greater financial liquidity," and credited Perceptive Advisors as "a healthcare lending partner of the caliber" willing to commit up to $50 million of additional debt financing "if needed." No specific dollar figure or percentage for the referenced cost synergies was disclosed in the filings. DocGo stated in the same press release that its full-year 2026 financial guidance (revenue of $305-$310 million and adjusted EBITDA of negative $17 million to negative $22 million) does not include any contribution from the Hicuity acquisition, because the transaction had not yet closed. The merger agreement contains customary closing conditions, including accuracy of representations and warranties, compliance with covenants, absence of governmental orders prohibiting the transaction, delivery of closing deliverables, and Ambulnz's entry into a definitive credit agreement assuming Hicuity's indebtedness (since satisfied via the October 1, 2026 credit agreement). Ambulnz will procure a representations-and-warranties insurance policy as the primary source of recovery for breaches of Hicuity's representations and warranties. The agreement may be terminated by mutual consent or by either party for an uncured material breach, material failure to perform obligations, or a final non-appealable governmental order prohibiting the transaction. No termination fee was disclosed in the filings reviewed. The agreement is governed by Delaware law. Norton Rose Fulbright is acting as legal counsel to DocGo for the transaction. TD Cowen is acting as exclusive financial advisor to Hicuity Health, and Stradling Yocca Carlson Rauth is acting as Hicuity Health's legal counsel, according to DocGo's press release.

TTM Technologies Inc, a public industrials company trading under the ticker TTMI, is the acquirer in this leveraged finance transaction. The deal involves the establishment of incremental term loan facilities with a disclosed aggregate principal amount of $1.1 billion USD. This is a credit facility transaction falling within the levfin product group, specifically categorized as incremental term loan facilities that will augment TTM Technologies' existing debt structure. The information regarding this transaction is sourced from an SEC filing published on the SEC EDGAR platform on August 17, 2026. The specific form type is not disclosed in the available documentation. As of the current date, the transaction remains pending regulatory approval and has not yet closed. Four financial institutions are advising on the arrangement and syndication of these incremental facilities. JPMorgan Chase Bank, N.A., Barclays Bank PLC, and BofA Securities, Inc. are all serving as joint lead arrangers and bookrunners for the incremental facilities, with all three carrying lead status in the transaction. Bank of America, N.A. is also providing commitment as a lender, specifically committing to provide 33.33% of the principal amount of the Term A Incremental Facility and 30.5% of the principal amount of the Term B Incremental Facility. No legal advisors to either party have been identified or disclosed in the available documentation. The transaction contemplates the creation of two distinct tranches of incremental facilities: a Term A Incremental Facility and a Term B Incremental Facility. The commitment percentages for Bank of America differ across these two facilities, with the bank providing a larger proportional commitment to the Term A tranche than to the Term B tranche. No additional structural details regarding interest rate margins, pricing tiers, financial covenants, or other loan-specific terms have been disclosed in the materials reviewed. Several material details regarding this transaction remain undisclosed or unknown. The specific tenor or maturity date of either the Term A or Term B Incremental Facility is not provided. The interest rate structure, margins, and all pricing details are not disclosed. The expected closing date for the transaction has not been communicated. The full syndication breakdown and commitment amounts for JPMorgan, Barclays, and BofA Securities beyond their roles as bookrunners are not specified. Additionally, the rationale for the transaction, the use of proceeds, and any conditions precedent to funding beyond the regulatory approval status remain unknown.

Skye Bioscience, Inc. (Nasdaq: SKYE), a clinical-stage biotechnology company, has agreed to acquire Redx Pharma Limited, a privately held UK clinical-stage biotechnology company focused on small-molecule medicines for fibrotic disease, through a scheme of arrangement under Part 26 of the UK Companies Act 2006. The Transaction Agreement was entered into on August 14, 2026 and announced the same day in a joint press release and investor presentation filed as exhibits to a Form 8-K. Upon closing, the combined company is expected to rebrand as Fibrx Therapeutics, Inc., be led by Redx's current management team under CEO Lisa Anson, and continue trading on Nasdaq, headquartered in Alderley Park, UK. Under the Transaction Agreement, each Redx scheme share will be exchanged for Skye common stock (or, for certain electing holders, non-voting common stock convertible one-for-one into common stock) based on an Exchange Ratio tied to relative valuations set in the agreement: a valuation of $14.5 million for Skye (subject to a Company Net Cash adjustment and, if a "Specified Adjustment" is unresolved at closing, an automatic reduction to a $2.0 million valuation floor) and a valuation of $125.0 million for Redx. Skye's investor presentation separately shows a pro forma capitalization table with implied valuations of $14.5 million for Skye's 50,254,721 fully diluted shares, $161.0 million for Redx's 558,191,980 fully diluted shares (which include new Series A shares), and $89.0 million for the 325,789,219 shares tied to the concurrent financing, for total pro forma fully diluted shares outstanding of 934,235,920 and an implied combined value of approximately $264.5 million. Using this capitalization table, pre-transaction Skye holders are shown owning approximately 5.38%, Redx holders approximately 59.75%, and concurrent-financing investors approximately 34.87% of the combined company. The body of the 8-K separately describes the expected split, based on the Exchange Ratio formula and assuming $67.9 million of gross Concurrent Financing proceeds and $36.0 million of gross Series A proceeds, as approximately 5.38% for pre-transaction Skye equityholders, 46.17% for pre-transaction Redx equityholders, and 48.45% for Concurrent Financing and Series A Financing investors combined, all calculated on a fully diluted, treasury-stock-method basis and subject to adjustment based on final Company Net Cash at closing. The filings do not reconcile why the two disclosed ownership breakdowns differ, and no single, unambiguous enterprise value or EV/EBITDA-style multiple for the transaction is stated in the source documents reviewed. The deal includes concurrent financing of approximately $125 million in aggregate gross proceeds. This is composed of a $67.9 million private placement (the "Concurrent Financing" or PIPE), which may increase to up to $72.9 million under a side letter with an existing investor who agreed to invest up to an additional $5.0 million, and a separate $36.0 million Series A financing raised directly by Redx (expected to close within days of signing, subject to Redx shareholder approval) led by new investor Abingworth and including British Business Bank and Redmile. The PIPE investor syndicate includes Abingworth, British Business Bank, NextBio Capital, 5AM Ventures, and Redmile. Separately, Skye entered a binding term sheet (later finalized in a definitive Securities Purchase Agreement filed as an 8-K on August 24, 2026) with a fund affiliated with Redmile Group, LLC for a three-year committed equity line facility (ELOC) of up to $22.0 million, which will be reduced dollar-for-dollar once Concurrent Financing/Series A proceeds exceed $103.0 million and eliminated entirely if those proceeds reach $125.0 million; Skye will also issue Redmile a warrant to purchase up to $5.0 million of common and/or non-voting common stock at closing, exercisable from January 1, 2027 through January 1, 2030. Skye stated that, including proceeds from these financings, the combined company's cash is expected to fund operations into 2029 and through topline data from Redx's RXC008 Phase 2 clinical trial, expected in the second half of 2028. Quoting Redx CEO Lisa Anson in the joint press release: "This transaction gives Redx the capital and the platform to progress our pipeline and deliver the Phase 2 program for our lead asset, RXC008, a GI-restricted pan-ROCK inhibitor. We believe this is an exciting opportunity to be a leader in developing a therapeutic option for patients suffering with fibrostenotic Crohn's disease, considered by many to be one of the largest unmet medical needs in IBD..." Skye President and CEO Punit Dhillon stated: "Over the last several months, Skye has evaluated a wide range of options to maximize shareholder value, including an assessment of our internal pipeline, financing opportunities and strategic alternatives... We believe this transaction provides our shareholders a compelling opportunity to realize both short- and long-term value creation through Redx's novel anti-fibrotic therapies, led by their first-in-class pan-ROCK inhibitor, RXC008." The investor presentation adds that Skye discontinued its CBeyond Phase 2a trial for lead asset nimacimab and paused its development in the second quarter of 2026 after reviewing the evolving anti-obesity drug landscape, and engaged a financial advisor to evaluate strategic alternatives before agreeing to the Redx transaction, which the company describes as "a capital decision not a biology conclusion." As part of the transaction structure, pre-transaction Skye shareholders will receive one contingent value right (CVR) per share entitling them, in aggregate, to 90% of any net cash proceeds realized from monetization of Skye's legacy nimacimab program and associated intellectual property during the 12-month period following closing. Certain pre-transaction Redx shareholders will separately receive one CVR per Redx ordinary share entitling them to 100% of net proceeds, paid in Fibrx shares, from monetization of certain Redx legacy and partnered assets during the 15 years following closing. Additionally, Skye's board approved a 1-for-8 reverse stock split of its common stock, effective August 24, 2026, undertaken to regain compliance with Nasdaq's $1.00 minimum bid price requirement; a subsequent 8-K dated September 11, 2026 confirmed that Nasdaq notified Skye it had regained compliance after 10 consecutive trading days at or above $1.00. On the advisory side, Stifel is acting as exclusive financial advisor to Skye on the strategic transaction, with Morrison & Foerster LLP serving as Skye's legal counsel. Wedbush PacGrow is acting as exclusive financial advisor to Redx, with Cooley LLP serving as Redx's legal counsel. In the PIPE Financing, Leerink Partners and MTS Health Partners are acting as placement agents, with MTS Health Partners acting as exclusive placement agent for the separate Series A Financing; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. is advising the placement agents as legal counsel. The transaction is subject to numerous closing conditions, including approval by Redx shareholders of the scheme of arrangement, sanction of the scheme by the High Court of Justice of England and Wales, approval by Skye stockholders of the share issuance and related matters (including a possible reverse stock split and articles amendments), receipt of at least $67.9 million in Concurrent Financing proceeds, Nasdaq listing approval for the new shares, and a minimum Company Net Cash threshold of at least $1.0 million at closing. If the "Specified Adjustment" referenced in the agreement has not been resolved by a certain date, closing cannot occur before October 31, 2026. Voting and support agreements covering approximately 83.34% of Redx's outstanding share capital and approximately 1.05% of Skye's voting power have been signed in favor of the transaction, and certain Redx executives and directors signed 180-day lock-up agreements. The agreement includes reciprocal termination fees: either party can be required to pay the other an amount equal to 3% of the combined company's valuation (including the Concurrent Financing purchase price) under specified circumstances, including a change in board recommendation, failure to obtain required shareholder approvals combined with a competing proposal, or acceptance of a superior proposal. The Transaction Agreement also provides for automatic termination if the deal has not closed by August 14, 2027 (with up to a four-business-day extension in limited circumstances). The press release states the companies expect to close the transaction in the fourth quarter of 2026, subject to these conditions; no closing 8-K, vote-result 8-K, or merger proxy statement (PREM14A/DEFM14A) had been filed as of the filings reviewed, so the deal remains pending and unconsummated based on available information.

This transaction is a follow-on common stock offering by Zentalis Pharmaceuticals, Inc. (ticker ZNTL), a healthcare sector company. The offering falls under the equity capital markets (ECM) product group and carries a disclosed value of $95,450,000. The deal is currently in pending regulatory status. This summary is sourced from an SEC EDGAR Form 424B5 filed and published on August 14, 2026. The offering involved a syndicate of financial advisors in differentiated roles, all on the issuer side. TD Cowen, Guggenheim Securities, and Oppenheimer & Co. are each named as joint bookrunners in a lead capacity, per the source sentence listing the joint bookrunners as TD Cowen, Guggenheim Securities, and Oppenheimer & Co. H.C. Wainwright & Co. served in the distinct role of passive bookrunner, a non-lead capacity, while Rodman & Renshaw LLC served simply as manager, also non-lead. No legal advisors are identified in the facts block for this transaction. As a follow-on common stock offering, this transaction involves the sale of additional shares by an already-public issuer, but the facts block does not disclose the number of shares offered, the offering price per share, or any underwriters' over-allotment option terms. Several material facts remain undisclosed. No legal advisors are named for the issuer or the underwriting syndicate. No expected closing date is given beyond the filing date, and no detail is provided on share count, price per share, or use of proceeds.

Intercontinental Exchange, Inc. (ICE), a financial services sector company trading under ticker ICE, priced and completed a four-tranche senior notes offering totaling $3,750,000,000 in aggregate principal amount. The notes were sold pursuant to a prospectus supplement dated August 11, 2026 (filed with the SEC on August 11 and again, in final form, on August 13, 2026) under ICE's automatic shelf registration statement on Form S-3 (File No. 333-277603), and the offering closed on August 20, 2026, as confirmed in a Form 8-K filed that same week disclosing that ICE had completed the public offering and issuance of the notes. The offering consisted of four fixed-rate tranches: $1,250,000,000 of 4.700% senior notes due August 20, 2029; $1,100,000,000 of 4.900% senior notes due September 1, 2031; $650,000,000 of 5.150% senior notes due September 1, 2033; and $750,000,000 of 5.400% senior notes due September 1, 2036. There is no floating-rate tranche in the final structure. Interest on the 2029 notes is payable semi-annually on each February 20 and August 20, beginning February 20, 2027; interest on the 2031, 2033 and 2036 notes is payable semi-annually on each March 1 and September 1, beginning March 1, 2027. Public offering prices were 99.735% of par for the 2029 notes, 99.488% for the 2031 notes, 99.370% for the 2033 notes and 99.128% for the 2036 notes, with underwriting discounts of 0.350%, 0.600%, 0.625% and 0.650% of principal, respectively, for each tranche. The net proceeds of approximately $3.71 billion, together with anticipated borrowings under a new senior unsecured term loan facility, issuance of commercial paper, borrowings under ICE's revolving credit facility, cash on hand and/or borrowings under a bridge facility, are intended to finance the purchase price of ICE's pending acquisition of MarketAxess Holdings Inc., announced July 29, 2026, under which ICE will pay $167.00 per share in cash for aggregate consideration of approximately $6.0 billion. The 2033 and 2036 notes are designated 'SMR notes' and are subject to special mandatory redemption at 101% of principal plus accrued interest if the MarketAxess acquisition is not consummated by an outside date of July 29, 2027 (subject to up to two six-month extensions to January 29, 2028 and July 29, 2028 if regulatory approvals remain outstanding) or if the merger agreement is terminated beforehand. The 2029 and 2031 notes (the 'non-SMR notes') carry no such special mandatory redemption right; if the MarketAxess acquisition is not completed, ICE intends to use the non-SMR notes' net proceeds of approximately $2.33 billion for general corporate purposes, including paying down commercial paper or repurchasing/redeeming outstanding senior notes. Each tranche is also optionally redeemable by ICE in whole or in part at any time prior to its par call date at a make-whole price equal to the greater of the present value of remaining scheduled payments (discounted at the Treasury Rate plus 10 basis points for the 2029 and 2031 notes, or plus 15 basis points for the 2033 and 2036 notes) or 100% of principal, plus accrued interest; on or after the applicable par call date (one month before maturity for the 2029 and 2031 notes, two months before maturity for the 2033 notes, and three months before maturity for the 2036 notes), redemption is at par plus accrued interest. The notes are general unsecured, unsubordinated obligations of ICE, rank equally with its other unsecured debt, and are not listed on any exchange. The governing indenture (dated August 13, 2018, as supplemented by an Eighth Supplemental Indenture dated August 20, 2026, with Computershare Trust Company, National Association, as successor trustee) contains covenants limiting ICE's and certain subsidiaries' ability to create liens, enter sale-and-leaseback transactions, and consolidate, merge or transfer substantially all assets. The prospectus supplement states ICE expects the notes to be rated by one or more nationally recognized statistical rating organizations but does not disclose specific ratings or rating agencies in the filing. The joint book-running managers were BofA Securities, Wells Fargo Securities, Goldman Sachs & Co. LLC, Mizuho, MUFG (lead for the 2036 notes), Citigroup (lead for the 2029 notes), Fifth Third Securities (lead for the 2033 notes) and PNC Capital Markets LLC (lead for the 2031 notes). Senior co-managers were BBVA, BMO Capital Markets and Huntington Capital Markets. Co-managers were M&T Securities, KeyBanc Capital Markets and Societe Generale. The underwriting agreement, dated August 11, 2026, named BofA Securities, Inc., Wells Fargo Securities, LLC, MUFG Securities Americas Inc., Citigroup Global Markets Inc., Fifth Third Securities, Inc. and PNC Capital Markets LLC as representatives of the underwriters. Sullivan & Cromwell LLP acted as counsel to ICE on the validity of the notes, and Davis Polk & Wardwell LLP acted as counsel to the underwriters, both New York, New York, per the prospectus supplement's 'Validity of Securities' section. The offering itself has closed, with notes issued and net proceeds received on August 20, 2026. The MarketAxess acquisition that the proceeds are intended to fund remains pending, subject to MarketAxess stockholder approval, expiration of the HSR Act waiting period, and other customary regulatory approvals.

Gentherm Incorporated, a Michigan-based company trading on Nasdaq under ticker THRM, agreed to combine with Modine Manufacturing Company's Performance Technologies business in a Reverse Morris Trust (RMT) transaction, with the deal announced on January 29, 2026 and completed on October 1, 2026. The transaction was structured so that Modine spun off its Performance Technologies business into a newly formed subsidiary, Platinum SpinCo Inc., which Modine then distributed pro rata to its shareholders before SpinCo merged with Platinum Gold Merger Sub Inc., a Gentherm subsidiary, with SpinCo surviving as a wholly owned subsidiary of Gentherm under the name Modine Global, Incorporated. At announcement, Gentherm and Modine valued the transaction at approximately $1.0 billion, representing approximately 6.8 times Modine Performance Technologies' LTM (September 2025) post-synergy adjusted EBITDA of $147 million, based on Gentherm's 30-day volume-weighted average price as of January 23, 2026. Modine was expected to receive a cash distribution of $210 million from SpinCo prior to the spin-off, subject to adjustment, with Modine shareholders set to receive approximately 21 million shares of newly issued Gentherm common stock, representing equity consideration of approximately $790 million. At signing, the companies expected Modine shareholders to own approximately 40% of the combined company and Gentherm shareholders to own approximately 60%, subject to adjustment. Modine Performance Technologies reported annual revenue of approximately $1.1 billion and adjusted EBITDA of approximately $123 million, serving vehicular and power generation end markets through 5,000 employees across 10 countries. At closing on October 1, 2026, each share of SpinCo common stock was converted into 0.44619 shares of Gentherm common stock, with cash paid in lieu of fractional shares. Prior to closing, SpinCo made a cash distribution to Modine of approximately $156 million, used to repay outstanding indebtedness, which was lower than the $210 million originally contemplated at announcement. Gentherm issued 23,735,961 shares of common stock to Modine's record-date shareholders, resulting in Modine shareholders owning approximately 43.62% of the combined company's outstanding shares and continuing Gentherm shareholders owning approximately 56.38%, without taking into account any overlapping shareholder ownership. In connection with closing, Gentherm also declared a special cash dividend of $2.07 per share (an aggregate of $63,500,492), payable October 7, 2026 to Gentherm shareholders of record as of September 28, 2026; Modine's Record Date shareholders who received Gentherm shares in the merger were not entitled to this dividend on those newly issued shares. On financing, SpinCo entered into a Credit Agreement on June 29, 2026 with Bank of America, N.A. as administrative agent, providing a senior secured delayed draw term loan facility of up to $250.0 million. SpinCo borrowed the full $250.0 million at closing, using proceeds to fund the SpinCo cash distribution to Modine, a related cash transfer, and general corporate purposes. Term loans bear interest, at SpinCo's option, at term SOFR plus a margin of 1.125% to 2.000% per annum or base rate plus 0.125% to 1.000% per annum, based on Gentherm's consolidated net leverage ratio. Gentherm guaranteed the obligations and granted security interests in substantially all of its assets, as did certain domestic subsidiaries that also guarantee Gentherm's existing revolving credit facility. Gentherm disclosed expected annual cost synergies of approximately $25 million from cost optimization and operational efficiencies, with additional anticipated value creation from indirect purchasing and logistics efficiencies and commercial opportunities such as cross-selling, product integration, and entry into new global markets where Gentherm had not previously operated. Management described the combination as providing a path to a mid-teens adjusted EBITDA margin for the combined company and said the transaction was expected to be accretive to adjusted EPS by year two. No specific phase-in timeline or percentage of a defined cost base was disclosed for the $25 million synergy figure. On a pro forma basis, the combined company was said to have generated revenue of $2.6 billion for the trailing twelve months ended September 30, 2025, with an adjusted EBITDA margin of approximately 13% on a synergy-adjusted basis, and the RMT structure was designed to preserve Gentherm's balance sheet with pro forma net leverage of approximately 1.0 times. Approximately one-third of the combined company's pro forma revenue was said to come from end markets outside of light vehicles. Bill Presley, President and CEO of Gentherm, said at announcement: "This transaction accelerates the execution of our strategic framework with the combined company increasing its presence across multiple attractive end markets to drive profitable growth... The engineered solutions of Modine Performance Technologies are well aligned to our four core technology platforms, Thermal Management, Air Moving Devices, Pneumatic Solutions, and Valves, and we expect to create significant cross-selling opportunities and strengthen our ability to meet the rising demand for our combined, mission-critical offerings." Ron Hundzinski, Chair of Gentherm's Board, said: "Our Board is confident that the strong strategic fit, compelling transaction structure that preserves our balance sheet strength, and attractive financial position of the combined company will enable Gentherm to deliver significant long-term value for our shareholders and our customers." Neil Brinker, President and CEO of Modine, said the transaction "establishes two stronger, more focused companies, each equipped to serve its end markets more effectively, accelerate growth, and drive long-term value for shareholders, customers, and employees," adding that Modine would focus resources on data center cooling capacity expansion and targeted acquisitions, now anticipating 50% to 70% annual growth in its data center business over the following two years. Barclays served as exclusive financial advisor to Gentherm, with Honigman LLP and Latham & Watkins LLP serving as legal advisors to Gentherm. BofA Securities served as exclusive financial advisor to Modine, with Gibson, Dunn & Crutcher LLP serving as legal advisor to Modine, according to the January 29, 2026 joint announcement press release. The merger agreement, filed as Exhibit 2.2 to Gentherm's January 29, 2026 Form 8-K, provided for a termination fee of $45,000,000 payable by Gentherm (defined in the agreement as the "Gold Termination Fee," with Gentherm referred to as "Gold" and Modine as "Mercury") under specified circumstances, including termination in connection with a competing proposal. No corresponding termination fee payable by Modine was identified in the agreement. Gentherm filed a registration statement on Form S-4 (File No. 333-297224) on July 2, 2026, which was declared effective by the SEC on August 12, 2026, together with SpinCo's Form 10 registration statement, and a definitive proxy statement/prospectus was first mailed to Gentherm shareholders on or about August 12, 2026. At a special meeting held September 10, 2026, approximately 94.8% of Gentherm's outstanding shares voted (29,142,794 shares), and shareholders approved both the share issuance proposal (28,125,535 for versus 8,725 against) and the charter amendment proposal increasing authorized shares from 55,000,000 to 110,000,000 (28,950,597 for versus 161,933 against). The transaction closed October 1, 2026, with Gentherm issuing 23,735,961 new shares, appointing former Ford CTO Paul Mascarenas to its board (expanding the board from 9 to 10 members) as Modine's designee, and acquiring the Modine brand and trademarks; Modine intends to rename itself (pending shareholder approval) while continuing to use the Modine brand under license in its remaining Heat Transfer Solutions and HVAC Technologies businesses. Bill Presley and Jon Douyard continue to lead the combined company as CEO and CFO, respectively, with Katrin Schatz serving as Interim President of the Modine Performance Technologies division. Pro forma financial information required under Item 9.01(b) of Form 8-K had not yet been filed as of the October 1, 2026 closing 8-K; Gentherm stated it intended to file this information by amendment within 71 calendar days of the filing deadline for that report.

Sangamo Therapeutics, Inc., trading under ticker SGMOQ, is the subject of a bankruptcy asset sale within the healthcare sector. This restructuring transaction, classified as a product group matter, involves the sale of assets with a disclosed transaction value of 263.55 million USD. The transaction information is sourced from an SEC filing published on the SEC EDGAR platform on August 13, 2026. While the specific form type is not identified in the available materials, the filing represents the primary disclosure document for this matter. The deal's current status is pending regulatory approval or clearance. Sangamo Therapeutics has retained a comprehensive advisory team across financial and legal disciplines. On the financial side, the company engaged MERU, LLC to serve as its financial advisor, and Raymond James to serve as its restructuring banker. These advisors are working in tandem to manage the financial and restructuring aspects of the asset sale process. The company's legal counsel consists of two firms: Cooley LLP and Richards, Layton & Finger, PA, both of which are representing Sangamo in the transaction. No additional information regarding specific deal terms, consideration structure, or the identity of the acquiring party or parties has been disclosed in the available materials. The transaction timeline, including any expected closing date, has not been specified. Similarly, no details regarding the composition of the assets being sold, any earn-out provisions, assumed liabilities, or other material transaction structure elements have been made public. The 263.55 million USD valuation represents the sole quantitative metric disclosed for this restructuring transaction.

Semtech Corp, a technology company trading under ticker SMTC, has announced the divestiture of a business unit for a disclosed transaction value of $62 million in USD. This is a mergers and acquisitions transaction, specifically classified as a divestiture within the technology sector. The announcement represents Semtech's decision to divest a portion of its operating business, though the specific business unit or assets being sold are not detailed in the available disclosure. The transaction was announced via an 8-K filing submitted to the SEC on August 13, 2026. The 8-K is the operative disclosure document in this case and appears on SEC EDGAR. The deal has been announced but the current status beyond announcement, including whether it has closed or remains pending, is not specified in the available information. UBS Investment Bank is serving as the financial advisor to Semtech Corp on this divestiture. UBS is identified as the lead financial advisor, though no other financial advisors to either Semtech or any potential purchaser have been disclosed. No legal advisors have been identified or disclosed for this transaction. The transaction is structured as a sale with a disclosed purchase price or consideration of $62 million in USD. However, the specific structure of consideration, such as whether it is being paid in cash, stock, or a combination thereof, is not specified. No information regarding earn-outs, working capital adjustments, or other contingent consideration is available. Several critical details remain undisclosed. The identity of the buyer or purchaser is not named. The specific business unit, division, product line, or assets being divested are not described. No expected closing date or timeline for completion has been provided. The precise structure and form of the $62 million consideration payment, and whether any portion is contingent or subject to adjustment, is not disclosed. Additionally, whether this $62 million represents gross or net proceeds, and whether any transaction expenses or net adjustments are embedded in that figure, is not stated.

Semtech Corporation (Nasdaq: SMTC) announced on August 13, 2026 that it has entered into a definitive agreement to sell its cellular module business to Compal Electronics, Inc. (TWSE: 2324) for $62 million in cash, subject to customary adjustments. Under the agreement, Compal will acquire substantially all of the assets and operations comprising Semtech's cellular module business, including its associated intellectual property, customer relationships, and personnel. Semtech framed the sale as part of a broader portfolio discipline effort meant to sharpen its focus on data center and LoRa connectivity products. This record is sourced from Semtech's own 8-K press release (Exhibit 99.1), furnished to the SEC on August 13, 2026, describing the transaction as having been approved by both companies' boards of directors. The release is the company's original disclosure of the divestiture and does not reference the underlying purchase agreement as a separate exhibit, so additional mechanics beyond what is described in the press release are not available from this document. UBS Investment Bank served as financial advisor to Semtech in connection with the transaction, per the press release's advisors section. No financial advisor to Compal Electronics is identified in this filing. O'Melveny & Myers LLP served as legal counsel to Semtech in connection with the transaction. No legal counsel to Compal Electronics is named in this release. The transaction is structured as a $62 million all-cash sale, subject to customary adjustments, of substantially all assets and operations of Semtech's cellular module business. The deal was approved by both companies' boards and is expected to close during the fourth quarter of Semtech's 2027 fiscal year, subject to the satisfaction or waiver of customary closing conditions including receipt of certain regulatory approvals. Not disclosed in this filing: any financial advisor representing Compal Electronics, legal counsel for Compal, the specific regulatory approvals required, any termination fee, and financial details of the cellular module business being divested (such as its standalone revenue or EBITDA).

National CineMedia, Inc. (NASDAQ: NCMI), the largest cinema advertising platform in the United States, announced on August 11, 2026 that it has entered into a definitive agreement to acquire Captivate Holdings, LLC, the leading operator of digital video elevator and lobby advertising in North America, for an enterprise value of $275.0 million. NCM is purchasing Captivate from Generation Partners, a growth equity firm that acquired Captivate in 2013. The combination is intended to create a premium video and digital out-of-home advertising platform spanning more than 48,000 screens across 185 Designated Market Areas, including all of the top 100. This record is sourced from National CineMedia's own 8-K press release (Exhibit 99.1), furnished to the SEC on August 11, 2026, announcing the signing of the definitive agreement. The release states the acquisition is subject to customary closing conditions but does not specify an expected closing date. BofA Securities is serving as exclusive financial advisor to National CineMedia on the acquirer side. Solomon Partners is serving as exclusive financial advisor to Captivate on the target/seller side. Hogan Lovells Cadwalader is serving as legal counsel to National CineMedia. Gibson, Dunn & Crutcher LLP is serving as legal counsel to Captivate. The transaction is valued at an enterprise value of $275.0 million. Captivate operates more than 26,000 digital video screens across more than 11,000 office and residential buildings in more than 170 DMAs in the U.S. and Canada, with its core business concentrated in more than 1,600 Class A and Class B office buildings that generate approximately 90% of Captivate's advertising revenue; the press release does not specify the consideration structure (cash versus other forms) or financing sources for the purchase. Not disclosed in this filing: the cash/stock or financing mix for the $275.0 million purchase price, the expected closing date or timeline, any termination fee, and Captivate's standalone revenue or EBITDA figures.

EagleRock Land, LLC, a natural resources company trading under ticker EROK, is acquiring an unnamed target in a mergers and acquisitions transaction valued at $78,200,000. The deal has been announced and is classified within the mergers and acquisitions product group. The transaction involves the natural resources sector and represents a disclosed equity value of $78.2 million, though the specific identity of the target company has not been provided in the available documentation. The transaction was publicly announced through an 8-K filing submitted to the SEC and published on August 11, 2026. This current-events report represents the primary disclosure of the deal in the public record to date. The deal has reached announced status, indicating that material terms have been made public, though the transaction appears not yet to have closed as of the filing date. Raymond James has been engaged as the financial advisor to the special committee of EagleRock Land and is serving in a lead capacity on the acquirer side. This engagement structure, in which the advisor represents a special committee rather than the full board or management, is typical where conflict mitigation or enhanced governance processes are warranted. No other financial advisors to either party have been identified in the available source materials. No legal advisors to either the acquirer or target have been identified or disclosed in the filing materials reviewed. Beyond the headline transaction value of $78.2 million, the specific structure and composition of consideration has not been disclosed. The filing does not specify whether the deal will be settled in cash, stock, debt instruments, or a combination of these, nor does it describe any earnout, working capital adjustment, or other contingent consideration provisions. The deal subtype within mergers and acquisitions (such as whether this is an asset purchase, stock purchase, or merger) remains unspecified. The 8-K filing does not provide an expected closing date or any conditions precedent to close. The identity of the target company, its size, operations, or strategic fit with EagleRock Land is not disclosed. No information about financing sources for the $78.2 million purchase price has been made public. The role and scope of Raymond James' advisory engagement, including any specific fee arrangements, remains undisclosed.

Katapult Holdings, Inc. (NASDAQ: KPLT) completed a previously announced three-way, all-stock business combination with The Aaron's Company, Inc. (operating through Aaron's Intermediate Holdco, Inc.) and CCF Holdings LLC ("CCFI") on August 11, 2026. The Agreement and Plan of Merger was originally signed December 11, 2025 and was amended once, on June 17, 2026. The transaction closed, and the combined company continues to trade on Nasdaq under the ticker KPLT. This record covers the Aaron's leg of that three-party combination. Under the merger mechanics, Aaron's equityholders (including Aaron's MIP unit holders) received an aggregate of approximately 12,312,815 shares of Katapult common stock, while CCFI equityholders received approximately 69,772,607 shares (inclusive of warrant-related shares) and Katapult's pre-existing stockholders retained the remainder. On a fully diluted basis immediately after closing, roughly 87.4 million shares of Katapult common stock were outstanding, with former CCFI equityholders owning approximately 79.8-80%, former Aaron's equityholders owning approximately 14-14.1%, and legacy Katapult stockholders owning approximately 6-6.1% of the combined company. The mergers were accounted for as a reverse acquisition under ASC 805, with Katapult as the legal acquirer but CCFI treated as the accounting acquirer, based on CCFI unitholders holding the largest voting stake, CCFI controlling six of the combined company's ten board seats (including the board chair), and CCFI being the largest of the three businesses by net income and enterprise value. Per Katapult's preliminary purchase price allocation (Form 8-K/A, Exhibit 99.5), the estimated fair value of total merger consideration for Aaron's was approximately $79.8 million (based on 12,312,815 Katapult shares valued at Katapult's August 11, 2026 market price of $6.48 per share), with estimated goodwill of approximately $91.5 million recognized on the Aaron's acquisition. Katapult itself (also treated as acquired for accounting purposes under the reverse-merger structure) was assigned estimated merger consideration of approximately $34.2 million and goodwill of approximately $46.6 million. These figures are explicitly labeled preliminary and subject to revision as the purchase price allocation is finalized within one year of closing; no separate enterprise value, EV/EBITDA, or P/E multiple for the Aaron's transaction specifically was disclosed in the filings reviewed. In connection with the closing, Katapult entered into new secured term loan facilities: a Katapult Intermediate Holdings, LLC ("TopCo") term loan of up to $200.0 million, consisting of an initial tranche of approximately $121.7-122.0 million funded in full at closing and a delayed draw facility of up to approximately $78.0 million, bearing interest at 15.0% per annum cash plus 5.0% per annum paid-in-kind, maturing August 11, 2029. A separate Katapult MidCo, LLC term loan of approximately $75.0 million was also entered into at 15.0% per annum (with PIK election available), maturing November 3, 2030, with proceeds used to fund Katapult's repurchase of all 65,000 outstanding shares of its Series A/B preferred stock previously held by Hawthorn (HHCF Series 21 Sub, LLC). CCFI separately amended its existing Sparrow Term Loan, increasing the maximum commitment by $25.0 million to $75.0 million and raising the blended interest rate to 16.6%. Katapult's existing TMX asset-based credit facility was also amended (Seventh Amendment) to extend its draw period to December 31, 2027 and reset legacy loan balances. Per the combined company's closing press release, the business generated more than $4 billion in 2025 pro forma revenue and more than $460 million in 2025 pro forma adjusted EBITDA. Kyle Hanson, Executive Chairman of Katapult Holdings (former CCFI Executive Chairman and CEO), said the combination unites "three businesses with distinct strengths and a shared commitment to serving nonprime consumers" and creates "a stronger, more diversified platform with broader customer relationships, a vast proprietary data set, complementary capabilities," adding that management has "tremendous confidence" in the leadership team's ability to "integrate these businesses successfully, drive meaningful cost savings and operational efficiencies over time, and create long-term value." Cory Miller, Chief Executive Officer (former CEO of The Aaron's Company), said the deal lets the company "redefine how nonprime consumers access the financial solutions they need," bringing together "complementary brands, a nationwide retail and digital footprint, and the technology and data that connect them." No specific dollar synergy target, percentage of cost base, or phase-in timeline was disclosed in the sources reviewed; management described synergies only qualitatively as "meaningful cost savings and operational efficiencies over time." Post-closing, the combined company reports results through two segments: Lease-to-Own & Retail (comprising Aaron's -- including its Aaron's, BrandsMart U.S.A., and BrandsMart Leasing brands -- and Katapult) and Consumer Finance (comprising CCFI). Katapult's board was expanded to ten directors, with Kyle Hanson as Executive Chairman and Jennifer Baldock as Lead Director; Cory Miller became CEO, Russell Falkenstein became CFO, William Baker became President, and Douglass Noe became Chief Accounting Officer, alongside new director and executive appointments and several legacy Katapult officer resignations (including former CEO Orlando Zayas and former CFO Nancy Walsh, who received change-in-control severance under their existing employment agreements). On the advisory side, J.P. Morgan Securities LLC served as exclusive financial advisor to Aaron's, with King & Spalding LLP as Aaron's legal counsel. Guggenheim Securities, LLC served as financial advisor to Katapult Holdings, with Davis Polk & Wardell LLP as Katapult's legal counsel. Morrison Foerster LLP served as legal counsel to CCFI. These roles are confirmed directly in Katapult's August 11, 2026 closing press release (Exhibit 99.1 to the Form 8-K). The shares of Katapult common stock issued to former Aaron's and CCFI equityholders were registered on a Form S-4 (File No. 333-296909) filed with the SEC on June 18, 2026, except for 76,765,355 shares issued in reliance on the Section 4(a)(2) private-placement exemption, which are subject to a registration rights agreement requiring Katapult to file a resale registration statement within 45 days of closing. Unaudited financial statements and management's discussion and analysis for both CCFI and Aaron's for the six months ended June 30, 2026 and 2025, along with Article 11 unaudited pro forma condensed combined financial information (balance sheet as of June 30, 2026 and income statements for the six months ended June 30, 2026 and full year 2025), were filed by amendment on Form 8-K/A on September 11, 2026, as permitted under the 71-day extension for acquired-business financials. No EPS accretion/dilution figure, termination fee, or further regulatory-approval contingency was disclosed in the filings reviewed; because the transaction has already closed, those items are no longer applicable deal conditions.

Archer Aviation Inc., a publicly traded company in the industrials sector trading under the ticker ACHR, is the acquirer in a mergers and acquisitions transaction. The target company name and details are not specified in the source materials. This is a merger and acquisition in the industrials sector. The transaction was announced, and Archer Aviation is proceeding as the acquiring party. The disclosed deal value is not stated in the source document. The transaction details were disclosed through a Form 8-K filing published on the Securities and Exchange Commission's EDGAR system on August 10, 2026. The Form 8-K serves as the current source document for this transaction. The deal is currently at the announced stage. No expected closing date or other forward-looking timeline milestones have been disclosed in the available documentation. J.P. Morgan Securities LLC is serving as the lead financial advisor to the target company on this transaction. On the acquirer side, Moelis & Company LLC has been engaged as the lead financial advisor to Archer Aviation Inc. Both advisors are in lead positions on their respective sides. No secondary or co-advisor roles have been identified in the source materials, and no specific functional roles beyond lead financial advisor status have been disclosed. No legal advisors have been identified or disclosed in the source materials for either party to this transaction. The specific consideration structure, deal subtype, and any structural details regarding the merger have not been disclosed in the available documentation. Whether the transaction will involve cash, stock, debt, or a combination thereof remains undisclosed. Similarly, the payment terms, any earnouts, holdbacks, or other contingent consideration mechanisms have not been specified. The following material details remain unknown or undisclosed: the identity of the target company, the total enterprise value or purchase price, the consideration structure and form of payment, any financing arrangements or credit facilities associated with the transaction, the expected closing date or any material interim milestones, and the detailed transaction structure or purchase agreement terms. No information has been disclosed regarding regulatory approvals, shareholder votes, or any material conditions to closing.

TPG Mortgage Investment Trust, Inc., trading under ticker MITT, is acquiring Cherry Hill Mortgage Investment Corp., ticker CHMI, in an all-cash merger transaction within the real estate sector. The disclosed deal value is $117.5 million. This is a mergers and acquisitions transaction within the real estate industry. The transaction information is sourced from SEC EDGAR filings published on August 10, 2026. The specific SEC filing form type is not disclosed in the available materials. The deal is currently pending regulatory approval. On the target side, BTIG, LLC is serving as exclusive financial advisor to Cherry Hill Mortgage Investment Corp. On the acquirer side, Piper Sandler & Co. is serving as exclusive financial advisor to TPG Mortgage Investment Trust, Inc. Both advisory relationships are lead positions. For legal representation, Mayer Brown LLP is acting as legal advisor to Cherry Hill Mortgage Investment Corp. on the target side. On the acquirer side, TPG Mortgage Investment Trust, Inc. is represented by two firms: Hunton Andrews Kurth LLP and Freshfields LLP are acting as legal counsel to MITT. Additionally, Fried, Frank, Harris, Shriver & Jacobson LLP is acting as legal counsel specifically to MITT's independent directors. The transaction is structured as a merger with a disclosed consideration value of $117.5 million. However, the specific mix of consideration, whether cash, stock, or other instruments, is not disclosed in the available materials. No details regarding the per-share price, exchange ratio, or other structural terms have been provided. The following material details remain undisclosed: the specific form of SEC filing containing this information, the expected closing date or timeline for regulatory approval, whether the $117.5 million represents the full equity consideration or includes debt assumptions or other liabilities, and any conditions, termination fees, or financing conditions associated with the transaction.

CoreWeave, Inc., a technology sector company trading under ticker CRWV, is the issuer in a leveraged finance transaction consisting of a delayed draw term loan facility with a disclosed size of $2.6 billion. This is a credit product within the leveraged finance space, structured specifically as a delayed draw facility, which allows the borrower to draw funds at specified future dates rather than upon initial closing. The transaction was announced and sourced from SEC filings published on the SEC EDGAR platform on two dates: May 18, 2026 and August 10, 2026. The specific SEC form type is not disclosed in the available information. The deal is currently in announced status, indicating that terms have been made public but the facility has not yet closed. The financing was arranged by four joint lead arrangers and bookrunners. Morgan Stanley and Mitsubishi UFJ Financial Group served jointly as lead arrangers and bookrunners advising the issuer side of the transaction. On the lender side, JPMorgan and Mitsubishi UFJ Financial Group served as joint lead arrangers and bookrunners. Notably, Mitsubishi UFJ Financial Group appears in both a joint lead arranger and bookrunner capacity across both the issuer and lender relationships, indicating its prominent role in structuring and distributing the facility. No other financial advisors are identified in the available documentation. No legal advisors have been identified or disclosed in the sourced materials. The facility is structured as a delayed draw term loan, meaning the borrower has committed access to $2.6 billion that will be drawn over time according to the terms of the credit agreement rather than in a single advance at closing. Beyond the facility type and aggregate size, no other structural details have been disclosed regarding the delayed draw mechanics, including the specific draw schedule, pricing, tenor, financial covenants, or other material terms. The following key deal terms and details remain undisclosed: the specific interest rate or pricing grid, the tenor or maturity date of the facility, the expected closing date, detailed draw conditions or schedule mechanics, financial covenant packages, prepayment terms, and the identity of the administrative agent or other arranger roles. The specific form type of the SEC filings has also not been identified from the available source materials.

Amneal Pharmaceuticals, Inc., a biopharmaceutical company trading under ticker AMRX, has completed its acquisition of Kashiv BioSciences, LLC, a vertically integrated biosimilars developer and manufacturer, after entering into a Membership Interest Purchase Agreement dated April 21, 2026 and obtaining stockholder approval on July 31, 2026. The acquisition closed on August 10, 2026, with Amneal purchasing 100% of Kashiv's outstanding membership interests. Because Kashiv is owned by members of the Amneal Group, including Amneal's Co-Founders and Co-Chief Executive Officers Chirag Patel and Chintu Patel, the transaction was structured and negotiated as a related-party deal, delegated to an Independent (Conflicts) Committee of Amneal's board and subjected to a majority-of-the-disinterested-stockholders vote in addition to standard approval of the stock issuance. "The completion of this acquisition marks a pivotal step in Amneal's strategy to become America's #1 Affordable Medicines company," said Chirag Patel at closing. "With this acquisition, we have created an integrated biosimilars business that can launch multiple biosimilars each year and extends our growth profile into the next decade." At signing, Chirag Patel said the deal makes Amneal "a fully integrated global biosimilars leader at the forefront of the next wave of U.S. affordable medicines," while Chintu Patel said combining "Kashiv's deep R&D and manufacturing capabilities with our commercial strength" creates a platform to deliver "a strong and consistent cadence of biosimilar launches." Kashiv's CEO, Dr. Sandeep Athalye, called it an opportunity to combine "highly complementary portfolio and capabilities with Amneal at this critical inflection point for the biosimilar market," noting the deal builds on a collaboration of more than ten years between the companies. Amneal said the acquisition provides access to a market facing more than $300 billion of projected global biologics loss-of-exclusivity over the next decade and that it expects more than 12 commercial biosimilars by 2030 with over 20 more in the pipeline. Under the terms of the Purchase Agreement, Amneal paid Kashiv's sellers $375 million in cash (subject to customary adjustments for cash, interim operating funding, indebtedness, transaction expenses and working capital) plus 28,942,098 shares of Class A common stock (originally 28,942,108 shares before a fractional-share adjustment), which the companies valued at signing at approximately $375 million, for combined upfront consideration of roughly $750 million. Sellers are also eligible for up to an additional $350 million in contingent payments tied to the achievement of U.S. regulatory milestones for up to six designated Kashiv product candidates, plus contingent royalty payments over a 12-year period following closing equal to 25% of the amount by which annual aggregate gross profits for certain products exceed specified hurdle amounts. A portion of the cash consideration was funded through a new $350 million incremental term loan provided by Bank of America, N.A. under Amendment No. 4 to Amneal LLC's existing Term Loan Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. Goldman Sachs & Co. LLC, financial advisor to the Independent Committee, rendered a fairness opinion dated April 21, 2026 covering the cash, stock, milestone and royalty consideration. In its discounted cash flow analysis, using discount rates of 11.0% to 13.0% and perpetuity growth rates of 0.0% to 1.5% (implying terminal-year EBITDA exit multiples of 5.6x to 7.8x), Goldman Sachs derived an illustrative intrinsic enterprise value for Kashiv of between $1.6 billion and $2.1 billion excluding synergies, and between $1.9 billion and $2.3 billion including Amneal's estimated cost synergies. Separately, Goldman Sachs calculated a risk-adjusted net present value of the full consideration package, finding the $350 million of contingent milestone payments (probability-weighted at 20% to 93% depending on product, discounted at an estimated 12.0% weighted average cost of capital) had a present value of approximately $125 million as of December 31, 2025. Amneal disclosed that the transaction is "highly synergistic," with $400 million to $500 million in expected financial benefits through elimination of upcoming milestone and royalty obligations through 2030 and incremental tax and structural benefits over time, and said it expects minimal impact to its leverage profile with a path to deleveraging below 3x net leverage by 2028. The proxy statement's negotiation history shows the deal terms were substantially reduced from Kashiv's initial, non-binding June 2025 proposal, which had sought $900 million of upfront consideration ($250 million cash and $500 million stock, with Kashiv's existing term loan not deducted from the purchase price), up to $1.125 billion in success-based milestones, and a 10-year, 7.5%-of-net-sales royalty on Kashiv's first seven pipeline programs. On the Independent Committee side, Goldman Sachs & Co. LLC served as financial advisor and Richards, Layton & Finger, P.A. and Blue Raven LLP served as outside legal counsel; The Boston Consulting Group, Inc. and InterPharmaLink AG were also engaged as industry consultants during the Committee's review. Simpson Thacher & Bartlett LLP served as legal counsel to Amneal, with KPMG US serving as Amneal's outside tax, finance and accounting advisor. On the Kashiv/seller side, J.P. Morgan Securities LLC served as financial advisor, Holland & Knight LLP served as legal counsel, and Dhinal Shah Associates served as an India-based advisor. Ernst & Young LLP audited Amneal's financial statements and Grant Thornton LLP audited Kashiv's financial statements. Innisfree M&A Incorporated acted as Amneal's proxy solicitor for the special stockholder meeting. At a July 31, 2026 special meeting, Amneal stockholders approved both the Transaction Proposal and the Stock Issuance Proposal. Of 319,331,346 shares outstanding, 288,567,159 were present or represented by proxy, including 138,987,985 shares held by disinterested stockholders; the Transaction Proposal (requiring majority approval of disinterested stockholders under DGCL Section 144 safe-harbor standards) passed with 138,265,079 votes for, 655,759 against and 67,147 abstentions, and the Stock Issuance Proposal passed with 286,714,072 votes for, 1,791,016 against and 62,071 abstentions. The agreement was not subject to any financing condition, and the parties had set an outside date of November 17, 2026 (automatically extendable to January 12, 2027 if only certain regulatory conditions remained outstanding), though the deal closed well ahead of that date. As required by the agreement, Amneal also issued the stock consideration in an unregistered placement under Section 4(a)(2) of the Securities Act and has agreed to file a Form S-3 resale registration statement for those shares. Amneal stated it intends to file Kashiv's historical and pro forma financial statements required under Item 9.01 by amendment within 71 days of the closing report; those statements were not yet available as of the closing 8-K and so detailed combined/pro forma income statement or balance sheet figures are not yet disclosed.

MarineMax, Inc. (NYSE: HZO), a marina operator, superyacht services company and boat and yacht retailer, announced on August 10, 2026 that it has entered into a definitive agreement to be acquired by Safe Harbor Marinas, a Blackstone Infrastructure portfolio company, in an all-cash transaction. Under the agreement, Safe Harbor will acquire all issued and outstanding shares of MarineMax common stock for $53.00 per share in cash, representing an enterprise value of approximately $1.5 billion. The sale followed a competitive strategic review process led by MarineMax's board of directors after an earlier unsolicited non-binding proposal became public. This record is sourced from MarineMax's own 8-K press release (Exhibit 99.1), furnished to the SEC on August 10, 2026. The release states the transaction was unanimously approved by MarineMax's board following a comprehensive strategic review, and that if completed, MarineMax will become a privately held company and its common stock will no longer be listed on the NYSE. Wells Fargo is serving as exclusive financial advisor to MarineMax on the target side. Evercore is serving as exclusive financial advisor to Safe Harbor on the acquirer side. Sidley Austin LLP is serving as legal counsel to MarineMax. Simpson Thacher & Bartlett LLP is serving as legal counsel to Safe Harbor. The $53.00 per share cash purchase price represents a 96% premium to MarineMax's closing share price of $27.03 on January 30, 2026, the last trading day before public disclosure of the earlier unsolicited proposal, and a 110% premium to the company's 90-day volume-weighted average price through that date. The deal is not subject to a financing condition and is expected to close by the end of calendar year 2026, subject to customary closing conditions including certain regulatory approvals and approval by MarineMax shareholders at a special meeting. Not disclosed in this filing: any termination fee payable by either party, the specific regulatory approvals required, financing sources backing Safe Harbor's/Blackstone's purchase, and whether any go-shop provision applies.

HBT Financial, Inc., a financial services company, is acquiring Tri-County Financial Group, Inc., a publicly traded firm in the financial institutions and services sector trading under ticker TYFG, in an all-stock merger transaction. The disclosed transaction value is $204,600,000 in U.S. dollars. This is a merger and acquisition within the financial institutions sector, representing a significant consolidation move in regional banking. The transaction was announced on August 10, 2026, as disclosed in a Form 8-K filing submitted to the SEC and available through SEC EDGAR. The deal has been announced but the current status does not indicate whether it has closed or remains subject to regulatory approval and customary closing conditions. No expected closing date has been disclosed in the available source materials. HBT Financial engaged Piper Sandler & Co. as its lead financial advisor on the transaction. On the target side, Tri-County Financial Group retained Performance Trust Capital Partners, LLC as its lead financial advisor. Both advisors served in the capacity of lead financial advisor to their respective clients, with no co-advisors or co-managers identified in the available disclosure. The roles and responsibilities of each advisor beyond the lead advisory designation have not been specified in the source materials. No legal advisors or counsel to either party have been identified in the available disclosure documents. The transaction is structured as a merger, with the disclosed consideration totaling $204,600,000. However, the specific consideration mix, including whether payment will be made entirely in HBT Financial common stock or through some combination of stock, cash, and other consideration, has not been disclosed. The precise exchange ratio or per-share consideration for Tri-County Financial Group shareholders remains undisclosed. The announcement provides limited detail on deal terms and conditions. While the transaction value and general structure are known, critical details remain unavailable: the specific composition of consideration (equity, cash, debt instruments, or combinations thereof), any earnout provisions or contingent consideration, the per-share or per-unit economics for Tri-County shareholders, anticipated closing conditions or regulatory approvals required, any termination provisions or reverse termination fees, and the precise effective date or expected closing timeline have not been disclosed in the available source material.

Backstop Parties, acting as financial supporters in a rights offering, are the subject of this equity capital markets transaction, with the issuer conducting a rights offering valued at $125 million in U.S. dollars. A rights offering is a form of primary equity issuance in which existing shareholders are granted the right to purchase additional shares of the company at a predetermined price, typically at a discount to the current market price, before the offering is made available to the general public. This transaction falls within the equity capital markets product group and represents a mechanism for the issuer to raise capital while providing existing shareholders with the opportunity to maintain their proportional ownership stakes in the company. The transaction was announced via an SEC Form 8-K filing published on August 10, 2026, which serves as the primary source document for this briefing. The Form 8-K, filed with the SEC on the EDGAR system, indicates that the deal has been announced. The current status of the offering has not yet progressed to completion, as the filing represents the initial public disclosure of the transaction rather than notification of a closed transaction. On the financial advisory side, Perella Weinberg Partners has been engaged as the lead financial advisor to the issuer. The specific advisory role was described in source materials as positioning Perella Weinberg as taking the lead role in advising the company on the offering structure and execution. On the backstop parties' side, White & Case LLP is serving as legal counsel to the Backstop Parties, providing legal guidance on the backstop arrangement and related transaction documentation and protections. No legal counsel has been identified in the available source materials for the issuer side of this transaction, and no other financial advisors, co-managers, or additional advisors have been identified in the sourced documents. The sole identified financial advisor relationship is Perella Weinberg's lead role on behalf of the issuer. The transaction has been structured as a rights offering with a disclosed aggregate value of $125 million. Beyond the identification of the transaction type and total size, no additional disclosure regarding the specific terms has been provided in the sourced materials. Details regarding the subscription price per share, the ratio of rights granted to existing shareholders, the length of the subscription period, or any other specific rights offering mechanics have not been disclosed in the available sources. Several material details regarding this transaction remain undisclosed or unknown based on the available source documents. The expected closing or completion date for the rights offering has not been provided. The consideration structure, including whether there are any cash, stock, or other forms of consideration involved beyond the primary equity issuance itself, is not specified. The specific terms of the backstop agreement, including the size of the backstop commitment, the financial terms offered to the Backstop Parties, or their identities beyond their classification as "Backstop Parties," are not disclosed. Additionally, the identity of the issuer itself is not provided in the sourced materials, nor is information regarding subscription price, share count, or dilutive impact.

Liberty Interactive Corporation and QVC Inc. jointly announced a Chapter 11 bankruptcy restructuring with a disclosed enterprise value of $5 billion. The transaction involves the reorganization of these entities under chapter 11 of the U.S. Bankruptcy Code, a product that falls within the restructuring advisory space. The announcement was made public through an SEC Form 8-K filing, which represents the official disclosure vehicle for this material corporate action. The transaction was announced via SEC EDGAR filing on August 7, 2026, as documented in a Form 8-K submission. This represents an announced restructuring, meaning the parties have publicly disclosed the transaction terms but the Chapter 11 process remains in progress toward confirmation and emergence. The company engaged Evercore Group L.L.C. as its primary financial advisor on the restructuring. Additionally, AlixPartners, LLP was retained as restructuring advisor to the company, providing specialized advisory services focused on operational and financial restructuring matters. On the creditor side, multiple financial advisors were appointed to represent distinct stakeholder groups. Centerview Partners LLC was retained as financial advisor to the ad hoc noteholders of Liberty Interactive (LINTA), representing the interests of holders of unsecured notes in that entity. PJT Partners LP serves as financial advisor to the ad hoc noteholders of QVC Inc., advising those creditors on their restructuring strategy. Lazard Frères & Co. LLC was engaged as financial advisor to the revolving credit facility lender group, representing the secured lender constituency. No legal advisors were disclosed in the available filing materials. The restructuring contemplates a total enterprise value of $5 billion as the disclosed valuation metric for the reorganized entities emerging from the Chapter 11 process. Beyond this headline figure, the specific structure of the plan of reorganization, the treatment of various claim classes, the distribution waterfall, and any consideration to be received by equity holders or creditors have not been disclosed in the materials reviewed. The timeline for emergence from Chapter 11 is not disclosed, nor has a projected effective date for the plan of reorganization been announced. Additionally, the specific consideration mix as between cash, new equity, or debt instruments in the reorganized entities is not detailed in the available filing. The allocation of value among different classes of creditors and the treatment of unsecured claims remain unspecified in the disclosed information to date.

Red Violet, Inc. (NASDAQ: RDVT), a Boca Raton, Florida-based analytics and information solutions provider, conducted an underwritten public offering of its common stock announced on August 5, 2026. The transaction was disclosed across a series of SEC filings: a Form 8-K with three press release exhibits (launch, pricing, and closing), and a prospectus supplement on Form 424B5 filed pursuant to an effective shelf registration statement on Form S-3 (File No. 333-291649, filed November 19, 2025 and declared effective November 25, 2025). The offering launched on August 5, 2026, with the size and terms initially unspecified and subject to market conditions. Later that same day, Red Violet announced pricing of 1,666,667 shares of common stock at a public offering price of $60.00 per share, for expected gross proceeds of $100 million before underwriting discounts and offering expenses. The public offering price of $60.00 represented a discount of approximately 12.1 percent to the $68.28 last reported Nasdaq sale price of Red Violet common stock on August 5, 2026, the pricing date, as stated in the prospectus supplement. The underwriting discount was $3.00 per share (5 percent), yielding proceeds to the company, before expenses, of $57.00 per share, or $95,000,019 in aggregate on the firm shares. Red Violet also granted the underwriters a 30-day option to purchase up to an additional 250,000 shares (15 percent of the base offering) at the public offering price less underwriting discounts. The underwriters exercised this option in full on August 6, 2026. The offering closed on August 7, 2026, with total issuance of 1,916,667 shares and estimated net proceeds to the company of approximately $108.6 million, after deducting underwriting discounts, commissions, and estimated offering expenses, consistent with the $115 million aggregate gross offering size (1,916,667 shares multiplied by $60.00 per share) on file for this deal. Based on the prospectus supplement, Red Violet had 14,130,308 shares of common stock outstanding as of August 3, 2026, prior to the offering. With the underwriters' option exercised in full, shares outstanding immediately after the offering were expected to be approximately 16,046,975, implying dilution of approximately 13.6 percent of pre-offering shares outstanding from the new issuance. The prospectus supplement does not disclose any concurrent share repurchase program tied to this offering. Raymond James and Needham & Company acted as joint book-running managers and as representatives of the underwriters for the offering. B. Riley Securities and Craig-Hallum acted as co-managers. Lake Street Capital Markets served as financial advisor to Red Violet. Akerman LLP served as legal counsel to Red Violet, including issuing the legal opinion on the legality of the shares (filed as Exhibit 5.1 to the Form 8-K), and Cooley LLP served as legal counsel to the underwriters. Red Violet stated that it intends to use the net proceeds from the offering for working capital and general corporate purposes, including potential strategic acquisitions. No specific acquisition target, debt repayment use, or other itemized use of proceeds is disclosed in the available filings. The underwriting agreement, dated August 5, 2026, between Red Violet and Raymond James & Associates, Inc. and Needham & Company, LLC, as representatives of the several underwriters, was filed as Exhibit 1.1 to the Form 8-K and includes customary representations, warranties, indemnification obligations, and termination provisions. The timeline from announcement to settlement was compressed: the offering was announced on August 5, 2026, priced the same day, the underwriters' option was exercised the following day (August 6, 2026), and the transaction closed with delivery of shares on August 7, 2026, two days after launch.

AbbVie Inc., a healthcare sector company trading under the ticker ABBV, is undertaking a debt capital markets transaction in the form of a debt offering with a disclosed aggregate value of $10 billion USD. This is a primary debt issuance by the company in the healthcare industry. The transaction is sourced from SEC filings published on the SEC EDGAR system on August 4, 2026 and August 6, 2026. The specific SEC form type has not been identified. The current status of the transaction is pending regulatory approval. A substantial syndicate of financial advisors has been assembled to manage the offering, all serving in the capacity of joint book-running managers on behalf of the issuer. The lead book-running managers include Morgan Stanley, BofA Securities, J.P. Morgan, and Societe Generale, who are described as managing all notes issued in this offering. Additional joint book-running managers with specific tranche assignments include Deutsche Bank Securities managing the 2036 notes, Wells Fargo Securities managing the 2056 notes, Mizuho managing the 2031 notes, HSBC managing the 2033 notes, BNP Paribas managing the 2030 notes, Barclays managing the floating rate notes and 2028 notes, and Citigroup managing the 2038 notes and 2066 notes. This structuring reflects a multi-tranche offering with different maturity profiles, with individual managers assigned lead responsibility for specific note tranches while the primary managers coordinate the overall syndication. No legal advisors have been identified in the available source materials. The transaction structure involves multiple note tranches with distinct maturity dates ranging from 2028 through 2066, suggesting a laddered debt maturity profile. Specific terms regarding interest rates, coupons, pricing, or other consideration mechanics have not been disclosed in the available documentation. The offering includes both fixed-rate and floating-rate note components, as evidenced by Barclays' assignment to manage floating rate notes alongside specific tenor tranches. The expected closing date for this transaction has not been disclosed. The specific coupon rates, pricing spreads, and final terms for individual note tranches remain undisclosed. The aggregate $10 billion represents the total disclosed value but does not specify how much each individual tranche within the multi-tranche offering will comprise. No information regarding use of proceeds has been provided.

Tarsus Pharmaceuticals, Inc., a publicly traded healthcare company trading under the ticker TARS, is acquiring Alkeus in an all-stock or cash transaction valued at $450 million. This is a mergers and acquisitions deal within the healthcare sector. The transaction is currently pending regulatory approval. The deal information has been sourced from an SEC filing published on the SEC EDGAR database on August 6, 2026. The specific form type is not identified in the available documentation. Given the pending regulatory status, the transaction has not yet closed and remains subject to customary conditions and regulatory clearance. Barclays is serving as the exclusive financial advisor to Tarsus, the acquirer, in a lead capacity on this transaction. On the target side, Jefferies is acting as the exclusive financial advisor to Alkeus, also in a lead advisory role. Both firms are providing comprehensive financial advisory services to their respective clients throughout the deal process. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is providing legal counsel to Tarsus in connection with the acquisition. Latham & Watkins LLP is serving as legal counsel to Alkeus, the target company. Both firms are handling all legal matters related to the transaction for their respective clients. The transaction is valued at $450 million, though the specific mix of consideration, whether structured as cash, stock, or a combination thereof, has not been disclosed. The deal structure remains undisclosed beyond the headline valuation figure. No information has been provided regarding the relative weighting between cash and equity consideration, any earnout provisions, closing conditions beyond regulatory approval, timing for regulatory review, or an expected closing date. The target company Alkeus' sector classification and operational details have not been specified. Additionally, the specific regulatory agencies with jurisdiction over this transaction and their anticipated approval timelines have not been disclosed.

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) announced on August 6, 2026 that it has entered into a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held, retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease, a rare inherited retinal disease with no FDA-approved treatment. Tarsus said the acquisition is intended to expand its presence in retina therapeutics and complement its existing eye care pipeline, including the earlier acquisition of iRenix Medical. This record is sourced from Tarsus's own press release, furnished as an exhibit to an 8-K filed with the SEC on August 6, 2026. The release states the transaction has been approved by the boards of directors of both companies and by Alkeus's stockholders, and that closing is not contingent on any financing condition. Barclays is acting as exclusive financial advisor to Tarsus on the acquirer side. Jefferies is acting as exclusive financial advisor to Alkeus on the target side. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is acting as legal counsel to Tarsus. Latham & Watkins LLP is acting as legal counsel to Alkeus. The upfront consideration is approximately $450 million, consisting of $270 million in cash and $180 million in Tarsus common stock priced at $61.38 per share at closing, roughly a 60/40 cash-to-stock split. Alkeus stockholders are also eligible for up to $350 million in milestone payments tied to regulatory approval and first commercial sale, plus low single digit tiered descending royalties on gildeuretinol net sales. The transaction is expected to close in 2026, subject to expiration or termination of the Hart-Scott-Rodino waiting period and other customary closing conditions. Not disclosed in this filing: the specific HSR filing or antitrust review timeline beyond the standard waiting period reference, any termination fee, Alkeus's historical financials, and the precise royalty percentage range (described only as "low single digit").

This transaction is a cash acquisition in which Nielsen is acquiring DoubleVerify Holdings, Inc. (ticker DV), a tech sector company. The deal falls under the M&A product group and carries a disclosed value of $2,150,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on August 6, 2026. On the financial advisory side, PJT Partners LP is serving as the exclusive financial advisor to DoubleVerify, the target, in a lead capacity. Barclays is serving as financial advisor to Nielsen, the acquirer, in a non-lead capacity relative to PJT's exclusive designation. Legal counsel is split across three firms. Paul Hastings LLP is serving as legal advisor to DoubleVerify, the target, alongside PJT Partners' financial advisory role. Gibson, Dunn & Crutcher LLP is serving as legal advisor to Nielsen, the acquirer. Separately, Davis Polk & Wardwell LLP is serving as legal advisor to Providence, a party referenced in the facts block distinct from DoubleVerify and Nielsen, though its specific relationship to the transaction structure is not further elaborated. The facts block confirms this is a cash acquisition with a disclosed value of $2,150,000,000, but provides no further detail on the per-share price, financing sources for Nielsen, or the specific role Providence plays in the transaction beyond having its own named legal counsel. Several material facts remain undisclosed. No expected closing date is given. The per-share purchase price is not specified beyond the aggregate disclosed value, and Providence's precise role in the transaction, despite having legal counsel named, is not clarified in the available facts.

Gran Tierra Energy Inc., a natural resources company trading under ticker GTE, is divesting assets in a transaction valued at $1,330,000,000 USD. This is a mergers and acquisitions transaction, specifically a divestiture in the natural resources sector. The transaction has been announced as of the filing date. The transaction was disclosed via a Form 8-K filing published on the Securities and Exchange Commission's EDGAR system on August 5, 2026. This current status is announced, meaning the transaction has been publicly disclosed but the closing has not yet occurred, or closure status is not reflected in the available source material. Gran Tierra Energy engaged two financial advisors to represent its interests as the divesting party. BofA Securities Inc. is serving as the lead financial advisor to the target, while RBC Capital Markets is serving in a supporting financial advisory capacity to Gran Tierra Energy on this divestiture transaction. No other financial advisors to either party were identified in the source material. No legal advisors were identified in the available source material for this transaction. The transaction is structured as a divestiture with a disclosed deal value of $1,330,000,000 USD. However, the specific composition of the consideration, whether in cash, stock, or a combination thereof, is not disclosed in the available source material. Similarly, the identity of the acquirer or purchasing party is not specified in the information provided. The following material details remain undisclosed or unknown: the identity and name of the acquirer purchasing these divested assets, the specific composition of consideration (whether all-cash, mixed, or other structure), the expected closing date or timeline for completion, which specific assets or business lines Gran Tierra Energy is divesting, any conditions precedent to closing, and whether any regulatory approvals are required or pending. The source material confirms only the announcement and the headline transaction value.

Hillman Solutions Corp., a publicly traded industrials company trading under ticker HLMN, agreed to acquire Kanebridge Corporation, a privately held master distributor of industrial fasteners, through a wholly owned subsidiary pursuant to an Equity Purchase Agreement dated July 31, 2026. The deal was announced on August 3, 2026 via a press release and was disclosed in a Form 8-K filed with the SEC on August 4, 2026, which also furnished Hillman's second-quarter 2026 earnings materials. The transaction subsequently closed on August 28, 2026, as confirmed in a Form 8-K filed September 3, 2026. Hillman agreed to acquire all of the outstanding equity interests of Kanebridge for aggregate consideration of approximately $315 million, subject to customary adjustments for cash, indebtedness, working capital and transaction expenses. Kanebridge supplies more than 44,000 commercial and military-grade fastener SKUs to distributors in the U.S. and Canada from warehouses in Illinois and California, selling exclusively to distributors in commercial and industrial channels, and has served customers for more than 50 years. The sellers were identified in the purchase agreement as the Robert J. Williams 2024 Family Trust, the Carol Ann Williams 2024 Family Trust, and the McGrath 2020 Family Trust. The filings do not disclose an EV/EBITDA multiple, P/E multiple, or any other valuation multiple tied to the $315 million price. Hillman funded the acquisition with a combination of cash on hand, borrowings under its existing asset-based revolving credit facility, and a new $200 million senior secured term loan. The company entered into a debt commitment letter with Jefferies Finance LLC on July 31, 2026 for the $200 million term loan commitment, and at closing on August 28, 2026, Hillman's subsidiaries executed Amendment No. 1 to their existing Term Loan Credit Agreement (dated July 22, 2026) to add the $200 million of senior secured term loans. The additional term loans carry the same maturity as Hillman's existing senior secured term loans (July 22, 2033) and are priced, at the borrower's option, at SOFR plus 2.00% or ABR plus 1.00%, with no financial maintenance covenants. The transaction is structured as a 100 percent cash acquisition; no stock consideration or exchange ratio is involved since Kanebridge was privately held. Hillman stated the acquisition is expected to be accretive to its margins and earnings, consistent with its disciplined acquisition framework, citing anticipated cost synergies from Hillman's sourcing and distribution expertise, sales synergies from cross-selling opportunities, and material tax benefits from the transaction. No specific dollar amount or percentage for these synergies, nor a phase-in timeline, was disclosed in the filings. Hillman President and CEO Jon Michael Adinolfi said: "Kanebridge gives us an immediate and credible foothold in the industrial channel, which we've identified as one of our biggest growth opportunities. Their master distributor model, capabilities-driven platform, and long-standing distributor relationships make it a great fit for us." Chris Martin, Hillman's EVP of Commercial & Industrial, who will lead Kanebridge going forward, added that Kanebridge's U.S. industrial focus "complements Hillman's existing industrial presence in Canada, broadening our combined reach across North America." The acquisition was said to expand Hillman's industrial addressable market by $1 billion, bringing its total industrial TAM to approximately $3 billion, following strategy outlined at Hillman's recent Investor Day. Jefferies LLC served as financial advisor and Thompson Hine LLP served as legal counsel to Hillman. Piper Sandler served as financial advisor and Koley Jessen P.C., L.L.O. served as legal counsel to Kanebridge. The Equity Purchase Agreement contained customary representations, warranties, covenants and indemnification provisions, and Hillman obtained representations and warranties insurance in connection with the transaction. Closing conditions included expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period, accuracy of the parties' representations and warranties (subject to negotiated materiality standards), and compliance with covenants. The agreement was terminable by mutual written consent or, in specified circumstances, if the acquisition had not closed by October 29, 2026; no specific termination fee dollar amount was disclosed in the filings reviewed. At signing, Hillman said it expected the deal to close around the start of the fourth quarter of 2026, and it in fact closed earlier, on August 28, 2026. The transaction has closed. Status is updated from announced to closed based on the Form 8-K filed September 3, 2026 reporting completion of the acquisition on August 28, 2026 and the press release confirming the purchase price of approximately $315 million.

This transaction is a cash acquisition structured as a take-private of AstroNova, Inc., trading under the ticker ALOT, by a parent entity that is an affiliate of investment funds managed by Arcline. The deal is classified within the technology sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form DEFM14A filing published on July 31, 2026. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Rockefeller Financial LLC served as financial advisor and is identified as the lead advisor, having been retained by AstroNova as its exclusive financial advisor with respect to the merger and the other transactions contemplated by the merger agreement, according to the source material. No financial advisor to the Arcline-affiliated parent entity is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that this is a cash acquisition structured as a take-private transaction, no further detail on the specific per-share price or other terms of the cash consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no financial or legal advisor to the Arcline-affiliated acquirer is identified, nor is any legal advisor to AstroNova named. No expected closing date or per-share purchase price is provided in the facts available.

Deluxe Corp, a media sector company trading under ticker DLX, is the acquirer in a mergers and acquisitions transaction. The specific target company and transaction structure have not been disclosed in the available source materials. This is a publicly announced deal that has been reported via SEC filing, indicating that Deluxe is a public company subject to disclosure obligations under securities law. The deal information originates from a current report on Form 8-K filed with the Securities and Exchange Commission and made available through SEC EDGAR. The filing was published on July 31, 2026, which marks the announcement date. At present, the deal is in announced status, meaning the transaction has been publicly disclosed but has not yet closed. No expected closing date or timeline has been provided in the available documents. On the financial advisory side, Deluxe Corp has engaged BofA Securities to serve as its lead financial advisor for the transaction. BofA Securities is responsible for providing financial advisory services and acting as lead advisor to the acquirer throughout the deal process. No other financial advisors have been identified in the source materials for either the acquirer or target side. Legal advisors to either party have not been identified or disclosed in the available source documents. Regarding deal structure and terms, virtually no substantive details have been disclosed. The consideration structure, whether paid in cash, stock, debt, or some combination thereof, remains undisclosed. No purchase price or transaction value has been stated in the filing. The mechanics of how the acquisition will be effected, any financing arrangements, regulatory approvals required, or other material terms have not been provided in the source material reviewed. Several critical pieces of information remain absent from the available disclosure. Most notably, the identity of the target company has not been stated, nor has any transaction value or consideration structure. The expected closing date is unknown. The specific assets, business lines, or strategic rationale for the acquisition have not been disclosed. Whether any debt financing, equity commitment, or other financing arrangements have been put in place is not indicated. The filing provides announcement-level disclosure only, and substantially more detail would ordinarily be expected to emerge as the transaction progresses toward completion.

CBIZ, Inc. (NYSE: CBZ), a business-services firm serving middle-market companies, has agreed to be acquired by Grant Thornton Advisors LLC in an all-cash transaction with an enterprise value of $5 billion. The deal was announced on July 29, 2026 via a joint press release, and the merger agreement was signed July 28, 2026 among CBIZ, Viking ParentCo, Inc. ("Parent") and its wholly owned subsidiary Viking MergerCo, Inc., both affiliates of Grant Thornton Advisors. New Mountain Capital, L.L.C., which led a May 2024 investment in Grant Thornton Advisors, is providing incremental equity to help finance the acquisition. Under the merger agreement, each share of CBIZ common stock will be converted into the right to receive $55.00 in cash, representing a premium of approximately 54% to CBIZ's 30-day volume-weighted average share price as of July 28, 2026, the last trading day before announcement. Goldman Sachs' fairness opinion to the CBIZ board calculated additional premium reference points as of July 24, 2026: 63.8% over the $33.58 closing price on June 8, 2026 (the date of Parent's initial $55.00 bid), 29.0% over the July 24, 2026 closing price of $42.63, 56.1% over the 30-trading-day VWAP, 76.1% over the 90-trading-day VWAP, and a 29.3% discount to the 52-week high of $77.81 set on July 25, 2025. Goldman Sachs' discounted cash flow analysis, using discount rates of 9.5% to 10.5% and terminal exit multiples of 8.0x to 10.0x EV/LTM EBITDA, implied a per-share value range of $44.27 to $59.37. Goldman Sachs also reviewed selected M&A transactions in the accounting/specialty consulting industry since January 2021 (including CBIZ's own 2024 acquisition of Marcum LLP at 12.0x LTM EBITDA) as a reference, though the proxy does not state a single headline EV/EBITDA multiple for the CBIZ transaction itself. Parent estimates total funds needed to complete the merger and pay the merger consideration, including fees and expenses, at approximately $5,235,000,000. Financing is expected to come from a combination of committed debt and equity. Under the Opco Commitment Letter, lenders committed to a $750 million U.S. dollar incremental term facility, a Euro-denominated incremental term facility equivalent to $500 million, a $200 million incremental revolving facility (together, senior secured first-lien facilities under Grant Thornton's existing credit agreement), and a $1.75 billion senior secured notes bridge facility (reduced dollar-for-dollar by any notes issued before closing). Under the Equity Commitment Letter, equity investors committed to fund an Investor Commitment into an entity called Turbo Parent, including up to $200 million for convertible preferred equity securities with warrants and up to $635 million of additional equity funding, which Turbo Parent will then contribute to Parent. Grant Thornton Advisors LLC itself has provided a limited guarantee backstopping payment of the Parent Termination Fee. The merger is not subject to a financing condition. According to the joint press release, the combination is expected to create the fifth-largest professional services, tax and advisory provider in the U.S., with Grant Thornton's U.S. business generating more than $5 billion in annual domestic revenue after closing, and the combined multinational platform spanning more than 20 countries, generating nearly $7.5 billion in revenue and employing more than 34,500 professionals. The companies describe it as "the largest transaction of its kind in more than 25 years." Grant Thornton Advisors CEO Jim Peko said: "By combining our multinational platform with CBIZ's strong market presence, we're broadening our ability to support businesses through every stage of growth...Together, we'll bring the quality, scope and capabilities clients need to navigate an increasingly complex and rapidly evolving business environment." CBIZ President and CEO Jerry Grisko said: "This is a historic combination with a complementary cultural and strategic fit...Joining Grant Thornton Advisors accelerates the realization of that vision, creating a stronger firm with new and exciting opportunities for our team members and enhanced service offerings for clients, while delivering significant value to CBIZ shareholders." New Mountain Capital managing director Andre Moura added that the deal would make Grant Thornton "the fifth largest professional services, tax and advisory provider in the nation and one of the most forward-thinking firms in the world regarding AI." The release also states the deal builds on Grant Thornton Advisors' previously announced $1 billion investment in AI and advanced technologies. Following closing, Grant Thornton Advisors plans to separate CBIZ's Benefits and Insurance Services segment into a new stand-alone company backed by New Mountain Capital; Evercore is advising New Mountain Capital and Grant Thornton specifically on this Benefits & Insurance segment matter. No dollar synergy targets, cost-saving estimates, or EPS accretion/dilution figures are disclosed in the filings reviewed, consistent with an all-cash acquisition by a private, sponsor-backed acquirer rather than a public strategic buyer. The proxy statement's "Background of the Merger" section describes a competitive price-discovery process rather than a negotiated single bid. Grant Thornton first contacted CBIZ CEO Jerry Grisko on March 20, 2026. On April 13, 2026, Grant Thornton and New Mountain submitted a non-binding indication of interest of $47.00-$50.00 per share, which the CBIZ board rejected in May as insufficient. Grant Thornton raised its offer to $51.00-$52.50 per share on May 19, 2026 (also rejected), then to $54.30 per share on May 29, 2026, which it called its "best offer." The board rejected that too and countered that it would engage further only above $55.00 per share; Grant Thornton returned on June 8, 2026 with $55.00 per share, calling it its "best and final" indication, which the board accepted as the basis for exclusive due diligence beginning June 17, 2026. The merger agreement was negotiated and signed July 28, 2026, with Goldman Sachs delivering a fairness opinion that the $55.00 cash consideration was fair to CBIZ stockholders from a financial point of view (for which CBIZ agreed to pay Goldman Sachs a transaction fee of approximately $53 million, about $52.8 million of which is contingent on closing). Following signing, the agreement included a 30-day go-shop period: Goldman Sachs contacted 24 parties (18 financial sponsors and 6 strategic parties), 6 of which signed confidentiality agreements (with no standstill restrictions) and gained data-room access, and 2 of which met with CBIZ management; the go-shop period expired August 27, 2026 without a superior proposal emerging. Legal advisors were also identified in the filings: Weil, Gotshal & Manges LLP represented CBIZ as legal counsel, and Simpson Thacher & Bartlett LLP, Mayer Brown LLP and Hunton Andrews Kurth LLP represented Grant Thornton Advisors as legal counsel. Teneo served as CBIZ's strategic communications advisor and Goldin Solutions served in that role for Grant Thornton Advisors. The merger agreement provides for a Company Termination Fee of $107,500,000 payable by CBIZ under specified circumstances (including termination for a superior proposal), and a Parent Termination Fee of $198,400,000 payable by Parent under specified circumstances. The transaction is subject to CBIZ stockholder approval and regulatory clearance. CBIZ and Parent filed their Hart-Scott-Rodino notification and report forms on August 11, 2026, and the HSR waiting period expired September 10, 2026. CBIZ's special stockholder meeting to vote on the merger agreement is scheduled for October 27, 2026, held virtually, requiring approval by holders of a majority of outstanding shares. The transaction is expected to close in the fourth quarter of 2026, subject to stockholder approval and satisfaction of other customary closing conditions; it has not yet closed as of the date of this summary.

Energy Fuels Inc. (NYSE American: UUUU, TSX: EFR), through its wholly owned subsidiary EFR Critical Materials Pty Ltd, agreed to acquire all outstanding ordinary shares of Australian Strategic Materials Limited (ASM), an ASX-listed rare earth and critical metals company, by way of an Australian court-approved scheme of arrangement. The parties signed a Scheme Implementation Deed on January 20, 2026 (January 21, 2026 Australian Western Standard Time), disclosed in a Form 8-K filed with the SEC on January 26, 2026. The deal closed on August 28, 2026, when EFR Critical Materials Pty Ltd completed the acquisition of all ASM ordinary shares. Under the original terms, each ASM share was exchangeable for 0.053 Energy Fuels common shares or CHESS Depositary Interests plus up to A$0.13 in cash (to be funded by a special ASM dividend), implying a value of A$1.60 per ASM share and a total transaction value of approximately A$447 million based on Energy Fuels' closing price on January 16, 2026, the date the exchange ratio was fixed. On March 12/13, 2026, the parties entered a Deed of Amendment and Restatement that replaced the contingent special dividend with a fixed A$0.13 per share cash consideration funded directly by Energy Fuels, with no other material changes to deal terms. ASM optionholders separately received A$0.50 per option under a concurrent option scheme of arrangement, which was conditioned on the share scheme becoming effective (but not vice versa). At closing, ASM shareholders as a group were expected to hold approximately 5.8% of Energy Fuels' outstanding shares, before dilution from any further Energy Fuels share issuances prior to closing. At closing on August 28, 2026, Energy Fuels reported total Scheme Consideration of approximately US$243.4 million, comprising approximately US$217.2 million of share consideration (based on Energy Fuels' closing share price that day) and approximately US$26.2 million of cash consideration; 14,808,572 new Energy Fuels common shares were issued to ASM shareholders as share consideration, exempt from registration under Section 3(a)(10) of the U.S. Securities Act. A supplementary scheme booklet dated July 27, 2026 disclosed that, based on Energy Fuels' June 30, 2026 closing price of US$14.50 and an AUD:USD exchange rate of 0.6869, the scheme consideration implied an offer price of approximately A$1.249 per ASM share, representing a 72% premium to ASM's last closing price prior to the announcement date (A$0.725) and an 82% premium to ASM's 30-day volume-weighted average price prior to announcement (approximately A$0.687). ASM's board unanimously recommended the schemes, subject to the independent expert continuing to conclude they were in ASM shareholders' and optionholders' best interests, absent a superior proposal. BDO Corporate Finance Australia Pty Ltd, acting as independent expert, issued an original Independent Expert's Report dated May 12, 2026 and, after Energy Fuels disclosed a series of subsequent corporate developments (described below), issued a Replacement Independent Expert's Report accompanying the supplementary scheme booklet, which continued to conclude that the share scheme was fair and reasonable and in the best interests of ASM shareholders, and that the option scheme was fair and reasonable and in the best interests of ASM optionholders, in each case absent a superior proposal. SRK Consulting (Australasia) Pty Ltd served as independent technical specialist supporting that report. MA Moelis Australia and Moelis & Company LLC acted as financial adviser to ASM, and Allen Overy Shearman Sterling acted as legal adviser to ASM, according to the consents section of the supplementary scheme booklet. No financial or legal adviser to Energy Fuels is named in the filings reviewed. The strategic rationale centers on vertical integration of the rare earth supply chain. The supplementary scheme booklet states that the combination of Energy Fuels' upstream rare earth element (REE) mining and separation assets (including the White Mesa Mill in Utah and the Donald Project) with ASM's planned metals-and-alloys production (the Korean Metals Plant and planned American Metals Plant) is "intended to enable the Enlarged Combined Company" to internalize the upstream margin on rare earth feedstock currently paid to third-party suppliers and to reduce exposure to third-party supply chain disruptions and pricing volatility, "particularly in light of recent Chinese export restrictions on certain rare earth alloy forms." Around the same time ASM shareholders were asked to vote, Energy Fuels also disclosed, and the supplementary booklet described, several other corporate developments: a June 23, 2026 definitive merger agreement to acquire 100% of Vacuumschmelze GmbH & Co. KG (VAC), a magnet manufacturer, which the booklet said would "unlock[] the last stage of mine-to-magnet vertical integration for Energy Fuels" and, together with the ASM acquisition, "complete a fully western/western-allied-origin rare earth supply chain from feedstock projects through to finished permanent magnets"; a June 15, 2026 conditional US$725 million, 20-year financing commitment from the U.S. Office of Strategic Capital to fund expansion of White Mesa Mill processing capacity and a planned U.S. rare earth metals and alloys facility; and a June 23, 2026 commitment letter from Goldman Sachs Bank USA for a US$250 million senior secured term loan facility intended to help fund the VAC transaction's cash consideration. The VAC merger and related financings were not conditions to closing of the ASM scheme and were not assured; the booklet cautioned that "anticipated synergies, strategic benefits or financial returns anticipated by Energy Fuels in connection with the VAC Merger" might not be achieved or could take longer than expected. No dollar figure or percentage for cost synergies specific to the ASM transaction itself is disclosed in the filings reviewed. Under the Scheme Implementation Deed, ASM was required to pay a reimbursement fee of A$4,470,000 (1.0% of transaction value at signing) to Energy Fuels if the deed were terminated in specified circumstances (including an adverse change in ASM board recommendation or endorsement of a competing proposal), and Energy Fuels was required to pay a reciprocal reverse reimbursement fee of the same amount (A$4,470,000) to ASM under specified reverse circumstances. Conditions to closing included approval by scheme shareholders under Australia's Corporations Act, approval by Australia's Foreign Investment Review Board, approval of the scheme by the Federal Court of Australia (Perth registry), the absence of prohibitive government orders from Australian, U.S., Canadian or South Korean authorities, issuance of a supportive independent expert report, and listing approvals for the new Energy Fuels shares on NYSE American, the Toronto Stock Exchange and CHESS Depositary Interests on the ASX. The share scheme meeting, originally scheduled earlier, was rescheduled to August 12, 2026 at 11:30am AWST per the supplementary booklet's revised timetable, with the second court hearing expected August 18, 2026 in Perth; the deal subsequently closed August 28, 2026, consistent with that revised timetable.

Luxfer Holdings PLC, a public company trading under ticker LXFR on the New York Stock Exchange in the industrials sector, has agreed to be acquired by Double Eagle Acquisition Buyer, Inc., a newly formed Delaware holding company owned by funds managed by Wynnchurch Capital, L.P., in an all-cash take-private transaction. The parties entered into a Transaction Agreement dated July 26, 2026, and announced the deal on July 27, 2026, through a Form 8-K that attached the Transaction Agreement (Exhibit 2.1) and press releases from both Luxfer and Wynnchurch. Under the terms of the agreement, Luxfer shareholders will receive $17.37 in cash for each ordinary share, to be implemented through a court-sanctioned scheme of arrangement under Part 26 of the U.K. Companies Act 2006. Based on the 26,993,204 Company Ordinary Shares disclosed as outstanding as of September 14, 2026, the cash consideration implies an equity value of approximately $468.9 million; the filings do not state a single round aggregate transaction value figure. The Company Board disclosed that the $17.37 price represents a premium of approximately 31% to Luxfer's $13.29 closing price on April 28, 2026 (the last trading day before its first-quarter 2026 earnings release), a premium of approximately 22% to the $14.24 closing price the following day after Luxfer raised its 2026 guidance, and a premium of approximately 17% to the 90-day volume-weighted average price before signing. The transaction is not subject to a financing condition. Deutsche Bank Securities Inc., Luxfer's financial advisor, rendered a fairness opinion dated July 25, 2026, using a discounted cash flow analysis (12.5% to 14.5% discount rates, 7.0x to 9.5x terminal EBITDA multiples) that implied values of approximately $15.05 to $20.80 per share; a precedent transactions analysis across 17 specialty-materials and cylinder/tank deals since 2013 showing EV/LTM EBITDA multiples with medians of 11.3x (specialty materials) and 7.2x (cylinders and tanks), implying $14.95 to $22.00 per share when applying 7.0x-10.0x to Luxfer's LTM Management Pro Forma Adjusted EBITDA; and a comparable companies analysis against eight peers (including AMG Critical Materials, Alleima, Kaiser Aluminum, Neo Performance Materials, Hexagon Composites, Ecovyst, Johnson Matthey and Umicore) implying $12.45 to $17.85 per share on 2026E EBITDA (6.5x-9.0x) and $12.90 to $18.90 per share on 2027E EBITDA (6.0x-8.5x). Deutsche Bank's engagement fee is estimated at approximately $8,000,000, of which $1,000,000 was payable upon delivery of its opinion and the remainder contingent on closing. Management's financial forecasts provided to the board and to Deutsche Bank project revenue growing from $357 million in 2026E to $473 million in 2030E, and Management Pro Forma Adjusted EBITDA growing from $59 million in 2026E to $90 million in 2030E. These are company-prepared, non-public projections disclosed only because they were shared with the board, Deutsche Bank and the buyer, and the company cautions they should not be relied upon as predictive. The transaction followed a broad, Deutsche Bank-run strategic review that began publicly in October 2023 and widened into a formal sale process in March 2026. Deutsche Bank contacted 48 counterparties in total (14 strategic acquirers and 34 financial sponsors), of which 25 signed confidentiality agreements, 12 submitted preliminary non-binding indications of interest, five submitted revised proposals, and ultimately only two submitted final proposals (Wynnchurch for the whole company and a strategic party, referred to as Party A, for only the Gas Cylinders division). A competing bidder, Party B, submitted a non-binding proposal of $18.00 per share on June 3, 2026 but withdrew without submitting a final offer, citing insufficient diligence progress and an unwillingness to meet the process timeline. Wynnchurch's offer moved from an initial indication range of $16.12-$16.89 per share (May 4, 2026) to $17.25 (June 3), to $17.40 (July 14 proposal), to $17.50 (July 18 proposal), before being reduced to the final $17.37 per share on July 24, 2026 following Wynnchurch's confirmatory due diligence, which identified inventory valuation adjustments, potential environmental remediation liabilities at a closed facility, and supply chain/cost risks tied to critical rare earth materials. On the financial advisory side, Deutsche Bank Securities Inc. served as exclusive financial advisor to Luxfer, and Lazard served as financial advisor to Wynnchurch. On the legal side, Fried, Frank, Harris, Shriver & Jacobson LLP acted as legal counsel to Luxfer, and Kirkland & Ellis LLP acted as legal counsel to Wynnchurch and the buyer. Buyer has obtained committed financing for the transaction consisting of an equity commitment from Wynnchurch Capital Partners VI, L.P. for an aggregate equity contribution of up to approximately $265 million, together with debt financing from MidCap Financial Trust and Guggenheim Credit Services, LLC consisting of a $290 million secured term loan facility and a $50 million secured revolving facility, under a debt commitment letter originally dated July 26, 2026 and amended and restated on September 11, 2026. The deal does not disclose any synergy targets, consistent with a financial-sponsor acquisition rather than a strategic combination. The Transaction Agreement provides for a termination fee payable by Luxfer (the Company Termination Payment) of $18,000,000, and a larger termination fee payable by Buyer (the Buyer Termination Payment) of $32,250,000, in each case payable under specified circumstances including a change of board recommendation, a superior competing proposal, or failure to close by the End Date of February 26, 2027. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on September 8, 2026, satisfying the U.S. antitrust closing condition; the companies also made foreign investment filings in the United Kingdom and Italy in August 2026. The transaction remains subject to approval by Luxfer shareholders at a Scheme Meeting and a General Meeting, both scheduled for November 4, 2026, as well as sanction of the scheme of arrangement by the High Court of Justice in England and Wales. As of the most recent company communications, the transaction is expected to close in the fourth quarter of 2026, with closing anticipated in mid-to-late November 2026, subject to satisfaction of these remaining conditions. The deal has not yet closed.

Central Garden & Pet Company, a leading consumer goods company in the pet and garden industries trading under tickers CENT and CENTA, has agreed to acquire approximately 80% of the outstanding shares of TRIXIE Heimtierbedarf GmbH & Co. KG, a German limited partnership described as the leading European pet supplies and pet snacks company, together with certain related entities. The transaction was announced on July 27, 2026, in a Form 8-K filed with the SEC under Item 8.01, accompanied by a joint press release filed as Exhibit 99.1. TRIXIE, founded in 1974 and headquartered in Tarp, Germany, is being acquired from founder Bonnik Hansen and current shareholders Dirk Jessen and Volker Haak. Under the terms of the Sale and Purchase Agreement, Central will pay total consideration of up to EUR 400 million, consisting of approximately EUR 340 million in upfront cash paid at closing plus an earn-out of up to EUR 60.0 million based on 2026 performance, each subject to certain adjustments. No equity value, enterprise value, or EV/EBITDA multiple for TRIXIE was disclosed in the filings reviewed. The purchase price and structure were confirmed identically in Central's Form 10-Q for the quarter ended June 27, 2026 (filed August 6, 2026) and referenced again in Central's third-quarter fiscal 2026 earnings press release (filed August 5, 2026). Certain shareholders of TRIXIE, referred to as the Continuing Shareholders, will retain approximately 20% of TRIXIE's shares following closing. At future dates over at least three years, the Continuing Shareholders will have the right to require Central to purchase their remaining shares, and if those rights are not exercised after three years, Central will have a corresponding right to purchase those shares from the Continuing Shareholders. No financing arrangements (such as new debt issuance or credit facility draws) for the cash consideration were disclosed in the filings reviewed; Central's Q3 FY2026 earnings release separately disclosed total company debt of $1.2 billion, gross leverage of 2.8x, and net leverage of 0.5x as of June 27, 2026, but did not tie these figures specifically to financing the TRIXIE acquisition. TRIXIE employs close to 600 people and serves more than 30,000 pet retail stores internationally with a portfolio of more than 6,000 products for dogs, cats, birds, reptiles, and small animals, including accessories, toys, treats, snacks, habitats, apparel, bedding, and travel solutions. Approximately 90% of TRIXIE's sales come from its own-brand portfolio, and the company introduces around 500 new products per year through its in-house design team. The press release describes the European pet supplies and snacks market as approximately EUR 10 billion in annual sales, expected to grow at a mid-single-digit rate, citing favorable long-term trends including pet health focus, pet tech, humanization, and premiumization. Central's CEO, Niko Lahanas, said: "The addition of TRIXIE strengthens Central's position across key European pet supplies markets and adds a scaled platform with deep category expertise, strong retail relationships, and industry-leading logistics and fulfillment capabilities across the region. Bonnik Hansen and the TRIXIE team have built a remarkable company over the past 50 years. We are pleased that a very strong management team will continue leading the business, and we believe this partnership positions us well to drive long-term growth and better serve pet parents across Europe and the United States." TRIXIE founder Bonnik Hansen said: "Joining forces with Central Garden & Pet marks an important milestone in TRIXIE's 50-year history. In looking for a partner, it was important to us to find a company that shares our values, our culture, and our long-term thinking. We are confident that Central is the right partner to build on our strong foundation and carry the company successfully through its next stage of growth." TRIXIE will operate within Central's Pet segment, and management will continue to be led by Dirk Jessen, Burkhard Friedrichsen, and Danny Bollerey; Dirk Jessen and Volker Haak will remain minority shareholders, with Volker Haak also continuing as a consultant to the business. The acquisition is expected to give Central a differentiated presence with approximately 10% of net sales generated outside the United States and is described as establishing a scaled platform to consolidate the fragmented European pet specialty market. No specific cost synergy dollar amount, percentage of cost base, or phase-in timeline was disclosed in the filings reviewed, nor was any EPS accretion/dilution guidance tied to the transaction. Deutsche Bank AG served as financial advisor to TRIXIE, and Gibson, Dunn & Crutcher LLP served as legal advisor to TRIXIE. Rothschild & Co served as financial advisor to Central, and Freshfields LLP served as legal advisor to Central, per the July 27, 2026 press release. The transaction is subject to regulatory approval and other customary closing conditions, and is expected to close in the first half of Central's fiscal year ending September 25, 2027. No termination fee, specific regulatory approvals required, or prior bidders considered were disclosed in the filings reviewed. As of Central's most recent 10-Q (filed August 6, 2026), the deal remained pending with no change to the disclosed terms.

Neuphoria Therapeutics Inc., a healthcare company trading under ticker NEUP, is the target in an all-share merger transaction. The acquirer has not been identified in the source materials reviewed. This is a mergers and acquisitions transaction within the healthcare sector. The transaction was announced on July 24, 2026, according to the SEC filing. The transaction details are sourced from a Form 8-K filing published on the SEC EDGAR database on July 24, 2026. The deal has been announced, meaning the parties have made the transaction public, though the current status beyond announcement (for example, whether regulatory approvals have been obtained or a closing date has been set) is not specified in the available materials. On the financial advisory side, Leerink Partners is serving as lead financial advisor to the acquirer. For the target, Neuphoria Therapeutics, two lead financial advisors have been retained: H.C. Wainwright & Co. and WG Partners LLP. Both advisors are acting in a co-lead capacity on behalf of the target company. No legal advisors are identified in the source materials provided, so the identity of counsel representing either party cannot be specified at this time. The transaction is structured as an all-share merger, meaning consideration will be paid entirely in the form of equity rather than cash or a combination thereof. Beyond this structural detail, no additional terms regarding the specific consideration mix, the exchange ratio, or other deal mechanics have been disclosed in the available documentation. Several material details remain undisclosed or unknown. Most significantly, the acquirer's identity has not been identified in the source materials. The deal value or transaction size is not stated anywhere in the filing. The expected closing date is not provided. The number of shares or exchange ratio to be used in the all-share merger is not specified. No information regarding timing to close, conditions precedent, termination provisions, or any financing arrangements is available in the materials reviewed.

Matador Resources Company, an independent energy company trading under ticker MTDR, agreed on July 22, 2026 to acquire Paloma Permian, LLC, a portfolio company of EnCap Investments L.P., through a Securities Purchase Agreement among Matador subsidiary MRC Ranger, LLC as purchaser, MRC Energy Company as purchaser guarantor, and sellers Paloma Permian Holdings, LLC and Paloma Permian Intermediate, LLC. The transaction was structured as a purchase of all issued and outstanding membership interests of Paloma Permian, LLC, which together with its subsidiaries owns proved undeveloped acreage and oil and natural gas producing properties in Eddy and Lea Counties, New Mexico. The deal was announced via an 8-K filed July 24, 2026 (reporting a July 22, 2026 signing), with the Securities Purchase Agreement filed as Exhibit 2.1 and a joint press release as Exhibit 99.1. The agreed consideration (the "Unadjusted Purchase Price") was $1,275,000,000 in cash, subject to customary adjustments for working capital, title defects and environmental defects, with an effective date of June 1, 2026. At signing, Matador deposited $63,750,000 (5% of the unadjusted purchase price) into escrow. The acquired assets included 16,235 net undeveloped acres in Eddy and Lea Counties, New Mexico (majority held by production), more than 156 net drilling locations normalized to two-mile laterals primarily in the Bone Spring and Wolfcamp formations, $816 million of PV-10 as of May 31, 2026 (calculated using $70.00 per barrel of oil and $3.00 per MMBtu of natural gas), total proved oil and natural gas reserves of 55 million BOE, and estimated third-quarter 2026 production of approximately 10,600 to 11,600 BOE per day (57% oil). Joseph Wm. Foran, Matador's Founder, Chairman and CEO, said at announcement that Matador anticipated the acquisition "will be integrated efficiently into Matador's operating plan, contribute to Matador's cash flow generation and deliver significant efficiency gains, increases in oil and natural gas production, and reserve growth." Purchaser obtained a representation and warranty insurance policy covering certain breaches of the sellers' and target's representations and warranties, since, except for specified representations or fraud, seller and target representations and warranties did not survive closing. The purchase agreement's termination provisions used the escrow deposit as a liquidated-damages mechanism rather than a traditional termination fee: if the deal failed to close due to a material seller/target breach, Matador could elect specific performance or terminate and receive the full deposit plus reimbursement of documented third-party transaction expenses up to $4,000,000; if it failed to close due to a material purchaser-side breach, sellers could elect specific performance or terminate and receive the full deposit as liquidated damages. The agreement set a Target Closing Date of October 1, 2026, with an Outside Date 30 days later, and designated Vinson & Elkins LLP's Houston office as the closing location. The transaction closed on October 1, 2026, as confirmed in an 8-K filed October 5, 2026 reporting Item 2.01 completion of acquisition, together with a closing press release. At closing, Matador paid an as-adjusted purchase price of approximately $1.255 billion in cash (down from the $1.275 billion unadjusted price), subject to further customary post-closing adjustments. The closing release added that Paloma had 59 approved drilling permits on its acreage, that Matador expected to commence drilling operations on up to 25 wells associated with the acreage by year-end 2027, and that since the June 1, 2026 effective date, production associated with the acquisition had outperformed Matador's underwriting estimates by approximately 10%, driven largely by Paloma's newest wells in Eddy County. Mr. Foran stated that, together with the concurrent, separately announced Ridge Runner Resources II, LLC acquisition (also an EnCap portfolio company, expected to close later in October 2026) and the May 2026 federal lease sale, Matador's net acreage position in the Delaware Basin would reach approximately 240,000 net acres, an increase of almost 20% over its October 2025 position of 203,000 net acres. On financing, the closing release stated that Matador expects to use free cash flow to pay down approximately $350 million to $400 million on its reserves-based lending credit facility led by PNC Bank following the fourth-quarter 2026 closings (of both the Paloma and Ridge Runner transactions), depending on commodity prices. No new debt issuance or equity financing tied specifically to the Paloma purchase price was disclosed. On advisors, the closing press release discloses that Baker Botts L.L.P. served as legal advisor to Matador for the Paloma Acquisition, while Vinson & Elkins LLP served as legal advisor and RBC Richardson Barr served as financial advisor to Paloma and EnCap. No financial advisor to Matador was disclosed. This supersedes the prior unresolved summary, which had the target, seller, and legal advisors as undisclosed.

Northrim BanCorp Inc., a financial institution trading under ticker symbol NRIM, is acquiring an undisclosed target company in a merger and acquisition transaction within the financial services sector. This is a mergers and acquisitions engagement, classified within the product group covering corporate M&A. The specific target entity is not named in the available source materials, and notably, no transaction value has been disclosed in the source documentation. The transaction was announced via an SEC filing, specifically Form 8-K submitted to SEC EDGAR on July 23, 2026. This current status is listed as announced, indicating the deal has been publicly disclosed but final closing and integration remain incomplete. Form 8-K filings are typically used to report material events and significant corporate developments, making this the formal channel through which the acquisition was communicated to the market and regulatory authorities. On the financial advisory side, Hovde Group LLC is serving as the lead financial advisor to Northrim BanCorp, the acquiring party. On the target company's side, D.A. Davidson & Co. is acting as the lead financial advisor. Both firms are positioned as lead advisors to their respective clients, indicating they are the primary financial counsel guiding each party through the transaction process and negotiations. No legal advisors have been identified or extracted from the available source documentation for either party to this transaction. Regarding the deal structure and terms, the source materials provide minimal detail on the mechanics of the transaction. The consideration structure, whether paid in cash, stock, a combination of both, or some other form, is not specified in the available filing. Similarly, no information has been disclosed regarding earnouts, contingent consideration, or other structural elements that might accompany the transaction. Several material elements of this deal remain undisclosed in the source documentation. Most notably, the transaction value is not stated, nor has the identity of the target company been made public in these materials. No expected closing date or timing has been disclosed. The consideration mix and payment structure are unspecified. Beyond the identification of financial advisors, no details regarding legal counsel, underwriters, or other transaction participants have been extracted from the available sources. The specific assets, business lines, or strategic rationale behind the acquisition are likewise not detailed in the filing summary.

Northrim BanCorp, Inc. (NASDAQ: NRIM), the holding company of Northrim Bank, and PBCO Financial Corporation, the holding company of People's Bank of Commerce, jointly announced on July 22, 2026 the signing of an Agreement and Plan of Merger under which Northrim will acquire 100% of PBCO's common stock in an all-stock transaction. The deal marks Northrim's first out-of-state branch expansion, extending its Alaska-based community banking franchise into Southern Oregon and the Willamette Valley, and is expected to bring the combined company's total assets to more than $4 billion. This record is sourced from the companies' joint press release (Exhibit 99.1) filed with Northrim's 8-K on July 23, 2026. The release states the transaction has been unanimously approved by both companies' boards of directors and is subject to regulatory approval and shareholder approval by both PBCO and Northrim. Hovde Group, LLC served as financial advisor to Northrim on the acquirer side. D.A. Davidson & Co. served as financial advisor to PBCO on the target side. The release does not indicate which, if either, advisor rendered a formal fairness opinion, and no lead-versus-co-advisor distinction is made for either engagement. Accretive Legal, PLLC served as legal counsel to Northrim. Hunton Andrews Kurth LLP served as legal counsel to PBCO. Under the terms of the merger agreement, each PBCO shareholder will receive 1.160 shares of Northrim common stock for each share of PBCO common stock, with PBCO restricted stock and restricted stock units receiving the same ratio and PBCO phantom stock units cashed out. The aggregate consideration is valued at approximately $167.3 million, or $32.36 per share of PBCO common stock, based on Northrim's closing stock price of $27.90 as of July 21, 2026; the value will fluctuate with Northrim's stock price. Upon closing, PBCO shareholders are expected to own approximately 21.1% of the combined company, and one PBCO director will join the Northrim and Northrim Bank boards. The merger is expected to qualify as a tax-free reorganization for PBCO shareholders, with closing expected in the fourth quarter of 2026 or early in the first quarter of 2027, and system conversion anticipated in the fourth quarter of 2027. Not disclosed in this filing: whether either financial advisor delivered a fairness opinion, any advisory or legal fees, a specific termination fee, and pro forma earnings accretion or dilution estimates for Northrim.

Apex Treasury Corp, trading under ticker APXT and classified in the sponsors sector, is acquiring an undisclosed target company in a SPAC business combination transaction valued at $4 billion USD. This is a merger and acquisitions engagement within the product group, structured as a reverse merger or similar blank-check company combination typical of SPAC transactions. The $4 billion enterprise value represents the disclosed consideration for the transaction, though the breakdown between cash, stock, and any other consideration components has not been specified in available filings. The transaction was announced on July 22, 2026, as disclosed in an SEC Form 8-K filing published on that date via the SEC EDGAR system. The deal is currently in announced status, meaning it has been publicly disclosed but has not yet closed. No expected closing date or interim milestones have been disclosed in the available documentation. Financial advisory services on the target side are being provided by Revere Securities LLC, which is serving as the lead financial advisor. No other financial advisors, co-advisors, arrangers, or bookrunners have been extracted from the available filing materials. The specific scope of Revere Securities' engagement, whether it extends to fairness opinions, valuation work, or transaction negotiation support, is not detailed in the sourced documents. No legal advisors have been identified or disclosed in the available filing materials for either the acquirer or the target company. The deal structure reflects a SPAC business combination transaction, which typically involves the reverse merger of the target into the blank-check company shell. However, the specific terms and structure of this combination have not been detailed in the filing. The consideration is stated at $4 billion in aggregate, but neither the mix of consideration types (equity versus cash, for example) nor the allocation of that value across different deal components or security holders has been disclosed. Critical information gaps remain substantial at this stage. The target company has not been publicly identified in the filing. The exact composition and structure of consideration, including the split between cash and stock components, the number of shares to be issued, any earnout provisions, working capital adjustments, or seller financing, remains undisclosed. No expected closing date or regulatory approval timeline has been provided. The sources and uses of funds for the SPAC, including the amount of sponsor capital, PIPE (private investment in public equity) commitments, and any debt financing, have not been specified. Additionally, there is no information regarding governance changes, management continuity, board composition post-closing, or other material terms typical of SPAC documentation.

The Hillman Group, Inc., a wholly-owned subsidiary of Hillman Solutions Corp. (Nasdaq: HLMN) and a provider of hardware and related products including fasteners, builder's and door hardware, and key duplication and engraving services, closed a refinancing of its existing credit facilities on July 22, 2026. The refinancing consists of a new $735.0 million senior secured Term Loan B and a new $375.0 million asset-based revolving credit facility (ABL Revolver), together totaling the disclosed $1,110,000,000 aggregate value. The transaction was disclosed in a Form 8-K filed with the SEC on July 22, 2026 under Items 1.01 and 9.01, with the Term Loan Credit Agreement and ABL Credit Agreement filed as Exhibits 10.1 and 10.2, respectively. The Term Loan B was established under a Term Credit Agreement among The Hillman Companies, Inc. ("Holdings"), The Hillman Group, Inc. (the "Borrower"), and Jefferies Finance LLC as administrative agent. Proceeds were used to refinance in full and terminate all outstanding term loans and commitments under the Borrower's existing term loan credit agreement dated July 14, 2021 (the "Original Term Credit Agreement," also with Jefferies Finance LLC as administrative agent), to refinance in full and terminate the existing asset-based revolving credit agreement dated May 31, 2018 (the "Original ABL Credit Agreement," with Barclays Bank PLC as administrative agent), and to pay related fees and expenses. The Term Loan B is priced, at the Borrower's option, at SOFR plus a margin of 2.00% or ABR plus a margin of 1.00%, consistent with pricing on the prior facility, and matures July 22, 2033. The agreement contains no financial maintenance covenants. The term loans are guaranteed by Holdings and, subject to exceptions, the Borrower's material wholly-owned domestic subsidiaries, and are secured by substantially all assets of the Borrower and the guarantors. Jefferies Finance LLC acted as Lead Left Arranger, with U.S. Bank, BofA Securities, PNC Capital Markets LLC, and Fifth Third Bank, N.A. as Joint Lead Arrangers and First Financial Bank also participating in the syndicate. The ABL Revolver was established under a separate ABL Credit Agreement among Holdings, the Borrower, The Hillman Group Canada ULC (the "Canadian Borrower"), and U.S. Bank National Association as administrative agent, providing aggregate senior secured revolving commitments of $375.0 million, of which $325.0 million is available to the Borrower and $50.0 million to the Canadian Borrower, subject to a borrowing base. As of the closing date the facility had a zero balance. Pricing for revolving loans is, at the Borrower's option, SOFR (or Term CORRA for Canadian dollar loans) plus a margin ranging from 1.25% to 1.50% per annum based on availability, or an alternate base rate (or Canadian prime rate for Canadian dollar loans) plus a margin of 0.25% to 0.50% based on availability; this pricing is also consistent with the prior ABL facility. The facility matures July 22, 2031. Unlike the Term Loan B, the ABL Credit Agreement contains a springing financial covenant: during any "Covenant Trigger Period" (commencing when availability falls below the greater of 10% of the facility's Line Cap or $30.0 million, and continuing until availability has exceeded that threshold for 30 consecutive days), the Fixed Charge Coverage Ratio must not be less than 1.00:1.00. The ABL facility is guaranteed by Holdings and, subject to exceptions, the Borrower's wholly-owned domestic subsidiaries, and is secured by substantially all assets of the Borrower and guarantors, plus, in the case of the Canadian Borrower, its and its wholly-owned Canadian subsidiary's assets. U.S. Bank acted as lead arranger and administrative agent, with Bank of America, N.A., PNC Bank N.A., and Fifth Third Bank, N.A. as Joint Lead Arrangers and First Financial Bank also participating. Thompson Hine LLP is identified in both credit agreements as special counsel to the Loan Parties (the Borrower and guarantors), delivering closing legal opinions. Davis Polk & Wardwell LLP is listed as counsel to be copied on notices to the administrative agents under both agreements. The ABL Credit Agreement additionally identifies Stikeman Elliott LLP and MLT Aikins LLP as local Canadian counsel to the Loan Parties in connection with the Canadian Borrower provisions. Subsequent to this closing, on August 28, 2026, the Borrower and Holdings entered into a First Amendment to the Term Credit Agreement, disclosed in an 8-K filed September 3, 2026, that provided for an additional $200.0 million of senior secured term loans on the same pricing (SOFR+200bps/ABR+100bps) and maturity (July 22, 2033) terms as the original Term Loan B. Proceeds of the Additional Term Loans, together with cash on hand and revolver borrowings, were used to help fund the Company's approximately $315 million acquisition of Kanebridge, LLC, which closed the same day. This upsizing is a separate, later amendment and is not included in the $1,110,000,000 aggregate value of the original July 22, 2026 refinancing described above. The deal has closed. No further disclosed material terms beyond those above were identified; the original 8-K does not break out upfront or commitment fees, pricing-grid thresholds for the Term Loan B (it carries a flat, non-grid margin), or the specific borrowing-base formula components for the ABL facility.

Horace Mann Educators Corporation, a Delaware corporation trading under ticker HMN on the New York Stock Exchange, and Medical Mutual of Ohio announced on July 21, 2026 that they had entered into two separate agreements. Under a Membership Interest Purchase Agreement, Horace Mann agreed to acquire all of the equity interests of Employee Services, LLC (ESI), a New York limited liability company and employee assistance program provider, from Medical Mutual of Ohio for approximately $115 million. Under a separate Master Transaction Agreement with Medical Mutual of Ohio (MMO) and Medical Mutual Life Insurance Company (MML), Horace Mann agreed to acquire all of the outstanding common stock of Reserve National Insurance Company (RNIC), an Illinois-domiciled insurer, for approximately $125 million, while an affiliate of Horace Mann will separately reinsure substantially all of MML's in-force group life and disability insurance policies in exchange for a ceding commission of approximately $7.4 million paid to MML. Together, Horace Mann describes the two agreements as having a total net purchase price of approximately $240 million. Horace Mann said the RNIC purchase price includes approximately $10 million of excess statutory capital expected to remain in RNIC at closing, and that RNIC's existing Medicare supplement insurance policies are excluded from the acquisition and will be reinsured to MMO or otherwise transferred out of RNIC before closing. Both the ESI purchase price and the RNIC purchase price plus ceding commission are being funded with cash on hand and borrowings under Horace Mann's existing revolving credit facility; no new debt issuance or stock consideration has been disclosed. The agreements were approved by Horace Mann's Board of Directors. No price-to-earnings, price-to-book, or other valuation multiple has been disclosed for either transaction in the available filings. Horace Mann stated the combined transactions are expected to add nearly $200 million in annual revenue, serve more than one million covered lives across approximately 7,000 employer relationships, and add more than 1,000 agents and brokers to its distribution network. The company said the transactions are expected to be immediately accretive to its core earnings per share and shareholder return on equity "by strengthening the company's earnings profile through a combination of high-margin insurance businesses, recurring fee-based revenue and enhanced capital efficiency," though no specific EPS accretion percentage or dollar figure was quantified in the filings reviewed. No cost synergy dollar amount, percentage of combined cost base, or phase-in timeline was disclosed. Marita Zuraitis, President and CEO of Horace Mann, said in the companies' joint press release that "our strategy has always been centered on creating stronger customer relationships by providing meaningful solutions that meet our customer needs," adding that the businesses "build on our long-term strategy by enhancing our employer value proposition, broadening our distribution capabilities and expanding customer relationships." She further stated that "these transactions also reflect the disciplined approach we've consistently taken to capital allocation," calling the acquired businesses "both a natural strategic fit and an attractive financial investment." Tony Helton, President and CEO of Medical Mutual, said the divestiture "reflects our ongoing focus to align our portfolio with our long-term strategy," noting Medical Mutual will "continue to focus our investment and leadership attention on our core businesses." On the financial advisory side, Raymond James & Associates acted as financial advisor to Horace Mann and Sherman & Company acted as financial advisor to Medical Mutual of Ohio, consistent with the prior summary. On the legal side, Eversheds Sutherland (US) LLP acted as legal counsel to Horace Mann, and Squire Patton Boggs acted as legal counsel for Medical Mutual of Ohio, both disclosed in the July 21, 2026 joint press release filed as Exhibit 99.2 to Horace Mann's Form 8-K filings. The two transactions carry different closing timelines. The ESI acquisition was expected to close in the fourth quarter of 2026, subject to customary closing conditions, and Horace Mann confirmed in an October 1, 2026 Form 8-K that it had completed the ESI acquisition in an all-cash transaction for $115 million, subject to customary purchase price adjustments, making ESI a wholly owned subsidiary. The RNIC stock purchase and the related MML reinsurance transaction remain pending and are expected to close in the first quarter of 2027, subject to customary closing conditions and required regulatory approvals; as of the most recent filing reviewed, this leg of the transaction had not yet closed. No termination fee, negotiation background, or information about other bidders has been disclosed in any filing reviewed, as the transaction was not structured as a public merger requiring a proxy statement.

First Financial Bancorp. (Nasdaq: FFBC) announced on July 21, 2026, alongside its second quarter 2026 earnings release, that it has agreed to acquire Finward Bancorp, the holding company for Peoples Bank, in an all-stock transaction. The merger agreement has been unanimously approved by the boards of directors of both First Financial and Finward. This record is sourced from First Financial's own 8-K press release (Exhibit 99.1), furnished to the SEC on July 21, 2026, which combines the company's quarterly earnings announcement with disclosure of the pending Finward acquisition in a single filing. Morgan Stanley & Co. LLC is serving as financial advisor to First Financial on the acquirer side. Stephens Inc. is serving as financial advisor to Finward on the target side and rendered a fairness opinion to Finward's board of directors. Squire Patton Boggs (US) LLP is serving as legal counsel to First Financial. Barack Ferrazzano Kirschbaum & Nagelberg LLP is serving as legal counsel to Finward. Under the terms of the agreement, each outstanding share of Finward common stock will be converted into the right to receive 1.35 shares of First Financial common stock, an all-stock structure valuing the transaction at approximately $208 million based on First Financial's closing stock price on July 20, 2026. The transaction is expected to be approximately 5% accretive to First Financial's earnings per share, with only slight (0.4%) dilution to First Financial's tangible book value per share at closing and an anticipated tangible book value earnback of 0.6 years. The deal is expected to close in the fourth quarter of 2026, subject to customary closing conditions, regulatory approvals, and approval of Finward's shareholders. Not disclosed in this filing: any termination fee, Finward's standalone balance sheet metrics (total assets, loans, deposits) as of the announcement date, and post-closing governance or management appointments resulting from the combination.

GoHealth, Inc., a financial services company, is pursuing a Chapter 11 emergence restructuring transaction. This is a restructuring product within the financial services sector. The transaction involves the company's financial reorganization and emergence from bankruptcy protection. No transaction value has been disclosed in the source documentation. This information is sourced from an SEC EDGAR filing published on July 21, 2026. The form type is not specified in the available source documents. The deal is currently in pending regulatory status, indicating that it has not yet closed or received final approval. The financial advisory team is split between the company and the creditor constituency. On the company side, Alvarez & Marsal North America, LLC serves as restructuring advisor in a lead capacity. For the lenders, FTI Consulting, Inc. serves as lead financial advisor, while RPA Advisors, LLC serves as financial advisor to a subset of the lenders. Akin Gump Strauss Hauer & Feld LLP, operating as lead counsel to the lenders, also functions in a legal capacity for the broader lending group. Legal representation is similarly divided. Kirkland & Ellis LLP serves as lead legal counsel to GoHealth in connection with the company's financial restructuring. On the creditor side, Akin Gump Strauss Hauer & Feld LLP operates as lead legal counsel to the lenders, while Cahill Gordon & Reindel LLP provides legal counsel to a subset of the lenders. The specific deal structure, including consideration mix, emergence terms, and any reorganization plan details, has not been disclosed in the available source documents. The expected closing date or emergence effective date is not stated. The transaction value remains undisclosed. No information is available regarding the company's debt structure, the treatment of different creditor classes, or the post-emergence equity or ownership structure. The precise role and status of each advisor subset serving specific creditor groups versus the broader lender constituency is not fully detailed beyond the mention of subset representation.

Brookfield Asset Management (NYSE: BAM, TSX: BAM), together with Canada Pension Plan Investment Board (CPP Investments), and LXP Industrial Trust (NYSE: LXP), a REIT focused on Class A warehouse and distribution investments across 12 Sunbelt and Midwest target markets, announced on July 20, 2026 that they entered into a definitive merger agreement under which Brookfield and CPP Investments will acquire LXP in an all-cash transaction valued at approximately $5.2 billion, including net debt and preferred equity. LXP owns approximately 53 million square feet across 108 properties in industrial markets in the Sunbelt and Midwest. This entry is sourced from LXP's Exhibit 99.1 press release filed as part of an 8-K on July 20, 2026. The transaction is a signed definitive merger agreement unanimously approved by LXP's Board of Trustees; it had not yet closed and was expected to close in the fourth quarter of 2026, subject to LXP shareholder approval and other customary closing conditions. The agreement includes a 40-day go-shop period expiring August 28, 2026, during which LXP, with its advisors, may solicit and consider alternative acquisition proposals. BofA Securities, Inc. is acting as lead financial advisor to LXP, with J.P. Morgan Securities LLC acting as co-financial advisor. Citigroup Global Markets Inc. and Morgan Stanley & Co. LLP are serving as financial advisors to Brookfield and CPP Investments. Hogan Lovells Cadwalader US LLP is serving as legal advisor to LXP. Gibson, Dunn & Crutcher LLP and Thompson Hine LLP are serving as legal advisors to Brookfield and CPP Investments, with DLA Piper LLP serving as legal advisor to CPP Investments specifically on certain aspects of the transaction. Dechert LLP is acting as legal advisor to Citigroup Global Markets Inc. and Morgan Stanley & Co. LLP in their advisory capacity. Under the terms disclosed, LXP shareholders will receive $61.20 per share in cash, representing a 12.3% premium to LXP's 30-day volume-weighted average price and a 19.8% premium to its 90-day VWAP, each measured through July 17, 2026. The transaction is not subject to a financing condition. LXP agreed to suspend common share dividend payments until the earlier of closing or termination of the agreement, and upon completion LXP will become a privately held company delisted from the NYSE. The release does not disclose the amount of any termination fee payable if LXP accepts a superior proposal during or after the go-shop period, the specific ownership split between Brookfield and CPP Investments in the acquiring consortium, or fee arrangements for any of the six named financial and legal advisors.

This deal is a cash tender offer classified as an M&A transaction in the financial institutions group (FIG) sector, involving Open Lending Corp as the target, with ANV Group Holdings Ltd named in connection with the deal. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from a Schedule 14D-9/A filing with the SEC, filed via SEC EDGAR and published on July 20, 2026. The deal's current status is pending regulatory approval. No financial advisors were extracted for this deal in the facts block. This means the facts available do not identify any investment bank or financial advisory firm working on behalf of either Open Lending Corp or ANV Group Holdings Ltd in connection with this tender offer. Similarly, no legal advisors were identified in the facts block for either side of the transaction. Beyond the classification of this transaction as a cash tender offer, no further detail on the offer price, minimum tender condition, or other structural terms is provided in the facts block. This is a case where the underlying record is notably thin. No financial advisors, no legal advisors, and no disclosed transaction value are present in the facts block, and no expected closing date is given beyond the pending-regulatory status reflected in the July 2026 SC 14D9/A filing. Readers should not assume any advisor involvement or deal terms beyond what is explicitly stated here, as none has been disclosed in the available source material.

Sunshine Biopharma Inc., a healthcare sector company trading under ticker SBFM on the Nasdaq Capital Market, entered into an At-The-Market Issuance Sales Agreement with Aegis Capital Corp. on July 20, 2026, under which the company may sell shares of common stock having an aggregate offering price of up to $4,000,000 from time to time through Aegis as its exclusive sales agent. The agreement was disclosed in a Form 8-K filed that day and in a prospectus supplement on Form 424B5, filed the same date under the company's effective Form S-3 shelf registration statement (File No. 333-284142, declared effective January 15, 2025). The ATM is structured as a continuous, uncommitted offering rather than a single priced block trade. Aegis is not required to sell any specific number or dollar amount of shares and will act on a commercially reasonable efforts basis; the company is not obligated to sell, and Aegis is not obligated to buy or sell, any shares. Sales may be made directly on or through Nasdaq or any other existing trading market for the stock, with the company delivering placement notices to Aegis specifying the number of shares, timing, and any minimum sale price for each tranche. Because there is no minimum offering amount, the prospectus supplement states the actual total public offering amount, commissions, and net proceeds to the company could not be determined at the time of filing. Aegis will receive a fixed cash commission equal to 3.0% of gross proceeds on each sale made under the agreement, plus reimbursement of certain expenses, and will be deemed an "underwriter" under the Securities Act with respect to that compensation. The prospectus supplement discloses that the last reported Nasdaq sale price of SBFM common stock on July 17, 2026 (the last trading day before the prospectus supplement date) was $1.80 per share; no separate per-share ATM pricing or discount to that price is specified, consistent with the program's at-the-market, variable-price structure. The stock had undergone a 10-for-1 reverse stock split effective June 1, 2026. The company stated it intends to use net proceeds from the offering for general corporate purposes, including working capital, with no specific allocation (such as debt repayment or acquisition financing) identified; management was given broad discretion over use of proceeds. No greenshoe or over-allotment option applies, as is typical for ATM programs, and none is mentioned in the filings. Sunshine Biopharma's Form 10-Q for the quarter ended June 30, 2026 (filed August 13, 2026) discloses, as a subsequent event, that from July 27, 2026 through August 12, 2026 -- roughly one week after signing through the quarter's filing date -- the company sold 1,430,521 shares of common stock under the ATM Offering and received $1,722,555 in net proceeds, equating to roughly $1.20 per share net of the 3.0% commission. The same disclosure notes that on August 3, 2026 the company's outstanding Series B Warrants were adjusted to 25,477,133 warrants with a $1.2202 exercise price as an anti-dilution consequence of the ATM share sales. As of August 13, 2026, the company had 3,877,337 shares of common stock issued and outstanding, which includes the ATM shares sold to that date; the 10-Q does not break out what percentage of shares outstanding the ATM sales alone represented, and no concurrent share repurchase program is disclosed. On the legal side, Hart & Hart, LLC (Denver, Colorado) acted as counsel to the issuer on the validity of the shares, delivering an opinion dated July 20, 2026 and filed as Exhibit 5.1 to the Form 8-K, consenting also to its reference under "Legal Matters" in the prospectus supplement. The prospectus supplement additionally identifies Sichenzia Ross Ference Carmel LLP, New York, as issuer's counsel on U.S. federal securities and New York state law matters, and Kaufman & Canoles, P.C., Richmond, Virginia, as counsel to Aegis Capital Corp. (the sales agent) in connection with the offering. The consolidated financial statements incorporated by reference were audited by M&K CPAs, PLLC. No closing 8-K, termination notice, or filing indicating the $4,000,000 ATM capacity has been fully utilized or the program has been terminated was identified. Given that active, ongoing sales under the program were confirmed as of the August 13, 2026 10-Q, the deal is best treated as an open, in-progress ATM program rather than a single dated closing; status is left as announced/ongoing pending any filing disclosing full utilization or termination of the Sales Agreement.

This record concerns Inotiv, Inc., a healthcare-sector company, as the issuer in a Chapter 11 plan of reorganization. The transaction falls under the restructuring product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published July 16, 2026. The deal's status is pending regulatory, indicating the restructuring process had not yet concluded as of that filing. Only one financial advisor is disclosed: Perella Weinberg Partners, which is serving as investment banker to the company (Inotiv) and is designated lead. The source sentence states that Inotiv is advised in this matter by Ropes & Gray LLP as legal counsel, Perella Weinberg Partners as investment banker, and FTI Consulting as financial and communications advisor, indicating FTI Consulting also plays an advisory role to the company though it is not separately broken out as a distinct financial-advisor entry with lead status in the facts block. Multiple legal advisors are disclosed across different constituencies. Ropes & Gray LLP serves as legal counsel to the issuer, Inotiv. The Noteholder Ad Hoc Group, a creditor constituency, is advised by Paul, Weiss, Rifkind, Wharton & Garrison LLP as legal counsel. Separately, the Prepetition First Lien Lenders, another creditor constituency, are advised by Davis Polk & Wardwell LLP as legal counsel and BRG as financial advisors, per the source sentence describing that lender group's advisory team. Beyond identifying this as a Chapter 11 plan of reorganization, the facts block does not provide the specific terms of the plan, such as recovery percentages for different creditor classes or the treatment of existing equity. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected timeline for plan confirmation is given, and the facts block does not specify BRG's lead-versus-non-lead status as financial advisor to the Prepetition First Lien Lenders, nor FTI Consulting's lead status on the company side.

First Bancorp (Nasdaq: FBNC), the Southern Pines, North Carolina parent of First Bank, has agreed to acquire First Carolina Bancshares Corporation, the parent of Carolina Bank & Trust Company headquartered in Florence, South Carolina, in a stock-and-cash transaction with an aggregate value of $166 million based on First Bancorp's closing stock price of $64.22 on July 13, 2026. The deal was announced on July 14, 2026 via a Form 8-K containing a joint press release, the merger agreement (Exhibit 2.1), and an investor presentation (Exhibit 99.2). Carolina Bank is a privately held, fourth-generation family-run community bank founded in 1936 with approximately $831 million in assets, $596 million in loans and $714 million in deposits, operating 14 branches across six South Carolina counties in the Pee Dee region, and reported an LTM return on average assets of 1.60% for the twelve months ended March 31, 2026. Under the merger agreement, each share of First Carolina common stock will be converted into the right to receive $294.94 in cash plus 14.5340 shares of First Bancorp common stock, subject to adjustment if First Carolina's tangible common equity capital at closing falls outside a target range of $110 million (minimum) to $125 million (maximum). In aggregate, First Carolina shareholders will receive approximately $40 million in cash and 1,967,017 First Bancorp shares, a mix of roughly 75% stock and 25% cash. At closing, First Bancorp shareholders are expected to own approximately 95% of the combined company and former First Carolina shareholders approximately 5%. The $166 million transaction value represents 1.53 times First Carolina's tangible common equity (versus 1.47 times at the June 23, 2026 letter-of-intent stage, when the deal was valued at $160 million), 11.9 times First Carolina's estimated 2027 earnings, and 9.1 times estimated 2027 earnings including fully phased-in cost savings, according to First Bancorp's investor presentation. The presentation also cites a pay-to-trade ratio of approximately 68%. First Bancorp disclosed expected cost savings equal to 30% of Carolina Bank's noninterest expense base, with 75% of those savings realized in 2027 and the full amount realized thereafter. The presentation's key transaction assumptions also include an allowance for credit losses of $10.9 million (1.75% of Carolina Bank's loans at closing), a loan interest rate mark of $12.5 million (2.0% of loans at closing, accreted into earnings over six years), a fixed-asset write-up of $4.5 million, a core deposit intangible of 3.00% of non-time deposits (amortized over 10 years), and approximately $15.8 million of after-tax merger charges fully reflected in tangible book value dilution at closing. First Bancorp expects the transaction to be accretive to fully phased-in earnings per share by approximately 3%, with initial tangible book value dilution of approximately 1% and an earnback period of 1.7 years (based on when pro forma tangible book value per share crosses and begins to exceed projected standalone First Bancorp tangible book value per share). The company also cites an expected internal rate of return of 20%-plus. On a pro forma basis, the combined company is expected to have approximately $13.8 billion in total assets, $9.4 billion in gross loans and $11.7 billion in deposits, with a 2027 estimated return on average assets of 1.6%, return on average tangible common equity of 15%, and efficiency ratio of 47%. First Bancorp states the deal will increase its South Carolina deposit base by more than 50%, double its South Carolina branch footprint, and place it in the top 10 for deposit market share in both North Carolina and South Carolina and number 2 in the Pee Dee region, based on FDIC deposit data as of June 30, 2025. Adam Currie, President and CEO of First Bank, said in the press release that "Carolina Bank has deep roots in the communities it serves and a strong reputation for relationship-based banking," adding that "their approach to serving customers aligns closely with our own." Rick Beasley, Chairman and CEO of Carolina Bank, said "this partnership brings together two organizations that share a commitment to community banking" and that customers "will benefit from expanded resources, while continuing to work with the team they know and trust." Per the investor presentation, Beasley and Carolina Bank CFO R.W. "Bubba" DeMaurice III are expected to retire upon closing, while other Carolina Bank leaders are expected to remain with First Bank in local leadership roles. The registration statement on Form S-4 (declared effective October 9, 2026, with a final prospectus filed October 13, 2026 on Form 424B3) discloses the negotiation background. Discussions began with informal talks between First Bancorp CEO Richard Moore and First Carolina CEO Rick Beasley in mid-April 2026, followed by a non-disclosure agreement on April 29, 2026 and several weeks of due diligence. First Bancorp made a verbal proposal on June 11, 2026 at an implied value of approximately $157 million (75% stock / 25% cash), which was followed by negotiation to approximately $160 million by June 16-18, 2026 and a non-binding letter of intent on June 23, 2026 reflecting the final exchange ratio of 14.5340 shares and $294.94 cash per share. The merger agreement was finalized by July 9, 2026 and executed July 13, 2026 after both boards' unanimous approval; First Carolina's board received a fairness opinion from Piper Sandler dated July 13, 2026 concluding the merger consideration was fair to First Carolina shareholders from a financial point of view. The filings do not indicate that First Carolina solicited or received competing offers from other acquirers during this process. Stephens Inc. served as financial advisor to First Bancorp, and Brooks, Pierce, McLendon, Humphrey & Leonard, LLP served as its legal counsel. Piper Sandler & Co. served as financial advisor to First Carolina, and Nelson Mullins Riley & Scarborough LLP served as its legal counsel. The merger agreement provides for a termination fee of $6.4 million payable by First Carolina to First Bancorp under specified circumstances, including termination following an alternative acquisition proposal. Closing is subject to approval by two-thirds of First Carolina's outstanding shares, regulatory approvals from the Federal Reserve, FDIC, and North and South Carolina state banking regulators, and effectiveness of the Form S-4 registration statement. The transaction is expected to close in the fourth quarter of 2026 or early in the first quarter of 2027, with systems integration scheduled for the first quarter of 2027. As of this update, no closing 8-K or shareholder vote result has been identified, so the deal remains in announced/pending status.

Ares Management Corporation, through affiliated Ares Real Estate funds, has completed its acquisition of Whitestone REIT in an all-cash merger that closed on July 14, 2026, with Whitestone shareholders and operating partnership unitholders receiving $19.00 per share or unit in a transaction valued at approximately $1.7 billion. The deal was originally announced on April 9, 2026 in a joint press release filed as an exhibit to a Form 8-K, with the definitive Agreement and Plan of Merger dated April 8, 2026 filed as Exhibit 2.1 to that same 8-K. Whitestone shareholders approved the merger at a special meeting held July 9, 2026, with 37,039,161 shares voting in favor versus 116,016 against and 86,516 abstaining, out of 37,241,693 shares present representing about 72.46% of shares outstanding. The $19.00 per share cash price represented a 12.2% premium to Whitestone's closing stock price on April 8, 2026, the last full trading day before announcement, and a 26.5% premium to Whitestone's unaffected share price before a March 5, 2026 Reuters article reported that the company had engaged advisors to explore a sale. At signing, Whitestone's portfolio comprised 56 convenience-focused retail properties totaling approximately 4.9 million square feet in Phoenix, Austin, Dallas-Fort Worth, Houston and San Antonio; by the closing press release the portfolio was described as 54 properties totaling approximately 4.8 million square feet in the same markets. Dave Holeman, Whitestone's CEO, said the transaction "is a testament to the value that strategy has created for our business and, ultimately, for our shareholders." Christine Mastandrea, Whitestone's President and COO, said the company looked "forward to the continued success of our portfolio as part of Ares' leading Real Estate business." Amy Feng, Chair of the Whitestone Board, said the deal "delivers significant, immediate and certain value to our shareholders while positioning Whitestone's assets for continued success." David Roth, Global Head of Real Estate Strategy and Growth in Ares Real Estate, said the portfolio provides "an attractive opportunity to further diversify Ares Real Estate's footprint with necessity-based retail centers in high-demand, supply-constrained metro regions across Arizona and Texas," citing "high conviction in New Economy real estate as today's consumers are increasingly seeking convenient experiences for their grocery, pharmacy, healthcare, fitness and dining needs." The definitive merger proxy statement (DEFM14A) discloses that the deal followed an extended, multi-bidder process. Whitestone's board had rejected two prior unsolicited all-cash proposals from activist shareholder MCB Real Estate at $14.00 and $15.00 per share since mid-2024, and received a third MCB proposal at $15.20 per share in November 2025. Separately, a large privately held real estate fund referred to as "Party A" raised its interest from a joint-venture discussion to a $16.00 per share all-cash proposal in December 2025, and a firm referred to as "Party C" submitted an unsolicited $17.25 per share proposal in January 2026 that contemplated debt and preferred-equity financing with highly confident letters from financing sources. A parallel joint-venture process run by Jones Lang LaSalle Securities beginning in September 2025 contacted roughly 40 potential capital partners, of which 21, including Party A, a firm referred to as "Party B," and Ares, signed non-disclosure agreements and received due diligence access. Ares ultimately emerged as the winning bidder at $19.00 per share, above the earlier MCB, Party A and Party C proposals, and the Whitestone board unanimously determined the Ares transaction was more favorable than remaining an independent public company. BofA Securities delivered a fairness opinion to the Whitestone board dated April 8, 2026, concluding the $19.00 merger consideration was fair, from a financial point of view, to Whitestone shareholders. In its selected publicly traded companies analysis, BofA applied 2026E FFO multiples of 11.9x to 16.2x and 2026E AFFO multiples of 16.4x to 20.4x drawn from nine peer REITs (including Kimco Realty, Regency Centers, Federal Realty and Brixmor Property Group), implying per-share equity value ranges of $14.08 to $19.24 and $14.57 to $18.10, respectively, versus the $19.00 deal price. A selected precedent transactions analysis of seven REIT/property-management deals (including Blackstone/Alexander & Baldwin and Blackstone/Retail Opportunity Investments) applied forward-year FFO multiples of 11.0x to 17.7x and AFFO multiples of 14.7x to 23.4x, implying ranges of $13.03 to $21.00 and $13.04 to $20.82. A discounted cash flow analysis, using an adjusted EBITDA exit multiple of 15.0x to 17.0x and discount rates of 7.3% to 8.1%, implied a per-share value range of $13.60 to $18.33. Whitestone management projections underlying these analyses showed projected 2026E FFO of $64 million ($1.16 per share) and AFFO of $48 million ($0.87 per share), rising to 2030E FFO of $97 million ($1.43 per share) and AFFO of $81 million ($1.18 per share), with Net Debt/Adjusted EBITDA projected to decline from 6.9x in 2026E to 5.8x in 2030E on a standalone basis. The proxy does not disclose a specific EV/EBITDA multiple for the transaction itself. The merger agreement set a Company Termination Fee of $36,000,000 payable by Whitestone under specified circumstances (such as accepting a superior proposal) and a Parent Termination Fee of $77,000,000 payable by the Ares entities under specified circumstances. The transaction was not subject to a financing condition: Ares-affiliated investment vehicles committed to fund Parent with equity financing sufficient to close, backed by a limited guarantee from Ares funds covering the termination fee and certain other potential obligations, while Citigroup Global Markets Inc. committed to provide debt financing under a debt commitment letter subject to customary conditions. No registered stock was issued; the entire purchase price was paid in cash, and the merger agreement and proxy do not disclose a post-closing pro forma ownership split since Whitestone became a wholly owned subsidiary of Ares-affiliated Parent. Financial advisors were previously disclosed and are unchanged: BofA Securities and Jones Lang LaSalle Securities advised Whitestone, and Citigroup Global Markets Inc. (lead) and Morgan Stanley advised Ares, with Citigroup and Morgan Stanley also acting as financing providers to Ares. The April 9, 2026 announcement press release and the July 14, 2026 closing press release both name legal advisors: Kirkland & Ellis LLP served as legal advisor to Ares, Dechert LLP served as legal advisor to Citigroup Global Markets Inc. and Morgan Stanley, and Bass Berry & Sims served as Whitestone's legal advisor. The DEFM14A additionally identifies Venable LLP as Whitestone's Maryland corporate counsel, which advised the board alongside Bass Berry on statutory fiduciary-duty matters during the process. At the Company Merger Effective Time, concurrent with closing, Whitestone repaid and terminated its Fourth Amended and Restated Credit Agreement with Bank of Montreal as administrative agent, a separate Nationwide Life Insurance Company loan agreement, and its 2019 Note Purchase and Guaranty Agreement. Outstanding time-based and performance-based (TSR) equity awards were cancelled and converted into the right to receive cash equal to the $19.00 merger consideration per underlying share, with TSR awards deemed earned based on the greater of target or actual performance through closing. Six Whitestone trustees, including Amy Feng, Julia Buthman, Kristian Gathright, David Holeman, Jeffrey Jones and Donald Miller, ceased serving on the board at closing. Whitestone shares were suspended from trading on the NYSE on July 14, 2026, and the company intended to file a Form 15 to deregister its shares and suspend SEC reporting obligations. No synergy estimates, pro forma combined financial statements, or EPS accretion/dilution figures were disclosed in any of the filings reviewed, consistent with this being a going-private cash acquisition of a REIT by a private fund sponsor rather than a stock-for-stock combination of two operating companies.

Ares Management Corporation (NYSE: ARES), a global alternative investment manager with over $644 billion in assets under management as of March 31, 2026, announced on July 14, 2026 that certain Ares Real Estate funds completed the previously announced acquisition of all outstanding common shares and operating partnership units of Whitestone REIT for $19.00 per share or unit in an all-cash transaction valued at approximately $1.7 billion. The deal adds 54 convenience-focused retail properties totaling approximately 4.8 million square feet in fast-growing markets including Phoenix, Austin, Dallas-Fort Worth, Houston, and San Antonio to Ares Real Estate's portfolio. This entry is sourced from Ares's Exhibit 99.1 press release filed as part of Whitestone's 8-K on July 14, 2026, announcing that the acquisition had already closed. With completion, Whitestone ceased to be traded or listed on any public securities exchange. Citigroup Global Markets Inc. acted as lead financial advisor and financing provider to Ares, with Morgan Stanley also acting as financial advisor and financing provider. BofA Securities served as Whitestone's financial advisor and provided a fairness opinion to Whitestone's Board of Trustees; Jones Lang LaSalle Securities also served as a financial advisor to Whitestone. Kirkland & Ellis LLP served as legal advisor to Ares. Dechert LLP served as legal advisor to Citigroup Global Markets Inc. and Morgan Stanley in their capacity as financing providers. Bass Berry & Sims served as Whitestone's legal advisor. The transaction closed at $19.00 per share or operating partnership unit, in an all-cash deal valued at approximately $1.7 billion. Additional information regarding the disbursement of merger consideration to Whitestone shareholders was stated to be available in an 8-K filed by Whitestone with the SEC, which was not separately reviewed for this extraction. The release does not disclose the original signing date of the merger agreement (only that the acquisition had been "previously announced"), a breakdown of the $1.7 billion valuation into equity versus assumed debt components, any termination fee that had applied prior to closing, or specific fee arrangements for any of the four named financial advisors or three named law firms.

Ligand Pharmaceuticals Inc., a publicly traded healthcare company trading under the ticker LGND, is acquiring XOMA Royalty Corp., a healthcare sector target, in a merger and acquisition transaction. The deal carries a disclosed value of $739 million in USD. Both the acquirer and target operate in the healthcare sector, and the transaction was announced as of the filing date. This transaction was disclosed through an SEC Form 8-K filing published on July 14, 2026, which serves as the primary source document for deal information. The deal has been announced, indicating that the parties have publicly confirmed the transaction, though no closing date or other timeline milestones have been disclosed. On the acquirer side, Ligand Pharmaceuticals engaged Stifel as its lead financial advisor. Supporting Ligand's transaction efforts, Citi also served as a financial advisor to the acquirer. On the target side, XOMA Royalty Corp. retained Leerink Partners as a lead financial advisor and H.C. Wainwright & Co. as an additional financial advisor, ensuring that XOMA had dual representation throughout the transaction process. No legal advisors have been disclosed in the available transaction documents. The transaction is structured as a merger and acquisition in the healthcare sector. The total consideration is valued at $739 million; however, the specific composition of the consideration, whether paid in cash, stock, or a combination thereof, has not been disclosed. Similarly, the precise structure of the merger, including details about merger subsidiary structures or any earnout provisions, has not been publicly detailed in the available filings. Key details that remain undisclosed include the expected closing date and timing, the breakdown of consideration by type and payment method, any financing arrangements or conditions precedent, material terms specific to the merger structure, and details regarding any regulatory filings or approvals that may be required. The sources do not specify whether any debt financing, equity financing, or other transaction financing has been arranged.

This transaction is a cash acquisition with a contingent value right in which Ligand Pharmaceuticals Incorporated, trading under the ticker LGND, is acquiring XOMA Royalty Corp. The deal is classified within the healthcare sector, and the disclosed value of the transaction is 739,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on July 14, 2026. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Leerink Partners served as lead financial advisor to XOMA Royalty, the target, with H.C. Wainwright & Co. also serving as a financial advisor to XOMA Royalty in a supporting, non-lead capacity. On the acquirer side, Stifel served as lead financial advisor to Ligand, with Citi also serving as a financial advisor to Ligand, and the source material additionally notes that Collected Strategies served as strategic communications advisor to Ligand, rounding out the acquirer's advisory team. On the legal side, Gibson, Dunn & Crutcher LLP served as legal advisor to XOMA Royalty, the target, while Paul Hastings LLP served as legal advisor to Ligand, the acquirer. Beyond confirming that this is a cash acquisition structured with a contingent value right and a disclosed value of 739,000,000 dollars, no further detail on the specific cash amount per share, the CVR terms, or the milestones triggering any CVR payout is included in the facts available. Several elements of this deal remain undisclosed. No specific per-share cash price or CVR payout terms are given beyond the aggregate disclosed value of 739,000,000 dollars, and no expected closing date is provided. The facts also do not specify what regulatory approvals are required to complete the transaction.

First Hawaiian, Inc., a financial institutions sector company trading under ticker FHB, has agreed to acquire TriCo Bancshares, ticker TCBK, also in the financial institutions sector, in an all-stock merger valued at approximately $2.02 billion. The deal was announced on July 13, 2026, in a current report on Form 8-K filed with the SEC that included a joint press release and investor presentation. Under the terms of the agreement, each TriCo share will be exchanged for 2.095 shares of First Hawaiian common stock, equivalent to $63.12 per TriCo share based on First Hawaiian's July 10, 2026 closing price. The transaction is valued at approximately 1.98 times TriCo's tangible book value and 14.4 times TriCo's estimated 2027 earnings per share, or 10.7 times on a fully synergized basis. At closing, First Hawaiian shareholders are expected to own approximately 65 percent of the combined company, with TriCo shareholders owning the remaining 35 percent. First Hawaiian Chief Executive Officer Bob Harrison said TriCo is "an ideal partner to execute this next phase of our growth: a well-managed, relationship-focused bank in California with a strong deposit franchise, disciplined credit culture, experienced local leadership and deep commitment to its communities." TriCo Chief Executive Officer Rick Smith said First Hawaiian "shares those values and brings the scale, capital strength and broader product capabilities to help us do even more for our customers and communities." The combined bank is expected to have approximately $34 billion in total assets, $21.5 billion in loans and $29.2 billion in deposits across 117 branches, making it the sixth largest bank headquartered in the western United States. The California franchise will continue to operate as Tri Counties Bank, a division of First Hawaiian Bank, with no branch closures anticipated. First Hawaiian disclosed expected annual run-rate cost savings of $61 million pretax, equal to approximately 25 percent of TriCo's estimated 2026 cash non-interest expense base, with 50 percent of those savings phased in during 2027 and the full amount realized thereafter. The company estimates the deal will be accretive to earnings per share by approximately 1 percent on a 50-percent-phased-in basis and by approximately 6 percent once synergies are fully phased in, with tangible book value dilution of approximately 4.7 percent and an earnback period of approximately 2.8 years. First Hawaiian also disclosed one-time pretax merger and integration costs of approximately $125 million and a credit mark on acquired loans of approximately $135 million, or 1.8 percent of TriCo's gross loans. On the financial advisory side, Keefe, Bruyette & Woods, A Stifel Company served as the lead financial advisor to the target, TriCo Bancshares, while Holland & Knight LLP served as TriCo's legal counsel. For the acquirer, First Hawaiian, Evercore acted as the lead financial advisor and Sullivan & Cromwell LLP served as legal counsel. Both financial advisors held lead roles in their respective engagements advising each party on the transaction. As part of the agreement, four current TriCo directors, including Rick Smith, are expected to join the boards of First Hawaiian and First Hawaiian Bank at closing, with three additional TriCo directors to be mutually agreed upon before the transaction closes. The transaction has not yet closed. It remains subject to approval by both companies' shareholders and customary regulatory approvals, with First Hawaiian's and TriCo's special shareholder meetings scheduled for October 29, 2026. The companies have targeted closing by the end of the fourth quarter of 2026.

Air T, Inc., a transportation-infrastructure holding company trading on Nasdaq under the ticker AIRT, entered into an At the Market Offering Agreement (the Sales Agreement) with Ascendiant Capital Markets, LLC on July 10, 2026, permitting the company to sell up to $8,000,000 of common stock, par value $0.25 per share, from time to time through the agent. The agreement and the related prospectus supplement, dated July 10, 2026, were disclosed in a Form 8-K filed the same day and in a Form 424(b)(5) prospectus supplement to the company's shelf registration statement on Form S-3 (File Nos. 333-277855 and 333-277855-01), which became effective March 27, 2024. Notably, Air T Funding, a Delaware statutory trust subsidiary that issues Air T's 8% Alpha Income Trust Preferred Securities (Nasdaq: AIRTP) and is guaranteed by Air T, Inc., established a separate, parallel at-the-market program the same day, also sized at up to $8,000,000, likewise through Ascendiant Capital Markets as sales agent, evidenced by its own 424B5 filed July 10, 2026. The two programs are tracked together for purposes of the General Instruction I.B.6 capacity limit under Form S-3 (since Air T's public float held by non-affiliates was approximately $27.1 million as of July 6, 2026, limiting combined sales under that instruction to roughly $9.0 million across both programs), but they are legally distinct offerings of different securities (common stock versus trust preferred securities), and this deal record's $8,000,000 figure corresponds to the common stock program. Under the Sales Agreement, Ascendiant Capital Markets will use commercially reasonable efforts to sell shares designated by Air T at prevailing market prices on Nasdaq, in negotiated transactions, or, with Air T's prior written approval, in privately negotiated or principal transactions. Air T is not obligated to sell any shares and may instruct the agent not to sell below a company-designated price. Ascendiant will receive a placement fee equal to 3.0% of the gross sales price of shares sold, and Air T agreed to reimburse the agent up to $10,000 of expenses (excluding periodic due diligence fees), subject to FINRA Rule 5110(f)(2)(D)(i). Air T estimated total offering expenses, excluding agent compensation, at approximately $50,000. Settlement for any sales is expected on the first trading day following the trade date. The program will terminate upon the earlier of the sale of the full $8,000,000, July 10, 2029, or termination of the agreement by either party. As of the July 10, 2026 prospectus supplement, no shares had yet been sold under the common stock program; the prospectus supplement illustrates dilution using an assumed sale of 52,757 shares at $31.99 per share (Air T's last reported Nasdaq closing price on July 6, 2026), which is the only pricing reference disclosed and is explicitly described as illustrative rather than an actual or committed transaction. Based on that illustrative assumption, Air T's net tangible book value of approximately $66.4 million ($24.57 per share, based on 2,701,375 shares outstanding as of March 31, 2026) would increase to approximately $68.0 million ($24.68 per share) after deducting estimated commissions and expenses, representing an immediate increase in net tangible book value of $0.11 per share to existing holders and immediate dilution of $7.31 per share to new investors. No greenshoe or over-allotment option applies, as is typical for ATM programs, since shares are sold incrementally into the market rather than in a single underwritten tranche. Air T stated it intends to use net proceeds, if any, for general corporate purposes, which may include investments in or advances to existing or future subsidiaries, repayment of matured obligations, and reduction of other debt, with management retaining broad discretion over the application of proceeds. Because there is no minimum offering amount, the actual proceeds, number of shares sold, and timing of sales are not determinable in advance; the company is required to report sales activity at least quarterly. As of Air T's Form 10-Q for the quarter ended June 30, 2026 (filed August 14, 2026), the common stock Sales Agreement was listed only as an incorporated-by-reference exhibit, with no separate disclosure of actual sales to date, and no subsequent Form 424(b) prospectus supplement reporting a completed sale or updated terms had been filed as of the most recent EDGAR check. Winthrop & Weinstine, P.A. of Minneapolis, Minnesota served as legal counsel to Air T, Inc. in the offering, issuing the Exhibit 5.1 opinion (dated July 10, 2026) on the legality of the shares, as previously identified. Additionally, Clyde Snow & Sessions, PC of Salt Lake City, Utah is identified in the prospectus supplement as counsel passing on certain legal matters relating to the securities on behalf of the sales agent, Ascendiant Capital Markets, LLC. Deloitte & Touche LLP is named as Air T's independent registered public accounting firm whose audit report on the fiscal year 2026 financial statements is incorporated by reference. The deal remains pending in the sense that the ATM program is an open-ended facility rather than a single completed transaction; no closing, pricing, or full utilization of the $8,000,000 capacity has been confirmed in any filing reviewed to date.

RF Acquisition Corp III, a special purpose acquisition company trading under ticker RFAM and operating in the sponsors sector, has announced a business combination transaction with an undisclosed target company. This is a merger and acquisitions transaction structured as a SPAC business combination, a subtype of deal in which a publicly traded blank-check company combines with a private or public operating business. The transaction was announced on July 10, 2026, as evidenced by a Form 8-K filing published on that date with the SEC via EDGAR. The specific dollar value of the transaction has not been disclosed in the available source documentation. The deal announcement is sourced directly from an SEC Form 8-K current report filed by RF Acquisition Corp III on July 10, 2026. The Form 8-K is the standard disclosure vehicle used to announce material corporate events, including merger announcements. The deal is currently in announced status, meaning the transaction has been publicly disclosed but the closing or completion of the combination has not yet occurred. No expected closing date or timeline to completion has been provided in the source materials reviewed. On the financial advisory side, EarlyBirdCapital, Inc. has been retained to advise the acquirer, RF Acquisition Corp III, in connection with this transaction. EarlyBirdCapital's specific advisory role within the deal structure, whether as lead or co-advisor, and any additional scope of engagement beyond financial advisory services, have not been specified in the source documentation. No financial advisors for the target company have been identified or disclosed in the materials available. No legal advisors have been identified or disclosed in the source documentation for either side of the transaction. The specific structure and terms of the business combination, including the consideration to be paid, the form of consideration (cash, stock, or a combination thereof), and any other material deal terms, have not been disclosed in the available documentation. Details such as the expected capitalization of the combined entity, governance structure, or any transaction conditions precedent are similarly absent from the source materials reviewed. The target company in this SPAC business combination has not been publicly identified as of the filing date. No deal valuation has been disclosed, no consideration structure has been specified, no expected closing date has been provided, and no information regarding transaction conditions, financing, or expected governance of the combined entity has been included in the available source documents.

This transaction is a cash tender offer in which GlaxoSmithKline LLC, an affiliate of GSK plc, is seeking to acquire Nuvalent, Inc. The deal is classified within the healthcare sector, and the disclosed value of the transaction is 10,300,000,000 dollars. The transaction is sourced from an SEC EDGAR Form SC 14D9/A filing (an amendment to the Schedule 14D-9) published on July 7, 2026. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Centerview served as financial advisor to Nuvalent, the target, and is identified as the lead advisor in this transaction. The source material references an amendment adding bold and underlined language to the "Summary of Centerview Financial Analysis, Selected Public Company Analysis" discussion within the section covering the opinions of the financial advisor to the company board, indicating Centerview rendered a fairness opinion that was subsequently the subject of supplemental disclosure. No financial advisor to GlaxoSmithKline or GSK plc is identified in the facts provided. On the legal side, Ropes & Gray LLP is identified as legal advisor to Nuvalent, the target, with the source material citing the firm's Boston address at 800 Boylston Street, Prudential Tower, in a copy line for correspondence. No legal advisor to GlaxoSmithKline or GSK plc is identified in the facts provided. Beyond confirming that the transaction is structured as a cash tender offer with a disclosed value of 10,300,000,000 dollars, no further detail on the specific per-share offer price or the conditions of the tender is included in the facts available. Several elements of this deal remain undisclosed. No financial or legal advisor to GlaxoSmithKline or GSK plc is named, and no detail on the per-share tender offer price is given beyond the aggregate disclosed value. The fact that this is sourced from an amendment to the Schedule 14D-9 indicates supplemental disclosure was made, but the facts do not specify an expected closing date for the tender offer.

This deal is an unsolicited take-private proposal structured as a management buyout, in which Seer, Inc. (ticker SEER), a company in the healthcare sector, is the target of a proposal involving Dr. Omid Farokhzad, M.D. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 2, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners LP is serving as financial advisor to Seer, the target, with no lead designation specified in the facts block. No financial advisor is disclosed for the proposing party (Dr. Farokhzad) in the facts block. Legal counsel was disclosed only for the target: Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel to Seer. No legal advisor is disclosed for the proposing party. Beyond its characterization as an unsolicited take-private proposal structured as a management buyout, the facts block provides no further detail on proposed consideration, pricing, or financing structure. Several material facts are not disclosed in the source material. The overall proposed deal value is not stated. No financial or legal advisor is named for the proposing party, Dr. Omid Farokhzad. The facts block also does not disclose an expected timeline, proposed price per share, or whether the Seer board has responded to or accepted the unsolicited proposal.

Bending Spoons S.p.A., an Italian technology company, priced its initial public offering at $29.00 per ordinary share, with trading approved on the Nasdaq Global Select Market under the ticker BSP. The prospectus is dated June 30, 2026, and was filed with the SEC on Form 424B4 on July 1, 2026, following an F-1 registration statement originally filed June 8, 2026 and amended June 22, 2026 before being declared effective on June 30, 2026. The underwriters expected to deliver the shares to purchasers against payment on July 2, 2026, meaning roughly three weeks elapsed from the public F-1 filing to pricing and settlement. The offering totaled 57,971,015 ordinary shares, split between 34,398,640 shares sold by the company and 23,572,375 shares sold by existing shareholders (the Selling Shareholders). At the $29.00 offering price, the combined offering size was $1,681,159,435, consisting of $953,917,285.50 of proceeds before expenses to the company and $653,691,424.22 of proceeds before expenses to the Selling Shareholders. The per-share underwriting discount and commission was $1.26875, for aggregate underwriting discounts of $73,550,725.28. The company will not receive any proceeds from shares sold by the Selling Shareholders. After the offering, 324,978,625 ordinary shares were expected to be outstanding (or 330,222,651 if the underwriters' option is exercised in full), meaning the primary and secondary shares sold represented roughly 18 percent of post-offering ordinary shares outstanding. The underwriters were granted a 30-day option to purchase up to an additional 5,244,026 ordinary shares from the company and up to an additional 3,451,626 ordinary shares from the Selling Shareholders to cover over-allotments. If exercised in full, net proceeds to the company would rise from an estimated $933 million to $1,079 million. The 424B4 prospectus does not disclose whether this over-allotment option was ultimately exercised. The company estimated net proceeds to itself of approximately $933 million after underwriting discounts and offering expenses. It stated it intends to use the net proceeds for general corporate purposes and to invest in new acquisitions, but specified it did not have binding agreements for any material acquisition at the time of the prospectus. The company said it would have broad discretion over the specific application of proceeds and has not declared or paid cash dividends, with no dividends anticipated in the foreseeable future. The underwriting syndicate, in order of allocated shares per the underwriting agreement, was led by Goldman Sachs International (11,594,203 shares) and J.P. Morgan Securities LLC (11,594,203 shares) as Global Leads and Joint Bookrunning Managers, together with Allen & Company LLC (9,710,145 shares), also a Global Lead. The remaining joint bookrunning managers and their allocated shares were Wells Fargo Securities, LLC (3,623,188), BofA Securities, Inc. (3,478,261), Jefferies LLC (3,478,261), Evercore Group L.L.C. (2,898,551), BNP Paribas Securities Corp. (2,898,551), Mizuho Securities USA LLC (2,898,551), SG Americas Securities, LLC (2,898,551), Credit Agricole Securities (USA) Inc. (869,565), Intesa Sanpaolo S.p.A. (869,565), UniCredit Capital Markets LLC (869,565), and Banca Akros S.p.A./Gruppo Banco BPM (289,855), totaling 57,971,015 shares. Underwriters proposed to offer shares to the public at the IPO price and to certain dealers at a concession of up to $0.76125 per share, with any reselling dealers able to extend a further discount of up to $0.25375 per share. Because this was an initial public offering with no prior public market for the shares, there is no prior closing price against which to measure a premium or discount; the $29.00 IPO price was set through negotiation between the company and the underwriters. The prospectus discloses that investors purchasing in the offering would face immediate dilution of $34.44 per share (or $34.16 per share if the underwriters' option is exercised in full), based on a pro forma as further adjusted net tangible book value of $(5.44) per share as of March 31, 2026, versus the $29.00 offering price. Actual net tangible book value per share as of March 31, 2026 was $(7.30), reflecting the company's leveraged balance sheet prior to the offering; the IPO increased net tangible book value per share by $1.86 for existing shareholders. The company disclosed its legal advisors in the prospectus: Latham & Watkins LLP passed upon the validity of the ordinary shares and certain other matters of Italian and U.S. federal law for the company, Milbank LLP passed upon certain matters of U.S. federal law for the underwriters, and Legance Avvocati Associati passed upon certain matters of Italian law for the underwriters. The company's financial statements for 2023, 2024, and 2025 were audited by Deloitte & Touche S.p.A. The company also registered its ordinary shares for listing under Section 12(b) of the Exchange Act via a Form 8-A12B filed July 1, 2026, confirming the Nasdaq Stock Market LLC as the listing exchange. No separate pricing 8-K or free-writing prospectus pricing term sheet was identified; as a foreign private issuer, Bending Spoons reports ongoing corporate events via Form 6-K rather than Form 8-K. A 6-K filed July 28, 2026 disclosed a subsequent, separate debt financing (a new EUR 500 million term loan facility, part of EUR 1.49 billion in new and expanded credit facilities since the beginning of the second quarter of 2026) for general corporate purposes and acquisitions, but this is a distinct financing event from the IPO itself and does not alter or confirm the equity offering's final terms or over-allotment outcome.

Select Medical Holdings Corporation, a Mechanicsburg, Pennsylvania-based operator of critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics, announced the completion of its going-private acquisition on July 1, 2026. The buyer was a consortium led by Robert A. Ortenzio (Select Medical's Executive Chairman and Co-Founder), Martin F. Jackson (a senior Select Medical executive), and private equity firm Welsh, Carson, Anderson & Stowe (WCAS). The transaction was structured under an Agreement and Plan of Merger dated March 2, 2026, and the healthcare services company valued the deal at approximately $3.9 billion based on a purchase price of $16.50 per share, an 18% premium to the unaffected share price. This extraction is drawn from Select Medical's 8-K press release exhibit announcing deal completion, filed with the SEC on July 1, 2026. Because the buying group included company insiders (Ortenzio and Jackson) alongside the sponsor, the Company's Board of Directors formed a Special Committee of disinterested, independent directors to evaluate the transaction, and stockholders including unaffiliated holders voted to approve it at a June 26, 2026 special meeting. Barclays served as financial advisor to WCAS, the private equity sponsor in the consortium, alongside legal counsel Ropes & Gray LLP. On the other sides of the transaction, Goldman Sachs served as exclusive financial advisor to the Special Committee of independent directors, and Wells Fargo and J.P. Morgan served as financial advisors to the broader Consortium (with J.P. Morgan and Wells Fargo also acting as joint lead arrangers and bookrunners on the committed debt financing). Legal counsel included Skadden, Arps, Slate, Meagher & Flom LLP for the Special Committee, Dechert LLP for Select Medical itself, Cravath, Swaine & Moore LLP for the Consortium, and Paul Hastings LLP for the debt financing sources, in addition to Ropes & Gray LLP representing WCAS. Upon closing, the Consortium obtained effective and operational control along with a majority economic interest in Select Medical, and the company's common stock ceased trading on the New York Stock Exchange. Existing management, including Ortenzio and Jackson, was to continue leading the business in their current roles. The press release does not disclose the specific allocation of debt versus equity financing within the $3.9 billion transaction value, the individual fees paid to Barclays or any other advisor, or the precise ownership split among Ortenzio, Jackson, and WCAS within the Consortium following closing.

This transaction involves LCI Industries (ticker LCII), an industrials-sector company, as the target, and Patrick Industries Inc (ticker PATK) as the acquirer. The deal is an M&A transaction structured as an all-stock merger, and its disclosed value is not stated in the source document. The facts are sourced from a Form 425 filing with the SEC via EDGAR, published June 30, 2026. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. J.P. Morgan Securities LLC is serving as lead financial advisor to Patrick Industries (the acquirer), with Baird serving as co-lead financial advisor to Patrick Industries per the same source sentence, and McDermott Will & Schulte LLP serving as legal advisor to Patrick Industries. On the target side, Perella Weinberg Partners LP is serving as financial advisor to LCI Industries, with Kirkland & Ellis LLP serving as LCI's legal advisor, per the corresponding source sentence. Legal advisors are disclosed for both sides: Kirkland & Ellis LLP is serving as legal advisor to the target, LCI Industries, while McDermott Will & Schulte LLP is serving as legal advisor to the acquirer, Patrick Industries. Beyond identifying the transaction as an all-stock merger, the facts block does not specify the exchange ratio or any other structural terms of the stock consideration. A number of facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given. The facts block also does not clarify Baird's lead-versus-non-lead status relative to J.P. Morgan on the Patrick Industries side beyond its explicit designation as "co-lead" in the source sentence.

H.B. Fuller Company and Advanced Medical Solutions Group plc (AMS) announced on June 25, 2026 that they had reached agreement on the terms of a recommended cash acquisition of AMS by H.B. Fuller Medical Adhesive Technologies Inc., a wholly-owned H.B. Fuller subsidiary, to be effected by a scheme of arrangement under Part 26 of the UK Companies Act 2006. AMS shareholders are entitled to receive 285 pence in cash per share, valuing AMS's entire issued and to-be-issued share capital at approximately £659 million and implying an enterprise value of approximately £715 million. This record is sourced from an Exhibit 2.1 announcement furnished with H.B. Fuller's Form 8-K filed June 26, 2026, structured as a formal UK Takeover Code "Rule 2.7" recommended-offer announcement. At announcement, the AMS board of directors had unanimously recommended the acquisition to shareholders, and the deal was expected to complete by the end of calendar year 2026, subject to shareholder and regulatory approvals. Goldman Sachs and Perella Weinberg both acted as financial advisers to H.B. Fuller, per the announcement's statement that "Goldman Sachs and Perella Weinberg are acting as financial advisers to H.B. Fuller." On the AMS side, Evercore served as Joint Financial Adviser and Rule 3 Adviser, and Investec served as Joint Financial Adviser, Rule 3 Adviser, Nominated Adviser and Corporate Broker, per the announcement's enquiries section; no advisor is designated as sole lead on either side given the joint structures described. On the legal side, Ashurst LLP and Perkins Coie LLP advised H.B. Fuller, while Addleshaw Goddard LLP advised AMS. The announcement states H.B. Fuller expects to capture approximately $55 million (about £41 million) in combined run-rate revenue and cost synergies by 2031, including roughly $20 million in commercial synergies and $35 million in cost synergies, and that the acquisition is expected to add approximately 100 basis points to consolidated EBITDA margin within 24 months; the 285 pence offer represents a premium of approximately 34.8% to AMS's closing price on the last business day before the offer period began. Not disclosed in the sourced document is the precise percentage fee or compensation arrangement for any of the named advisers, the exact expected completion date beyond "end of the calendar year 2026," or whether the transaction will ultimately be implemented via scheme of arrangement versus a takeover offer, since Bidco reserved the right to elect either structure.

Energy Fuels Inc., a critical minerals company trading on NYSE American and the Toronto Stock Exchange under tickers UUUU and EFR, has agreed to acquire 100% of Vacuumschmelze GmbH & Co. KG and Ara VAC TopCo US LLC (together, "VAC"), a global advanced magnetics manufacturer, from Ara Partners. The transaction was documented in a Form 8-K filed with the SEC on June 26, 2026 disclosing an Agreement and Plan of Merger dated June 23, 2026, filed as Exhibit 2.1 to that filing. Under the Merger Agreement, Energy Fuels will pay aggregate consideration consisting of $718.0 million in cash, 65,853,000 Energy Fuels common shares, and, in certain circumstances, preferred shares. Preferred shares will be issued either to replace common shares that would otherwise exceed the maximum issuable without Canadian shareholder approval, or as a value top-up of up to $135.0 million if Energy Fuels' 20-day volume-weighted average share price ending two trading days before closing falls below a reference price of $20.93 per share. The cash consideration is subject to adjustments for repayment of certain Acquired Companies indebtedness, unpaid transaction expenses, leakage, and permitted interim financing, and $12.5 million otherwise payable at closing will be held in escrow to secure post-closing obligations. In a Form 8-K filed October 13, 2026 containing unaudited pro forma financial information prepared under Article 11 of Regulation S-X, Energy Fuels estimated total Merger consideration at $1,786.4 million as of a September 25, 2026 measurement date (common share price of $11.35), comprising approximately $747.4 million of estimated share consideration (65,853,000 shares, split between 44,353,000 shares not subject to value protection and 21,500,000 shares subject to value protection), $135.0 million of estimated preferred share consideration, $718.0 million of cash consideration, and approximately $185.9 million of VAC debt to be repaid upon change in control. Of the $718.0 million cash consideration, the filing states $379.0 million is expected to go to Ara Partners, $300.0 million directly to the lender of VAC's U.S. entity, and $39.0 million to an escrow agent. A sensitivity table in the same filing shows that a 20% increase in Energy Fuels' share price to $13.62 would raise total Merger consideration to approximately $1,935.9 million, while a 20% decrease to $9.08 would lower it to approximately $1,636.9 million. Separately, VAC's own recent-developments disclosure in that filing described the deal as having "total cash and equity consideration with an implied equity value of approximately $1.9 billion." The preliminary purchase price allocation in the pro forma filing shows net assets acquired of $833.4 million and resulting goodwill of approximately $953.0 million against total estimated consideration of $1,786.4 million; identifiable intangible assets were preliminarily valued at $325.96 million, split between customer relationships ($92.7 million, 20-year life), trademarks/trade names ($60.9 million, 10-year life) and developed technology ($172.4 million, 15-year life). To help fund the cash portion, Energy Fuels entered into a commitment letter on June 23, 2026 under which Goldman Sachs Bank USA committed to provide a senior secured term loan facility of up to $250 million, to be used together with cash on hand to fund the merger, with no financing condition to closing. Separately, on June 18, 2026 Energy Fuels received a conditional $725 million, 20-year financing commitment from the Department of War's Office of Strategic Capital intended to support expansion of rare earth processing capacity at the White Mesa Mill and a planned U.S. rare earth metals and alloy facility; this financing is not contractually tied to the VAC acquisition but was disclosed in the same 8-K. Strategically, Energy Fuels describes the VAC acquisition as completing the "last stage of mine-to-magnet vertical integration," combining its upstream rare earth mining, separation and (through its pending/completed Australian Strategic Materials acquisition) metals and alloys capabilities with VAC's downstream permanent-magnet manufacturing. Company materials state the combination is intended to let Energy Fuels "capture value at each conversion step in the supply chain" and "internalize the upstream margin on REE feedstock currently paid to third-party suppliers." VAC is described as a 100-plus-year-old advanced magnetics manufacturer headquartered in Hanau, Germany, with more than 400 patents, over 1,000 customers, and more than one billion rare earth permanent magnets shipped over the past decade, organized into three divisions: Rapid Solidification (soft-magnetic alloys; approximately 48% of FY2025 revenue of about €156 million, 21.5% gross margin), Crystalline (soft-magnetic NiFe/CoFe alloys; approximately 28% of FY2025 revenue, about €91 million, 18.5% gross margin), and Permanent Magnets (sintered NdFeB and SmCo magnets; approximately 24% of FY2025 revenue, about €79 million, 10.4% gross margin). VAC's consolidated (Ara VAC IE Aggregator, LP) revenue was €325.1 million in FY2025 versus €353.5 million in FY2024, with a loss after tax of €87.9 million in FY2025 versus €96.8 million in FY2024; for the six months ended June 30, 2026, revenue was €211.5 million, up 34.8% year over year, with a loss after tax of €57.4 million. VAC's U.S. Sumter, South Carolina magnet facility, operated through subsidiary e-VAC Magnetics LLC, began initial production in the fourth quarter of 2025 with current capacity of 2,000 tonnes per annum of permanent magnets, scalable to 12,000 tonnes per annum, and received U.S. government support including Section 48C investment tax credits. A separate July 2026 Energy Fuels investor presentation (furnished as Exhibit 99.1 to an 8-K filed July 14, 2026) stated an expected run-rate EBITDA of "$400M+" from the Sumter facility at 12,000 tonnes-per-annum capacity and cited a greater than $2 billion annual permanent-magnet customer pipeline across the automotive, defense, robotics and data-center markets, though the presentation did not disclose a specific companywide cost-synergy dollar figure or phase-in schedule for the VAC transaction. On a pro forma basis combining Energy Fuels, the completed ASM acquisition and the pending VAC acquisition, the October 13, 2026 filing shows a pro forma net loss attributable to Energy Fuels of $118.8 million for the six months ended June 30, 2026 (basic and diluted loss per share of $0.39) and $255.5 million for the year ended December 31, 2025 (basic and diluted loss per share of $0.89), reflecting pro forma weighted-average shares outstanding of 326.1 million and 305.4 million, respectively, after adding 14.8 million shares for the ASM consideration and 65.9 million shares for the VAC consideration. These figures indicate the combined company is pro forma loss-making over the presented historical periods rather than accretive, based on the companies' historical results. The Merger Agreement, as amended, is subject to customary closing conditions including expiration of the HSR Act waiting period and other specified regulatory approvals, conditional NYSE American and TSX listing approval for the share consideration, execution of an Investors' Rights Agreement, and absence of a material adverse effect. At closing, Holder (the VAC seller entity) will receive the right to nominate one Energy Fuels director and a one-time veto over one independent director nominee, rights that continue only while the Ara Parties collectively hold at least 7.5% of Energy Fuels' outstanding shares; Holder and the Minority Holders will also enter into a Lock-Up Agreement restricting transfers of the share consideration for twelve months post-closing, with scheduled partial releases, and will be subject to standstill restrictions for two years post-closing. Either party may terminate if closing has not occurred by 5:00 p.m. New York time on March 22, 2027, automatically extended to June 22, 2027 if only regulatory conditions remain unsatisfied by that date, or for uncured breach or a final non-appealable injunction. No specific termination fee amount was disclosed in the filings reviewed. On October 13, 2026, the parties entered into a First Amendment to the Merger Agreement (filed as Exhibit 2.1 to the October 13, 2026 Form 8-K) to address an ongoing arbitration dispute between e-VAC Magnetics LLC and a customer over a commercial supply agreement that the customer purported to terminate on July 1, 2026, and to provide for a direct repayment at closing of amounts outstanding under VAC's U.S. credit agreement (the "e-VAC Repayment Amount"), with the agreement stating that Energy Fuels was aware of the customer dispute during negotiation of the original Merger Agreement and that the parties had already incorporated a related purchase price adjustment mechanism; the specific dollar amount of the e-VAC Repayment Amount is redacted in the publicly filed exhibit. VAC's own financial statements reference a note on its ability to continue as a going concern in light of this dispute. Dorsey & Whitney LLP is identified in the Merger Agreement's notices clause as counsel to Energy Fuels (with copies to attorneys James Guttman and Richard Raymer at the firm's Toronto office). Latham & Watkins LLP is identified in the same notices clause as counsel to Ara Partners and the Holder/Acquired Companies parties (with copies to attorneys Justin Stolte, Ryan Maierson and Ryan Lynch at the firm's Houston office). No financial advisor to either side has been identified in the filings reviewed; the Merger Agreement contains a standard "No Brokers" representation from each side but does not name any investment bank or financial advisor engaged in connection with the transaction. The transaction remains pending and has not closed. It is distinct from Energy Fuels' separate, already-completed acquisition of Australian Strategic Materials Limited, which closed on August 28, 2026 under a Scheme Implementation Deed for approximately $243.4 million of share and cash consideration; Energy Fuels' filings describe the VAC and ASM transactions together as completing its vertically integrated "mine-to-magnet" rare earth strategy, but only the VAC acquisition is pending as of the most recent filing reviewed.

This transaction involves a senior secured term loan facility with a disclosed size of $1.5 billion. The deal is structured as a leveraged finance product in the form of a term loan. The borrower and ultimate sponsor are not specified in the available information, nor is the sector identified. The transaction is sourced from an SEC EDGAR filing published on June 26, 2026. The specific form type is not identified. The deal is currently in pending-regulatory status, indicating that regulatory approvals or other conditions precedent remain outstanding and the facility has not yet closed. The lender side is advised by two coordinating lead arrangers: Deutsche Bank and ING. According to the source documentation, both institutions acted as coordinating lead arrangers for the facility. In addition to its arranger role, ING serves as facility agent and security trustee for the term loan. ING is designated as the lead advisor on the lender side. No other lenders, co-managers, or syndication participants are identified in the available information. No legal advisors are identified or extracted from the available source documentation. The facility is structured as a senior secured term loan. The security package includes a security trustee function performed by ING. No other structural details are disclosed, including information about pricing, tenor, financial covenants, or conditions precedent to funding. The consideration structure, if applicable, is not specified. Several material facts about this transaction remain undisclosed or unknown. The borrower entity, guarantors, and sponsor or parent company are not identified. The sector or industry of the borrower is not stated. The expected closing or funding date is not provided. Pricing, including spread and any applicable margin or base rate, is not disclosed. The tenor or maturity of the facility is unknown. Detailed use of proceeds is not specified. The identity of any additional lenders, co-arrangers, co-managers, or documentation agents beyond Deutsche Bank and ING is not provided. Legal advisors to either the borrower or the lenders are not named. Any other material terms or conditions are similarly not disclosed.

Colony Bankcorp, Inc. (NYSE: CBAN), the holding company for Colony Bank, and First Reliance Bancshares, Inc. (OTCQX: FSRL), the holding company for First Reliance Bank, jointly announced on June 24, 2026 the signing of a definitive merger agreement under which Colony will acquire 100% of First Reliance's stock in a combined stock-and-cash transaction valued at approximately $163 million. The combination is designed to expand Colony's footprint across Alabama, Florida, Georgia and South Carolina, with the combined organization expected to hold approximately $5 billion in total assets, $4.0 billion in total deposits, and $3.2 billion in loans. This record is sourced from the companies' joint press release (Exhibit 99.1) filed with Colony's 8-K on June 24, 2026. The release states that the boards of directors of both Colony and First Reliance have unanimously approved the transaction. Keefe, Bruyette & Woods, A Stifel Company, served as financial advisor to Colony on the acquirer side. Hovde Group, LLC served as financial advisor to First Reliance on the target side. The release does not specify whether either bank's advisor delivered a formal fairness opinion or indicate a lead-versus-co-advisor distinction. Alston & Bird, LLP served as legal counsel to Colony. Ward and Smith, P.A. served as legal advisor to First Reliance. Under the terms of the agreement, each First Reliance shareholder may elect to receive either $19.75 in cash or 0.94 of a share of Colony common stock per share of First Reliance common stock, subject to proration such that approximately 20% of First Reliance stock converts to cash and the remaining 80% converts to Colony stock. The transaction is expected to be immediately accretive to Colony's earnings per share, excluding one-time merger-related expenses, and is expected to close in the fourth quarter of 2026, subject to regulatory approval, shareholder approval, and other customary closing conditions. Several leadership and governance changes were also announced, including First Reliance's CEO Rick Saunders joining Colony as Executive Vice Chairman and a board member. Not disclosed in this filing: whether either financial advisor rendered a fairness opinion, specific advisory or legal fees, a termination fee, and the precise pro forma earnings accretion percentage for Colony.

Boundless Bio, Inc. (Nasdaq: BOLD) and Serapha Bio, Inc., a privately held biotechnology company developing an investigational in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency, announced on June 23, 2026 that they have entered into a definitive merger agreement to combine in an all-stock transaction. The combined company is expected to operate as Serapha Bio, Inc. and trade on Nasdaq under the ticker "AATD," advancing Serapha's lead program SERP-01, which targets the SERPINA1 E342K mutation underlying severe AATD. Boundless Bio's CEO said its oncology program BBI-940, aimed at extrachromosomal DNA biology, did not produce clinical data supporting continued advancement, prompting the strategic combination. This record is sourced from Boundless Bio's own 8-K press release (Exhibit 99.1), furnished to the SEC on June 23, 2026. The release states the transaction has received unanimous board approval from both companies and is paired with a concurrent private placement financing. Lucid Capital Markets is serving as exclusive financial advisor to Boundless Bio. Wedbush Securities Inc. is serving as exclusive financial advisor to Serapha. Latham & Watkins LLP is serving as legal counsel to Boundless Bio. Gibson, Dunn & Crutcher LLP and Goodwin Procter LLP are serving as legal counsel to Serapha. Under the merger agreement, pre-merger Boundless Bio stockholders are expected to own approximately 3.7% of the combined company and pre-merger Serapha stockholders approximately 96.3%. Serapha has secured commitments for an oversubscribed private placement of approximately $230 million co-led by RA Capital Management and RTW Investments, with participation from Janus Henderson Investors, Decheng Capital, Vivo Capital, Casdin Capital, LifeSci Venture Partners, Logos Capital, Balyasny Asset Management, and Eventide Asset Management; approximately $138 million of that total was already funded in a prior Series A round, with the remaining $92 million expected to close alongside the merger. Boundless Bio expects to declare a cash dividend of approximately $44 to $48 million to its pre-merger stockholders prior to closing. The deal is expected to close in the fourth quarter of 2026, subject to stockholder approval at both companies, Nasdaq listing approval, S-4 effectiveness, and expiration of the Hart-Scott-Rodino waiting period if applicable. Not disclosed in this filing: the exact final ownership split subject to net cash adjustment, any termination fee, and Serapha's financial terms with YolTech Therapeutics beyond the disclosed milestone and royalty structure for its separately licensed SERP-01 asset.

QXO, Inc., a business-services company trading under ticker QXO, is the acquirer in a pending merger transaction. The transaction is classified as a mergers and acquisitions deal within the business-services sector. No deal value has been disclosed in the available source documents. This briefing is sourced from an SEC EDGAR filing published on June 22, 2026. The specific form type is not identified in the source materials. The transaction currently holds pending-regulatory status, indicating that regulatory approval or clearance remains outstanding and the deal has not yet closed. Morgan Stanley has been retained as the lead financial advisor to QXO in this transaction. According to the bank's opinion letter disclosure, Morgan Stanley and its affiliates have received aggregate fees totaling between 85 million and 110 million dollars over the two-year period preceding the delivery of Morgan Stanley's written opinion for financial advisory and financing services provided to QXO. This fee range encompasses both the advisory services related to the current transaction and other prior engagements with the acquirer. No legal advisors have been identified in the source materials provided for this transaction. The specific deal structure, consideration composition, form of consideration (cash, stock, or mixed), and any other material transaction terms have not been disclosed in the available documentation. Similarly, the identity of the target company or any details specific to the target's business, size, or assets remain absent from the source materials. Notably, no expected closing or completion date has been disclosed. The consideration amount is entirely undisclosed. The target company's name and sector are not identified. The specific nature of the regulatory approvals or conditions required for closing are not detailed. The roles and identities of any other financial or legal advisors to either party, if any exist, have not been extracted from the available sources. The structure of any transaction consideration, including whether it will be all-cash, all-stock, or some combination, remains completely unspecified in the materials reviewed.

QXO, Inc., a business-services company trading under the ticker QXO, is the acquirer in a pending merger transaction. The target company and transaction details regarding the business combination have not been disclosed in the available source materials. This is a mergers and acquisitions transaction within the business-services sector. The information regarding this transaction is sourced from an SEC EDGAR filing of unknown form type, published on June 22, 2026. The deal is currently in pending regulatory status, indicating that approvals or clearances remain outstanding before the transaction can close. No expected closing date has been provided in the available documentation. Morgan Stanley is serving as the financial advisor to QXO, the acquirer, in a lead capacity on this transaction. According to language in the SEC filing, Morgan Stanley and its affiliates received aggregate fees totaling between 85 million and 110 million dollars over the two-year period preceding delivery of Morgan Stanley's written opinion for financial advisory and financing services rendered to QXO. This fee disclosure suggests Morgan Stanley has provided substantial advisory support to the acquirer, though the breakdown between services related to this specific merger and other prior engagements is not specified in the available source material. No legal advisors have been identified in the source documents provided for either party to this transaction. The specific structure and terms of the merger, including the consideration mix, form of payment, exchange ratio if applicable, or any other transaction mechanics, have not been disclosed in the available SEC filing. The identity of the target company has likewise not been stated in the source material. Notably absent from the available documentation are several material details necessary for comprehensive deal understanding. The identity of the target company is not disclosed, nor is the total transaction value or consideration amount. The specific consideration structure, whether cash, stock, debt, or a combination thereof, remains undisclosed. Additionally, no expected closing date or regulatory approval timeline has been provided. The acquiring company's financial advisors beyond Morgan Stanley have not been identified, and no legal counsel representation has been disclosed for either side. Without these details, a complete picture of the transaction's scope, financing, and path forward cannot be fully constructed from the current source material.

This deal involves Open Lending Corp, a financial-institutions-group (fig) sector company, as the target of an all-cash tender offer by ANV Group Holdings Ltd. The transaction falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published June 16, 2026. The deal's status is pending regulatory, indicating the tender offer had not yet closed as of that filing. Two financial advisors are disclosed, one per side, with no lead designation specified for either. Financial Technology Partners is serving as financial advisor to Open Lending (the target), with the source sentence noting that Jones Day is acting as legal counsel to Open Lending in connection with the transaction. On the acquirer side, Evercore is serving as financial advisor to ANV, with Paul, Weiss, Rifkind, Wharton & Garrison LLP serving as legal counsel to ANV, per the corresponding source sentence. Legal advisors are disclosed for both sides: Jones Day is acting as legal counsel to the target, Open Lending, while Paul, Weiss, Rifkind, Wharton & Garrison LLP is acting as legal counsel to the acquirer, ANV. Beyond classifying this as an all-cash tender offer, the facts block does not specify the per-share tender price or the percentage of shares sought. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and no lead-advisor designation is specified for either Financial Technology Partners or Evercore, both of which are described only as "financial advisor" without further distinction.

Sable Offshore Corp., a natural resources company trading under ticker SOC, is undertaking a term loan refinancing transaction valued at $1,000,000,000 in disclosed size. This is a leveraged finance product within the debt capital markets space, specifically structured as a senior secured term loan refinancing. The transaction falls within the natural resources sector. The transaction is sourced from an SEC EDGAR filing published on June 16, 2026. The specific form type has not been identified in available documentation. The deal is currently pending regulatory approval, indicating it has not yet closed and remains subject to regulatory conditions or clearances. JPMorgan Chase Bank, N.A. has been identified as the financial advisor to the issuer on this transaction, serving in the capacity of administrative agent for the New Senior Secured Term Loan. JPMorgan is understood to be playing a lead role in this capacity based on the source language indicating it is "expected to be administrative agent" for the facility. No legal advisors have been identified or extracted for either party to this transaction based on available documentation. The deal structure involves the establishment of a New Senior Secured Term Loan facility. The transaction is characterized as a refinancing, suggesting it involves the repayment and replacement of existing debt obligations. The disclosed size of $1,000,000,000 represents the principal amount of the term loan facility. However, the specific terms of the facility, including final maturity date, pricing, spread, base rate, amortization schedule, and any financial covenants or conditions, have not been disclosed in the available documentation. Several material aspects of this transaction remain undisclosed or unknown at this time. No expected closing date has been provided. The complete syndicate of lenders, beyond the administrative agent role held by JPMorgan Chase Bank, has not been identified. The detailed terms and conditions of the term loan, including interest rate mechanics, tenor, and repayment terms, have not been specified. Additionally, the consideration structure or any fees associated with the transaction are not detailed in the available source materials.

This transaction is a cash acquisition in which Nuvei is acquiring Payoneer, a deal classified under the M&A product group. The disclosed transaction value is $2,750,000,000. The deal is currently in pending regulatory status, meaning it has not yet closed. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filing published on June 15, 2026. No additional source documents were provided beyond this filing. On the financial advisory side, Nuvei (the acquirer) retained two advisors: Goldman Sachs & Co. LLC is serving as lead financial advisor to Nuvei, while Barclays Capital Inc. has also provided financial advice to Nuvei in a non-lead capacity. On the target side, Qatalyst Partners is serving as exclusive financial advisor to Payoneer, in a lead role. Legal counsel is split along the same sides of the transaction. Simpson Thacher & Bartlett LLP and Stikeman Elliott LLP are both serving as legal counsel to Nuvei, the acquirer. Davis Polk & Wardwell LLP is serving as legal counsel to Payoneer, the target. Beyond the parties, product group, disclosed value, and status, no further structural detail is available. The facts block does not specify the consideration mix beyond characterizing this as a cash acquisition, nor does it provide any detail on financing structure or regulatory approval requirements. Several elements remain undisclosed in the available record. There is no expected or actual closing date stated anywhere in the facts block. No sector classification for either party is given. No further detail is provided on deal timeline milestones or termination provisions beyond the general pending-regulatory status label.

Isabella Bank Corp, a financial institution trading under the ticker ISBA, is acquiring Grand River (target name inferred from advisor context) in a bank merger transaction within the financial services sector. The deal is valued at $54.6 million in disclosed consideration. This is a merger and acquisition transaction, representing a consolidation in the regional banking space. The transaction details are sourced from an SEC EDGAR filing published on June 12, 2026, though the specific form type has not been identified. The deal currently holds a pending regulatory status, indicating that it has been announced and is awaiting necessary approvals before closing. On the financial advisory side, Isabella Bank Corp retained Piper Sandler & Co. as its lead financial advisor. Piper Sandler rendered a fairness opinion to the board of directors of Isabella, confirming the financial fairness of the proposed transaction terms. On the target side, Grand River engaged Brean Capital, LLC as its lead financial advisor. Brean Capital similarly provided a fairness opinion to Grand River's board of directors in connection with the proposed merger. Legal representation for the transaction is divided between two firms. Luse Gorman, PC serves as legal counsel to Isabella Bank Corp in the proposed transaction. Hunton Andrews Kurth LLP represents Grand River as its legal advisor. The transaction structure specifies a disclosed consideration value of $54.6 million, though no further detail has been provided regarding the mix or form of consideration (whether cash, stock, or a combination thereof). No information is available regarding the specific mechanics of the merger, such as whether this will be structured as a statutory merger, asset purchase, or stock purchase, nor are there any details about the relative equity or debt components of any transaction financing. The following material details remain undisclosed or unknown: the specific closing timeline or expected completion date, the detailed composition of consideration (stock versus cash, or other forms), any earnout or contingent payment provisions, and the precise regulatory approvals required or their current status. The form type of the SEC filing from which this information was sourced has not been specified, which may affect the completeness of disclosure available in the source document itself.

Public Storage, a publicly traded real estate company operating under ticker PSA, has agreed to acquire National Storage Affiliates Trust, also a real estate sector participant, in an all-stock merger transaction. This is a merger and acquisition within the real estate sector, specifically involving self-storage operators. The transaction has not yet closed and remains pending regulatory approval. The specific dollar value of the transaction has not been disclosed in the available source documents. The information regarding this transaction has been sourced from SEC filings available through SEC EDGAR, with publication occurring on June 12, 2026. The filing form type has not been identified in the available materials. The current status of the deal is pending regulatory approval, indicating that while the parties have reached an agreement on terms, the transaction has not yet received all necessary regulatory clearances to proceed to closing. No financial advisors have been identified or extracted for either Public Storage or National Storage Affiliates Trust in connection with this transaction based on the available source materials. This represents a notable gap in typical merger and acquisition documentation, where investment banks and financial advisors customarily play roles ranging from advisory counsel to underwriting or placement support. No legal advisors have been identified in the available source materials for either party to the transaction. The deal structure involves an all-stock consideration, meaning that National Storage Affiliates Trust shareholders will receive shares of Public Storage as payment for their interests rather than cash or a mixed consideration package. Beyond the all-stock nature of the consideration, specific details regarding the exchange ratio, the exact number of shares to be issued, or any collar provisions have not been disclosed in the available documents. Several material details remain undisclosed or unknown at this time. The transaction value or implied valuation has not been stated in the source materials, making it impossible to assess the relative size of the acquisition. The expected closing date or timeline for regulatory approval has not been specified. The specific regulatory approvals required or the stage of the approval process is not detailed. Additionally, the identity and roles of any legal counsel advising either party remain unknown based on the available information.

Sleep Number Corporation, ticker SNBR (Nasdaq), agreed to sell substantially all of its assets to SNBR, Inc., a wholly owned subsidiary of Sleep Country Canada Inc., in a transaction structured as an asset sale under Section 363 of the U.S. Bankruptcy Code. The deal was first announced on June 12, 2026, when Sleep Number entered into a stalking horse Asset Purchase Agreement with Sleep Country Canada for a purchase price of $415 million in cash plus assumption of certain liabilities, and simultaneously commenced voluntary Chapter 11 cases (In re: Sleep Number Corporation, et al., Case No. 26-11399) in the U.S. Bankruptcy Court for the Southern District of New York, with Sleep Country Canada serving as the stalking horse bidder in a court-supervised sale process open to higher and better offers. Linda Findley, President and Chief Executive Officer of Sleep Number, said the company's "capital structure remains unsustainable" despite progress on its turnaround, and that "moving forward with the Sleep Country Canada agreement and this court-supervised sale process will enable us to address our financial constraints," while also positioning the business "to expand," including through "future international expansion." Stewart Schaefer, President and Chief Executive Officer of Sleep Country Canada, said the companies have "long admired Sleep Number, its game-changing personalized sleep products and the talented team behind them," and that together they see "a tremendous opportunity to build on our complementary strengths and accelerate growth across the United States while introducing Sleep Number's innovative sleep solutions to consumers in Canada and other markets." Following a Bankruptcy Court-supervised auction process, Sleep Number entered into an Amended and Restated Asset Purchase Agreement with the purchaser and Sleep Country Canada on July 18, 2026 (disclosed in an 8-K filed July 23, 2026), which increased the base cash purchase price from $415.0 million to $529.5 million, subject to certain purchase price adjustments. The amended agreement also reduced the purchaser's required adjustment escrow deposit from $25.0 million to $10.0 million, eliminated or narrowed several potential purchase-price deductions (including those tied to undelivered customer orders, payment-card processor reserve deposits, and cure costs for assumed contracts and leases), removed certain pre-closing covenants and closing conditions (including a minimum marketing spend covenant, a pre-closing inventory count, and minimum employee/executive acceptance thresholds), and added a new closing condition requiring Sleep Number to fund a segregated Stub Rent Reserve of $5,193,168 for unpaid lease obligations. Closing conditions disclosed in that filing included entry of a Bankruptcy Court sale order, expiration or termination of the Hart-Scott-Rodino antitrust waiting period, absence of FTC or DOJ antitrust action to block the sale, and the absence of a material adverse effect at Sleep Number. The amended agreement also provided for a break-up fee and expense reimbursement payable to the purchaser, and forfeiture of a deposit to the company, in certain circumstances, though the specific dollar amounts of those fees were not disclosed in the 8-K. The transaction has closed. The Bankruptcy Court entered a Sale Order on July 21, 2026 approving the amended purchase agreement and authorizing the debtors to consummate the sale, and the parties closed the Asset Sale on July 31, 2026, per an 8-K filed August 3, 2026. Total cash proceeds were $529.5 million, of which approximately $267.4 million was used to repay debtor-in-possession term loans and roll-up loans provided by the company's prepetition lenders (together with certain other fees and expenses), and $10.0 million was deposited into an escrow account to settle post-closing purchase price adjustments. Sleep Number stated it does not expect any proceeds from the Asset Sale, or from the ultimate settlement of claims under its plan of liquidation, to be available for distribution to stockholders, and that the company's outstanding common stock will be cancelled upon effectiveness of the plan. The company also disclosed that it was unable to prepare pro forma financial information for the transaction without unreasonable effort or expense and that none was included in the closing 8-K; as a debtor-in-possession, it instead files monthly operating reports with the Bankruptcy Court that are limited in scope and not intended as a basis for investment decisions. No earnings or EBITDA multiple was disclosed for the transaction in any available filing, consistent with its structure as a cash asset sale out of bankruptcy rather than a valuation-driven strategic or going-concern acquisition. Sleep Number was advised by Davis Polk & Wardwell LLP as lead legal advisor, Guggenheim Securities, LLC as investment banker, AP Services (an affiliate of AlixPartners) as interim management, and Joele Frank, Wilkinson Brimmer Katcher as strategic communications advisor; A&G Real Estate Partners assisted with store footprint matters. Sleep Country Canada was advised by Goodwin Procter LLP as lead legal advisor and PwC as financial advisor. In connection with the June 2026 filing, Sleep Number also disclosed it expected to secure up to $260 million of debtor-in-possession financing, including up to $65 million in new financing, to fund operations during the court-supervised process.

Figure Technology Solutions, Inc., ticker FIGR, a company operating in the fig sector, is the acquirer in this leveraged finance transaction. The deal involves a bridge loan facility with a disclosed size of $600,000,000 in USD. This is a levfin product subtype classified as a bridge loan facility, which typically provides interim financing pending longer-term capital sourcing or refinancing. The transaction was announced and sourced from an SEC EDGAR filing published on June 10, 2026. The specific form type has not been identified from available data. The deal is currently in announced status, meaning it has been publicly disclosed but may not yet have closed. Bank of America, N.A. is serving as the sole administrative agent for the Bridge Facility and is identified as a lead financial advisor to the acquirer. BofA Securities, Inc. and Barclays Bank PLC are serving jointly as lead arrangers and bookrunners for the Bridge Facility, also in a lead capacity. Both BofA Securities and Barclays are explicitly named in the source material as fulfilling the roles of lead arrangers and bookrunners for this facility. No legal advisors have been identified or extracted from the available transaction data. The transaction is structured as a bridge loan facility with a principal amount of $600,000,000. Beyond the identification of the facility type and size, no additional details regarding consideration mix, pricing, tenor, financial covenants, or other facility-specific terms have been disclosed in the available documentation. Several material facts remain undisclosed or unknown at this time. The expected closing date for the transaction has not been provided. The purpose or end use of bridge financing proceeds is not stated. The identity of the target company or asset being acquired is not disclosed. The form type of the SEC filing itself has not been identified. No information regarding any syndication, commitments from other lenders, or the ultimate term loan or refinancing structure contemplated has been made available. Additionally, whether other financial or legal advisors are involved in the transaction remains unknown based on the extracted data.

Health Catalyst, Inc. (Nasdaq: HCAT), a healthcare intelligence company, agreed to divest VitalWare, LLC, its mid-revenue cycle business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, for a total cash consideration of $147 million. The parties signed a Unit Purchase Agreement on June 4, 2026, announced in an 8-K filed that day, and the transaction closed on July 31, 2026, as confirmed in an 8-K filed August 6, 2026. CEO Ben Albert said at signing, "This is a big step forward for Health Catalyst. We are concentrating our business around the areas where we have the deepest conviction, and we plan to put the capital structure in place to back our long-term strategy. Vitalware is a great business, and we are pleased to have found a partner in Med-Metrix who is well positioned to carry it forward, which we believe puts both companies in a strong position for what comes next." The press release described VitalWare as a best-in-KLAS software provider for health system coding compliance, chargemaster management, charge capture and price transparency, with approximately $37 million in fiscal year 2025 revenue. Under the Purchase Agreement, Med-Metrix agreed to pay an aggregate base purchase price of $147 million in cash for all of the equity interests of VitalWare, LLC, subject to customary adjustments for cash, indebtedness, net working capital and transaction expenses. The deal is structured as an all-cash divestiture of a wholly owned subsidiary rather than a merger; no exchange ratio, EV/EBITDA multiple, or P/E multiple was disclosed in the filings reviewed. Health Catalyst's stockholders were not required to approve the transaction. Health Catalyst used the net cash proceeds from the sale, combined with cash on hand, to voluntarily prepay in full and terminate its senior secured credit facility with Silver Point Finance, LLC as administrative agent. The repayment totaled approximately $163.7 million, consisting of a $122,812,500 initial term loan balance, a $37,134,500 delayed-draw facility balance, a $3,198,940 prepayment premium, and $548,022 of accrued and unpaid interest, plus other fees. The company stated that retiring the credit facility eliminates approximately $19 million in annual GAAP interest expense, based on annualizing first-half 2026 interest costs. No new financing or stock consideration was part of the transaction; it was funded entirely with the buyer's cash payment. No cost synergies were disclosed, as this is a sale of a non-core business line rather than a combination of two companies integrating operations. Health Catalyst instead framed the transaction as sharpening its strategic focus: the company said the divestiture lets it concentrate capital and investment on its core technology and AI-driven products, built on what it describes as 18 years of proprietary healthcare improvement data and $2.8 billion in documented outcomes across more than 380 client case studies. Unaudited pro forma financial statements filed as Exhibit 99.3 to the August 6, 2026 Form 8-K show the transaction's financial impact. Pro forma for the disposition and debt repayment as if they had occurred January 1, 2025, Health Catalyst's loss from operations for the year ended December 31, 2025 improves from a historical operating loss (which included a $110.2 million goodwill and intangible asset impairment) to a pro forma operating loss of $107.7 million, aided by a $65.9 million pro forma gain on sale recognized as a transaction accounting adjustment. Interest expense is reduced by an estimated $22.1 million for the year ended December 31, 2025 and $9.4 million for the six months ended June 30, 2026, reflecting the elimination of the credit facility. The pro forma balance sheet as of June 30, 2026 shows total assets declining from $358.6 million historical to $245.99 million pro forma, with cash of $39.4 million pro forma after giving effect to both the $145.2 million of net proceeds received and the approximately $166.4 million used for the debt repayment and related adjustments. Health Catalyst stated the divestiture does not meet the criteria for discontinued-operations presentation under U.S. GAAP because it does not represent a strategic shift with a major effect on the company's operations or financial results, and the gain on sale does not create a current income tax expense given the company's net operating loss carryforwards (approximately $787.8 million federal and $647.7 million state as of December 31, 2025, per its 10-K). Closing conditions disclosed in the June 4, 2026 8-K included expiration or termination of the Hart-Scott-Rodino Antitrust Improvement Act waiting period, absence of any law or order restraining the transaction, acceptance of qualifying employment offers by at least 80% of VitalWare employees receiving offers from the buyer, and accuracy of customary representations and warranties. The agreement set an Outside Date of December 4, 2026 (with a potential three-month automatic extension to obtain required regulatory approvals), after which either party could terminate if closing had not occurred, along with termination rights for mutual agreement, illegality, or uncured material breach after 60 days' notice. All conditions were satisfied and the transaction closed on July 31, 2026, roughly seven weeks after signing. Concurrently with closing, Health Catalyst and Med-Metrix entered into a transition services agreement under which Health Catalyst will provide certain transition services related to VitalWare for up to six months following closing. Raymond James served as exclusive financial advisor to Health Catalyst, and Latham & Watkins LLP served as outside legal counsel to Health Catalyst, per the company's press releases announcing both signing and closing. No financial or legal advisors to Med-Metrix were identified in the filings reviewed.

Wellington Management is acquiring Hartford Funds, the asset management subsidiary of The Hartford, in a transaction The Hartford estimates has a net present value of approximately 1.9 billion dollars. The deal was announced June 3, 2026, in a definitive agreement between The Hartford Insurance Group, Inc. (NYSE: HIG) and Wellington Management Company LLP, disclosed in a Form 8-K filed with the SEC. The acquiring entity is Wellington Investment Advisors Holdings, LLP, Wellington's corporate parent; Wellington itself is a private partnership and is not an SEC filer, so the transaction is described here based on The Hartford's filings. Strategically, the companies describe the deal as converting a four-decade sub-advisory partnership, which began in 1978 and formalized in 1984, into a single integrated firm. Wellington CEO and managing partner Jean Hynes said the combination builds on the fact that "Wellington and Hartford Funds have partnered together in support of advisors and investors" for more than 40 years. The Hartford's Chairman and CEO Christopher Swift said the deal "allows us to realize immediate and continued value for The Hartford's shareholders and positions Hartford Funds' exceptional people for ongoing success." Hartford Funds had approximately 160.2 billion dollars in discretionary and non-discretionary assets under management as of April 30, 2026, of which Wellington already sub-advised 83 percent; upon closing, Hartford Funds will be folded into Wellington's U.S. Wealth business and rebranded under the Wellington name, with the combined organization expected to include approximately 200 client-facing professionals. The consideration structure, as disclosed in The Hartford's 8-K and corroborated in its Form 10-Q for the quarter ended June 30, 2026, consists of 300 million dollars in cash payable at closing plus contingent consideration equal to 95 percent of after-tax available cash generated by the combined Hartford Funds/Wellington wealth business (including sales of certain other Wellington-sponsored products), payable quarterly over an expected seven years following closing. That period can end early or be extended based on performance thresholds: if, starting five years after closing, the net present value of the quarterly payments plus the 300 million dollar upfront proceeds (discounted at 11 percent) reaches 2.1 billion dollars, the payment obligation terminates; if, at the end of the initial seven years, that net present value is below 1.5 billion dollars, payments continue until the threshold is met or for up to eight additional quarters. The Hartford's 1.9 billion dollar headline valuation is its own estimate of this contingent stream's net present value, calculated at an 11 percent discount rate, and is explicitly subject to the business's future market and operating performance rather than a fixed, guaranteed price. The agreement itself (and any investor presentation) was not filed as an exhibit to the 8-K, so terms beyond what is described in the 8-K's Item 8.01 narrative and the press release are not disclosed in the SEC record. The Hartford's 10-Q discloses accounting mechanics not in the press release. Hartford Funds has been classified as held for sale and reported as discontinued operations beginning in the second quarter of 2026. Its reporting-unit goodwill of 272 million dollars was tested for impairment upon that classification; the fair value of the unit significantly exceeded carrying value, so no impairment was recorded. The Hartford recognized a 251 million dollar deferred tax asset and associated income tax benefit in the second quarter of 2026, reflecting the difference between Hartford Funds' tax basis and its U.S. GAAP carrying value; this is the figure that actually hit net income (slightly refined from the 250 million dollar estimate given in the original 8-K). As of June 30, 2026, total assets held for sale associated with Hartford Funds were 901 million dollars (515 million in cash and investments, 272 million in goodwill, 114 million in other assets) against 180 million dollars of liabilities held for sale. For the three months ended June 30, 2026, the discontinued Hartford Funds business generated 307 million dollars of total revenue (295 million of fee income) and 85 million dollars of pretax income, with net income from discontinued operations of 318 million dollars including the one-time tax benefit. Prior to closing, The Hartford expects to receive a pre-closing dividend of approximately 170 million dollars from Hartford Funds. At closing, it expects to recognize an estimated after-tax realized loss of approximately 150 million dollars, reflecting the difference between Hartford Funds' GAAP carrying value and the 300 million dollar upfront cash proceeds; this loss is separate from, and not netted against, the contingent consideration, which will be treated as a gain contingency and recognized only as cash is actually received in future quarters. The Hartford estimates after-tax transaction costs through closing of approximately 55 million dollars, and expects initial quarterly contingent payments of approximately 65 million dollars once they begin, following the first full quarter after closing. J.P. Morgan Securities LLC acted as financial advisor to Wellington, with Paul, Weiss, Rifkind, Wharton & Garrison LLP as Wellington's legal advisor. Goldman Sachs & Co. LLC acted as financial advisor to The Hartford, with Weil, Gotshal & Manges LLP as The Hartford's legal advisor. The transaction has not yet closed. It is expected to close in the first quarter of 2027, subject to customary closing conditions including regulatory approvals and fund-level approvals (reflecting that Hartford Funds operates registered investment companies requiring board and shareholder approvals under the Investment Company Act). No merger agreement exhibit, investor presentation, or proxy statement has been filed with the SEC for this transaction as of the most recent 8-K on file (filed September 30, 2026, which does not reference Hartford Funds), and no termination fee or breakup fee is disclosed in any filing reviewed. No subsequent SEC filing confirms closing or termination of the deal.

Wiley has agreed to acquire Emerald in a merger transaction valued at $452 million in disclosed consideration. The transaction falls within the mergers and acquisitions product group. Both target and acquirer operate in the publishing and information services sector. The transaction is currently pending regulatory approval. This briefing is sourced from an SEC EDGAR filing of unknown form type, published on June 2, 2026. The filing indicates that the transaction remains in pending-regulatory status, meaning it has not yet closed and is awaiting regulatory clearance or approval. Evercore is serving as financial advisor to Emerald, the target company, in a lead capacity. On the acquirer side, Centerview Partners LLC is serving as financial advisor to Wiley in a lead capacity. Both firms are providing primary financial advisory support to their respective clients on this transaction. Fried, Frank, Harris, Shriver & Jacobson LLP is serving as legal advisor to Emerald, the target. Arnold & Porter Kaye Scholer LLP is serving as legal advisor to Wiley, the acquirer. The transaction is structured as a merger. The consideration is disclosed at $452 million, but the specific mix of consideration, timing of payments, and any conditions precedent to closing have not been disclosed in the available source materials. No information has been provided regarding the mechanics of the transaction, the percentage of equity versus cash consideration, earnout provisions, or any other structural details beyond the aggregate dollar value. Several material aspects of this transaction remain undisclosed. The exact form of the SEC filing used as the source for this information has not been identified, which limits context about the filing's purpose and required disclosures. The expected closing date for the transaction has not been disclosed. The specific regulatory approvals or conditions required before closing are not detailed. The breakdown of the $452 million consideration between cash, equity, debt, or other consideration types is not specified. Additionally, no information is provided regarding deal financing, any representations and warranties insurance, indemnification provisions, or post-closing adjustments to purchase price.

Wiley (NYSE: WLY), the academic and professional publishing company, announced it has acquired Emerald Publishing Limited from Cambridge Information Group (CIG) in an all-cash transaction valued at £337 million, or USD 452 million. The deal expands Wiley's journal portfolio to approximately 2,500 titles and is positioned as establishing category leadership in economics, business, finance, and the social sciences. The filer is classified under SIC 2731 (book publishing), and the target is a UK-headquartered scholarly publisher founded in 1967 with nearly 500 journal brands and 8,000 book titles. This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by John Wiley & Sons, Inc. with the SEC on June 2, 2026, announcing that the acquisition had already been completed ("today announced it has acquired Emerald Publishing Limited"), making this a closed-deal announcement rather than a signing announcement. Emerald was expected to generate over USD 85 million of revenue in its fiscal year ending December 31, 2026, with mid-single-digit revenue growth and 92% recurring subscription revenue. On financial advisory, Centerview Partners LLC served as financial advisor to Wiley, the acquirer, while Evercore served as financial advisor to Emerald, the target being sold by Cambridge Information Group. On legal advisory, Arnold & Porter Kaye Scholer LLP served as legal advisor to Wiley, and Fried, Frank, Harris, Shriver & Jacobson LLP served as legal advisor to Emerald. The deal structure disclosed is a straightforward all-cash purchase of Emerald from its parent, Cambridge Information Group, valued at £337 million (USD 452 million). Wiley expects to realize approximately USD 30 million of annual run-rate cost synergies by year three post-close, with meaningful synergy realization by year two, and expects the deal to be accretive to Adjusted EPS in year one. What is not disclosed: the press release does not specify a closing date beyond confirming the deal had already closed as of the announcement, does not break out the £337 million valuation into enterprise versus equity components or disclose any assumed debt, and does not state a termination fee (consistent with this being an announced-as-closed transaction rather than a pending signed agreement).

Array Digital Infrastructure, Inc. (NYSE: AD), the shared wireless tower infrastructure company roughly 82%-owned by Telephone and Data Systems, Inc. (TDS), announced the successful closing of its previously announced agreement to sell a portion of its retained spectrum licenses to Verizon for total consideration of $1.0 billion. The release also notes related spectrum sales to T-Mobile totaling $168 million, primarily 700MHz and 600MHz licenses, completed in May. The deal sits in the telecommunications sector (SIC 4812). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Array Digital Infrastructure, Inc. with the SEC on June 1, 2026, announcing closing of the Verizon spectrum sale. Following close of the Verizon transaction and other spectrum sales, and considering current cash on hand, Array's board declared a special cash dividend of $11.00 per common share and Series A common share, payable June 25, 2026. The release separately notes that the special dividend declaration is unrelated to a non-binding proposal, dated May 7, 2026 and announced May 8, 2026, from TDS to acquire all outstanding Array common shares it does not already own; the Array special committee had not made a decision on that non-binding proposal as of this release. On financial advisory, Citigroup Global Markets Inc. served as lead financial advisor and Centerview Partners LLC served as financial advisor to TDS in connection with the Verizon transaction, with TD Securities (USA) LLC and Wells Fargo also serving as financial advisors to TDS. PJT Partners LP served as financial advisor to the independent directors of Array. On legal advisory, Wilkinson Barker Knauer, LLP served as lead transactional and FCC regulatory counsel to both TDS and Array, Clifford Chance LLP served as regulatory advisor to both companies, Sidley Austin LLP served as legal advisor to TDS, and Cravath, Swaine & Moore LLP served as legal advisor to Array's independent directors. What is not disclosed: the release does not provide the specific spectrum bands or markets involved in the Verizon sale beyond referencing "a portion" of retained licenses, does not disclose the status or terms of the separate TDS non-binding proposal to acquire the rest of Array (which remains preliminary, not a definitive agreement, and is therefore not treated here as its own deal), and does not state individual advisor fees.

OceanFirst Financial Corp. (NASDAQ: OCFC), a financial institutions sector company, has completed its acquisition of Flushing Financial Corporation (NASDAQ: FFIC), the holding company for Flushing Bank, in an all-stock merger. The Agreement and Plan of Merger was signed December 29, 2025, and the transaction was announced the same day alongside a concurrent $225 million strategic investment from affiliates of funds managed by Warburg Pincus LLC. The merger closed on June 1, 2026, with Flushing merging into OceanFirst in a two-step merger structure, followed the next day by the merger of Flushing Bank into OceanFirst Bank, National Association. Under the merger agreement, each share of Flushing common stock was converted into the right to receive a fixed 0.85 of a share of OceanFirst common stock, plus cash in lieu of fractional shares. At announcement, based on OceanFirst's December 26, 2025 closing price of $19.76, the transaction was valued at approximately $16.80 per Flushing share, or approximately $579 million in aggregate deal value, equivalent to roughly 10.6 times Flushing's estimated 2026 earnings, 9.6 times estimated 2027 earnings (5.0 times on a fully synergized 2027 basis), and 0.80 times Flushing's tangible book value per share, with a pay-to-trade ratio of 79% referenced in the companies' investor materials. OceanFirst issued approximately 29.30 million shares of its common stock to former Flushing stockholders (including converted restricted stock unit awards) to fund the merger consideration. Concurrent with the merger closing, OceanFirst completed a $225 million investment from affiliates of Warburg Pincus LLC, consisting of approximately 9.5 million shares of OceanFirst common stock at $19.76 per share, approximately 1,812 shares of a newly created non-voting, common-equivalent stock (NVCE Stock) economically equivalent to roughly 1.8 million common shares, and a seven-year warrant to purchase approximately 11.4 million shares of NVCE Stock at an exercise price of $19,760 per NVCE share (equivalent to $19.76 per underlying common share). The warrant cannot be voluntarily exercised before the third anniversary of closing except if OceanFirst's stock closes at or above $30 per share, and is subject to mandatory exercise if the stock sustains that level for a specified period. Immediately after closing, OceanFirst had approximately 96.7 million shares outstanding, with pro forma ownership of roughly 58% OceanFirst legacy holders, 30% former Flushing holders, and 12% Warburg Pincus, per the companies' deal-announcement investor materials. As part of the merger, OceanFirst also assumed approximately $251.9 million in aggregate principal amount of Flushing's outstanding subordinated and junior subordinated debt securities, comprising $125 million of 3.125% fixed-to-floating rate subordinated notes due 2031, $65 million of 6.000% fixed-to-floating rate subordinated notes due 2032, and three tranches of junior subordinated debentures totaling approximately $61.9 million due 2037. At announcement, OceanFirst disclosed expected cost savings equal to 35.0% of Flushing's non-interest expense base, with 50% of those savings phased in during 2026 and the full amount realized thereafter, alongside pre-tax one-time merger and restructuring expenses of approximately $106 million (described as 1.7 times fully phased-in 2026 cost synergies, or about 18% of deal value). The companies' pro forma earnings-per-share reconciliation modeled approximately $46.4 million of after-tax cost savings and $18.5 million of after-tax accretion from fair value marks, producing a pro forma 2027 estimated EPS of $2.48 versus OceanFirst's standalone estimated 2027 EPS of $2.15, equivalent to $0.34, or 16%, EPS accretion to OceanFirst. The companies modeled tangible book value dilution to OceanFirst of approximately 6% including interest rate marks (or approximately 3% excluding rate marks), with an estimated earnback period of 3.1 years, assuming a 10.0 times exit multiple and a 10.0% CET1 target. The deal materials also disclosed a gross credit mark of 2.6% of Flushing's gross loans (approximately $174 million, about 4.1 times Flushing's then-current reserves), including an 8% credit mark on Flushing's $1.4 billion rent-regulated multifamily portfolio, and a core deposit intangible of 1.15% amortized over seven years. Announcing the strategic rationale, the companies described the deal as creating "a scaled, high performing franchise" that pairs OceanFirst's commercial products and treasury management capabilities with Flushing's 95-plus year deposit franchise concentrated in Long Island and the New York City boroughs, where Flushing held the number 2 community-bank deposit market share position. At closing, CEO Christopher Maher said the combination "pairs Flushing's deeply rooted, 95-year community franchise with OceanFirst's relationship-driven business model, expanded capabilities, and broader product set, and immediately scales our presence in the deposit-rich markets of Long Island and the New York City boroughs," adding that adding Warburg Pincus as a capital partner positions the combined company "to deliver enhanced value to our clients, accelerate profitable growth, and create meaningful long-term value for our shareholders." Materials at announcement also emphasized a goal of reducing commercial real estate concentration over time and improving profitability metrics (NIM, ROAA, and ROATCE) on a pro forma basis. Following the closing, the combined company operates 71 retail branches across New Jersey, New York, Long Island, and markets from Massachusetts through Virginia, under the OceanFirst brand, with approximately $23 billion in pro forma total assets as referenced in deal materials. John R. Buran, former President and CEO of Flushing, joined the OceanFirst board as non-executive Chairman for a two-year term, after which Christopher Maher is slated to resume the Chairman role. Five other former Flushing directors (Alfred DelliBovi, Steven D'Iorio, Louis C. Grassi, Sam S. Han, and Caren C. Yoh) joined the OceanFirst board, along with Warburg Pincus designee Todd Schell, bringing the OceanFirst board to 17 members. In connection with the merger, OceanFirst also committed a $5 million contribution to the OceanFirst Foundation supporting community organizations across the combined company's markets. Both companies' stockholders approved the merger at special meetings. At Flushing's special stockholder meeting held April 6, 2026, the merger proposal was approved with 24,102,136 shares voted in favor versus 628,640 against (with 40,182 abstentions), out of 24,770,958 shares represented at the meeting (33,883,626 shares outstanding as of the February 20, 2026 record date). OceanFirst's stockholders approved the related share issuance at a special meeting held April 2, 2026. The merger agreement specified a Termination Fee of $21,431,924 payable by Flushing under specified circumstances (including a change in the Flushing board's recommendation or acceptance of a superior proposal) and a Reverse Termination Fee of $46,339,296 payable by OceanFirst under specified circumstances. OceanFirst's registration statement on Form S-4 (File No. 333-293282) covering the share issuance was filed February 6, 2026, amended February 23, 2026, and declared effective February 25, 2026. On the financial advisory side, Keefe, Bruyette & Woods, Inc., A Stifel Company, served as financial advisor to OceanFirst, and Piper Sandler & Co. served as financial advisor to Flushing. J.P. Morgan acted as capital markets advisor and sole placement agent to OceanFirst in connection with the Warburg Pincus investment. Jefferies LLC served as financial advisor to Warburg Pincus. On the legal side, Simpson Thacher & Bartlett LLP served as legal counsel to OceanFirst, Hughes Hubbard & Reed LLP served as legal counsel to Flushing, and Wachtell, Lipton, Rosen & Katz served as legal counsel to Warburg Pincus.

United States Cellular Corporation (USCC), an approximately 82-percent-owned subsidiary of Telephone and Data Systems, Inc. (NYSE: TDS), agreed to sell a portion of its retained wireless spectrum licenses to Verizon Communications Inc. (NYSE, Nasdaq: VZ) for total consideration of $1.0 billion in cash. The agreement, a License Purchase Agreement dated October 17, 2024, was disclosed in a Form 8-K filed by USCC on October 18, 2024, and covers wireless spectrum licenses in the cellular (850 MHz) band together with select licenses in the AWS and PCS bands. According to the October 2024 press release, the deal involved 663 million MHz POPs of Cellular (850 MHz) spectrum, 11 million MHz POPs of AWS spectrum, and 19 million MHz POPs of PCS spectrum. The transaction was part of a broader spectrum-monetization program USCC announced on May 28, 2024, to sell spectrum assets not included in its separate, previously announced sale of its wireless operations to T-Mobile US, Inc. (that wireless-operations sale closed August 1, 2025, per the June 2026 press release). Laurent C. Therivel, USCC's President and CEO at the time of the October 2024 announcement, said: "We are pleased that significant value for a portion of the remaining licenses will be realized, and, importantly, that these agreements with multiple mobile network operators ensure that this spectrum will be put to work for consumers throughout the country. We are continuing the process to opportunistically monetize the remaining spectrum assets not included in today's announcement." Alongside the Verizon agreement, USCC separately agreed to sell 12 million MHz POPs of spectrum across the CBRS, C-Band, and 700 MHz B/C Block bands to two other, unnamed mobile network operators; buyers and terms for those sales were not disclosed in the filing. The $1.0 billion purchase price is payable entirely in cash, subject to potential adjustments specified in the Verizon Purchase Agreement, including adjustments if certain licenses are excluded due to court orders or to mitigate FCC-imposed "burdensome conditions," or if the term of a related T-Mobile Short-Term Spectrum Manager Lease is extended. No equity, stock consideration, exchange ratio, or financing structure was disclosed, consistent with this being a cash asset sale rather than a merger. No synergy estimates, EPS accretion/dilution figures, or pro forma combined-company metrics were disclosed, as this is a divestiture of discrete spectrum licenses rather than a corporate combination. Closing was contingent on the related T-Mobile Purchase Agreement (dated May 24, 2024) having closed, on expiration of the Hart-Scott-Rodino waiting period, and on receipt of FCC approval. The agreement set an outside closing date of December 31, 2026, with provisions for up to two six-month extensions (one year in aggregate) if regulatory approvals or termination of the T-Mobile spectrum lease remained outstanding. TDS, as 82-percent shareholder of USCC, delivered written consent approving the transaction on October 17, 2024, so no further USCC shareholder vote was required. The agreement included mutual indemnification provisions, with sellers' indemnification capped at their pro-rata portion of the purchase price and a 5-percent cap on non-fundamental representations. The transaction closed on June 1, 2026, as disclosed in a Form 8-K filed that day by Array Digital Infrastructure, Inc. (the renamed successor to USCC, NYSE: AD). Array confirmed it "completed the previously announced sale of select spectrum assets to Verizon" and received the full $1.0 billion purchase price in cash at closing. In conjunction with the Verizon closing, the completion of a separate $168 million spectrum sale to T-Mobile (primarily 700MHz and 600MHz licenses) in May 2026, and current cash on hand, Array's Board declared a special cash dividend of $11.00 per Common Share and Series A Common Share, payable June 25, 2026 to shareholders of record as of June 11, 2026. Array stated it does not anticipate paying additional dividends during 2026 and expects the special dividend will largely be designated as an ordinary and qualified dividend for 2026 Form 1099-DIV purposes. The June 2026 press release separately disclosed that TDS had made a non-binding proposal, dated May 7, 2026 and previously announced May 8, 2026, to acquire all outstanding Array common shares not already owned by TDS; Array stated that the special dividend declaration "is unrelated to" that proposal and that its special committee had not made any decision on it at the time of the release. That proposed going-private transaction is a separate, distinct matter from the Verizon spectrum sale and is not otherwise detailed in the filings reviewed for this deal. Financial advisors to TDS on the Verizon transaction were Citigroup Global Markets Inc., serving as lead financial advisor, along with Centerview Partners LLC, TD Securities (USA) LLC, and Wells Fargo. PJT Partners LP served as financial advisor to the independent directors of USCC/Array. Wilkinson Barker Knauer, LLP served as lead transactional and FCC regulatory counsel to both TDS and USCC/Array, Clifford Chance LLP served as regulatory advisor to both, Sidley Austin LLP served as legal advisor to TDS, and Cravath, Swaine & Moore LLP served as legal advisor to the independent directors of USCC/Array. Details not disclosed in the filings reviewed include the specific purchase-price adjustment amounts (if any) that were ultimately applied at closing, the identities of the two other mobile network operators that purchased CBRS, C-Band, and 700 MHz B/C Block spectrum, the book gain or loss Array recognized on the sale, and any further terms of TDS's separate non-binding proposal to acquire the remaining Array shares.

SOLV Energy, Inc., a Nasdaq-listed (ticker MWH) industrials-sector solar and energy infrastructure construction company, priced a follow-on public offering of 15,000,000 shares of Class A common stock at $36.00 per share, for total gross proceeds of $540,000,000. The offering combined 7,301,590 primary shares sold by the company and 7,698,410 secondary shares sold by existing stockholders (described in the prospectus as the "selling stockholders" or "Redeeming Holders"). The prospectus is dated May 28, 2026 and was filed with the SEC on Form 424B4 on May 29, 2026, with shares expected to settle on June 1, 2026. The $36.00 offering price represented a discount of approximately 1.9 percent to SOLV Energy's $36.71 Nasdaq closing price on May 28, 2026, the last trading day before pricing. The underwriting discount was $1.26 per share, or $18,900,000 in aggregate. Net proceeds before expenses were approximately $34.74 per share, equating to $253,657,236.60 to the company and $267,442,763.40 to the selling stockholders. The underwriters were granted a 30-day option to purchase up to an additional 1,095,240 shares from the company and up to 1,154,760 shares from the selling stockholders at the public offering price, less underwriting discounts; the prospectus does not indicate whether this option was exercised. SOLV Energy stated it will use its net proceeds, estimated at approximately $251.66 million (or approximately $289.71 million if the underwriters' option is exercised in full), exclusively to purchase a corresponding number of LLC Interests in its operating subsidiary, SOLV Energy Holdings LLC, from the Redeeming Holders at a price per LLC Interest equal to the public offering price net of underwriting discounts. This is a pass-through mechanic tied to the company's Up-C organizational structure; the company will not receive any proceeds from shares sold by the selling stockholders, and the prospectus does not disclose any use of proceeds for debt repayment, acquisitions, or general corporate purposes. SOLV Energy Holdings LLC will bear or reimburse the company for offering expenses estimated at approximately $2.0 million. Jefferies LLC and J.P. Morgan Securities LLC acted as joint book-running managers and representatives of the underwriters, underwriting 4,317,857 shares each. Other underwriters and their allocations were KeyBanc Capital Markets Inc. (900,000 shares), TD Securities (USA) LLC (900,000 shares), UBS Securities LLC (900,000 shares), Robert W. Baird & Co. Incorporated (642,857 shares), Evercore Group L.L.C. (642,857 shares), Guggenheim Securities, LLC (642,857 shares), Nomura Securities International, Inc. (610,715 shares), WR Securities, LLC (32,142 shares, part of the Wolfe | Nomura Alliance), CIBC World Markets Corp. (514,285 shares), Roth Capital Partners, LLC (514,285 shares), and Academy Securities, Inc. (64,288 shares), for a total syndicate commitment of 15,000,000 shares. The offering was priced and sold under a waiver of the lock-up agreements the company, its directors, executive officers and certain stockholders signed in connection with SOLV Energy's initial public offering, which priced via a Form 424B4 prospectus dated February 11, 2026. Jefferies and J.P. Morgan, as representatives, provided a limited waiver of the IPO lock-up specifically to permit this sale and the filing of the related registration statement. Class A shares held by selling stockholders that were not sold in this offering remain subject to the original 180-day IPO lock-up period. Weil, Gotshal & Manges LLP, New York, passed upon the validity of the Class A common stock for the company and the selling stockholders. Latham & Watkins LLP, New York, represented the underwriters on legal matters related to the offering. Prior to this offering, SOLV Energy had 115,348,571 shares of Class A common stock and 87,043,055 shares of Class B common stock outstanding. After the offering, Class A shares outstanding are expected to rise to 122,650,161 (or 123,745,401 if the underwriters' option is exercised in full), while Class B shares outstanding fall to 79,741,465, representing approximately 39.4 percent of combined voting power (or 78,646,225 shares and approximately 38.9 percent if the option is exercised in full). The prospectus does not disclose any concurrent share repurchase by the company. The offering was registered on a Form S-1 filed May 26, 2026, with an S-1MEF filed May 28, 2026 adding the additional shares and related registration fees. No free-writing prospectus or separate pricing press release filed with the SEC was identified for this offering, and the company has not filed an 8-K confirming the closing or settlement of the transaction. The deal's regulatory/closing status is therefore not independently confirmed beyond the prospectus's statement that delivery was expected on June 1, 2026.

The Brink's Company, a financial institutions sector company trading under the ticker BCO, has agreed to acquire NCR Atleos Corporation, ticker NATL, in a cash and stock transaction valued at approximately $6.6 billion. The deal was announced on February 26, 2026, through a current report on Form 8-K filed by Brink's that attached the merger agreement, a joint press release and an investor presentation. Mark Eubanks, President and CEO of Brink's, said the acquisition "further supports Brink's ability to deliver enhanced customer solutions and accelerates our value creation strategy," adding that NCR Atleos "is a partner we know well" with closely aligned business cultures. Tim Oliver, President and CEO of NCR Atleos, called the deal "a strategic opportunity for NCR Atleos" that would "enable us to enhance offerings to financial institutions and retailers, and create more opportunities for our employees." Under the terms of the Agreement and Plan of Merger, each share of NCR Atleos common stock will be converted into the right to receive $30.00 in cash and 0.1574 shares of Brink's common stock. Based on Brink's closing share price of $129.58 on February 25, 2026, the stock-and-cash consideration implied a value of $50.40 per NCR Atleos share, representing a premium of approximately 24% over NCR Atleos' closing price that day and approximately 26% over its 30-day volume-weighted average price. The transaction is comprised of approximately 13.3 million Brink's shares and $2.2 billion in cash, plus the assumption of approximately $2.6 billion of NCR Atleos indebtedness. Upon closing, Brink's shareholders are expected to own approximately 78% and former NCR Atleos shareholders approximately 22% of the combined company. In its fairness opinion analysis disclosed in the joint proxy statement/prospectus, Morgan Stanley compared NCR Atleos to Diebold Nixdorf, Euronet Worldwide and Hyosung Corporation, deriving average AV/EBITDA multiples for the peer group of 6.9x (2026E) and 6.2x (2027E), and applied selected representative ranges of 6.0x-8.0x (2026E) and 5.5x-7.5x (2027E) Adjusted EBITDA to imply equity values of $36-$59 and $35-$60 per NCR Atleos share, respectively; a discounted equity value analysis using a 6.0x-8.0x NTM AV/EBITDA multiple and an 11.7% discount rate implied a value range of $43-$66 per share. The cash portion of the purchase price will be financed with a combination of balance-sheet cash and new debt. Brink's obtained a debt commitment letter from Morgan Stanley Senior Funding, Inc. providing up to $2,276 million of senior unsecured bridge term loans under a base bridge facility, plus, in certain circumstances, up to $873 million of senior secured bridge term loans to refinance NCR Atleos' existing term A loans, for committed bridge financing described in the press release as totaling $4.5 billion. Brink's expects the transaction to generate approximately $200 million in annual run-rate pre-tax cost synergies within three years of closing, and disclosed that the deal is expected to be "highly accretive to earnings, including at least 35% accretive to EPS," calculated using 2027 consensus net income estimates for both companies. The combined company is anticipated to generate approximately $10 billion in total revenue, with mid-single-digit organic revenue growth and improving free cash flow, and Brink's expects to reduce net leverage to a target range of 2.0x-3.0x by the end of 2027, assuming a first-quarter 2027 closing. NCR Atleos operates the largest independent network of ATMs, with approximately 78,000 owned-and-operated machines in retail locations that are part of its global installed base of approximately 600,000 ATMs; Brink's said this network will expand its retail footprint and allow integration with its existing Digital Retail Solutions business. The joint proxy statement/prospectus discloses that Brink's began evaluating a potential transaction with NCR Atleos, as well as a separate unnamed target referred to as "Party A," in late 2024, with Morgan Stanley advising Brink's on both alternatives. Management-level contacts between NCR Atleos and Brink's began in March 2025, the companies signed a mutual confidentiality agreement on May 29, 2025 containing a nine-month standstill, and NCR Atleos formally engaged J.P. Morgan as lead financial advisor on July 18, 2025. Due diligence, a cost-synergy workshop, and exchanges of management financial projections continued through early 2026 before the companies signed the merger agreement on February 26, 2026. The transaction has not yet closed. Both companies' stockholders approved the merger: NCR Atleos stockholders voted to approve the transaction at a special meeting held June 30, 2026, with 59,403,719 votes for, 92,237 against and 63,782 abstaining. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on May 11, 2026 following a grant of the parties' request for early termination. Remaining closing conditions include other required governmental and foreign antitrust approvals, including certain money transmitter license consents, and customary conditions regarding the accuracy of representations and the absence of a material adverse effect. The companies expect the mergers to close by the end of the first quarter of 2027; the merger agreement's "Outside Date" is February 26, 2027, automatically extendable to August 26, 2027 under specified circumstances related to obtaining regulatory approvals. If the merger agreement is terminated under specified circumstances, including a change in the NCR Atleos board's recommendation or NCR Atleos entering into an agreement for a competing proposal, NCR Atleos would owe Brink's a termination fee of $145,000,000; if terminated under specified circumstances involving Brink's, including a change in the Brink's board's recommendation or Brink's entering into an agreement for a competing proposal, Brink's would owe NCR Atleos a termination fee of $175,000,000. As of mid-2026, two shareholder lawsuits challenging the mergers (Connolly v. NCR Atleos Corp. and Thompson v. NCR Atleos Corp., both filed in New York Supreme Court, New York County) were pending, along with demand letters alleging disclosure deficiencies in the joint proxy statement/prospectus; both companies have stated they believe no further disclosure is required. Morgan Stanley & Co. LLC is serving as financial advisor and Sidley Austin LLP is serving as legal advisor to Brink's; FGS Global is serving as Brink's strategic communications advisor. J.P. Morgan Securities LLC is serving as financial advisor and King & Spalding LLP is serving as legal advisor to NCR Atleos; Collected Strategies is serving as NCR Atleos' strategic communications advisor. Upon closing, Mark Eubanks and Kurt McMaken will continue as CEO and CFO, respectively, of the combined company, and one independent director jointly designated from the NCR Atleos board will join the Brink's board.

This record concerns an unsolicited take-private proposal, which was rejected, in the healthcare sector, involving Seer, Inc. (ticker SEER) as the target and the Radoff/JEC Group, consisting of Bradley L. Radoff and Michael Torok, as the proposing party. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on May 22, 2026. The deal's current status is pending regulatory review, notwithstanding that the proposal itself is described as having been rejected. Only one financial advisor is identified in the facts block: Perella Weinberg Partners LP, serving as financial advisor to Seer, the target. The source sentence states: "Perella Weinberg Partners LP is serving as financial advisor to Seer, and Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel." No lead designation is specified, and no financial advisor to the Radoff/JEC Group is identified in the facts provided. One legal advisor is identified: Wilson Sonsini Goodrich & Rosati, Professional Corporation, serving as legal counsel to Seer, the target, per the same source sentence. No legal advisor to the Radoff/JEC Group is identified in the facts provided. Beyond the classification of this matter as an unsolicited take-private proposal that was rejected, no further detail on the proposed consideration, valuation, or other specific terms of the Radoff/JEC Group's proposal is included in the facts provided. Several items are not disclosed in this record: the proposed transaction value and consideration terms are not stated, no financial or legal advisor to the Radoff/JEC Group is identified, and no further detail on the basis for rejection or subsequent timeline is given beyond the pending-regulatory status field and the characterization of the proposal as rejected.

Sila Realty Trust, Inc. (NYSE: SILA), a net lease real estate investment trust focused on healthcare properties, agreed to be acquired by affiliates of Blue Owl Capital Inc. (NYSE: OWL) in an all-cash transaction valued at approximately $2.4 billion. The deal was announced on April 20, 2026, via a joint press release (Exhibit 99.1) accompanying a Form 8-K that disclosed the Agreement and Plan of Merger, dated April 19, 2026, among Sila, Sunshine Ultimate Parent LLC ("Parent") and its wholly owned subsidiary Sunshine Holding REIT LLC ("Merger Sub"), both Delaware entities and affiliates of Blue Owl Real Estate Capital LLC. Under the merger agreement, each outstanding share of Sila common stock was converted into the right to receive $30.38 in cash, without interest. The per-share price represented a 19.0% premium to Sila's closing stock price of $25.53 on April 17, 2026 (the last full trading day before announcement) and a 25.6% premium to the 30-trading-day volume-weighted average price. Sila's financial advisor, BofA Securities, valued the deal using a selected publicly traded companies analysis (applying 2026E Adjusted EBITDA multiples of 13.0x-17.0x and 2026E AFFO multiples of 10.5x-14.5x to comparable healthcare and net lease REITs, including Healthpeak Properties, Healthcare Realty Trust, Universal Health Realty Income Trust, Community Healthcare Trust, NNN REIT, Essential Properties Realty Trust, Broadstone Net Lease, Four Corners Property Trust and Netstreit), a selected precedent transactions analysis (using one-year-forward Adjusted EBITDA multiples of 11.5x-15.5x and AFFO multiples of 10.5x-14.5x from deals such as Healthpeak/Physicians Realty Trust, Omega Healthcare/MedEquities, Sabra/Care Capital Properties, Blackstone/BioMed Realty, Brookfield/Peakstone Realty, Realty Income/Spirit Realty, Global Net Lease/Necessity Retail, GIC-Oak Street/STORE Capital, Government Properties Income Trust/Select Income REIT, and Blackstone/Gramercy Property Trust and Chambers Street/Gramercy), and a discounted cash flow analysis (7.8%-8.7% discount rates, a 12.0x-15.0x terminal Adjusted EBITDA exit multiple applied to an estimated FY2030 Adjusted EBITDA of $168 million) that together implied per-share equity values ranging roughly from $21.80 to $37.92, bracketing the $30.38 merger price. BofA Securities also cited third-party analyst net asset value estimates of $28.39-$30.74 per share and the company's own estimated NAV range of $25.66-$30.70 per share (based on nominal cap rates of 7.6%-8.6%). The transaction will be funded through equity financing: affiliates of Parent delivered an Equity Funding Letter under which Blue Owl-affiliated guarantors agreed to contribute equity sufficient to consummate the merger, together with a Limited Guarantee backing Parent's payment obligations; the merger agreement and 8-K state the closing is not subject to any financing condition. Per the DEFM14A's "Background of the Merger" disclosure, Sila's board engaged BofA Securities in December 2025 after CEO Michael Seton recommended exploring strategic alternatives given the company's small public float and persistent trading discount to peers. BofA Securities contacted 81 prospective buyers beginning January 20, 2026 and ultimately brought six bidders into a second round: Blue Owl, a two-party "Consortium A," a two-party "Consortium B" (Party C/Party D), and Parties E and G, alongside parties F and H and others that were not advanced. Initial first-round cash bids on March 11-13, 2026 ranged from Party F's $25.50-$26.50 per share up to Consortium A's $30.25 per share, with Blue Owl's opening bid the lowest of those advanced to round two at $28.50 per share. In the final round, Consortium B's last bid came in at $26.00 per share while Blue Owl raised its offer to $30.38 per share in cash on the night of April 15, 2026 after BofA Securities repeatedly pushed Blue Owl to improve on its low initial bid; Consortium A never submitted a final binding proposal before the board's meeting, citing the need for more time, and was effectively eliminated from contention. The board unanimously approved the Blue Owl agreement on April 19, 2026. The merger agreement provides for a company termination fee of $55,746,219, payable by Sila to Parent in specified circumstances including a change of board recommendation or termination to accept a superior proposal, and a reverse/parent termination fee of $152,035,142, payable by Parent in specified circumstances including a financing-related breach or failure to close. The agreement contains no financing closing condition; closing conditions include approval by holders of a majority of Sila's outstanding common stock, absence of any injunction or law prohibiting the merger, and the absence of a company or parent material adverse effect. The outside date for termination was set at January 19, 2027. During the pendency of the deal, Sila was permitted to pay up to two regular quarterly dividends not exceeding $0.40 per share per quarter, with any additional REIT-related distributions offsetting the per-share merger consideration. Sila's board unanimously approved the merger. At a June 26, 2026 special meeting, 64.5% of outstanding shares voted (quorum of 35,654,676 of 55,241,098 shares eligible), and the merger proposal was approved with 34,955,162 votes for, 325,441 against, and 374,073 abstentions, as reported in an 8-K filed under Item 5.07. The merger closed on July 1, 2026: Sila merged with and into Merger Sub, which survived and was renamed Sunshine Realty Holdings LLC, with Sila shares delisted from the NYSE and deregistered under the Exchange Act, per a closing Form 8-K reporting Items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01 and 9.01. As of March 31, 2026, Sila owned 137 real estate properties and three undeveloped land parcels across 65 markets in the United States, described in the companies' joint press release as "one of the best-in-class healthcare net lease portfolios in the market," with Blue Owl's Marc Zahr, Co-President and Global Head of Real Assets, citing the portfolio's "strong tenant fundamentals, long-term triple-net leases, and robust rent coverage." CEO Michael Seton stated the transaction "will provide significant and immediate realized benefit to our shareholders." On financial and legal advisors: BofA Securities served as Sila's exclusive financial advisor (with an aggregate fee currently estimated at approximately $24.9 million, $2.5 million of which was payable on delivery of its fairness opinion), and Hogan Lovells US LLP served as Sila's legal counsel (Venable LLP served as the company's outside tax counsel during negotiations per the proxy). Citigroup Global Markets Inc. acted as lead financial advisor to Blue Owl, with Truist Securities, Inc. also serving as financial advisor to Blue Owl and Newmark Group, Inc. serving as Blue Owl's real estate advisor. Kirkland & Ellis LLP served as legal advisor to Blue Owl, and Dechert LLP served as legal advisor to Citigroup Global Markets Inc. and Truist Securities, Inc.

Sun Communities, Inc. (NYSE: SUI), a real estate investment trust operating manufactured housing (MH) and recreational vehicle (RV) communities, agreed on May 21, 2026 to sell its United Kingdom business, Park Holidays, to Panther Bidco Limited, an affiliate of Aermont Capital LLP. The transaction was disclosed in a Form 8-K filed with the SEC that day, which included a press release and a supplemental risk factors exhibit. The deal valued the UK operations at an enterprise value of £768 million, or approximately $1.03 billion, in an all-cash transaction with customary locked-box adjustments entitling the buyer to Park Holidays' cash profits through closing. Sun Communities described the sale as enabling it to become a pure-play North American MH and RV owner-operator. Following the divestiture, the company expected North American MH and RV real property net operating income to represent approximately 95% of total NOI, which it said would create more predictable revenue streams and an improved growth and margin profile. CEO Charles Young said at announcement, "This exciting transaction allows us to focus on and drive growth through our core North American MH and RV platform." Park Holidays CEO Jeff Sills said, "We are grateful for Sun's partnership and support over the past several years." The purchase agreement included customary representations and warranties, with representation and warranty insurance serving as the buyer's primary recourse, and imposed two-year post-closing non-solicitation and non-competition provisions on the sellers with respect to Park Holidays' UK business. Because the agreed consideration was below Sun Communities' estimated net asset value for the UK business, the company disclosed in its Item 2.06 notice that it expected non-cash impairment-related charges of approximately $1.0 billion to $1.1 billion, to be recorded across the quarters ended June 30 and September 30, 2026. In its Q2 2026 earnings release (Form 8-K filed July 27, 2026), Sun Communities confirmed it had recorded a non-cash valuation allowance charge of $1.1 billion in the second quarter of 2026 to write down the UK business to estimated fair value less costs to sell upon its classification as held for sale and discontinued operations; that release also referenced slightly updated base consideration of £785.7 million (approximately $1.04 billion). Lazard Frères & Co. LLC served as lead financial advisor to Sun Communities, and Jones Day and Taft Stettinius & Hollister LLP served as legal advisors to the company. Rothschild & Co served as financial advisor to Aermont, and Macfarlanes acted as legal advisor to Aermont. Closing was conditioned on approval from the UK Financial Conduct Authority (required because of Park Holidays' loan brokering activities) and other customary closing conditions; risk factors filed as Exhibit 99.2 to the May 21, 2026 Form 8-K flagged the possibility that the transaction could be delayed or fail to close, along with risks of client decision delays, employee retention issues, and interim operating covenants under the purchase agreement pending closing. The transaction closed on September 22, 2026. Sun Communities disclosed in a Form 8-K filed September 23, 2026 (Item 2.01) that Panther Bidco Limited paid cash consideration of approximately £772.3 million (approximately $1.05 billion) at closing, which translated to net proceeds of approximately $1.03 billion to Sun Communities after locked-box and transaction cost adjustments. The company said it intends to use the proceeds primarily for share repurchases, debt reduction, and general corporate purposes, and noted that through September 21, 2026 it had already repurchased approximately 3.5 million shares for roughly $425 million year-to-date. At closing, CEO Charles Young said, "The sale of Park Holidays positions Sun to execute on our strategy of driving long-term, durable growth through our best-in-class North American MH and RV platform, backed by a flexible, low-leverage balance sheet." Unaudited pro forma financial statements filed as Exhibit 99.2 to the September 23, 2026 Form 8-K show the transaction eliminating approximately $1,446.7 million of assets (previously classified as held for sale/discontinued operations) and approximately $428.9 million of associated liabilities from Sun Communities' balance sheet as of June 30, 2026, reducing pro forma total assets from $10,867.6 million to $10,453.7 million. The pro forma materials show an estimated incremental loss of approximately $10.4 million tied to the change in valuation allowance and disposal, reflecting the difference between final net proceeds and the net carrying value of assets eliminated; no separate EBITDA or NOI figure specific to Park Holidays was disclosed in the pro forma statements. As of June 30, 2026, Sun Communities reported owning, operating, or holding interests in 455 properties comprising approximately 156,130 developed sites across its North American MH and RV portfolio.

INNO Holdings Inc., a Texas-incorporated holding company trading on Nasdaq under the ticker INHD that conducts its operations through Hong Kong subsidiaries in the electronic products trading business, entered into an at-the-market equity offering sales agreement dated May 15, 2026 with Aegis Capital Corp. as exclusive sales agent. The agreement permits the company to sell shares of its common stock, no par value, having an aggregate offering price of up to $60.0 million from time to time at prevailing market prices through Aegis Capital Corp. The program was announced via a press release dated May 19, 2026 and formalized through a prospectus supplement filed May 19, 2026 under Rule 424(b)(5) and a Form 8-K filed May 20, 2026 reporting entry into the sales agreement. This $60.0 million ATM program replaces the company's prior $50.0 million ATM sales agreement with the same agent, Aegis Capital Corp., which had been entered into on November 12, 2025 and which the prospectus supplement states "has been terminated according to its terms and conditions." Under that prior program, INNO Holdings disclosed it had received approximately $39,675,127 in proceeds before termination. The shares are being offered under the company's existing effective shelf registration statement on Form S-3 (File No. 333-284054), declared effective by the SEC on January 10, 2025. Sales may be made directly on Nasdaq, to or through a market maker other than on an exchange, in negotiated transactions, or by other methods permitted under Rule 415(a)(4) of the Securities Act, at the company's discretion as to volume and timing. There is no minimum offering amount, so the actual total public offering price, commissions, and net proceeds are not determinable in advance. The offering is scheduled to terminate automatically on the earlier of December 31, 2026 or the sale of all shares subject to the sales agreement, unless terminated earlier by either party under the agreement's terms. Aegis Capital Corp. will be paid a fixed commission of 3.0% of gross proceeds from shares sold under the program. The company also agreed to reimburse the sales agent for expenses not to exceed $60,000, plus accountable legal fees of $2,500 following each Form 10-Q filing and $7,500 following each Form 10-K filing incurred by the sales agent's counsel in updating due diligence. The company stated it currently intends to use net proceeds from the offering for general corporate purposes and general working capital, retaining broad discretion over the precise application of funds; no debt repayment or acquisition use has been disclosed. The prospectus supplement's dilution table uses an assumed offering price of $1.37 per share, the Nasdaq Official Closing Price of INNO Holdings common stock on May 12, 2026, as a reference point for illustrative purposes only (not a fixed or final offering price, since ATM sales occur at prevailing market prices). At that assumed price, the maximum number of shares issuable under the full $60.0 million program would be approximately 43,795,620 shares. As of March 31, 2026, the company had 420,661 shares of common stock outstanding (post a 1-for-24 reverse stock split effective December 22, 2025) and a historical net tangible book value of approximately $100.11 per share. On a pro forma basis reflecting the 4.1 million shares already issued under the prior ATM agreement for approximately $10 million of net proceeds, pro forma net tangible book value was approximately $11.61 per share. Giving further effect to the full assumed issuance under this new $60.0 million program at $1.37 per share, pro forma as adjusted net tangible book value would be approximately $2.29 per share, reflecting an immediate decrease of $9.33 per share to existing stockholders and immediate dilution of $(0.92) per share to new investors purchasing at the assumed price, according to the prospectus supplement's dilution table. These figures are illustrative based on the maximum program size and the May 12, 2026 reference price; actual dilution will depend on the number of shares actually sold and at what prices. Kirton McConkie, P.C., based in Salt Lake City, Utah (not Texas, correcting the prior summary), is serving as special Texas counsel to the company and delivered its legal opinion on the legality of the shares, filed as Exhibit 5.1 to the May 20, 2026 Form 8-K and dated May 20, 2026. According to the press release, McCarter & English, LLP is acting as U.S. counsel to the company, and Kaufman & Canoles, P.C. is acting as U.S. counsel to Aegis Capital Corp. in connection with the sales agreement. No pricing 8-K, free-writing prospectus, or separate underwriting agreement beyond the at-the-market sales agreement (filed as Exhibit 1.1 to the May 20, 2026 Form 8-K) has been identified, consistent with the nature of an ATM program, which does not price as a single discrete transaction. No greenshoe or over-allotment option applies to this ATM structure. Subsequent 8-Ks filed by the company in June and July 2026 relate to a Nasdaq trading halt and related special committee investigation into unusual trading activity, and do not disclose updates on amounts sold under this ATM program; accordingly the offering's actual utilization, final proceeds, and closing/termination status beyond what is described above are not disclosed in the available filings.

This deal is a convertible senior notes offering whose proceeds are partly intended to fund an acquisition, classified under debt capital markets (DCM) in the tech sector, involving SiTime Corp (ticker SITM) as both issuer and acquirer, with the assets being acquired related to the timing business of Renesas Electronics. The disclosed value of the transaction is $1,100,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on May 19, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Barclays is identified as one of several book-running managers for the notes offering, named alongside Wells Fargo Securities, Goldman Sachs & Co. LLC, UBS Investment Bank, and Morgan Stanley in the same source sentence, though only Barclays is broken out as a separate structured entry, with no lead designation specified among them. Separately, HudsonWest LLC served as financial advisor to SiTime in a lead capacity, a role distinct from the notes offering's book-running managers. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing SiTime or any other party. Beyond the classification of this transaction as a convertible senior notes offering with proceeds partly funding the Renesas timing business acquisition, with a disclosed value of $1,100,000,000, no further detail on the notes' coupon, conversion terms, or maturity is provided in the facts block. Several items are not disclosed in the available record. While the source sentence names Wells Fargo Securities, Goldman Sachs & Co. LLC, UBS Investment Bank, and Morgan Stanley alongside Barclays as book-running managers, these are not broken out as separate structured financial advisor entries. No legal advisors are identified, the specific notes terms (coupon, conversion price, maturity) are not given, and no expected closing date or further timeline detail beyond the May 2026 filing date and pending-regulatory status is provided.

Analog Devices, Inc. (NASDAQ: ADI) agreed to acquire Empower Semiconductor, Inc., a privately held Silicon Valley-based provider of integrated voltage regulators and power management solutions, in an all-cash transaction valued at $1.5 billion. The deal was announced on May 19, 2026 in a press release filed as Exhibit 99.1 to a Form 8-K, and the transaction has since closed. Under the terms of the agreement, which was approved by the boards of directors of both companies, ADI paid Empower's stockholders $1.5 billion entirely in cash; no stock consideration was used and no exchange ratio applies. The press release and subsequent SEC filings do not disclose Empower's revenue, EBITDA, or other historical financial metrics, so no EV/EBITDA, P/E, or similar valuation multiple can be calculated from the public record. Empower is a venture-backed, privately held company (it had filed a Form D exempt securities notice in 2021) and does not report financials publicly. ADI framed the acquisition as addressing a core bottleneck in AI infrastructure. Vincent Roche, ADI's CEO and Chair, said "AI infrastructure is fundamentally reshaping how power must be delivered, with energy now the most persistent constraint to scaling next-generation systems. ADI already delivers some of the highest-performance power management solutions in the industry, and with Empower we are further expanding our portfolio to help customers rearchitect their power systems and achieve the compute densities next-generation AI demands." Empower CEO Tim Phillips said "Empower was founded to solve the hardest problem in AI power delivery - the power bottleneck that is limiting AI throughput... The combination of ADI's power management platform, scale and operational excellence, along with the system level benefits our merger enables, will accelerate our adoption with customers." The companies said the deal expands ADI's addressable market in AI compute power delivery through Empower's Integrated Voltage Regulator (IVR) and silicon capacitor technology, which enable power conversion closer to the processor to shorten the power delivery path. The release noted Empower's silicon capacitors are already in production and that its IVR programs are advancing in collaboration with hyperscalers and AI silicon providers. Following closing, Tim Phillips continued leading IVR technology efforts as part of ADI. The filings do not disclose any financing structure beyond the all-cash purchase price (no bridge loan or new deal-specific debt instrument tied to the acquisition was identified in ADI's SEC filings), nor do they disclose any cost or revenue synergy targets, phase-in timeline, or one-time costs to achieve synergies, nor any EPS accretion/dilution guidance. ADI's financial statements note the acquisition's revenue and earnings were immaterial to its consolidated results, consistent with no synergy or accretion figures being disclosed. ADI's Form 10-Q for the fiscal quarter ended August 1, 2026 confirms the transaction closed: "On July 7, 2026, the Company completed the acquisition of all of the voting interests of Empower Semiconductor, Inc. (Empower)... for approximately $1.5 billion." The 10-Q discloses that the acquisition was accounted for as a business combination, with a preliminary purchase price allocation recognizing approximately $1.0 billion of goodwill, $0.6 billion of intangible assets (primarily technology-based), and $0.1 billion of deferred tax liabilities. None of the goodwill is expected to be deductible for tax purposes. ADI recognized approximately $23.4 million of transaction-related costs (legal, accounting and other fees) expensed during the third quarter of fiscal 2026, within selling, marketing, general and administrative expenses. The purchase accounting remains preliminary and subject to adjustment as ADI completes its valuation of acquired assets and assumed liabilities, with completion expected within one year of the acquisition date. At announcement, the transaction was expected to close in the second half of calendar 2026, subject to customary closing conditions and expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. No termination fee was disclosed in the press release. Based on ADI's 10-Q, the deal in fact closed on July 7, 2026, ahead of that expected window. No merger agreement, investor presentation, or proxy statement was identified as having been separately filed with the SEC for this transaction (consistent with Empower being a private company acquired for cash, which does not require a proxy statement or registration statement); the terms described above are based on the press release and ADI's subsequent periodic reports.

Digimarc Corp, trading under ticker DMRC and operating in the technology sector, is the subject of a reorganization transaction. This deal falls within the mergers and acquisitions product group and is classified as a reorganization subtype. The transaction is currently in pending regulatory status, meaning that while the deal has been announced or filed, it has not yet received all necessary regulatory clearances. The disclosed value of the transaction has not been stated in the available source documents. The information regarding this transaction is sourced from an SEC EDGAR filing that was published on May 18, 2026. While the specific SEC form type has not been identified in the available documentation, the filing represents the primary public disclosure of the deal's details and status. Given the pending regulatory status, the transaction remains subject to regulatory review and approval processes before it can proceed to closing. No financial advisors have been extracted or identified as having been engaged on this transaction based on the available source documents. This represents an unusual situation in the investment banking market, as reorganization transactions of this nature typically involve financial advisory support. However, either no advisors have been formally announced, or their roles were not disclosed in the specific SEC filing reviewed for this briefing. No legal advisors have been identified in the source materials reviewed. Similar to the absence of financial advisors, this may reflect the stage of public disclosure or the manner in which the transaction was structured and announced, though reorganization transactions typically engage legal counsel on both sides of the transaction. Specific details regarding the deal structure and transaction terms have not been disclosed or are not available in the reviewed documents. This includes information about the consideration mix, the precise reorganization mechanism, or any other structural details that would typically characterize how the reorganization will be executed. Multiple material details remain undisclosed or unknown at this stage. The deal value or consideration amount has not been stated in any source document reviewed. No expected closing or completion date has been provided. The specific identities of all parties involved beyond Digimarc Corp have not been extracted. The precise legal structure of the reorganization, the form of consideration to be paid or exchanged, and the anticipated tax treatment of the transaction have all gone unstated. Additionally, no information is available regarding the regulatory bodies overseeing this transaction or the specific regulatory approvals that remain pending. These gaps represent significant unknowns that would typically be clarified before a transaction reaches the stages of advanced discussions or public disclosure.

AES Corp, an industrial sector company trading under ticker AES, is the target of a leveraged buyout transaction valued at $15 million. The acquiring party has not been disclosed in the available information. This is a mergers and acquisitions engagement classified as a leveraged buyout, representing a significant restructuring event within the industrial sector. The information regarding this transaction is sourced from an SEC filing published on the SEC EDGAR platform on May 15, 2026. The specific form type has not been identified in the available documentation. The deal is currently in pending regulatory status, indicating that approvals or clearances remain outstanding before the transaction can proceed to close. Two financial advisors have been retained to provide opinions on behalf of AES Corp as the target. J.P. Morgan Securities LLC is serving as a financial advisor to the target and has provided an opinion on the transaction. Wells Fargo Securities, LLC is also serving as a financial advisor to the target and has similarly provided an opinion. Both institutions are evaluating the fairness and financial aspects of the proposed transaction from the target's perspective. The source materials reference formal opinions from both firms, suggesting they have completed substantive analyses of the deal terms. No lead or non-lead designations have been specified, and it is unclear whether either firm holds a primary advisory role relative to the other. No legal advisors have been identified in the available information for either the target or acquiring party. The specific structure and terms of the leveraged buyout have not been disclosed. This includes the composition of consideration (whether cash, stock, debt, or a combination), the capital structure envisioned post-close, any debt financing arrangements, or the roles of debt providers or equity sponsors. Without this detail, the mechanics of how the acquisition will be funded and how AES Corp's balance sheet will be restructured remain unknown. Several material facts about this transaction remain undisclosed or unconfirmed. The identity of the acquiring party or sponsor has not been revealed. The expected closing date or timing milestones have not been provided. The specific consideration structure and any mix of cash, equity, or other forms of payment have not been detailed. The form type of the SEC filing itself has not been specified. Additionally, the specific nature of the regulatory approvals pending is not clear from the available information.

This is an initial public offering in the equity capital markets product group, with a disclosed offering size of 1.89 billion U.S. dollars. The transaction involves the issuance of equity securities, though the specific issuer identity is not disclosed in the available source material. The deal falls within the technology or financial services sector, though the sector classification is not explicitly stated in the provided facts. The transaction is sourced from an SEC EDGAR filing published on May 14, 2026, though the specific form type is not identified in the available documentation. The current status of the deal is pending regulatory approval or clearance, indicating that the offering has been registered or is in the process of receiving SEC clearance but has not yet priced or closed. The offering has assembled a substantial syndicate of financial advisors serving as underwriters on the issuer side. Three firms hold the position of Joint Lead Bookrunning Manager: J.P. Morgan, BofA Securities, and RBC Capital Markets. Eleven additional firms serve as Bookrunning Managers in the offering, including Barclays, William Blair, Societe Generale, BBVA, Guggenheim Securities, MUFG, Baird, Piper Sandler, and Wolfe Nomura Alliance. This substantial bookrunner syndicate suggests a large, broadly marketed public offering with significant demand expectations. No legal advisors are identified in the extracted deal facts provided. The transaction structure is a traditional initial public offering with a disclosed aggregate offering size of 1.89 billion dollars. No information regarding the number of shares to be offered, the price range, or the post-offering capitalization structure has been disclosed in the available source material. The offering size represents the total equity value being brought to market, though the pricing and final share count remain undetermined at this stage. Several material details regarding this transaction remain undisclosed or unknown. The identity of the issuer is not specified. The expected pricing date and closing date for the offering are not provided. The number of shares being offered and the anticipated price range are not disclosed. The post-offering ownership structure, including any lock-up provisions or secondary selling shareholders, is not disclosed. Additionally, no underwriting discount or commission structure has been specified in the available documentation.

This deal involves G-III Apparel Group Ltd (ticker GIII), a consumer-retail-sector company, as the acquirer of the Marc Jacobs brand operating business, structured as a joint venture and brand acquisition. The transaction falls under the M&A product group, and its disclosed value is $500,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published May 14, 2026. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Morgan Stanley & Co. LLC serves as financial advisor to WHP Global (labeled as the target side in this record, consistent with WHP Global's ownership of the Marc Jacobs brand), with the source sentence also noting that Gibson Dunn serves as legal advisor to WHP Global. On the acquirer side, UBS serves as financial advisor to G-III, with Paul, Weiss, Rifkind, Wharton & Garrison serving as G-III's legal advisor, per the corresponding source sentence. Legal advisors are disclosed for both sides: Gibson Dunn serves as legal advisor to WHP Global (target side), while Paul, Weiss, Rifkind, Wharton & Garrison serves as legal advisor to G-III (the acquirer). Beyond describing the transaction as a joint venture and brand acquisition valued at $500,000,000, the facts block does not specify the ownership split in the resulting joint venture, royalty arrangements, or other structural terms of the brand deal. Several facts are not disclosed in this record. No expected closing date is given. The facts block does not elaborate on how the joint venture will be governed or what specific rights to the Marc Jacobs brand are being transferred beyond the general classification of the deal.

Trinseo PLC, an industrials sector company trading under ticker TSEOQ, is pursuing a pre-packaged Chapter 11 reorganization with a disclosed enterprise value of $2,000,000,000 USD. A pre-packaged reorganization, or "prepack," is a restructuring strategy in which a debtor negotiates a plan of reorganization with its major stakeholders prior to filing for bankruptcy protection, enabling a faster and more orderly court process. This transaction falls within the restructuring product group and represents a significant financial event for the company. The transaction details are sourced from an SEC filing published on the SEC EDGAR platform on May 14, 2026. The form type is not specified in the available source material. The deal currently holds a pending regulatory status, indicating that approvals or clearances from relevant authorities have not yet been finalized. On the company side, Trinseo has assembled a comprehensive advisory team. Latham & Watkins LLP serves as the lead legal advisor, while Hunton Andrews Kurth LLP provides co-counsel support. For investment banking and capital markets guidance, Centerview Partners LLC acts as the investment banker. Additionally, FTI Consulting provides financial and communications advisory services to the company. The creditor constituencies are separately advised. An ad hoc group of Senior Secured Lenders is represented by Paul Hastings LLP as legal advisor and PJT Partners as financial advisor. An ad hoc group of Term Lenders is represented by Gibson, Dunn & Crutcher LLP as legal advisor and Lazard Frères & Co. as financial advisor. The legal advisory structure reflects the multi-stakeholder nature of the prepackaged reorganization. The company's legal strategy is coordinated between Latham & Watkins in a lead capacity and Hunton Andrews Kurth in a supporting role. The creditor groups have engaged separate counsel reflecting their different claim positions and negotiating dynamics: Paul Hastings and PJT Partners advise the Senior Secured Lenders while Gibson Dunn and Lazard advise the Term Lenders. The transaction structure and detailed terms remain largely undisclosed in the available materials. The $2,000,000,000 valuation figure is provided, but the specific composition of the consideration, treatment of different claim classes, equity rollover provisions, and the detailed terms of any financing or exit strategy are not stated in the sourced documents. Notable gaps in the disclosure include the expected timeline to emergence from bankruptcy, the detailed capital structure post-emergence, any financing facilities supporting the reorganization, the treatment and recovery percentages for different claim classes, management and governance changes, and any asset sales or operational restructuring contemplated as part of the plan. The form type of the SEC filing itself is not identified in the available source material, which would typically clarify whether this briefing is sourced from a disclosure statement, 8-K, or other regulatory document.

This transaction is a debt capital markets offering in the subordinated notes product category, with a disclosed size of $1,250,000,000 in U.S. dollars. The issuer has not been explicitly named in the source materials provided, though the offering is structured as a subordinated notes issuance. This represents a capital raise through the issuance of subordinated debt securities in the public markets. The transaction documentation is sourced from an SEC EDGAR filing of unknown form type, published on May 14, 2026. The deal currently holds a pending regulatory status, indicating that it has not yet reached completion or closing but remains in process through the regulatory approval phase. The financial advisory team on the issuer side is composed of three joint book-running managers and two co-managers. U.S. Bancorp Investments, Inc., J.P. Morgan Securities LLC, and RBC Capital Markets, LLC are acting jointly as the lead book-running managers of the offering. CastleOak Securities, L.P. and Drexel Hamilton are serving as co-managers in the transaction. Willkie Farr & Gallagher LLP is serving as counsel to the issuer in connection with this offering. The offering consists of subordinated notes with a total disclosed size of $1,250,000,000. Beyond this disclosed principal amount, the specific terms of the notes are not included in the source material. Key structural details that remain undisclosed include the tenor or maturity date of the notes, the coupon or interest rate that will be paid to investors, the detailed use of proceeds, the pricing of the offering, any pricing date or expected closing timeline, and whether this is a fixed-rate or floating-rate subordinated debt issuance.

Outlook Therapeutics, Inc., a healthcare sector company trading under ticker OTLK, entered into an at-the-market offering agreement on May 13, 2026. This is an equity capital markets transaction with a disclosed aggregate offering price of up to $100,000,000 in common stock. The at-the-market offering structure allows the company to issue and sell shares of its common stock, par value $0.01 per share, on an opportunistic basis over time rather than in a single upfront issuance. This transaction was disclosed in an SEC filing published on May 13, 2026. While the specific form type is not definitively identified in the source materials, the legal opinion relating to the shares being offered was filed as an exhibit to a Current Report on Form 8-K, which is the typical vehicle for reporting material agreements such as at-the-market sales agreements. The deal has been announced and the sales agreement has been executed as of the filing date. No expected closing date or completion timeline has been disclosed. H.C. Wainwright & Co., LLC serves as the sales agent and/or principal in this offering and is the lead financial advisor to the issuer. The company entered into the Sales Agreement with H.C. Wainwright specifically to facilitate the issuance and sale of the common stock under the at-the-market structure. Cooley LLP serves as legal counsel to Outlook Therapeutics on this transaction, with their legal opinion regarding the validity of the shares being offered filed as an exhibit to the Form 8-K. The offering permits Outlook Therapeutics to issue and sell shares from time to time through H.C. Wainwright acting in its capacity as sales agent and/or principal. The aggregate offering price of the shares that may be issued under the Sales Agreement is up to $100,000,000. However, several material terms remain undisclosed or are inherent to the at-the-market structure itself. The actual offering price per share is not specified and will be determined by market conditions at the time of sale. The timeline for actual share issuances, the pace at which shares will be offered, any limitations on daily or other periodic issuances, and the actual amount ultimately to be raised (which may be less than the $100,000,000 maximum) have not been disclosed. Additionally, no information has been provided regarding any underwriting or sales agent commissions, any standstill or lock-up provisions, or any other material terms of the Sales Agreement beyond its basic structure and purpose.

European Wax Center, Inc. (NASDAQ: EWCZ), the leading franchisor and operator of out-of-home waxing services in the United States, has completed its take-private acquisition by General Atlantic, its existing strategic investor since 2018. The transaction was first announced on February 10, 2026 and closed on May 8, 2026, following approval by EWC stockholders at a special meeting held May 7, 2026. Under the terms of the Agreement and Plan of Merger, dated February 9, 2026, General Atlantic acquired 100 percent of the outstanding shares of EWC Class A common stock that it did not already own. Stockholders other than General Atlantic affiliates received $5.80 in cash for each share of Class A common stock, with Class B common stock converted into a nominal $0.00001 per share. At signing, the transaction implied an equity value of approximately $330 million. The $5.80 per-share price represented a 45 percent premium to EWC's closing stock price on February 9, 2026, the last trading day before announcement, and a 51 percent premium to the company's 90-day volume-weighted average share price through that date. General Atlantic beneficially owned approximately 42 percent of the combined voting power of EWC's common stock (29.8 percent of Class A shares and 92.3 percent of Class B shares) prior to the deal. According to EWC's definitive merger proxy (DEFM14A), General Atlantic submitted an unsolicited, non-binding proposal on November 13, 2025 at $5.25 per share, a 42 percent premium to the 30-day volume-weighted average price at that time, and stated it would not sell its stake to a third party and would only proceed if a special committee of independent directors was formed to evaluate and had authority to reject the proposal. The Special Committee, advised by Ropes & Gray LLP and Moelis & Company LLC, countered at $6.25 per share; General Atlantic raised its offer to $5.60 per share; the Special Committee countered again at $6.00 per share; General Atlantic then proposed $5.80 per share, which the Special Committee accepted. The proxy states that the Special Committee concluded not to solicit competing bids from third parties because General Atlantic had stated it would not sell its stake and held contractual rights under the companies' Stockholders' Agreement to block any competing transaction, making a market check unlikely to produce a viable alternative offer. Moelis, as the Special Committee's financial advisor, used three principal methodologies to assess fairness of the $5.80 price. A discounted cash flow analysis using a 9.25 percent to 12.00 percent discount rate range and 6.5x to 8.5x terminal EBITDA multiples produced an implied per-share reference range of $4.46 to $7.65. A selected public companies analysis, applying a 6.5x to 8.5x TEV/2026E Adjusted EBITDA multiple range drawn from lower-growth restaurant and wellness franchisors (including Wendy's, Papa John's, Jack in the Box, Dine Brands, Xponential Fitness and El Pollo Loco), produced an implied per-share range of $2.73 to $5.23. A selected precedent transactions analysis, applying an 8.0x to 10.0x TEV/LTM EBITDA multiple range informed by deals such as Denny's/TriArtisan Capital, Del Taco/Yadav Enterprises and Papa Murphy's/MTY Food Group, produced an implied per-share range of $4.85 to $7.36. Moelis separately noted (without relying on it for its opinion) an illustrative leveraged buyout analysis assuming a 17.5 percent to 22.5 percent target IRR, which implied a per-share range of approximately $3.80 to $5.79, as well as a 52-week trading range of $3.10 to $7.45 and Wall Street analyst price targets of $3.75 to $15.00 as of early February 2026. The merger agreement provides for a Company Termination Fee of $6,600,000 payable by EWC to General Atlantic's parent entity under specified circumstances, including entry into or consummation of an alternative acquisition within twelve months of termination, and a Parent Termination Fee of $19,000,000 payable by the Parent to the Company under specified circumstances. Approval required both a statutory majority of all outstanding shares and a separate majority of votes cast by disinterested, unaffiliated stockholders (excluding General Atlantic and its affiliates). At the May 7, 2026 special meeting, the Merger Agreement Proposal received 41,008,435 votes for and 5,122,714 against on a statutory basis, and 17,884,892 votes for and 5,122,714 against among unaffiliated stockholders, with both thresholds satisfied. The acquisition was funded through a combination of new asset-backed securitization debt, equity financing from General Atlantic, and available cash on hand. Concurrently with closing, EWC's indirect subsidiaries, EWC Master Issuer LLC and EWC Sub Issuer LLC, issued $460,000,000 of Series 2026-1 6.40% fixed-rate senior secured notes (Class A-2) and up to $40,000,000 of Series 2026-1 variable funding senior secured notes (Class A-1) under an Amended and Restated Base Indenture with Citibank, N.A. as trustee. Proceeds, together with equity financing and cash on hand, were used to fund the merger consideration and related fees, and to prepay in full approximately $388.1 million (comprising $385,000,000 of principal plus approximately $3.1 million of accrued interest) of EWC's existing Series 2022-1 5.50% fixed-rate senior secured notes, with no make-whole premium or early termination penalty. No separate synergy figures, EPS accretion/dilution estimates, or pro forma ownership percentages were disclosed in the filings reviewed, as this is an all-cash going-private transaction rather than a stock-for-stock combination. Upon closing, EWC's Class A common stock ceased trading and was delisted from the Nasdaq Stock Market, and the company notified Nasdaq of its intent to file a Form 25 to deregister the stock, with EWC intending to subsequently file a Form 15 to suspend its Exchange Act reporting obligations. Moelis & Company LLC acted as exclusive financial advisor and Ropes & Gray LLP as legal counsel to the Special Committee of the EWC Board; Edelman Smithfield served as strategic communications advisor to EWC; BofA Securities and Guggenheim Securities acted as financial advisors and Paul, Weiss, Rifkind, Wharton & Garrison LLP as legal counsel to General Atlantic.

Americold Realty Trust, Inc., a real estate investment trust trading under ticker COLD, entered into a contribution agreement on May 7, 2026 with Snowfall Topco LP, an affiliate of EQT's Active Core Infrastructure fund, to form a joint venture focused on the ownership, operation, and potential development of high-quality cold storage warehouse facilities in North America. The Contribution Agreement was unanimously approved by Americold's Board of Directors upon the unanimous recommendation of the Board's Finance Committee. The full Contribution Agreement was subsequently filed as Exhibit 10.1 to an amended Form 8-K/A on May 12, 2026. The joint venture transaction closed on August 31, 2026. Under the terms of the agreement, Americold indirectly contributed 12 temperature-controlled warehouse facilities located across the United States to the new joint venture entity, Americold-EQT Cold Storage Partnership, LLC, with an aggregate value in excess of $1.3 billion at inception. The facilities comprise approximately 124 million cubic feet of temperature-controlled capacity with over 400,000 combined pallet positions. EQT acquired a 70 percent equity interest in the joint venture entity, while Americold retained a 30 percent interest and continues to serve as day-to-day manager of the platform. The joint venture is governed by a six-person board, with three directors appointed by Americold's JV member and three appointed by EQT's JV member. The joint venture is intended to be treated as a partnership for U.S. federal, and to the extent permissible, state and local income tax purposes. In conjunction with closing, Americold received approximately $1.1 billion in net cash proceeds from the transaction, which the company stated it intends to use to repay outstanding debt, in order to strengthen its balance sheet, reduce leverage, and enhance financial flexibility. In connection with the closing, the joint venture obtained mortgage financing of up to $863,500,000 secured by the real properties owned by the joint venture, of which $845,500,000 was drawn at closing. The joint venture agreement contains an income support arrangement under which Americold may be required to make contingent payments to the joint venture entity during the 10-year period following execution of the agreement if specified performance thresholds are not achieved; Americold's maximum net exposure under this arrangement is capped at up to $70 million over the term, with any payments subject to reimbursement to the extent cumulative performance exceeds agreed-upon thresholds. The agreement also includes a contractual repurchase mechanism relating to a specified property that may be exercised by either joint venture member under certain circumstances. Separately, on August 29, 2026, the parties entered into a First Amendment to the Contribution Agreement under which certain customer contracts that were originally contemplated to be assigned to joint venture subsidiaries will instead be addressed through license agreements between joint venture subsidiaries and Americold subsidiaries that are party to those contracts. Rob Chambers, Americold's Chief Executive Officer, said in the closing press release dated August 31, 2026 that the transaction represents an important milestone for Americold and demonstrates strong execution against one of its five key priorities, adding that in addition to generating substantial proceeds that further strengthen the balance sheet and reduce leverage, the company has established a long-term capital and development partnership with EQT, and that together they have created a platform with the scale, expertise, and financial capacity to pursue future opportunities as the cold storage industry continues to evolve. In the company's first-quarter 2026 earnings release issued the same day the deal was announced, Chambers said the joint venture with EQT, described as a world-class real estate investor, showed meaningful progress towards the company's goal to strengthen the balance sheet and highlighted the quality and attractiveness of its mission-critical assets and operating platform. Beyond the initial 12-facility contribution, Americold and EQT stated they intend for the joint venture to serve as a long-term platform for additional ownership, development, and strategic growth opportunities in the North American cold storage sector, combining Americold's operating capabilities and customer relationships with EQT's infrastructure investment expertise and capital resources. Kirkland & Ellis LLP acted as legal counsel to Americold, and Simpson Thacher & Bartlett LLP acted as legal counsel to EQT, according to the advisors section of the closing press release. The transaction was structured as a contribution of assets to a newly formed joint venture rather than a conventional merger or stock and cash acquisition of a public target, so there is no per-share exchange ratio, acquisition premium, or EV/EBITDA multiple disclosed in the filings. No synergy dollar targets, phase-in timelines, or EPS accretion/dilution estimates have been disclosed in connection with the transaction. The company's 2026 financial guidance disclosed in the Q1 2026 supplemental materials was stated to be presented prior to giving effect to the joint venture, but no updated guidance reflecting the closed joint venture has been identified in the filings reviewed. No termination fee has been disclosed in the portions of the agreement summarized in the filings.

Chatham Lodging Trust, a real estate investment trust trading under the ticker symbol CLDT, is acquiring assets in a transaction valued at $92 million. The transaction is classified as an asset acquisition within the mergers and acquisitions product group, and the sector involved is real estate. The specific identity of the target or assets being acquired has not been disclosed in available materials. This briefing is sourced from an SEC EDGAR filing published on May 6, 2026. The specific form type of the filing is not identified in the available documentation. The deal is currently in pending regulatory status, indicating that it has not yet closed and remains subject to regulatory review or approval processes. No financial advisors have been identified or extracted for this transaction. This is notable as asset acquisitions of this size often engage investment banking advisors, though in some cases REITs may execute transactions without formal banking advisors or such advisory relationships may not be publicly disclosed in the filing. No legal advisors have been identified in the available documentation for either party to the transaction. The deal structure specifies an asset acquisition with a disclosed transaction value of $92 million in USD. Beyond the total consideration, no additional detail regarding the composition of consideration, payment mechanics, timing, or specific asset classes or properties being acquired has been disclosed. Several material details remain unknown. The specific form type of the SEC filing has not been identified. The identity of the target or the specific assets being acquired is not disclosed. The expected closing date for the transaction has not been provided. No information is available regarding the consideration mix, payment schedule, financing structure, or whether any portion of the purchase price is contingent. The filing does not identify the seller or target entity. Additionally, while the deal is noted as pending regulatory approval, the specific regulatory body or bodies whose approval is required has not been specified.

This transaction is a divestiture in which Archer Foodservice is acquiring Sterno's food service business from SternoCandleLamp Holdings, Inc., a subsidiary of or affiliate related to CODI. The disclosed value of the transaction is 292,500,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on May 5, 2026. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Jefferies acted as financial advisor to CODI and is identified as the lead advisor in that capacity. Raymond James acted as financial advisor to Sterno and is likewise identified as the lead advisor for Sterno. Each firm's role is confirmed in its own dedicated source sentence naming the specific client it advised. On the legal side, Brownstein Hyatt Farber Schreck, LLP acted as legal counsel to both Sterno and CODI, serving as a shared legal advisor across what the facts classify together as the target side of this divestiture. Beyond confirming that this is a divestiture with a disclosed value of 292,500,000 dollars, no further detail on the specific assets comprising Sterno's food service business or any adjustment mechanisms to the purchase price is included in the facts available. A number of elements of this deal remain undisclosed. No financial or legal advisor to Archer Foodservice, the acquirer, is identified, and no expected closing date is given. The facts also do not specify what regulatory approvals are required to complete the transaction beyond the disclosed value of 292,500,000 dollars.

Fundrise eREIT, LLC, a newly organized Delaware limited liability company in the real estate sector, completed mergers with seven affiliated non-traded REITs on April 29, 2026, including Fundrise East Coast Opportunistic REIT, LLC (referred to as East Coast), the target implied by this record's slug. The other six merging entities were Fundrise Development eREIT, LLC, Fundrise Equity REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, Fundrise Midland Opportunistic REIT, LLC and Fundrise West Coast Opportunistic REIT, LLC, together with East Coast referred to as the Fundrise Merger Entities. All seven entities merged with and into Fundrise eREIT, with Fundrise eREIT as the surviving entity, pursuant to an Agreement of Merger and Plan of Reorganization dated April 29, 2026. The mergers were reported as completed in a Form 8-K filed with the SEC on May 4, 2026, under Items 1.01, 2.01, 5.03, 8.01 and 9.01. All of the Fundrise Merger Entities, including East Coast, are externally managed by Fundrise Advisors, LLC, the Manager, a subsidiary of Rise Companies Corp., the Sponsor, and the Manager explained the rationale for the mergers in the joint Information Statement/Prospectus: the Manager believes that consolidating the assets and liabilities of the Fundrise Merger Entities into a single company, Fundrise eREIT, will result in a larger company that is able to pursue a similar investment objective and strategies as the Fundrise Merger Entities while at the same time streamlining operations, cutting administrative costs, spreading fixed costs over a larger asset base, providing additional liquidity to shareholders, and maximizing returns to the benefit of shareholders. The Manager further stated that the combined entity would be able to be more competitive in the real estate market through its institutional scale, effectuate more deals, increase the total investments of the entity, and unlock leverage from lenders at more attractive pricing than the Fundrise Merger Entities could previously achieve on their own. The filing states the Manager did not consider a reorganization, merger with a third party, or sale of the entities, because it viewed continuity of the Manager's role as critical to Fundrise eREIT's success. Each Fundrise Merger Entity shareholder received Fundrise eREIT common shares, which are LLC interests rather than corporate stock, equal in total value to the shares of the Fundrise Merger Entity held immediately before the merger, based on an exchange ratio calculated from each entity's net asset value per share as of 4:00 p.m. Eastern time on April 28, 2026, the Valuation Time, divided by Fundrise eREIT's NAV per share at the same time. The final exchange ratio for East Coast, as disclosed in the 8-K, was 0.961 Fundrise eREIT shares for each East Coast share, versus an estimated ratio of 1.074 to 1.00 disclosed in the April 27, 2026 prospectus, which was subject to change through closing. Based on shares outstanding as of January 1, 2026, Fundrise eREIT expected to issue approximately 65.4 million common shares across all seven mergers combined; a per-entity or aggregate dollar value of consideration is not disclosed. No sales charges or redemption fees were imposed, and each merger is intended to qualify as a tax-free reorganization. As of December 31, 2025, East Coast had raised total gross offering proceeds of approximately 176.3 million dollars since inception, versus 176.0 million dollars as of December 31, 2024, primarily through a Regulation A offering; this figure is offering proceeds, not a merger consideration value, and no separate enterprise or equity valuation for East Coast in the merger is disclosed. The transaction did not require a shareholder vote under the Fundrise Merger Entities' operating agreements. Because each merger was a transaction between affiliates of the Sponsor, it was treated as a principal transaction requiring approval from both the Manager and William Thomas Lockard, Jr., the Independent Representative appointed to review conflicted transactions; the Agreement of Merger and Plan of Reorganization states both had approved the merger as of its April 29, 2026 signing date. No fairness opinion was obtained from a third-party investment bank or financial advisor regarding the fairness of the mergers or the consideration received by shareholders. Goodwin Procter LLP passed upon the validity of the securities issued by Fundrise eREIT and certain U.S. federal income tax consequences of the mergers; no separate legal counsel is identified for the individual Fundrise Merger Entities, including East Coast. The share issuance to Fundrise Merger Entity shareholders was registered on a Form S-4 registration statement, File No. 333-293216, which was the subject of a Rule 424(b)(3) prospectus and Joint Information Statement filed April 27, 2026. The mergers are expected to be accounted for as asset acquisitions under ASC Topic 805, as the Fundrise Merger Entities were determined not to meet the definition of a business for accounting purposes, since no substantive processes, employees, or operating platforms were acquired. No termination fee applicable to the merger agreement is disclosed in the reviewed filings. The transaction has closed: the Form 8-K filed May 4, 2026 confirms the mergers became effective at 11:59 p.m. Eastern time on April 29, 2026, with Fundrise eREIT as the surviving entity in each merger and the separate existence of East Coast and the other six Fundrise Merger Entities terminated.

ARCHIMED is acquiring Esperion Therapeutics, Inc., a healthcare company, in an all-cash transaction valued at $1,100,000,000. This is a merger and acquisition transaction in the healthcare sector. The deal remains pending regulatory approval as of the most recent available information. The transaction details are sourced from an SEC EDGAR filing published on May 1, 2026. The specific form type is not identified in the available documentation. The deal is currently in pending regulatory status, meaning all material conditions to closing have not yet been satisfied and the transaction has not closed. Centerview Partners has been retained as exclusive financial advisor to Esperion, the target company, in a lead advisory role. On the acquirer side, Moelis & Company LLC is serving as exclusive financial advisor to ARCHIMED in a lead capacity. For debt financing, investment funds managed by Pharmakon Advisors, LP are providing debt financing for the transaction, positioning Pharmakon in a financing provider role. Goodwin Procter LLP is serving as legal counsel to Esperion Therapeutics. Sidley Austin LLP has been engaged as legal advisor to ARCHIMED. Akin Gump LLP is providing legal advisory services to Pharmakon Advisors, the debt financing provider. The transaction is structured as an acquisition with a disclosed equity value of $1,100,000,000. Debt financing has been committed by Pharmakon Advisors' investment funds, indicating a leveraged component to the overall financing structure. Beyond this confirmation of debt involvement, no further details have been disclosed regarding the specific mix of debt and equity consideration, the amount or terms of any debt facility, interest rates, maturity dates, or other financing terms. Several material facts remain undisclosed or unknown at this time. No expected closing date or regulatory timeline has been provided. The consideration structure (whether cash at close, the role of any escrow, earn-outs, or other adjustments) is not specified. The specific amount of debt financing relative to equity has not been disclosed. Additionally, the regulatory approvals required and the current status of those approvals beyond the general "pending regulatory" designation are not detailed in the available documentation.

Inseego and Nokia announced on April 30, 2026 that they had signed an agreement under which Inseego will acquire Nokia's Fixed Wireless Access (FWA) customer premises equipment business, a deal the companies said is expected to approximately double Inseego's revenue and position it as a global leader in wireless broadband across fixed wireless and mobile connectivity. As part of the transaction, Nokia will become a significant shareholder in Inseego, holding approximately an 11% equity stake. This record is sourced from an Exhibit 99.1 press release furnished with Inseego's Form 8-K filed April 30, 2026. At announcement, the deal was a signed agreement pending customary closing conditions, with closing expected in the fourth quarter of 2026. Perella Weinberg Partners served as financial advisor to Nokia, the seller of the FWA business and the resulting equity-stake holder in Inseego, per the release's single-sentence disclosure: "Perella Weinberg Partners served as financial advisor to Nokia." No financial advisor to Inseego, the acquirer, is named in this release, and no lead designation is specified since Perella Weinberg is the only advisor disclosed. No legal advisors for either party are disclosed in the fetched document. Under the terms, Nokia will receive approximately a 7% equity stake in Inseego, valued at US$20 million, in the form of common stock and warrants as consideration for the FWA business at closing, and will separately make an additional $10 million investment in Inseego common stock and warrants to deepen the companies' commercial collaboration, bringing Nokia's total ownership to approximately 11%. The companies also plan joint go-to-market and innovation initiatives in 6G and wireless edge technology. Not disclosed in the sourced document is the standalone purchase price attributable to the FWA business itself separate from the equity consideration and additional investment, Inseego's financial or legal advisor (if any), or Nokia's legal advisor on the transaction.

Hawthorn Bancshares, Inc. (NASDAQ: HWBK), the Jefferson City, Missouri-based holding company for Hawthorn Bank, agreed on April 29, 2026 to acquire FSC Bancshares, Inc., the holding company for Farmers State Bank of Cameron, Missouri, in a cash-and-stock transaction valued at approximately $28.3 million based on Hawthorn's closing stock price of $34.57 on April 28, 2026. The transaction was structured as a two-step reorganization in which Hawthorn's merger subsidiary merged into FSC, FSC then merged into Hawthorn with Hawthorn surviving, and Farmers State Bank was merged into Hawthorn Bank. The deal was disclosed in a Form 8-K (Items 1.01 and 7.01) that attached the Agreement and Plan of Reorganization as Exhibit 2.1 and a joint press release as Exhibit 99.1, and later detailed in a Form S-4 registration statement, S-4/A amendment, and 424B3 proxy statement/prospectus used to solicit the FSC shareholder vote. Under the terms of the agreement, FSC shareholders were entitled to receive $14.0 million in cash in the aggregate plus 413,101 shares of Hawthorn common stock, with the cash consideration subject to reduction if FSC did not deliver at least $19.0 million of GAAP total shareholders' common equity, net of intangibles and certain merger costs, at closing. Hawthorn's financial advisor, Olsen Palmer LLC (FSC's fairness opinion provider), calculated implied transaction metrics of 1.35x FSC's tangible book value, 9.0x FSC's last-twelve-months net income, and a 2.2% core deposit premium, all as of March 31, 2026. In a comparable-transactions analysis of seven bank deals announced between January 2023 and April 2026 involving similarly sized Mid-Atlantic, Midwest, and Southeast targets, Olsen Palmer found a median deal value/tangible common equity of 1.27x and a median deal value/LTM earnings of 9.0x, placing the FSC deal roughly in line with recent precedent transactions on an earnings basis and slightly above median on a tangible book value basis. Hawthorn disclosed in its announcement press release that the transaction is expected to be accretive to earnings per share by approximately 20% on a fully phased-in basis, with tangible book value dilution at closing of approximately 9.8% and an earnback period of approximately 3.0 years using the crossover method. Neither the press release nor the proxy statement/prospectus disclosed a specific dollar figure or percentage-of-expense-base target for cost savings or synergies; both documents reference the existence of expected "cost synergies" and "expense efficiencies" only in qualitative terms. On a pro forma basis, former FSC shareholders were expected to own approximately 5.6% of the combined company, with Hawthorn's pre-existing shareholders owning the remaining approximately 94.4%. According to the background-of-the-merger disclosure in the S-4/A, FSC's board began exploring a sale or merger in early 2025 and engaged Northland (then The Capital Corp., now Northland Securities/Northland Capital Markets) in June 2025 as exclusive financial advisor. Northland contacted twelve potential partners, seven of which signed confidentiality agreements, and FSC received two written indications of interest in July 2025, including one from Hawthorn and one from an unnamed "Bank A." FSC's board favored Hawthorn's offer because it exceeded Bank A's all-cash bid in total value and offered FSC shareholders continued participation in community banking through publicly traded stock. The parties signed a non-binding letter of intent on August 25, 2025 valuing the deal at approximately $28 million (based on $19 million of FSC tangible common equity) with a consideration mix of 45%-55% cash and 45%-55% stock, before executing the definitive merger agreement on April 29, 2026. Olsen Palmer rendered its fairness opinion to the FSC board on April 27, 2026. Combining the two companies was expected, based on financial data as of March 31, 2026, to create a company with approximately $2.2 billion in total assets, $1.7 billion in total loans, and $1.9 billion in total deposits, with the FSC acquisition adding approximately $384 million in total assets and nine branch locations in northern Missouri. Hawthorn's CEO Brent Giles said the deal reflected the company's "strategy of disciplined growth" and that "Farmers has developed strong customer relationships and a respected community presence that align closely with Hawthorn's values." FSC President Michael Poland said the transaction "represents a compelling opportunity for our customers, employees, and communities" and would allow FSC to "offer broader capabilities, enhanced technology, and additional financial solutions while preserving the local decision-making and service culture." Raymond James & Associates, Inc. served as financial advisor to Hawthorn, with Hunton Andrews Kurth LLP as its legal counsel. Northland Capital Markets served as financial advisor to FSC, with Stinson LLP as its legal counsel, and Olsen Palmer LLC rendered the fairness opinion to FSC's board. The merger agreement provided for a termination fee of $1,120,000 payable by FSC under certain circumstances, and an outside termination date of January 31, 2027 (subject to extension). Completion was conditioned on FSC shareholder approval, Nasdaq listing of the shares to be issued, receipt of required regulatory approvals, and effectiveness of Hawthorn's Form S-4 registration statement, which was declared effective by the SEC on July 21, 2026. The merger closed on September 3, 2026, as confirmed in a Form 8-K (Item 2.01) and accompanying press release. FSC's shareholders approved the deal at a special meeting held September 1, 2026. At closing, each share of FSC common stock was converted into the right to receive $73.7099 in cash and 2.1823 shares of Hawthorn common stock, for total aggregate consideration of 413,101 Hawthorn shares and $13,953,000 in cash (plus cash in lieu of fractional shares). Following the closing, the combined company reported total assets of approximately $2.2 billion, and Hawthorn Bank began operating twenty-seven banking locations across northern, central, western, and mid-Missouri plus one location in Kansas. Hawthorn stated that customer account conversion for former Farmers State Bank customers is anticipated to occur in the first quarter of 2027.

First Eagle Investments, an independent, privately owned investment management firm, acquired Diamond Hill Investment Group, Inc. (Nasdaq: DHIL), a boutique asset manager, in an all-cash transaction. The deal was announced via a definitive merger agreement dated December 10, 2025 and disclosed in a joint press release the following day, and it closed on April 22, 2026, with Diamond Hill becoming a wholly owned subsidiary of First Eagle and its shares delisted from Nasdaq. Under the terms of the merger agreement, Diamond Hill shareholders received $175.00 per share in cash, valuing the company at approximately $473 million. The price represented a 49% premium over Diamond Hill's closing share price of $117.48 on December 10, 2025, the last trading day before announcement, and a 44% premium over the company's 30-day volume-weighted average price. The merger agreement structured Diamond Hill's merger into Soar Christopher Holdings, Inc., a wholly owned merger subsidiary of First Eagle Investment Management, LLC. First Eagle funded the merger consideration through a combination of cash on hand and by drawing on existing credit facilities under its Existing Credit Agreement; the transaction was not subject to a financing condition. Upon closing, amounts outstanding under Diamond Hill's own credit agreement were expected to be fully repaid and terminated. First Eagle's CEO Mehdi Mahmud stated the deal reflected First Eagle's "ongoing effort to expand the range of investment solutions" offered to clients, citing cultural fit in "fiduciary mindset, commitment to investment excellence, and long-term orientation." The acquisition was described as materially expanding First Eagle's footprint in traditional fixed income, an area of recent growth for Diamond Hill, while Diamond Hill's U.S.-focused multi-cap equity platform was described as complementary to First Eagle's existing Global Value and Small Cap franchises. Pro forma for the transaction, First Eagle's combined assets under management and under advisement were approximately $208 billion as of September 30, 2025 (as stated at announcement) and approximately $213 billion as of March 31, 2026 (as stated at closing); Diamond Hill's standalone AUM/AUA was $32.4 billion as of September 30, 2025 and approximately $27 billion as of March 31, 2026. Diamond Hill CEO Heather Brilliant continued to lead Diamond Hill post-closing while also assuming the newly created role of Chief Operating Officer of First Eagle. Diamond Hill's financial advisor, Broadhaven Capital Partners, valued the company using a comparable public companies analysis of publicly traded asset managers (including Cohen & Steers, Federated Hermes, Franklin Resources, Invesco, Janus Henderson, T. Rowe Price, Victory Capital and Virtus Investment Partners), applying reference ranges of enterprise value to estimated EBITDA of 5.0x-8.0x for 2025E, 4.5x-7.0x for 2026E and 4.0x-6.5x for 2027E, which implied per-share values of $136-$189, $128-$172 and $119-$163, respectively, versus an estimated present value of the merger consideration of approximately $171.86-$170.29 per share (assuming six- to nine-month periods to closing, discounted at 3.70%). Broadhaven also performed a precedent transactions analysis referencing announced asset-management M&A deals such as Guardian Capital/Desjardins, CCLA/Jupiter Fund Management, AXA Investment Managers/BNP Paribas Cardif, Amundi Holdings US/Victory Capital, Putnam Investments/Franklin Resources, and others, analyzing EV/EBITDA multiples (with and without expected synergies) of those deals at announcement. According to the "Background of the Merger" section of the merger proxy, First Eagle CEO Mehdi Mahmud first approached Diamond Hill CEO Heather Brilliant on July 31, 2025 to discuss industry trends, with Mahmud indicating First Eagle (following Genstar Capital's acquisition of a controlling interest in First Eagle) was looking to expand through acquisitions of smaller asset managers. The merger agreement included a 35-day "go-shop" period running through January 14, 2026, during which Broadhaven contacted 14 parties (four private equity sponsors and ten strategic counterparties) to solicit superior proposals; all 14 declined to pursue a transaction without requesting further diligence, and the go-shop period ended with no alternative proposals received. The merger agreement provided for a company termination fee of $18,000,000 payable by Diamond Hill under specified circumstances (such as termination for a superior proposal or an adverse board recommendation change), reduced to $9,000,000 if Diamond Hill terminated for a superior proposal from a party that qualified as an "Excluded Party" under the go-shop provisions prior to the applicable cut-off date. The transaction was subject to approval by Diamond Hill shareholders, certain mutual fund/registered fund board and client-consent related approvals, and clearance under the Hart-Scott-Rodino Antitrust Improvements Act; the agreement contained no financing contingency. Diamond Hill shareholders approved the merger agreement at a special meeting held March 3, 2026; as of the January 27, 2026 record date there were 2,705,580 common shares outstanding, and holders of 1,916,147 shares (approximately 70.82% of shares outstanding) were present or represented by proxy, constituting a quorum. The merger closed on April 22, 2026. Diamond Hill's common shares ceased trading and were removed from listing on the Nasdaq Global Select Market, and the company became a wholly owned subsidiary of First Eagle, continuing to operate under its existing brand from its Columbus, Ohio headquarters with no stated changes to its investment philosophy or process. On the financial advisory side, Broadhaven Capital Partners served as lead financial advisor to Diamond Hill, and UBS Investment Bank served as financial advisor to First Eagle. For legal representation, Davis Polk & Wardwell LLP and Vorys, Sater, Seymour & Pease LLP served as legal advisors to Diamond Hill, while Willkie Farr & Gallagher LLP served as legal advisor to First Eagle. FGS Global served as strategic communications advisor to Diamond Hill.

This transaction is a divestiture/cash sale involving a regulatory and medical writing business being sold to Veristat. The product group is M&A, and the disclosed transaction value is $135,000,000. The facts block does not specify the sector classification for this record, and the seller is identified only through context as Certara, based on the source language referencing "legal counsel to Certara." The deal is sourced from an 8-K filed with the SEC via EDGAR, published on April 22, 2026. The current status of this transaction is pending regulatory review. On the financial advisory side, Guggenheim Securities, LLC served as financial advisor to Veristat, the acquirer, per the statement "Guggenheim Securities, LLC served as the financial advisor, and McDermott Will & Schulte served as legal counsel to Veristat." Perella Weinberg Partners LP served as financial advisor to the company side (identified in the source sentence as Certara, the seller), consistent with the language "Perella Weinberg Partners LP served as the financial advisor, and Troutman Pepper Locke LLP served as legal counsel to Certara." Neither advisor is designated as lead in the facts provided. Legal advisors are disclosed for both sides. Troutman Pepper Locke LLP served as legal counsel to Certara (the target/seller side), and McDermott Will & Schulte served as legal counsel to Veristat (the acquirer). Beyond the classification of this transaction as a divestiture/cash sale with a disclosed value of $135,000,000, no further detail on consideration structure, financing, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no expected closing date is given beyond the pending-regulatory status, and no further detail on the structure of the cash consideration (such as payment timing or any contingent elements) is provided.

SoundHound AI, Inc. (Nasdaq: SOUN), a voice and conversational AI company, entered into a definitive agreement to acquire LivePerson, Inc. (Nasdaq: LPSN), an enterprise conversational AI and digital messaging company, combining SoundHound's voice and agentic AI platform with LivePerson's Conversational Cloud digital engagement technology. The release describes the deal as SoundHound's fifth strategic acquisition and states the combined company would serve enterprise customers across more than 30 countries, including 12 of the top 15 global banks and 4 of the top 5 global airlines. This record is sourced from an 8-K exhibit (Exhibit 99.1), the joint press release of SoundHound AI and LivePerson dated April 21, 2026, as filed with the SEC. At the time of this filing the deal was newly announced and pending customary regulatory approvals, LivePerson stockholder approval, and other closing conditions, with the parties targeting a close in the second half of 2026. Barclays served as the financial advisor to SoundHound AI on the acquisition, per the release: "Barclays is serving as financial advisor to SoundHound AI." On the target's side, Lazard served as financial advisor to LivePerson. Legal counsel to SoundHound AI was provided by Latham & Watkins LLP, while Fried, Frank, Harris, Shriver & Jacobson LLP served as legal counsel to LivePerson. On deal structure, SoundHound is acquiring LivePerson for an equity value of 43 million dollars, representing approximately a 22 percent premium over the corresponding 30-day volume-weighted average value. At closing, SoundHound expects to receive 74 million dollars of LivePerson's cash balance prior to repayment of LivePerson's 2026 convertible senior notes; after accounting for significant discounts on LivePerson's remaining debt, the release states the transaction implies a total enterprise value of 250 million dollars, with SoundHound planning to retire the discounted debt using a mix of cash and equity at its discretion, leaving the combined company with no debt. Not disclosed in this exhibit: the precise cash-versus-stock split of the merger consideration paid to LivePerson stockholders, the specific exchange ratio or per-share consideration, any fee arrangement for Barclays or Lazard, and the actual closing date beyond the general expectation of the second half of 2026.

USA Rare Earth, Inc., a natural resources company trading under ticker USAR, is acquiring Serra Verde in a merger transaction valued at $2,800,000,000 in disclosed consideration. This is a mergers and acquisitions transaction within the natural resources sector. This transaction is documented in an SEC EDGAR filing that was published on April 20, 2026. The specific form type has not been identified in the available source materials. The deal is currently pending regulatory approval and has not yet closed. On the acquirer side, Moelis & Company LLC has been retained as exclusive financial advisor to USA Rare Earth. On the target side, Goldman Sachs & Co. LLC serves as exclusive financial advisor to Serra Verde. Both advisory relationships represent lead advisory mandates for their respective clients. USA Rare Earth is being represented by Latham & Watkins LLP as legal counsel. Serra Verde is being represented by two legal advisors: White & Case LLP is acting as legal counsel for Serra Verde in the transaction, and Allen Overy Shearman Sterling US LLP is acting as legal counsel specifically for the shareholders of Serra Verde. The transaction is valued at $2,800,000,000 in total disclosed consideration. Beyond this headline figure, the specific composition of consideration, whether in cash, stock, or a combination thereof, has not been disclosed. The deal structure, including any details regarding how consideration will be allocated, whether there are any earn-out provisions, or the mechanics of the transaction closure, remain undisclosed. The expected closing date for this transaction has not been provided. Additionally, while the transaction is identified as pending regulatory approval, the specific regulatory body or bodies whose approval is required and the current stage of that regulatory review process are not detailed in the available information.

QXO, Inc. announced on April 19, 2026 a definitive agreement to acquire TopBuild Corp., the largest distributor and installer of insulation and related building products in North America, for approximately $17 billion in a cash-and-stock transaction. The deal, QXO's largest acquisition to date, was expected to make QXO the second-largest publicly traded building products distributor in North America, with the combined company generating more than $18 billion in revenue and more than $2 billion in adjusted EBITDA. This extraction is sourced from QXO's 8-K exhibit (Exhibit 99.1) filed with the SEC on April 20, 2026, announcing the signed definitive agreement. The transaction subsequently closed on July 1, 2026, per a separate QXO 8-K exhibit filed that date confirming completion. Morgan Stanley & Co. LLC acted as lead financial advisor to QXO, with Barclays and Wells Fargo Securities acting as additional financial advisors to QXO on the buy side. Goldman Sachs & Co. LLC and RBC Capital Markets served as financial advisors to TopBuild on the sell side. On the legal side, Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal counsel to QXO, while Jones Day served as legal counsel to TopBuild. The transaction valued each TopBuild share at $505, a premium of 19.8% to TopBuild's 60-day volume-weighted average price and 23.1% to its closing price on April 17, 2026. TopBuild stockholders could elect to receive $505 in cash or 20.2 shares of QXO common stock per share held, subject to proration, with total consideration fixed at approximately 45% cash and 55% QXO stock. The purchase price represented 14.9 times TopBuild's 2025 adjusted EBITDA before expected synergies and 11.8 times after an expected $300 million of run-rate synergies by 2030. Both boards unanimously approved the deal, which was subject to shareholder votes at both companies and was expected to close in the third quarter of 2026. The press release does not disclose the specific advisory fees paid to Barclays, Morgan Stanley, Wells Fargo Securities, Goldman Sachs, or RBC Capital Markets, nor does it specify a termination fee or other deal-protection terms in the merger agreement.

FONAR Corporation, a Melville, New York-based healthcare imaging company trading on Nasdaq under ticker FONR, agreed to be acquired by FONAR, LLC, an entity controlled by an Acquisition Group led by FONAR's own Chief Executive Officer and Chairman, Timothy Damadian, in an all-cash going-private merger. The Agreement and Plan of Merger was signed December 23, 2025 and disclosed in a Form 8-K filed December 30, 2025, with the transaction also structured as a Rule 13e-3 going-private transaction requiring a jointly filed Schedule 13E-3 (originally filed February 26, 2026, with a Final Amendment filed June 3, 2026 reporting the results of the transaction). The transaction closed on June 3, 2026, when FONAR Acquisition Sub, Inc. merged into FONAR, which became a wholly owned subsidiary of Parent, as confirmed in a Form 8-K filed that day. Under the terms of the Merger Agreement, FONAR stockholders received $19.00 in cash per share of common stock and Class B common stock, $6.34 per share of Class C common stock, and $10.50 per share of Class A non-voting preferred stock. According to the Company's press release, the $19.00 common stock price represented a 31.5% premium to the closing share price on the last trading day before the transaction's announcement, a 21.9% premium to the closing price on July 8, 2025 (the last trading day before the Acquisition Group's initial non-binding proposal was announced), and a 39.7% premium to the average closing price over the 90 trading days ended June 30, 2025. A stockholder class action complaint attached as an exhibit to the definitive proxy statement alleged the all-cash merger valued FONAR at approximately $123.5 million; this figure originates from plaintiffs' pleading rather than from a valuation disclosed by the Company or its financial advisor. The Special Committee's independent financial advisor, Marshall & Stevens Transaction Advisory Services LLC, rendered a fairness opinion dated December 23, 2025 concluding that the per-share merger consideration was fair, from a financial point of view, to FONAR's unaffiliated public stockholders. Marshall & Stevens' discounted cash flow analysis, using a weighted average cost of capital of 14.5% (cost of equity of approximately 16.2%, after-tax cost of debt of approximately 4.6%) applied to 10-year management projections, produced an indicated fair market value of FONAR's common equity on a controlling basis of approximately $97.6 million to $104.0 million, implying a per-share value of approximately $14.48 to $15.52 for the common stock, Class B common stock and Class C common stock (on an as-converted basis) -- below the $19.00 per share ultimately paid. According to the DEFM14A's "Background of the Merger" section, Damadian and Chief Operating Officer Luciano Bonanni began considering a going-private transaction as early as December 2021, motivated by the view that the costs of being a Nasdaq-listed public company, including compliance, audit and legal expenses, had become a significant drag on net profits. The Acquisition Group's first non-binding proposal, delivered around July 7, 2025, offered $17.25 per share of common stock (about a 27% premium to the 90-trading-day average price through June 30, 2025); the Special Committee, advised by Marshall & Stevens and its legal counsel Meister Seelig & Fein PLLC, initially countered that this price was inadequate and proposed $22.50 per share. The Acquisition Group subsequently raised its offer to $18.00 per share and then to a final $19.00 per share before the Special Committee agreed to support the deal on December 11, 2025, conditioned on receipt of the Marshall & Stevens fairness opinion. During the negotiation period, an unidentified institutional stockholder referred to in the proxy as "Stockholder 4" sent letters in October and November 2025 expressing non-binding interest in acquiring FONAR for $24.00 per share, calling the Acquisition Group's then-current offer price "inadequate" relative to the Company's reported tangible book value; the Special Committee requested supporting information and documentation from Stockholder 4, which the proxy states was not provided, and no competing transaction materialized. The merger was financed through a combination of new debt, new equity and rollover of existing FONAR securities by Acquisition Group members. Per the announcement 8-K, Parent obtained a committed debt financing facility of $35,000,000 from OceanFirst Bank, N.A., debt subscription commitments of not less than $10,000,000 from other financing sources, and equity subscription commitments (comprising cash and rollover securities) of not less than $45,000,000; the Transaction was not contingent on obtaining this financing. At the closing on June 3, 2026, Parent and the Company (as successor to Merger Sub) entered into a new Credit Agreement with OceanFirst Bank providing a $20 million term loan facility and a $15 million revolving credit facility, secured by substantially all assets of the borrowers and guarantors. Approval required (i) the affirmative vote of a majority of FONAR's capital stock outstanding and entitled to vote, (ii) the affirmative vote of a majority of votes cast by disinterested stockholders, and, out of caution, (iii) satisfaction of the 66 2/3% supermajority threshold under Section 203 of the Delaware General Corporation Law, even though the Company maintained the transaction was not subject to that statute. At a special meeting held May 28, 2026 (record date April 13, 2026, with 15,737,293 total votes and 9,114,425 votes held by non-affiliated holders outstanding and entitled to vote), the Merger Proposal was approved: the Company Stockholder Approval passed 13,124,769 for to 551,079 against; the Disinterested Stockholder Approval passed 3,279,090 for to 551,079 against; and the Section 203 vote passed 6,502,501 for to 551,079 against, as disclosed in a Form 8-K filed May 29, 2026. Upon the Merger Agreement's termination under specified circumstances, FONAR would have owed Parent a termination fee of $450,000, which also covers Parent's documented out-of-pocket deal expenses. Following the closing, FONAR's common stock was suspended from Nasdaq trading, the Company filed to deregister its common stock under the Exchange Act, and four non-employee directors (Ronald G. Lehman II, Richard E. Turk, Jessica Maher and Robert M. Carrino) resigned from the board effective at the effective time of the merger. Legal advisors in the transaction were DLA Piper LLP (US), which represented the Company; Meister Seelig & Fein PLLC, which represented the Special Committee; and Moritt Hock & Hamroff LLP, which represented the Acquisition Group/Buyer entities. Marshall & Stevens Transaction Advisory Services LLC served as financial advisor and independent valuation consultant to the Special Committee; no financial advisor to the Acquisition Group/Buyer side was identified in the filings reviewed.

Clearwater Analytics Holdings, Inc. (NYSE: CWAN), a technology sector company providing a cloud-native investment accounting and analytics platform, agreed on December 20, 2025 to be acquired by GT Silver BidCo, Inc., an entity formed by an investor group led by Permira Advisers LLC and Warburg Pincus LLC, with participation from Temasek Holdings (Private) Limited and support from Francisco Partners Management, L.P. The transaction was structured as a merger of GT Silver Merger Sub, Inc., a wholly owned subsidiary of Parent, with and into Clearwater, with Clearwater surviving as a wholly owned subsidiary of Parent. The deal closed on June 25, 2026, and Clearwater's Class A common stock was delisted from the NYSE and deregistered under the Exchange Act. Under the terms of the merger agreement, Clearwater stockholders received $24.55 per share in cash, without interest, for each share of Class A common stock. The press release announcing the deal described the transaction as valued at approximately $8.4 billion. The per-share price represented a premium of approximately 47 percent (47.1 percent per the proxy statement) over Clearwater's undisturbed closing share price of $16.69 on November 10, 2025, the last trading day before media reports of a potential transaction surfaced, and a premium of approximately 15.3 percent over the $21.29 closing price on December 15, 2025, the day before the deal terms were finalized. At closing, the total cash consideration payable to Clearwater's equityholders was approximately $7.4 billion, funded through approximately $5.7 billion of equity commitments from funds affiliated with Permira, Warburg Pincus, Francisco Partners and Temasek, and approximately $2.7 billion of debt financing. The acquisition financing was arranged through a new credit agreement entered into substantially concurrently with closing among Parent (as guarantor), Merger Sub (as initial borrower) and Clearwater (as borrower), with Goldman Sachs Private Credit Corp. as administrative agent. The new facilities consist of a senior secured term loan of $2,700,000,000, a senior secured delayed draw term loan of $500,000,000, and a senior secured revolving credit facility of $325,000,000, guaranteed by Parent and certain domestic subsidiaries and secured by substantially all assets of the borrower and guarantors. Proceeds were used in part to repay in full and terminate all commitments under Clearwater's prior credit agreement, dated April 21, 2025, with JPMorgan Chase Bank, N.A. as administrative agent. Private Credit at Goldman Sachs Alternatives is described in the companies' press releases as having provided 100 percent committed debt financing to the investor group. According to the proxy statement's Background of the Merger section, the transaction originated from informal discussions in August 2025 between Clearwater's CEO Sandeep Sahai and Permira/Warburg Pincus board designees about a potential take-private, following a decline in Clearwater's stock price after its August 2025 earnings release. On October 23, 2025, Warburg Pincus and Permira submitted a non-binding proposal to acquire all shares at $24.50 per share in cash, representing an approximately 29 percent premium to the prior day's closing price. The Board formed a Transaction Committee, and later a Special Committee comprised solely of independent and disinterested directors, which engaged J.P. Morgan as financial advisor to the Company and PJT Partners as financial advisor to the Special Committee, with Kirkland & Ellis LLP as the Company's legal counsel and Cravath, Swaine & Moore LLP as the Special Committee's legal counsel. A rival financial sponsor, referred to in the proxy as Sponsor Party A, submitted a competing non-binding proposal on December 14, 2025 in the range of $20.00 to $22.00 per share, which the Special Committee determined was not competitive. The Permira/Warburg Pincus consortium raised its offer through several rounds, including a December 14, 2025 proposal of $24.25 per share and a December 15, 2025 proposal of $24.35 per share, before the Special Committee countered at $25.75 per share; the parties ultimately agreed to $24.55 per share on December 16, 2025, alongside a five-day exclusivity period and go-shop terms. PJT Partners rendered a fairness opinion to the Special Committee, and J.P. Morgan rendered a fairness opinion to the Board, both dated December 20, 2025, that the merger consideration was fair to Clearwater stockholders from a financial point of view. The merger agreement included a go-shop period running through January 23, 2026 (with a potential extension to February 2, 2026 for certain parties), during which Clearwater could solicit alternative acquisition proposals; the proxy does not disclose that any superior proposal emerged from this process. The agreement provided for a termination fee payable by Clearwater of $111,670,000 if triggered during the go-shop or go-shop extension period, or $241,950,000 if triggered under other specified circumstances, and a reverse termination fee payable by Parent of $521,130,000 if Parent breached its obligations or failed to consummate the merger when required. The outside date for termination (absent extension) was September 20, 2026. CEO Sandeep Sahai stated that the transaction represents a great outcome for Clearwater Analytics and our stockholders and positions us well for our next chapter of growth, citing plans to integrate the platforms to deliver a next-generation front-to-back solution that natively addresses alternative assets following the company's acquisitions of Enfusion, Beacon Platform and Bistro. Permira's Andrew Young said the firm is excited to leverage our deep financial technology expertise and partner with Permira and the CWAN team to drive the next wave of innovation and growth, and at closing Sahai said going private would let Clearwater accelerate investment in its AI roadmap and next-generation platform capabilities and build its Gen AI agentic platform. Clearwater's stockholders approved the merger agreement at a special meeting held May 6, 2026, with approximately 70.6 percent of outstanding shares represented at the meeting; the merger agreement proposal received both the required majority of total voting power (205,143,338 votes for) and the required majority of disinterested stockholder votes (200,228,312 votes for). The merger closed on June 25, 2026. In connection with closing, Clearwater's certificate of incorporation and bylaws were amended and restated, a new board was installed (retaining only CEO Sandeep Sahai among prior directors, joined by Parent-appointed directors Peter Flynn, Thomas Lafrance and Jim Cox), and the company's 2021 Omnibus Incentive Plan, Enfusion 2021 Stock Option and Incentive Plan, and 2021 Employee Stock Purchase Plan were terminated. Outstanding equity awards were canceled in exchange for cash based on the $24.55 merger consideration. The transaction value and consideration mix (100 percent cash) are now fully disclosed; however, the source filings do not disclose a specific EV/EBITDA, EV/revenue, or other valuation multiple for the deal, nor do they disclose any quantified cost synergy target or expected EPS/earnings impact for the (now private) combined platform, since Clearwater is a going-private acquisition by financial sponsors rather than a merger of operating companies with a public pro forma entity.

Hologic, Inc., a Nasdaq-listed (HOLX) healthcare sector company, agreed on October 21, 2025 to be acquired by affiliates of investment funds managed by Blackstone Inc. and TPG Global, LLC in an all-cash-plus-CVR going-private transaction. The transaction was valued at up to $79.00 per share, comprising $76.00 per share in cash plus a non-tradable contingent value right (CVR) of up to $3.00 per share, representing an enterprise value of up to $18.3 billion (based on 228 million diluted shares, $2.2 billion of cash and short-term investments, and $2.5 billion of debt as of September 27, 2025). The aggregate purchase price represented approximately a 46 percent premium to Hologic's closing stock price on May 23, 2025, the last full trading day before media reports of a possible transaction surfaced. The deal also included significant minority equity investments from a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and an affiliate of GIC alongside Blackstone and TPG. Stephen P. MacMillan, Hologic's Chairman, President and CEO, said the transaction marked "an exciting new chapter for Hologic" and that Blackstone and TPG's "resources, expertise and commitment to women's health" would "help accelerate our growth." Ram Jagannath, a Senior Managing Director at Blackstone, called Hologic "an outstanding global leader in advancing women's health" with a "longstanding reputation for groundbreaking and high-quality medical device and diagnostic products." John Schilling, Co-Managing Partner of TPG Capital, said Hologic represented "a compelling opportunity to draw upon our deep thematic expertise to support the development of next-generation solutions." The non-tradable CVR entitled each Hologic stockholder to up to two payments of up to $1.50 each, contingent on Hologic's Breast Health business achieving specified global revenue milestones in fiscal years 2026 and 2027. Per the definitive merger proxy, the CVR revenue targets were set at $1,571,844,377 for the fiscal 2026 milestone period and $1,666,256,283 for the fiscal 2027 milestone period, matching management's internal Breast Health revenue forecasts for those years. The proxy also disclosed that a stop-ship issue involving the company's Brevera biopsy device needles, which arose after the October 20, 2025 signing, made the Board believe the 2026 CVR milestone would be more challenging to achieve. Goldman Sachs & Co. LLC, Hologic's financial advisor, rendered a fairness opinion to the Board and performed an illustrative discounted cash flow analysis using discount rates of 8.5% to 10.5% and perpetuity growth rates of 2.0% to 3.0% (implying terminal year EBITDA exit multiples of 8.5x to 13.2x), which produced a range of illustrative present values of $66.67 to $99.09 per share, bracketing the agreed $76.00 upfront cash price. The merger agreement included a 45-day go-shop period during which Hologic and its advisors could solicit superior proposals; per the proxy, the go-shop period ended with the company not having received any competing acquisition proposal. Parent funded the merger consideration through a combination of debt and equity financing. Blackstone and TPG obtained a debt financing commitment letter from Citi, Bank of America, Barclays, Royal Bank of Canada and SMBC, together with equity commitment letters from Blackstone- and TPG-advised funds. Goldman Sachs & Co. LLC served as exclusive financial advisor to Hologic, and Wachtell, Lipton, Rosen & Katz served as legal counsel to the company. Citi served as exclusive financial advisor to the Blackstone-and-TPG-led consortium, with Kirkland & Ellis LLP as legal counsel and Ropes & Gray as healthcare regulatory counsel to the sponsors. The merger agreement provided for a Company termination fee of $540,000,000 in most circumstances (reduced to $225,000,000 if Hologic terminated to accept a superior proposal from an "excluded party" that emerged during the go-shop period), and a reverse termination fee payable by Parent of $900,000,000 if the deal failed to close due to parent-side breach or failure of debt/equity financing. Hologic's stockholders approved the merger agreement at a special meeting held February 5, 2026, with holders of 178,777,739 shares (representing the vast majority of the 179,046,131 shares voting) in favor, versus 151,271 against and 117,121 abstaining; a separate, non-binding advisory vote on golden-parachute compensation was not approved. As of late January 2026, Hologic also disclosed several disclosure-based stockholder lawsuits and demand letters challenging the adequacy of the proxy statement, which the company stated it believed were without merit. The transaction closed on April 7, 2026. Pursuant to the Agreement and Plan of Merger dated October 21, 2025, Hopper Merger Sub Inc. merged with and into Hologic, with Hologic surviving as a wholly owned subsidiary of Hopper Parent Inc., an entity affiliated with Blackstone and TPG. At closing, each outstanding Hologic share was converted into the right to receive $76.00 in cash plus one CVR. The total cash consideration payable to Hologic equityholders was approximately $17.3 billion. In connection with closing, Hologic repaid and terminated its existing credit agreement, deposited funds to redeem all $400 million of its outstanding 4.625% Senior Notes due 2028 and all $950 million of its outstanding 3.250% Senior Notes due 2029, entered into a CVR agreement with Equiniti Trust Company, LLC as rights agent, delisted its common stock from Nasdaq, and amended and restated its certificate of incorporation. Stephen P. MacMillan resigned as CEO and from the board, and Jos (Joe) E. Almeida was appointed CEO and a director; eight other legacy directors also resigned from the board.

BioCorRx Inc. (ticker BICX), a Nevada-incorporated healthcare company based in Anaheim, California, entered into a stock exchange agreement on March 26, 2026 with three related-party shareholders of its majority-owned subsidiary, BioCorRx Pharmaceuticals, Inc.: Lourdes Felix (BioCorRx's Chief Executive Officer and a director), Louis C. Lucido (BioCorRx's President and a director), and Kent Emry (a director). Under the agreement, the three shareholders transferred to BioCorRx Inc. an aggregate of 1,215 shares of BioCorRx Pharmaceuticals common stock, representing approximately 12.15% of the subsidiary's outstanding common stock, in exchange for an aggregate of 2,263,371 newly issued shares of BioCorRx Inc. common stock, par value $0.001 per share. The exchange, referred to in the filings as "the Exchange," closed on March 27, 2026, the day after signing. The Exchange was undertaken pursuant to a Plan of Reorganization that BioCorRx Inc.'s board adopted on February 25, 2026, under which the company intends to acquire full control of BioCorRx Pharmaceuticals within the meaning of Section 368(c) of the Internal Revenue Code. The Exchange itself was structured to qualify as a tax-free reorganization under Section 368(a)(1)(B) of the Code. The company's common stock issued to the shareholders constituted the sole consideration; no cash or other property was paid or transferred. Because the recipients are officers and directors of BioCorRx Inc., the board approved the Exchange under the company's related-party transaction policy, and the agreement grants the shareholders certain registration rights for the shares received, subject to limitations. No purchase price, enterprise value, or per-share exchange price is disclosed in the filings; the agreement fixed the consideration as a specific share count (2,263,371 shares) rather than a formula tied to a valuation or exchange ratio. BioCorRx Inc.'s first-quarter 2026 Form 10-Q quantifies the accounting impact: the acquisition of the noncontrolling interest was recorded through equity, increasing the noncontrolling interest balance by $158,835 with an offsetting $161,098 adjustment within additional paid-in capital, moving the reported noncontrolling interest deficit from $(303,429) at December 31, 2025 to $(173,259) at March 31, 2026 (a change that also reflects a $28,665 net loss allocation to the noncontrolling interest during the quarter). Because BioCorRx Inc. already controlled and consolidated BioCorRx Pharmaceuticals before the Exchange, the transaction was accounted for as an equity transaction between owners rather than a new business combination; no goodwill or purchase-price allocation is disclosed in connection with it. The 10-Q states that BioCorRx Inc.'s ownership interest in BioCorRx Pharmaceuticals (and its share of the subsidiary's earnings) increased from 75.8% before March 26, 2026 to 88.15% afterward, with the noncontrolling interest's share of earnings correspondingly reduced from 24.2% to 12.85%. BioCorRx Pharmaceuticals is the operating subsidiary that in 2025 acquired certain assets, including the FDA-approved opioid-withdrawal medication Lucemyra, from USWM, LLC (d/b/a US WorldMeds) under a separate asset purchase agreement; that prior acquisition is unrelated to this stock exchange but provides context on the subsidiary being consolidated. No financial advisor or legal advisor is identified in any filing related to this transaction; given its nature as an internal, related-party exchange of minority shares for parent stock under a board-adopted reorganization plan, outside advisors may not have been retained, or their involvement was not disclosed. The Exchange has already closed. BioCorRx Inc.'s Form 8-K filed April 2, 2026 states explicitly that "The Exchange closed on March 27, 2026," and the company's Form 10-Q for the quarter ended March 31, 2026 confirms the share issuance and resulting ownership-percentage shift occurred during that quarter. No pending regulatory approval, shareholder vote, or other closing condition is referenced in any filing; the transaction was a private issuance exempt from registration under Section 4(a)(2) of the Securities Act, based on the restricted, non-public nature of the offer, the direct negotiation between the company and the three accredited-investor shareholders, and the absence of any general solicitation.

South Plains Financial, Inc. (NASDAQ: SPFI), the Lubbock, Texas-based parent company of City Bank, agreed on December 1, 2025 to acquire BOH Holdings, Inc., the Houston, Texas-based parent company of Bank of Houston, in an all-stock transaction. South Plains announced the deal in a current report on Form 8-K that included a joint press release and an investor presentation. The merger closed on April 1, 2026, with BOH merging into South Plains and Bank of Houston merging into City Bank. The transaction was valued at approximately $105.9 million, or $7.27 per BOH common share, based on South Plains' closing stock price of $37.79 on November 28, 2025. Under the merger agreement, each BOH share was exchanged for 0.1925 shares of South Plains common stock, subject to certain adjustments, and South Plains issued approximately 2.8 million shares (based on 14,334,219 BOH shares outstanding). Holders of BOH stock appreciation rights and unexercised warrants received cash consideration instead of stock. On a pro forma basis at signing, former BOH shareholders were expected to own approximately 14.5% of the combined company, with South Plains shareholders owning the remaining 85.5%. The deal was structured to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code; if the stock consideration's value fell below 40% of total merger consideration before closing, the agreement provided for the exchange ratio to be adjusted upward (with a corresponding reduction in any cash consideration) to preserve that threshold. South Plains disclosed several valuation multiples for the deal in its investor presentation: the transaction value represented approximately 143% of BOH's tangible common equity, 6.8 times BOH's estimated 2027 earnings per share, and a franchise premium of 7.4% of BOH's core deposits. As of September 30, 2025, BOH had approximately $772 million in total assets, $633 million in gross loans, and $629 million in deposits; at December 31, 2025 (per the closing press release) BOH had $744 million in total assets, $624 million in total loans, and $603 million in total deposits. The pro forma combined company was expected to have approximately $5.4 billion in total assets, $3.8 billion in gross loans, and $4.6 billion in total deposits, and a pro forma market capitalization of approximately $718 million at the time of signing. South Plains disclosed expected pre-tax cost savings of approximately $4.6 million in 2027, equal to about 25% of BOH's non-interest expense base, with 75% of the savings expected to be realized in 2026 and 100% thereafter. The company also disclosed a loan mark of $9.2 million (comprising a $7.6 million gross credit mark, equal to 1.20% of BOH's loans as of September 30, 2025, and a $1.6 million interest rate mark to be amortized over 5.0 years), a core deposit intangible of 1.50% of non-time deposits to be amortized over 10 years using the sum-of-years-digits method, and pre-tax transaction expenses of $13.8 million. The transaction was expected to be approximately 11% accretive to South Plains' earnings per share in 2027, with an estimated tangible book value per share earnback period of less than 3.0 years. Curtis Griffith, Chairman and CEO of South Plains, said the acquisition was "an important step in achieving our goal given the impressive franchise they have built in the fast-growing Houston market, which will add scale to our existing operations while also bringing long standing customer relationships to City Bank," adding that he believed "this combination will deliver substantial value to both South Plains' and BOH's shareholders which will make this a true win-win transaction." Jim Stein, Chairman, President and CEO of BOH, said "Houston is a dynamic community banking market, and this partnership provides needed resources to help accelerate our combined growth which we believe will drive value for our shareholders that we could not have achieved on our own," citing South Plains' "low cost, community deposits as well as their more expansive product portfolio." Cory Newsom, President of South Plains, said the company performed "a thorough, deep dive into BOH's loan portfolio and underwriting processes and found a credit culture that resembled ours," which he said "provides real confidence in the potential synergy and success of this acquisition." Upon completion, BOH's Chairman, President and CEO Jim Stein joined the boards of directors of both South Plains and City Bank and continued leading the Houston team; City Bank also entered into a new employment agreement with James D. Stein (base salary of not less than $350,000, a target annual bonus of 23.33% of base salary and a maximum of 35%) to help transition and assimilate Bank of Houston post-merger. Retention agreements were also put in place for other key BOH employees. On the target side, Hillworth Bank Partners served as financial advisor to BOH and rendered a fairness opinion to BOH's board of directors. Fenimore Kay Harrison LLP served as BOH's legal advisor. On the acquirer side, Raymond James & Associates, Inc. served as financial advisor to South Plains and rendered a fairness opinion to its board of directors, and Hunton Andrews Kurth LLP served as South Plains' legal advisor. The merger agreement, filed as Exhibit 2.1 to the December 1, 2025 Form 8-K, provided for a termination fee of $4,235,314 payable by BOH to South Plains in specified circumstances, including if BOH's board terminated the agreement to accept a superior proposal, if South Plains terminated after a change in BOH's board recommendation or a breach of BOH's no-shop covenant, or in certain scenarios tied to failure to hold the BOH shareholder vote after the Form S-4 registration statement had been effective for at least 25 business days. The agreement's outside date was November 1, 2026, extendable unilaterally by South Plains for up to an additional 60 days if the only unmet condition was pending regulatory approval. In the signing press release, South Plains stated it would file a Form S-4 registration statement with the SEC that would include a proxy statement for a special meeting of BOH shareholders and would also serve as a prospectus for the SPFI shares to be issued. The companies also noted the transaction required the approval of BOH's shareholders and "customary closing conditions, including the receipt of all required regulatory approvals." On March 23, 2026, South Plains and BOH jointly announced that BOH's shareholders had approved the merger at a shareholder meeting held March 20, 2026, and that the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation, and the Texas Department of Banking had granted the required regulatory approvals and non-objections. With all approvals obtained, the companies said the merger was expected to close on April 1, 2026, subject to satisfaction of remaining customary closing conditions. The merger closed as planned on April 1, 2026, with BOH merging into South Plains and Bank of Houston merging into City Bank, both with South Plains and City Bank as the surviving entities, respectively.

This transaction is a bank holding company merger in which South Plains Financial, Inc. (ticker SPFI), a company in the financial institutions group (FIG) sector, is the acquirer of BOH Holdings, Inc., the target. The deal is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on April 1, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Raymond James & Associates, Inc. served as financial advisor to South Plains, the acquirer, rendering a fairness opinion to its board of directors, and is designated as lead advisor. On the target side, Hillworth Bank Partners served as financial advisor to BOH, likewise rendering a fairness opinion to its board of directors, and is also designated as lead advisor. Legal counsel was also disclosed for both sides. Hunton Andrews Kurth LLP served as South Plains' (the acquirer's) legal advisor. Fenimore Kay Harrison LLP served as BOH's (the target's) legal advisor. Beyond the characterization of the deal as a bank holding company merger, the facts block does not disclose further detail on consideration structure, such as whether the merger consideration is cash, stock, or a combination. Several facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not specify the consideration structure (cash, stock, or mixed) for BOH shareholders, nor does it give an expected closing date.

Mission Produce, Inc., a business-services company trading under the ticker AVO, is the borrower in a leveraged finance credit facility transaction. This is an amendment and restatement of an existing credit agreement, classified within the levfin product group. The transaction has a disclosed value of $550 million in USD and is currently pending regulatory approval. The transaction is documented in an SEC filing published on April 1, 2026, though the specific form type was not identified in the source materials. Mission Produce and certain of its direct and indirect subsidiaries, which serve as guarantors alongside the company itself, are the loan parties to this transaction. The deal remains in pending regulatory status as of the filing date. The lender consortium is arranged and managed by multiple financial institutions fulfilling distinct roles. Bank of America, N.A. serves as the administrative agent and holds the lead position in this capacity. BofA Securities, Inc. and AgWest Farm Credit, PCA are co-leads functioning as joint lead arrangers and bookrunners for the facility. Beyond the lead roles, AgWest Farm Credit, PCA and JPMorgan Chase Bank, N.A. serve as co-syndication agents, while City National Bank and ING Capital, LLC are co-documentation agents. Additional lenders are parties to the agreement on a from-time-to-time basis as the syndicate expands. No legal advisors to either party were identified in the source materials provided. The transaction is structured as an Amended and Restated Credit Agreement between the company and the lender group. The agreement consolidates the borrowing relationship under a single restated facility with a stated commitment size of $550 million. Beyond the facility size and the amendment-and-restatement structure, no additional terms were disclosed regarding the composition of the facility, specific facility types (term loan, revolvers, or other tranches), pricing, financial covenants, or other substantive credit terms. Several material details remain undisclosed or unknown. The specific SEC filing form is not identified. No expected closing or effective date for the amendment and restatement has been disclosed. The internal composition of the $550 million commitment, whether it comprises term loans, revolving credit facilities, or other structures, is not specified. Pricing terms, margin, base rates, fees, and financial or operational covenants are not provided. Maturity dates, amortization schedules if any, and other repayment mechanics are not disclosed. The rationale or business drivers for the amendment and restatement are not stated. Whether this represents an increase, decrease, or refinancing of prior commitments is not indicated.

Home BancShares, Inc., a financial institutions sector company trading under ticker HOMB and parent of Centennial Bank, agreed to acquire Mountain Commerce Bancorp, Inc., ticker MCBI (OTCQX), parent of Mountain Commerce Bank, in an all-stock merger. The deal was announced on December 7, 2025 via a definitive Agreement and Plan of Merger dated December 7, 2025, disclosed in a Form 8-K filed December 8, 2025 that included a joint press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2). The transaction closed on April 1, 2026, with Mountain Commerce merging into Home BancShares and Mountain Commerce Bank merging into Centennial Bank, as confirmed in a closing press release filed as Exhibit 99.1 to an 8-K on April 1, 2026. Under the terms of the merger agreement, each Mountain Commerce shareholder received 0.850 shares of Home BancShares common stock for each MCBI share, plus cash in lieu of fractional shares. Based on a 20-trading-day volume-weighted average closing price of Home BancShares stock of $27.66 through December 5, 2025, the implied per-share consideration was $23.51 and the aggregate implied transaction value was approximately $150.1 million at announcement; Home BancShares' April 1, 2026 closing press release cited a value of approximately $146 million for the roughly 5.4 million shares issued at closing. The deal priced Mountain Commerce at approximately 105% of tangible book value and 8.1 times estimated 2026 earnings per share, according to Home BancShares' investor presentation. Mountain Commerce shareholders were expected to own approximately 3% of the combined company. Home BancShares described the deal as "immediately triple accretive," projecting EPS accretion of approximately 1.4% in 2026 and 3.0% in 2027 (assuming 25% realization of cost savings in 2026, rising to full realization in 2027; full realization in 2026 would imply approximately 2.4% EPS accretion), book value per share accretion of 0.7%, and tangible book value per share accretion of 0.2% at closing, per the December 8, 2025 press release and investor presentation. Pro forma capital ratios at closing were projected at a 15.9% CET1 ratio and an 18.5% total capital ratio, with return on average tangible common equity expected to increase by approximately 35 basis points. Home BancShares disclosed expected cost savings equal to approximately 20% of Mountain Commerce's noninterest expense base, with 25% phased in during 2026 and the full amount realized thereafter, alongside one-time merger and integration costs of approximately $14 million pre-tax. Key purchase accounting assumptions disclosed in the investor presentation included a 2.1% credit mark and a 3.3% interest rate mark on acquired loans (accreted over five years on a straight-line basis), an approximately $16 million pre-tax accumulated other comprehensive income securities markdown (accreted over seven years straight-line), and a core deposit intangible of 3.0% of non-time deposits amortized on a sum-of-the-years-digits basis over 10 years. The transaction assumed no revenue synergies. As of December 31, 2025, Mountain Commerce had approximately $1.77 billion in total assets, $1.49 billion in loans, and $1.54 billion in deposits, operating seven branches in the Knoxville, Johnson City, and Brentwood areas of Tennessee, with an eighth branch scheduled to open by the end of the first quarter of 2026. The investor presentation characterized Mountain Commerce as having a history of strong performance, including 43 basis points of year-over-year net interest margin expansion, average ROATCE of 12.3% and average ROAA of 1.02% for 2021 through 2024, a 55.2% efficiency ratio, and zero net charge-offs to average loans, positioning Home BancShares to enter the high-growth Knoxville, Nashville, and Johnson City metropolitan markets. Following closing, the combined company operated 78 branches in Florida, 75 in Arkansas, 59 in Texas, eight in Tennessee, five in South Alabama, and one in New York City. John Allison, Chairman and CEO of Home, and William E. "Bill" Edwards III, CEO and founder of Mountain Commerce, were both quoted in the announcement expressing enthusiasm about the companies' entry into Tennessee markets; Bill Edwards was named President of Tennessee for the combined company and Kevin Horne, EVP of MCBI, was named Regional President over the former MCBI markets, with employment and voting agreements in place for key personnel. A Form S-4 registration statement (File No. 333-292708) covering the Home BancShares shares to be issued was filed January 13, 2026 and amended January 29, 2026; it included the combined proxy statement of MCBI and prospectus of Home. A supplemental disclosure 8-K filed March 2, 2026 added additional detail to the proxy statement/prospectus in response to shareholder demand letters, including updated comparable company tables, discount rate calculations used by Piper Sandler (10.86% for MCBI common stock and 9.33% for Home common stock, per the Duff & Phelps Cost of Capital Navigator methodology), and background on the sale process: Mountain Commerce had shared information or held discussions with fifteen companies regarding a potential transaction during the first quarter of 2025 under nondisclosure agreements, most of which contained standstill provisions; as of March 1, 2026, only one such standstill provision (set to expire March 6, 2026) remained in effect, and no party had approached MCBI about an alternative transaction since the Merger Agreement was announced. The Federal Reserve Board of Governors and the Arkansas State Bank Department approved the merger and related bank merger on March 24, 2026, per an 8-K filed that day, with closing anticipated early in the second quarter of 2026 at that time; the deal in fact closed April 1, 2026. On the target side, Piper Sandler & Co. served as financial advisor to Mountain Commerce and provided a fairness opinion, with Bass, Berry & Sims PLC serving as legal advisor. On the acquirer side, Hovde Group, LLC served as financial advisor to Home BancShares and provided a fairness opinion, with DD&F Consulting Group serving as financial consultant to Home and Mitchell, Williams, Selig, Gates & Woodyard, PLLC serving as legal advisor to Home. The merger agreement provides for a termination fee of $6.0 million payable by MCBI to Home BancShares under specified circumstances, including termination following a competing acquisition proposal. The agreement was approved unanimously by both companies' boards of directors, and closing was subject to MCBI shareholder approval and customary regulatory approvals, all of which were obtained prior to the April 1, 2026 closing.

Aptose Biosciences Inc., a clinical-stage biotechnology company trading on the Toronto Stock Exchange, agreed to be taken private by Hanmi Pharmaceutical Co., Ltd., a Korean pharmaceutical company, through Hanmi's wholly owned subsidiary HS North America Ltd. The companies entered into a definitive arrangement agreement on November 18, 2025, which was later amended and restated on February 23, 2026, primarily to move the shareholder vote date from January 16, 2026 to March 31, 2026. The transaction closed on June 30, 2026, after the Court of King's Bench of Alberta approved the arrangement on March 31, 2026. Under the terms of the arrangement, each Aptose common share not already owned by Hanmi was converted into the right to receive C$2.41 in cash, representing a 28 percent premium to Aptose's 30-day volume-weighted average price of C$1.88 on the TSX as of the November 2025 announcement. Hanmi already owned 508,710 common shares, or 19.93 percent of Aptose's 2,552,429 shares outstanding, prior to closing, stemming from its position as Aptose's existing lender. The aggregate cash consideration paid for the 2,043,719 minority shares was approximately US$3,466,470 (C$4,925,362.79), excluding transaction fees and expenses, implying a total equity value for all outstanding shares of roughly C$6.15 million. No enterprise value, EV/EBITDA, or P/E multiple was disclosed, consistent with Aptose being a pre-revenue clinical-stage company; the merger proxy states Aptose had more liabilities than assets and a shareholder's deficit, and the Transaction Committee therefore did not consider book value or going-concern value material to the fairness analysis. The consideration was all cash with no financing condition. Locust Walk Securities, LLC, financial advisor to Aptose's Special Committee (referred to as the Transaction Committee), delivered a formal valuation under Canadian multilateral instrument MI 61-101 concluding a fair market value range of C$1.00 to C$5.08 per share, and a fairness opinion concluding the C$2.41 cash consideration was fair, from a financial point of view, to the minority shareholders. The Transaction Committee and Board, after a targeted market check to solicit alternative acquirers or licensees for Aptose's lead drug candidate tuspetinib that produced no superior proposals, unanimously recommended the arrangement, citing the cash premium, certainty of value, and the company's limited alternatives given continuing dependence on Hanmi-provided financing and the risk of insolvency absent the deal. The arrangement agreement included customary non-solicitation covenants with a right for Hanmi to match competing proposals, and an expense fee of C$300,000 payable by Aptose to Hanmi if the agreement were terminated in specified circumstances, including a change in the board's recommendation or acceptance of a superior proposal. There was no reverse break fee payable by Hanmi. Completion required approval by at least two-thirds of votes cast by Aptose shareholders at a special meeting, plus Alberta court approval, both of which were obtained. Concurrently with signing, Hanmi Purchaser entered into voting support agreements with all of Aptose's directors and officers, who agreed to vote their shares in favor of the transaction. Following the closing, Aptose became a wholly owned subsidiary of the Hanmi Purchasers, all of Aptose's directors resigned, the common shares were delisted from the TSX on or about July 3, 2026, and Aptose filed a Form 15-12G to deregister from SEC reporting obligations. McCarthy Tetrault LLP acted as legal counsel to Aptose and its Transaction Committee throughout the negotiation, and Stikeman Elliott LLP acted as legal counsel to Hanmi as Parent. No synergy estimates, pro forma ownership splits, or post-closing integration targets were disclosed in the filings reviewed, consistent with this being a 100 percent cash squeeze-out of a small, financially distressed clinical-stage company by its controlling lender rather than a stock-for-stock strategic combination.

Allegiant Travel Company and Sun Country Airlines Holdings, Inc. entered into an Agreement and Plan of Merger dated January 11, 2026 under which Allegiant will acquire Sun Country in a stock-and-cash transaction structured as a two-step merger. The deal consolidates two U.S. budget airlines: upon closing, former Sun Country equityholders were expected to hold approximately 33% of the combined company and existing Allegiant equityholders approximately 67%, calculated on a fully diluted basis. This extraction is sourced from the joint proxy statement/prospectus on Form DEFM14A filed by Sun Country with the SEC on March 31, 2026, which details the background, terms, and advisory opinions behind the January 2026 merger agreement. As of this filing the transaction was still pending stockholder votes and had not yet closed. Barclays was engaged by Allegiant as its financial advisor under an engagement letter dated October 27, 2025, and rendered a fairness opinion to the Allegiant board on January 11, 2026. Goldman Sachs served as financial advisor to Sun Country and rendered its own fairness opinion to the Sun Country board the same day. Both banks' opinions addressed the fairness, from a financial point of view, of the consideration to be paid or received by their respective client's board. On the legal side, Skadden, Arps, Slate, Meagher & Flom LLP served as Allegiant's outside legal counsel, while Milbank LLP served as Sun Country's outside legal counsel throughout the negotiation and drafting process. Under the terms of the merger agreement, each share of Sun Country common stock was to be converted into the right to receive a fixed exchange ratio of 0.1557 shares of Allegiant common stock plus $4.10 in cash, without interest. The exchange ratio was fixed and would not adjust for stock price movements prior to closing. Based on Allegiant's closing share price on January 9, 2026 (the last trading day before announcement), the implied value of the merger consideration was $18.89 per Sun Country share, representing a 19.8% premium. The proxy discloses that Allegiant paid Barclays customary fees for other engagements in the two years prior, including advising Allegiant on its July 2025 sale of Sunseeker Resort Charlotte Harbor, and notes Sun Country separately agreed to pay Goldman Sachs a transaction fee of approximately $22.6 million. The proxy statement reviewed here does not state the specific fee Allegiant agreed to pay Barclays for this transaction (unlike the disclosed $22.6 million Goldman Sachs fee from Sun Country), nor does it provide a single aggregate dollar value for the overall transaction, since the consideration is a fixed exchange ratio plus per-share cash rather than a stated lump-sum purchase price.

Two Harbors Investment Corp. (NYSE: TWO), a mortgage servicing rights-focused REIT headquartered in St. Louis Park, Minnesota, agreed to be acquired by CrossCountry Intermediate Holdco, LLC ("CCM"), an affiliate of CrossCountry Mortgage, LLC, the nation's largest distributed retail mortgage lender. The definitive merger agreement was announced March 27, 2026 in a Form 8-K with an attached press release and the merger agreement itself (Exhibit 2.1). In connection with signing the CCM agreement, TWO simultaneously terminated a prior merger agreement with UWM Holdings Corporation (NYSE: UWMC) that had been signed December 17, 2025; CCM, on TWO's behalf, paid UWMC's $25.4 million termination fee, and TWO's special meeting to approve the UWMC deal, previously scheduled for April 7, 2026, was canceled. The transaction was a cash merger whose per-share price was increased twice during the pendency of the deal in response to a competing unsolicited proposal from UWMC. At signing on March 27, 2026, CCM agreed to pay $10.80 per share in cash, representing a premium of approximately 13.3% to TWO's $9.53 closing price on March 18, 2026 (the last trading day before the unsolicited CCM proposal became public) and approximately 16.0% to the 10-day volume-weighted average price of $9.31, according to the board's reasons for the merger disclosed in the definitive merger proxy (DEFM14A filed April 20, 2026). After UWMC submitted an unsolicited competing proposal on April 20, 2026, CCM raised its offer to $11.30 per share on April 28, 2026, and then to $12.00 per share on May 8, 2026. TWO disclosed that the final $12.00 per share represented a 21% premium to TWO's unaffected share price and a 19% premium to TWO's fully diluted tangible book value, and noted that UWMC's default stock consideration was worth only $7.88 per TWO share based on UWMC's May 7, 2026 closing price. Based on 105,046,333 shares of TWO common stock outstanding as of the April 15, 2026 record date, the final $12.00-per-share price implies an equity value of approximately $1.26 billion; the source filings do not separately disclose an aggregate enterprise value or an EV/EBITDA-type multiple, consistent with the use of a tangible-book-value framework typical for mortgage REIT transactions. Houlihan Lokey's fairness opinion (dated March 26, 2026, addressing the original $10.80 price) valued TWO using a selected companies analysis of mortgage REITs (Annaly Capital Management, Rithm Capital, PennyMac Mortgage Investment Trust and Cherry Hill Mortgage Investment Corporation, trading at 0.75x to 1.06x price/tangible book value) and a selected transactions analysis of past mortgage REIT M&A (transaction value/tangible book value ranging from 0.74x to 1.16x, median 0.97x), implying reference ranges of $8.15-$10.86 and $10.32-$12.49 per share, respectively, against the then-current $10.80 offer. Holders of TWO's Series A, Series B and Series C Preferred Stock were not acquired for cash consideration up front; instead, the merger agreement required TWO to redeem all outstanding preferred shares within 120 days of closing at $25.00 per share plus accumulated and unpaid dividends. TWO stockholders of record as of August 24, 2026 also received a pro-rated stub-period dividend of $0.20326 per share, paid alongside, and not reducing, the merger consideration. The deal carried no financing condition; CCM's press releases cited a fully committed financing package (described at signing as a $2 billion secured loan facility from a national bank, and later referenced in a CCM statement as a $3.4 billion financing package) and the merger agreement itself contains no reverse termination fee payable by CCM/Parent, while TWO's company termination fee was fixed at $25,400,000.00 (the same amount as the terminated UWMC break fee). Strategic rationale centered on vertical integration of mortgage origination and servicing. CrossCountry Mortgage founder and CEO Ron Leonhardt said the combination of "CCM's #1 retail origination and servicing platform" with "TWO's best-in-class capital markets team and RoundPoint's established servicing infrastructure and operational expertise" would create "a fully integrated mortgage company" spanning "the full mortgage customer lifecycle -- from origination through servicing -- driving higher customer retention, recurring revenue streams, and lower customer acquisition costs." TWO President and CEO Bill Greenberg characterized the CCM offer as delivering "a fixed price all-cash consideration to every TWO stockholder -- automatically and without election -- with committed financing, no financing contingency, and a clear path to close in the shortest timeframe," contrasting it with UWMC's competing stock-based proposal. No specific cost-synergy dollar figure, percentage of cost base, or phase-in timeline was disclosed in the filings reviewed. The source documents do not disclose pro forma EPS accretion/dilution or leverage metrics for the combined company, as CCM is a privately held mortgage lender that does not file separate public financial statements in this record set. The transaction received TWO stockholder approval at a special meeting held July 2, 2026 (after being adjourned twice, from May 19 to May 28 to June 11, and ultimately reconvened July 2), as disclosed in a Form 8-K filed July 6, 2026 reporting voting results under Item 5.07; approximately 75% of TWO's outstanding common stock was represented at the meeting, which constituted a quorum. Regulatory approvals proceeded alongside the stockholder vote; a May 8, 2026 press release stated that HSR filing requirements had been completed and 35 of 53 required state mortgage-licensing approvals had already been obtained at that time. The merger closed on August 25, 2026, as confirmed in a Form 8-K filed August 25, 2026 reporting completion under Item 2.01 and a same-day closing press release. At the effective time, each share of TWO common stock was canceled and converted into the right to receive $12.00 in cash, TWO became a wholly owned subsidiary of CCM, and TWO common stock was delisted from the NYSE (TWO notified the NYSE to suspend trading and file a Form 25). TWO's Series A, B and C Preferred Stock remained outstanding at closing pending the subsequent redemption process described above, with the aggregate consideration for that preferred stock redemption expected to be approximately $622.0 million. TWO also disclosed plans to repurchase its $115.0 million of outstanding 9.375% Senior Notes due 2030 at 104% of principal plus accrued interest, with expected aggregate consideration of approximately $120.0 million, or to discharge the notes' indenture if not all notes are tendered. The source of funds for the common stock merger consideration was described as "a combination of cash on hand and borrowings under existing financing facilities of CCM and its affiliates." As part of the closing, eight TWO directors (E. Spencer Abraham, James J. Bender, Sanjiv Das, William Greenberg, Karen Hammond, Stephen G. Kasnet, James A. Stern and Hope B. Woodhouse) departed the board, while Ron Leonhardt, previously the sole director of Merger Sub, became TWO's director. On financial advisors: Houlihan Lokey Capital, Inc. acted as financial advisor to TWO throughout the process, and the closing press release additionally identifies PJT Partners as having served as strategic advisor to TWO. Citigroup Global Markets Inc. (referred to as "Citi") acted as exclusive financial advisor to CCM. On legal counsel: Jones Day represented TWO and Simpson Thacher & Bartlett LLP represented CCM, consistent across the signing, amendment and closing disclosures.

This transaction involves Olaplex Holdings, Inc., a consumer-retail-sector company, as the target of a cash acquisition by Henkel AG & Co. KGaA, structured as a sponsor exit. The deal falls under the M&A product group, and its disclosed value is $1,400,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published March 26, 2026. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed: J.P. Morgan Securities LLC, which is acting as financial advisor to OLAPLEX (the target) and is designated lead on that side. The source sentence states that J.P. Morgan Securities LLC is acting as financial advisor and Ropes & Gray LLP is serving as legal counsel to OLAPLEX. No financial advisor is named for the acquirer, Henkel, in the facts provided. The only legal advisor disclosed is Ropes & Gray LLP, serving as legal counsel to the target, OLAPLEX, per the same source sentence naming J.P. Morgan as financial advisor. No legal advisor is named for the acquirer side. Beyond describing the transaction as a cash acquisition structured as a sponsor exit, valued at $1,400,000,000, the facts block does not provide further detail on the per-share price or the identity of the exiting sponsor beyond the general "sponsor exit" subtype label. Several facts are not disclosed in this record. No financial or legal advisor is named for the acquirer, Henkel. No expected closing date is given, and the facts block does not identify the specific sponsor whose exit this transaction represents.

Mission Produce, Inc., a publicly traded company trading under the ticker AVO in the business services sector, is acquiring Calavo Growers Inc., also in the business services sector, in an all-stock merger transaction. The deal represents a combination of two established companies within the same industry vertical. The specific disclosed value of the transaction has not been stated in the source documents reviewed, meaning the financial consideration remains undisclosed at this time. This transaction is sourced from an SEC filing published on the SEC EDGAR platform on March 20, 2026. While the exact form type has not been specified, the filing was made with the Securities and Exchange Commission as part of standard regulatory disclosure requirements. The deal is currently in pending regulatory status, indicating that it has not yet received all necessary regulatory approvals or closed, and further regulatory review or clearance may still be required before the transaction can be completed. No financial advisors have been extracted or identified for either side of this transaction in the available source documents. This represents a notable gap in advisor disclosure, as most transactions of this scale typically involve investment banking firms serving in various capacities such as financial advisory, fairness opinion providers, or other advisory roles. The absence of extracted financial advisor information does not necessarily mean advisors are not involved, but rather that they have not been identified or disclosed in the documents reviewed. No legal advisors have been identified in the source materials for either Mission Produce or Calavo Growers in connection with this transaction. The specific deal structure and terms have not been disclosed in the available source documents. While this is characterized as a merger transaction, no information regarding the consideration mix, exchange ratio, cash versus stock components, or any other structural details have been provided. Similarly, no information about timing, expected closing conditions, or transaction milestones has been disclosed. Several material aspects of this transaction remain undisclosed or unknown at this time. The transaction value is not stated anywhere in the source documents. The complete form type of the SEC filing has not been specified. No expected closing date or regulatory approval timeline has been provided. The specific terms and structure of the merger consideration, including whether it involves an exchange ratio, any cash component, or contingent consideration, remain entirely unknown. Additionally, the names and roles of any legal advisors have not been extracted. These gaps represent significant information voids that would typically be filled in subsequent SEC filings, press releases, or proxy statements as the transaction progresses toward completion.

Zynex Inc, a healthcare sector company, is the subject of a Chapter 11 reorganization proceeding. This is a restructuring transaction, specifically a bankruptcy reorganization under Chapter 11 of the U.S. Bankruptcy Code. The transaction involves the formal restructuring of the company's capital structure and operations through the bankruptcy process. No transaction value has been disclosed in the available source documents. The information regarding this deal is sourced from an SEC filing published on the SEC EDGAR platform on March 20, 2026. The specific form type associated with this filing was not identified in the source materials. The deal is currently in pending regulatory status, indicating that the Chapter 11 reorganization is active but has not yet reached completion or emergence from bankruptcy protection. No financial advisors have been identified as advising either the debtor or other parties involved in this Chapter 11 reorganization based on the available source materials. This absence of disclosed financial advisory representation may reflect that either no such advisors were retained, or their engagement has not yet been publicly disclosed through the SEC filings examined. No legal advisors have been identified in the available source materials for this transaction. The deal structure and specific terms of the reorganization have not been disclosed in the source documents reviewed. This includes information about the treatment of claims, any proposed reorganization plan, the capital structure of the reorganized entity, or any other material terms that would typically be outlined in Chapter 11 bankruptcy documentation. Several material details remain unknown or undisclosed at this stage. The transaction value is not stated anywhere in the source materials. The specific reorganization plan terms are not disclosed. No expected emergence or closing date has been provided. The identity of equity or debt holders, the treatment of various classes of claims, and any proposed financing for the reorganization have all not been disclosed in the available filings. Additionally, while the form type was not specified in the source materials, it is unclear whether this comes from an initial Chapter 11 petition, a disclosure statement, a plan of reorganization, or other bankruptcy court filings, which would materially affect the level of detail available regarding the transaction structure.

The AES Corporation, a Fortune 500 energy company trading under ticker AES, has agreed to be acquired by a consortium led by Global Infrastructure Partners (GIP, a part of BlackRock) and the EQT Infrastructure VI fund, together with co-underwriters the California Public Employees' Retirement System (CalPERS) and the Qatar Investment Authority (QIA), in an all-cash take-private transaction. The deal was announced March 2, 2026 and is structured through Horizon Parent, L.P. and its wholly owned merger subsidiary, Horizon Merger Sub, Inc., which will merge into AES, with AES surviving as a private company. AES common stock will no longer trade on the NYSE upon closing. Under the Agreement and Plan of Merger dated March 1, 2026, each share of AES common stock will be converted into the right to receive $15.00 in cash, without interest. The aggregate equity value of the transaction is approximately $10.7 billion, and the enterprise value is approximately $33.4 billion, including the assumption of existing debt (based on proportional net debt of $22,724 million and a share count of 712 million as of December 31, 2025; consolidated net debt was $27,561 million as of that date). The merger consideration represents a 40.3% premium to the 30-day volume weighted average share price prior to July 8, 2025, the last full trading day before the first media report of a potential acquisition. The Consortium is funding 100% of the purchase price with equity (no incremental acquisition leverage on the company), and the transaction is not conditioned on Parent's receipt of financing. According to the DEFM14A background-of-the-merger narrative, the company ran a multi-year, competitive process beginning in 2024 that at various points included GIP, a publicly traded international energy holding company referred to as "Party B," a sovereign wealth fund referred to as "Party A," a publicly traded renewable power and utility owner referred to as "Party C," a pension fund referred to as "Party D," and EQT, among other parties that expressed interest but did not submit bids ("Party E," "Party F," and a large infrastructure investor "Party G"). GIP submitted the only Round 1 non-binding indication of interest on June 12, 2025, at $15.00 per share (a 30.66% premium to the prior close of $11.48). After GIP's co-investor Party D withdrew, GIP partnered with EQT, and the consortium (with CalPERS and QIA eventually joining as co-investors) submitted a written proposal on January 20, 2026 at $14.75 per share, following an earlier verbal offer of $14.25 per share on November 24, 2025. After AES pushed for a higher price, the consortium raised its offer to a final $15.00 per share on February 5, 2026, which was negotiated to signing by March 1, 2026. AES' board cited the 40.3% premium to the unaffected price, certainty of cash value, and the company's structural need for capital beyond 2027 as key reasons for the transaction. Board chairman Jay Morse said the board "ran a robust process that included several parties" and concluded that, absent the deal, AES would likely need "a plan that includes reduction or elimination of the dividend and/or substantial new equity issuances." CEO Andres Gluski said the transaction "maximizes value for existing stockholders and positions the Company for long-term success." GIP chairman and CEO Bayo Ogunlesi and EQT Infrastructure head Masoud Homayoun both emphasized AES' role in meeting growing U.S. power demand; QIA CEO Mohammed Saif Al-Sowaidi and CalPERS managing investment director Sarah Corr described the investment as supporting long-term energy transition and infrastructure portfolio goals, respectively. J.P. Morgan Securities LLC and Wells Fargo Securities LLC each delivered a fairness opinion to the AES board, dated March 1, 2026, that the merger consideration was fair, from a financial point of view, to AES stockholders. J.P. Morgan Securities LLC acted as lead financial advisor to AES and Wells Fargo Securities LLC as additional financial advisor. Goldman Sachs & Co. LLC advised GIP, CalPERS and QIA, and Citi advised EQT. On the legal side, Skadden, Arps, Slate, Meagher & Flom LLP acted as lead transaction counsel to AES, with Davis Polk & Wardwell advising AES on certain debt matters. Kirkland & Ellis LLP acted as counsel to the Consortium and to GIP (confirmed in both the press release and the DEFM14A's description of merger-agreement negotiations), and Simpson Thacher & Bartlett LLP acted as legal advisor to EQT (also named as EQT's notice counsel in the merger agreement). AES Indiana and AES Ohio will continue as locally operated, locally regulated utilities after closing, and the Consortium said the deal is not expected to affect customer rates. The merger agreement provides for termination fees: Parent would owe AES $100 million or approximately $588 million depending on the circumstances of termination, while AES would owe Parent approximately $321 million under specified circumstances. The agreement can be terminated if the merger has not closed by June 1, 2027, subject to two possible three-month extensions if only regulatory conditions remain outstanding. AES stockholders approved the merger at a June 26, 2026 special meeting, with 479,072,642 shares (representing the substantial majority of the 489,710,776 shares voted) voting in favor, 10,131,991 against, and 506,143 abstaining; a nonbinding advisory vote on merger-related executive compensation also passed. The Hart-Scott-Rodino antitrust waiting period expired on June 22, 2026. The transaction remains subject to additional regulatory approvals, including from the Public Utility Commission of Ohio, the New York Public Service Commission, the Federal Energy Regulatory Commission, the Committee on Foreign Investment in the United States, and applicable foreign regulators, and is expected to close in late 2026 or early 2027. No closing has yet been confirmed in any filing reviewed.

Refresco Holding B.V., through its subsidiaries Pegasus BidCo B.V. and 2786694 Alberta Ltd., agreed to acquire SunOpta Inc. (Nasdaq: STKL; TSX: SOY), a North American supply chain solutions provider in beverages, broths and better-for-you snacks, for $6.50 per common share in an all-cash transaction. The Arrangement Agreement was signed February 6, 2026 and was structured as a court-approved plan of arrangement under section 192 of the Canada Business Corporations Act. The transaction closed on May 1, 2026, and SunOpta became a wholly owned subsidiary of Refresco; its shares were delisted from Nasdaq and the Toronto Stock Exchange and the company has since deregistered with the SEC. The $6.50 per share cash consideration implied an enterprise value for SunOpta of approximately $1.1 billion, representing a 44 percent premium to the company's 20-trading-day volume-weighted average price as of February 5, 2026. The SunOpta board and Special Committee calculated this as an acquisition multiple of approximately 12.0 times the midpoint of SunOpta's then-available adjusted EBITDA guidance for fiscal year ended January 3, 2026, and approximately 10.8 times SunOpta's projected adjusted EBITDA for the fiscal year ending January 2, 2027. SunOpta's financial advisor, Lazard, separately calculated a discounted cash flow analysis (9.00%-10.00% discount rate, 2.25%-2.75% perpetuity growth) implying an equity value range of $5.45 to $7.30 per share; a trading comparables analysis (applying 7.5x-9.5x EV/2026E adjusted EBITDA to peers including Post Holdings, Lamb Weston, BellRing Brands, Flowers Foods, Utz Brands, Simply Good Foods, TreeHouse Foods and Westrock Coffee) implying $3.80 to $5.45 per share; a precedent transactions analysis of eleven food-and-beverage deals since March 2021 (EV/LTM EBITDA multiples ranging 8.0x to 13.6x, mean 10.9x) implying $4.35 to $6.60 per share; and a premia-paid analysis implying $5.55 to $6.40 per share. SunOpta's 52-week trading range prior to signing was $3.35 to $7.64 per share. Under the plan of arrangement, each SunOpta common share was transferred to the purchaser for the $6.50 cash consideration, less withholdings. Each outstanding share of Series B-1 Preferred Stock of subsidiary SunOpta Foods, Inc. (held by Oaktree Investors) was exchanged into common shares at a rate of 405.9555467 common shares per preferred share and then converted into the same cash consideration, while special shares were cancelled without payment. Outstanding stock options, RSUs and PSUs were cashed out based on the $6.50 consideration less applicable exercise prices. Refresco financed the acquisition with a senior secured incremental term loan facility of up to $1,250.0 million committed by Morgan Stanley Senior Funding, Inc., KKR Capital Markets LLC and KKR Corporate Lending LLC under a debt commitment letter dated February 6, 2026; the transaction was not subject to a financing condition. At closing, SunOpta repaid in full and terminated its existing credit agreement with Bank of America, N.A. as administrative agent, with Refresco arranging a backstop letter of credit through JPMorgan Chase Bank, N.A. for outstanding letters of credit. No synergy figures were disclosed in the reviewed filings. Refresco CEO Steve Presley said SunOpta "represents an exceptional strategic addition to our portfolio and is consistent with our proven growth strategy to expand our capabilities into adjacent beverage categories," adding that the deal "significantly broadens our position in the fast-growing plant-based beverages category" and "enhances our existing North American presence and capabilities, supporting a more balanced geographic footprint between North America and the rest of the world." SunOpta CEO Brian Kocher said the transaction "validates our vision of transforming SunOpta into a premier solutions partner in the high-growth better-for-you food and beverage space" and would provide "the resources and scale to unlock SunOpta's full potential." The proxy statement's background section describes an extended strategic review beginning in February 2025, during which SunOpta's board directed management to pursue transformational acquisitions and later a potential sale. Refresco (referred to as "Parent" in the filing) submitted three successive non-binding indications of interest beginning at $5.00-$5.25 per share in November 2025, raised to $5.25-$6.00, then to $5.75-$6.50 per share by early December 2025, before the board authorized management to proceed toward signing at the top of that range. Three other parties also engaged in diligence and submitted indications of interest during the process: a private equity sponsor referred to as "Party D" bid $5.60 per share, then $6.00 per share; a private equity sponsor referred to as "Party C" bid $5.50-$6.00 per share; and private equity sponsors referred to as "Party A" and "Party B" explored but ultimately did not submit competing offers (Party A preferred a more complex roll-up structure; Party B wanted SunOpta to acquire one of its portfolio companies first). The board determined Refresco had the greatest willingness and ability to pay, the least closing risk, and the most advanced diligence progress, and that it was unlikely another party could exceed Refresco's offer. The deal includes a $41,450,000 termination fee payable by SunOpta to Refresco in specified circumstances, including a change of board recommendation or acceptance of a superior proposal. Shareholders approved the arrangement resolution at a special meeting held April 16, 2026, with 95,088,870 votes for versus 1,728,826 against (out of 118,372,041 common shares and 2,932,453 special shares outstanding as of the March 10, 2026 record date). SunOpta obtained a final order from the Ontario Superior Court of Justice (Commercial List) on April 22, 2026, and the arrangement closed on May 1, 2026. As contemplated by the agreement, directors Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned from SunOpta's board effective at closing, while Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as directors; Brian Kocher continued as a director. On the advisory side, Lazard served as financial advisor to SunOpta and delivered a fairness opinion to the SunOpta board (aggregate transaction fee of approximately $17 million, of which $1.0 million was payable upon delivery of the fairness opinion). Scotia Capital Inc. (Scotiabank) served as independent financial advisor to SunOpta's Special Committee on a fixed fee basis (C$1.0 million) and delivered a fairness opinion to the Special Committee. Faegre Drinker Biddle & Reath LLP and Davies Ward Phillips & Vineberg LLP served as SunOpta's legal counsel, and Wildeboer Dellelce LLP served as legal counsel to SunOpta's Special Committee. Morgan Stanley & Co. LLC served as exclusive financial advisor to Refresco. Simpson Thacher & Bartlett LLP and Bennett Jones LLP served as legal advisors to Refresco. Sodali & Co served as proxy solicitor for SunOpta in connection with the special meeting.

This deal is a cash acquisition via a plan of arrangement in which SunOpta Inc., a company in the consumer-retail sector, is the target being acquired by Pegasus BidCo B.V., an affiliate of Refresco Holding B.V. and KKR. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: a DEFM14A filed with SEC EDGAR and published on March 18, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Lazard Frères & Co. LLC was retained by the company, SunOpta, as its financial advisor in connection with the arrangement, and is designated as lead advisor. Scotia Capital also served as a financial advisor to the target, referenced in the source material via a proxy statement section titled "Opinion of Scotia Capital," with no lead designation specified. No financial advisor is disclosed for the acquirer side, Pegasus BidCo/Refresco/KKR. Legal counsel was disclosed only for the target: Davies Ward Phillips & Vineberg LLP served as SunOpta's Canadian legal counsel, with the source material further identifying the firm's address in Toronto, Ontario, and naming attorneys Patricia Olasker and Kevin Greenspoon as points of contact. No legal advisor is disclosed for the acquirer side. Beyond the cash consideration implied by the "cash acquisition via plan of arrangement" subtype, the facts block does not specify a per-share purchase price or the aggregate transaction value. Several facts are not disclosed in the source material. The overall deal value is not stated. No financial or legal advisor is named for the acquirer side (Pegasus BidCo, Refresco, or KKR). The facts block also does not give a per-share price or an expected closing date for the plan of arrangement.

Office Properties Income Trust, trading under ticker OPI, announced a Chapter 11 restructuring transaction with a disclosed enterprise value of $310 million. The transaction falls within the restructuring product group, specifically a Chapter 11 bankruptcy case involving creditor negotiations. As a real estate investment trust, OPI's restructuring represents a significant capital structure reconfiguration within the commercial real estate sector. The transaction was disclosed through an SEC filing published on March 13, 2026, though the specific form type associated with this filing has not been identified in the available documentation. The deal is currently in announced status, meaning the restructuring plan has been made public but the transaction has not yet closed. The filing via SEC EDGAR represents the official public notice of the restructuring proceedings and creditor involvement. No financial advisors have been extracted or identified as advising any party in connection with this restructuring transaction. This absence of identified financial advisory representation may indicate that either no external financial advisors were retained for the transaction, or that such advisor information was not disclosed or captured in the available documentation. Given the scale of the transaction at $310 million, the typical involvement of restructuring advisors cannot be confirmed from the available record. No legal advisors have been identified in the materials reviewed for this transaction. As with financial advisors, legal representation information either has not been disclosed in publicly available documents or was not captured in the data extraction process. In Chapter 11 proceedings, legal counsel typically plays a central role in structuring the plan of reorganization and negotiating with creditor constituencies, yet such information is not available here. The restructuring involves creditor negotiations within the Chapter 11 framework at OPI, with an enterprise value of $310 million assigned to the reorganized entity or the transaction consideration involved in the restructuring. Beyond this valuation figure, the specific structure of the reorganization plan, the treatment of different creditor classes, the consideration mix for various stakeholder groups, and the anticipated emergence structure have not been disclosed in the available documentation. Several material details regarding this transaction remain unknown or undisclosed. The specific form type of the SEC filing has not been identified. No expected closing date or emergence date has been provided. The composition of the $310 million valuation, whether it represents equity value, enterprise value, or a different measure, is not specified. The treatment of equity holders, secured creditors, unsecured creditors, and other stakeholder classes under the reorganization plan has not been disclosed. Additionally, no information about any debtor-in-possession financing, exit financing, or other transaction financing has been captured.

Digimarc Corporation, an Oregon-incorporated technology company trading under ticker DMRC, completed a holding company reorganization on May 15, 2026, converting its public corporate structure into a new parent holding company, Digimarc Parent, Inc. (formerly named Deschutes Parent, Inc., and subsequently renamed Digimarc Corporation following the transaction). The reorganization was effected pursuant to an Agreement and Plan of Reorganization, including an Agreement and Plan of Merger, dated March 12, 2026, among Digimarc Corporation, Holdings, and a newly formed merger subsidiary, Deschutes Merger Sub, Inc. Under the structure, Merger Sub merged with and into Digimarc, with Digimarc surviving as a wholly owned subsidiary of Holdings, and Digimarc was then immediately converted into an Oregon limited liability company (Digimarc LLC). The stated purpose of the reorganization, as disclosed in the combined proxy statement/prospectus (DEF 14A, filed March 24, 2026), was to enable Holdings to realize expected substantial cash savings primarily through the institution of a new "Long-Term Equity Incentive" program for key management and executive employees, paid in the form of profits-interest-like "Equity Units" in Digimarc LLC rather than traditional restricted stock, RSUs, or PRSUs. The filing states that "Holdings expects to realize substantial cash savings when compared to Digimarc's current share-based incentive plan because (a) awards under the Long-Term Equity Incentive will not require cash tax withholding...and (b) employer taxes with respect to such key employees will not be due on awards under the Long-Term Equity Incentive." The Digimarc Board stated it believed the structure would also reduce share dilution to Holdings shareholders (because grantees may realize more after-tax value per unit than under a share-based plan, requiring fewer units to be granted), strengthen pay-for-performance alignment, and support recruitment and retention of technical and commercial talent in a competitive labor market. The specific dollar amount of expected cash savings was not quantified in the filing. The transaction was structured as a tax-free reorganization for shareholders: each outstanding share of Digimarc common stock was exchanged on a one-for-one basis for a share of Holdings common stock, and each share of Digimarc preferred stock (10,000 shares of Redeemable Nonvoting Preferred Stock were outstanding) was exchanged one-for-one for Holdings preferred stock. Outstanding stock options, restricted stock, RSUs, and PRSUs were all assumed by Holdings and converted into equivalent awards over Holdings common stock on materially the same terms. The proxy states shareholders would experience no dilution of their ownership position and no change in voting power or shareholder rights as a result of the exchange itself. In the opinion of Perkins Coie LLP, tax counsel to Holdings, "the Reorganization should constitute a 'reorganization' within the meaning of Section 368(a)(1)(F) of the Code for U.S. federal income tax purposes," such that shareholders should recognize no gain or loss on the share exchange. No cash consideration, exchange premium, enterprise value, or valuation multiple was associated with this transaction because it was a corporate restructuring among a company and its own newly formed, wholly owned subsidiaries, not an arm's-length acquisition; the proxy confirms the consolidated assets, liabilities and shareholders' equity of Holdings immediately following the reorganization were identical to those of Digimarc immediately prior, and no financial advisor or fairness opinion was engaged or disclosed in connection with the transaction. The reorganization was approved by Digimarc shareholders at the company's 2026 Annual Meeting held April 30, 2026, where the reorganization proposal received 15,133,305 votes in favor, 188,478 against, 105,252 abstentions and 3,806,476 broker non-votes, out of 19,233,511 shares represented (87% of shares outstanding). The agreement contained no breakup or termination fee; it permitted either the Digimarc board to abandon the reorganization at any time before filing articles of merger with the Oregon Secretary of State, or to defer consummation, if the board determined doing so would be advisable and in shareholders' best interests. Closing was also conditioned on Nasdaq treating the listing of Holdings common stock as a substitution listing event (or otherwise approving it for listing). The reorganization closed on May 15, 2026, as confirmed in a Form 8-K filed May 18, 2026 reporting completion under Items 2.01, 3.03, 5.01, 5.02 and 8.01. Holdings common stock continued trading on Nasdaq under the ticker "DMRC" without interruption, with the entity name on Nasdaq changing to "Digimarc Parent, Inc." effective May 19, 2026 (later renamed "Digimarc Corporation") and a new CUSIP (25382K100). Holdings became the successor issuer under SEC Rule 12g-3(a), assuming reporting obligations under CIK No. 0002119322, while the original operating company (now Digimarc LLC, under former CIK 0001438231) filed a Form 15-12G to deregister its common stock. The directors and executive officers of Digimarc immediately prior to the reorganization, including CEO Riley McCormack and CFO Charles Beck, continued in the same roles at Holdings.

NGL Energy Partners LP, a publicly traded master limited partnership trading under ticker NGL-PB in the energy-power sector, is obtaining a $950 million term loan facility. This is a leveraged finance transaction in the form of a senior secured term loan, classified as a levfin product within the debt capital markets space. The facility size of $950 million represents a meaningful refinancing or growth capital raise for the partnership. The transaction was announced on March 12, 2026, based on information extracted from an SEC filing published on the SEC EDGAR database. The specific form type is not yet identified in available materials. The deal is currently in announced status, meaning terms have been disclosed to the market but closing has not yet occurred. No financial advisors have been identified or extracted for this transaction at this stage. This absence of named advisors in the available materials is notable and may reflect either incomplete disclosure in the source documents reviewed, the early stage of advisor engagement, or the possibility that advisory roles have not yet been formally assigned or announced as of the filing date. No legal advisors have been identified for this transaction in the materials reviewed. The term loan facility totals $950 million. Beyond the facility size, no further structural details have been disclosed regarding the loan's terms, including but not limited to pricing, spread over an applicable benchmark rate, maturity date, amortization schedule, covenants, or any other facility-specific mechanics typical to leveraged credit agreements. The current briefing materials do not disclose the expected closing date, the lenders or arranger(s) participating in the facility, any conditions precedent to closing, the specific use of proceeds beyond the general classification as a term loan, or the detailed commercial terms governing the credit agreement. The form type of the SEC filing itself remains unidentified. These gaps should be clarified through additional filings, SEC EDGAR searches, or direct inquiry to the issuer before client discussions or interviews where deal specificity is required.

This transaction is a partial cash tender offer involving Lands' End, Inc. (ticker LE), a consumer-retail sector company, as the target, with WH Topco L.P., doing business as WHP Global, as the counterparty. The deal is classified under the M&A product group and carries a disclosed value of $100,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form SC 14D9 filed and published on March 11, 2026. Only one financial advisor is named in the facts block: PWP served as financial advisor to the target, Lands' End, in a lead capacity. According to the source sentence, representatives of Wachtell Lipton discussed the material terms of an engagement letter which provided that PWP would act as a financial advisor to the company, indicating the advisory relationship was formalized through an engagement letter process. On the legal side, Wachtell Lipton is identified as legal advisor to the target, Lands' End. The source sentence notes that on March 6, 2025, the board held a meeting attended by members of the company's senior management and representatives of Wachtell Lipton, indicating the firm's ongoing involvement in board-level deliberations. The facts block characterizes this transaction specifically as a partial cash tender offer, meaning not all outstanding shares are being sought, but it does not specify what percentage or number of shares the tender offer targets, the offer price per share, or the conditions to the offer's completion. Several material facts are not disclosed in the available record. No financial or legal advisor is named for the acquirer, WH Topco L.P. doing business as WHP Global. No expected closing date is given. The specific percentage of shares sought in the partial tender offer is not disclosed, nor is detail on the offer price per share beyond the aggregate disclosed value of $100,000,000.

HSBC Holdings plc, the London-based multinational banking and financial services group trading under the ticker HSBC, priced an $8 billion four-tranche offering of senior unsecured notes under its existing shelf registration statement (Registration No. 333-277306). The prospectus supplement is dated March 5, 2026, the notes were issued on March 10, 2026, and the final (non-preliminary) prospectus supplement was filed with the SEC on March 9, 2026 under Rule 424(b)(5). The offering consists of four series. The first is $2,000,000,000 of 4.398% Fixed Rate/Floating Rate Senior Unsecured Notes due March 10, 2030, paying a fixed 4.398% coupon semi-annually until March 10, 2029 and then a floating rate equal to compounded daily SOFR plus 0.990% quarterly through maturity. The second is $2,000,000,000 of 4.675% Fixed Rate/Floating Rate Senior Unsecured Notes due March 10, 2032, fixed at 4.675% semi-annually until March 10, 2031, then floating at SOFR plus 1.210% quarterly. The third is $2,750,000,000 of 5.279% Fixed Rate/Floating Rate Senior Unsecured Notes due March 10, 2037, fixed at 5.279% semi-annually until March 10, 2036, then floating at SOFR plus 1.550% quarterly. The fourth is $1,250,000,000 of Floating Rate Senior Unsecured Notes due March 10, 2032, paying compounded daily SOFR plus 1.210% quarterly from issuance. All four tranches were sold at a public offering price of 100.000% of principal (par), with underwriting discounts of 0.250% on the 2030 notes, 0.300% on the 2032 fixed/floating notes, 0.400% on the 2037 notes, and 0.300% on the 2032 floating notes, yielding proceeds to HSBC before expenses of approximately $1.995 billion, $1.994 billion, $2.739 billion and $1.24625 billion, respectively, for combined proceeds before expenses of roughly $7.97 billion. HSBC disclosed that it expects to use the net proceeds from the sale of the notes for general corporate purposes. No more specific use of proceeds, such as refinancing a named facility, redeeming a particular prior instrument, or funding a specific business line, was disclosed in the prospectus supplement. The fixed/floating rate notes (2030, 2032 and 2037 tranches) are redeemable at HSBC's sole discretion during a defined make-whole redemption period at the greater of par or a make-whole price plus accrued interest, and thereafter at par on a specified par redemption date, plus accrued and unpaid interest. The notes may also be redeemed upon certain tax or regulatory events. The notes were issued under HSBC's base indenture dated August 26, 2009, as amended and supplemented by a thirty-eighth supplemental indenture entered into on March 10, 2026. No financial maintenance covenants specific to this offering were disclosed; as senior unsecured notes issued off an investment-grade shelf, the prospectus supplement does not describe high-yield-style covenants. The document does not disclose any specific credit ratings assigned to the notes by Moody's, S&P, Fitch or any other agency. HSBC Securities (USA) Inc. (HSI), an HSBC affiliate, acted as sole book-running manager for all four tranches and also served as stabilization manager. Because HSI is an HSBC affiliate, the offering was conducted in compliance with FINRA Rule 5121, which governs conflicts of interest in affiliate-distributed securities offerings. A large syndicate of senior co-managers and co-managers also participated in each tranche, including BNP Paribas Securities Corp., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, UBS Securities LLC, Wells Fargo Securities, LLC, and more than a dozen additional banks and broker-dealers named in the underwriting tables, each committing to purchase a specified principal amount of notes. Cleary Gottlieb Steen & Hamilton LLP, acting as HSBC's U.S. counsel and English solicitors, passed on certain legal matters for HSBC in connection with the notes. Allen Overy Shearman Sterling LLP represented the underwriters. PricewaterhouseCoopers LLP is named as HSBC's independent registered public accounting firm whose audit report on HSBC's financial statements and internal controls, incorporated by reference from the 2025 Form 20-F, is referenced in the prospectus. The prospectus supplement also discloses HSBC Holdings' consolidated capitalization and indebtedness as of December 31, 2025: total shareholders' equity of $198,225 million, total equity of $205,666 million, and total indebtedness of $253,798 million (comprising $99,675 million of debt securities in issue, $40 million of trading-liability debt securities in issue, $116,502 million of debt securities in issue designated at fair value, and $37,581 million of subordinated liabilities), for total capitalization and indebtedness of $459,464 million as of that date. Separately, the filing notes that on February 11, 2026, HSBC Holdings issued a notice of redemption for its outstanding $1,000,000,000 4.000% Perpetual Subordinated Contingent Convertible Securities, expected to be redeemed on March 9, 2026, one day before this notes offering's March 10, 2026 settlement date; the prospectus supplement does not explicitly characterize this notes offering as a refinancing of that redemption. The notes carry a March 10, 2026 issue date per the final prospectus supplement, but no independent closing confirmation document (such as a closing 6-K) was identified in this review, so the deal's status is left as announced pending such confirmation.

This transaction is a convertible senior notes offering conducted under Rule 144A by Dave Inc./DE (ticker DAVE), a company in the fig (financial institutions group) sector. The offering falls under the debt capital markets (DCM) product group and carries a disclosed value of $175,000,000. The deal is currently in pending regulatory status. This summary is sourced from an SEC EDGAR Form 8-K filed and published on March 6, 2026. According to the source sentence, on March 4, 2026, Dave Inc. entered into a purchase agreement by and among the company and J.P. Morgan Securities LLC, UBS Securities LLC, and Evercore Group L.L.C., as representatives of the several initial purchasers named in the agreement. Three financial advisors are identified, all serving as initial purchasers for the issuer, Dave Inc. J.P. Morgan Securities LLC, UBS Securities LLC, and Evercore Group L.L.C. are each named as initial purchasers and representatives of the broader syndicate of initial purchasers party to the purchase agreement. The facts block does not designate any of the three as the sole lead; all three are named jointly as representatives. No legal advisors are identified in the facts block for this transaction. As a Rule 144A convertible senior notes offering, this transaction involves notes that will convert into equity under specified terms, but the facts block does not disclose the notes' coupon rate, tenor or maturity date, conversion price, or conversion ratio. Several material facts are not disclosed in the available record. No notes tenor, coupon, or conversion terms are specified. No legal advisors are named for the issuer or the initial purchasers. No expected closing date for the offering is given beyond the purchase agreement date of March 4, 2026.

This transaction is a secondary offering of common stock by Medline Inc., trading under the ticker MDLN, classified under the equity capital markets product group. The deal is classified within the healthcare sector, and the disclosed value of the offering is 3,075,000,000 dollars. The transaction is sourced from two SEC EDGAR filings: one of unknown form type published on March 6, 2026, and a Form 424B4 prospectus also published on March 6, 2026. Based on the facts provided, the deal's status is pending regulatory approval. The underwriting syndicate for this secondary offering is structured around a group of global coordinators and joint bookrunning managers, each identified as holding lead status. Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are all named as global coordinators and joint bookrunning managers for the issuer, Medline. The source material lists these four firms together repeatedly under the heading "Global Coordinators and Joint Bookrunning Managers," confirming a shared lead role across the syndicate on this offering. No legal advisor is identified for the issuer or for the underwriting syndicate in the facts provided for this transaction. Beyond confirming that this is a secondary offering of common stock with a disclosed value of 3,075,000,000 dollars, no further detail on the number of shares offered, the offering price per share, or the identity of the selling stockholders is included in the facts available. A number of elements of this deal remain undisclosed. No legal advisor to the issuer or underwriters is identified, and no detail is provided on the per-share offering price, the number of shares sold, or the identity of the selling stockholders in this secondary offering. The facts also do not specify an expected closing or settlement date.

Leerink Partners is serving as the exclusive financial advisor to an unnamed company (the target/seller) in a divestiture transaction valued at $112 million USD. This is a mergers and acquisitions transaction, specifically a divestiture product, meaning the target company is divesting or selling a business unit or asset rather than acquiring one. The sector and identity of both the divesting company and the acquirer have not been disclosed in the available source material. The information regarding this transaction has been sourced from an SEC EDGAR filing published on March 5, 2026. The specific form type has not been identified in the available documentation. The transaction is currently in pending regulatory status, indicating that it has been announced or filed but has not yet closed and remains subject to regulatory review or approval. Leerink Partners has been retained as the exclusive financial advisor to the target company (the seller) in this divestiture. The firm is acting in a lead advisory capacity on behalf of the divesting entity. No other financial advisors have been identified as advising either the target or the acquirer in this transaction. No legal advisors have been identified in the available source material for either party to this transaction. The specific structure and terms of the divestiture have not been disclosed. There is no information available regarding the form of consideration to be paid (whether cash, stock, or a mix thereof), the timing of any earnouts or contingent payments, any representations and warranties insurance, transaction expenses, or other deal mechanics. The following material details remain undisclosed or unknown: the identity of the target company and the acquirer, the specific business unit or asset being divested, the industry sector involved, the expected closing date or timeline, the detailed structure of the $112 million consideration (whether all cash or otherwise), any conditions to closing, and the specific SEC form under which this information was filed. Without access to the underlying filing itself, additional transaction specifics cannot be confirmed from the source material provided.

Six Flags Entertainment Corporation announced on March 5, 2026 that it had entered into definitive agreements to sell seven of its amusement and water parks, Valleyfair, Worlds of Fun, Michigan's Adventure, Schlitterbahn Waterpark Galveston, Six Flags St. Louis, Six Flags Great Escape and Six Flags La Ronde, to EPR Properties (NYSE: EPR) for total cash consideration of $331 million, subject to customary purchase price adjustments. The release describes the sale as part of Six Flags' "disciplined portfolio optimization strategy," with the divested parks having generated approximately $260 million in net revenue and approximately $45 million in Adjusted EBITDA for the parks collectively in 2025. This record is sourced from an Exhibit 99.1 press release furnished with Six Flags' Form 8-K filed March 5, 2026. At announcement, the transaction was a signed set of definitive agreements pending closing conditions and third-party approvals, with closing expected by the end of the first quarter or beginning of the second quarter. Perella Weinberg Partners served as sole financial advisor to Six Flags on the divestiture, per the release's statement "Perella Weinberg Partners acted as financial advisor to Six Flags, and Weil, Gotshal & Manges LLP acted as legal counsel." No financial advisor to EPR Properties is named in this release, and no lead designation applies since Perella Weinberg was the only financial advisor disclosed. On the legal side, Weil, Gotshal & Manges LLP represented Six Flags; no legal advisor for EPR Properties is disclosed in this release. Under the terms, EPR plans to partner with Enchanted Parks to run the six domestic properties, and with La Ronde Operations, Inc. (owned by Kieran Burke) to operate Six Flags La Ronde; EPR will retain rights to use the Six Flags brand through the end of 2026. Cash proceeds, after taxes and transaction expenses, will be used to pay down debt, and Six Flags said it plans to operate its remaining 34 parks across 23 locations for the 2026 season. Not disclosed in the sourced document is any valuation multiple implied by the $331 million price relative to the parks' $45 million combined Adjusted EBITDA, EPR Properties' financial advisor (if any), or a specific calendar closing date beyond "end of the first quarter or beginning of the second quarter."

Mid Penn Bancorp, Inc. (Nasdaq: MPB), headquartered in Harrisburg, Pennsylvania, agreed to acquire 1st Colonial Bancorp, Inc. (OTCPK: FCOB), the Mount Laurel, New Jersey-based parent of 1st Colonial Community Bank, in a cash-and-stock merger. The deal was announced on September 24, 2025 via a joint press release and investor presentation filed as exhibits to a Form 8-K, with the definitive Agreement and Plan of Merger filed as Exhibit 2.1 to a companion Form 8-K the same week. The transaction closed after the close of business on February 27, 2026, with completion confirmed in a Form 8-K (Item 2.01) filed March 2, 2026; 1st Colonial Community Bank was merged into Mid Penn Bank at that time. Under the merger agreement, each share of 1st Colonial common stock was convertible, at the holder's election and subject to proration, into either 0.6945 of a share of Mid Penn common stock or $18.50 in cash, with the consideration mix fixed at 60% stock and 40% cash in the aggregate. At announcement this implied a value of $20.03 per 1st Colonial share and an aggregate transaction value of approximately $101 million, equal to 1.16 times 1st Colonial's tangible book value and 11.6 times its last-twelve-months earnings per share, based on Mid Penn's September 23, 2025 closing stock price. Because the stock portion of consideration floats with Mid Penn's share price, the value disclosed at closing had risen to approximately $106.1 million. All outstanding 1st Colonial stock options were cashed out at closing, and outstanding restricted stock units vested and settled in 1st Colonial shares shortly before closing. Upon completion, former 1st Colonial shareholders owned approximately 8% of Mid Penn's outstanding common stock, with Mid Penn shareholders owning the remaining approximately 92%. Mid Penn disclosed fully phased-in cost savings equal to 40% of 1st Colonial's noninterest expense base, with 80% of those savings phased in during 2026. The company also disclosed one-time merger and integration charges of approximately $12 million pretax (approximately $9.6 million after-tax), fully reflected in pro forma tangible book value at close. Mid Penn estimated the transaction would be accretive to earnings per share by approximately 10% in 2026 and approximately 14% in 2027 (full-year estimate), with tangible book value per share dilution of approximately 6% at closing and an earnback period of approximately 3.4 years on a crossover-method basis. Mid Penn projected an internal rate of return of approximately 24%, assuming a 10.0 times terminal price/earnings multiple and an 8.5% minimum tangible common equity to tangible assets ratio, and pro forma regulatory ratios of approximately 11.7% CET1, 9.4% TCE ratio and 13.0% total capital ratio. Mid Penn Chair, President and CEO Rory G. Ritrievi said the deal was "a strategic move to further expand our footprint into the greater Philadelphia metropolitan area, particularly southern New Jersey," adding that "the combined bank will continue the positive impact Mid Penn has made in the greater Philadelphia metropolitan area market, creating a more powerful, resilient, and dynamic financial institution." 1st Colonial President and CEO Robert B. White said the transaction would allow for "an expansion of our product and service offering, as well as bring greater financial capacity for continued investment in our company and our communities." As of June 30, 2025, 1st Colonial, founded in 2000, operated three full-service branches and one loan production office, with approximately $877 million in total assets, $743 million in total deposits and approximately $640 million in total loans. The combined company had pro forma total assets of more than $7.2 billion at announcement, and press materials at closing cited consolidated assets of approximately $7 billion. The registration statement on Form S-4 (declared effective ahead of a 1st Colonial special shareholder meeting) discloses that 1st Colonial ran a competitive sale process beginning in early 2025, soliciting and receiving non-binding indications from Mid Penn and two other unnamed parties referred to as "Financial Institution A" and "Financial Institution B." 1st Colonial initially signed an exclusive term sheet with Financial Institution A in June 2025, but its board terminated that process in mid-July 2025 after reverse due diligence revealed credit-quality and credit-philosophy concerns, and it rejected a revised offer from Financial Institution A on July 21, 2025 before re-engaging Mid Penn on July 25, 2025. The merger agreement was signed September 24, 2025 following unanimous approval by both companies' boards. As part of the transaction, 1st Colonial CEO Robert B. White became Senior Executive Vice President, Greater Philadelphia Metro Area Market President and Senior Risk Advisor of Mid Penn Bank, and one former 1st Colonial director, Thomas R. Brugger, was appointed to the Mid Penn and Mid Penn Bank boards. Keefe, Bruyette & Woods, A Stifel Company, served as exclusive financial advisor to Mid Penn, and Holland & Knight LLP served as Mid Penn's legal advisor. Stephens Inc. served as exclusive financial advisor to 1st Colonial and rendered a fairness opinion to 1st Colonial's board, and Stradley Ronon Stevens & Young, LLP served as 1st Colonial's legal advisor. The merger agreement provided for a termination fee of $4,040,000 payable by 1st Colonial under specified circumstances, and an outside termination date of September 30, 2026. Closing conditions included 1st Colonial shareholder approval, Nasdaq listing approval for the new Mid Penn shares, and regulatory approvals from the Federal Reserve, FDIC, Pennsylvania Department of Banking and Securities, and New Jersey Department of Banking and Insurance; the companies' initial regulatory applications were filed November 24, 2025. The transaction was intended to qualify as a tax-free reorganization for shareholders receiving Mid Penn stock. All of these conditions were satisfied and the transaction closed on February 27, 2026, well ahead of the September 30, 2026 outside date.

The AES Corporation, a publicly traded independent power producer and regulated utility holding company trading under ticker AES, has agreed to be acquired by a consortium led by Global Infrastructure Partners (GIP, a part of BlackRock) and EQT Infrastructure VI, together with co-underwriters CalPERS and the Qatar Investment Authority, in an all-cash transaction valued at an equity value of approximately $10.7 billion and an enterprise value of approximately $33.4 billion (including assumption of existing debt). The deal was announced on March 2, 2026, through a definitive Agreement and Plan of Merger dated March 1, 2026, among AES, Horizon Parent, L.P. and Horizon Merger Sub, Inc., disclosed in a Form 8-K that included the merger agreement (Exhibit 2.1), a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2). Under the merger agreement, each share of AES common stock will be converted into the right to receive $15.00 in cash, without interest. This represents a 40.3 percent premium to AES's 30-day volume-weighted average share price prior to July 8, 2025, the last full trading day before the first media reports of a potential acquisition. The deal is structured as a one-step merger, not a tender offer, and AES common stock will be delisted from the New York Stock Exchange and the company will become privately held upon closing. The consortium is funding 100 percent of the purchase price with equity; GIP V, Tower Bridge and EQT VI (the "Issuing Sponsors") each executed equity commitment agreements totaling a maximum aggregate amount of approximately $10.69 billion. Separately, Goldman Sachs Bank USA and Citigroup Global Markets Inc. provided a debt commitment letter for backstop facilities (a 364-day term loan of up to approximately $4.72 billion, a 364-day revolving credit facility of up to $2.15 billion, and a letter-of-credit facility of up to $475 million) intended to address change-of-control provisions in AES's existing debt agreements rather than to fund the purchase price itself; the merger is not subject to any financing condition. AES Board Chairman Jay Morse said the board "ran a robust process that included several parties and evaluated the transaction with the Company's standalone prospects in mind," noting AES has "a significant need for capital to support growth beyond 2027" and that absent the deal, the company would likely need to cut or eliminate its dividend and/or issue substantial new equity. According to the proxy statement, the board considered that AES needed to raise approximately $2 billion of equity capital from 2026 to 2030 to fund growth, a need that was not reflected in the pre-announcement stock price because the company had not issued guidance beyond 2027. AES CEO Andres Gluski said the deal "maximizes value for existing stockholders and positions the Company for long-term success," while GIP chairman and CEO Bayo Ogunlesi and EQT Infrastructure head Masoud Homayoun both framed the acquisition around the need for new investment in power generation, transmission and grid modernization amid rising electricity demand. AES Indiana and AES Ohio, the company's regulated utilities, are expected to continue to be locally operated and regulated, and the transaction is not expected to affect customer rates. The definitive merger proxy (DEFM14A), filed May 15, 2026, discloses that the transaction followed an extended process beginning with informal discussions between AES management and GIP, a company referred to as "Party B," and later a sovereign wealth fund referred to as "Party A" and a publicly traded renewable/utility owner referred to as "Party C," starting in 2024. Formal negotiations with the GIP/EQT consortium intensified in late 2025 and early 2026. On January 20, 2026, the consortium submitted a written proposal to acquire AES for $14.75 per share; AES's board and its advisors, J.P. Morgan Securities LLC and Skadden, Arps, Slate, Meagher & Flom LLP, pushed for a higher price. After news of the talks was reported by Bloomberg on February 2, 2026 (after which AES shares jumped 9.23 percent the next trading day), the consortium raised its offer to $15.00 per share on February 5, 2026, which was the price ultimately agreed in the signed merger agreement on March 1, 2026. J.P. Morgan's sum-of-the-parts discounted cash flow analysis of AES's business segments produced an implied per-share equity value range of $10.50 to $20.25, which the board compared to the $15.00 merger consideration; both J.P. Morgan and Wells Fargo Securities LLC delivered fairness opinions to the AES board. The proxy does not disclose a single blended EV/EBITDA or P/E multiple for the whole transaction. The merger agreement sets a Company Termination Fee of $320,651,487 payable by AES under specified circumstances, and Parent Termination Fees of $587,861,060 (general) or $100,000,000 (if termination relates to a failure to obtain required regulatory approvals), which are backstopped by limited guaranties from GIP V and CalPERS and a termination equity commitment letter from EQT. Required regulatory approvals include clearance under the Hart-Scott-Rodino Antitrust Improvements Act (DOJ/FTC), approval from the Federal Energy Regulatory Commission under Section 203 of the Federal Power Act, the Federal Communications Commission, the Committee on Foreign Investment in the United States (CFIUS), state public utility commissions in Ohio, New York, California and North Carolina, filings with PJM, and non-U.S. competition and foreign-direct-investment approvals in jurisdictions where AES or the sponsors operate. AES stockholders approved the merger at a special meeting held June 26, 2026, with roughly 97.9 percent of shares voted (479,072,642 of 489,710,776 shares present) cast in favor of the merger proposal, satisfying the shareholder-vote closing condition. As of the information reviewed, the transaction still requires the remaining regulatory approvals listed above; no filing was identified confirming that all required approvals have been obtained or that the merger has closed. The press release stated the transaction was expected to close in late 2026 or early 2027, subject to the satisfaction of these conditions; no SEC filing was found confirming closing has occurred or that the deal has been terminated.

KORE Group Holdings, Inc., a telecom sector company, is the target in a merger and acquisition transaction valued at $726 million USD. The acquirers are Searchlight Capital Partners and Abry Partners, acting in concert. This is an M&A transaction in the telecom sector. The transaction details are sourced from an SEC filing published on February 27, 2026, through SEC EDGAR, though the specific form type is not identified in the available information. The deal is currently pending regulatory approval, indicating that while the transaction has been announced and advisors engaged, it has not yet closed and requires regulatory clearance before completion. On the target side, Rothschild & Co is acting as financial advisor to the Special Committee of KORE Group's board, holding a lead advisory role. The acquirer side is advised on financial matters by TD Cowen, which is acting as financial advisor to both Searchlight and Abry in their joint pursuit of the transaction, also in a lead capacity. On the legal advisory front, KORE Group is represented by two separate counsel. Richards, Layton & Finger, P.A. is serving as legal advisor to the Special Committee, while Troutman Pepper Locke LLP is serving as legal advisor to KORE itself. The acquirer side retains two legal advisors as well. Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Searchlight, and Kirkland & Ellis LLP is acting as legal advisor to Abry. Beyond the headline transaction value of $726 million and the identities of the parties and advisors, the specific structure of the transaction, including the consideration mix, any debt or equity components, any earnouts or contingent consideration, the anticipated financing sources, and the expected closing timeline, have not been disclosed in the available filing materials. The regulatory status indicates the transaction is under review, but no timeline for regulatory approval or expected closing has been provided.

KORE Group Holdings, Inc. (NYSE: KORE), a pure-play Internet of Things (IoT) connectivity and analytics company, announced a definitive agreement under which existing investors Searchlight Capital Partners, L.P. and Abry Partners will acquire all shares of KORE common stock they do not already own in an all-cash transaction valued at approximately $726 million. Shareholders will receive $9.25 per share, representing a roughly 691% premium to KORE's closing price before Searchlight's prior Schedule 13D amendment signaling interest in a full acquisition. The company is classified under SIC 4899 (communications services, not elsewhere classified). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by KORE Group Holdings with the SEC on February 27, 2026, announcing the signing of the merger agreement. At announcement, Abry already beneficially owned approximately 28% of KORE's common stock, and Searchlight held all of KORE's Series A-1 preferred stock (with a liquidation preference of approximately $275 million) plus warrants for roughly 14% of common stock on a fully diluted basis, making this a going-private transaction by existing, affiliated investors. The deal had been unanimously approved by the KORE board based on the recommendation of a Special Committee of independent directors, and KORE expected to close in the second or third quarter of 2026, subject to stockholder and regulatory approvals including HSR and CFIUS clearance. On financial advisory, Rothschild & Co acted as financial advisor to the Special Committee, while TD Cowen acted as financial advisor to Searchlight and Abry, the acquiring parties. On legal advisory, Richards, Layton & Finger, P.A. advised the Special Committee, Troutman Pepper Locke LLP served as legal advisor to KORE itself, Wachtell, Lipton, Rosen & Katz served as legal advisor to Searchlight, and Kirkland & Ellis LLP served as legal advisor to Abry. The deal structure disclosed is an all-cash merger at $9.25 per share, not subject to a financing condition, with concurrent voting, support, and rollover agreements executed by Searchlight, Abry, the SPAC sponsor Cerberus Telecom Acquisition Holdings, LLC, and certain other stockholders holding up to 2,500,000 shares. KORE and Parent also intended to jointly file a Schedule 13E-3 transaction statement given the going-private, affiliated-party nature of the deal. What is not disclosed: a precise breakdown of how the $726 million valuation reconciles to the $9.25 per share price and outstanding share count was not stated in the press release, nor was any termination fee amount or detailed financing structure for the cash consideration.

The Brink's Company (NYSE: BCO), the global cash management and valuables logistics provider, announced a definitive agreement to acquire NCR Atleos Corporation (NYSE: NATL), the ATM network and services company, in a cash-and-stock transaction valued at approximately $6.6 billion, comprised of 13.3 million shares of Brink's common stock, $2.2 billion in cash, and the assumption of approximately $2.6 billion of NCR Atleos' indebtedness. The deal is in the armored car/transportation services sector (SIC 4731) and is framed by the companies as creating a leading financial technology infrastructure company. This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by The Brink's Company with the SEC on February 26, 2026, announcing the signing of the definitive merger agreement. A later Brink's 8-K filed June 18, 2026 confirms the transaction remained pending at that time, noting the Registration Statement on Form S-4 had been declared effective May 27, 2026, a joint proxy statement/prospectus had been mailed to shareholders, and two stockholder complaints alleging disclosure deficiencies had been filed in New York state court, which Brink's and NCR Atleos addressed through voluntary supplemental disclosures without admitting liability. The deal was expected to close in the first quarter of 2027, subject to regulatory and shareholder approvals, with post-closing ownership of approximately 78% Brink's shareholders and 22% former NCR Atleos shareholders. On financial advisory, Morgan Stanley & Co. LLC served as financial advisor to Brink's, while J.P. Morgan Securities LLC served as financial advisor to NCR Atleos. The later supplemental disclosure filing further discloses that NCR Atleos agreed to pay J.P. Morgan an estimated aggregate fee of $43.0 million for its services, $4.0 million of which was payable upon delivery of its fairness opinion with the remainder contingent on consummation, plus a potential additional $7.0 million discretionary fee. On legal advisory, Sidley Austin LLP served as legal advisor to Brink's, and King & Spalding LLP served as legal advisor to NCR Atleos; FGS Global and Collected Strategies served as strategic communications advisors to Brink's and NCR Atleos, respectively. The deal structure disclosed: Brink's will acquire each outstanding NCR Atleos share for $30.00 in cash plus 0.1574 shares of Brink's common stock, implying a value of $50.40 per NCR Atleos share based on Brink's February 25, 2026 closing price, representing premiums of approximately 24% to NCR Atleos' prior closing price and 26% to its 30-day volume-weighted average price. Brink's obtained $4.5 billion in committed bridge financing from Morgan Stanley Senior Funding, Inc. for the cash portion, and the combined company expects approximately $200 million in annual run-rate cost synergies within three years of closing. What is not disclosed in the original announcement: the specific termination fee payable under the merger agreement, and (as of the original February 2026 announcement) the full detail of J.P. Morgan's fee arrangement, which only became available in the later supplemental disclosure filing reviewed alongside this release.

Boston Scientific Corp, a healthcare sector company trading under ticker BSX, is acquiring Penumbra Inc (ticker PEN), also in the healthcare sector. This transaction is being structured through a leveraged finance product consisting of a revolving credit facility and a delayed draw term loan. The aggregate disclosed value of the transaction is not stated in the source documents reviewed. The information regarding this deal has been sourced from an SEC filing published on February 26, 2026, retrieved from SEC EDGAR. The specific form type is not identified in the available documentation. The deal is currently pending regulatory approval and has not yet closed. On the financial advisory side, Wells Fargo Bank, National Association has been engaged by Boston Scientific Corp, the acquirer, to serve as administrative agent for the financing arrangement. Wells Fargo holds a lead position in this capacity. No other financial advisors have been identified in the available source materials for either the borrower or the lender syndicate. No legal advisors have been identified or disclosed in the source documentation reviewed for this transaction. The deal structure comprises two credit facilities: a revolving credit facility and a delayed draw term loan. Both facilities are being provided to Boston Scientific Corp as the borrower by multiple lenders coordinated through Wells Fargo Bank, National Association in its administrative agent capacity. However, the specific terms of these facilities, including tenor, pricing, interest rate mechanics, commitment amounts, or any other quantitative details, have not been disclosed in the source documents. Several material terms and structural details remain undisclosed or unknown at this time. The aggregate transaction value is not stated in any reviewed source material. The tenor, spread, base rate, and pricing terms of both the revolving credit facility and the delayed draw term loan have not been specified. The identity of the lending syndicate members beyond the administrative agent, as well as any lead arranger or book manager roles, is not disclosed. Additionally, no expected closing date or timeline for regulatory approval has been provided. The consideration structure for the acquisition itself, including whether it is being funded entirely through these credit facilities or through other means, is not specified in the available documentation.

Abbott Laboratories, a healthcare sector company trading under the ticker ABT, issued $20 billion in aggregate principal amount of senior notes across eight tranches. The offering priced on February 23, 2026 pursuant to a pricing agreement among Abbott and representatives Morgan Stanley & Co. LLC, Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, and closed on March 9, 2026, when Abbott completed the issuance and sale of the notes, according to a Form 8-K filed with the SEC that date. The eight tranches, their principal amounts, coupons and maturities are: Floating Rate Notes due 2029 ($1.0 billion, SOFR plus 0.500%, maturing March 9, 2029); 3.700% Notes due 2029 ($2.25 billion, maturing March 9, 2029); 4.000% Notes due 2031 ($2.5 billion, maturing March 15, 2031); 4.300% Notes due 2033 ($2.75 billion, maturing March 15, 2033); 4.650% Notes due 2036 ($3.75 billion, maturing March 15, 2036); 4.750% Notes due 2038 ($2.0 billion, maturing March 15, 2038); 5.500% Notes due 2056 ($3.75 billion, maturing March 15, 2056); and 5.600% Notes due 2066 ($2.0 billion, maturing March 15, 2066). Settlement for all tranches occurred March 9, 2026. Per the final pricing term sheet (free writing prospectus filed February 24, 2026), the fixed-rate tranches priced at the following prices to public and yields to maturity: the 2029 Notes at 99.873% (yield 3.745%, +30 bps to the benchmark 3.500% Treasury due February 15, 2029); the 2031 Notes at 99.855% (yield 4.032%, +45 bps to the 3.750% Treasury due January 31, 2031); the 2033 Notes at 99.813% (yield 4.331%, +55 bps to the 4.000% Treasury due January 31, 2033); the 2036 Notes at 99.753% (yield 4.681%, +65 bps to the 4.125% Treasury due February 15, 2036); the 2038 Notes at 99.718% (yield 4.781%, +75 bps to the same 2036 benchmark Treasury); the 2056 Notes at 99.882% (yield 5.508%, +80 bps to the 4.625% Treasury due November 15, 2055); and the 2066 Notes at 99.872% (yield 5.608%, +90 bps to the same 2055 benchmark Treasury). The Floating Rate Notes priced at 100.000% of par. Each fixed-rate tranche carries a par call date ranging from one to six months before its stated maturity, after which Abbott may redeem at par plus accrued interest; prior to the par call date, Abbott may redeem at a make-whole price based on the applicable Treasury rate plus a spread of 5 to 15 basis points depending on the tranche. The Floating Rate Notes are not redeemable prior to maturity except via special mandatory redemption. Abbott estimated net proceeds of approximately $19,825,943,100 after underwriting discounts and estimated offering expenses, according to the prospectus supplement. Per-tranche underwriting discounts ranged from 0.250% (Floating Rate Notes and 2029 Notes) up to 0.875% (2056 and 2066 Notes). Abbott stated it intends to use the net proceeds, together with cash on hand and/or additional borrowings (which may include commercial paper issuances), to fund the cash consideration for its acquisition of Exact Sciences Corporation under an Agreement and Plan of Merger dated November 19, 2025 (Abbott, Exact Sciences and Badger Merger Sub I, Inc.), to repay certain existing indebtedness of Exact Sciences, to pay related fees and expenses, and for general corporate purposes, which may include repayment of other indebtedness. The notes are unsecured, unsubordinated obligations ranking equally with Abbott's other unsecured and unsubordinated debt. The notes carry a special mandatory redemption feature: if the Exact Sciences acquisition is not consummated within five business days after the later of February 17, 2027 or any later merger-agreement "End Date," or if Abbott notifies the trustee it will not pursue the acquisition, Abbott must redeem all outstanding notes at 101% of principal plus accrued and unpaid interest to the special mandatory redemption date. The joint book-running managers across all eight tranches were Morgan Stanley, Barclays, BofA Securities and J.P. Morgan. Additional joint book-running managers with tranche-specific roles were BNP Paribas (2031 and 2038 Notes), Citigroup (Floating Rate Notes, 2029 Notes and 2066 Notes), Deutsche Bank Securities (2056 Notes), MUFG (2033 Notes) and Societe Generale (2036 Notes). The senior co-manager tier included Santander, HSBC, RBC Capital Markets, Siebert Williams Shank, BBVA, Mizuho, Academy Securities, U.S. Bancorp, Goldman Sachs, Standard Chartered Bank and ING, generally covering all or multiple tranches. The notes were issued under an existing indenture dated March 10, 2015 between Abbott and U.S. Bank National Association, as supplemented by an officers' certificate dated March 9, 2026. For legal counsel, the prospectus supplement states that certain legal matters in connection with the offering were passed upon for Abbott by Wachtell, Lipton, Rosen & Katz, New York, and for the underwriters by Davis Polk & Wardwell LLP, New York. No credit rating agency names (Moody's, S&P or Fitch) or specific assigned ratings appear in the prospectus supplement, the pricing term sheet, or either Form 8-K reviewed. As disclosed, the notes are not listed on any national securities exchange and there is currently no public trading market for them.

This transaction is a cash divestiture involving the sale of an electrical balance of systems (EBOS) business for renewables, a subsidiary of Gibraltar. The deal is classified under the M&A product group and carries a disclosed value of $70,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on February 23, 2026. Only one financial advisor is named in the facts block: Perella Weinberg served as financial advisor to the target, identified in the source sentence as Gibraltar, the seller of the EBOS business. No lead or non-lead designation is given for this advisory role. On the legal side, Honigman LLP served as legal counsel to the target, also representing Gibraltar in the divestiture. As a cash divestiture, the transaction involves Gibraltar selling its electrical balance of systems business for renewables for total disclosed consideration of $70,000,000, but the facts block does not name the buyer, nor does it specify any post-closing arrangements, working capital adjustments, or earnout provisions. Several material facts remain undisclosed. No buyer or acquirer is named in the facts block beyond the general characterization of this as a divestiture. No financial or legal advisor is identified for the buyer's side. No expected closing date is given, and no sector classification is specified in this facts block.

Camden Property Trust, a real estate investment trust trading under ticker CPT, issued $600,000,000 aggregate principal amount of 4.900% senior unsecured notes due 2036 in a registered debt capital markets offering. The notes were priced on February 17, 2026 and settled on February 19, 2026, as disclosed in a final pricing term sheet (free writing prospectus) and a prospectus supplement filed with the SEC, together with a current report on Form 8-K dated February 19, 2026. The notes carry a 4.900% coupon, payable semiannually on February 28 and August 28 of each year beginning August 28, 2026, computed on a 30/360 day-count basis, and mature on February 28, 2036. The notes were priced at 99.936% of their principal amount to yield 4.908% to maturity, representing a spread of 0.85% (85 basis points) over the benchmark 4.125% U.S. Treasury note due February 15, 2036. The underwriting discount was 0.650% of the principal amount. Camden Property Trust expects net proceeds of approximately $594.0 million from the offering, after underwriting discounts and offering expenses. The company intends to use the net proceeds to repay a portion of the outstanding balance on its $1.2 billion unsecured revolving credit facility and a portion of the amounts outstanding under its $600 million commercial paper program, with any remaining proceeds used for general corporate purposes, which may include property acquisitions and development, capital expenditures and working capital. The prospectus supplement discloses that certain underwriters or their affiliates are lenders under the revolving credit facility and/or holders of the company's commercial paper, and will therefore receive a portion of the offering proceeds through repayment of those obligations. The notes are redeemable, in whole or in part, at any time prior to November 28, 2035 (three months ahead of the maturity date) at a make-whole redemption price equal to the greater of the full principal amount or the present value of remaining scheduled payments discounted at the applicable Treasury rate plus 15 basis points, plus accrued and unpaid interest. On or after November 28, 2035, the notes are redeemable at 100% of principal plus accrued and unpaid interest. The notes carry expected ratings of A3 from Moody's, A- from S&P, and A- from Fitch, as disclosed in the final pricing term sheet, with the usual caveat that a rating is not a recommendation to buy, sell or hold the securities and may be revised or withdrawn. BofA Securities, Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc. acted as joint book-running managers along with Truist Securities, Inc. and Wells Fargo Securities, LLC, which were also named joint book-running managers in the final pricing term sheet and prospectus supplement (expanding on the four lead underwriters previously identified in the 8-K). Regions Securities LLC, BMO Capital Markets Corp., BNP Paribas Securities Corp., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc. and TD Securities (USA) LLC served as senior co-managers, and M&T Securities, Inc. and Samuel A. Ramirez & Company, Inc. served as co-managers. Per the underwriting table in the prospectus supplement, principal amounts were allocated as follows: $67.5 million each to BofA Securities, J.P. Morgan Securities, PNC Capital Markets and U.S. Bancorp Investments; $42.0 million each to Truist Securities and Wells Fargo Securities; $36.0 million to Regions Securities; $30.0 million each to BMO Capital Markets, BNP Paribas Securities, Deutsche Bank Securities, Mizuho Securities, Scotia Capital and TD Securities; $18.0 million to M&T Securities; and $12.0 million to Samuel A. Ramirez & Company. Dentons US LLP, Dallas, Texas, served as securities and tax counsel to Camden Property Trust and provided opinions regarding the legality of the notes and certain tax matters, including the company's qualification as a REIT. Sidley Austin LLP, New York, New York, acted as counsel to the underwriters in the offering. The CUSIP/ISIN for the notes are 133131BC5 / US133131BC55. The notes were offered under Camden Property Trust's existing shelf registration statement (File No. 333-271865), with the base prospectus dated May 12, 2023. The transaction settled on February 19, 2026, two business days after pricing, consistent with standard T+2 settlement for registered notes offerings. No independent closing confirmation filing (beyond the pricing term sheet and prospectus supplement reflecting the settlement date) was identified, so status is not being changed to closed in this update.

Leidos, Inc., the direct wholly-owned operating subsidiary of Leidos Holdings, Inc. (ticker LDOS), priced a two-tranche senior notes offering totaling $1,400,000,000, fully and unconditionally guaranteed by Leidos Holdings. The offering consists of $600,000,000 aggregate principal amount of 4.100% Notes due March 15, 2029 and $800,000,000 aggregate principal amount of 5.000% Notes due March 15, 2036. Interest on both series is payable semiannually in arrears on March 15 and September 15 of each year, beginning September 15, 2026. The notes were priced at a public offering price of 99.936% of par for the 2029 notes and 99.678% of par for the 2036 notes, plus accrued interest, if any, from March 2, 2026. Underwriting discounts were 0.350% for the 2029 notes and 0.650% for the 2036 notes, producing proceeds to Leidos, before expenses, of 99.586% and 99.028% of par, respectively. The company estimated net proceeds of approximately $1,387 million after underwriting discounts and estimated offering expenses. The notes settled on March 2, 2026, the seventh business day after the final prospectus supplement, pursuant to an indenture dated October 8, 2020 among Leidos, Inc. as issuer, Leidos Holdings as guarantor, and Citibank, N.A. as trustee, as supplemented by an officers' certificate dated March 2, 2026. The use of proceeds is specific: Leidos intends to use the net proceeds to fund a portion of the consideration payable for its proposed acquisition of all outstanding shares of capital stock of KENE Parent, Inc. (referred to in the filings as "ENTRUST"), pursuant to a Stock Purchase Agreement dated January 23, 2026 among Leidos, Inc., KENE Holdings, L.P. and KENE Parent, Inc. Leidos disclosed a purchase price of approximately $2.4 billion in cash for that acquisition, subject to certain adjustments, to be funded through a combination of new debt (including these notes), cash on hand, and commercial paper. As of the February 2026 prospectus supplement, that acquisition was expected to close by the end of the second quarter of 2026, subject to customary closing conditions including regulatory approvals; the notes offering itself was not conditioned on completion of that acquisition. Pending use of proceeds, Leidos said it may temporarily deploy the funds for general corporate purposes or short-term, liquid investments; the proceeds were not placed in escrow. The notes carry a special mandatory redemption feature tied to the Entrust/KENE acquisition: if that acquisition is not consummated by the later of August 14, 2026 (the "End Date") or five business days after any extended End Date under the acquisition agreement, or if Leidos notifies the trustee it will not pursue the acquisition, Leidos must redeem all of the notes at a special mandatory redemption price equal to 101% of principal plus accrued and unpaid interest to, but excluding, the redemption date. Separately, each series is also subject to an ordinary make-whole optional redemption at any time prior to its par call date (February 15, 2029 for the 2029 notes; December 15, 2035 for the 2036 notes), priced at the greater of par or a Treasury Rate-plus-spread calculation (10 basis points for the 2029 notes, 15 basis points for the 2036 notes), and at par thereafter. Holders may also require Leidos to repurchase the notes at 101% of principal plus accrued interest upon a Change of Control Triggering Event. The indenture includes a limitation-on-liens covenant permitting Leidos and the parent guarantor to incur secured debt without equally and ratably securing the notes so long as Leidos Holdings' "Aggregate Debt" does not exceed 15% of its Consolidated Net Worth, along with a related limitation on sale-and-leaseback transactions; no specific credit ratings for the notes are disclosed in the filings reviewed. The notes are senior unsecured obligations of Leidos, Inc., ranking equally with its other existing and future senior indebtedness, and are structurally subordinated to liabilities of non-guarantor subsidiaries. A capitalization table in the prospectus supplement shows Leidos Holdings' pro forma long-term debt rising from $4,648 million (actual, as of January 2, 2026) to $6,048 million as adjusted for this offering, alongside existing senior unsecured notes due 2030, 2031, 2032 (two tranches), 2033 (two tranches), 2035, and 2040, and a term loan due March 2028. Citigroup Global Markets Inc., BofA Securities, Inc. and MUFG Securities Americas Inc. acted as representatives of the underwriters and, together with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, PNC Capital Markets LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc. and U.S. Bancorp Investments, Inc., served as joint book-running managers; BMO Capital Markets Corp., Regions Securities LLC and TD Securities (USA) LLC served as senior co-managers. Davis Polk & Wardwell LLP acted as counsel to Leidos, and Cravath, Swaine & Moore LLP acted as counsel to the underwriters. The notes offering itself has closed (settled March 2, 2026), but it was conducted ahead of and to help finance the pending Entrust/KENE Parent acquisition, which as of the cited filings remained subject to regulatory approval and was not yet confirmed closed in the documents reviewed. No rating-agency press releases were identified among the filings reviewed.

Pebblebrook Hotel Trust, a real estate investment trust trading under the ticker PEB, is undertaking a debt refinancing transaction in the leveraged finance product group with a disclosed value of $450 million. The transaction involves the refinancing of existing debt obligations within the hotel real estate sector. This information is sourced from an SEC filing published on the SEC EDGAR database on February 13, 2026. The specific form type is not disclosed in the available materials. The transaction is currently pending regulatory approval and has not yet closed. The financial advisory team supporting the issuer is extensive and multi-tiered. BofA Securities, Inc. and Wells Fargo Securities, LLC jointly serve as Bookrunners and Joint Lead Arrangers, having organized the debt maturity extensions and upsizing. In addition to these lead roles, seven institutions serve as Joint Lead Arrangers: Capital One National Association, M&T Bank, PNC Capital Markets LLC, Raymond James Bank, TD Bank N.A., Truist Securities, Inc., and U.S. Bank National Association. Bank of America N.A. functions as the Administrative Agent for the transaction. Regions Bank serves as the Senior Managing Agent, overseeing key aspects of the syndication process. On the documentation side, multiple agents share responsibility: PNC Bank National Association, Truist Bank, and Raymond James Bank serve as Documentation Agents. Wells Fargo Bank National Association and U.S. Bank National Association jointly function as Syndication Agents, managing the distribution of the facility to other lenders. Additionally, Royal Bank of Canada is now a participant in the senior unsecured revolving credit facility component of the transaction. No legal advisors have been identified or disclosed in the materials provided. The transaction structure encompasses debt maturity extensions and upsizing and includes a senior unsecured revolving credit facility as a component. However, the detailed term sheet information remains largely undisclosed in the available materials. The consideration structure, specific tenor and coupon terms for any debt instruments, the size of the revolving credit facility, the nature of the maturity extensions, and the upsizing amounts are not specified in the sourced information. Critical gaps remain in the public disclosure of this transaction. No expected closing or funding date has been provided. The specific terms of the debt, including interest rates, maturity dates, financial covenants, and other material terms, are not disclosed. The amount representing the extension versus the amount representing the upsizing is unknown. Additionally, the identity of lenders beyond the arrangers and agents listed is not yet public, and any conditions precedent to closing have not been detailed.

Great Lakes Dredge & Dock Corporation, the largest provider of dredging services in the United States (NASDAQ: GLDD), agreed to be acquired by Saltchuk Resources, Inc., a privately owned Seattle-based family of freight transportation, marine services and energy distribution companies, in an all-cash tender offer valued at approximately $1.5 billion. The transaction was structured as a one-step tender offer followed by a back-end merger under Section 251(h) of the Delaware General Corporation Law, requiring no shareholder vote, and has since closed: Saltchuk's merger subsidiary, Huron MergeCo., Inc., accepted for payment all validly tendered shares on April 1, 2026, with approximately 79.88% of outstanding shares tendered, and the merger was completed the same day. Under the Agreement and Plan of Merger dated February 10, 2026, Saltchuk agreed to pay $17.00 per share in cash for all outstanding Great Lakes common stock, representing an aggregate equity value of approximately $1.2 billion and a total transaction value of approximately $1.5 billion. The $17.00 offer price represented a 25% premium to Great Lakes' 90-day volume-weighted average share price as of February 10, 2026 and a 5% premium to the company's all-time high closing price. Based on fully diluted shares of 68.847 million and net debt of $367 million disclosed in Great Lakes' Schedule 14D-9, the deal implied an enterprise value of approximately $1,537 million, equal to approximately 9.0 times the company's 2025 estimated LTM Adjusted EBITDA of $171 million on a management-estimate basis (9.1 times on a Wall Street consensus basis). Lawrence R. Dickerson, Chairman of the Great Lakes Board, said the agreement "delivers immediate and certain value at a premium to the Company's all-time high valuation." Lasse Petterson, Great Lakes President and CEO, said the company was "happy to join Saltchuk's family of companies who share our unique company culture, with focus on safety and our community, customers and employees," adding that Great Lakes' "long-term growth strategy will continue with a partner who shares our vision while maintaining our leadership position in U.S. dredging and global offshore energy." Mark Tabbutt, Chairman of Saltchuk, called Great Lakes "a perfect match" and said Saltchuk's goal is "to provide a permanent home for great companies that serve their communities," welcoming the roughly 1,200 Great Lakes employees joining Saltchuk. The transaction was not subject to a financing condition; it was backed by fully committed financing from Bank of America, Wells Fargo, U.S. Bank and PNC, according to the companies' joint press release. Separately, on March 18, 2026, Saltchuk commenced a cash tender offer and consent solicitation for any and all of Great Lakes' outstanding 5.25% Senior Notes due 2029 in connection with the pending business combination, seeking to amend the notes' indenture to eliminate substantially all restrictive covenants; that tender and consent process was disclosed to be expected to close early in the second quarter of 2026, around the same time as the equity transaction. No separate dollar synergy target, cost-savings figure, or pro forma combined-company financial statement was identified in the filings reviewed. Great Lakes' Schedule 14D-9, filed March 4, 2026, discloses that Saltchuk's chairman first approached Great Lakes' CEO in April 2025, and that a separate unnamed financial investor ("Party A") also expressed interest around the same time but never submitted a proposal. Saltchuk's financial advisor, Evercore Group L.L.C., submitted an initial non-binding indication of interest on November 7, 2025 in a range of $13.25 to $15.00 per share, which Great Lakes' board rejected as inadequate. Saltchuk subsequently raised its offer to $17.00 per share, a $3.75 increase from the low end of its initial range, on November 20, 2025. At the board's direction, Great Lakes' financial advisor, Guggenheim Securities, LLC, then contacted seven other potential counterparties (three financial sponsors and four strategic parties, including Party A) to gauge interest in a competing transaction; all seven declined to pursue a deal, and Great Lakes received no other proposals. The board ultimately determined that $17.00 per share was the highest price Saltchuk was willing to pay and that pushing further risked the loss of the transaction altogether. Guggenheim Securities delivered a fairness opinion to the Great Lakes board on February 10, 2026 that the $17.00 offer price was fair, from a financial point of view, to shareholders. Guggenheim's discounted cash flow analysis implied a per-share reference range of $14.72 to $19.00; its selected publicly traded companies analysis (using peers Orion Group Holdings, Oceaneering International, Tidewater and Helix Energy Solutions Group) implied $10.83 to $18.90 per share on 2026E EV/EBITDA and $13.26 to $20.69 on 2026E EV/EBITA; and its selected precedent transactions analysis (including Cyan Renewables/MMA Offshore, HAL Holding/Royal Boskalis Westminster, and American Industrial Partners/SEACOR Holdings) implied $12.17 to $22.94 per share. An illustrative leveraged buyout analysis, presented for informational purposes only, implied $14.27 to $18.49 per share. The merger agreement provided for a termination fee of $36,861,914 payable by Great Lakes to Saltchuk under specified circumstances, including a change in the board's recommendation or acceptance of a superior proposal. Guggenheim Securities, LLC acted as exclusive financial advisor to Great Lakes and Sidley Austin LLP as its legal advisor; Evercore acted as exclusive financial advisor to Saltchuk and Fried, Frank, Harris, Shriver & Jacobson LLP as its legal advisor. Closing was conditioned on the expiration of the Hart-Scott-Rodino Act waiting period and the tender of a majority of outstanding shares (the Minimum Tender Condition); both conditions were satisfied, and the deal closed April 1, 2026, with Great Lakes continuing as a standalone, privately held subsidiary of Saltchuk and its common stock delisted from Nasdaq.

This deal is a take-private all-cash merger in which Clear Channel Outdoor Holdings, Inc. (ticker CCO), a company in the business-services sector, is the target being acquired by Mubadala Capital in partnership with TWG. The transaction is classified under the M&A product group, with a disclosed deal value of $6,200,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on February 9, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised the target: Morgan Stanley & Co. LLC and Moelis & Company LLC both served as financial advisors to Clear Channel, both designated as lead advisors. On the acquirer side, Guggenheim Securities, LLC and J.P. Morgan Securities LLC both served as financial advisors to Mubadala Capital, also both designated as lead advisors. Legal counsel was also disclosed for both sides. Kirkland & Ellis LLP is acting as legal advisor to Clear Channel, the target (referred to as "the Company" in the source sentence). Freshfields is acting as legal advisor to Mubadala Capital, the acquirer. Beyond the all-cash consideration structure implied by the subtype and the disclosed $6,200,000,000 deal value, the facts block does not provide a per-share purchase price or other specific terms of the merger. Several facts are not disclosed in the source material. The facts block does not give a per-share cash price for the merger consideration, nor does it specify an expected closing date. It also does not detail the specific roles or ownership split between Mubadala Capital and its partner, TWG, in the acquiring consortium.

P10, Inc. (NYSE: PX), a leading private markets solutions provider with over $40 billion in assets under management, agreed to acquire Stellus Capital Management, LLC, a U.S. direct lender specializing in senior secured loans in the lower-middle market with approximately $3.8 billion in assets under management. The transaction was announced February 5, 2026 in a Form 8-K filed by P10 that included the interest purchase agreement (Exhibit 2.1), a press release (Exhibit 99.1), and an investor presentation (Exhibit 99.2). P10 Chairman and CEO Luke Sarsfield said the deal "is a continuation of P10's long-term strategy to partner with leading specialized investment managers operating in the middle and lower-middle market and adds a best-in-class direct lending franchise to our platform," while Stellus Managing Partner Robert Ladd said the transaction "will enhance our ability to develop additional strategies and investment vehicles that meet the evolving needs of global investors." P10 also disclosed it would rebrand to Ridgepost Capital, Inc., effective February 11, 2026, with its stock trading under new ticker "RPC" on the NYSE and NYSE Texas. The initial purchase price was $250 million, composed of $125 million in cash and $125 million in units of P10 Intermediate Holdings, LLC (later renamed Ridgepost Capital, LLC), exchangeable into P10/Ridgepost Class A common stock on a one-for-one basis following lock-up restrictions that release over three years. The investor presentation disclosed this upfront consideration represented approximately 12 times Stellus's estimated 2025 fee-related earnings (FRE). P10 is acquiring 100% of Stellus's equity interests and 100% of its fee-related earnings (after minority interest payments related to Stellus Private BDC Advisor, LLC), excluding existing private fund carried interest and performance fees. P10 said it expected to finance the cash portion with cash on hand and its existing revolving credit facility. The agreement also provided for up to $60 million in additional earnout consideration based on Stellus's fee-related revenue performance in fiscal years 2027 and 2029, payable in units or Class A common stock, with up to 50 percent payable in cash at the sellers' option. P10 stated the transaction was expected to be modestly accretive to adjusted net income (ANI) per share and to fee-related earnings (FRE) margin in the first full year post-close, assuming no synergies in either case; no dollar or percentage synergy target was disclosed. At closing, the final consideration paid consisted of $125 million in cash (subject to customary working-capital adjustments), 11,191,149 Class A membership units of Ridgepost Capital, LLC, and 579,096 shares of Ridgepost Class A common stock, according to P10's (by then renamed Ridgepost Capital, Inc.) Form 8-K reporting completion of the acquisition. A subsequent Form 8-K/A, filed to add Stellus's audited and unaudited financial statements and pro forma financial information, disclosed a total purchase consideration fair value of $230.9 million ($129.8 million cash, $94.5 million fair value of equity consideration, and $6.6 million fair value of contingent/earnout consideration), net identifiable assets acquired of $183.6 million, and preliminary goodwill of $55.3 million. The pro forma financial statements explicitly state they do not reflect any integration costs or benefits from future cost savings, revenue synergies, procurement savings, or operational efficiencies. Goldman, Sachs & Co. acted as exclusive financial advisor to Stellus. Eversheds Sutherland (US) LLP and Winston & Strawn LLP served as legal advisors to Stellus, while Kirkland & Ellis LLP and Troutman Pepper Locke LLP served as legal advisors to P10. Because the acquisition of Stellus Capital Management constituted a change in control of the investment adviser to the publicly traded Stellus Private Credit BDC, the BDC was required under the Investment Company Act of 1940 to obtain shareholder approval of a new investment advisory agreement with identical terms (other than date and term) to the prior agreement. The BDC's special meeting of shareholders was held June 16, 2026, and shareholders approved the new advisory agreement by a vote of 10,314,546 for, 0 against, and 0 abstentions out of 12,973,271 shares eligible to vote. The purchase agreement set an "Outside Date" of September 30, 2026, after which either party could terminate if closing had not occurred; no termination fee was disclosed in the portions of the agreement reviewed. The acquisition closed on June 22, 2026, as confirmed in a Form 8-K filed by Ridgepost Capital, Inc. (formerly P10, Inc.) reporting completion of the acquisition under Item 2.01. The new investment advisory agreement for the Stellus Private Credit BDC became effective that same day. The deal is no longer pending; it has closed.

P10, Inc. (NYSE: PX), a private markets solutions provider, agreed on February 4, 2026 to acquire 100 percent of the outstanding equity interests of Stellus Capital Management, LLC, a Houston-based direct lender to lower-middle-market, sponsor-backed companies with approximately $3.8 billion in assets under management. The transaction is a purchase of the external investment manager/advisor entity, not a merger of Stellus Capital Investment Corporation (NYSE: SCM), the publicly traded business development company that Stellus Capital Management advises; per Stellus Capital Investment Corporation's April 16, 2026 proxy statement, the BDC itself is not a party to the purchase agreement and its stockholders do not receive any consideration in the transaction. Shortly after the deal was announced, P10, Inc. changed its corporate name to Ridgepost Capital, Inc. (NYSE: RPC), effective February 11, 2026, and its acquisition subsidiary, P10 Intermediate Holdings LLC, was renamed Ridgepost Capital, LLC; Ridgepost Capital, Inc. is the same company as P10, Inc. under a new name. According to P10's February 5, 2026 investor presentation (Exhibit 99.2 to its Form 8-K), the deal totals $250 million in upfront consideration, split evenly between $125 million in cash and $125 million in P10 Intermediate Holdings LLC units exchangeable 1-for-1 into P10/Ridgepost Class A common stock, plus up to $60 million in earnout consideration tied to Stellus' fee-related revenue in fiscal years 2027 and 2029 (payable up to 50 percent in cash at the sellers' option). The presentation states the upfront consideration represents approximately 12 times Stellus' estimated 2025 fee-related earnings (FRE). Equity consideration delivered at closing is subject to a lock-up that releases in thirds on the first, second and third anniversaries of closing; earnout equity is subject to an 18-month lock-up releasing in thirds every six months. P10 stated the transaction is expected to be modestly accretive to its adjusted net income (ANI) per share in the first full year post-close and modestly accretive to its fee-related earnings margin, with both figures assuming no synergies, and said it would finance the upfront cash consideration with cash on hand and its existing credit facility. Strategically, P10's investor presentation described the deal as an expansion into lower-middle-market direct lending that is a natural fit with P10's existing middle and lower-middle-market GP ecosystem, particularly its RCP strategy, citing Stellus' 20-plus year track record, $10.3 billion invested across more than 375 portfolio companies, and a disciplined underwriting approach that produced a five-year average leverage at origination of approximately 3.4x versus a cited middle-market average of about 5.0x, with an annualized default rate of about 1.10 percent and annualized loss rate of about 0.14 percent since inception. In the original February 5, 2026 press release, Stellus Managing Partner Robert Ladd said, "Luke Sarsfield and the P10 team have established a highly scaled and diversified private markets platform with a clear focus on the middle and lower-middle market, and we see strong alignment in our respective approaches," while P10 Chairman and CEO Luke Sarsfield called the deal "a continuation of P10's long-term strategy to partner with leading specialized investment managers operating in the middle and lower-middle market." Stellus will continue to be run by its existing partners, who retain day-to-day control of investment decisions and the investment committee; the deal excludes existing private fund carried interest and performance fees, though up to 15 percent of future carry tied to new funds may be allocated to non-Stellus P10 employees. The transaction closed on June 22, 2026, as confirmed by Ridgepost Capital, Inc.'s Form 8-K filed that day (Item 2.01, Completion of Acquisition of Assets). At closing, consideration consisted of $125,000,000 in cash, 11,191,149 Class A membership units of Ridgepost Capital, LLC, and 579,096 shares of Ridgepost Class A common stock, subject to customary working-capital and other adjustments; the slightly different unit/share split from the announcement reflects those closing adjustments. Ridgepost funded the cash portion with cash on hand and borrowings under its existing credit facility; in connection with closing, Ridgepost LLC drew $139,000,000 on its revolving credit facility, which lenders including JPMorgan Chase Bank, N.A. had increased by $20,000,000 (from $175,000,000 to $195,000,000) under a June 11, 2026 Increase Agreement, leaving approximately $14,000,000 available under the facility immediately after closing. Pro forma financial statements and financial statements of the acquired business were not filed with the closing 8-K; Ridgepost stated it would file any required financial statements and pro forma information by amendment no later than 71 days after the 8-K's required filing date. At closing, Ridgepost Capital Chairman and CEO Luke Sarsfield said, "Closing the Stellus transaction marks another significant milestone in Ridgepost's strategy to partner with leading specialized investment managers operating in the middle and lower-middle market... This acquisition is a natural fit with Ridgepost's lower-middle market GP ecosystem, creating growth opportunities and further differentiating our investment strategies." Robert Ladd said, "We are pleased to join Ridgepost's leading alternatives platform and begin this next phase of growth together... Ridgepost's broad and collaborative platform, extensive sponsor relationships, and commitment to partnership strengthen our ability to originate attractive investment opportunities across our BDCs and private funds." Goldman, Sachs & Co. acted as exclusive financial advisor to Stellus, with Eversheds Sutherland (US) LLP and Winston & Strawn LLP serving as Stellus' legal advisors; Kirkland & Ellis LLP and Troutman Pepper Locke LLP served as legal advisors to Ridgepost Capital (P10), as confirmed in both the February 5, 2026 announcement release and the June 22, 2026 closing release. No financial advisor to P10/Ridgepost was identified in the filings reviewed. Separately, because the change of control of Stellus Capital Management constituted an "assignment" of its existing investment advisory agreement with Stellus Capital Investment Corporation under the Investment Company Act of 1940, that agreement terminated automatically at closing. Stellus Capital Investment Corporation's stockholders approved a new investment advisory agreement with identical economic terms at the company's June 16, 2026 annual meeting (14,244,374 votes for, 721,794 against, 806,722 abstentions), and the new agreement became effective June 22, 2026, concurrent with the Stellus Capital Management ownership change. No purchase price, exchange ratio, or other consideration was paid to or received by Stellus Capital Investment Corporation or its public stockholders in connection with the Stellus Capital Management ownership change; the BDC was not a party to the purchase agreement. Given the closing 8-K and confirmed deal terms described above, status should be treated as closed; prior guidance characterizing the deal as merely "pending regulatory approval" is superseded by this filing evidence of consummation on June 22, 2026.

This is a cash acquisition via plan of arrangement in the healthcare sector in which REM Aggregator LLC is acquiring Quipt Home Medical Corp., the target. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from a DEFM14A filed with the SEC via EDGAR, published on February 4, 2026. A DEFM14A is a definitive merger proxy statement, consistent with the plan-of-arrangement structure requiring shareholder approval. The deal's current status is pending regulatory review. Two financial advisors are identified on the target side, each having rendered a fairness opinion. Evans & Evans, Inc. provided a fairness opinion, as referenced by the source sentence "ANNEX D OPINION OF EVANS & EVANS, INC." Truist Securities, Inc. served as the lead financial advisor and also provided a fairness opinion, per the source sentence "ANNEX C OPINION OF TRUIST SECURITIES, INC." No financial advisor to REM Aggregator LLC, the acquirer, is identified in the facts provided. Only one legal advisor is identified in the facts block: DLA Piper (Canada) LLP, representing the target side, Quipt Home Medical Corp. The source sentence notes that "a copy of the Arrangement Agreement will also be available for inspection at the offices of DLA Piper (Canada) LLP, Suite 2700, 1133 Melville Street Vancouver, BC V6E 4E5 Canada during statutory business hours," indicating DLA Piper's role in connection with the arrangement agreement. Beyond the classification of this transaction as a cash acquisition via plan of arrangement, no further detail on the per-share cash consideration or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the per-share cash consideration is not specified, no financial or legal advisor to REM Aggregator LLC is identified, and no expected closing date is given beyond the pending-regulatory status.

Jamf Holding Corp., a technology sector company trading under ticker JAMF, was acquired by Francisco Partners Management, L.P. in an all-cash going-private transaction valued at approximately $2.2 billion. Jamf and affiliates of Francisco Partners, Jawbreaker Parent, Inc. and Jawbreaker Merger Sub, Inc., entered into the Agreement and Plan of Merger on October 28, 2025, and the transaction was announced the next morning in a press release filed with the SEC. The deal closed on January 30, 2026, after which Jamf became a wholly owned subsidiary of Parent, its common stock was delisted from Nasdaq, and the company filed a Form 15 on February 9, 2026 to terminate its SEC reporting obligations. Under the terms of the merger agreement, Jamf stockholders received $13.05 in cash for each share of common stock, with outstanding stock options and restricted stock units cashed out on the same per-share basis. The $13.05 price represented a premium of approximately 17 percent over Jamf's closing stock price on October 28, 2025, the last trading day before the deal was announced, a premium of approximately 24 percent over the closing price on September 11, 2025 (the last trading day before Reuters reported Jamf was exploring a sale), and a premium of approximately 50 percent over Jamf's 90-day volume-weighted average closing price prior to September 11, 2025. The proxy statement describes the transaction value as a merger consideration of $13.05 per share rather than disclosing a specific EV/EBITDA or EV/revenue multiple, though Jamf's financial advisor's selected-companies and precedent-transactions analyses applied ranges of 2026 estimated revenue and adjusted unlevered free cash flow multiples to derive implied per-share value ranges, as described below. John Strosahl, Jamf's CEO, said "Since Jamf's founding more than 20 years ago, we have made significant strides in advancing our mission to help organizations succeed with Apple," adding that "transitioning to a private company will provide greater financial flexibility and strategic alignment to accelerate growth, expand through innovation and M&A, and strengthen our market leadership." Francisco Partners' Brian Decker, Partner and Co-CIO, and Karl Shum, Partner, said "We have long admired Jamf and its commitment to providing customers with best-in-class products that are absolutely beloved in the Apple community," and "we continue to see tremendous opportunity for Jamf given its enviable position in the market." Michael Fosnaugh, Senior Managing Director and Co-Head of Vista Equity Partners' Flagship Fund and Chairman of Jamf's board, called the deal a reflection of "the strength of the Jamf team and the distinctiveness of its platform." The cash merger consideration and related fees and expenses were funded through a combination of equity contributions from Francisco Partners and its affiliated funds, proceeds from a new senior secured term loan facility entered into by Parent at closing, and Jamf's available cash balance; the Jamf 8-K filed at closing did not disclose the specific dollar size of the new term loan. Francisco Partners-affiliated investment funds committed, under an Equity Commitment Letter, to capitalize Parent with an aggregate equity contribution of up to approximately $1.14 billion. In connection with closing, Jamf's existing credit agreement with JPMorgan Chase Bank, N.A. (dated May 3, 2024) was repaid in full and terminated. Jamf also entered into a First Supplemental Indenture governing its 0.125% Convertible Senior Notes due 2026 (approximately $373.75 million aggregate principal outstanding as of January 29, 2026), giving noteholders the right to convert notes into $13.05 in cash per underlying share, or alternatively to require Jamf to repurchase the notes at par plus accrued interest on a fundamental change repurchase date expected around April 20, 2026. Vista Equity Partners, which owned approximately 34.0% of Jamf's outstanding shares as of October 24, 2025, along with then-CEO John Strosahl (approximately 0.2%) and former CEO Dean Hager (approximately 1.1%), signed voting agreements committing to vote their shares in favor of the merger; Vista's investment in Jamf concluded at closing. Jamf's board unanimously approved the merger and recommended it to stockholders, who adopted the merger agreement at a special meeting held January 8, 2026, with approximately 99.6% of shares voted (115,067,968 for versus 231,296 against, out of 115,515,200 shares present, representing about 86.15% of shares outstanding). The proxy statement's "Background of the Merger" section discloses that Jamf conducted a strategic review spanning roughly two years, during which Francisco Partners and several other financial sponsors (referred to as Parties A through F) periodically approached Jamf regarding a potential transaction beginning in 2023. Beginning in August 2025, Jamf and its financial advisor contacted 32 potential counterparties, both strategic and financial, and entered into confidentiality agreements with 16 of them, which produced three initial indications of interest; the board determined that none of the other interested parties offered as high a price per share as Francisco Partners. On September 12, 2025, Reuters publicly reported that Jamf was exploring a sale, which the board noted gave any other interested party an opportunity to come forward. The board considered Francisco Partners' reputation and deal track record, the certainty and immediate liquidity of all-cash consideration, and Citi's fairness opinion in reaching its unanimous decision, and concluded that further negotiation risked causing Francisco Partners to walk away from what the board viewed as its best and final offer. Citi served as Jamf's financial advisor and rendered a fairness opinion dated October 28, 2025, for which Jamf agreed to pay Citi a fee of approximately $32 million, $4 million of which was payable on delivery of the opinion and the remainder contingent on closing. In its selected public companies analysis of 18 comparable software firms, Citi applied multiples of 1.6x to 4.6x 2026 estimated revenue and 7.2x to 21.6x 2026 estimated adjusted unlevered free cash flow, implying per-share equity values of $6.75 to $22.00 and $7.00 to $24.00, respectively, versus the $13.05 deal price. A selected precedent transactions analysis of 16 software-sector deals (including Thoma Bravo/Verint Systems, Silver Lake-GIC/Zuora, and Insight Partners/Alteryx, among others) applied multiples of 2.0x to 5.2x next-twelve-months revenue and 9.2x to 23.0x next-twelve-months adjusted unlevered free cash flow, implying per-share values of $8.50 to $24.50 and $9.00 to $25.00. A discounted cash flow analysis using a 2.0% to 5.0% perpetuity growth rate and 12.1% to 13.5% discount rate implied a per-share range of $9.00 to $13.50. Jamf's financial advisor is Citi; Kirkland & Ellis LLP served as legal counsel to Jamf. RBC Capital Markets served as lead financial advisor to Francisco Partners, with Goldman Sachs & Co. LLC and Deutsche Bank Securities Inc. also advising FP; Simpson Thacher & Bartlett LLP served as legal counsel to Francisco Partners. The merger agreement set a Company Termination Fee of $68,080,000 payable by Jamf under specified circumstances and a Parent Termination Fee of $136,170,000 payable by Parent under specified circumstances, including failure to obtain financing. The transaction's primary regulatory condition was clearance under the Hart-Scott-Rodino Antitrust Improvements Act; the proxy statement does not disclose any other industry-specific regulatory approval requirement or any opposition encountered during the HSR review. No synergy targets, EPS accretion/dilution figures, or pro forma combined-company metrics were disclosed, consistent with this being an all-cash take-private of a standalone target rather than a strategic stock-for-stock combination.

Bed Bath & Beyond, Inc. (NYSE: BBBY), a consumer-retail sector company, agreed to acquire The Brand House Collective, Inc. (Nasdaq: TBHC), formerly known as Kirkland's, Inc., in an all-stock merger. The parties entered into an Agreement and Plan of Merger on November 24, 2025, disclosed in a Form 8-K filed by TBHC and in a joint press release. Based on the companies' closing stock prices on November 21, 2025, the transaction implied an equity value of approximately $26.8 million, a figure the companies stated includes the TBHC stock already held by Bed Bath & Beyond. At signing, Bed Bath & Beyond already owned approximately 40% of TBHC's outstanding shares, the result of an earlier $8.0 million equity investment (4,324,324 shares at $1.85 per share) completed in February 2025 as part of a broader strategic financing and collaboration relationship between the companies dating to an October 2024 term loan and subscription agreement. Under the terms of the merger agreement, each share of TBHC common stock was converted into the right to receive 0.1993 shares of Bed Bath & Beyond common stock, plus cash in lieu of fractional shares. The companies stated this exchange ratio reflected each company's volume-weighted average share price over the thirty trading days prior to November 20, 2025. The merger agreement was unanimously approved by both companies' boards. No separate enterprise value, EV/EBITDA, or P/E multiple was disclosed; TBHC's financial advisor, Consensus, noted in its fairness opinion analysis that TBHC's standalone discounted cash flow value was negative (approximately negative $6.01 per share), compared with an implied value per share of approximately $1.11 based on the exchange ratio and Bed Bath & Beyond's November 20, 2025 closing price, and that a hypothetical Chapter 7 liquidation of TBHC would have produced no net proceeds available to equity holders under either a "low value" or "high value" liquidation scenario. Marcus Lemonis, Executive Chairman of Bed Bath & Beyond, said: "This acquisition is a big step in building a profitable, growth oriented Everything Home company. The power of this deal comes from a more efficient and productive engagement with the consumer, while extracting over $20 million in duplicate costs," adding that "the most valuable asset of this transaction is the talent and leadership that comes with it, giving our historical marketplace business a stronger product and consumer experience focus." Amy Sullivan, CEO of The Brand House Collective (who was expected to become CEO of a newly organized Beyond Retail Group division overseeing the combined company's omni-channel retail operations, including the Bed Bath & Beyond, buybuy BABY, Overstock and Kirkland's Home brands), said the combined entity "strengthens our financial position and reaffirms our mandate to grow revenue and profit at the pace the market expects." The companies disclosed expected cost eliminations of at least $20 million, attributed to removal of duplicated functions, overlapping systems, and operational inefficiencies across merchandising support, logistics, technology, and administrative structures; no phase-in timeline or percentage-of-cost-base figure was disclosed for these savings. Separately, the companies disclosed plans to close more than 40 underperforming or non-strategic TBHC stores in early 2026 as part of the broader efficiency strategy. The press release noted that early conversions of Bed Bath & Beyond-branded stores under the existing collaboration arrangement had delivered double-digit sales growth shortly after reopening. At signing, Bed Bath & Beyond advanced $10 million under an existing delayed-draw term loan facility to TBHC (increasing total delayed-draw commitments to $30 million, of which $20 million remained available) to fund store conversions and operations, and the companies amended TBHC's senior secured credit facility with Bank of America to permit the increased borrowing. Closing was conditioned on, among other things, TBHC shareholder approval (including a separate majority-of-disinterested-shareholders vote given Bed Bath & Beyond's status as a large existing shareholder), effectiveness of a Form S-4 registration statement for the Bed Bath & Beyond shares to be issued (File No. 333-292622, declared effective January 30, 2026), NYSE approval to list the additional shares, and a financing condition requiring the refinancing, amendment, or repayment of TBHC's Bank of America credit facility. If the merger agreement were terminated for failure to obtain TBHC shareholder approval, TBHC would owe Bed Bath & Beyond an expense reimbursement fee of $341,800; if terminated in connection with a superior proposal or an adverse board recommendation change, TBHC would owe a termination fee of $1,025,300. TBHC's proxy statement disclosed that the transaction was the culmination of a strategic review process that began in May 2024, when TBHC's board initiated a review in response to a sustained period of post-pandemic operating losses and a letter from a significant beneficial owner urging consideration of strategic alternatives. TBHC's financial advisor, Consensus, contacted more than 75 strategic and financial prospects beginning in mid-2024; twenty of those parties executed confidentiality agreements and conducted due diligence, but TBHC's board determined that Bed Bath & Beyond's proposal was the only one offering a going-concern outcome, as other interested parties were only willing to pursue a transaction structured around a bankruptcy or liquidation process. TBHC's auditor, Ernst & Young LLP, had issued a going-concern qualification in its May 2025 audit report citing recurring operating losses and a working-capital deficiency. Consensus rendered its fairness opinion to the TBHC board on November 21, 2025, concluding the merger consideration was fair, from a financial point of view, to TBHC shareholders. On the legal side, Latham & Watkins LLP served as legal advisor to Bed Bath & Beyond, and Bass, Berry & Sims PLC served as legal advisor to The Brand House Collective, per the joint press release. TBHC shareholders approved the merger agreement at a special meeting held March 17, 2026, with approximately 14.16 million shares voting in favor (versus approximately 421,000 against) of the overall proposal, and approximately 5.23 million of the votes cast by disinterested shareholders in favor (versus the same approximately 421,000 against) under the separate majority-of-disinterested-shareholders requirement. The merger closed on April 2, 2026, per a Form 8-K filed by TBHC, at which point Knight Merger Sub II, Inc. merged with and into TBHC, TBHC became a wholly owned subsidiary of Bed Bath & Beyond, TBHC's board members resigned, TBHC common stock was delisted from Nasdaq, and Bed Bath & Beyond contributed $30,000,000 in capital to TBHC to fund general corporate purposes, including partial repayment of TBHC's outstanding Bank of America indebtedness. TBHC subsequently filed a Form 15-12G to deregister its common stock.

CVR Energy, Inc., a publicly traded petroleum refining and nitrogen fertilizer holding company trading under ticker CVI, completed a $1 billion private offering of senior unsecured notes in two tranches on February 12, 2026. The Company issued $600 million in aggregate principal amount of 7.500% Senior Notes due 2031 and $400 million in aggregate principal amount of 7.875% Senior Notes due 2034. The notes were sold in a private placement under Rule 144A and Regulation S of the Securities Act of 1933, so they were not registered with the SEC. The transaction was first disclosed on January 29, 2026, when CVR Energy announced, subject to market conditions, its intent to offer $1 billion of senior unsecured notes due 2031 and 2034, and it closed on February 12, 2026 under an Indenture dated that same day among the Company, its subsidiary guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2031 Notes mature on February 15, 2031, and the 2034 Notes mature on February 15, 2034, unless earlier redeemed or purchased. Interest on both tranches is payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2026. The notes are fully and unconditionally guaranteed on a senior unsecured, joint and several basis by all of CVR Energy's existing domestic subsidiaries, other than Wynnewood Insurance Corporation, CVR Aviation, LLC, CVR GP, LLC, CVR Partners, LP and their respective subsidiaries, and CHC GP, LLC, RHC GP, LLC and FHC GP, LLC. The filings reviewed do not disclose an issue price, yield to maturity, or credit ratings assigned to the notes; no rating agency press releases were identified in CVR Energy's SEC filings for this offering. CVR Energy disclosed specific, non-generic use of proceeds in the January 29, 2026 launch announcement: net proceeds from the offering, together with cash on hand or borrowings under the Company's senior secured asset-based revolving credit facility (the Petroleum ABL), were intended to (i) repay all outstanding principal under the Company's senior secured term loan facility, (ii) redeem all of its outstanding 8.500% Senior Notes due 2029, and (iii) redeem $217 million in aggregate principal amount of its outstanding 5.750% Senior Notes due 2028. This offering therefore functioned as a refinancing of CVR Energy's term loan and a partial refinancing of its 2028 and 2029 senior notes, extending the Company's maturity profile out to 2031 and 2034. The notes carry call protection and make-whole provisions. CVR Energy may redeem all or part of the 2031 Notes at any time prior to February 15, 2028 at 100% of principal plus a make-whole premium and accrued interest, and may redeem the 2031 Notes on or after February 15, 2028 at redemption prices specified in the Indenture. The Company may also redeem up to 40% of the 2031 Notes prior to February 15, 2028 using net cash proceeds of certain equity offerings, at a redemption price of 107.500% of principal plus accrued interest. The 2034 Notes have parallel structure: redeemable prior to February 15, 2029 at 100% of principal plus a make-whole premium, redeemable at specified prices on or after February 15, 2029, and up to 40% redeemable prior to February 15, 2029 from equity offering proceeds at 107.875% of principal plus accrued interest. If a change of control triggering event occurs, noteholders may require CVR Energy to repurchase the notes at 101% of principal plus accrued interest. The Indenture also requires an offer to purchase notes using unreinvested asset sale proceeds not used to repay certain debt, at 100% of principal plus accrued interest. Because the notes are unsecured and were sold via Rule 144A/Reg S rather than registered, the Indenture contains high-yield-style restrictive covenants limiting CVR Energy and its restricted subsidiaries' ability to, among other things, incur additional indebtedness or issue disqualified equity, create liens on certain assets, pay dividends or make other equity distributions, purchase or redeem capital stock, make certain investments, sell certain assets, restrict subsidiary distributions to the Company, or consolidate, merge, or sell substantially all assets, along with customary events of default. In a related transaction completed the same day, certain CVR subsidiaries and CVR Refining, LP entered into Amendment No. 5 to their Amended and Restated ABL Credit Agreement with Wells Fargo Bank, National Association as administrative and collateral agent. The amendment extended the ABL facility's maturity from June 2027 to February 2031 (subject to a springing maturity tied to certain material indebtedness), increased commitments from $345 million to $550 million (with capacity to increase further to $700 million), removed the letter-of-credit subfacility dollar cap and the credit spread adjustment from SOFR-based pricing, and added a new $25 million restricted payments basket, among other changes. No underwriters, initial purchasers, or bookrunners for the notes offering were named in the filings reviewed. No legal counsel to CVR Energy, the guarantors, the trustee, or any initial purchasers was identified in the 8-K or the Indenture.

This record concerns Fat Brands, Inc, a consumer-retail-sector company, as the target in a Chapter 11 filing. The transaction falls under the restructuring product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published January 27, 2026. The deal's status is pending regulatory, indicating the Chapter 11 process had not yet concluded as of that filing. Two financial advisors are disclosed, both serving the company and both designated lead. GLC Advisors & Co., LLC is serving as investment banker to the company, and Huron Consulting Services LLC is serving as financial advisor to the company, per the source sentence that also notes Latham & Watkins LLP is serving as legal counsel to the company and Omni Agent Solutions, Inc. is serving as claims, noticing, and solicitation agent, a role distinct from financial or legal advisory. The only legal advisor disclosed is Latham & Watkins LLP, serving as legal counsel to the target, Fat Brands, per the source sentence: "Latham & Watkins LLP is serving as legal counsel to the Company." Beyond identifying this as a Chapter 11 filing, the facts block does not specify whether this is a pre-packaged, pre-arranged, or free-fall filing, nor does it provide any detail on the company's debt structure, DIP financing, or plan of reorganization terms. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected timeline for the Chapter 11 process is given. No legal or financial advisor is named for any creditor constituency, and the facts block does not clarify the nature of the Chapter 11 filing (pre-packaged, pre-arranged, or otherwise) beyond the general "Chapter 11 filing" label.

This deal involves Willis Towers Watson plc (ticker WTW), a financial-institutions-group (fig) sector company, as the acquirer of Newfront. The transaction falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published January 27, 2026. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. J.P. Morgan Securities LLC acted as exclusive financial advisor to WTW (the acquirer), with the source sentence noting that Weil, Gotshal & Manges LLP acted as legal advisor to WTW. On the target side, Perella Weinberg served as exclusive financial advisor to Newfront, with Reed Smith LLP serving as legal advisor to Newfront, per the corresponding source sentence. Legal advisors are disclosed for both sides: Reed Smith LLP served as legal advisor to the target, Newfront, while Weil, Gotshal & Manges LLP served as legal advisor to the acquirer, WTW. Beyond describing this as an acquisition of Newfront by WTW, the facts block does not specify the deal's structure in further detail, such as whether consideration is cash, stock, or a mix, nor does it provide any per-unit or aggregate pricing information. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not specify the consideration structure (cash, stock, or a combination) for the acquisition.

This transaction is a follow-on common stock offering by Ambiq Micro, Inc., trading under the ticker AMBQ, classified under the equity capital markets product group. The deal is classified within the technology sector, and the disclosed value of the offering is 83,067,600 dollars. The transaction is sourced from an SEC EDGAR Form 424B4 filing published on January 26, 2026. Based on the facts provided, the deal's status is pending regulatory approval. The underwriting syndicate for this offering includes four named underwriters serving the issuer, Ambiq Micro. BofA Securities and UBS Investment Bank are both identified as holding lead status among the underwriters, while Needham & Company and Stifel are also named as underwriters without a specified lead designation. The source material lists all four firms together under a single listing of underwriters: BofA Securities, UBS Investment Bank, Needham & Company, and Stifel. No legal advisor is identified for the issuer or for the underwriting syndicate in the facts provided for this transaction. Beyond confirming that this is a follow-on common stock offering with a disclosed value of 83,067,600 dollars, no further detail on the number of shares offered or the per-share offering price is included in the facts available. A number of elements of this deal remain undisclosed. No legal advisor to the issuer or underwriters is identified, and no detail is provided on the per-share offering price or the number of shares sold in this follow-on offering. The facts also do not specify an expected closing or settlement date.

This transaction is a cash acquisition taking Alexander & Baldwin, Inc., a real-estate sector company, private, involving Tropic Purchaser LLC and an investor group that includes MW Group Ltd. The deal is classified under the M&A product group, and the disclosed value is not stated in the source document. The facts in this summary come from an SEC EDGAR Form DEFM14A filed and published on January 23, 2026. The transaction's current status is pending regulatory review. Only one financial advisor is identified in the facts block: BofA Securities, Inc. served as financial advisor to the target, Alexander & Baldwin, in a lead capacity. In connection with the merger, BofA Securities delivered to the company's board its oral opinion, later confirmed in a written opinion dated December 8, 2025, addressing the fairness, from a financial point of view, of the merger consideration to be received by holders of the company's common stock, excluding cancelled and dissenting shares. No legal advisors are listed in the facts block for either the target or the acquiring investor group. Beyond the fact that this is a cash acquisition resulting in a take-private of Alexander & Baldwin, and that a fairness opinion was delivered to the board on December 8, 2025, the facts block provides no further detail on the specific per-share price, financing structure, or terms of the merger agreement with Tropic Purchaser LLC and the investor group. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either side. No expected closing date is given, and no detail is provided on the composition or financing sources of the investor group beyond the named entities Tropic Purchaser LLC and MW Group Ltd.

Capital One Financial Corporation, a financial services company trading under ticker COF, acquired Brex Inc., a privately held AI-native business finance platform, in a combination stock-and-cash transaction originally valued at $5.15 billion. The deal was announced January 22, 2026 and has since closed, with Capital One completing the acquisition on April 7, 2026, according to the company's Form 10-K for fiscal year 2025 and its Form 10-Q filings for the first and second quarters of 2026. Capital One Founder, Chairman and Chief Executive Officer Richard D. Fairbank said in the joint announcement that "since our founding, we set out to build a payments company at the frontier of the technology revolution," adding that "acquiring Brex accelerates this journey, especially in the business payments marketplace." Fairbank also said Brex "invented the integrated combination of corporate credit cards, spend management software and banking together in a single platform" and has "taken the rarest of journeys for a fintech, building a vertically integrated platform from the bottom of the tech stack to the top." Brex Founder and CEO Pedro Franceschi said the companies would "maximize founder mode by combining Brex's payments expertise and spend management software with Capital One's massive scale, sophisticated underwriting, and compelling brand to accelerate growth and increase the speed at which we can offer better finance solutions to the millions of businesses in the U.S. mainstream economy." Franceschi was expected to continue leading Brex within Capital One following completion, per the press release. As announced, the transaction was valued at $5,150,000,000 in aggregate consideration, consisting of approximately $2.75 billion in cash and approximately 10.6 million shares of Capital One common stock, subject to adjustments set out in the merger agreement. Capital One's 10-K (covering the period through the January 22, 2026 signing) restated the expected cash portion as approximately $2.58 billion. At closing on April 7, 2026, per the 8-K filed that day, the final consideration paid was approximately $2.56 billion in cash and 10,646,306 shares of Capital One common stock, subject to customary post-closing adjustment. Capital One's Form 10-Q for the quarter ended June 30, 2026 (which finalized the preliminary purchase price allocation) put the fair value of total consideration transferred at $4,521 million, comprising $2,630 million of cash and $1,891 million in fair value of Capital One stock (including $13 million attributable to assumed restricted stock units). Brex's equity was acquired, not merged by tender offer; no separate proxy statement or Form S-4 was required because Brex was a privately held company and the stock portion was issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act, as disclosed in the 8-Ks filed at signing and at closing. Immediately following closing, Capital One paid off (or, per the Q1 2026 10-Q, "settled") Brex's outstanding debt of approximately $1.1 billion, which is reflected in the company's securitized debt obligations and purchase accounting disclosures for the second quarter of 2026. No separate new acquisition debt, bridge facility or financing details beyond this debt payoff were disclosed in the filings reviewed. Under purchase accounting disclosed in the second-quarter 2026 Form 10-Q, Capital One recognized approximately $5.8 billion in acquired assets, consisting primarily of $3.1 billion in goodwill (preliminary), $815 million of loans, $725 million of cash and cash equivalents, $510 million of developed technology (to be amortized over five years), and $432 million of customer relationship and other intangible assets (to be amortized over ten to twelve years). The more detailed Table 2.1 purchase price allocation in that filing showed $2,774 million of preliminary fair value of assets acquired, $1,322 million of preliminary fair value of liabilities assumed, $1,452 million of preliminary net assets acquired, and $3,069 million of preliminary goodwill. Because the Brex acquisition was structured as a nontaxable corporate reorganization, that goodwill is not deductible for tax purposes; it has been preliminarily allocated $2.4 billion to the Credit Card segment and $710 million to the Consumer Banking segment. Results of Brex have been included within Domestic Card, part of Capital One's Credit Card segment, since the second quarter of 2026, and legacy corporate card results were combined with Brex's results in that segment starting that quarter. Capital One disclosed $96 million of integration expenses related to the Brex acquisition in the three and six months ended June 30, 2026, driven primarily by salaries and associate benefits and professional services, recorded within operating expense. No separate run-rate cost synergy target, EPS accretion/dilution estimate, tangible book value dilution figure, or earnback period for the Brex deal was disclosed in any of the filings reviewed (the 8-Ks, the FY2025 10-K, or the Q1 and Q2 2026 10-Qs); these figures are not disclosed, unlike the detailed synergy and accretion metrics banks sometimes publish for larger bank-to-bank mergers. According to the company's background description, Brex offers an AI-native finance platform enabling businesses to issue corporate cards, automate expense management, and make real-time payments, serving more than 25,000 companies in over 50 countries, including named customers such as DoorDash, TikTok, Anthropic, Robinhood, Crowdstrike, Zoom, Plaid, Intel, SeatGeek and the Boston Celtics, per the joint press release. Capital One's FY2025 10-K described the only disclosed closing condition as satisfaction of customary closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. No termination fee was disclosed in the filings reviewed. The transaction closed within the timeframe the companies had targeted ("middle of calendar year 2026" per the original press release, though it closed somewhat earlier, in early April 2026). On the Capital One side, BofA Securities served as financial advisor and Wachtell, Lipton, Rosen & Katz served as legal advisor, with Baker McKenzie providing counsel on certain foreign legal matters. For Brex, Centerview Partners LLC served as financial advisor and Wilson Sonsini, Simpson Thacher and Skadden Arps served as legal advisors, all per the joint press release filed as Exhibit 99.1 to Capital One's January 22, 2026 Form 8-K.

Urban Edge Properties, a real estate sector issuer trading under ticker UE, has announced a leveraged finance credit facility amendment and extension transaction with a disclosed aggregate size of $950 million. This is a structured refinancing involving multiple tranches of debt across different tenors, reflecting a complex capital structure reorganization in the real estate investment sector. The transaction details are sourced from an SEC filing published on the EDGAR system on January 22, 2026. The specific form type has not been identified in the source materials provided. The deal has been announced and is currently in progress, though no closing date or status updates beyond the announcement have been disclosed. The financial advisor landscape is extensive and syndicated across multiple institutions. On the creditor side, the revolving credit facility has Wells Fargo Bank, National Association serving as Administrative Agent, with Wells Fargo Securities, LLC and PNC Capital Markets LLC acting as Joint Lead Arrangers and Joint Bookrunners. The Passive Joint Lead Arrangers for the revolving facility are TD Securities (USA) LLC, Truist Securities Inc., and U.S. Bank National Association. Beyond the lead roles, Bank of America, N.A., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., and Morgan Stanley Bank, N.A. participate in the revolving credit facility. The Documentation Agents for the revolving facility are TD Bank, N.A., Truist Bank, and U.S. Bank National Association. PNC Bank, National Association serves as Syndication Agent for the revolving credit facility. For the 5-year term loan component, Wells Fargo Securities, LLC serves as Administrative Agent and Sole Bookrunner, with Truist Securities Inc. as Joint Lead Arranger. The participants in this tranche include Bank of America, N.A., and U.S. Bank National Association. For the 7-year term loan, PNC Capital Markets LLC acts as Lead Arranger and Sole Bookrunner, while TD Securities (USA) LLC and U.S. Bank National Association serve as Lead Arrangers. TD Bank, N.A. is the Syndication Agent for the 7-year tranche, and Truist Bank participates in this facility along with U.S. Bank National Association. Regarding deal structure and terms, the transaction involves three distinct credit facilities: a revolving credit facility that continues under existing administrative arrangements, a newly amended or extended 5-year term loan, and a 7-year term loan. The roles of the various financial advisors across these facilities reflect a multi-facility capital structure. However, specific details concerning the sizing of individual tranches, the coupon or pricing of the facilities, any fees or pricing grids, the amortization schedule, or the exact nature of the amendments and extensions to existing credit agreements have not been disclosed in the available source materials. The briefing cannot address several material points that remain unknown: the specific tenor and pricing terms for each facility component are not disclosed; the breakdown of the $950 million aggregate among the three tranches is not specified; the reasons for or strategic drivers behind the amendment and extension are not stated; the expected closing date is not provided; any changes to financial covenants or other material terms are not detailed; and the underlying financial metrics or company circumstances motivating the refinancing remain undisclosed.

Blue Owl Technology Finance Corp., trading under ticker OTF, priced and closed a public offering of $400,000,000 aggregate principal amount of 6.125% Notes due 2031. The notes were priced on January 20, 2026 and settled on January 23, 2026, with the transaction documented in a preliminary prospectus supplement and pricing term sheet dated January 20, 2026, a final prospectus supplement dated January 21, 2026, and a closing Form 8-K filed January 23, 2026 that reported execution of a Sixth Supplemental Indenture to the Company's base indenture dated June 12, 2020. The notes were priced at 98.835% of principal amount to yield 6.401% to maturity, representing a spread of 255 basis points over the benchmark 3.625% Treasury due December 31, 2030. The notes carry a fixed 6.125% coupon paid semiannually on January 23 and July 23 of each year, commencing July 23, 2026, and mature on January 23, 2031. They are direct, general unsecured obligations of the Company. Moody's, S&P and Fitch assigned ratings of Baa3, BBB-, and BBB-, respectively, each with a stable outlook. Blue Owl Technology Finance Corp. estimated net proceeds of approximately $390.9 million after underwriting discounts and commissions and estimated offering expenses of approximately $1.2 million. The Company stated it would use the proceeds to pay down existing indebtedness under its Revolving Credit Facility, which bears interest at SOFR plus an applicable margin and matures December 20, 2029. The prospectus supplement noted that affiliates of certain underwriters are lenders under the Revolving Credit Facility and could therefore receive more than 5 percent of the offering proceeds through paydown of that facility. Prior to December 23, 2030 (the par call date, one month before maturity), the Company may redeem the notes at a make-whole price equal to the greater of the present value of remaining scheduled payments discounted at the applicable Treasury rate plus 40 basis points, or 100% of principal, plus accrued interest. On or after the par call date, the notes are redeemable at par plus accrued interest. If a change of control repurchase event occurs (a change of control combined with a ratings downgrade of the notes below investment grade by Moody's, S&P and Fitch), noteholders may require the Company to repurchase the notes at 100% of principal plus accrued and unpaid interest. The indenture includes a covenant requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A) of the Investment Company Act of 1940, as modified by Section 61(a), and to provide financial information to noteholders if the Company ceases to be subject to Exchange Act reporting requirements. The offering was led by ten joint book-running managers: Mizuho Securities USA LLC ($59 million allocation), BofA Securities, Inc. ($51 million), MUFG Securities Americas Inc. ($51 million), SMBC Nikko Securities America, Inc. ($51 million), U.S. Bancorp Investments, Inc. ($44 million), ING Financial Markets LLC ($16 million), Regions Securities LLC ($16 million), SG Americas Securities, LLC ($16 million), Synovus Securities, Inc. ($16 million), and Truist Securities, Inc. ($16 million). Eight co-managers each took $8 million allocations: Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Natixis Securities Americas LLC, R. Seelaus & Co., LLC, RBC Capital Markets, LLC, Scotia Capital (USA) Inc., and Siebert Williams Shank & Co., LLC. Eversheds Sutherland (US) LLP acted as legal counsel to Blue Owl Technology Finance Corp. and its investment adviser in connection with the offering. Kirkland & Ellis LLP acted as legal counsel to the underwriters. The notes have CUSIP 095924 AC0 and ISIN US095924AC09 and were issued under the Company's existing shelf registration statement on Form N-2 (File No. 333-289793).

Community Health Systems, Inc. (NYSE: CYH), through its subsidiary CHS/Community Health Systems, Inc., agreed on January 20, 2026 to sell substantially all of the assets of Crestwood Medical Center, a 180-licensed-bed hospital in Huntsville, Alabama, and its associated outpatient centers and practices, to The Health Care Authority of the City of Huntsville, doing business as Huntsville Hospital Health System. The agreement was disclosed in a Form 8-K filed with the SEC that attached the Asset Purchase Agreement as Exhibit 2.1. The base purchase price under the Asset Purchase Agreement was $450 million, subject to adjustment for net working capital as of the effective time and for finance lease obligations assumed by the buyer (as scheduled in the agreement), with any post-closing working capital adjustment to be determined within 90 days after closing. The agreement's closing conditions for the buyer included satisfaction of the seller's representations and warranties, receipt of required governmental approvals, issuability of title policies, absence of a material adverse change, and receipt of material third-party consents; the seller's conditions included satisfaction of the buyer's representations and warranties, receipt of governmental approvals, and absence of buyer insolvency. The agreement contemplated post-closing transition services agreements covering information technology, hospital and clinic operations, billing, and Medicare/Medicaid matters. No termination fee is disclosed in the filed agreement excerpts, and no legal advisors to either party are identified in the filings reviewed. The transaction closed on April 1, 2026, as reported in a subsequent Form 8-K (Item 2.01) filed by Community Health Systems. At closing, the purchase price actually paid to CHS, after giving effect to estimated working capital and before transaction expenses, was $459 million in cash, subject to a further post-closing working capital adjustment. Leerink Partners served as exclusive financial advisor to Community Health Systems (the seller) on the transaction; no financial advisor to Huntsville Hospital Health System (the buyer) is identified in the filings. Community Health Systems filed unaudited pro forma condensed consolidated financial statements reflecting the sale as if it had occurred on December 31, 2025 (balance sheet) and January 1, 2025 (income statement). On a pro forma basis, cash and cash equivalents would have increased by $450 million (the $459 million in proceeds net of $9 million of transaction expenses) to $710 million, and total assets would have increased from $13,204 million to $13,343 million. Total stockholders' deficit would have improved from $(1,159) million to $(1,021) million, reflecting a $138 million after-tax gain on the sale. The gain was calculated as $459 million of consideration received, less $9 million of transaction expenses, less a $136 million carrying value of the facility, and less $129 million of allocated goodwill, yielding a $185 million pretax gain ($138 million after a $47 million tax provision). For the year ended December 31, 2025, pro forma net operating revenues would have been reduced by $327 million and total operating costs and expenses by $483 million to reflect the elimination of the divested facility's results, while pro forma basic loss per share would have increased from $3.81 to $4.57 (diluted: $3.77 to $4.52), driven by the combination of eliminated operating income and the tax effects of the pro forma adjustments. The company's subsequent quarterly disclosures (its first-quarter 2026 results press release) separately confirmed that of the hospitals divested by Community Health Systems during 2026 through that filing date, one group of facilities was completed effective April 1, 2026, which corresponds to the Crestwood transaction. No sector-specific synergy figures, exchange ratio, stock consideration, or financing/new debt details are disclosed in connection with this transaction, as it was an all-cash asset sale. No legal advisors for either Community Health Systems or Huntsville Hospital Health System are identified anywhere in the filings reviewed, and no termination fee was disclosed.

Okeanis Eco Tankers Corp., a Marshall Islands-incorporated international tanker owner trading under ticker ECO on the NYSE and OET on the Oslo Stock Exchange, priced a registered direct offering of 3,239,436 new common shares at USD 35.50 per share on November 19, 2025, raising gross proceeds of USD 114,999,978. The offering was announced on November 18, 2025, alongside two memoranda of agreement to purchase newbuilding Suezmax tanker vessels (sister ships to vessels already in the fleet, each under construction at Daehan Shipbuilding Co., Ltd. in South Korea) for an acquisition price of USD 97.0 million per vessel. The offering priced at $35.50 per share, a discount of approximately 8.8 percent to the November 17, 2025 NYSE closing price of $38.94. The offering was structured as an accelerated bookbuild / registered direct offering to several investors under the company's effective shelf registration statement on Form F-3 (File No. 333-287032, declared effective May 21, 2025), rather than a traditional underwritten public offering; the placement agents purchased no shares and had no commitment to buy any shares. Fearnley Securities AS acted as global coordinator and joint bookrunner and Clarksons Securities AS acted as joint bookrunner (together, the "Placement Agents"); Pareto Securities AS was not a participant in this November 2025 offering (it joined as a third placement agent only in a subsequent, separate January 2026 offering by the company). As compensation, the company agreed to pay the placement agents a cash fee equal to 3.25% of gross proceeds (plus up to an additional discretionary 0.25%), equating to $1.15375 per share, or $3,737,499.29 in aggregate fees on the shares sold to non-affiliates, plus reimbursement of up to $20,000 of offering expenses plus legal and other out-of-pocket expenses. Net proceeds to the company, before expenses, were disclosed as $111,262,478.71 (or $34.34625 per share), with the prospectus supplement separately estimating net proceeds of approximately $110.7 million after deducting placement agent fees and other estimated offering expenses. No over-allotment or greenshoe option was disclosed in connection with this offering, and no concurrent share repurchase was announced alongside it. The company stated it intended to use all net proceeds from the offering to partially fund the acquisition of the two newbuilding Suezmax vessels referenced above, with the balance of the purchase price expected to be funded through cash on hand, loan or sale-leaseback arrangements, or a combination thereof. If one or both vessel acquisitions were not consummated, net proceeds were to be redirected to general corporate purposes. The offering was not conditioned on completion of the vessel acquisitions. On a dilution basis, the company had 32,194,108 common shares outstanding (excluding 695,892 shares held in treasury) immediately prior to the offering; the 3,239,436 new shares issued represented dilution of approximately 10.1 percent of shares outstanding, increasing the share count to 35,433,544 shares immediately after the offering. The prospectus supplement disclosed a historical net tangible book value of $429.8 million, or $13.35 per share, as of September 30, 2025, which was expected to increase to an as-adjusted $540.5 million, or $15.25 per share, after the offering, representing an immediate $1.90 per share increase in net tangible book value to existing shareholders and immediate dilution of $20.25 per share to new investors in the offering. On the announcement, Advokatfirmaet BAHR AS acted as Norwegian legal counsel and Watson Farley & Williams LLP acted as US legal counsel to the company, while Advokatfirmaet Thommessen AS acted as Norwegian legal counsel and Seward & Kissel LLP acted as US legal counsel to the placement agents (Managers). Watson Farley & Williams LLP separately delivered the legal opinion as to the validity of the common shares issued, filed as Exhibit 5.1 to the company's Form 6-K dated November 20, 2025, which also disclosed the engagement letter (dated November 17, 2025) among the company, Clarksons Securities AS and Fearnley Securities AS, and the form of application agreement used with investors. Timing ran from announcement on November 18, 2025 (bookbuilding commencing that evening) to pricing and allocation on November 19, 2025, with closing and delivery of shares through DTC, and listing on the NYSE, expected on or about November 21, 2025. The final prospectus supplement was filed with the SEC on Form 424B5 on November 20, 2025. This transaction is distinct from, and precedes, the company's subsequent and separate January 2026 registered direct offering of common shares (which priced at $36.00 per share for gross proceeds of approximately $130 million and added Pareto Securities AS as a third placement agent), which should not be conflated with this November 2025 offering despite both being linked to related Suezmax newbuilding vessel acquisitions from Daehan Shipbuilding Co., Ltd.

GSK plc, through its subsidiary GlaxoSmithKline LLC, acquired RAPT Therapeutics, Inc. in an all-cash tender offer and second-step merger valued at an estimated aggregate equity value of $2.2 billion, or $1.9 billion net of RAPT's cash. The deal was announced on January 20, 2026 via a joint press release and was structured as a cash tender offer under the Agreement and Plan of Merger dated January 19, 2026, rather than a one-step shareholder vote merger. The transaction has since closed: GlaxoSmithKline LLC's acquisition subsidiary, Redrose Acquisition Co., completed its tender offer on March 3, 2026, with approximately 30,137,567 shares (about 93.36% of RAPT's then-outstanding shares) validly tendered, and the companies completed a back-end merger that same day under Section 251(h) of the Delaware General Corporation Law, with no RAPT stockholder vote required. RAPT now operates as a direct, wholly owned subsidiary of GlaxoSmithKline LLC. The strategic rationale centers on RAPT's lead asset, ozureprubart, a long-acting anti-IgE monoclonal antibody in Phase IIb development for prophylactic protection against food allergens. GSK's Chief Scientific Officer, Tony Wood, said: "The addition of ozureprubart brings another promising new, potential best-in-class treatment to GSK's pipeline... Ozureprubart offers the opportunity to bring sustained protection to patients with dosing every 12 weeks, and is consistent with our approach to acquire assets that address validated targets and where there is clear unmet medical need." RAPT's President and CEO, Brian Wong, said the deal "offers an attractive path forward for our programs, particularly the opportunity we envision for ozureprubart in food allergy" and would provide "access to the global development and commercialisation capabilities, resources and infrastructure that GSK has to offer." The transaction gives GSK global rights to ozureprubart excluding mainland China, Macau, Taiwan and Hong Kong; GSK assumes responsibility for success-based milestone and royalty payments owed to RAPT's China-market partner, Shanghai Jeyou Pharmaceutical Co., Ltd. Under the terms of the agreement, GSK paid $58.00 per RAPT share in cash. GSK stated the purchase price would be funded entirely with cash on hand, with no external debt financing and no financing condition attached to the offer. As a clinical-stage biopharmaceutical company with no material revenue, RAPT's valuation was assessed using a discounted cash flow analysis rather than revenue or EBITDA multiples; J.P. Morgan, the company's financial advisor, modeled unlevered free cash flows for fiscal years 2026 through 2047 based on management projections, discounted at rates of 12.0% to 14.0%, adjusted for an assumed net cash position of $390 million as of December 31, 2025, dilution from assumed future equity raises, and tax savings from net operating losses of $318 million as of December 31, 2024. This analysis produced an implied equity value range of $49.45 to $62.05 per share, which J.P. Morgan compared to the $58.00 offer price. The $58.00 per share offer price represented an approximately 65% premium to RAPT's $35.10 closing price on January 16, 2026 (the last trading day before signing), a 70% premium to the 30-day volume-weighted average price, a 97% premium to the 90-day volume-weighted average price, and a 58% premium to the highest closing price in the preceding 52 weeks. According to RAPT's Schedule 14D-9, GSK's offer progressed through three increases during negotiations: an initial non-binding proposal of $50.00 per share in cash on December 22, 2025; a revised proposal of $53.00 per share in cash plus a $4.00 per share contingent value right (CVR) tied to initiation of a pivotal Phase 3 trial of ozureprubart in food allergy by year-end 2027, submitted December 23, 2025; a further revised proposal of $55.50 per share in cash plus a CVR on December 30, 2025; and finally $58.00 per share in cash with no CVR, which RAPT's board viewed as reducing risk to stockholders relative to the earlier offers' contingent consideration. J.P. Morgan rendered a fairness opinion to RAPT's board on January 19, 2026, concluding the offer price was fair, from a financial point of view, to RAPT stockholders. Per the Schedule 14D-9's "Background of the Offer" narrative, GSK first approached RAPT in September 2025 regarding ozureprubart partnering, with discussions evolving toward an acquisition proposal by December 2025. At the board's direction, J.P. Morgan contacted eight other potential strategic counterparties to solicit competing interest; one unnamed publicly traded global pharmaceutical company ("Party A") received a management presentation but did not submit a proposal, and all others formally declined or did not respond. The board concluded GSK's $58.00 per share, all-cash offer represented the highest value reasonably obtainable and the best alternative available to stockholders, citing certainty of value, the absence of financing conditions, and the results of the market check. The merger agreement specifies a termination fee payable by RAPT to GSK of $78,400,000 under specified circumstances, such as RAPT's board changing its recommendation or accepting a superior proposal. The deal closed within the first quarter of 2026 as the parties had targeted, following a cash tender offer that commenced February 2, 2026 and expired March 2, 2026, subject to a minimum tender condition and clearance under the Hart-Scott-Rodino Antitrust Improvements Act; the original closing 8-K confirms the HSR waiting period requirement was satisfied as a condition of the merger's completion. In connection with closing, RAPT's common stock was delisted from Nasdaq and its outstanding equity awards (options, RSUs and warrants) were cancelled and converted into cash-based rights tied to the $58.00 merger consideration, with certain post-March-2025 equity grants subject to a vesting schedule (50% at closing, 50% nine months later or upon an involuntary termination, if earlier). Evercore served as exclusive financial advisor and A&O Shearman served as legal counsel to GSK. J.P. Morgan Securities LLC served as exclusive financial advisor and Cooley LLP served as legal counsel to RAPT Therapeutics.

This transaction is a cash merger with a contingent value right (CVR) attached, in which TreeHouse Foods, Inc., a company in the consumer-retail sector, is the target being acquired by Industrial F&B Investments II, Inc., an affiliate of Investindustrial. The deal falls under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on January 20, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Goldman Sachs served as financial advisor to the target, TreeHouse Foods, and is designated as lead advisor. Goldman Sachs representatives discussed the firm's financial analyses of the potential transaction with the TreeHouse board and rendered an oral opinion, later confirmed in a written opinion dated November 10, 2025, that the merger consideration to be paid to the company's stockholders was fair from a financial point of view to those holders. No financial advisor was disclosed on the acquirer side in the facts block. Legal counsel was disclosed only for the target: Jones Day is named as legal advisor to TreeHouse Foods, noted as present (along with Goldman Sachs and senior management) at a November 9, 2025 board meeting. No legal advisor was disclosed for the acquirer side. Beyond the structure noted in the subtype description, cash merger consideration paired with a contingent value right, the facts block does not specify the cash amount, the CVR's terms, or any triggers or milestones associated with it. Several material facts are not disclosed in the source material. The overall deal value is not stated. No financial or legal advisor is identified for the acquirer, Industrial F&B Investments II/Investindustrial. The facts block also does not disclose an expected closing date, nor does it specify the dollar value of the cash component of the merger consideration or the detailed mechanics of the CVR.

This deal is a take-private cash acquisition in which Denny's Corp, a company in the consumer-retail sector, is the target being acquired by a group that includes TriArtisan Capital Advisors LLC, Treville Capital Group, and Yadav Enterprises. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on January 16, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Truist Securities served as financial advisor to Denny's Corporation, the target, and is designated as lead advisor. On the acquirer side, Global Leisure Partners LLP served as financial advisor to TriArtisan and is also designated as lead advisor. Legal counsel was disclosed extensively for this transaction. On the target side, three firms served as Denny's legal advisors: Morgan, Lewis & Bockius LLP, Sidley Austin LLP, and Caiola & Rose, LLC. On the acquirer side, Ropes & Gray LLP served as legal counsel to TriArtisan, Choate, Hall & Stewart LLP served as legal counsel to Treville, and Yadav Enterprises was advised by its General Counsel, Steven M. Kries, rather than outside counsel. Beyond the cash consideration implied by the "cash acquisition" subtype, the facts block does not disclose a per-share purchase price or other specific terms of the transaction. Several facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not give a per-share cash price, nor does it specify an expected closing date for the transaction.

This deal is a cash acquisition with an earnout component, classified as an M&A transaction in the tech sector, involving Altamira Technologies Corporation as target and Parsons Corp (ticker PSN) as acquirer. The disclosed value of the transaction is $375,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on January 15, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Baird acted as exclusive financial advisor to Altamira, the target, in a lead capacity, while Barclays acted as exclusive financial advisor to Parsons, the acquirer, also in a lead capacity, per the same source sentence naming both firms' respective exclusive roles. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either side of the transaction. Beyond the cash consideration with an earnout structure, with a disclosed deal value of $375,000,000, no further detail on the specific earnout terms, milestones, or the split between upfront cash and earnout payments is provided in the facts block. Several items are not disclosed in the available record. No legal advisors for either party are identified, and the specific earnout mechanics (milestones, caps, timing) referenced by the 'cash acquisition with earnout' subtype are not further detailed. No expected closing date or further timeline detail beyond the January 2026 filing date and pending-regulatory status is given.

This deal is an asset manager acquisition in which Raymond James Financial Inc (ticker RJF), a company in the financial institutions group (FIG) sector, is the acquirer of Clark Capital Management Group, Inc., the target. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on January 15, 2026. The deal's current status is pending regulatory approval. On the financial advisory side, Evercore acted as exclusive financial advisor to Clark Capital, the target, and is designated as lead advisor. On the acquirer side, Raymond James & Associates, Inc. acted as financial advisor to Raymond James (the parent acquirer) in connection with the transaction, with no lead designation specified. Legal counsel was also disclosed for both sides. Paul Weiss acted as legal advisor to Clark Capital, the target. Eversheds Sutherland acted as legal advisor to Raymond James, the acquirer. Beyond its characterization as an asset manager acquisition, the facts block provides no further detail on consideration structure, such as whether the purchase price is cash, equity, or some combination, nor on the specific assets under management or other operational metrics involved. Several material facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not specify the consideration structure for the acquisition, nor does it give an expected closing date.

LXP Industrial Trust, a real estate investment trust trading under the ticker LXP, is the issuer in this leveraged finance transaction within the real estate sector. The deal involves a refinancing of a revolving credit facility and term loan with a disclosed aggregate principal amount of 850 million dollars. This is a levfin product within the real estate sector, classified as a revolving credit facility and term loan refinancing. The transaction was announced on January 14, 2026, and sourced from an SEC filing published on that date via SEC EDGAR. The specific form type of the filing has not been identified. The deal is currently in announced status, meaning the transaction has been publicly disclosed but the closing has not yet occurred. The financing structure involves a substantial syndicate of financial institutions across multiple roles. KeyBank National Association serves as the Administrative Agent. The three joint lead arrangers and joint bookrunners are KeyBanc Capital Markets, Inc., Wells Fargo Securities, LLC, and Regions Capital Markets. Wells Fargo Bank, National Association and Regions Bank both serve as syndication agents. The documentation agents for the transaction include Bank Of America, N.A., Citizens Bank, N.A., Mizuho Bank, Ltd., JPMorgan Chase Bank, N.A., PNC Bank, National Association, TD Bank, N.A., and U.S. Bank National Association. Associated Bank, National Association participated in the transaction as a lender. No legal advisors have been identified in the available documentation for this transaction. The transaction structure is characterized as a revolving credit facility and term loan refinancing with a total disclosed size of 850 million dollars. However, no additional structural details have been disclosed regarding the specific allocation between the revolving facility and term loan components, tenor or maturity dates for either facility, interest rate pricing or structure, or any other terms and conditions governing the credit agreement. The disclosed transaction value and facility structure are the primary elements of public knowledge regarding this deal. Not disclosed are the specific amounts allocated to the revolving facility versus the term loan portions, pricing terms and margin spreads, expected closing date, any financial covenants or conditions precedent to closing, whether there are any accordion or commitment increase features, or the tenor of each facility component. Additionally, no information has been disclosed regarding the uses of proceeds or any other negotiated economic terms.

Array Digital Infrastructure, Inc. (NYSE: AD), the former United States Cellular Corporation and now a shared wireless tower infrastructure company approximately 82%-owned by Telephone and Data Systems, Inc. (TDS), announced the successful closing of its previously announced agreement to sell a portion of its retained spectrum licenses to AT&T for total consideration of $1.018 billion. Following the closing, Array's board declared a special cash dividend of $10.25 per common share and Series A common share. The deal sits in the telecommunications sector (SIC 4812, radiotelephone communications). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Array Digital Infrastructure, Inc. with the SEC on January 13, 2026, announcing closing of the transaction. This spectrum sale furthers an objective announced on May 28, 2024, to opportunistically monetize spectrum not included in Array's prior sale of wireless operations to T-Mobile, which closed August 1, 2025. The special dividend was payable February 2, 2026 to shareholders of record January 23, 2026. On financial advisory, Citigroup Global Markets Inc. served as lead financial advisor and Centerview Partners LLC served as financial advisor to Telephone and Data Systems, Inc. (TDS) in connection with the AT&T transaction; TD Securities (USA) LLC and Wells Fargo also served as financial advisors to TDS. Separately, PJT Partners LP served as financial advisor to the independent directors of Array, reflecting the related-party dynamic given TDS's majority ownership of Array. On legal advisory, Wilkinson Barker Knauer, LLP served as lead transactional and FCC regulatory counsel to both TDS and Array, Clifford Chance LLP served as regulatory advisor to both companies, Sidley Austin LLP served as legal advisor to TDS specifically, and Cravath, Swaine & Moore LLP served as legal advisor to the independent directors of Array. The deal structure disclosed is a straightforward asset sale of spectrum licenses for $1.018 billion in total consideration, which had already closed as of the announcement, funding a subsequent special shareholder dividend. What is not disclosed: the press release does not break out the $1.018 billion consideration by spectrum band or geography, does not state a separate equity versus enterprise value distinction (the sale is of specific assets, not the whole company), and does not disclose individual advisor fees.

AT&T Inc., a major telecom sector participant, is acquiring assets from Telephone and Data Systems, Inc. (TDS) in an asset sale transaction valued at $1,018,000,000. The deal was announced as of the publication date of the source documents. The transaction details are sourced from SEC EDGAR filings published on January 13, 2026. The specific SEC filing form type is not disclosed in the available documentation. The deal has been announced and is currently in process, though no expected closing date is provided. On the target side advising TDS, Citigroup Global Markets Inc. served as lead financial advisor, alongside Centerview Partners LLC and Wells Fargo, both acting as financial advisors. TD Securities (USA) LLC also provided financial advisory services to TDS. For AT&T on the acquirer side, PJT Partners LP served as financial advisor. The financial advisory team was therefore split among multiple firms across both parties, with Citigroup holding the lead role among TDS advisors. On the legal side, TDS retained multiple counsel. Sidley Austin LLP served as legal advisor to TDS, while Wilkinson Barker Knauer, LLP acted as lead transactional and FCC regulatory counsel to both TDS and AT&T. Clifford Chance LLP served as regulatory advisor to both parties. For AT&T's independent directors, Cravath, Swaine & Moore LLP provided legal advice. The regulatory complexity of this telecom asset transaction is reflected in the involvement of specialized regulatory counsel across both sides. The transaction is structured as an asset sale with a disclosed consideration amount of $1,018,000,000 in USD. However, the specific composition of consideration, whether cash, stock, or a mix, is not disclosed in the available documentation. No details regarding payment terms, closing conditions, or the specific assets being transferred have been extracted from the source materials. The briefing contains several material gaps that would be necessary for complete deal discussion. The exact closing date or expected timeline for completion is not disclosed. The specific composition and structure of the consideration is not specified. The particular assets, business units, or operations being transferred from TDS to AT&T are not identified. Finally, while a form type is referenced as coming from SEC EDGAR, the specific SEC filing form (such as 8-K, S-4, or other disclosure document) is not identified in the extracted information.

KALA BIO, Inc., a healthcare sector company trading under the ticker KALA, entered into an At The Market Offering Agreement (the Sales Agreement) with H.C. Wainwright & Co., LLC on January 8, 2026, providing for the sale and issuance of shares of common stock, par value $0.001 per share, having an aggregate offering price of up to $15,000,000. The transaction was documented in a Form 8-K filed with the SEC on January 8, 2026, and in a prospectus supplement on Form 424B5, also dated and filed January 8, 2026, under the company's existing shelf registration statement on Form S-3 (File No. 333-270263), initially filed March 3, 2023 and declared effective May 11, 2023. The prospectus supplement discloses that shares may be sold from time to time through Wainwright acting as sales agent or principal, using any method permitted under Rule 415(a)(4) of the Securities Act, including ordinary brokerage transactions on Nasdaq, sales to or through a market maker, or, with KALA's prior written approval, privately negotiated or block transactions. Wainwright is not obligated to sell any specific number or dollar amount of shares, and the gross sales price will be the prevailing market price on Nasdaq at the time of each sale. For illustrative purposes only, the prospectus supplement calculates that the full $15,000,000 would equate to approximately 24,150,700 shares at an assumed offering price of $0.6211 per share, the last reported Nasdaq sale price on January 2, 2026, which would bring shares outstanding to approximately 52,000,425 from a base of 27,849,725 shares outstanding as of December 31, 2025 (before giving effect to outstanding options, pre-funded warrants, warrants, RSUs, and convertible preferred stock). The cover page separately notes that the last reported sale price on January 7, 2026, the trading day before the Sales Agreement was signed, was $0.665 per share. Because the ATM is a continuous program with sales made at prevailing market prices rather than a single priced transaction, the filings do not disclose a discrete premium or discount to a specific reference price, nor do they disclose any greenshoe or over-allotment option, which is not a standard feature of ATM programs. Wainwright will be entitled to a sales commission equal to 3.0% of the gross sales price of shares sold under the Sales Agreement, and KALA has agreed to reimburse Wainwright up to $50,000 for legal fees and expenses incurred in connection with entering into the agreement, plus up to $3,500 per due diligence update on each representation date. In connection with the offering, Wainwright will be deemed an "underwriter" within the meaning of the Securities Act, and its compensation will be deemed underwriting commissions or discounts. KALA has agreed to provide customary indemnification and contribution rights to Wainwright. On use of proceeds, KALA states it currently intends to use net proceeds for general corporate purposes, including working capital, pending investment in short- and intermediate-term capital preservation instruments. However, the prospectus supplement also discloses mandatory proceeds sweeps tied to other financing arrangements: under the terms of a Loan Agreement, in the event KALA or its subsidiary obtains debt financing or receives proceeds from the sale of securities or other indebtedness, 25% of such proceeds must be used to repay the loan, due on the one-year anniversary of receipt and bearing 15% simple interest per annum; and under an Oxford Settlement Agreement, 10% of proceeds from the sale and issuance of equity securities on or after a defined shareholder meeting date must be paid directly to Oxford as collateral agent, without deduction, up to a maximum of $1,000,000. Haynes and Boone, LLP, New York, New York, passed on the validity of the shares for KALA as issuer's counsel and delivered the legal opinion filed as Exhibit 5.1 to the 8-K. Wainwright was represented in the offering by Ellenoff Grossman & Schole LLP, New York, New York, as disclosed in the prospectus supplement's Legal Matters section. The company's Form 10-Q for the quarter ended March 31, 2026 (filed May 15, 2026) confirms the ATM Agreement remained in place with $15.0 million of common stock still eligible for sale as of that filing date, and describes the ATM as one of several financing alternatives (alongside private placements and asset monetization) the company was evaluating to extend its cash runway into the second quarter of 2027; it does not disclose any shares having yet been sold or proceeds raised under this specific ATM program. No pricing 8-K, free-writing prospectus, or closing/termination announcement specific to actual sales under the January 2026 Sales Agreement has been identified. A separate, later at-the-market prospectus supplement was filed by KALA on July 22, 2026 under a different, newly effective shelf registration statement (File No. 333-295667); because that filing relates to a distinct registration statement and Sales Agreement rather than an update to the January 8, 2026 program, it is treated as a separate transaction and is not incorporated into this summary. The deal remains in announced status, with no explicit confirmation found that the January 2026 ATM program has closed, been fully utilized, or been terminated.

Bank First Corporation (Nasdaq: BFC), the Manitowoc, Wisconsin-based holding company of Bank First, N.A., agreed to acquire Centre 1 Bancorp, Inc. ("Centre"), the Beloit, Wisconsin-based holding company of The First National Bank and Trust Company, in an all-stock transaction. The deal was announced on July 18, 2025 via a signed Agreement and Plan of Merger dated July 17, 2025, and closed effective January 1, 2026, as confirmed by a Form 8-K filed January 2, 2026 reporting completion under Item 2.01. The merger is therefore closed, not pending; Bank First completed the acquisition and the combined bank now operates under the Bank First, N.A. name, with First National Bank and Trust continuing to operate as a division until a planned system conversion in May 2026. Under the terms of the merger agreement, each share of Centre common stock was converted into the right to receive 0.9200 of a share of Bank First common stock, plus cash in lieu of fractional shares. At announcement, the aggregate consideration was valued at approximately $174.3 million, based on Bank First's July 17, 2025 closing price of $125.78 per share. Bank First issued approximately 1,382,978 shares of its common stock to former Centre shareholders at closing. In the Form S-4/A registration statement (proxy statement/prospectus), Centre's financial advisor Hovde Group, LLC calculated a total assumed merger value of $167,958,493 (as of the July 17, 2025 signing, using a $121.22 Bank First share price), implying a Price-to-LTM Earnings Multiple of 26.3x, a Price-to-Tangible Book Value Multiple of 204.4%, and a Premium-to-Core Deposits Multiple of 7.24%, based on Centre's March 31, 2025 financials. Upon completion, Centre shareholders were expected to own approximately 12.3% of the combined company, with Bank First shareholders owning the remainder. The merger agreement includes a tangible-book-value-based adjustment mechanism to the merger consideration (Section 2.02) and a price-protection/walk-away right for Centre if Bank First's average closing stock price falls below $110.06 and underperforms the Nasdaq Bank Index by more than 12.5%, unless Bank First elects to adjust the exchange ratio. Strategically, Bank First characterized the deal as combining "two strong community banks" with deep community roots, extending Bank First's footprint into southern Wisconsin and northern Illinois (the "Stateline" region) in what the company called its first out-of-state expansion into non-overlapping, relationship-driven markets. As of June 30, 2025, First National Bank and Trust had approximately $1.55 billion in consolidated assets, $994.9 million in gross loans, $1.29 billion in deposits, and $112.6 million in stockholders' equity; the combined company was expected to have total assets of approximately $5.91 billion. Following closing, Bank First's January 2, 2026 press release stated the combined organization operates 38 branch locations across Wisconsin and the Stateline area of Illinois with approximately $6 billion in assets. Bank First CEO Mike Molepske said, "This partnership brings together two long-standing, community-focused institutions united by a shared commitment to responsive, relationship-based banking." Centre CEO Steve Eldred said, "Joining forces with Bank First allows us to build on a legacy of trust and service while expanding opportunities to care for the communities we serve." Eldred joined the Bank First and Bank First, N.A. boards of directors following closing. No specific dollar synergy or cost-savings figure was disclosed; the S-4/A proxy explicitly states that anticipated cost savings and revenue synergies were not incorporated into the pro forma financial adjustments, and the pro forma combined financial statements filed as Exhibit 99.3 to the 8-K/A (filed March 16, 2026) likewise exclude integration costs or synergy benefits. No EPS accretion/dilution percentage or tangible book value earnback period was disclosed in the reviewed filings, though the proxy notes Bank First's board considered "projected potential accretion to earnings per share and the projected payback period of the estimated decrease in tangible book value" in its own (unquantified, in the public filings reviewed) deliberations. According to the "Background of the Merger" section of the S-4/A, Centre and Bank First's relationship began in 2020 through loan participations, with exploratory discussions beginning in earnest in January 2025 and a formal non-binding indication of interest delivered by Bank First on May 23, 2025 (valuing Centre at $141-144 million). The price was negotiated upward through a June 7, 2025 revised offer (0.9200 exchange ratio, $155.5 million) before the parties signed the definitive agreement on July 17, 2025. The process was a bilateral negotiation; the proxy does not describe a competitive auction or other bidders. Centre's board received a fairness opinion from Hovde Group, LLC, dated July 17, 2025, and Bank First's board received a financial analysis from Piper Sandler & Co. on July 15, 2025. The merger agreement provided for a termination fee of $5,300,000 (calculated in the agreement as $5,038,755 based on Bank First's July 16, 2025 closing price, though the proxy summary states the fee as $5,300,000) payable by Centre to Bank First under specified circumstances, including a change in board recommendation or acceptance of a superior proposal. Required regulatory approvals included the Board of Governors of the Federal Reserve System, the Office of the Comptroller of the Currency (for the bank-level merger of First National Bank into Bank First, N.A.), and the Wisconsin Department of Financial Institutions, in addition to approval by Centre's shareholders; Bank First filed its Bank Holding Company Act notification for the acquisition on August 15, 2025. The transaction was structured to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. Piper Sandler & Co. served as financial advisor to Bank First, and Alston & Bird LLP served as legal counsel to Bank First. Hovde Group, LLC served as financial advisor to Centre, and Barack Ferrazzano Kirschbaum & Nagelberg LLP served as legal counsel to Centre, confirmed in both the July 18, 2025 announcement press release and the January 2, 2026 closing press release.

ModivCare Inc, a company operating in the transportation-infrastructure sector, is the subject of a Chapter 11 reorganization and asset sale. This is a restructuring transaction, classified as a bankruptcy reorganization combined with a disposal of assets. The transaction represents a significant corporate restructuring event, though the disclosed value of the deal has not been stated in the source materials available. The information regarding this transaction has been sourced from an SEC filing published through SEC EDGAR on December 29, 2025. While the specific form type has not been identified, the filing constitutes the primary document capturing details of this restructuring proceeding. The deal currently carries a pending-regulatory status, indicating that it has not yet reached completion and remains subject to ongoing regulatory oversight, likely including court approval as part of the Chapter 11 process. No financial advisors have been identified or extracted in connection with this restructuring transaction based on the available source materials. This absence of disclosed advisor information may reflect the nature of the filing or the stage of the proceeding at which information was reported. Similarly, no legal advisors have been disclosed or extracted from the documents reviewed for this matter. Regarding the specific structure and terms of the reorganization and asset sale, the available source documents do not provide detail on the consideration mix, treatment of creditor claims, the identity of potential acquirers of assets, the expected timeline for emergence or asset dispositions, or other material transaction mechanics that would typically be disclosed in bankruptcy filings or supplementary disclosures. The critical gaps in publicly available information on this transaction are substantial. The disclosed value of the transaction or the reorganization estate remains unknown. The specific assets targeted for sale have not been identified, nor has any buyer or bidding process been described. No expected closing or emergence date has been provided. The treatment of equity, unsecured creditors, and secured creditors under any proposed plan of reorganization remains undisclosed. The timing and status of any required regulatory approvals beyond the federal bankruptcy court has not been specified. These omissions mean that while the basic fact of the restructuring is established, the financial and operational details necessary for a complete understanding of the transaction's scope and implications are not yet available from the source document reviewed.

This is a cash merger structured as a sponsor buyout in the consumer-retail sector, in which Hillenbrand, Inc. is the target being acquired by LSF12 Helix Parent LLC, an affiliate of Lone Star Fund XII, L.P. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on December 23, 2025. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Evercore, which served as the lead financial advisor to Hillenbrand, the target. The source sentence references Evercore's analysis within the proxy disclosure: "The disclosure in the section of the Definitive Proxy Statement entitled 'Proposal 1: Approval of the Merger Agreement, Opinion of Hillenbrand's Financial Advisor, Summary of Evercore's Financial Analyses, Discounted Cash Flow Analysis' on page 38." This confirms Evercore rendered a fairness opinion to Hillenbrand that included a discounted cash flow analysis among its financial analyses. No financial advisor to the Lone Star Fund affiliate, the acquirer, is identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as a cash merger structured as a sponsor buyout, no further detail on the per-share cash consideration or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the per-share cash consideration is not specified, no financial advisor to the Lone Star Fund affiliate is identified, no legal advisors to either side are identified, and no expected closing date is given beyond the pending-regulatory status.

Anebulo Pharmaceuticals, Inc., a Delaware corporation in the healthcare sector trading on the Nasdaq Capital Market under ticker ANEB, commenced an issuer self-tender offer on December 22, 2025 to purchase up to 300,000 shares of its common stock at a fixed price of $3.50 per share, for an aggregate purchase price of up to approximately $1,050,000 in cash. The Offer was structured as part of a going-private transaction under Rule 13e-3 and was disclosed in a combined Schedule TO / Schedule 13E-3 (Schedule TO-I) filed with the SEC, together with an accompanying Form 8-K (Items 8.01 and 9.01) and press release. According to the Offer to Purchase, the Board established a Strategic and Review Committee (the "Special Committee"), composed of independent directors, in February 2025 to evaluate strategic alternatives including a potential going-private transaction. The Special Committee and the Board determined that "the costs of being an SEC reporting company outweigh the benefits" and that it was no longer in the best interests of stockholders to remain an SEC reporting company. The stated primary purpose of the Offer was to reduce the number of record holders of common stock below 300, the threshold at or above which SEC public reporting is required, allowing the Company to deregister under the Exchange Act, suspend periodic reporting, and delist from Nasdaq. Anebulo estimated it would save approximately $1.3 million per year in costs (auditor and legal fees, Nasdaq fees, printing and mailing, internal compliance, transfer agent costs, and higher director/officer insurance premiums and board compensation associated with being public) if it became a private company. The Offer to Purchase discloses that the Board determined to offer $3.50 per share "after considering our current financial condition and the limited opportunities for liquidity available for our stockholders." The $3.50 offer price represented a premium to the $2.17 Nasdaq closing price on December 19, 2025, the last full trading day before commencement of the Offer, and to the $1.83 closing price on July 22, 2025, the last trading day before Anebulo announced its intention to go private. The transaction's background section discloses that the Special Committee originally pursued a reverse stock split (with a split ratio range of not less than 1-for-2,500 and not greater than 1-for-7,500 Shares and a $3.50 cash payment for fractional shares) before ultimately pursuing the tender offer structure instead. Houlihan Capital, LLC was retained by the Special Committee in June 2025 to render a fairness opinion; Houlihan Capital delivered a "bring down" fairness opinion dated December 17, 2025 concluding that the cash tender offer at $3.50 per share was fair, from a financial point of view, to the Company's unaffiliated stockholders. The Offer was not subject to a financing condition or a minimum tender condition, and Anebulo stated it would pay for the Shares, including related fees and expenses, from cash on hand. As of December 19, 2025, the Company had 41,084,731 shares outstanding; a fully subscribed Offer would represent approximately 0.7% of shares outstanding. The Offer to Purchase discloses that Anebulo's directors and executive officers (nine persons, collectively beneficially owning approximately 80.0% of outstanding shares before the Offer) informed the Company they would not tender any shares, which the filing states would raise their collective beneficial ownership to approximately 80.5% if the Offer were fully subscribed. The Offer was originally scheduled to expire on January 26, 2026 and was amended twice (January 8, 2026 and January 27, 2026) before a Final Amendment on Schedule TO-I/A filed January 29, 2026 reported the results: the Offer expired as scheduled on January 26, 2026, was oversubscribed with 4,907,881 shares validly tendered, and Anebulo accepted 300,000 shares for payment (including 134,306 "odd lots" accepted in full, with other tenders prorated at a factor of approximately 3.47392%), for an aggregate cost of approximately $1.05 million excluding fees and expenses, representing approximately 0.73% of shares outstanding as of the January 26, 2026 expiration. Payment was wired to the depositary on January 29, 2026. Following completion of the tender offer, Anebulo's Board approved voluntary delisting from Nasdaq and deregistration with the SEC, as disclosed in a Form 8-K (Items 3.01 and 8.01) filed February 6, 2026 reporting Board action taken February 5, 2026. The Company filed a Form 25 to delist from Nasdaq (filed February 17, 2026 per EDGAR records) and subsequently filed a Form 15-12G on March 2, 2026 certifying fewer than 300 holders of record and terminating its registration under the Exchange Act, confirming the going-private transaction was completed and Anebulo's SEC reporting obligations were suspended. Blank Rome LLP, with attorneys Leslie Marlow and Melissa Murawsky, served as the Company's outside legal counsel throughout the going-private process, as identified on the Schedule TO cover page and referenced throughout the Offer to Purchase's background section. No financial advisor fairness-opinion fee or underwriting/dealer-manager fee amount was disclosed in the sections reviewed. Broadridge Corporate Issuer Solutions, LLC acted as depositary and information agent for the Offer.

Howard Hughes Holdings Inc. (NYSE: HHH) has completed its acquisition of Vantage Group Holdings Ltd., a privately held specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman, for approximately $2.1 billion in cash. The deal was announced on December 18, 2025 via a Form 8-K containing a definitive Purchase and Sale Agreement, a press release, and an investor presentation, and it closed on June 4, 2026, well ahead of the outside date of December 17, 2026 set in the agreement. Bill Ackman, Executive Chairman of Howard Hughes, called the acquisition "a milestone event in the transformation of Howard Hughes into a diversified holding company," saying that "In Vantage, HHH obtains an exceptional diversified specialty insurance and reinsurance platform managed by an excellent and highly experienced team." Vantage CEO Greg Hendrick said the deal represented "Vantage's next chapter," adding that with Howard Hughes' "permanent capital and long-term vision, we expect to strengthen our balance sheet and expand opportunities in specialty insurance, reinsurance, and partnership capital." HHH Chief Investment Officer Ryan Israel said the company structured the deal "to enable Howard Hughes to acquire 100% legal ownership of Vantage today, and over time to increase its economic ownership to 100% in what we expect to be a highly accretive manner." The transaction was structured as a purchase of 100% of Vantage's outstanding capital stock by Howard Hughes Insurance Holdings, LLC, a wholly owned HHH subsidiary, from Vantage's founding institutional owners, Carlyle Partners VII Cayman Holdings V, L.P. and H&F Vantage Aggregator, L.P., along with other Vantage shareholders. The approximately $2.1 billion cash purchase price represented 1.5 times Vantage's estimated year-end 2025 book value and an implied approximately 1.4 times price-to-book-value multiple at closing. The agreement included a "locked box" mechanism under which HHH retained the benefit of any book value accretion at Vantage between signing and closing. At signing, HHH disclosed that if closing had not occurred by June 30, 2026 for reasons other than Vantage's or the sellers' breach, the purchase price would have increased by the average yield on the J.P. Morgan 100% U.S. Treasury Securities Money Market Fund from January 1, 2026 through closing; because closing occurred on June 4, 2026, before that date, no such increase applied. The deal was funded with approximately $1.2 billion of cash on HHH's balance sheet and $1.0 billion from Pershing Square Holdings, Ltd. (PSH) in the form of non-voting, non-interest-bearing Exchangeable Perpetual Preferred Stock issued by HHH, pursuant to an equity commitment letter signed concurrently with the purchase agreement. The PSH Preferred ranks pari passu with HHH common stock, carries no liquidation preference, and is convertible into Vantage common stock if not redeemed by HHH within seven years of issuance. HHH holds a call option during a 60-to-90-day window after each of the first seven fiscal years to repurchase the preferred for cash equal to the greater of (i) the original issue price plus 4% per annum (compounded daily), or (ii) 1.5 times Vantage's book value multiplied by the preferred holders' as-exchanged ownership percentage; HHH has stated it expects to fully redeem the PSH Preferred and reach 100% economic ownership of Vantage well within that seven-year term. If HHH does not redeem it in full, PSH retains the right to cause a public listing of Vantage, and unpurchased shares would begin accruing a 10% annual "Defaulted Repurchase Dividend Rate." Pershing Square Capital Management, L.P. will act as investment manager of Vantage's general account and investment portfolios on a fee-free basis under HHH's existing services agreement with Pershing Square, with Vantage's portfolio to be repositioned over time into cash, short-term Treasurys, and common stocks. According to the investor presentation, Vantage generated $1.2 billion of net premiums written over the trailing twelve months ended September 30, 2025 (approximately 60% specialty insurance, 40% reinsurance), held a book value of $1.3 billion as of that date, and carried an "A-" rating from both AM Best and S&P. On a trailing-twelve-month basis as of September 30, 2025, Vantage reported $1,601 million of gross written premium, a 97.1% combined ratio (61.4% loss ratio, 35.7% expense ratio), $150 million of pre-tax income, and a 13% pre-tax return on equity, with 370 employees. The company was founded in 2020 and has no legacy reserve issues. The purchase agreement and presentation do not disclose any cost-synergy dollar figure, phase-in schedule, or EPS accretion/dilution estimate for the transaction; instead, HHH's stated value-creation thesis rests on de-levering Vantage's balance sheet, repositioning its investment portfolio toward equities managed fee-free by Pershing Square, and improving underwriting profitability by removing pressure for premium growth. Closing conditions disclosed in the agreement included receipt of insurance regulatory approvals in the United States and Bermuda, expiration or termination of the Hart-Scott-Rodino antitrust waiting period, continued accuracy of representations and warranties, performance of covenants, and the absence of a material adverse effect at Vantage. The filings reviewed do not disclose a specific termination fee dollar amount; the agreement instead described mutual termination rights tied to failure to close by December 17, 2026, failure of a closing condition, a burdensome regulatory condition, or uncured material breach. All conditions were satisfied, and the transaction closed on June 4, 2026, with HHH entering a Subscription Agreement with PSH for the $1.0 billion of Series A Non-Voting Exchangeable Perpetual Preferred Stock on terms consistent with the original equity commitment letter.

iRobot Corp, an industrials sector company, is the target in a restructuring transaction structured as an acquisition via pre-packaged chapter 11 bankruptcy filing. The transaction involves an acquirer identified as Picea. This is a product group restructuring matter, subtype pre-packaged chapter 11 acquisition. No transaction value has been disclosed in the source documents. The transaction information is sourced from an SEC filing published on the SEC EDGAR platform on December 15, 2025. The form type is not specified in the available documentation. The deal is currently in pending regulatory status, indicating that approvals or other regulatory clearances remain outstanding. On the target side, iRobot Corp has assembled a comprehensive advisory team. Alvarez & Marsal is serving as investment banker and financial advisor to the target. Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as lead legal counsel to iRobot. Young Conaway Stargatt & Taylor, LLP is providing Delaware counsel to the target. C Street Advisory Group is serving as strategic communications advisor to iRobot Corp. On the acquirer side, Picea has retained White & Case LLP as legal counsel. The legal advisor landscape reflects a team specifically assembled for a complex restructuring. Paul, Weiss, Rifkind, Wharton & Garrison LLP functions as lead legal counsel on the target side, supported by Young Conaway Stargatt & Taylor, LLP in a Delaware counsel capacity. White & Case LLP serves as legal counsel to the acquirer, Picea. Beyond the basic transaction structure as a pre-packaged chapter 11 acquisition, no additional details regarding deal structure, consideration, or terms have been disclosed. The source materials do not provide information on the form of consideration, whether any cash, equity, or assumption of liabilities is involved, the timing of the filing or expected emergence, or any other transaction mechanics specific to the bankruptcy process. Several critical details remain undisclosed or unknown: the purchase price or transaction value is not stated in the source documents; the specific form and mix of consideration has not been disclosed; the expected closing or emergence date is not provided; and the detailed transaction structure beyond the pre-packaged chapter 11 framework is not specified. Additionally, the specific roles and responsibilities of Picea as acquirer, beyond its identity, have not been articulated in the available materials.

Legence Corp., a publicly traded industrials company trading under the ticker LGN, is conducting a secondary offering of its common equity. The transaction is classified as an equity capital markets offering and carries a disclosed value of approximately $378.1 million in U.S. dollars. The transaction information is sourced from an SEC filing published on the SEC EDGAR database on December 15, 2025. The specific form type is not identified in the available documentation. The deal currently holds a regulatory pending status, indicating that it has been filed with the SEC but has not yet received all necessary approvals or clearances to proceed. The issuer has engaged a substantial underwriting syndicate for this secondary offering. The joint lead book-running managers are Goldman Sachs & Co. LLC and Morgan Stanley, both identified as lead advisors. Additional bookrunners include Jefferies, BofA Securities, Barclays, BMO Capital Markets, RBC Capital Markets, Santander, Cantor, BTIG, Wolfe | Nomura Alliance, Roth Capital Partners, Guggenheim Securities, SOCIETE GENERALE, Rothschild & Co, and MUFG. The co-managers in the syndicate are C.L. King & Associates, Drexel Hamilton, Stifel, Blackstone Capital Markets, Tigress Financial Partners, Independence Point Securities, Loop Capital Markets, and Penserra Securities LLC. Each of these financial advisors is serving the issuer in connection with the offering. No legal advisors are identified in the available transaction documentation. The offering structure is a secondary offering of equity with an aggregate value of $378,098,010. Beyond the disclosed offering size and the identification of the underwriting syndicate roles, no additional structural details regarding the offering have been disclosed. Specifically, no information is provided regarding the number of shares to be offered, the pricing mechanism, any lock-up provisions, or the allocation of shares among the underwriting group. The following material terms and conditions remain undisclosed or unknown: the expected closing or settlement date for the offering, the specific pricing of the shares being offered, the number of shares that Legence or its shareholders plan to sell through the offering, and any use of proceeds or allocation of proceeds. The form type of the SEC filing is also not specified in the available information.

This transaction is a cash and stock acquisition in which Kimberly-Clark Corporation, trading under the ticker KMB, is acquiring Kenvue Inc., trading under the ticker KVUE. The deal is classified within the consumer and retail sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on December 12, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, PJT Partners LP served as financial advisor to Kimberly-Clark, the acquirer, and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter referencing PJT Partners's opinion, cited under the heading "Summary, Opinions of Financial Advisors, Opinion of PJT Partners, K-C's Financial Advisor," confirming that PJT Partners rendered a fairness opinion to Kimberly-Clark in connection with the merger. No financial advisor to Kenvue, the target, is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a cash and stock acquisition, no further detail on the specific mix between cash and stock, the exchange ratio, or other terms of consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Kenvue or Kimberly-Clark is identified. The heading referenced in the source material notes "Opinions of Financial Advisors" in the plural, suggesting more than one advisor to Kimberly-Clark may be involved, but only PJT Partners is named in the facts available, and no financial advisor to Kenvue, the exchange ratio, or an expected closing date is provided.

This deal is a cash acquisition structured as a take-private transaction, classified as an M&A deal in the real-estate sector, involving Sotherly Hotels Inc. as target and KW Kingfisher LLC as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from a DEFM14A filing with the SEC, filed via SEC EDGAR and published on December 12, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Piper Sandler & Co. is identified as financial advisor to the Special Committee of Sotherly Hotels, the target, in a lead capacity. The source material specifies that the Special Committee retained Piper Sandler & Co. to act as its exclusive financial advisor in connection with the merger. No financial advisor is identified for the acquirer, KW Kingfisher LLC, in the facts provided. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either side of the transaction. Beyond the cash consideration and take-private structure, no further detail on per-share pricing, financing arrangements, or other structural terms is provided in the facts block. Several material facts are not disclosed in the available record. The overall transaction value is not stated in the source document. No acquirer-side financial advisor and no legal advisors for either party are identified. No expected closing date or further timeline detail beyond the December 2025 filing date and pending-regulatory status is given.

Contango ORE, Inc. (NYSE American: CTGO), an Alaska-focused gold exploration and production company, agreed to combine with Dolly Varden Silver Corporation (TSX-V: DV, NYSE American: DVS), a British Columbia-focused silver and gold exploration company, in a merger of equals. The companies entered into an Arrangement Agreement on December 7, 2025, disclosed in a Form 8-K filed December 11, 2025 with an accompanying joint press release and investor presentation. Under the agreement, Contango, through a newly formed British Columbia subsidiary, acquired all outstanding Dolly Varden common shares by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia). Each Dolly Varden share was exchanged for 0.1652 of a share of Contango common stock, with eligible Canadian resident holders able to elect tax-deferred exchangeable shares of the acquiring subsidiary instead, convertible one-for-one into Contango shares. On a fully diluted, in-the-money basis, former Dolly Varden shareholders and existing Contango stockholders each held approximately 50% of the combined company, which was renamed Contango Silver & Gold Inc. The combined company's market capitalization at announcement was approximately US$812 million (C$1.1 billion). The press release did not disclose an enterprise value, EV/EBITDA, P/E, or other valuation multiple for the transaction; pricing was expressed through the fixed exchange ratio rather than a cash value per share. Rick Van Nieuwenhuyse, President and CEO of Contango, said the merger was "an exciting transaction for both Contango and Dolly Varden shareholders given the complementary and synergistic nature of our North American asset portfolios," citing the cash-flowing Manh Choh gold mine as a source of non-dilutive funding to advance the Lucky Shot and Johnson Tract projects in Alaska and the Kitsault Valley project in British Columbia. Shawn Khunkhun, President and CEO of Dolly Varden, said the deal "represents a step-change for the company, adding production and combining an exceptional portfolio of projects with the potential for high-grade precious-metal development," positioning the combined entity as "a unique, multi-asset platform for silver and gold production, focused exclusively on the United States and Canada." The transaction was structured entirely as a stock-for-stock exchange; no cash consideration or new acquisition debt was disclosed. The companies described the combined company as having over US$100 million in combined cash on hand and only US$15 million in debt at announcement, with annual cash flow from the producing Manh Choh gold mine (a joint venture 30% owned by Contango and 70% by Kinross Gold, which operates it). No specific cost-synergy dollar figure, percentage of combined cost base, or phase-in timeline was disclosed in the filings reviewed; the stated rationale centered on asset complementarity (both Kitsault Valley and Johnson Tract being high-grade, similarly metallurgical, near tidewater, and suited to a Direct Shipping Ore development model) rather than quantified cost synergies. No EPS accretion/dilution guidance was disclosed. Post-closing governance was set at seven board seats: four from Contango (Clynt Nauman as Chairman, Brad Juneau, Mike Cinnamond and Rick Van Nieuwenhuyse) and three from Dolly Varden (Darren Devine, Tim Clark and Shawn Khunkhun). Management of the combined company comprised Rick Van Nieuwenhuyse as CEO, Shawn Khunkhun as President, and Mike Clark as Executive Vice President and CFO. Directors, officers and certain major shareholders holding approximately 22% of each company's outstanding shares signed voting support agreements in favor of the transaction. Canaccord Genuity Corp. acted as financial advisor to Contango and delivered a fairness opinion to the Contango board that the exchange ratio was fair to Contango stockholders from a financial point of view. Blake, Cassels & Graydon LLP acted as Canadian legal counsel and Holland & Knight LLP as U.S. legal counsel to Contango. Haywood Securities Inc. acted as financial advisor to Dolly Varden and delivered an oral fairness opinion to the Dolly Varden board; Raymond James Ltd. acted as financial advisor to a special committee of independent Dolly Varden directors formed to evaluate the transaction and delivered a separate oral fairness opinion to that committee, both opining that the consideration was fair to Dolly Varden shareholders from a financial point of view. Stikeman Elliott LLP acted as Canadian legal counsel and Dorsey & Whitney LLP as U.S. legal counsel to Dolly Varden. The arrangement agreement included reciprocal fiduciary-out provisions, non-solicitation covenants, a right to match superior proposals, and a mutual termination fee of US$15 million payable under customary circumstances (including a board's failure to unanimously recommend the deal, a party's withdrawal of its recommendation, acceptance of a superior proposal, or failure to obtain the required shareholder vote followed by consummation of an alternative transaction within a specified period). The agreement could be terminated if closing did not occur by May 7, 2026, absent a later date agreed by both parties. Closing was conditioned on approval by both companies' shareholders, approval by the Supreme Court of British Columbia under Section 291 of the BCBCA, applicable regulatory and exchange approvals (NYSE American and TSX Venture Exchange), and other customary conditions. A definitive merger proxy statement (DEFM14A) was filed with the SEC on February 13, 2026, and the arrangement agreement was subsequently amended on February 11, 2026 per the closing press release (amendment terms not reviewed in this summary). Contango's special meeting of stockholders was held March 17, 2026; shareholders approved the share issuance proposal with 99.70% of votes cast in favor (9,946,594 for, 23,635 against, 6,049 abstained, out of 9,976,278 shares present representing roughly 66% of the 15,120,615 shares outstanding as of the February 2, 2026 record date), along with proposals to increase authorized shares from 45,000,000 to 250,000,000 and to adopt a 2026 Omnibus Incentive Plan. The transaction closed on March 26, 2026, following receipt of all required shareholder and court approvals. At closing, Contango issued 13,686,278 Contango shares and replacement options to purchase 417,048 Contango shares, and its acquisition subsidiary issued 1,597,301 exchangeable shares, resulting in 30,507,599 Contango shares outstanding (excluding exchangeable shares). Dolly Varden shares were delisted from the TSX Venture Exchange at the close of trading on March 27, 2026 and from the NYSE American on April 6, 2026; Contango, renamed Contango Silver & Gold Inc., applied to list its shares on the Toronto Stock Exchange following closing.

Soho House & Co Inc. (NYSE: SHCO), a global membership platform operating 46 Soho Houses plus Soho Works, Scorpios Beach Clubs, Soho Home and related hospitality brands, entered into an Agreement and Plan of Merger dated August 15, 2025 with EH Parent LLC and its wholly owned merger subsidiary EH MergerSub Inc. The transaction, announced in an 8-K filed August 18, 2025, is led by an investor group headed by MCR (the third-largest hotel owner-operator in the United States) and its Chairman and CEO Tyler Morse, with Soho House's Executive Chairman Ron Burkle and The Yucaipa Companies LLC rolling their controlling equity interests and retaining majority control of the business. Under the merger agreement, holders of Soho House common stock (other than rollover and owned shares) received $9.00 per share in cash, a premium of approximately 83% over the stock's closing price on December 18, 2024, the last trading day before the company's disclosure of the initial offer. The company's press release characterized the offer as implying a total enterprise value of approximately $2.7 billion for Soho House. The financing and ownership structure combined several elements. Funds managed by affiliates of Apollo supported the transaction through a hybrid capital solution providing both debt and common equity, part of which was used to refinance Soho House's then-existing senior secured notes. A consortium of strategic investors led by technology investor Ashton Kutcher provided additional new equity capital, and existing significant shareholders including Richard Caring, Nick Jones and Goldman Sachs Alternatives rolled the majority of their shares, with Goldman Sachs Alternatives also committing additional capital. At the closing on January 29, 2026, Soho House Holdings Limited entered into a new senior unsecured HoldCo Notes Facility of $220.0 million (84-month maturity, paid-in-kind interest escalating from 12.500% to 14.500% over its first five years, then 7.750% cash plus 7.750% PIK thereafter), and Soho House Bond Limited (OpCo) entered into a new senior secured OpCo Notes Facility of $695.0 million (72-month maturity, cash/PIK interest tied to LTM Consolidated EBITDA tiers ranging from 7.500% to 10.750% cash-pay equivalent). The pre-existing notes purchase agreement dated March 23, 2021 was repaid in full and terminated. A revolving credit facility (GBP 75.0 million) was amended and restated to extend its maturity to January 31, 2029. At closing, equity funding included approximately $100.0 million from MCR Hospitality Fund IV LP, MCR Hospitality Fund IV QP LP and Morse Ventures Inc. combined, and a further $100.0 million from Momentum Solutions II, LLC (controlled by board member George Popstefanov) under a new equity commitment letter entered January 26, 2026. Reflecting these new commitments, Goldman Sachs-affiliated funds and Richard Caring reduced their rollover share counts, leaving 13,859,953 Class A shares (GS funds) and 39,845,438 Class B shares (Richard Caring) as rollover shares outstanding after closing. The deal followed a multi-year strategic review process described in the merger proxy. Since 2022, Soho House's board and Yucaipa periodically evaluated strategic alternatives, including a 2023 unsolicited $8.25 (later reduced to $7.50) per-share proposal from a private equity firm referred to as "Party A," which was ultimately rejected by an initial special committee in May 2024. A reconstituted Special Committee (ultimately composed of Eric Deardorff, chairman, and Yusef Jackson) was formed in December 2024 after the company received a formal proposal from an investor group referred to in the proxy as the "Bruce Group," led by Ashton Kutcher and Dan Rosensweig with advisor LionTree, which had expressed interest to Yucaipa starting in mid-2024 at $8.50 per share before raising its offer to $9.00 per share by August 2024 and delivering a final confirming proposal on December 16, 2024 (an 81% premium to the December 13, 2024 closing price of $4.96). During the process, Citi (engaged by Soho House) and Morgan Stanley (engaged by the Special Committee) separately contacted and received interest from numerous other parties referred to as Party B through Party G, including private equity firms, strategic investors, family offices and MCR (which initially declined to participate in April 2024 before later re-engaging at the end of December 2024 to make its own equity investment). None of these other parties ultimately submitted a superior proposal or completed diligence toward an alternative transaction. The Special Committee was advised by Morgan Stanley as financial advisor and by Fried, Frank, Harris, Shriver & Jacobson LLP and Morris, Nichols, Arsht & Tunnell LLP as independent legal counsel; Morgan Stanley rendered a written fairness opinion dated August 15, 2025, dated to the Special Committee, opining that the $9.00 per share price was fair, from a financial point of view, to holders of common stock other than excluded shares. Soho House Executive Chairman Eric Deardorff said the Special Committee determined that the deal "delivers meaningful and immediate value to stockholders." Soho House CEO Andrew Carnie said the transaction "reflects the strong confidence our existing and incoming shareholders have in the future of Soho House & Co., and the transformation we've led since becoming a public company," citing average annual double-digit revenue growth and Adjusted EBITDA growth of over 50% annually from 2022 through 2024. MCR's Tyler Morse said the firm has "long admired Soho House for bringing together cultures from around the world into a global network of 46 Houses," and Apollo's Reed Rayman described the transaction as "a prime example of Apollo's hybrid capital at work, flexing across both debt and equity." Soho House was advised by Citi as financial advisor and Sidley Austin LLP as legal counsel. The Special Committee retained Morgan Stanley & Co. LLC as financial advisor and Fried, Frank, Harris, Shriver & Jacobson LLP and Morris, Nichols, Arsht & Tunnell LLP as independent legal counsel. Gibson, Dunn & Crutcher LLP served as legal counsel to the Apollo Funds. Canaccord served as financial advisor to MCR. Herbert Smith Freehills Kramer (US) LLP served as legal counsel to Richard Caring. LionTree served as financial advisor to Ashton Kutcher's investor group. Okapi Partners LLC was separately engaged as proxy solicitor for Soho House in connection with the stockholder vote, as previously disclosed. The merger agreement provided for a termination fee of $20.0 million payable by Soho House to certain of the Equity Investors under specified circumstances, and a reverse termination fee of $10.0 million payable to Soho House by certain Equity Investors under specified circumstances, according to the definitive merger proxy statement. The transaction required both majority approval of all outstanding common stock and separate majority approval of votes cast by "Unaffiliated Stockholders" (excluding the buyer parties, equity investors, rollover stockholders, directors, and officers). The transaction has since closed. At a special stockholder meeting held virtually on January 9, 2026, stockholders approved the merger proposal, with 99.14% of total voting power and 99.79% of the votes cast by Unaffiliated Stockholders voting in favor, as disclosed in an 8-K filed that day. The merger became effective, with Merger Sub merging into Soho House, on January 29, 2026, as disclosed in a closing 8-K filed that date; Soho House's Class A common stock ceased trading on the NYSE and the company became privately held, owned by the Reinvestment Stockholders and Equity Investors. The board was reconstituted to consist of Ron Burkle, Richard Caring, Mark Ein, Joe Hage, Ashton Kutcher, R. Tyler Morse, George Popstefanov, Reed Rayman and Scott Stedman, while directors Andrew Carnie, Eric Deardorff, Alice Delahunt, Yusef D. Jackson, Nick Jones, Andrew Sasson, Ben Schwerin, Sheikha Al Mayassa bint Hamad Al-Thani and Dasha Zhukova departed the board. Soho House subsequently filed a Form 15-12G on February 9, 2026 to terminate its SEC registration. No synergy estimates, pro forma combined financial projections, or EPS accretion/dilution figures were disclosed in the materials reviewed, as this is a going-private transaction rather than a strategic combination of two operating companies.

Church & Dwight Co., Inc. announced on December 9, 2025 that, following the conclusion of its strategic review of its vitamin, minerals and supplement (VMS) business, it had entered into a definitive agreement to sell the VitaFusion and L'il Critters brands to Piping Rock Health Products, Inc. The agreement includes the VitaFusion and L'il Critters brands, relevant trademarks and licenses, and manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. The release states the VMS brands represent less than 5% of Church & Dwight's anticipated 2025 net sales. This record is sourced from an Exhibit 99.1 press release furnished with Church & Dwight's Form 8-K filed December 9, 2025. At announcement, the deal was a signed definitive agreement pending customary closing conditions, with closing expected before year-end 2025. Perella Weinberg served as sole financial advisor to Church & Dwight on the divestiture, per the release's statement that "Perella Weinberg acted as financial advisor to Church & Dwight and Proskauer Rose LLP acted as legal advisor." No financial advisor to Piping Rock is named in this release, and no lead designation applies since Perella Weinberg was the only financial advisor disclosed. On the legal side, Proskauer Rose LLP represented Church & Dwight, while Freshfields LLP represented Piping Rock as its legal advisor. Church & Dwight disclosed that, as a result of the transaction, it expects to incur a one-time after-tax charge of $40 million to $45 million in the fourth quarter of 2025, covering a non-cash impairment, transition costs and transaction costs, net of proceeds; CEO Rick Dierker characterized the move as sharpening focus on the company's remaining "power brands." Not disclosed in the sourced document is the purchase price or any valuation multiple for the VMS business sale, nor any valuation basis (enterprise or equity); the filing also does not name Piping Rock's financial advisor, if any.

This transaction is a follow-on common share offering by Borr Drilling Ltd, trading under the ticker BORR, classified under the equity capital markets product group. The deal is classified within the natural resources sector, and the disclosed value of the offering is not stated in the source document. The transaction is sourced from an SEC EDGAR Form 424B5 filing published on December 8, 2025. Based on the facts provided, the deal's status is pending regulatory approval. The underwriting syndicate for this offering is organized into two tiers. Clarksons Securities and DNB Carnegie are both named as joint global coordinators and joint bookrunners and are identified as holding lead status, listed together under the heading "Joint Global Coordinators and Joint Bookrunners." A second tier of joint bookrunners, Citigroup, Fearnley Securities, and Pareto Securities, is listed together under the separate heading "Joint Bookrunners," without a lead designation specified for this group. BTIG is separately identified simply as manager on the offering, per the source material's standalone listing of "Manager BTIG." No legal advisor is identified for the issuer or for the underwriting syndicate in the facts provided for this transaction. Beyond confirming that this is a follow-on common share offering with a multi-tiered underwriting syndicate, no further detail on the number of shares offered or the per-share offering price is included in the facts available, and the deal value itself is explicitly noted as not stated in the source document. A number of elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to the issuer or underwriters is identified. No detail is provided on the per-share offering price, the number of shares sold, or an expected closing or settlement date for this offering.

This deal involves Antero Resources Corp (ticker AR), a natural-resources-sector company, as the acquirer of assets from HG Energy II LLC, in a cash acquisition structured as an asset divestiture. The transaction falls under the M&A product group, and its disclosed value is $2,800,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published December 8, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. This deal involves an unusually layered advisory structure reflecting multiple constituencies. On the acquirer side, RBC Capital Markets served as lead financial advisor to Antero Resources on the HG Energy acquisition, while Lazard separately served as financial advisor to the Antero Resources Conflicts Committee, a distinct governance body within the acquirer's structure. On the target side, Wells Fargo and Truist both served as financial advisors to HG Energy, per the source sentence naming both together, while Jefferies LLC served as lead financial advisor to HG Energy and Quantum Capital Group, per a separate source sentence. On the legal side, Kirkland & Ellis served as legal counsel to HG Energy (the target), while Vinson & Elkins L.L.P. served as legal counsel to both Antero (the acquirer) and the Antero Resources Conflicts Committee, per the source sentence describing Vinson & Elkins's dual representation. Beyond identifying the transaction as a cash acquisition/asset divestiture valued at $2,800,000,000, the facts block does not detail the specific assets being divested (e.g., acreage, wells, or production volumes) or the financing structure of the cash consideration. Several facts are not disclosed in this record. No expected closing date is given. The facts block does not clarify Wells Fargo's and Truist's respective lead-versus-non-lead status on the HG Energy side relative to Jefferies LLC, which is separately designated lead for HG Energy and Quantum Capital Group.

This matter involves a potential take-private of Priority Technology Holdings, Inc., trading under the ticker PRTH, structured around a non-binding proposal from an investor group led by Thomas Priore, the Company's Chairman and Executive Officer, currently under evaluation. The deal is classified within the business services sector, and the disclosed value of any potential transaction is not stated in the source document, consistent with the preliminary, non-binding nature of the proposal. The matter is sourced from an SEC EDGAR Form 8-K filing published on December 8, 2025. Based on the facts provided, the status is pending regulatory approval. On the financial advisory side, Barclays is serving as financial advisor and is identified as holding lead status, retained by a committee of independent and disinterested directors of the Company's Board of Directors, referred to as the Special Committee, specifically to evaluate the preliminary, non-binding proposal dated November 9, 2025, from Thomas Priore. On the legal side, Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as independent legal counsel to the same Special Committee, retained alongside Barclays for the same evaluation process, as described in the single source sentence covering both the financial and legal advisor appointments. Because this is a non-binding proposal under evaluation rather than a definitive transaction, no deal structure, consideration terms, or specifics of how the proposal would be financed are included in the facts available. A number of elements remain undisclosed or not yet applicable given the preliminary stage of this matter. No transaction value, consideration structure, or financing details for Thomas Priore's proposal are given, and no expected timeline for the Special Committee's evaluation or any decision on the proposal is provided in the facts available.

This transaction is a cash-and-stock acquisition in which Skyworks Solutions, Inc., trading under the ticker SWKS, is acquiring Qorvo, Inc., trading under the ticker QRVO. The deal is classified within the technology sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on December 4, 2025. According to the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Goldman Sachs & Co. LLC served as financial advisor to Skyworks, the acquirer, and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter referencing Goldman Sachs's opinion, cited under headings including "Summary, Skyworks' Reasons for the Mergers" and "Opinions of Skyworks' Financial Advisors, Opinion of Goldman Sachs," confirming that Goldman Sachs rendered a fairness opinion to Skyworks in connection with the merger. No financial advisor to Qorvo, the target, is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a cash-and-stock acquisition, no further detail on the specific mix of cash versus stock, the exchange ratio, or other terms of consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Qorvo or Skyworks is identified. The source material also references "Skyworks' Financial Advisors" in the plural, suggesting more than one advisor may be involved on that side, but only Goldman Sachs is named in the facts available, so no additional co-advisors, exchange ratio, or expected closing date can be confirmed.

This record concerns Kestra Medical Technologies, Ltd. (ticker KMTS), a healthcare-sector company, as the issuer in a follow-on common share offering. The transaction falls under the equity capital markets (ecm) product group, and its disclosed value is $138,000,000. The facts are sourced from a Form 424B4 filing with the SEC via EDGAR, published December 3, 2025. The deal's status is pending regulatory, indicating the offering process had not yet fully concluded as of that filing. Five financial advisors, all acting as underwriters for the issuer, are disclosed. BofA Securities is named with a lead designation, while Piper Sandler, J.P. Morgan, Goldman Sachs & Co. LLC, and Wells Fargo Securities are also listed as underwriters. The source sentence underlying all five entries is simply the list of names as they appeared in the filing: "BofA Securities Piper Sandler J.P. Morgan Goldman Sachs & Co. LLC Wells Fargo Securities," reflecting a standard underwriter cover-page listing rather than a narrative description of each bank's specific role (e.g., bookrunner versus co-manager) beyond BofA's designated lead status. No legal advisors are identified in the facts block for this transaction. Beyond identifying this as a follow-on common share offering with a disclosed value of $138,000,000, the facts block does not specify the offering price per share, the number of shares offered, or the use of proceeds. Several facts are not disclosed in this record. No legal advisors are named for the issuer. The facts block does not distinguish between bookrunner and co-manager roles among the five named underwriters beyond BofA Securities's lead designation, and no expected closing date for the offering is given.

Solaris Energy Infrastructure, Inc., a technology sector company trading under the ticker SEI, is acquiring Stratos (referred to as "the target") in a strategic investment transaction valued at $544 million in U.S. dollars. This represents a merger and acquisition engagement within the technology sector, with Solaris Energy Infrastructure serving as the acquirer. The transaction details are sourced from an SEC EDGAR filing published on December 3, 2025. The specific form type is not currently disclosed. The deal is presently pending regulatory approval, indicating that while the transaction has been announced and advisors engaged, it has not yet closed and remains subject to regulatory scrutiny and approval. Goldman Sachs & Co. LLC served as the lead financial advisor to Stratos, the target company. On the acquirer side, Wells Fargo acted as the lead financial advisor to Solaris Energy Infrastructure. Both firms functioned in a core financial advisory capacity to their respective clients throughout the transaction process. Alston & Bird LLP provided legal counsel to Stratos, the target entity. Holland & Knight served as legal counsel to Solaris Energy Infrastructure, the acquiring company. Both law firms were engaged to handle the legal aspects of their respective clients' participation in the transaction. The transaction is structured as a strategic investment, though the specific consideration mix, payment terms, closing conditions, and other structural mechanics remain undisclosed in the sourced filing. No information has been provided regarding whether the deal involves cash, stock, debt, or some combination thereof, nor are there details on any earnout provisions, escrow arrangements, or phased consideration schedules. The deal timeline and expected closing date have not been disclosed. Additionally, while the total disclosed value is $544 million, the composition of this consideration and the basis for its calculation are not specified. No detail is available regarding any financing arrangements, reverse termination fees, expense caps, or other customary deal protections and mechanics.

Bending Spoons is acquiring Eventbrite, Inc., a technology sector company, in a merger transaction valued at $500 million in disclosed consideration. This is a merger and acquisition in the technology sector where Bending Spoons, the acquirer, is purchasing Eventbrite, the target company. This transaction is sourced from an SEC EDGAR filing of unknown form type, published on December 2, 2025. The deal is currently pending regulatory approval and has not yet closed. On the target side, Eventbrite is being advised by two legal counsel teams and one financial advisor. Skadden, Arps, Slate, Meagher & Flom LLP is serving as lead legal advisor to Eventbrite, while Allen & Company LLC is acting as the lead financial advisor to the target company. Additionally, Sullivan & Cromwell LLP is serving as legal advisor to Julia Hartz in connection with the transaction. On the acquirer side, Bending Spoons has retained Simpson Thacher & Bartlett, LLP as lead legal advisor and J.P. Morgan as lead financial advisor to the company. The legal representation has been split as described above, with Skadden, Arps, Slate, Meagher & Flom LLP and Sullivan & Cromwell LLP representing the target, and Simpson Thacher & Bartlett, LLP representing the acquirer. The transaction involves a $500 million all-cash or stock consideration, though the specific mix of consideration, whether cash, stock, or debt instruments, has not been disclosed. No details have been provided regarding the structure of the deal, such as whether this is an all-cash transaction, a stock-for-stock merger, or a combination of consideration types. The timing of regulatory approval and the expected closing date have not been disclosed. Additionally, the form type of the SEC filing has not been specified, and no information has been provided regarding any conditions precedent, termination provisions, or other material deal terms beyond the headline transaction value.

MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, agreed on March 16, 2025 to acquire First IC Corporation (OTCEM: FIEB), the holding company for First IC Bank, in a cash-and-stock transaction. Both companies are based in Doraville, Georgia, and the deal was announced via a joint press release on March 17, 2025. The transaction closed after the close of business on December 1, 2025. Under the terms of the Agreement and Plan of Reorganization, First IC shareholders were entitled to receive 3,384,588 shares of MetroCity common stock and $111,965,213 in cash in the aggregate, subject to adjustment, representing approximately 46 percent stock and 54 percent cash. Based on MetroCity's closing price of $27.78 on March 14, 2025, the implied purchase price was $22.71 per First IC share and the aggregate transaction value was approximately $206 million. At closing, the final exchange ratio was fixed at 0.3729 MetroCity shares plus $12.19 in cash for each First IC share (cash paid in lieu of fractional shares), and First IC shareholders ultimately received an aggregate of 3,384,381 MetroCity shares and approximately $110.6 million in cash. Holders of First IC stock options were cashed out. The stock portion was registered on a Form S-4 (File No. 333-287567) filed May 23, 2025 and declared effective June 6, 2025. Chong Chun, Chairman of First IC Corporation, said: "First IC Corporation and its wholly owned subsidiary, First IC Bank, are thrilled to announce the merger with MetroCity. We have been competitors and admirers of the MetroCity franchise for many years and combining our two organizations will create a stronger banking institution for our customers, employees and communities." Nack Paek, MetroCity's Chairman and CEO, said: "We too have long competed with and admired the First IC franchise and are excited about combining our two organizations. The combined bank will have the capacity to service our customers better, offer enhanced opportunities for our employees and continue offering excellent returns to our shareholders." The investor presentation cited similar business models, geographic proximity (First IC is headquartered near MetroCity) and familiarity between the two companies' employees as rationale for mitigating integration risk, alongside a history of strong asset quality and earnings at both banks. At signing, First IC had approximately $1.2 billion in total assets, $975 million in deposits and $993 million in loans as of December 31, 2024. The pro forma combined company was expected to have approximately $4.8 billion in assets, $3.7 billion in deposits and $4.1 billion in loans; following completion, MetroCity reported approximately $4.8 billion in total assets, $4.0 billion in total loans, $3.6 billion in total deposits and 30 full-service branches plus two loan production offices across Alabama, California, Florida, Georgia, New Jersey, New York, Texas and Virginia. Estimated pro forma ownership at close was approximately 88.4 percent MetroCity and 11.6 percent First IC shareholders. Per the investor presentation, pricing metrics at announcement implied a price-to-tangible-book-value ratio of 146 percent, a price-to-last-twelve-months EPS multiple of 8.3x, and a price-to-2025-estimated-EPS multiple of 8.9x, with a pay-to-trade ratio of approximately 26 percent and an internal rate of return of approximately 24 percent. The deal was expected to deliver approximately 26 percent EPS accretion to MetroCity shareholders in the first full year including fully phased-in cost savings, with an estimated tangible book value dilution at close of approximately 11 percent and a tangible book value earnback period of approximately 2.4 years. A detailed reconciliation in the presentation showed 2026 estimated pro forma net income of $101.3 million (versus $70.8 million MetroCity standalone consensus and $23.6 million First IC management estimate), pro forma EPS of $3.48 versus $2.75 standalone, equating to EPS accretion of $0.73 per share, or 26.4 percent. A separate tangible book value dilution reconciliation showed MetroCity's pro forma tangible book value per share falling from $17.92 to $15.89, a dilution of $2.03 per share or 11.3 percent, driven by $80.3 million of goodwill and core deposit intangibles created against $206.0 million of aggregate merger consideration. MetroCity disclosed anticipated pre-tax cost savings equal to 37 percent of First IC's non-interest expense base, phased in at 10 percent in 2025, 80 percent in 2026, and 100 percent thereafter. The deal also assumed $14.9 million of after-tax transaction costs, a gross credit mark of $12.7 million (1.2 percent of First IC's gross loans), of which 70 percent ($9.6 million) was allocated to non-PCD loans and amortized over four years, an $8.9 million CECL reserve for non-PCD loans, a $10.2 million loan interest rate mark (1.0 percent of gross loans) amortized over four years, elimination of a $3.3 million AOCI balance, and an $18.3 million core deposit intangible amortized over ten years using the sum-of-the-years'-digits method. Hillworth Bank Partners served as financial advisor to MetroCity and rendered a fairness opinion to its board of directors; Hunton Andrews Kurth LLP served as MetroCity's legal counsel. Stephens Inc. served as financial advisor to First IC and rendered a fairness opinion to its board of directors; Alston & Bird LLP served as First IC's legal counsel. Closing was subject to approval by First IC shareholders and receipt of required regulatory approvals from the Federal Reserve, the FDIC, and the Georgia Department of Banking and Finance, without a "Materially Burdensome Regulatory Condition," as well as effectiveness of the Form S-4 and Nasdaq listing of the shares. The agreement specified a termination fee of $8,239,563 payable by First IC under certain circumstances, and included a reciprocal walk-away collar: if MetroCity's average closing stock price fell below 80 percent of its pre-signing average and MetroCity stock underperformed the KBW Regional Bank Index by more than 20 percent, First IC could terminate unless MetroCity elected to increase the merger consideration. In connection with signing, FIEB directors and officers holding approximately 25 percent of First IC's outstanding shares entered into voting agreements to support the deal, and non-executive First IC directors signed director support agreements with two-year post-closing restrictive covenants. On November 14, 2025, MetroCity and First IC announced that all required regulatory approvals and non-objections, as well as First IC shareholder approval, had been obtained, and that the merger was expected to close on December 1, 2025. The merger closed as planned after the close of business on December 1, 2025: First IC Corporation merged with and into MetroCity Bankshares, with MetroCity as the surviving corporation, and First IC Bank then merged with and into Metro City Bank. MetroCity filed an 8-K/A on February 12, 2026 containing First IC's historical audited financial statements for 2022-2024 and unaudited financials through September 30, 2025, along with unaudited pro forma condensed combined financial statements for the nine months ended September 30, 2025 and the year ended December 31, 2024.

This is a bank holding company acquisition in the fig sector in which MetroCity Bankshares, Inc. (ticker MCBS) is acquiring First IC Corporation. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on December 2, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity and both rendering fairness opinions. Stephens Inc. served as lead financial advisor to First IC and rendered a fairness opinion to its board of directors, per the statement "Stephens Inc. acted as financial advisor to First IC and rendered a fairness opinion to its board of directors." On the acquirer side, Hillworth Bank Partners served as lead financial advisor to MetroCity and also rendered a fairness opinion to its board of directors, consistent with the language "Hillworth Bank Partners acted as financial advisor to MetroCity and rendered a fairness opinion to its board of directors." Legal advisors are disclosed for both sides: Alston & Bird LLP served as legal counsel to First IC, the target, while Hunton Andrews Kurth LLP served as legal counsel to MetroCity, the acquirer. Beyond the classification of this transaction as a bank holding company acquisition, no further detail on consideration structure, exchange ratio, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the consideration structure (cash, stock, or a mix) is not specified, and no expected closing date is given beyond the pending-regulatory status.

This deal is an all-stock merger in which Associated Banc-Corp, trading under the ticker ASB, is acquiring American National Corporation. The transaction sits within the financial institutions group sector and carries a disclosed value of 604,000,000 dollars. The deal is sourced from an SEC EDGAR Form 8-K filing published on December 1, 2025. Based on the facts provided, the transaction is currently pending regulatory approval. On the financial advisory side, Piper Sandler & Co. served as financial advisor to American National, the target in this transaction. Evercore served as financial advisor to Associated, the acquirer. Neither advisor is flagged as holding a specific lead designation beyond their stated role as financial advisor to their respective client. Legal counsel was also engaged on both sides of the deal. Alston & Bird LLP served as legal advisor to American National, the target, while Wachtell, Lipton, Rosen & Katz served as legal advisor to Associated, the acquirer. The source sentence for each pairing explicitly ties the financial and legal advisor together for that side of the transaction. Beyond the identification of this transaction as an all-stock merger, no further detail on the specific terms of the stock exchange, such as an exchange ratio or any collar provisions, is included in the facts provided. A number of elements remain undisclosed based on the available material. No expected closing date is given, and no detail is provided on the exchange ratio or other specific mechanics of the all-stock consideration beyond the aggregate disclosed value of 604,000,000 dollars. The regulatory approvals required to close, and any timeline associated with them, are also not specified.

South Plains Financial, Inc. (NASDAQ: SPFI), the Lubbock, Texas-based parent of City Bank, agreed to acquire BOH Holdings, Inc., the Houston, Texas-based parent of Bank of Houston, in an all-stock merger. The Agreement and Plan of Reorganization was signed December 1, 2025, with BOH merging into SPFI and SPFI surviving, followed immediately by a merger of Bank of Houston into City Bank. The deal closed on April 1, 2026, with SPFI confirming completion of the merger in a Form 8-K filed that day. Under the terms of the agreement, each share of BOH common stock was converted into the right to receive 0.1925 shares of SPFI common stock, with cash paid in lieu of fractional shares. Based on SPFI's closing price of $37.79 on November 28, 2025, the transaction was valued at approximately $105.9 million, or $7.27 per BOH common share. SPFI issued approximately 2.8 million shares (based on 14,334,219 BOH shares outstanding), with former BOH shareholders ending up owning approximately 14.5 percent of the combined company and SPFI shareholders retaining approximately 85.5 percent, according to SPFI's investor presentation. BOH stock appreciation rights and unexercised warrants were cashed out at closing rather than converted into SPFI equity. At signing of the earlier non-binding letter of intent on October 7, 2025, the same fixed 0.1925 exchange ratio had implied an aggregate value of approximately $111.1 million, based on SPFI's 20-day volume-weighted average price of $39.60 as of October 3, 2025, according to the merger proxy statement/prospectus (Form 424B3). SPFI's investor presentation disclosed transaction valuation metrics of deal value to tangible common equity of 143 percent, a price to estimated 2027 earnings per share multiple of 6.8x, and a franchise premium to core deposits of 7.4 percent. As of September 30, 2025, BOH had approximately $772 million in consolidated assets, $633 million in gross loans and $629 million in consolidated deposits, with a return on average assets of 1.47 percent and a net interest margin of 3.75 percent for the 2025 year-to-date period, per the presentation. Pro forma for the transaction, the combined company was expected to have approximately $5.4 billion in assets, $3.8 billion in loans and $4.6 billion in deposits based on balance sheets as of September 30, 2025, with roughly 26 branches across Texas and the 11th-most deposits among Texas-headquartered banks in Houston. SPFI disclosed expected pretax cost savings of approximately $4.6 million in 2027, equal to about 25 percent of BOH's non-interest expense base, with 75 percent of the savings expected to be realized in 2026 and 100 percent thereafter. The transaction assumptions also included a loan mark of $9.2 million (comprising a $7.6 million gross credit mark, equal to 1.20 percent of BOH's loans as of September 30, 2025, and a $1.6 million interest rate mark amortized over 5.0 years), a core deposit intangible of 1.50 percent of non-time deposits amortized on a sum-of-years-digits basis over 10 years, and pretax transaction expenses of $13.8 million. SPFI stated it did not expect to incur an additional mark related to Day-2 CECL accounting. SPFI disclosed the transaction was expected to be approximately 11 percent accretive to its earnings per share in 2027 (the first full year of combined operations), with tangible book value dilution at closing of approximately 3.5 percent including loan rate marks (3.1 percent excluding rate marks) and a tangible book value earnback period of 2.9 years including rate marks (2.8 years excluding rate marks). The presentation also disclosed an estimated internal rate of return of approximately 30 percent based on a 10x terminal multiple, and pro forma regulatory capital ratios of approximately 10.2-10.3 percent tangible common equity, 11.9 percent leverage, 13.9 percent CET1 and 16.5 percent total capital. Curtis Griffith, Chairman and CEO of South Plains, said the acquisition of BOH "is an important step in achieving our goal given the impressive franchise they have built in the fast-growing Houston market, which will add scale to our existing operations while also bringing long standing customer relationships to City Bank," adding that he believes "this combination will deliver substantial value to both South Plains' and BOH's shareholders which will make this a true win-win transaction." Jim Stein, Chairman, President and CEO of BOH, said the partnership "provides needed resources to help accelerate our combined growth which we believe will drive value for our shareholders that we could not have achieved on our own," citing the strength of South Plains' low-cost, community deposits and broader product portfolio. Cory Newsom, President of South Plains, said cultural and credit-culture compatibility between the two banks, confirmed through a deep dive into BOH's loan portfolio and underwriting, provided confidence in the deal's potential synergies. The merger proxy statement/prospectus (Form 424B3) disclosed that BOH's board and management had periodically evaluated strategic alternatives, including continuing independently, pursuing acquisitions, or merging with another institution. In December 2024, BOH held informal discussions with an unnamed Texas-based public bank holding company ("Company A") about a possible combination, which ended in January 2025 when the parties determined there was insufficient interest to proceed. In late August 2025, a second Texas-based public bank holding company ("Company B") expressed interest, signed a confidentiality agreement with BOH on September 8, 2025, requested information and discussed an expected price range, but discontinued discussions shortly thereafter. BOH engaged Hillworth Bank Partners as exclusive financial advisor on August 18, 2025. Discussions with SPFI began in mid-September 2025, a non-binding letter of intent was signed October 7, 2025, and the definitive merger agreement was signed December 1, 2025, after SPFI's board received a fairness analysis from Raymond James and BOH's board received an oral (later written) fairness opinion from Hillworth, both delivered December 1, 2025. Raymond James & Associates, Inc. served as financial advisor to South Plains and rendered a fairness opinion to its board of directors; Hunton Andrews Kurth LLP served as South Plains' legal advisor. Hillworth Bank Partners served as financial advisor to BOH and rendered a fairness opinion to its board of directors; Fenimore Kay Harrison LLP served as BOH's legal advisor. Completion of the merger was subject to approval by BOH's shareholders (requiring at least two-thirds of outstanding BOH shares, voted at a special meeting held March 20, 2026), Nasdaq listing approval for the SPFI shares to be issued, receipt of required regulatory approvals, and effectiveness of SPFI's Form S-4 registration statement (filed January 30, 2026, amended February 13, 2026, and declared effective by the SEC on February 18, 2026). The merger agreement provided for a termination fee of $4,235,314 payable by BOH under certain circumstances, and allowed either party to terminate if the merger did not close by November 1, 2026 (subject to extension). Under the agreement, James D. Stein, BOH's Chairman, President and CEO, joined the boards of SPFI and City Bank following closing. The merger closed effective April 1, 2026, with SPFI issuing approximately 2.8 million shares of common stock to former BOH shareholders, confirmed in a Form 8-K filed that day. Immediately following the merger, Bank of Houston merged into City Bank, with City Bank surviving. Mr. Stein was appointed to the SPFI board as a Class II director and to the City Bank board as a Class III director at closing.

Republic Airways Holdings Inc. and Mesa Air Group, Inc. completed their previously announced merger on November 25, 2025. Mesa Air Group, Inc., a Nevada corporation trading on Nasdaq under the ticker MESA, was the surviving legal entity: Republic Airways Holdings Inc. ("Legacy Republic") merged with and into Mesa pursuant to an Agreement, Plan of Conversion and Plan of Merger dated April 4, 2025, with the transaction publicly announced on April 7, 2025 and the resulting combined company renamed Republic Airways Holdings Inc., trading on the Nasdaq Global Select Market under the ticker RJET. Mesa also converted from a Nevada corporation to a Delaware corporation in connection with the closing. The transaction was structured as an all-stock merger with a fixed exchange ratio. Immediately before closing, Mesa effected a 15-for-1 reverse stock split. Each share of Legacy Republic common stock was then converted into the right to receive 38.9933 shares of the combined company's common stock (the exchange ratio, post-split-adjusted; the pre-split ratio disclosed in the registration statement was 584.90 shares of Mesa common stock per Republic share). Based on the Exchange Ratio and Mesa's $0.71 closing stock price on April 4, 2025 (the date the merger agreement was signed), each Republic share was implied to be worth approximately $415.34 at signing; because the exchange ratio is fixed, that implied value moved with Mesa's share price between signing and closing, and no aggregate dollar transaction value, enterprise value, or valuation multiple has been disclosed in the source filings. Upon closing, the combined company had approximately 46.9 million shares of common stock outstanding, including 1,264,210 restricted shares subject to vesting and 2,853,454 escrow shares. Under the terms of the merger, Legacy Republic stockholders received approximately 88% of the combined company's common stock, and pre-closing Mesa stockholders retained approximately 6%, together representing 94% of the company immediately at closing. The remaining approximately 6% of shares (2,853,454 shares) were placed into escrow for later allocation under a separate Three Party Agreement, dated April 4, 2025, among Mesa, Legacy Republic, Mesa Airlines, Inc., United Airlines, Inc., and a Mesa Shareholder Representative. Escrow shares become available first to United Airlines in exchange for forgiveness or repayment of certain Mesa debts and obligations (estimated at $54.2 million as of closing), second to the combined company to repay certain other liabilities, and third, to the extent any remain, pro rata to pre-closing Mesa stockholders; final allocation was not complete as of the closing 8-K and depends on Mesa's share price at a future "Share Settlement Date." Combined, Mesa stockholders are expected to end up owning at least 6% and up to 12% of the company once that escrow settlement is finalized, per the companies' joint press release. As part of the closing, Mesa Airlines and United Airlines terminated their prior capacity purchase agreement and entered into a new 10-year capacity purchase agreement (CPA) covering 60 Embraer E175 aircraft (70-76 seat configuration), under which Mesa Airlines will operate as United Express; the agreement allows United Airlines to terminate on 30 days' notice for sustained performance shortfalls (subject to cure rights) or immediately in the event of a 10-plus-day labor strike. Separately, United Airlines forgave and extinguished all of Mesa Airlines' debt and other obligations outstanding under a Second Amended and Restated Credit and Guaranty Agreement dated June 30, 2022, and Mesa Airlines repaid approximately $31.9 million (plus accrued interest and fees) to fully satisfy and terminate a separate Loan and Guarantee Agreement originally entered into with the U.S. Treasury in October 2020 and later assigned to Jefferies Capital Services, LLC, recognizing a $12.3 million gain on extinguishment in the process. According to the companies' joint press release, the combined company becomes "the world's largest Embraer jet fleet of 310 E-Jets supporting more than 1,300 daily departures," continuing to support American Airlines, Delta Air Lines and United Airlines under existing capacity purchase agreements. David Grizzle, CEO of Republic Airways, said the merger "establishes a combined company with a common mission to provide safe, clean, and reliable service to connect people and communities across America, [and] will create value for all of our stakeholders and strengthen the regional aviation industry," adding that "Republic returns to the public markets as a well-capitalized airline with a strong strategic plan, a capable and proven workforce of aviation professionals, and a horizon bright with opportunity." Matt Koscal, President of Republic Airways, called the combination "the natural next step for Republic," stating it "continues a growth trajectory that stretches back more than five decades, makes us a stronger and more capable partner for our customers, will create new job and career opportunities for our people, and offers a compelling investment opportunity in an essential industry." The companies describe more than 8,000 aviation professionals as affected by the combination; Republic and Mesa will maintain parallel flight operations while working toward single-carrier consolidation. No dollar synergy target, cost-savings percentage, or phase-in timeline has been disclosed in the source filings. Mesa stockholders approved the merger, the related Nasdaq stock issuance (under Nasdaq Listing Rules 5635(a) and (b)), an advisory say-on-merger-compensation proposal, and the Republic 2025 Equity Incentive Plan at a special meeting held November 17, 2025, with 29,918,869 of 41,879,859 eligible shares represented at the meeting (a quorum) and the merger proposal passing 29,695,963 votes for versus 185,635 against. The closing followed the effectiveness of Mesa's Form S-4/S-1 registration statement (File No. 333-288622), with a definitive proxy statement/prospectus dated September 30, 2025, and 36,664,653 shares of common stock were issued to Legacy Republic stockholders in an unregistered issuance (relying on Securities Act Section 4(a)(2)/Regulation D/Regulation S) ahead of the S-4/S-1 becoming effective, with the remainder registered under the S-4/S-1. In connection with the closing, Mesa's board members Mitchell I. Gordon, Dana J. Lockhart, Jonathan G. Ornstein, Harvey W. Schiller and Spyridon P. Skiados resigned, and Mesa's pre-merger executives Jonathan G. Ornstein (CEO), Michael J. Lotz (President and CFO) and Brian S. Gillman (EVP, General Counsel and Secretary) also resigned. The reconstituted board is chaired by David Grizzle (who becomes CEO), with Ellen N. Artist, Glenn S. Johnson, Michael C. Lenz, Ruth Okediji, Barry W. Ridings and James E. Sweetnam as directors. New officers include Matthew J. Koscal (President and Chief Commercial Officer), Joseph P. Allman (SVP and CFO), Paul K. Kinstedt (SVP and COO) and Chad M. Pulley (SVP, General Counsel and Secretary). CBIZ CPAs P.C. (formerly Marcum LLP), Mesa's prior auditor, was dismissed effective November 25, 2025, and Deloitte & Touche LLP, Legacy Republic's prior auditor, was engaged as the combined company's independent registered public accounting firm. On the advisory side, Simpson Thacher & Bartlett LLP served as legal counsel and Goldman Sachs & Co. LLC served as financial advisor to Republic Airways; FTI Capital Advisors, LLC served as financial advisor and DLA Piper LLP served as legal counsel to Mesa Air Group; and Sidley Austin LLP served as legal counsel to United Airlines, which was a key third-party stakeholder to the transaction through the Three Party Agreement, the new CPA, and the debt forgiveness described above. The following remains undisclosed in the source filings reviewed: any aggregate dollar transaction value, enterprise value, or valuation multiple (EV/EBITDA, P/E, etc.) for the combined transaction; any specific cost-synergy dollar figure, percentage of combined cost base, or phase-in schedule; pro forma combined financial statements' headline figures (e.g., combined revenue or EBITDA); and the final resolution/allocation of the 2,853,454 escrow shares, which remained pending as of the closing 8-K and depends on Mesa's share price as of a future Share Settlement Date.

Republic Airways Holdings Inc. (NASDAQ: RJET) announced the successful completion of its merger with Mesa Air Group, Inc., combining two U.S. regional airlines into what the companies describe as a leading publicly traded regional airline. The transaction, in the air transportation sector (SIC 4512), creates a combined fleet described as the world's largest Embraer jet fleet, with 310 E-Jets supporting more than 1,300 daily departures. This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Republic Airways Holdings Inc. on December 1, 2025, announcing closing of the merger. The underlying transaction was originally announced on April 7, 2025, and was approved by Mesa stockholders on November 17, 2025, with the merger itself completing on November 25, 2025 per the press release dateline. Republic Airways Inc. will continue to support American Airlines, Delta Air Lines, and United Airlines under existing capacity purchase agreements, while Mesa Airlines will support United Airlines under a new 10-year capacity purchase agreement signed in connection with the transaction. On financial advisory, Goldman Sachs & Co. LLC served as financial advisor to Republic Airways, while FTI Capital Advisors, LLC served as financial advisor to Mesa Air Group. Neither advisor is designated explicitly as "lead" in the release, and each appears to be the sole named financial advisor to its respective side. On legal advisory, Simpson Thacher & Bartlett LLP served as legal counsel to Republic Airways and DLA Piper LLP served as legal counsel to Mesa Air Group. Separately, Sidley Austin LLP served as legal counsel to United Airlines, a third party to the transaction given its new capacity purchase agreement with Mesa. The deal structure disclosed is an all-stock combination: under the terms of the merger agreement, Republic stockholders now own approximately 88% of the combined company's common stock, and Mesa stockholders will own between 6% and 12%, subject to final settlement of Mesa's pre-closing obligations. The combined company trades under the ticker RJET on the NASDAQ Global Select Market, and the two airlines will maintain parallel operations while working toward operating as a single carrier. What is not disclosed in this filing: no aggregate dollar value or enterprise/equity valuation was stated for the transaction, consistent with its structure as a stock-for-stock combination without a fixed cash price; this press release also does not break out any termination fee, synergy targets, or financing details.

Patient Square Capital, a dedicated health care investment firm, completed its previously announced acquisition of Premier, Inc., a Nasdaq-listed technology-driven health care improvement company, in a transaction valued at $2.6 billion. Premier stockholders received $28.25 in cash per share, and Premier common stock was delisted from Nasdaq upon closing. The deal is sourced from Premier's own 8-K closing-announcement exhibit, filed November 25, 2025, confirming completion of the previously announced merger and referencing an earlier Form 8-K that disclosed the definitive agreement. Perella Weinberg Partners LP served specifically as debt capital markets advisor to Patient Square, the acquirer, distinct from Patient Square's M&A financial advisors. The release states: "Kirkland & Ellis LLP served as legal counsel, Ropes & Gray served as health care legal counsel, Jefferies LLC and Santander served as financial advisors, and Perella Weinberg Partners LP served as debt capital markets advisor to Patient Square." On the target side, Goldman Sachs & Co. LLC and BofA Securities, Inc. served as financial advisors to Premier. Wachtell, Lipton, Rosen & Katz served as legal counsel to Premier, with Cravath, Swaine & Moore LLP advising the Transaction Committee of Premier's Board specifically. Kirkland & Ellis LLP served as general legal counsel to Patient Square, with Ropes & Gray serving as dedicated health care regulatory counsel. Joele Frank served as Premier's strategic communications advisor. The $2.6 billion aggregate transaction value and $28.25 per-share cash price are both explicitly disclosed in the closing press release. The transaction closed and Premier was delisted from Nasdaq as of November 25, 2025. Not disclosed in the reviewed excerpt: the specific debt financing package size or structure that Perella Weinberg advised on, the identity of debt financing providers, and whether Jefferies or Santander held lead-advisor status relative to each other on the M&A side.

This is a cash acquisition in the fig sector in which Exodus Movement, Inc. (ticker EXOD) is acquiring W3C Corp. The product group is M&A, and the disclosed transaction value is $175,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on November 25, 2025. The deal's current status is pending regulatory review. Financial advisory roles are disclosed for both sides, without a lead designation specified. D.A. Davidson is serving as financial advisor to W3C, the target, per the statement "D.A. Davidson is serving as financial advisor and Latham & Watkins, LLP as legal counsel to W3C." On the acquirer side, Perella Weinberg is serving as financial advisor to Exodus, consistent with the language "Perella Weinberg is serving as financial advisor to Exodus." Legal advisors are disclosed for both sides. Latham & Watkins, LLP is serving as legal counsel to W3C, the target. On the acquirer side, Gibson, Dunn & Crutcher LLP and Hogan Lovells are both acting as legal counsel to Exodus, with Gibson Dunn specifically noted as lead M&A counsel, per the source sentence "Gibson, Dunn & Crutcher LLP and Hogan Lovells are legal counsel to Exodus, with Gibson Dunn serving as lead M&A counsel." Beyond the classification of this transaction as a cash acquisition with a disclosed value of $175,000,000, no further detail on payment structure, financing sources, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no detail on financing sources for the cash consideration is provided, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a depositary shares and preferred stock offering by Bread Financial Holdings, Inc., trading under the ticker BFH, classified under the equity capital markets product group. The deal is classified within the financial institutions group sector, and the disclosed value of the offering is 75,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 424B5 filing published on November 21, 2025. Based on the facts provided, the deal's status is pending regulatory approval. The underwriting syndicate on this offering is organized as a group of joint bookrunners, all serving the issuer, Bread Financial. Morgan Stanley, Wells Fargo Securities, RBC Capital Markets, and J.P. Morgan are all named as joint bookrunners, and each is identified as holding lead status on this offering. The source material lists these four firms together under the heading "Joint Bookrunners," reflecting a shared lead role across the syndicate rather than a single designated lead manager. No legal advisor is identified for the issuer or for the underwriting syndicate in the facts provided for this transaction. Beyond confirming that the offering is structured as depositary shares tied to a preferred stock offering, with a disclosed value of 75,000,000 dollars, no further detail on the specific dividend rate, liquidation preference, or other terms of the preferred stock is included in the facts available. Several elements of this deal remain undisclosed. No legal advisor to the issuer or to the underwriters is identified, and no detail is provided on the dividend rate or other specific economic terms of the preferred stock or depositary shares. The facts also do not specify an expected closing or settlement date for the offering.

TILT Holdings Inc., a consumer-retail sector company, is pursuing a restructuring transaction in the form of a Plan of Arrangement and Companies' Creditors Arrangement Act (CCAA) restructuring. This is a debtor-in-possession type restructuring proceeding filed under Canadian insolvency law. The disclosed transaction value is not stated in the source materials. This matter is sourced from an SEC EDGAR filing of unknown form type, published on November 20, 2025. The deal is currently in pending-regulatory status. According to the source documents, PricewaterhouseCoopers Inc. was advised that TILT Holdings Inc. intended to make an application on November 7, 2025 (the Filing Date) to the Supreme Court of British Columbia for an Initial Order granting a stay of proceedings in favor of TILT under the Companies' Creditors Arrangement Act, with the stay of proceedings to run up to and including November 17, 2025. PricewaterhouseCooples Inc. (PwC) has been identified as the Proposed Monitor in this restructuring and is serving in a lead advisory capacity to the creditors. PwC's role as Monitor in a CCAA proceeding typically involves overseeing the debtor company's operations and affairs, investigating the company's financial situation, and reporting to the court and stakeholders throughout the restructuring process. Farris LLP, Barristers & Solicitors, is serving as legal advisor to the company. The firm's place of business is located at 2500 - 700 West Georgia Street, Vancouver, British Columbia, V7Y 1B3. Tevia Jeffries of Farris LLP executed the requisition document on behalf of the company in this proceeding. The specific deal structure and terms have not been disclosed in the available source materials. No details regarding the composition of any consideration, the treatment of creditor classes, the timeline for court approval, the terms of any proposed plan of arrangement, or other structural mechanics of the restructuring have been provided. Similarly, the expected closing date, any interim milestones beyond the Initial Order application, and the ultimate resolution or emergence terms remain undisclosed.

Aptose Biosciences Inc., a healthcare sector company, is the target of a going-private transaction. The acquiring entity is Hanmi Purchaser. This is a mergers and acquisitions transaction classified as a going-private deal. The disclosed value of the transaction is not stated in the source document. The information regarding this transaction is sourced from an SEC EDGAR filing published on November 19, 2025. The specific form type is not identified in the source materials. The deal is currently in pending regulatory status. On the acquirer side, Stikeman Elliott LLP is serving as independent legal advisor to Hanmi Purchaser. On the target side, Locust Walk Securities LLC is acting as financial advisor and independent valuator to both the Special Committee and the Company. McCarthy Tétreault LLP is serving as independent legal advisor to the Special Committee and the Company. Both Locust Walk Securities and McCarthy Tétreault are positioned as lead advisors on their respective roles. Stikeman Elliott LLP represents Hanmi Purchaser in a legal advisory capacity. McCarthy Tétreault LLP represents the target company's Special Committee and the Company itself in a legal advisory capacity. The specific structure, consideration mix, and terms of the transaction are not disclosed in the available source materials. The following material details remain undisclosed or unknown: the transaction value or purchase price; the specific consideration structure (whether cash, stock, or a combination thereof); the anticipated closing date; the detailed transaction structure and any conditions precedent; the form type of the SEC filing containing this information; and any other material deal terms. Additionally, the current stage of regulatory review and whether any regulatory approvals remain pending is not specified beyond the pending regulatory status notation.

L A M Y, a Wyoming shell corporation (later renamed Exousia Bio, Inc.), entered into a Plan and Agreement of Reorganization on November 11, 2025 with the shareholders of Exousia Ai, Inc., a privately held Florida corporation developing plant-based exosome technology initially targeted at oncology, dermatology and dentistry applications. Under the agreement, L A M Y acquired 100% of the issued and outstanding capital stock of Exousia Ai (70,000 shares of common stock and 30,000 shares of Series A Preferred Stock) in exchange for the issuance of 62,223,000 shares of L A M Y common stock, making Exousia Ai a wholly owned subsidiary. The transaction closed on November 17, 2025, six days after signing, and was disclosed in a Form 8-K filed with the SEC that day along with the Plan and Agreement of Reorganization as Exhibit 2.1. The agreement is structured as a tax-free reorganization under Section 368(a)(1)(B) of the Internal Revenue Code, with consideration consisting solely of voting stock of the acquirer and no cash component. No deal value, implied equity value, or valuation multiple was disclosed in the filing; the exhibit does not reference any independent valuation, fairness opinion, or per-share price for either company. Of the 62,223,000 Acquisition Shares issued, Exousia Pro Holding Management, LLC ("EPHM"), a subsidiary of Exousia Pro, Inc. (formerly Marijuana, Inc., ticker MAJI), received 41,223,000 shares, and Progenicyte Japan CO., LTD. received 21,000,000 shares. The 8-K states that EPHM's resulting stake represented approximately 58.89% of the Company's outstanding common stock, constituting a change of control because prior controlling shareholder Zhang Shengwu no longer held majority ownership after the issuance. In connection with the closing, Zhang Shengwu resigned as the Company's sole officer and director and was replaced by Matthew Dwyer, who had served since April 2025 as President of Exousia Pro, Inc. (MAJI). The 8-K states the board pursued the acquisition "after investigating the Exousia Ai opportunity" and determining it was in the best interests of the Company and its shareholders, without further elaboration on strategic rationale, projected synergies, or financial impact; no such figures are disclosed anywhere in the filing. The Reorganization Agreement also disclosed that Exousia Ai received Orphan Drug Designation from the FDA in November 2025 for its exosome-based treatment of malignant glioma (glioblastoma multiforme), a designation the combined company said "opens opportunities for advancing Exousia Ai's cancer therapy as it moves into the next clinical phases." The 8-K stated that audited financial statements of Exousia Ai and pro forma financial information would be filed by amendment no later than 71 days after closing; the agreement separately required shareholders to deliver audited financials for fiscal years 2024 and 2023 within 75 days of closing. No goodwill, purchase-price allocation, or pro forma combined financial figures tied to the acquisition were located in the Company's subsequent quarterly filings reviewed. The Plan of Reorganization does not name any financial advisor or law firm representing either party, and no legal or financial advisors have been identified in any filing reviewed for this transaction. A material post-closing development occurred on March 14, 2026, when the Company (by then renamed Exousia Bio, Inc.) entered into a Rescission Agreement and Mutual Release with Progenicyte Japan CO., LTD., disclosed in the Form 10-Q for the quarter ended November 30, 2025 (filed March 17, 2026). Under that agreement, "based on a mistake of fact, the 21,000,000 shares of Company common stock issued to Progenicyte under the Reorganization Agreement was cancelled," and the Company and Progenicyte mutually released all claims against each other. This reduced the scope of the original stock-for-stock consideration by roughly one-third of the shares originally issued, leaving EPHM as the remaining counterparty shareholder from the original transaction. No restated change-of-control percentage following the share cancellation was disclosed in the filings reviewed. The transaction has closed; it is not pending regulatory approval, as no regulatory review was required or referenced in any filing (the 8-K explicitly states the parties "closed the Reorganization Agreement" on November 17, 2025). Separately, the registrant filed a Form 15-12G on August 31, 2026 to terminate its Securities Exchange Act registration, which is a deregistration event unrelated to deal approval and does not itself indicate the underlying reorganization was unwound; the only identified unwind of consideration is the partial share cancellation under the March 2026 Rescission Agreement described above.

This transaction is a stock-for-stock merger in which Compass, Inc., trading under the ticker COMP, is acquiring Anywhere Real Estate Inc. The deal is classified within the real estate sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on November 14, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Goldman Sachs & Co. LLC served as financial advisor to Anywhere, the target company, and is identified as the lead advisor on that side of the transaction. The source language is drawn from a consent letter referencing Goldman Sachs's opinion letter, cited under headings including "Summary, Opinion of Anywhere's Financial Advisor" and "The Merger, Opinion of Goldman Sachs, Anywhere's Financial Advisor," confirming that Goldman Sachs rendered a fairness opinion in connection with the merger. No financial advisor to Compass, the acquirer, is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a stock-for-stock merger, no further detail on the exchange ratio or other specific terms of the stock consideration is included in the facts available. A number of elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Anywhere or Compass is identified. No expected closing date is given, and no detail on the specific exchange ratio or regulatory approvals required to close is provided.

MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, agreed to acquire First IC Corporation (OTCEM: FIEB), the holding company for First IC Bank, in a cash-and-stock transaction. Both companies are based in Doraville, Georgia. The deal was announced on March 17, 2025, via a Form 8-K that attached the Agreement and Plan of Reorganization (dated March 16, 2025) as Exhibit 2.1, a joint press release as Exhibit 99.1, and an investor presentation as Exhibit 99.2. The transaction closed after the close of business on December 1, 2025, as confirmed in an 8-K filed December 2, 2025, making this a completed deal rather than one still pending regulatory approval. Chong Chun, Chairman of First IC Corporation, stated: "First IC Corporation and its wholly owned subsidiary, First IC Bank, are thrilled to announce the merger with MetroCity. We have been competitors and admirers of the MetroCity franchise for many years and combining our two organizations will create a stronger banking institution for our customers, employees and communities." He added that the combination would "ensure our shared values to create a better bank, offering enhanced services and opportunities for our employees, customers, key partnerships, and the communities we serve." Nack Paek, MetroCity's Chairman and CEO, said: "We too have long competed with and admired the First IC franchise and are excited about combining our two organizations. The combined bank will have the capacity to service our customers better, offer enhanced opportunities for our employees and continue offering excellent returns to our shareholders." The investor presentation also cited similar business models, strong familiarity between the companies (First IC is headquartered near MetroCity, with many employees personally acquainted), and a shared history of strong earnings and asset quality as strategic rationale. Under the terms of the Reorganization Agreement, First IC shareholders were entitled to receive aggregate consideration of $111,965,213 in cash (subject to adjustment) and 3,384,588 shares of MCBS common stock, equal to approximately 46% stock and 54% cash. Based on MCBS's March 14, 2025 closing price of $27.78 per share, the implied purchase price was $22.71 per First IC share, with an aggregate transaction value of approximately $206 million. The investor presentation disclosed pricing multiples of 146% of First IC's tangible book value, 8.3x First IC's last-twelve-months earnings per share, and 8.9x First IC's estimated 2025 earnings per share, with an estimated internal rate of return of approximately 24%. At the time of signing, First IC had approximately $1.2 billion in total assets, $975.6 million in deposits, $984.1 million in net loans, tangible equity of $140.7 million, and a 2024 return on average assets of 2.10%. First IC stock options were to be cashed out. At closing (December 1, 2025), the final merger consideration delivered to First IC shareholders was 0.3729 MCBS shares plus $12.19 in cash per First IC share, resulting in an aggregate issuance of 3,384,381 MCBS shares and approximately $110.6 million in cash; MCBS had approximately 28,818,282 shares outstanding following the merger. The share issuance was registered on a Form S-4 (File No. 333-287567) initially filed May 23, 2025 and declared effective June 6, 2025. The pro forma combined company was projected to have approximately $4.8 billion in total assets, $3.7 billion in deposits, $4.1 billion in net loans, and 30 branches across markets including Georgia, New York, New Jersey, Texas, Alabama, Florida, Virginia, Washington, and California, with the First IC combination also extending MetroCity's footprint to the West Coast. At signing, the presentation estimated pro forma ownership of approximately 88.4% MCBS and 11.6% legacy First IC shareholders. MetroCity disclosed anticipated pre-tax cost savings equal to 37% of First IC's non-interest expense base, phased in at 10% in 2025, 80% in 2026, and 100% thereafter. The deal was expected to generate approximately 26% EPS accretion to MetroCity shareholders in the first full year including fully phased-in cost savings (the illustrative 2026E accretion reconciliation in the investor presentation calculated $0.73 per share, or 26.4%, bringing pro forma EPS to $3.48 versus a $2.75 MCBS standalone estimate). Pre-tax, non-restructuring transaction costs were estimated at $14.9 million net of tax. Fair value marks included a gross credit mark of $12.7 million (1.2% of First IC's gross loans), with 70%, or $9.6 million, allocated to non-PCD loans and accreted over four years on a straight-line basis; a loan interest rate mark of $10.2 million (1.0% of anticipated gross loans), amortized over four years; elimination of $3.3 million of First IC's accumulated other comprehensive income; and a core deposit intangible of $18.3 million amortized over ten years using the sum-of-the-years'-digits method. A CECL reserve of $8.9 million was established for non-PCD loans. On a tangible book value basis measured as of September 30, 2025, MCBS's pro forma tangible book value per share was estimated at $15.89, versus $17.92 on a standalone basis, implying dilution of $2.03 per share, or 11.3%, with an estimated earnback period of approximately 2.4 years. The reconciliation attributed the dilution to $80.3 million of goodwill and core deposit intangibles created, $4.9 million of after-tax restructuring costs, and a $6.5 million CECL non-PCD reserve, partly offset by $94.0 million of common stock issued as consideration. Goodwill of $62.0 million was created against an aggregate merger consideration of $206.0 million relative to First IC's adjusted tangible book value of $144.4 million at close. FIEB was permitted a pre-tax transaction expense allowance of up to $12,500,000; if actual costs exceeded that allowance, the aggregate cash consideration would be reduced dollar-for-dollar, while savings versus the allowance could instead be paid out to First IC shareholders as a pre-closing dividend. The agreement included a "collar" mechanism: if MCBS's average stock price fell below 80% of its pre-signing average and MCBS stock underperformed the KBW Regional Banking Index by more than 20%, First IC could terminate unless MCBS elected to increase the merger consideration (up to a value of $76,331,936 for the stock portion). The agreement provided for a termination fee of $8,239,563 payable by First IC under specified circumstances, including a change in the First IC board's recommendation or a superior competing proposal. Closing conditions included approval by First IC shareholders, regulatory approvals from the Federal Reserve, FDIC, and Georgia Department of Banking and Finance without a materially burdensome condition, effectiveness of the Form S-4, Nasdaq listing of the shares to be issued, and receipt of tax opinions that the merger would qualify as a reorganization under Section 368(a) of the Internal Revenue Code. On the financial advisory side, Stephens Inc. acted as financial advisor to First IC and rendered a fairness opinion to its board of directors, while Hillworth Bank Partners acted as financial advisor to MetroCity and rendered a fairness opinion to its board of directors. On the legal side, Alston & Bird LLP served as legal counsel to First IC, and Hunton Andrews Kurth LLP served as legal counsel to MetroCity. MetroCity and First IC previously announced receipt of all required regulatory approvals and non-objections along with First IC shareholder approval ahead of the merger's completion on December 1, 2025; First IC Bank merged into Metro City Bank immediately following the holding company merger. Financial statements of the acquired business and pro forma financial information required under Item 9.01 were filed by amendment on an 8-K/A dated February 12, 2026.

Edgewell Personal Care Company announced on November 12, 2025 that it had entered into a definitive agreement to sell its feminine care business, which includes the Playtex, Stayfree, Carefree and o.b. brands, to Essity, a Swedish global health and hygiene company, for $340 million. CEO Rod Little characterized the sale as "a pivotal step in Edgewell's transformation," sharpening the company's focus on its core shaving, sun and skin care, and personal care categories. This record is sourced from an Exhibit 99.1 press release furnished with Edgewell's Form 8-K filed November 13, 2025 (dated November 12, 2025). At announcement, the transaction was a signed definitive agreement pending customary closing conditions and regulatory approvals, with closing expected in the first quarter of calendar 2026. Perella Weinberg Partners LP served as sole financial advisor to Edgewell on the sale, per the release's statement "Perella Weinberg Partners LP is serving as financial advisor to Edgewell. Latham & Watkins LLP is serving as legal advisor to Edgewell." No financial advisor to Essity is named in this release, and no lead designation applies since Perella Weinberg was Edgewell's only disclosed financial advisor. On the legal side, Latham & Watkins LLP represented Edgewell; no legal advisor for Essity is disclosed in this release. Edgewell disclosed it intends to use net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in core-business growth, and that it will provide Essity with transition services to support the business's handover; beginning in the first quarter of fiscal 2026, Edgewell will classify Feminine Care as discontinued operations. The company estimated the divestiture's annualized impact at approximately $0.40 to $0.50 in adjusted EPS and $35 million to $45 million in adjusted EBITDA, net of transition-service income. Not disclosed in the sourced document is any enterprise-value-to-EBITDA multiple implied by the $340 million price, Essity's financial advisor (if any), or the precise split of the sale price between cash and other consideration beyond the stated $340 million aggregate figure.

Crescent Energy Company (NYSE: CRGY), an oil and gas sector company, agreed to acquire Vital Energy, Inc. (NYSE: VTLE), also in the oil and gas exploration and production sector, in an all-stock merger. The transaction was announced on August 25, 2025, pursuant to an Agreement and Plan of Merger dated August 24, 2025, and was disclosed in a Form 8-K (with the merger agreement filed as Exhibit 2.1) and a joint press release and investor presentation furnished the same day under Item 7.01. The deal subsequently closed on December 15, 2025, following a special meeting of Vital stockholders held on December 12, 2025, at which the merger proposal was approved; Vital was delisted from the NYSE and deregistered, and Crescent Energy Finance LLC succeeded to Vital's reporting obligations as the ultimate surviving entity after an internal reorganization. Under the terms of the merger agreement, each share of Vital common stock was converted into the right to receive 1.9062 shares of Crescent Class A common stock, with cash paid in lieu of fractional shares. Crescent described this exchange ratio as representing a 5% premium to the 30-day volume-weighted-average-price (VWAP) exchange ratio and a 15% premium to Vital's 30-day VWAP as of August 22, 2025. The joint press release characterized the transaction as valued at approximately $3.1 billion, inclusive of Vital's net debt. Separately, the companies' investor presentation showed a pro forma enterprise value of approximately $9.1 billion for the combined company (Crescent standalone enterprise value of approximately $6.1 billion plus Vital standalone enterprise value of approximately $2.9 billion), with combined 2025E EBITDA of approximately $3.4 billion and pro forma balance-sheet leverage (net debt to LTM EBITDA) of approximately 1.5x expected at closing. The deal was structured as an all-equity transaction with no cash component to shareholders. Upon completion, Crescent shareholders owned approximately 77% of the combined company and former Vital shareholders owned approximately 23%, on a fully diluted basis. Vital's outstanding stock options and time-based restricted stock awards were converted into or settled in Crescent equity or cash based on the exchange ratio, while certain cash-settled performance stock units and director deferred stock awards vested and were cashed out based on Vital's pre-closing closing stock price. Crescent's board of directors increased to 12 members, adding two directors designated by Vital; John Goff continued as Non-Executive Chairman and David Rockecharlie continued as CEO of the combined company, which remained headquartered in Houston. Crescent disclosed it was targeting $90 million to $100 million of estimated annual synergies to be realized within the first 12 months following closing, described in the investor presentation as encompassing cost-of-capital, overhead and capital-allocation benefits, with additional unmodeled potential from operational efficiencies (drilling-and-completion efficiencies, reduced small-pad development and lease-operating-expense efficiencies) that management said were not included in the transaction underwriting. The presentation also cited combined levered free cash flow generation of more than $4 billion over the next five years and said Crescent intended to maintain its existing $0.12 per share quarterly dividend. In the joint press release, Crescent Chairman John Goff said the acquisition was "transformative for Crescent and consistent with our strategy," adding that it "cemented the company as a top ten independent, with line of sight to an investment grade credit rating." Crescent CEO David Rockecharlie said the deal represented "compelling value for all shareholders, with attractive acquisition returns and significant accretion across all key financial metrics," and that the combination gave Crescent "more focus, more scale and more potential to deliver long-term value to shareholders." Vital CEO Jason Pigott said the combination would "create a premier, scaled, mid-cap operator with significant efficiencies across a larger asset base" with "more capital allocation flexibility across a vast development inventory." Crescent also said it was increasing its non-core divestiture pipeline to $1 billion as part of the post-closing plan. According to the definitive joint proxy statement/prospectus (DEFM14A) filed November 12, 2025, Houlihan Lokey, acting as one of Vital's financial advisors, performed a selected-companies analysis applying enterprise-value-to-CY2025E and CY2026E Adjusted EBITDAX multiples to peer sets for both Vital (including Chord Energy, Civitas Resources, Coterra Energy, Devon Energy, Diamondback Energy and others) and Crescent (including Baytex Energy, Civitas Resources, Magnolia Oil & Gas and SM Energy), deriving implied per-share value ranges and corresponding implied exchange-ratio ranges that bracketed the agreed 1.9062x exchange ratio. The proxy's "Background of the Mergers" section describes an extended process in which Vital's board and management, dating back to September 2024, received and evaluated inbound interest from at least ten other named counterparties (referred to in the filing as Company A through Company J, publicly traded and privately held oil and gas companies and trading firms) regarding potential strategic transactions involving some or all of Vital's asset base, before ultimately agreeing to the Crescent transaction. The merger agreement provided for a termination fee of $22.5 million payable by Vital to Crescent, and a termination fee of $76.9 million payable by Crescent to Vital, in each case under specified circumstances such as a change of board recommendation or pursuit of a superior competing proposal. The outside date for closing under the merger agreement was March 31, 2026, though the transaction closed well ahead of that date. Closing was conditioned on, among other things, approval by both companies' stockholders, expiration or termination of the HSR Act waiting period, effectiveness of Crescent's Form S-4 registration statement, and NYSE listing approval for the Crescent shares issued in the merger. On financial and legal advisors: Jefferies LLC served as lead financial advisor to Crescent, with Evercore also serving as a financial advisor to Crescent; Kirkland & Ellis LLP served as Crescent's legal counsel. Intrepid Partners, LLC served as financial advisor to a special committee of independent Crescent directors, with Richards, Layton & Finger, P.A. serving as that special committee's legal counsel. Houlihan Lokey and J.P. Morgan Securities LLC served as joint financial advisors to Vital, with Vinson & Elkins LLP serving as Vital's legal counsel. Lazard served as an additional, independent financial advisor to Vital. At the December 12, 2025 special meeting, Vital's stockholders approved the merger proposal by a vote of 26,111,925 shares for, 242,604 against and 265,150 abstaining. A separate, non-binding advisory proposal on merger-related executive compensation did not receive the required affirmative vote. The merger closed three days later, on December 15, 2025, completing the transaction.

This deal is a cash and stock acquisition classified as an M&A transaction in the tech sector, involving Nativo as target and Life360, Inc. (ticker LIF) as acquirer. The disclosed value of the transaction is $120,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on November 10, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as Nativo's financial advisor, the target side, with no lead designation specified. Stifel served as Life360's financial advisor, the acquirer side, also without a specified lead designation, per the respective source sentences. On the legal side, Cooley LLP served as legal advisor to Nativo, the target, while Sidley Austin LLP served as legal advisor to Life360, the acquirer. Beyond the cash and stock consideration mix noted in the deal subtype, with a disclosed deal value of $120,000,000, no further detail on the specific split between cash and stock components is provided in the facts block. Several items are not disclosed in the available record. No lead designation is specified for either Perella Weinberg Partners or Stifel in their respective advisory roles, the precise cash-versus-stock consideration split is not broken out beyond the general subtype classification, and no expected closing date or further timeline detail beyond the November 2025 filing date and pending-regulatory status is given.

BillionToOne, Inc., a healthcare company trading on the Nasdaq under the ticker BLLN, completed its initial public offering on November 7, 2025. The offering consisted of an aggregate of 5,233,765 shares of Class A common stock, which included the full exercise of the underwriters' option to purchase an additional 682,665 shares, at a public offering price of $60.00 per share. The base offering, before the overallotment option, was 4,551,100 shares, representing $273,066,000 in gross proceeds as stated on the prospectus cover page. With the overallotment exercised in full, aggregate gross proceeds were approximately $314.0 million, before deducting underwriting discounts, commissions, and offering expenses. The prospectus, dated November 5, 2025 and filed as a Form 424B4 on November 6, 2025, disclosed estimated net proceeds to the company of approximately $248.4 million based on the base offering, or approximately $286.4 million assuming full exercise of the overallotment option, after underwriting discounts and commissions and estimated offering expenses. The underwriting discount was $4.20 per share, totaling $19,114,620 on the base offering and $21,981,813 assuming full exercise of the option, consistent with the actual outcome since the option was exercised in full. J.P. Morgan Securities LLC, Piper Sandler & Co., Jefferies LLC, and William Blair & Company, L.L.C. acted as joint book-running managers and representatives of the underwriters. The prospectus's underwriting table disclosed specific share allocations among the syndicate: J.P. Morgan Securities LLC (1,592,885 shares), Piper Sandler & Co. (910,220 shares), Jefferies LLC (682,665 shares), William Blair & Company, L.L.C. (523,377 shares), Stifel, Nicolaus & Company, Incorporated (318,577 shares), Wells Fargo Securities, LLC (295,822 shares), and BTIG, LLC (227,554 shares), totaling 4,551,100 shares. The company also reserved up to 5 percent of the shares offered for sale at the IPO price to officers, directors, employees, and certain individuals identified by management through a directed share program. The company stated that it intends to use the net proceeds from the offering, together with existing cash and cash equivalents, for working capital and other general corporate purposes, including funding growth, research and development initiatives, technology development, and operating expenses. The prospectus specifically disclosed that the company does not currently have specific planned uses for the proceeds and may use a portion to acquire or invest in complementary products, technologies, or businesses, though it had no agreements or commitments for any such transactions as of the prospectus date. On a dilution basis, the prospectus disclosed that the company's historical net tangible book value deficit as of June 30, 2025 was $(22.46) per share, and its pro forma net tangible book value (reflecting preferred stock conversion and related reclassifications occurring immediately prior to the offering) was $4.25 per share. After giving effect to the sale of 4,551,100 shares at $60.00 per share, pro forma as adjusted net tangible book value was $9.43 per share, representing an immediate increase of $5.18 per share to existing stockholders and immediate dilution of $50.57 per share to new investors in the base offering. Assuming full exercise of the overallotment option, pro forma as adjusted net tangible book value would increase to $10.12 per share, with dilution to new investors of $49.88 per share. As this was the company's initial public offering, there was no prior public trading price against which to measure a premium or discount at pricing; the $60.00 per share price was set through the IPO bookbuilding process rather than relative to an existing market price. On the legal side, the prospectus disclosed that Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP of San Francisco passed on the validity of the shares being offered on behalf of BillionToOne, while Cooley LLP of San Francisco represented the underwriters in connection with the offering. On the closing timeline, BillionToOne filed its registration statement on Form S-1 on October 7, 2025, amended it on October 17, 2025, registered its Class A common stock for listing on Nasdaq via Form 8-A12B on November 3, 2025, priced the offering with the final prospectus dated November 5, 2025 (filed as a 424B4 on November 6, 2025), and completed the IPO closing on November 7, 2025, as confirmed in a Form 8-K filed November 10, 2025. In that closing 8-K, the company also reported that it filed its amended and restated certificate of incorporation and that its amended and restated bylaws became effective in connection with the IPO closing. Based on this closing 8-K, the offering has fully closed; it is not pending regulatory review as previously indicated.

This is a stock-for-stock bank merger in the fig sector in which Fifth Third Bancorp (ticker FITB) is the acquirer of Comerica Incorporated. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an S-4 registration statement filed with the SEC via EDGAR, published on November 5, 2025, consistent with the stock-for-stock structure, since an S-4 registers the shares to be issued as merger consideration. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Goldman Sachs & Co. LLC, which served as the lead financial advisor to Fifth Third, the acquirer. The source sentence is drawn from a consent letter excerpt: "we hereby consent to the reference to our Opinion Letter under the captions 'SUMMARY, Opinions of Fifth Third's Financial Advisor,' ... Very truly yours, /s/ Goldman Sachs & Co. LLC (GOLDMAN SACHS & CO. LLC)." This confirms Goldman Sachs rendered a fairness opinion referenced in the registration statement. No financial advisor to Comerica, the target, is identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as a stock-for-stock bank merger, no further detail on the exchange ratio or other specific consideration terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, no financial advisor to Comerica (the target) is identified, no legal advisors to either side are identified, the exchange ratio is not specified, and no expected closing date is given beyond the pending-regulatory status.

The Western Union Company (NYSE: WU) has agreed to acquire International Money Express, Inc. ("Intermex"), a Miami-based omnichannel money remittance company trading under ticker IMXI on Nasdaq, in an all-cash transaction. The deal was announced on August 10, 2025 and disclosed in a Form 8-K filed with the SEC on August 11, 2025 that included the merger agreement, a joint press release, and a separate same-day Form 8-K containing an investor presentation. Devin McGranahan, President and CEO of Western Union, said the acquisition "is a disciplined, strategic step that strengthens our North America operations and expands our presence with key consumer segments across the U.S." Bob Lisy, Chairman and CEO of Intermex, said the agreement "represents an exciting opportunity to provide Intermex's shareholders with significant and certain value, accelerating our omni-channel strategy, while continuing to deliver for our customers." Under the terms of the Agreement and Plan of Merger, dated August 10, 2025, Western Union will acquire Intermex for $16.00 per share in cash, representing approximately $500 million in total equity and enterprise value. The press release describes this price as a roughly 50 percent premium to Intermex's 90-day volume-weighted average price. The proxy statement separately discloses that the $16.00 price represents a discount of approximately 17 percent to Intermex's 52-week high of $19.24 (excluding the period of its publicly announced strategic alternatives process) and a discount of approximately 27 percent to its 52-week high of $21.87 (including that period). Western Union will acquire Intermex via a wholly owned merger subsidiary, Ivey Merger Sub, Inc., which will merge into Intermex, with Intermex surviving as a wholly owned subsidiary of Western Union. The transaction is not conditioned on financing; Western Union represented in the merger agreement that it will have sufficient cash and available credit to fund the merger consideration at closing. In its fairness opinion, Lazard Frères & Co. LLC performed a discounted cash flow analysis using discount rates of 11.00% to 14.00% and perpetuity growth rates of 0.5% to 1.5%, implying an equity value range of $13.40 to $18.60 per share. A selected publicly traded companies analysis (benchmarked against Euronet Worldwide, Western Union, EVERTEC, and OFX Group) applied EV/2025E Adjusted EBITDA multiples of 4.0x-5.5x and EV/2026E Adjusted EBITDA multiples of 3.5x-5.0x, implying equity values of $12.10-$16.70 and $10.40-$14.90 per share, respectively. A selected precedent transactions analysis of nine retail-remittance acquisitions since 2016 (observed multiples ranging from 4.6x to 16.1x EV/CY1 Adjusted EBITDA) applied a 4.5x-8.0x multiple range, implying an equity value of $13.70 to $24.30 per share. Intermex's net debt was treated as $0 in all analyses, consistent with company guidance that cash and debt are used primarily to finance operating settlement activity. Western Union disclosed expected annual run-rate cost synergies of approximately $30 million within 24 months of closing, with additional potential revenue synergies from broader distribution and product integration that were not quantified. The acquisition is expected to be immediately accretive to Western Union's adjusted EPS by more than $0.10 in the first full year after closing. Strategic rationale cited in the press release includes expanding Western Union's U.S. retail footprint, extending Intermex's historically high-growth Latin America corridors, access to Intermex's approximately 6 million customers, and accelerating digital new-customer acquisition. The DEFM14A's "Background of the Merger" section describes a formal sale process that began after Intermex's Board formed a Strategic Alternatives Committee in November 2024 in response to letters from two institutional stockholders urging exploration of strategic alternatives. Between November 2024 and February 2025, Intermex entered into non-disclosure agreements with 20 potential counterparties, including Western Union and an unnamed "Party A," and Financial Technology Partners LP ("FTP") ran outreach on Intermex's behalf. Western Union initially informed FTP on December 24, 2024 that it would not pursue a transaction, before re-engaging later in the process; the full chronology of re-engagement and the eventual signing on August 10, 2025 is described in detail in the proxy. Advisors named in the announcement press release: PJT Partners served as exclusive financial advisor and Sidley Austin LLP as legal advisor to Western Union; Financial Technology Partners LP served as financial advisor and Holland & Knight LLP as legal advisor to Intermex; Lazard Frères & Co. LLC served as financial advisor and Cravath, Swaine & Moore LLP as legal advisor to Intermex's Strategic Alternatives Committee. The merger agreement includes a Company Termination Fee of $19,800,000 payable by Intermex to Western Union in specified circumstances, including acceptance of a superior proposal or a change in the board's recommendation, and a Parent (reverse) Termination Fee of $27,300,000 payable by Western Union to Intermex if the agreement is terminated due to a legal restraint under antitrust law. The original Outside Date under the merger agreement was May 11, 2026, with automatic extensions to August 10, 2026 and then to November 10, 2026 available if closing is delayed solely due to antitrust restraints, money-transmitter regulatory approvals, or certain other specified consents. On December 9, 2025, Intermex stockholders voted at a special meeting to approve the merger agreement, with approximately 99.86% of votes cast in favor (21,231,094 votes for versus 5,524 against), as disclosed in a Form 8-K filed the same day. On October 7, 2025, the companies announced the expiration of the Hart-Scott-Rodino Act waiting period, at the time expecting the deal to close in mid-2026. However, the closing has since been delayed. A Form 8-K filed October 2, 2026 disclosed that the California Department of Financial Protection and Innovation ("DFPI") suspended its approval of the merger (as previously disclosed on August 14, 2026) pending further review, and that because of the resulting delay, Western Union's original HSR clearance (which expired after one year from the October 2025 waiting-period expiration) lapsed. As a result, Intermex and Western Union each filed new Premerger Notification and Report Forms under the HSR Act on October 2, 2026, commencing a new 30-day waiting period for which the parties have requested early termination. The filing states the parties do not expect the DFPI to reinstate its approval prior to October 6, 2026, and that the merger remains subject to expiration of the new HSR waiting period and reinstatement of the DFPI's approval, in addition to other customary closing conditions. As of the most recent filing, the transaction has not closed and remains pending these outstanding regulatory approvals.

TrueCar, Inc. (NASDAQ: TRUE), a technology sector automotive digital marketplace, agreed to be acquired by Fair Holdings, Inc., an entity led by TrueCar founder Scott Painter, in an all-cash going-private transaction. The deal was announced on October 15, 2025 in a Form 8-K that attached the Agreement and Plan of Merger (dated October 14, 2025) among TrueCar, Fair Holdings, Inc. ("Parent") and its wholly owned merger subsidiary, Rapid Merger Subsidiary, Inc. Under the agreement, TrueCar stockholders were entitled to receive $2.55 per share in cash, implying an equity value of approximately $227 million based on basic shares outstanding at signing. The transaction closed on January 21, 2026, with Merger Subsidiary merging into TrueCar, which became a wholly owned subsidiary of Fair Holdings; TrueCar's common stock ceased trading on Nasdaq and the company's Exchange Act reporting obligations were terminated. The board's October 15, 2025 press release stated the transaction was approved unanimously following "an extensive strategic review process initiated in late 2024, which included discussions with a number of potential strategic and financial counterparties." Barbara Carbone, Chair of the TrueCar Board, said the Board "unanimously approved this transaction after a thorough and careful evaluation of potential value creation opportunities." The definitive merger proxy (DEFM14A, filed November 24, 2025) discloses that Scott Painter first contacted CEO Jantoon Reigersman on September 6, 2024 to express interest in acquiring the company, and that Fair's initial unquantified offer on September 10, 2024 was followed by a September 30, 2024 letter proposing $4.63 per share, well above the eventual $2.55 deal price; TrueCar's common stock closed at $3.23 on October 1, 2024 and $3.31 on September 19, 2024 during that period. Morgan Stanley was engaged as financial advisor on October 8, 2024 to run a process alongside the Fair negotiation. Morgan Stanley's discounted cash flow analysis, using management case projections and a 21.0% to 25.0% discount rate with a 2.0% to 4.0% perpetuity growth rate, indicated an implied per-share equity value range of $2.35 to $2.80, bracketing the $2.55 deal price. Separately, a scenario analysis referenced in the proxy showed a range of $2.20 to $3.55 per share under management case projections versus $1.25 to $1.65 per share under TrueCar Street consensus projections. Morgan Stanley delivered a written fairness opinion dated October 14, 2025 that the merger consideration was fair, from a financial point of view, to TrueCar stockholders other than excluded and rollover shares. The transaction required approximately $248 million in total funds to pay stockholders, settle equity awards, and cover transaction expenses of both parties (the "Required Amount"). Financing was structured as a combination of an equity commitment, TrueCar's own cash on hand, and additional capital to be raised from a syndicate of investors. Alpha Auto 2, LLC, defined in the proxy as the "Investor," entered into an Equity Commitment Letter providing Parent a $164 million equity commitment, and deposited $15 million as an advance against that commitment and as security for a reverse termination fee. The merger agreement additionally required Parent to obtain at least $60 million of additional equity or debt commitments (the "Additional Financing Condition") from a syndicate described by the company as expected to include "seasoned leaders and institutions across automotive retail, finance, and technology." At closing, Fair Holdings entered into a Rollover and Contribution Agreement with Auto Holdings, LLC, an affiliate of AutoNation, Inc., under which AutoNation's TrueCar shares were rolled over into equity of Parent rather than cashed out. The merger agreement provided for an $8,000,000 termination fee payable by TrueCar to Parent in specified circumstances, including termination following a failure to obtain stockholder approval after an adverse recommendation change, or termination by TrueCar to accept a superior proposal. It also provided for a $15,000,000 reverse termination fee payable by Parent to TrueCar (with TrueCar entitled to retain the $15 million deposit in satisfaction of that obligation) if Parent breached its obligations or failed to close, and for reimbursement of up to $3,000,000 of Parent's transaction expenses in certain no-vote termination scenarios. The agreement also included a 30-day go-shop period that expired at 11:59 p.m. Pacific Time on November 13, 2025. TrueCar held a special meeting of stockholders on December 22, 2025, at which the merger proposal was approved by 69,723,284 shares for versus 84,731 against and 311,685 abstentions, representing approval by stockholders holding roughly 78.83% of the 88,940,050 shares outstanding as of the November 13, 2025 record date. TrueCar's largest stockholder, Caledonia (Private) Investments Pty Limited and Caledonia US, LP, had committed to vote in favor of the transaction. Upon closing, announced in a January 21, 2026 press release, Scott Painter returned as TrueCar's Chief Executive Officer, and the investor group was disclosed to include PenFed Credit Union, Zurich North America, AutoNation, Atlantic Coast Automotive, Impel AI, ID.me, CRIF, and In The Car. James Schenck, President and CEO of PenFed, joined the board of Fair Holdings, Inc., and Georg Bauer, a former Mercedes, BMW and Tesla executive, was named Chairman of Fair Holdings. Painter said the company's mandate was "to operate with discipline and focus on generating real and sustainable profit," and that TrueCar "remains an important and highly relevant platform that touches nearly 10% of all U.S. car buyers." Morgan Stanley & Co. LLC acted as exclusive financial advisor to TrueCar, and Alston & Bird LLP acted as lead legal counsel to TrueCar; Joele Frank, Wilkinson Brimmer Katcher served as TrueCar's strategic communications advisor. B. Riley Securities, Inc. acted as financial advisor and Perkins Coie LLP acted as legal counsel to Fair Holdings, Inc.

California Resources Corporation (NYSE: CRC), a Long Beach, California-based independent energy and carbon management company, agreed to acquire Berry Corporation (NASDAQ: BRY), a western United States independent upstream energy company with oil and gas operations in California's San Joaquin Basin and Utah's Uinta Basin plus a well-servicing and abandonment subsidiary, C&J Well Services. The transaction was announced jointly on September 15, 2025, in a current report on Form 8-K that included a joint press release and investor presentation, and the merger agreement was signed on September 14, 2025. The deal subsequently closed on December 18, 2025, as confirmed by a Form 8-K filed by Berry on that date (Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02 and 5.03) and a matching CRC Form 8-K, following approval by Berry stockholders at a special meeting held December 15, 2025. The transaction was structured as an all-stock merger, with Berry shareholders receiving a fixed exchange ratio of 0.0718 shares of CRC common stock for each Berry share, representing a 15% premium based on the companies' closing stock prices on September 12, 2025 (the last trading day before announcement). At announcement, the exchange ratio implied a per-share value of approximately $3.81 for Berry stock and valued Berry at approximately $717 million inclusive of its net debt, with the companies stating the deal implied an enterprise value for the combined entity of more than $6 billion. CRC disclosed the transaction was priced at approximately 2.9 times enterprise value to Berry's estimated 2025 adjusted EBITDAX. Existing CRC shareholders were expected to own approximately 94% of the combined company upon closing. At closing, CRC issued approximately 5.6 million shares of its common stock to former Berry equity holders, with an aggregate value of approximately $253 million based on CRC's closing share price on December 17, 2025, reflecting the decline in CRC's stock price between signing and closing. CRC president and CEO Francisco Leon said the deal would create "a stronger, more efficient California energy leader" that is "attractively valued and immediately accretive across key financial metrics," adding that by "realizing substantial corporate and operating synergies, we expect to significantly lower costs and generate higher free cash flow." Berry board chair Renee Hornbaker said the transaction "presents a compelling value proposition for our shareholders," citing the "industrial logic of this merger" and noting that "the strong tailwinds we are seeing on the regulatory front" made it the right time to consummate the deal. On a pro forma basis, CRC said the combined company would have produced approximately 161 thousand barrels of oil equivalent per day (81% oil) in the second quarter of 2025 and held approximately 652 million barrels of oil equivalent of proved reserves (87% proved developed) as of year-end 2024. CRC also highlighted that Berry's roughly 100,000 net acre Uinta Basin position in Utah would provide additional operational and financial optionality, noting a PV-10 of total proved reserves there of approximately $110 million as of year-end 2024. CRC expects to achieve annual cost synergies of $80 million to $90 million within 12 months of closing, equal to approximately 12% of the transaction value, with approximately 50% of run-rate synergies implemented within six months of closing and the remaining 50% within 12 months. Synergies are expected to come primarily from corporate cost reductions, lower interest costs from debt refinancing, operating improvements and supply chain efficiencies. CRC projected the deal would be accretive to net cash provided by operating activities and free cash flow, with projected second-half 2025 per-share accretion to both metrics of more than 10% before estimated synergies. Post-closing, CRC said it would retain an estimated pro forma trailing-twelve-month leverage ratio of less than 1.0x and approximately 70% of its expected second-half 2025 pro forma oil production hedged at a $68 per barrel Brent floor price. CRC also stated it planned to refinance Berry's outstanding debt using cash on hand and borrowings under its credit agreement, and the merger's pro forma financial statements reflect the issuance of approximately $400 million in new notes, with proceeds earmarked in part to repay Berry's existing indebtedness in connection with the merger. The S-4 registration statement filed by CRC on October 14, 2025 (which included Berry's proxy statement/prospectus and was later mailed as the DEFM14A dated November 4, 2025) disclosed an extensive background of the merger. Berry had run two prior sale-focused strategic alternatives processes, in 2021-2022 (with Financial Advisor A, which contacted roughly 30 potential counterparties) and beginning in 2022 (with Guggenheim Securities, which contacted roughly 30 additional potential counterparties not previously contacted, along with some re-contacted from the first process), including CRC in both processes, without producing an agreed transaction, with several parties citing California's regulatory and political environment and valuation disconnects. Berry separately held substantive, extended negotiations with two other named bidders, referred to as "Party A" (a publicly traded oil and gas company that proposed an at-market stock-for-stock merger in February 2024 before terminating talks in August 2024 over California regulatory risk and refinancing concerns) and "Party C" (a publicly traded independent oil and gas company that proposed an all-stock combination in September 2024 giving Berry shareholders 20% of the combined company, before pausing and ultimately discontinuing discussions in early 2025 after revising Berry's valuation downward). A third party, "Party B," proposed in March 2025 to contribute a privately held oil and gas portfolio company to Berry in exchange for Berry stock, which would have given Berry shareholders only 31% of the combined, Party B-controlled company. CRC's CEO Francisco Leon first contacted Berry's CEO Fernando Araujo about a potential combination in November 2024, and the companies executed a mutual confidentiality agreement in January 2025 before negotiating the final agreement, which the Berry board unanimously approved on September 13-14, 2025 after receiving a fairness opinion from Guggenheim Securities regarding the exchange ratio. On the legal advisory side, Sullivan & Cromwell LLP served as legal advisor to CRC, and Vinson & Elkins LLP served as legal advisor to Berry, both per the joint announcement press release. On the financial advisory side, RBC Capital Markets and Petrie Partners served as financial advisors to CRC, while Guggenheim Securities, LLC served as financial advisor to Berry and rendered a fairness opinion on the exchange ratio to Berry's board. Innisfree M&A Incorporated, as previously identified, served as Berry's proxy solicitor in connection with the shareholder vote, maintaining offices at 501 Madison Avenue, 20th Floor in New York. The merger agreement included a termination fee of $12,044,370 payable by Berry to CRC under specified circumstances, including a change in the Berry board's recommendation or Berry's entry into a competing acquisition agreement within nine months of certain terminations. CRC's aggregate monetary liability upon termination was capped at $45,255,219 (absent fraud), and the agreement also provided for expense reimbursement payments of up to $5 million in certain termination scenarios. Closing was conditioned on, among other things, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and receipt of approval under Section 203 of the Federal Power Act from the Federal Energy Regulatory Commission, as well as Berry stockholder approval and receipt of a tax opinion from Vinson & Elkins. CRC and Berry filed their joint FERC Section 203 application on October 1, 2025, and made their HSR filings with the FTC and DOJ on October 10, 2025. Berry stockholders approved the merger agreement at a December 15, 2025 special meeting, with 56,199,678 shares voting for the merger proposal against 1,153,772 against and 204,975 abstaining, out of 57,558,425 shares represented at the meeting (77,607,094 shares were outstanding and entitled to vote as of the October 30, 2025 record date). The merger closed three days later, on December 18, 2025, with Berry surviving as a direct, wholly-owned subsidiary of CRC and the combined company headquartered in Long Beach, California under CRC's existing executive management team.

This deal is a stock-for-stock merger in which California Resources Corp (ticker CRC), a company in the natural-resources sector, acquires Berry Corporation (BRY). The transaction is classified as an M&A deal in the natural-resources sector, and the disclosed value of the transaction is not stated in the source document. The deal is sourced from a DEFM14A filing with the SEC, published on November 4, 2025 and retrieved via SEC EDGAR. The deal's current status is pending regulatory approval. On the financial advisory side, Guggenheim Securities, LLC is named as the lead financial advisor to Berry, the target company. The source material frames this role as formal, referencing Guggenheim's fairness opinion delivered as financial advisor to Berry in connection with the transaction. No financial advisor is identified for the acquirer, California Resources Corp, in the facts provided. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either side of the transaction. Beyond the stock-for-stock structure noted for the merger, no further detail on the consideration mix, exchange ratio, or other structural terms is provided in the facts block. Several material facts are not disclosed in the available record. The overall transaction value is not stated in the source document. No acquirer-side financial advisor and no legal advisors for either party are identified. No expected closing date or other timeline detail beyond the November 2025 filing date and pending-regulatory status is given. Readers should treat these as open items rather than assume any particular structure or advisor lineup beyond what is stated here.

Heidrick & Struggles International, Inc. (Nasdaq: HSII), a global leadership advisory and on-demand talent solutions firm, agreed on October 5, 2025 to be acquired by Heron BidCo, LLC and its wholly-owned merger subsidiary Heron Merger Sub, Inc., entities affiliated with funds advised by Advent International, L.P. and Corvex PE Advisors LP (together with Advent, the Consortium), in an all-cash going-private transaction valued at approximately $1.3 billion in equity value. The agreement was disclosed in a Form 8-K filed October 6, 2025 (Item 1.01) that attached the Agreement and Plan of Merger as Exhibit 2.1 and a joint press release as Exhibit 99.1. Under the terms of the Merger Agreement, each outstanding share of Heidrick common stock will be converted into the right to receive $59.00 in cash, without interest, representing a premium of approximately 26 percent to Heidrick's 90-day volume-weighted average share price. The company's 52-week trading range as of October 3, 2025 was $36.75 to $51.79, and Wall Street analyst price targets as of that date ranged from $48.00 to $56.00. The deal followed a competitive process described in the DEFM14A (filed November 3, 2025). Corvex partner Joe Costa first approached Heidrick in March 2025 indicating Corvex had built a 4.9% stake and wanted to pursue a take-private, prompting the Heidrick board to retain BofA Securities and Paul Hastings LLP and to run a process that, by mid-2025, involved three potential counterparties referred to as the Consortium (Advent/Corvex), "Party A," and "Party C." Party A withdrew from the process on September 3, 2025. BofA Securities' fairness opinion incorporated a Selected Precedent Transactions Analysis of 19 staffing-industry deals applying an EV/LTM Adjusted EBITDA multiple range of 8.00x to 11.00x to Heidrick's trailing-twelve-month Adjusted EBITDA (through June 30, 2025), implying a per-share equity value range of $48.75 to $65.25 versus the $59.00 merger consideration. A Discounted Cash Flow analysis using terminal multiples of 6.00x to 8.00x on fiscal 2029 estimated Adjusted EBITDA and discount rates of 10.00% to 12.00% implied a per-share range of $52.50 to $67.25. A Selected Publicly Traded Companies analysis benchmarked Heidrick (whose primary comparable was Korn Ferry, trading at 7.7x CY2025E and 7.3x CY2026E EV/Adjusted EBITDA) against diversified staffing peers (Randstad, Adecco, ManpowerGroup, Hays, Kelly Services, SThree, TrueBlue, Resources Connection) and vertically focused peers (Robert Half, ASGN, AMN Healthcare, PageGroup, Kforce), applying a 6.00x to 8.00x multiple to Heidrick's CY2026E Adjusted EBITDA. The transaction is structured as all-cash with no financing condition to closing. Concurrently with signing, Advent-affiliated equity investors entered into an equity commitment letter to fund aggregate equity contributions of $1,350,000,000 to Parent, sufficient to cover the merger consideration and related payments, backstopped by a limited guarantee from the equity investors. The October 6, 2025 press release stated that Advent and Corvex had also secured committed debt financing for the transaction from Deutsche Bank, UBS Investment Bank, and Santander. The investor consortium includes significant investment from Heidrick partners and leaders alongside several family offices; the closing press release (December 10, 2025) named participating strategic investors as Salem Capital Management, Mousse Partners, TF Cornerstone, HighSage Ventures, and Barcliff Partners. The Merger Agreement provides for a new post-closing equity incentive plan for partners and leaders, which the DEFM14A's background section describes the Consortium as having proposed with a target pool of approximately 15%-17% of fully diluted equity. Financial advisors: BofA Securities served as exclusive financial advisor to Heidrick; William Blair & Company, L.L.C., Deutsche Bank, and UBS Investment Bank served as financial advisors to the investor consortium. Legal advisors: Paul Hastings LLP served as legal counsel to Heidrick; Weil, Gotshal & Manges LLP served as legal counsel to the investor consortium; Ropes & Gray LLP served as additional legal counsel to Advent. The Merger Agreement set a Termination Date of July 5, 2026 and provided for a Heidrick-payable termination fee of $38,900,000 under specified circumstances, with closing conditions including Heidrick stockholder approval, HSR Act expiration/termination, and clearance under certain foreign antitrust laws. Heidrick stockholders approved the Merger Agreement Proposal at a special meeting on December 5, 2025 (17,639,091 votes for versus 164,722 against, per the Form 8-K filed under Item 5.07), while a separate non-binding golden parachute compensation advisory proposal was not approved. The merger closed on December 10, 2025: per the Form 8-K filed that day (Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01), Heron Merger Sub, Inc. merged with and into Heidrick, with Heidrick surviving as a direct, wholly-owned subsidiary of Heron BidCo, LLC, and each share was canceled and converted into the right to receive the $59.00 per-share Merger Consideration. Heidrick's common stock was delisted from Nasdaq and the company subsequently filed a Form 15-12G (December 22, 2025) to deregister its securities. Heidrick continues to operate under its existing brand and headquarters in Chicago, with CEO Tom Monahan and President Tom Murray remaining in place, and Carmine Di Sibio (Advent Operating Partner and former EY Global Chair and CEO) appointed Chairman of the Board of Managers post-closing.

This transaction is a cash acquisition structured as a take-private of Heidrick & Struggles International Inc. by Heron Bidco LLC, an affiliate of funds advised by the acquiring sponsor. The deal falls within the business services sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form DEFM14A filing published on November 3, 2025. According to the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, BofA Securities, Inc. served as financial advisor to Heidrick & Struggles, the target, and is identified as the lead advisor in this transaction. The source material cites the "Opinion of BofA Securities, Inc.," indicating that BofA Securities rendered a fairness opinion in connection with the merger. No financial advisor to Heron Bidco LLC or its affiliated funds is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that this is a cash acquisition structured as a take-private transaction, no further detail on the specific per-share price or other terms of the cash consideration is included in the facts available. Several elements of this deal are not disclosed in the available material. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Heidrick & Struggles or Heron Bidco LLC is identified. No financial advisor to the acquiring side is named, and no expected closing date or detail on required regulatory approvals is provided.

Coeur Mining, Inc., a natural resources sector company trading under ticker CDE, acquired New Gold Inc., a Canadian intermediate mining company listed on the Toronto Stock Exchange and NYSE American under ticker NGD, in an all-stock arrangement valued at approximately $7 billion in total equity value. The deal was announced on November 3, 2025 via a joint press release, with the underlying Arrangement Agreement dated November 2, 2025 and filed as Exhibit 2.1 to Coeur's Form 8-K. The transaction closed on March 20, 2026, with New Gold becoming a wholly owned subsidiary of Coeur. Under the Arrangement Agreement, each New Gold common share was exchanged for 0.4959 shares of Coeur common stock. Based on Coeur's October 31, 2025 closing price of $17.17, the exchange ratio implied a value of $8.51 per New Gold share, a 16% premium to New Gold's October 31, 2025 closing price of $7.34 on NYSE American. The deal was structured as a plan of arrangement under the Business Corporations Act (British Columbia), approved by the Supreme Court of British Columbia, rather than a conventional one-step merger. In the proxy statement's fairness-opinion analysis, RBC Capital Markets calculated that the offer price implied multiples of 2.0 times New Gold's net asset value, 5.4 times its 2026 estimated EBITDA, and 5.2 times its 2026 estimated cash flow, compared with peer medians of 0.8x, 3.6x and 4.6x, respectively, for a group of North American precious metals companies RBC selected for comparison (Equinox Gold, IAMGOLD, B2Gold, OceanaGold, SSR Mining, Orla Mining and Wesdome Gold Mines). Upon completion, existing Coeur stockholders owned approximately 62% of the combined company and former New Gold shareholders owned approximately 38%, implying a pro forma combined equity market capitalization of approximately $20 billion. Coeur Chairman, President and CEO Mitchell J. Krebs said the deal would "create a stronger, more resilient, and larger scale precious metals mining company," adding that "this is an extraordinary opportunity to create an unrivaled North American-only, mining powerhouse at just the right time." New Gold President and CEO Patrick Godin said the combination "unlocks the next level of potential for our shareholders, uniting with a company of similar financial strength and cash flow generation while also gaining exposure to a larger scale, diversified portfolio with new long-life assets and immense exploration potential." The combined company added New Gold's two Canadian mines, the New Afton copper-gold mine and the Rainy River gold mine, to Coeur's five existing operations (Las Chispas, Palmarejo, Rochester, Kensington and Wharf), creating seven North American operations. Coeur and New Gold said the combined company was expected to generate approximately $3.0 billion of EBITDA and approximately $2.0 billion of free cash flow in 2026 from production of approximately 20 million ounces of silver, 900,000 ounces of gold and 100 million pounds of copper, compared with Coeur's own expected standalone 2025 EBITDA and free cash flow of approximately $1 billion and $550 million, respectively. No specific dollar synergy target, phase-in schedule, or EPS accretion/dilution percentage was disclosed in the press release, investor presentation, or definitive proxy statement; the companies described the deal only qualitatively as "accretive on all of Coeur's key per share metrics, including net asset value, operating cash flow, and free cash flow." The deal was financed entirely in stock, with no cash component, debt assumption, or bridge financing disclosed in connection with the exchange consideration itself. Separately, in connection with closing, Coeur entered into a new $1.0 billion senior secured revolving credit facility with National Bank of Canada as administrative agent, replacing its prior 2017 credit agreement, to fund working capital and general corporate purposes of the combined company. The proxy statement's background section discloses that Coeur's board had evaluated a potential combination with New Gold since at least late 2023 alongside other candidates, including SilverCrest Metals Inc. (which Coeur separately acquired in 2024) and two other unnamed potential counterparties with which Coeur conducted due diligence but ultimately did not pursue transactions. Coeur and New Gold signed a mutual non-disclosure agreement in March 2024 and conducted due diligence over more than a year before signing the Arrangement Agreement in November 2025. National Bank Capital Markets provided a fairness opinion to the New Gold board, and CIBC Capital Markets provided a fairness opinion to a special committee of independent New Gold directors formed to evaluate the deal; both opinions concluded the consideration was fair, from a financial point of view, to New Gold shareholders. BMO Capital Markets Corp. and RBC Capital Markets, LLC each provided fairness opinions to the Coeur board concluding the exchange ratio was fair, from a financial point of view, to Coeur. The Arrangement Agreement provided for termination fees of $413,705,000 payable by Coeur to New Gold, and $254,725,000 payable by New Gold to Coeur, in specified circumstances, plus a reciprocal expense-reimbursement provision capped at $33,965,000. Closing was conditioned on approval by at least 66 2/3% of votes cast by New Gold shareholders, approval of the stock issuance and a charter amendment (increasing Coeur's authorized shares from 900,000,000 to 1,300,000,000) by Coeur stockholders, approval by the Supreme Court of British Columbia, and antitrust and foreign-investment clearances from Mexico's antitrust authority and under Canada's Competition Act and Investment Canada Act. Coeur stockholders approved both the charter amendment (96.75% approval) and the stock issuance (97.12% approval) at a special meeting held January 27, 2026, with approximately 70% of outstanding shares voted. New Gold shareholders separately approved the arrangement at their own special meeting. The transaction closed on March 20, 2026, and New Gold shares were delisted from the TSX and NYSE American following closing. Upon closing, New Gold CEO Patrick Godin and one other New Gold director joined the Coeur board of directors, and several members of New Gold's management team joined Coeur. Following the close, Coeur issued updated 2026 consolidated production guidance of 680,000-815,000 gold ounces, 18.7-21.9 million silver ounces and 50-65 million pounds of copper, and announced an expanded $750 million share repurchase program along with an inaugural $0.02 per share semiannual dividend policy.

Leerink Partners is acting as the exclusive financial advisor to an unnamed acquirer in a divestiture transaction valued at $600 million. This is a mergers and acquisitions transaction structured as a divestiture, meaning a company is divesting or selling a business unit, subsidiary, or asset to another party. The target sector has not been disclosed in the available information. The transaction size is disclosed at $600 million in U.S. dollar terms, representing the purchase price or enterprise value of the divested asset or business. The transaction details are sourced from an SEC EDGAR filing published on October 31, 2025. The specific form type has not been identified, but the filing is publicly available through the SEC's EDGAR database. As of the time of filing, the transaction is pending regulatory approval, indicating that the deal has been announced and is awaiting clearance from relevant regulatory authorities before it can close. Leerink Partners has been retained as the exclusive financial advisor to the acquirer side of this transaction, serving in a lead advisory capacity. The role of Leerink Partners is to provide financial advisory services related to the divestiture. No other financial advisors have been identified or disclosed for either the acquirer or the divesting party at this stage. No legal advisors have been disclosed for either party in the available documentation. The consideration structure, payment mechanics, and any detailed terms of the transaction have not been disclosed. While the deal is valued at $600 million, the specific breakdown of consideration type (cash, stock, debt assumptions, or a combination) has not been provided. Similarly, no information has been given regarding the structure of the transaction, such as whether it is being conducted as an asset sale, stock sale, or other form of divestiture. The identity of both the acquirer and the divesting company has not been disclosed in the available source material. Additionally, no expected closing date has been provided, no detailed description of the divested business or assets has been disclosed, and no information regarding regulatory bodies reviewing the transaction has been identified. The reason for the divestiture, integration plans, or any other strategic context remains unknown.

Tiptree Inc. entered into an Agreement and Plan of Merger dated September 26, 2025 with its majority-owned subsidiary The Fortegra Group, Inc., a specialty insurance company, and DB Insurance Co., Ltd., a Republic of Korea-incorporated insurer, under which DB Insurance will acquire Fortegra for aggregate cash consideration of $1.65 billion. Fortegra's common stock will be converted into the right to receive a per-share cash amount at closing, with a Delaware merger subsidiary of DB Insurance being merged into Fortegra, which will survive as a wholly owned subsidiary of DB Insurance. This extraction is sourced from Tiptree's definitive merger proxy statement on Form DEFM14A filed with the SEC on October 31, 2025, prepared for a special meeting of Tiptree stockholders held virtually on December 3, 2025 to approve the merger. Barclays was engaged by Fortegra under a May 1, 2025 engagement letter to act as its financial advisor in pursuing strategic alternatives, including a possible sale, and rendered a fairness opinion to the Fortegra board on September 24, 2025 that the $1.65 billion aggregate cash consideration was fair to Fortegra common stockholders from a financial point of view. BofA Securities also acted as a financial advisor to Fortegra in the process but the proxy specifies that BofA Securities acted solely for Fortegra's benefit and not as an advisor to any other party, including Tiptree. On the legal side, Ropes & Gray LLP represented Fortegra (and, per the proxy, Tiptree) throughout negotiations, Sidley Austin LLP served as outside insurance counsel to both Tiptree and Fortegra, and Latham & Watkins LLP served as outside legal counsel to DB Insurance, the Purchaser. As compensation for its services, Fortegra paid Barclays a fee of $3 million upon delivery of its fairness opinion. The proxy describes an extended negotiation process beginning with due diligence calls in spring 2025 and culminating in the signed Merger Agreement in late September 2025, with Warburg Pincus (through the WP Investor entity) and a family office also involved in related ancillary transactions tied to the deal structure. The proxy excerpt reviewed here does not disclose the expected closing date or timeline for the transaction, the specific per-share cash merger consideration paid to Fortegra stockholders (only the aggregate $1.65 billion figure), or the total fee paid to BofA Securities for its advisory role.

This record concerns M&T Bank Corp (ticker MTB), a financial-institutions-group (fig) sector company, as the issuer in a depositary shares/preferred stock offering. The transaction falls under the equity capital markets (ecm) product group, and its disclosed value is $450,000,000. The facts are sourced from a Form 424B5 filing with the SEC via EDGAR, published October 30, 2025. The deal's status is pending regulatory, indicating the offering had not yet fully concluded as of that filing. Six financial advisors are disclosed, all acting as joint bookrunners for the issuer and all designated lead. Wells Fargo Securities, BofA Securities, UBS Investment Bank, M&T Securities, RBC Capital Markets, and Morgan Stanley are all named as joint bookrunners, per the source sentence listing them together: "Joint Bookrunners RBC Capital Markets BofA Securities Morgan Stanley M&T Securities UBS Investment Bank Wells Fargo Securities." Notably, M&T Securities, an affiliate of the issuer itself, is among the joint bookrunners. No legal advisors are identified in the facts block for this transaction. Beyond identifying this as a depositary shares/preferred stock offering valued at $450,000,000, the facts block does not specify the dividend rate on the preferred stock, the liquidation preference per depositary share, or the redemption terms of the securities. Several facts are not disclosed in this record. No legal advisors are named for the issuer. The facts block does not differentiate among the six joint bookrunners in terms of relative allocation or lead-left status beyond their collective "joint bookrunner" designation, and no expected closing date is given.

Terex Corporation and REV Group announced on October 30, 2025 that they had entered into a definitive merger agreement to combine in a stock-and-cash transaction, creating a specialty equipment manufacturer spanning emergency, waste, utilities, environmental and materials-processing equipment. The deal is an industrials-sector combination rather than a pure acquisition: Terex shareholders were expected to own approximately 58% of the combined company and REV Group shareholders approximately 42%, with the combined entity continuing to trade on the NYSE under the Terex ticker. This extraction is sourced from Terex's 8-K exhibit (Exhibit 99.1) filed with the SEC on October 30, 2025, which carried the joint press release announcing the signed merger agreement. The merger subsequently closed on February 2, 2026, as confirmed by a separate 8-K exhibit filed by Terex that day announcing completion. Barclays served as exclusive financial advisor to Terex on the transaction, while J.P. Morgan served as exclusive financial advisor to REV Group. Both banks held sole, lead advisory mandates for their respective sides rather than sharing the engagement with any co-advisor. On the legal side, Fried, Frank, Harris, Shriver & Jacobson LLP and Pryor Cashman LLP served as legal counsel to Terex, while Davis Polk & Wardwell LLP served as legal counsel to REV Group. Joele Frank, Wilkinson Brimmer Katcher acted as strategic communications advisor to Terex and Brunswick Group served the same role for REV Group, though these are not financial or legal advisory roles. Under the terms of the agreement, REV Group shareholders were to receive, for each REV Group share held, 0.9809 of a share of the combined company plus $8.71 in cash, aggregating to approximately $425 million in total cash consideration. Based on the exchange ratio and closing share prices as of October 28, 2025, the companies disclosed an implied total enterprise value for the combined company of approximately $9 billion, with expected run-rate synergies of $75 million by 2028. The deal was unanimously approved by both boards and was expected to close in the first half of 2026, subject to shareholder and regulatory approvals. The press release does not disclose a standalone transaction or deal value specific to REV Group (as opposed to the combined company's pro forma enterprise value), nor does it disclose specific advisory fees paid to either Barclays or J.P. Morgan. The breakdown of the $9 billion enterprise value between the Terex and REV Group legacy businesses, and any termination fee provisions in the merger agreement, are also not addressed in this exhibit.

Palomar Holdings, Inc. (NASDAQ: PLMR), a specialty insurer in the financial services sector, agreed to acquire The Gray Casualty & Surety Company ("Gray Surety") from Bernhard Capital Partners ("BCP") and The Gray Insurance Company. The transaction was structured as an equity purchase: on October 27, 2025, Palomar Insurance Holdings, Inc., a direct wholly owned subsidiary of Palomar, entered into an Equity Purchase Agreement with Gray Surety and BCP Surety Group Sole Member, LLC (the "Seller") to acquire all of the issued and outstanding equity interests of Gray Surety. The agreement and an accompanying press release were filed as Exhibits 2.1 and 99.1, respectively, to a Form 8-K filed October 30, 2025. The disclosed purchase price was $300 million in cash, subject to customary post-closing adjustments for Book Value, Indebtedness and Transaction Expenses as set out in the agreement's purchase-price adjustment mechanism. No per-share price, exchange ratio, or EV/EBITDA-style multiple was disclosed, consistent with a private, cash acquisition of a privately held target with no public shareholder vote. Gray Surety is described as a Treasury-listed surety carrier specializing in contract bonds for midsized and emerging contractors, founded in 1996 as a subsidiary of The Gray Insurance Company (a family-owned Louisiana insurer) and recapitalized by Bernhard Capital Partners in 2021; it is licensed in all 50 states, operates thirteen regional offices, and is described as a "Top 50" surety carrier that sustained annual double-digit growth while maintaining a below-industry-average loss ratio. Mac Armstrong, Palomar's Chairman and CEO, said the deal "meaningfully enhances Palomar's surety franchise, bolstering our current market position and complementing our existing operations," and that the Gray Surety team's expertise "will play a key role in advancing our Palomar 2x strategic imperative and driving sustained profitable growth." Cullen Piske, President of Gray Surety, said Palomar "shares our entrepreneurial culture, disciplined underwriting approach and commitment to the surety market" and that the deal provides "the financial strength, scale, and strategic support to expand our reach." No dollar synergy estimate, cost-base percentage, or phase-in timeline was disclosed in the filings reviewed. On the financial advisory side, Evercore acted as exclusive financial advisor to Palomar and J.P. Morgan acted as exclusive financial advisor to Gray Surety. On the legal side, DLA Piper LLP (US) represented Palomar and Kirkland & Ellis LLP represented Gray Surety. The original agreement called for closing conditions including expiration or termination of HSR Act waiting periods, required insurance regulatory approvals, and other customary closing conditions, with an outside termination date of March 27, 2026 (extendable to May 27, 2026 under the agreement's terms). No standalone termination fee was disclosed in the purchase agreement. The transaction has since closed. On January 30, 2026, the parties amended the purchase agreement to provide that closing would be effective on the last day of the month in which closing conditions were satisfied. The transaction closed on January 31, 2026, as disclosed in a Form 8-K filed February 2, 2026 (Items 1.01, 2.01, 2.03, 7.01 and 9.01). At closing, Palomar paid approximately $311 million in cash for Gray Surety's equity interests (reflecting the post-closing purchase-price adjustment from the originally disclosed $300 million), funded with proceeds from a new Term Loan and cash on hand. In connection with the closing, Palomar also entered into a new unsecured credit agreement on January 27, 2026 with U.S. Bank National Association (administrative agent), KeyBank National Association (syndication agent), and Citizens Bank, The Huntington National Bank, PNC Bank and Wells Fargo Bank as co-documentation agents, providing $450 million of unsecured credit facilities (a $150 million revolver and a $300 million term loan, maturing January 27, 2031, plus an uncommitted $100 million incremental facility), with proceeds usable for general corporate purposes, permitted acquisitions including this transaction, and refinancing of existing debt. Borrowings bear interest at Term SOFR or the Alternate Base Rate plus a margin of 1.5%-1.75% (Term SOFR) or 0.5%-0.75% (Alternate Base Rate), determined by Palomar's Debt to Capital Ratio. Obligations are guaranteed by several Palomar insurance subsidiaries pursuant to a Guaranty dated January 27, 2026. JPMorgan Chase Bank also participated in the term loan. Announcing the closing, Mac Armstrong said, "This transaction meaningfully strengthens Palomar surety franchise. It adds scale and geographic reach, complements our existing operations and puts us well on our way to building a market leader in the attractive surety sector." No EPS accretion/dilution guidance, pro forma combined financial metrics, or integration cost figures were disclosed in the filings reviewed. Gray Surety is now listed among Palomar's insurance subsidiaries with an "A" (Excellent) A.M. Best financial strength rating.

First Mid Bancshares, Inc., a financial institutions sector company trading under ticker FMBH, acquired Two Rivers Financial Group, Inc. (OTCQX: TRVR), the holding company for Two Rivers Bank & Trust, in an all-stock merger originally valued at approximately $94.1 million. The deal was announced October 30, 2025, in a Form 8-K that included a joint press release and investor presentation, with the merger agreement dated October 29, 2025. The transaction closed on February 28, 2026, with First Mid issuing a press release confirming completion on March 2, 2026. Under the terms of the merger agreement, each share of Two Rivers common stock was converted into the right to receive 1.225 shares of First Mid common stock, with cash paid in lieu of fractional shares. Based on First Mid's October 28, 2025 closing price of $36.80, the deal was announced at an implied aggregate value of approximately $94.1 million; the S-4 proxy statement/prospectus later recalculated the implied value at approximately $92.6 million using First Mid's October 29, 2025 closing price of $36.24 and the 2,086,645 Two Rivers shares outstanding as of the merger agreement date. At closing, First Mid issued approximately 2,539,879 shares of common stock to former Two Rivers shareholders. The investor presentation filed with the announcement disclosed valuation multiples of 104% of Two Rivers' tangible book value (as of September 30, 2025), an 80% pay-to-trade multiple, 8.5 times Two Rivers' estimated 2026 earnings per share, and 5.3 times 2026E EPS including fully phased-in cost savings. First Mid disclosed expected pro forma ownership of approximately 90% First Mid shareholders and 10% former Two Rivers shareholders. First Mid projected approximately 12.3% accretion to 2027 estimated EPS (approximately 11.3% excluding CECL double-count), tangible book value dilution of approximately 4.3% (3.7% excluding CECL), and a tangible book value per share earnback period of 2.1 years (1.9 years excluding CECL). Pro forma combined metrics at closing were disclosed as approximately $9.0 billion in total assets, $6.7 billion in total loans, $7.3 billion in total deposits, a CET1 ratio of approximately 12.8%, tangible common equity to tangible assets of approximately 8.8%, 2027E return on average assets of approximately 1.30%, and 2027E return on average tangible common equity of approximately 15%. First Mid's own closing press release put the combined company at $9.1 billion in total assets following the transaction. First Mid disclosed expected cost savings equal to approximately 27% of Two Rivers' noninterest expense base, with 50% phased in during 2026 and the full amount realized in subsequent years, alongside one-time pretax restructuring costs of $14.5 million. Revenue synergies were described as identified but not modeled into the financial projections. Purchase accounting marks disclosed in the investor presentation included an estimated $11.6 million pretax credit mark on Two Rivers' loan portfolio (1.3% of loans as of September 30, 2025, split 40% PCD and 60% non-PCD), a $38.3 million loan interest rate write-down accreted over five years, $16.2 million of available-for-sale securities AOCI accreted over seven years, a $1.9 million held-to-maturity securities write-down accreted over eight years, a core deposit intangible equal to 3.50% of non-time deposits amortized over 10 years, and a customer list intangible equal to 0.40% of assets under management amortized over 15 years. Two Rivers, as of September 30, 2025, reported approximately $1.1 billion in total assets, $901 million in loans, $988 million in deposits, $116 million in wealth management assets under management, and 14 branches concentrated in Burlington, Fort Madison, Des Moines, Iowa City and Henry County, Iowa, where it held leading or top-five deposit market share in several markets. Two Rivers reported a return on average assets of 0.97%, a leverage ratio of 11.6%, core deposits equal to 93% of total deposits, loan loss reserves of 1.29% of loans, and trailing-twelve-month net charge-offs of 0.13% of average loans. As of year-end 2025, per First Mid's closing press release, Two Rivers held approximately $1.2 billion in assets, $883 million in loans and $1.0 billion in deposits. The S-4 registration statement/proxy statement-prospectus, filed December 23, 2025, disclosed that the relationship between the two companies traced back to 2012 and that Two Rivers had worked with D.A. Davidson as its financial advisor for the prior decade, periodically modeling potential sale or merger scenarios including with First Mid. Formal deal discussions began June 4, 2025, when D.A. Davidson contacted First Mid CEO Joseph Dively about a confidentiality agreement; confidentiality agreements were executed June 10, 2025, and First Mid began due diligence via a data room on June 11, 2025. On July 22, 2025, First Mid's financial advisor Keefe, Bruyette & Woods delivered a non-binding indication of interest proposing an exchange ratio of 1.175 First Mid shares per Two Rivers share, implying an aggregate value of approximately $96 million based on First Mid's July 17, 2025 closing price of $39.08. On August 1, 2025, First Mid submitted a revised indication of interest raising the exchange ratio to 1.225 shares, which the Two Rivers board authorized management to pursue at an August 7, 2025 board meeting, with Dickinson, Bradshaw, Fowler & Hagen, P.C. and D.A. Davidson advising on legal and financial considerations. The indication of interest, executed August 8, 2025, included a 60-day exclusivity period for confirmatory and reverse diligence and merger agreement negotiation. The proxy does not describe a competitive sale process involving bidders other than First Mid. D.A. Davidson rendered its fairness opinion to the Two Rivers board on October 29, 2025, opining that the 1.225 exchange ratio was fair, from a financial point of view, to Two Rivers shareholders, based on review of the draft merger agreement, public filings, management projections for both companies, comparable public company and precedent transaction data, and discounted cash flow analyses; the specific multiples and comparable companies used in those analyses were not captured from the summary reviewed. Keefe, Bruyette & Woods, Inc. served as exclusive financial advisor to First Mid, and ArentFox Schiff LLP served as First Mid's legal counsel. D.A. Davidson & Co. served as exclusive financial advisor to Two Rivers and rendered the fairness opinion; Barack Ferrazzano Kirschbaum & Nagelberg LLP and Dickinson, Bradshaw, Fowler & Hagen, P.C. served as Two Rivers' legal counsel. Shareholders, directors and officers holding approximately 23.5% of Two Rivers' outstanding shares (490,148.5 shares) entered into a voting agreement committing to vote in favor of the merger. The merger agreement provided for a termination fee of $3,625,000 payable by Two Rivers to First Mid under specified circumstances, including termination following a breach of Two Rivers' no-solicitation covenant where a competing proposal was announced and later consummated, or termination by Two Rivers to accept a superior proposal. Required regulatory approvals included the Federal Reserve Board, the Iowa Division of Banking, and the Office of the Comptroller of the Currency for the subsequent bank-level merger, plus a post-approval antitrust waiting period and SEC effectiveness of the registration statement; the merger agreement set an outside termination date of August 31, 2026, and gave Two Rivers a right to terminate if First Mid's stock price fell below $29.15 and underperformed the Nasdaq Bank Index by more than 20%. The transaction closed on February 28, 2026, with Two Rivers merging into First Mid's subsidiary Star Sub LLC. First Mid also assumed approximately $10.31 million in Two Rivers' junior subordinated debt securities due March 15, 2035, and approximately $20.07 million in outstanding loans owed to Bankers' Bank. Two Rivers' outstanding equity awards fully vested upon closing. First Mid's closing press release quoted CEO Joe Dively stating the company had "worked closely with the Two Rivers team over the last few months to ensure a smooth transition" and that First Mid would "welcome Two Rivers' customers and employees to First Mid." Systems conversion for Two Rivers' customers was scheduled for June 2026, with customers to be notified in advance of any account changes. Shane Zimmerman, Two Rivers Bank & Trust's President and CEO, was expected to join First Mid as an Executive Vice President, Divisional President, under retention arrangements for Two Rivers' leadership team disclosed in the investor presentation.

This is an acquisition of an additional joint venture interest, structured with cash and stock consideration, in the natural-resources sector, in which BKV Corp (ticker BKV) is acquiring one-half of BPP's interest in BPP Power LLC. The product group is M&A, and the disclosed transaction value is $376,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on October 29, 2025. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Moelis & Company LLC, which served as independent financial advisor to the Special Committee on the acquirer side (BKV). The source sentence states: "Morris, Nichols, Arsht & Tunnell LLP acted as independent counsel to the Special Committee and Moelis & Company LLC served as independent financial advisor to the Special Committee." No lead designation is specified for Moelis in the facts provided. Two legal advisors are identified, both on the acquirer side. Morris, Nichols, Arsht & Tunnell LLP acted as independent counsel to BKV's Special Committee, per the same source sentence referenced above. Separately, Baker Botts L.L.P. acted as legal counsel to BKV generally, per the source sentence "Baker Botts L.L.P. acted as legal counsel to BKV." Beyond the classification of this transaction as an acquisition of an additional joint venture interest for cash and stock, with a disclosed value of $376,000,000, no further detail on the specific split between cash and stock consideration is included in the facts provided. Several items are not disclosed in this record: the precise cash/stock consideration mix is not specified, no financial or legal advisor to the seller side (BPP) is identified, and no expected closing date is given beyond the pending-regulatory status.

BKV Corporation (NYSE: BKV), a Denver-based natural gas production, midstream, and power generation company, announced on October 29, 2025 that it entered into a definitive purchase agreement with Banpu Power US Corporation (BPPUS) under which BKV will acquire one-half of BPPUS's interest in BKV-BPP Power, LLC, increasing BKV's ownership of the joint venture to 75% of its limited liability company interests at closing. BKV-BPP Power owns the Temple I and Temple II combined cycle gas and steam turbine power plants in the ERCOT North Zone in Temple, Texas. This entry is sourced from BKV's Exhibit 99.1 press release filed as part of an 8-K on October 29, 2025. The transaction had not yet closed as of the filing date; it was expected to close in the first quarter of 2026, subject to closing conditions including approval by at least 75% of the disinterested shareholders of Banpu Power Public Company Limited (BPP, the Thailand-listed sole stockholder of BPPUS) at an Extraordinary General Meeting. Because BPPUS is affiliated with Banpu North America Corporation, the majority holder of BKV common stock, the transaction was reviewed and recommended for approval by a special committee of independent, disinterested BKV directors. Moelis & Company LLC served as independent financial advisor to BKV's Special Committee. No financial advisor is named for BPPUS or BPP in this release; the release notes only that BPP's board resolved to propose the transaction for shareholder approval following its audit committee's review, in accordance with connected transaction requirements, and that an independent financial advisor was appointed to provide a fairness opinion to BPP shareholders, without naming that advisor. Baker Botts L.L.P. acted as legal counsel to BKV, and Morris, Nichols, Arsht & Tunnell LLP acted as independent counsel to BKV's Special Committee. Under the disclosed terms, BKV agreed to pay aggregate consideration calculated as $376.0 million less 25% of BKV-BPP Power's net indebtedness at closing, split 50% in cash and 50% in BKV common stock. As of September 30, 2025, net indebtedness of BKV-BPP Power was approximately $581.8 million, and the stock consideration was to be issued at a price of $21.6609 per share. BKV planned to fund the cash portion using cash on hand and borrowings under its reserve-based lending agreement, which had $800.0 million of available capacity as of September 30, 2025. The release does not name the independent financial advisor providing a fairness opinion to BPP shareholders, nor does it disclose a termination fee or any financing contingency beyond BKV's existing credit facility capacity. The precise net aggregate dollar consideration cannot be calculated from this release alone because it depends on net indebtedness of BKV-BPP Power at closing, which had not yet been finalized.

This deal is a sale of renewal rights, classified as an M&A transaction in the financial institutions group (FIG) sector, involving Everest's global retail and commercial insurance business as the target/divested business and American International Group, Inc. (ticker AIG) as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on October 28, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Ardea Partners LP served as exclusive financial advisor to Everest (the target/seller side), in a lead capacity. Evercore served as financial advisor to AIG, the acquirer, though no lead designation is specified for Evercore's role in the facts provided. On the legal side, Debevoise & Plimpton LLP served as legal advisor to Everest (the Company, target side), while Willkie Farr & Gallagher LLP served as legal advisor to AIG, the acquirer, per the respective source sentences pairing each financial and legal advisor by side. Beyond the classification of this transaction as a sale of renewal rights for Everest's global retail and commercial insurance business, no further detail on the specific business lines transferred, consideration structure, or other terms is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document, and no lead/non-lead designation is given for Evercore's role advising AIG. No expected closing date or additional timeline detail beyond the October 2025 filing date and pending-regulatory status is provided.

This transaction is an all-stock merger in which Huntington is acquiring Cadence Bank. The disclosed value of the transaction is 7,400,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on October 27, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Keefe, Bruyette & Woods, A Stifel Company, served as the financial advisor to Cadence, the target, in the transaction. On the acquirer side, Evercore served as the financial advisor to Huntington, and BofA Securities also served as advisor to Huntington, meaning the acquirer had two separate financial advisors on the deal, as confirmed by a dedicated source sentence stating that BofA Securities also served as advisor to Huntington. On the legal side, Sullivan & Cromwell LLP served as legal counsel to Cadence, the target, while Wachtell, Lipton, Rosen & Katz served as legal counsel to Huntington, the acquirer. Beyond confirming that this is an all-stock merger with a disclosed value of 7,400,000,000 dollars, no further detail on the specific exchange ratio or other mechanics of the stock consideration is included in the facts available. A number of elements of this deal remain undisclosed. No specific exchange ratio or other mechanics of the all-stock consideration are given beyond the aggregate disclosed value, and no expected closing date is provided. The facts also do not specify what regulatory approvals are required to complete the transaction.

FirstSun Capital Bancorp, a financial institutions sector company trading under ticker FSUN, agreed to acquire First Foundation Inc. (NYSE: FFWM) in an all-stock merger under an Agreement and Plan of Merger dated October 27, 2025. Under the agreement, First Foundation merged with and into FirstSun, with FirstSun as the surviving corporation, and First Foundation's subsidiary bank, First Foundation Bank, merged into FirstSun's subsidiary, Sunflower Bank, National Association, with Sunflower Bank as the surviving bank. The transaction was announced via press release and investor presentation describing it as 'Creating the Southwest's Premier Banking Franchise' and 'Unlocking Value via Strategic M&A,' with the combined company described as a premier $17 billion bank operating in the nation's best growth markets. Mollie Hale Carter, Executive Chairman of FirstSun, said: 'We are thrilled to welcome the customers and team members of First Foundation to the FirstSun and Sunflower Bank family. This merger represents an exciting opportunity to strengthen our platform for long-term, sustainable growth, expand our earnings power, and drive greater value for our stockholders... Together, FirstSun and First Foundation will form a premier regional bank with a powerful footprint across some of the most dynamic markets in the country.' Tom Shafer, CEO of First Foundation, said: 'Joining forces with FirstSun marks an exciting new chapter for First Foundation. This merger strengthens our ability to deliver exceptional financial services and expands our reach across key markets... We are particularly excited to accelerate the business plan of First Foundation Advisors, our private wealth management platform.' Under the terms of the merger agreement, First Foundation common and preferred stockholders (Series A Noncumulative Convertible Preferred Stock and Series C Non-Voting Common Equity Equivalent Stock) received 0.16083 of a share of FirstSun common stock for each First Foundation share on a fully converted basis, with cash paid in lieu of fractional shares. First Foundation warrant holders exercised their warrants early in exchange for FirstSun common stock plus an aggregate cash payment of approximately $17.5 million. The aggregate transaction value, inclusive of the warrant cash consideration, was estimated at $785 million based on FirstSun's closing stock price as of October 24, 2025 (FirstSun issued shares at an implied $40.44 per share). FirstSun stockholders owned approximately 59.5% and First Foundation stockholders approximately 40.5% of the combined company at closing. The investor presentation disclosed purchase price multiples of 0.80x First Foundation's September 30, 2025 stated tangible book value (adjusted for convertible preferred) and 0.73x tangible book value including reversal of First Foundation's deferred tax asset (DTA) valuation allowance; FirstSun shares were issued at 1.10x its own September 30, 2025 tangible book value. The deal was structured entirely as stock consideration with no new acquisition debt disclosed. FirstSun separately disclosed a related balance sheet 're-positioning' plan to downsize approximately $3.4 billion of First Foundation's non-core, wholesale-funded assets (targeting a wholesale funding ratio below 10%) concurrent with closing, which management said would unlock First Foundation's core franchise earnings power; no revenue synergies were included in management's financial modeling. FirstSun disclosed estimated pre-tax cost savings of $68.8 million, equal to 35.0% of First Foundation's run-rate core noninterest expense base (excluding customer service expense impacts), with an assumed phase-in schedule of approximately 66% realized in 2026 and 100% realized in 2027 and thereafter. The investor presentation separately disclosed a $425.0 million pre-tax interest rate mark on First Foundation's loan portfolio (5.60% of pre-close loan balances), of which $286.7 million was assumed to accrete into earnings over the estimated remaining life of the loans, plus a $50.3 million pre-tax held-to-maturity securities mark. On financial impact, FirstSun management projected 30%+ accretion to its estimated 2027 GAAP EPS (and mid-to-high single-digit percentage accretion to 2027 cash EPS), 2027 pro forma return on average assets of approximately 1.45% and return on average tangible common equity of approximately 13.3%, pro forma total assets of approximately $17 billion, approximately $6.8 billion in pro forma assets under management, and a pro forma fee-income-to-total-revenue ratio of approximately 20%. On tangible book value impact, a summary slide in the investor presentation showed an estimated 7% GAAP TBV dilution at close with a 3.3-year earnback (and TBV accretion, no earnback, on a cash basis), while a more detailed non-GAAP reconciliation elsewhere in the same presentation calculated pro forma FirstSun tangible book value per share at close of $33.27 versus FirstSun's standalone $38.80, implying dilution of $5.53 per share, or 14.3%, also with a 3.3-year earnback under the "crossover method." Management also projected an internal rate of return of 20%+ and return on invested capital of 12%+ for the transaction. FirstSun's board of directors and First Foundation's board of directors each unanimously approved the merger agreement. At closing, the combined company's board was to consist of thirteen directors, eight from FirstSun and five from First Foundation. Mollie Hale Carter (Executive Chairman), Neal Arnold (CEO, President and Director) and Rob Cafera (CFO) of FirstSun retained their roles, while Tom Shafer, CEO of First Foundation, became Vice Chairman of the combined company. Certain directors and stockholders of both companies entered into Support Agreements agreeing to vote their shares in favor of the merger. According to the "Background of the Merger" section of the joint proxy statement/prospectus (Form S-4), First Foundation and FirstSun had engaged in intermittent, ultimately discontinued merger discussions in 2022-2023 (with KBW advising FirstSun and Stephens advising First Foundation at that time), before renewed discussions began in February 2025 when FirstSun CEO Neal Arnold and First Foundation CEO Thomas Shafer re-engaged regarding FirstSun's expansion into Southern California. During First Foundation's 2025 strategic review, the company's board and KBW (its financial advisor) evaluated multiple alternative approaches, including: a March 19, 2025 introductory call (coordinated by Jefferies) with the CEO of another bank that did not lead to further talks; follow-up conversations in early June 2025 with three bank CEOs at a KBW-hosted conference, two of whom declined further dialogue while a third expressed interest that was not pursued further; introductory calls in June 2025 (coordinated by Jefferies) with CEOs of two additional banks that did not result in further interest from either side; an inbound inquiry in June-July 2025 from a bank with less than $500 million in assets proposing a market-premium, all-cash take-private transaction, which the First Foundation board rejected on July 10, 2025 as not in stockholders' best interests; and an August 14, 2025 meeting between Shafer, KBW and the CEO/CFO of a "substantially larger banking institution" regarding a potential acquisition of First Foundation, which that larger institution ultimately declined to pursue. The board determined that running a broader auction process risked deterring FirstSun, which it viewed as the strongest remaining counterparty, and authorized continued bilateral negotiations. FirstSun submitted non-binding term sheets on August 21 and August 25, 2025 and a further revised term sheet on September 9, 2025, with negotiations over the ownership split (ranging between approximately 40% and 42%), warrant treatment (including an increase in the proposed warrant termination payment from $10 million to $25 million, ultimately set at $17.5 million in the signed agreement), and a minimum tangible common equity closing condition. FirstSun delivered a "best and final" letter of intent on September 18, 2025 contemplating 100% stock consideration, a fixed exchange ratio with no collar, and FirstSun as legal and accounting acquirer, which led to the signed merger agreement on October 27, 2025. Closing of the merger was conditioned on, among other things: approval of the merger agreement by both companies' stockholders; approval by FirstSun stockholders of a charter amendment increasing authorized common stock and creating a new non-voting common stock class (available to First Foundation stockholders who would otherwise receive more than 4.99% of FirstSun's outstanding common stock); receipt of required bank regulatory approvals (FirstSun's primary regulator, the OCC, and First Foundation's primary regulator, the FDIC, were both involved in reviewing the companies' balance sheet repositioning plans) without materially burdensome conditions; effectiveness of the Form S-4 registration statement and Nasdaq listing approval for the shares to be issued; and receipt of tax opinions that the merger would qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. The merger agreement provided for termination fees of $45.1 million payable by FirstSun and $31.4 million payable by First Foundation under specified circumstances, and allowed either party to terminate if the deal did not close within 12 months of signing, subject to exceptions. FirstSun Capital Bancorp engaged Stephens Inc. as its exclusive financial advisor, and Stephens rendered a fairness opinion to FirstSun's board of directors. Nelson Mullins Riley & Scarborough LLP served as legal counsel to FirstSun. On the target side, First Foundation retained Keefe, Bruyette & Woods, A Stifel Company (lead financial advisor, providing a fairness opinion to First Foundation's board) and Jefferies LLC (financial advisor, also providing a fairness opinion to First Foundation's board). Alston & Bird LLP served as legal counsel to First Foundation. FirstSun filed a Form S-4 registration statement on December 11, 2025 (amended January 14, 2026) covering the shares to be issued in the merger, which included the joint proxy statement of FirstSun and First Foundation and a prospectus of FirstSun; the definitive joint proxy statement/prospectus was filed on January 15, 2026. FirstSun's stockholders approved the merger proposal, the charter amendment increasing authorized common stock, and the non-voting common stock proposal at a special meeting held February 27, 2026. The merger closed on April 1, 2026, with First Foundation merging into FirstSun and First Foundation Bank merging into Sunflower Bank, National Association, as disclosed in a Form 8-K filed that day. A subsequent Form 8-K filed June 5, 2026 confirmed that Sunflower Bank closed on the sale of approximately $890 million of performing multifamily commercial real estate loans acquired from First Foundation Bank to entities affiliated with Brookfield Asset Management, described as part of the previously disclosed post-merger balance sheet downsizing plan, with the remainder of the downsizing expected to be completed before the end of the second quarter of 2026.

FirstSun Capital Bancorp, ticker symbol FSUN, is acquiring First Foundation Inc. in a merger transaction within the financial institutions sector. The deal is valued at $785 million in disclosed consideration. Both parties operate in the financial institutions sector, and this transaction represents a merger-subtype mergers and acquisitions engagement. The transaction information is sourced from an SEC EDGAR filing published on October 27, 2025. The form type is not specified in the available data. As of the date of this briefing, the deal remains pending regulatory approval and has not yet closed. First Foundation retained two financial advisors to support the transaction. Keefe Bruyette and Woods, A Stifel Company, is serving as lead advisor to First Foundation and provided a fairness opinion to the target's board of directors. Jefferies LLC is also serving as financial advisor to First Foundation and rendered a fairness opinion to the board. On the acquirer side, Stephens Inc. is serving as exclusive financial advisor to FirstSun Capital Bancorp and rendered a fairness opinion to FirstSun's board of directors, functioning as the lead financial advisor for the acquirer. Legal representation has been retained by both parties. Alston & Bird LLP served as legal counsel to First Foundation. Nelson Mullins Riley & Scarborough LLP served as legal counsel to FirstSun Capital Bancorp. The transaction documentation does not disclose specific details regarding the consideration structure, such as the allocation between cash and stock consideration, any earnout provisions, or deal adjustments. Similarly, no information has been disclosed regarding deal timing, expected closing conditions beyond regulatory approval, or any collar mechanisms. The exact form of the SEC filing containing this information has not been specified in the available data.

Premier, Inc. (NASDAQ: PINC), a Charlotte, North Carolina-based technology-driven health care improvement company, entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital, LP, a dedicated health care investment firm with more than $14 billion in assets under management. The agreement was announced on September 22, 2025 and the merger was completed on November 25, 2025, with Premier becoming a wholly owned subsidiary of Premium Parent, LLC, a Delaware entity formed by funds managed by Patient Square Capital. Premium Merger Sub, Inc., a wholly owned subsidiary of Parent, merged into Premier. Under the terms of the Agreement and Plan of Merger, dated September 21, 2025, Premier stockholders received $28.25 in cash per share of Class A common stock, a transaction Premier's press release described as valued at $2.6 billion. The $28.25 per-share price represented a 23.8% premium to Premier's 60-day volume-weighted average price as of September 5, 2025, the last trading day before media reports of a potential transaction. The DEFM14A states the Board considered the merger consideration a premium over the unaffected share price and that the deal was not subject to a financing condition. Premier's closing 8-K disclosed that total cash consideration payable to equityholders at closing was approximately $2.4 billion, while the proxy statement separately estimated total funds needed to complete the merger and related transactions, including repayment of existing debt and fees, at approximately $2.8 billion. No aggregate enterprise value figure was stated outright in the filings reviewed, though Goldman Sachs' premia-paid analysis in the proxy referenced comparable LBO transactions with disclosed enterprise values between $2 billion and $5 billion as a benchmark set, not as a disclosed valuation of Premier itself. In its fairness analysis, Goldman Sachs (one of Premier's two financial advisors) performed an illustrative present-value-of-future-share-price analysis applying an EV/NTM EBITDA multiple range of 7.0x to 9.0x to the company's projected fiscal 2026-2028 EBITDA, which, combined with other adjustments and a 10.2% discount rate, produced an implied present value range of $22.18 to $30.86 per share. This was one of several analyses (also including a premia-paid analysis using 79 comparable all-cash LBO transactions from 2018-2025, which showed a median premium of 32%) that informed, but were separate from, the final agreed price of $28.25 per share. The deal is funded through a combination of equity financing from the Patient Square Capital Fund and debt financing from lenders party to a debt commitment letter, with Parent having obtained commitments for a $1,450 million senior secured first lien term loan facility and a $225 million senior secured revolving credit facility, as disclosed in Premier's Item 1.01 Form 8-K. Concurrently with closing, Premier repaid all loans and terminated commitments under its existing Amended and Restated Credit Agreement with Wells Fargo Bank as administrative agent. No debt or earnings-accretion/dilution metrics (this being a going-private cash transaction rather than a stock-for-stock bank merger) were disclosed, nor was a specific synergies figure disclosed in the filings reviewed. According to the DEFM14A's "Background of the Merger" section, Premier's board had explored strategic alternatives since November 2021, including a prior 2022-2023 process that contacted approximately 25 potential counterparties and produced one serious bidder ("Party A"), whose proposal fell through in December 2023 when Party A sought a price below Premier's then-trading level. That process was formally terminated in February 2024. A new process began after an April 2, 2025 lunch meeting in New York between Premier's CEO Michael Alkire, CFO Glenn Coleman, a BofA Securities representative, and Patient Square Capital advisory council member Brian McCarthy, which led to preliminary interest from Patient Square Capital, a confidentiality agreement on April 22, 2025, and ultimately exclusive negotiations culminating in the signed merger agreement on September 21, 2025. The Board's Transaction Committee held 14 meetings during the process. Board Chair Richard Statuto said the Board "unanimously approved this transaction, after careful consideration of a wide range of strategic alternatives in recent years and consultation with our financial and legal advisors," and that the deal would "deliver immediate and certain value to our stockholders, while simultaneously providing the Company with access to additional capital." CEO Michael Alkire said that "transitioning to private ownership will once again enhance the Company's financial flexibility and provide additional resources to accelerate the advancement and tech-enablement of our product portfolio." Patient Square Founding Partner Neel Varshney, M.D. said the firm has "long admired Premier as an innovator of essential services and products to its members" and sees "tremendous opportunity for Premier to continue growing its differentiated portfolio in supply chain services, data and technology offerings, and consulting solutions." Goldman Sachs & Co. LLC and BofA Securities, Inc. served as financial advisors to Premier, with Wachtell, Lipton, Rosen & Katz serving as Premier's legal counsel and Cravath, Swaine & Moore LLP serving as legal advisor to the Board's Transaction Committee. Joele Frank, Wilkinson Brimmer Katcher served as Premier's strategic communications advisor, and Innisfree M&A Incorporated served as proxy solicitation agent. On the buyer side, Kirkland & Ellis LLP served as legal counsel and Ropes & Gray served as health care legal counsel to Patient Square Capital, while Jefferies LLC and Santander served as financial advisors and Perella Weinberg Partners LP served as debt capital markets advisor to Patient Square. The merger agreement included a termination fee payable by Premier to Parent of approximately $66,215,100 under specified circumstances, including a change of Board recommendation or termination to accept a superior proposal, and a reverse termination fee payable by Parent to Premier of approximately $168,550,000, guaranteed by affiliates of Patient Square Capital, if the Company terminated due to Parent's uncured breach or failure to close. The outside date for closing was March 21, 2026, subject to one three-month extension under certain conditions, though the transaction closed well ahead of that date. The transaction received approval from Premier stockholders at a November 21, 2025 special meeting, where holders of 64,965,155 shares (representing the vast majority of the approximately 79% of outstanding shares that voted) voted in favor of the merger agreement proposal, against 52,235 votes and 486,484 abstentions. The merger closed on November 25, 2025. At the effective time, Premier's Class A common stock was converted into the right to receive the $28.25 per-share merger consideration, the stock was delisted from Nasdaq, and the registrant's certificate of incorporation and bylaws were amended and restated. CEO Michael Alkire and CFO/Chief Administrative Officer Glenn Coleman became the Company's directors, while the Company's prior independent directors (including Board Chair Richard Statuto) resigned.

This deal is a cash acquisition structured as a take-private, in which Premier, Inc., a company in the business-services sector, is the target being acquired by Premium Parent LLC, an indirect subsidiary of funds managed and advised by an unnamed sponsor. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: a DEFM14A filed with SEC EDGAR and published on October 22, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised the target, Premier: Goldman Sachs & Co. LLC and BofA Securities, Inc. both served as financial advisors, and both are designated as lead advisors. Goldman Sachs delivered an oral opinion, later confirmed in writing, to the Premier board on September 21, 2025, that the merger consideration was fair from a financial point of view to the relevant stockholders. BofA Securities, also described as the company's financial advisor, likewise delivered a written opinion dated September 21, 2025, addressing the fairness of the merger consideration from a financial point of view. No financial advisor is disclosed for Premium Parent LLC, the acquirer. No legal advisors were identified in the facts block for either Premier or Premium Parent LLC. Beyond the cash consideration implied by the "cash acquisition" subtype, the facts block does not disclose a per-share purchase price or other specific terms of the transaction. Several facts are not disclosed in the source material. The overall deal value is not stated. No financial or legal advisor is named for the acquirer, Premium Parent LLC, and no legal advisor is named for Premier either. The facts block also does not specify a per-share price or an expected closing date.

This transaction is a stock-for-stock merger in which Crescent Energy Company is acquiring Vital Energy, Inc., a natural-resources sector company. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form S-4 filed and published on October 22, 2025. The transaction's current status is pending regulatory review. Only one financial advisor is named in the facts block: Jefferies LLC served as financial advisor to the acquirer, Crescent Energy, in a lead capacity. The source sentence is drawn from a consent letter in which Jefferies LLC consents to the reference to its opinion letter and firm under captions including Summary, Opinions of Financial Advisors, and The Mergers, Opinion of Jefferies LLC, Crescent's Financial Advisor, confirming Jefferies' mandate was to render a fairness opinion to Crescent in connection with the merger. No legal advisors are identified in the facts block for either Vital Energy or Crescent Energy. The facts block confirms this is structured as a stock-for-stock merger, but does not specify the exchange ratio or the treatment of outstanding equity awards or convertible instruments. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No financial advisor is named for Vital Energy, the target, and no legal advisors are named for either party. No expected closing date is given, and the specific stock exchange ratio is not disclosed.

Guess?, Inc. (NYSE: GES), a Los Angeles based designer, marketer, distributor and licensor of contemporary apparel and lifestyle products, agreed to be taken private in a transaction with Authentic Brands Group LLC and certain existing Guess? shareholders (the Rolling Stockholders, including co-founders Maurice Marciano and Paul Marciano, Nicolai Marciano, and CEO Carlos Alberini). The Agreement and Plan of Merger was signed August 20, 2025 among Guess?, Authentic, Glow Holdco 1, Inc. (Parent) and Glow Merger Sub 1, Inc. (Merger Sub). The transaction closed on January 23, 2026. Under the structure, Authentic acquired 51% of substantially all of Guess?'s intellectual property, with the Rolling Stockholders retaining the other 49% of the IP, while current Guess? management continues to run the wholly Rolling Stockholder owned operating company. Guess? shareholders other than the Rolling Stockholders received $16.75 per share in cash, a premium of approximately 73% to Guess?'s unaffected closing stock price on March 14, 2025 (the last trading day before Guess? disclosed an earlier unsolicited proposal) and a premium of 24.4% to the August 18, 2025 closing price, the day before the Authentic deal was announced. The press release and proxy statement describe the deal as valuing Guess? at approximately $1.4 billion including debt; the proxy's financing section states anticipated total consideration necessary to complete the merger, including associated costs and expenses, of approximately $1.475 billion, funded by cash on hand (including Authentic's cash used to fund investor loans), Authentic's existing debt financing arrangements, and the value of rollover shares. The transaction was not subject to a financing condition. In its fairness opinion, Solomon Partners Securities, LLC calculated that the $16.75 per-share price implied a transaction multiple of 6.6x EV/LTM Adjusted EBITDA (based on Guess?'s LTM Adjusted EBITDA through fiscal month-end June 2025) and 6.0x EV/CY2025E EBITDA (based on management's "June Projections" of approximately $239.5 million of fiscal 2026 Adjusted EBITDA). Solomon's selected public companies analysis showed a range of 2.8x-5.8x LTM Adjusted EBITDA and 3.1x-6.6x CY2025E EBITDA across comparable apparel/retail companies, and its selected precedent transactions analysis cited EBITDA multiples including Sycamore Partners/Chico's FAS (4.9x, September 2023), JD Sports/Hibbett (6.2x, April 2024) and Dick's Sporting Goods/Foot Locker (6.4x, May 2025). The DEFM14A's "Background of the Merger" section discloses that Guess? received an unsolicited non-binding proposal from WHP Global (through affiliate WHP Investments, LLC) on March 13, 2025 at $13.00 per share in cash, which would not have required majority-of-unaffiliated-stockholder approval. A Special Committee of independent, disinterested directors (chaired by Alex Yemenidjian) ran a process that, in addition to WHP and Authentic, contacted 36 potential bidders and executed NDAs with eight of them (four brand management companies, one strategic company, and three financial sponsors) but received no other actionable proposals; ultimately the Special Committee negotiated the transaction with Authentic and the Rolling Stockholders up to the final $16.75 per share. Announcing the deal, Alex Yemenidjian, Chairman of the Guess? Board and the Special Committee, said the outcome was "the result of a thoughtful and independent review by the Special Committee" that "unanimously determined that the transaction with Authentic and the Rolling Stockholders is the best path forward for Guess?, providing Guess? shareholders with immediate and certain cash value at a compelling premium." Paul Marciano, Co-Founder and Chief Creative Officer, said joining "Authentic, the world's second largest licensor with a powerful lifestyle and entertainment platform, will enable us to build on this foundation and expand our reach as a global lifestyle brand." CEO Carlos Alberini said that as a private company "benefiting from the perspectives of a globally recognized licensing partner, Guess? will have enhanced flexibility to navigate today's complex operating environment and execute on a more targeted, long-term strategy." Jamie Salter, Founder, Chairman and CEO of Authentic, called Guess? "a powerhouse brand that has defined style and culture for over 40 years" and said Authentic has "tremendous respect for the Marcianos and their team." Solomon Partners Securities, LLC acted as financial advisor to the Special Committee; Willkie Farr & Gallagher LLP and Young Conaway Stargatt & Taylor LLP acted as legal counsel to the Special Committee; O'Melveny & Myers LLP and Morris, Nichols, Arsht & Tunnell LLP acted as legal counsel to Guess?; Joele Frank served as strategic communications advisor. The Sage Group, LLC acted as financial advisor and Jones Day and Ropes & Gray LLP (the latter joining in May 2025) acted as legal counsel to the Rolling Stockholders. J.P. Morgan Securities LLC acted as financial advisor and Latham & Watkins LLP acted as legal counsel to Authentic. Kirkland & Ellis LLP represented WHP Global in its earlier, unsuccessful proposal. The merger agreement included a termination fee payable by Guess? of $23,297,914, triggered by scenarios including termination to pursue a superior proposal or an Authentic termination following a change of Guess?'s recommendation, or failure to close by the August 20, 2026 outside date combined with a competing proposal. Closing was conditioned on Guess? stockholder approval requiring both a majority of all outstanding shares and a separate majority of disinterested (unaffiliated) stockholders under DGCL Section 144, Hart-Scott-Rodino clearance, and other customary regulatory approvals. At a special meeting held November 21, 2025, Guess? stockholders approved the merger proposal: the statutory merger approval passed 41,501,758 for versus 484,707 against (81,029 abstaining), and the separate unaffiliated stockholder approval passed 14,296,425 for versus 484,707 against (81,029 abstaining), out of 24,946,401 disinterested shares entitled to vote. A related non-binding, advisory say-on-golden-parachute compensation proposal was also approved. The merger closed on January 23, 2026. Per the closing 8-K, each outstanding Guess? share (other than excluded and rolled-over shares) was converted into the right to receive $16.75 in cash, all outstanding equity awards (options, RSUs, PSUs, RSAs) accelerated and were cashed out at the merger consideration (net of exercise price where applicable), and the Company IPCos became 51% owned by Authentic and 49% owned by the Rolling Stockholders, with the Surviving Corporation becoming a wholly-owned subsidiary of Parent and, indirectly, of certain Rolling Stockholders. Guess? requested suspension of NYSE trading prior to the open on January 23, 2026 and filing of a Form 25 to delist and deregister its shares, with Exchange Act reporting obligations to be suspended upon a subsequent Form 15 filing. In connection with closing, Guess? and U.S. Bank Trust Company, N.A., as trustee, entered into a First Supplemental Indenture governing the $351,947,000 of outstanding 3.75% Convertible Senior Notes due 2028, which gained fundamental-change conversion/repurchase rights as a result of the merger (make-whole conversion rate of 45.8732 shares per $1,000 of notes, implying $768.3761 in cash per $1,000 of notes converted during the make-whole period). Guess? also terminated related convertible note hedge and warrant transactions with certain option counterparties, under which those counterparties were to pay Guess? approximately $33 million and Guess? was to pay approximately $16 million to the counterparties.

This transaction is a cash acquisition in which HNI Corp (ticker HNI), a consumer-retail sector company, is acquiring Steelcase Inc. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this summary are sourced from an SEC EDGAR Form S-4 filed and published on October 16, 2025. The transaction's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Goldman Sachs & Co. LLC served as financial advisor to the target, Steelcase, in a lead capacity. The source sentence references consent language for Goldman Sachs & Co. LLC's opinion letter under the caption Summary, Opinions of Steelcase's Financial Advisors, the plural phrasing of which suggests additional advisors to Steelcase may exist in the full underlying document even though only Goldman Sachs is named in this facts block. No legal advisors are identified in the facts block for either Steelcase or HNI Corp. Beyond confirming this is a cash acquisition, the facts block provides no further detail on the per-share price, financing sources for HNI Corp, or any other structural terms of the merger agreement. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either party. No expected closing date is given, and despite the plural reference to Steelcase's financial advisors in the source language, no additional advisors beyond Goldman Sachs are named in the available facts.

This transaction is a cash acquisition representing the closing of a take-private of AvidXchange Holdings, Inc., a tech sector company, involving both TPG and Corpay as acquiring parties. The deal falls under the M&A product group and carries a disclosed value of $2,200,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on October 15, 2025. Financial advisory roles were extensive given the multiple acquiring parties. For AvidXchange, the target, Financial Technology Partners and Barclays both acted as financial advisors. For TPG, one of the acquirers, J.P. Morgan Securities LLC, Moelis & Company, and RBC Capital Markets all acted as financial advisors. For Corpay, the other acquirer, Goldman Sachs acted as financial advisor. No lead or non-lead distinctions are specified among these advisors in the facts block. Legal counsel also reflects the multi-party acquirer structure. For AvidXchange, Latham & Watkins LLP acted as the company's legal advisor. For TPG, Davis Polk & Wardwell LLP and Schulte Roth & Zabel LLP both acted as legal counsel. For Corpay, Eversheds Sutherland acted as legal counsel. The facts block characterizes this transaction as a cash acquisition marking the closing of a take-private, with a joint acquiring structure involving both TPG and Corpay, but does not specify how the two acquirers are splitting ownership, financing responsibilities, or any other arrangement between them regarding the acquired company. Several material facts are not disclosed. No expected closing date beyond the filing date is given. The facts block does not detail the relative ownership or financing split between TPG and Corpay as joint acquirers, nor does it specify the per-share price paid to AvidXchange shareholders beyond the aggregate disclosed value of $2,200,000,000.

Beyond Meat, Inc., a publicly traded company in the consumer-retail sector with ticker symbol BYND, is the issuer in a restructuring transaction classified as an exchange offer and consent solicitation. The disclosed transaction value is $1,114,603,000 in U.S. dollars. This type of transaction typically involves the exchange of existing securities for new or modified securities, combined with a solicitation of consents from security holders to amend or modify the underlying debt instruments. The transaction is documented in an SEC filing published on October 15, 2025, sourced from SEC EDGAR, though the specific form type was not identified. The deal is currently pending regulatory approval or clearance. No expected closing date or anticipated regulatory decision timeline has been disclosed. On the issuer side, Beyond Meat has retained two financial advisors with distinct roles. PJT Partners LP is serving as the lead financial advisor to the company and is also acting as the dealer manager in connection with the exchange offer and consent solicitation. Separately, MacKenzie Partners, Inc. is acting as both the exchange agent and the information agent, roles that are operational and administrative in nature rather than strategic advisory. On the creditor side, Houlihan Lokey Capital, Inc. is serving as financial advisor to certain holders of existing convertible notes that are party to a transaction support agreement. For legal representation, Latham & Watkins LLP is serving as legal counsel to Beyond Meat in connection with the exchange offer and consent solicitation. Akin Gump Strauss Hauer & Feld LLP is acting as legal counsel to the same holders of existing convertible notes represented by Houlihan Lokey. Winston & Strawn LLP is providing legal counsel to PJT Partners LP in its capacity as dealer manager, representing the interests of that financial advisor. The specific structure of the exchange offer, including what existing convertible notes are being exchanged for, the terms of any new securities, the pricing or consideration mix, and the consent modifications being solicited, have not been disclosed in the available information. The exact nature of the existing convertible notes and the proposed new instruments remain unstated. Additionally, no information has been provided regarding the expected closing or effectiveness date of the transaction, the percentage of consents required for approval, or any termination conditions or reverse termination fees that may apply.

TrueCar, Inc. (NASDAQ: TRUE), a technology sector company operating a digital automotive marketplace, has completed its acquisition by Fair Holdings, Inc., an entity led by TrueCar founder Scott Painter, in an all-cash go-private transaction. The deal was announced on October 15, 2025 and closed on January 21, 2026, after a merger subsidiary of Fair Holdings merged with and into TrueCar. TrueCar is now a wholly-owned subsidiary of Fair Holdings, its shares have ceased trading on Nasdaq, and the company has become privately held. Under the merger agreement, TrueCar stockholders received $2.55 per share in cash, for an aggregate equity value of approximately $227 million based on then-outstanding shares. The definitive merger proxy statement disclosed that TrueCar's closing stock price on October 13, 2025 (the last trading day before announcement) was $1.43 per share, implying the $2.55 offer was roughly 78 percent above that level, though the proxy itself does not state a premium percentage explicitly. The $2.55 price was below TrueCar's 52-week high closing price of $4.62 as of October 13, 2025. The transaction followed a strategic review process that began in September 2024, when Painter's Fair Holdings first approached then-CEO Jantoon Reigersman about acquiring the company. Fair Holdings' proposed price moved considerably during negotiations: an initial unquantified-premium proposal in September 2024 was followed by a $4.63-per-share proposal on October 1, 2024, before the price was renegotiated downward through 2025 amid financing uncertainty, reaching $2.58 per share (based on debt-financing capacity) in September 2025, then $2.50 per share on October 3, 2025, before settling at the final $2.55 per share on October 4, 2025. During the process, TrueCar's financial advisor Morgan Stanley & Co. LLC solicited interest from other potential counterparties referred to in the proxy as Party A, Party B, Party C, Party D, Party E and Stockholder A; several requested more time for diligence, and ultimately none submitted a superior proposal, leaving Fair Holdings as the sole bidder that reached a signed agreement. Morgan Stanley rendered a fairness opinion dated October 14, 2025 concluding the merger consideration was fair, from a financial point of view, to TrueCar stockholders (other than excluded shares). Its selected comparable company analysis, using CarGurus, Inc. and Cars.com Inc. as the core peer set, applied AV/2026E Adjusted EBITDA multiples of 5.0x to 10.0x, implying per-share values of $1.95 to $2.90 using management projections and $1.25 to $1.45 using Street consensus projections. A discounted cash flow analysis, using a 2.0%-4.0% perpetuity growth rate and a 21.0%-25.0% discount rate on management-case projections, implied a per-share equity value range of $2.35 to $2.80. For reference only, Morgan Stanley also noted broker price targets (12-month, undiscounted range of $2.00-$3.25, discounted to $1.63-$2.64) and a precedent premiums paid analysis applying a 20%-51% premium range to the $1.43 pre-announcement closing price, implying $1.70-$2.15 per share. TrueCar management's internal projections, prepared in October 2025 on a standalone basis, forecasted revenue growing from $184 million in 2025E to $461 million in 2029E, and Adjusted EBITDA moving from negative $3 million in 2025E to $101 million in 2029E, including contributions from the company's TrueCar+ initiative. These figures were presented to illustrate standalone prospects considered by the board and Morgan Stanley and do not reflect any post-merger operating plan. The transaction was financed through a combination of an equity commitment from an affiliate of a large dealer group (the Investor) and cash on TrueCar's balance sheet. Per an Equity Commitment Letter dated October 14, 2025, the Investor committed $164 million of equity financing to Fair Holdings and deposited $15 million into escrow as security for a reverse termination fee. The merger agreement provided for a Company Termination Fee of $8.0 million payable by TrueCar to Fair Holdings in specified circumstances (reduced to $4.0 million for a superior proposal accepted during or shortly after a 30-day go-shop period), and a Parent Termination Fee of $15.0 million payable by Fair Holdings to TrueCar if the buyer failed to close or breached the agreement in specified ways, which was pre-funded into escrow at signing. TrueCar's largest stockholder, Caledonia (Private) Investments Pty Limited and Caledonia US, LP, signed a support agreement committing to vote in favor of the deal. At the January 21, 2026 closing, in addition to the per-share cash consideration, outstanding vested RSUs and qualifying performance stock units were cashed out at the $2.55 merger consideration per underlying share, in-the-money stock options were cashed out net of exercise price, and unvested RSUs were converted into contingent cash awards that continue to vest on their original schedules. Separately, Auto Holdings, LLC, an affiliate of AutoNation, Inc., entered into a rollover and contribution agreement with Fair Holdings under which it contributed its TrueCar shares in exchange for equity in Fair Holdings rather than cash, becoming part of the post-closing ownership group. TrueCar stockholders approved the merger at a December 22, 2025 special meeting, with approximately 78.83 percent of outstanding shares represented and the merger proposal passing with 69,723,284 shares in favor versus 84,731 against. The merger agreement's outside (long-stop) date was February 28, 2026, and the deal closed ahead of that date. Following closing, TrueCar's common stock ceased trading on Nasdaq effective the close of business on January 21, 2026, and the company filed to deregister its shares and suspend SEC reporting obligations. Scott Painter returned as CEO of TrueCar and also serves as CEO of parent Fair Holdings, Inc.; prior board members Barbara A. Carbone, Jantoon E. Reigersman, Brendan L. Harrington, Faye M. Iosotaluno and Diego A. Rodriguez resigned, and Painter became sole director. The post-closing ownership and partner group named in the closing announcement includes PenFed Credit Union, Zurich North America, AutoNation, Atlantic Coast Automotive, Impel AI, ID.me, CRIF and In The Car; PenFed's CEO James Schenck joined the Fair Holdings board. Morgan Stanley & Co. LLC acted as exclusive financial advisor and rendered the fairness opinion to TrueCar's board; Alston & Bird LLP acted as lead legal counsel to TrueCar; Joele Frank, Wilkinson Brimmer Katcher served as TrueCar's strategic communications advisor. B. Riley Securities, Inc. acted as financial advisor to Fair Holdings, and Perkins Coie LLP acted as legal counsel to Fair Holdings. Greenberg Traurig LLP acted as counsel to the Investor providing the equity financing commitment.

This deal is a cash acquisition structured as a go-private transaction, classified as an M&A deal in the tech sector, involving TrueCar, Inc. as target and Fair Holdings, Inc. as acquirer. The disclosed value of the transaction is $227,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on October 15, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Morgan Stanley & Co. LLC acted as exclusive financial advisor to TrueCar, the target, in a lead capacity. B. Riley Securities, Inc. acted as financial advisor to Fair Holdings, Inc., the acquirer, also in a lead capacity, with each advisor paired with its respective legal counsel in the source material. On the legal side, Alston & Bird LLP acted as lead legal counsel to TrueCar, the target, while Perkins Coie LLP acted as legal counsel to Fair Holdings, Inc., the acquirer. Beyond the cash consideration and go-private structure, with a disclosed deal value of $227,000,000, no further detail on per-share pricing or financing arrangements is provided in the facts block. Several items are not disclosed in the available record. No further structural detail beyond the cash acquisition and go-private classification is given, and no expected closing date or further timeline detail beyond the October 2025 filing date and pending-regulatory status is provided.

Emeren Group Ltd (NYSE: SOL), a global solar and energy storage project developer, owner, and operator, agreed to be acquired by Shurya Vitra Ltd., a British Virgin Islands company affiliated with Himanshu H. Shah and Shah Capital Opportunity Fund LP, in an all-cash going-private merger. The Agreement and Plan of Merger was signed on June 18, 2025, with Emeren Holdings Ltd. (a wholly owned subsidiary of Shurya Vitra, referred to as Parent) serving as the merger sub that merged into Emeren. The merger closed on December 12, 2025, with Emeren surviving as a wholly owned subsidiary of Parent; its ordinary shares and ADSs were delisted from the NYSE effective December 15, 2025 and the company filed a Form 15 to deregister. Under the terms of the Merger Agreement, each Emeren ordinary share was converted into the right to receive $0.20 in cash, and each American Depositary Share (representing ten ordinary shares) was converted into the right to receive $2.00 in cash, both without interest. As of September 29, 2025, there were 513,216,222 Company ordinary shares outstanding, implying an aggregate equity payout of approximately $102.6 million at the $0.20 per-share price (a figure derived by the researcher from the disclosed share count and per-share price, not stated as a single number in the filings). The $2.00 per-ADS price represented a 68.1% premium over the unaffected ADS price as of March 14, 2025, the last trading day before media reports of a potential sale first surfaced, a period over which the ADS price had separately declined approximately 78.6%, according to the proxy statement's description of the Special Committee's reasons for the transaction. The Special Committee's financial advisor, Kroll, LLC (operating through its Duff & Phelps Opinion Practice), rendered a fairness opinion and performed a discounted cash flow analysis using a weighted average cost of capital of 13.00% to 15.00%, arriving at an indicated enterprise value range of $55.2 million to $74.2 million. Duff & Phelps then derived an implied aggregate equity value range of $90.9 million to $110.4 million by adding cash of $49.6 million (excluding cash tied to Zhejiang Emeren Smart Energy Co., Ltd., which was to be assumed by the buyer in a separate contemplated sale of that entity), adding $39.5 million to $40.1 million in present value of expected net proceeds from a contemplated sale of the company's China IPP assets (net of a 10% withholding tax), deducting debt of $50.9 million (also excluding Zhejiang Emeren Smart Energy debt), and deducting non-controlling interests. No single-number enterprise value or purchase-price multiple (e.g., EV/EBITDA) is stated in the filings reviewed. According to the DEFM14A's "Background of the Merger" section, the process began when the Board received a preliminary, non-binding proposal from Shah Capital Management, Inc. and Mr. Shah (the "Shah Proposal") on March 17, 2025, at the same $2.00 per ADS price that was ultimately agreed in the definitive Merger Agreement three months later; the filings do not show the per-ADS price changing during negotiations. On June 6, 2025, while the Special Committee was negotiating with the Buyers, it received an unsolicited, non-binding indication of interest from EEW Renewables Ltd. proposing to acquire all outstanding shares/ADSs for cash consideration in the range of $2.25 to $2.50 per ADS, a higher price than the Shah Proposal. The Special Committee's advisors found that EEW had twice previously signed, then aborted, merger agreements with special purpose acquisition companies (in late 2022 and late 2024), and the proxy states EEW was unable to provide timely evidence of financial resources or committed financing to consummate its proposal. Weighing the higher EEW price against financing credibility, deal certainty, and the Buyer Group's repeated threats to withdraw its offer if not signed expeditiously, the Special Committee proceeded with the Shah Capital/Shurya Vitra transaction at $2.00 per ADS rather than pursuing EEW's higher but less certain proposal; no price increase from the Buyer Group is disclosed as having resulted from the EEW competing proposal. The Buyer Group's beneficial ownership of approximately 37.6% of outstanding ordinary shares, and the fact that no party other than EEW contacted the company about an alternative transaction after the deal's announcement, were also cited as factors. The Special Committee consisted of three independent directors unaffiliated with the Buyer Group Parties: Martin Bloom, Ramnath Iyer, and Ramakrishnan (Ramki) Srinivasan. Himanshu H. Shah, the company's chairman and its largest shareholder (through Shah Capital Management), recused himself from Board discussions of the merger and alternative transactions, as well as from valuation discussions. Financing for the merger consideration was provided through an equity commitment letter from Himanshu H. Shah to Parent and a limited guarantee from Shah in favor of the company covering certain of Parent's payment obligations (excluding termination fees). Separately, Ke Chen, Enrico Bocchi, and (following a September 2, 2025 amendment to the Merger Agreement and Rollover Agreement) Shah Capital Opportunity Fund LP entered into rollover and support agreements agreeing to vote their shares for the merger and exchange their Emeren shares for newly issued Parent shares rather than receive cash consideration. The Merger Agreement included customary no-shop restrictions subject to a fiduciary-out for superior proposals, and provided for a termination fee of $4,500,000 payable by the company to Parent, or by Parent to the company, under specified circumstances, including either party's right to terminate if the merger was not consummated by December 31, 2025 (a deadline that was not triggered, as the deal closed December 12, 2025). Shareholders approved the Merger Agreement, the transactions it contemplates, and a non-binding advisory vote on merger-related executive compensation at an extraordinary general meeting held December 9, 2025, as disclosed in the company's December 10, 2025 Form 8-K and accompanying press release. On the Special Committee's side, Morrison & Foerster LLP served as independent U.S. legal counsel, Harney Westwood & Riegels (UK) LLP (Harneys) served as independent British Virgin Islands counsel, and DeHeng Law Offices (Shenzhen) served as independent PRC counsel. On the Buyer side, DLA Piper LLP (US) served as U.S. legal counsel to Parent and Mr. Shah. Kroll, LLC, through its Duff & Phelps Opinion Practice, served as the Special Committee's independent financial advisor.

This transaction is a cash and/or stock acquisition in which PNC Financial Services Group, Inc., trading under the ticker PNC, is acquiring FirstBank Holding Company. The deal is classified within the financial institutions group sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on October 7, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Goldman Sachs & Co. LLC served as financial advisor to FirstBank, the target, and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter referencing Goldman Sachs's opinion letter, cited under the heading "Summary, Opinion of Goldman Sachs & Co. LLC," confirming that Goldman Sachs rendered a fairness opinion in connection with the transaction. No financial advisor to PNC, the acquirer, is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured to allow cash and/or stock consideration, no further detail on the actual mix elected, the exchange ratio, or any collar mechanism is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either FirstBank or PNC is identified. No financial advisor to PNC is named, and no detail is given on the actual cash/stock election mechanics or an expected closing date.

This deal is a take-private transaction structured as an all-cash merger, in which Heidrick & Struggles International Inc, a company in the business-services sector, is being acquired by an investor consortium led by Advent. The transaction is classified under the sponsors-coverage product group, with a disclosed deal value of $1,300,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on October 6, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, the sponsor consortium was advised by three firms: William Blair & Company, L.L.C., Deutsche Bank, and UBS Investment Bank, all serving as financial advisor to the investor consortium, with no lead designation specified among them. On the target side, BofA Securities served as exclusive financial advisor to Heidrick & Struggles and is designated as lead advisor in that capacity. Legal counsel was also disclosed on both sides. On the sponsor side, Weil, Gotshal & Manges LLP served as legal counsel to the investor consortium, and Ropes & Gray LLP is noted as additionally serving as legal counsel to Advent specifically. On the target side, Paul Hastings LLP served as legal counsel to Heidrick & Struggles. Beyond the all-cash characterization of the merger consideration and the disclosed $1,300,000,000 deal value, the facts block provides no further detail on per-share pricing or other specific terms of the transaction. A number of facts are not disclosed in the source material. The facts block does not specify an expected closing date for the transaction. It also does not indicate which of the three sponsor-side financial advisors, if any, held a lead role, and it provides no detail on the financing structure behind the consortium's bid.

This is a cash-and-stock acquisition in the industrials sector, in which Firefly Aerospace Inc. (ticker FLY) is acquiring SciTec Inc. The product group is M&A, and the disclosed transaction value is $855,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on October 6, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead and exclusive capacity. Baird is serving as exclusive financial advisor to SciTec, the target, per the statement "Baird is serving as exclusive financial advisor and Cooley LLP is serving as legal advisor to SciTec." On the acquirer side, Goldman Sachs & Co. LLC is serving as exclusive financial advisor to Firefly, consistent with the language "Goldman Sachs & Co. LLC is serving as exclusive financial advisor and Kirkland & Ellis LLP is serving as legal advisor to Firefly." Legal advisors are disclosed for both sides: Cooley LLP is serving as legal advisor to SciTec, the target, while Kirkland & Ellis LLP is serving as legal advisor to Firefly, the acquirer. Beyond the classification of this transaction as a cash-and-stock acquisition with a disclosed value of $855,000,000, no further detail on the specific split between cash and stock consideration is included in the facts provided. Several items are not disclosed in this record: the precise cash/stock consideration mix is not specified, and no expected closing date is given beyond the pending-regulatory status.

This transaction involves Tile Shop Holdings, Inc. (ticker TTSH), a consumer-retail sector company, structured as a going-private transaction effected through a reverse/forward stock split. Tile Shop Holdings appears in the facts block as both the target and the issuer, consistent with a going-private restructuring of the company's own equity rather than a third-party acquisition. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. This summary is sourced from an SEC EDGAR Form SC 13E3 filed and published on October 6, 2025. The transaction's current status is pending regulatory review. Only one financial advisor is named: GuideCap Partners LLC served as financial advisor and fairness opinion provider to the company, in a lead capacity. The full text of the fairness opinion of GuideCap Partners LLC, referred to as GCP, dated October 3, 2025, is noted as attached as Annex C to the proxy statement, indicating the firm's role centered on rendering an independent fairness opinion for the going-private transaction. On the legal side, Sullivan & Worcester LLP is identified as legal advisor to the company. The source sentence is drawn from a correspondence copy line naming attorneys David E. Danovitch and Angela Gomes of Sullivan & Worcester LLP. The facts block confirms this is structured as a reverse/forward stock split, a mechanism commonly used to cash out small shareholders and reduce the number of record holders below a threshold that allows a company to deregister its securities, but it does not specify the split ratio, the cash-out price for fractional shares, or the resulting number of record holders. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given. The specific stock split ratio and cash-out terms for fractional shareholders are not disclosed in the available facts.

Seacoast Banking Corporation of Florida (NASDAQ: SBCF), through its wholly-owned subsidiary Seacoast National Bank, agreed to acquire Villages Bancorporation, Inc. ("VBI"), the parent company of Citizens First Bank based in The Villages, Florida. The transaction was announced on May 29, 2025 via an Agreement and Plan of Merger among Seacoast, Seacoast National Bank, VBI and Citizens First Bank, and closed on October 1, 2025, with VBI merging into Seacoast and Citizens First Bank merging into Seacoast National Bank. At signing, Seacoast valued the deal at approximately $710.8 million based on its May 28, 2025 closing stock price of $24.91; the final consideration paid at closing, reflecting Seacoast's higher share price, was approximately $829 million. Seacoast's Chairman and CEO, Charles M. Shaffer, said: "VBI serves a thriving and rapidly growing customer base characterized by strong financial stability and consistent demand for tailored financial products. This is a rare partnership opportunity to continue the legacy of high quality service to the Villages community with a shared vision for the many years of growth that lay ahead... We believe this partnership is attractive to all stakeholders, with the continuation of a strong service-oriented culture for our associates, an attractive increase in profitability and earnings within a reasonable earnback period for our shareholders, and expanding products and services for our new customers." VBI's CEO, Jay Bartholomew, said: "Since its founding in 1992, VBI has been committed to providing the very best banking experience for our customers. Now, in partnership with Seacoast, we are positioned to further accelerate this commitment... We are delighted to join with Seacoast Bank, which shares our values and has been serving Florida consumers and businesses for nearly a century." Under the merger agreement, each share of VBI common stock was convertible, at the shareholder's election, into (i) $1,000.00 in cash, (ii) 38.5000 shares of Seacoast common stock (the exchange ratio), or (iii) a 25%/75% combination of cash and stock, subject to a proration mechanism under which 25% of VBI shares in the aggregate received cash consideration and 75% received stock consideration. Shareholders or shareholder groups that would otherwise receive more than 9.75% of outstanding Seacoast common stock instead received non-voting convertible preferred stock (Series A Non-Voting Preferred Stock, 11,250 shares authorized) in lieu of the excess common shares. Seacoast's investor presentation disclosed an implied aggregate transaction value at signing of $710.8 million, equal to 161% of VBI's tangible book value per share and 15.8 times VBI's last-twelve-months earnings, or 6.7 times VBI's estimated 2026 earnings including fully phased-in cost savings and the benefit of an anticipated balance sheet restructuring. Pro forma ownership was expected to be approximately 81% Seacoast / 19% former VBI shareholders, inclusive of the non-voting preferred stock on a fully converted basis, with no changes to Seacoast's board of directors or executive leadership team. Seacoast disclosed pre-tax merger costs of approximately $52 million and expected cost savings equal to 27% of VBI's non-interest expense base, with 65% of those savings realized in 2026 and the remainder phased in thereafter; the company stated no branch closings were planned in connection with the acquisition. Seacoast also identified unmodeled revenue synergies from cross-selling its wealth management and insurance platforms to VBI's customer base and from extending Seacoast's broader product set to VBI's deposit-rich, retiree-heavy customer base in The Villages. On a pro forma basis, Seacoast expected the transaction to be approximately 22%-24% accretive to 2026 earnings per share (22% per the press release; approximately 24% per the investor presentation's illustrative 2026E run-rate basis), with tangible book value per share dilution of approximately 9.9% and an earnback period of approximately 2.8 years, assuming a transaction close of December 31, 2025 and fully phased-in cost savings. The combined company was expected to have pro forma total assets of approximately $21 billion, gross loans of $12 billion and total deposits of $17 billion (reflecting both the VBI and the previously announced, separate Heartland Bancshares acquisition), positioning Seacoast as the second-largest publicly traded bank in Florida by deposit market share and the largest "pure play" Florida public bank. VBI was described as the 11th largest bank in Florida with $4.1 billion in total assets, approximately $3.5 billion in deposits, approximately $1.3 billion in loans, 19 branches, and a deposit share of over 50% in the Wildwood-The Villages MSA, as of March 31, 2025. The merger agreement provided for a termination fee of $31.4 million payable by VBI under specified circumstances, including if VBI's board withdrew or adversely modified its recommendation in favor of the merger. Closing was conditioned on, among other things, approval of the merger agreement by VBI shareholders, receipt of required regulatory approvals, effectiveness of Seacoast's Form S-4 registration statement, and Nasdaq listing approval for the shares to be issued; the parties targeted a fourth-quarter 2025 closing at signing. Concurrently with signing, certain VBI shareholders holding approximately 75% of VBI's outstanding stock (Jennifer Morse Parr, Tracy Morse Dadeo and Mark Morse) entered into a Shareholders Agreement restricting their ability to accumulate, vote or dispose of Seacoast stock above specified thresholds, and Seacoast National Bank entered into a Developer Support Agreement with The Villages' developer entities governing future bank-branch leasing rights within The Villages community for an initial 10-year term. On the financial advisory side, Piper Sandler & Co. served as lead financial advisor to Seacoast, with Raymond James & Associates, Inc. rendering a fairness opinion to Seacoast's board of directors; Alston & Bird LLP served as legal counsel to Seacoast. Hovde Group, LLC served as financial advisor to VBI, and Smith Mackinnon, PA served as legal counsel to VBI. The transaction closed on October 1, 2025, as confirmed in Seacoast's Form 8-K filed October 6, 2025, which reported final merger consideration of approximately $829 million. In connection with closing, Seacoast National Bank and The Villages' developer entities entered into an amended and restated Developer Support Agreement, and Seacoast filed a Certificate of Designations establishing the terms of the Series A Non-Voting Preferred Stock issued in the merger.

This deal is a sale of a controlling interest involving a company referred to in the facts block as Bamboo, with CVC Capital Partners as the acquiring party and White Mountains also named as an affiliated seller-side party in the advisor disclosures. No sector classification or explicit target/acquirer labeling was provided in the facts block. The transaction is classified under the M&A product group, with a disclosed value of $1,750,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on October 3, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised the company (Bamboo) and its affiliate White Mountains: Evercore Group L.L.C. acted as lead financial advisor, while Piper Sandler & Co. acted as financial advisor without a lead designation. No financial advisor is disclosed for CVC, the acquirer, in the facts block. Legal counsel was also disclosed across multiple parties. Cravath, Swaine & Moore LLP served as legal counsel to White Mountains and Bamboo, the company/seller side. Separately, Willkie Farr & Gallagher acted as legal advisor to Bamboo management specifically. On the acquirer side, Latham & Watkins LLP acted as legal advisor to CVC. Beyond its characterization as a sale of a controlling interest and the disclosed $1,750,000,000 value, the facts block does not specify the percentage of the controlling interest being sold. Several facts are not disclosed in the source material. The facts block does not state the exact percentage stake comprising the "controlling interest" being sold, nor does it name a financial advisor for CVC, the acquirer. No sector classification or expected closing date is given.

This transaction is an acquisition, with the subtype notation indicating it is in a closing phase, in which Waystar is acquiring Iodine Software. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form 8-K filing published on October 1, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, J.P. Morgan Securities served as exclusive financial advisor to Iodine, the target, and is identified as the lead advisor on that side. Barclays served as exclusive financial advisor to Waystar, the acquirer, and is likewise identified as the lead advisor for the acquirer. Both firms are described as acting in an exclusive capacity for their respective clients. On the legal side, Weil, Gotshal & Manges LLP and Queen Saenz + Schultz PLLC both served as legal advisors to Iodine, the target, indicating two legal advisors on that side of the transaction. Simpson Thacher & Bartlett LLP served as legal advisor to Waystar, the acquirer. Beyond confirming that this is an acquisition in a closing phase, no further detail on the specific terms of consideration, such as a purchase price or payment structure, is included in the facts available. A number of elements of this deal are not disclosed in the available material. The deal value is explicitly noted as not stated in the source document, and no detail on the structure of consideration is provided. While the subtype description notes the deal is in a closing phase, no specific closing date is given, and no detail on required regulatory approvals is included.

This transaction is a stock-for-stock merger in which CoreWeave, Inc., trading under the ticker CRWV, is acquiring Core Scientific, Inc. The deal is classified within the technology sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on September 25, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, PJT Partners LP served as financial advisor to Core Scientific, the target, and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter referencing the inclusion of PJT Partners's opinion letter, cited under the headings "Summary, Opinions of Core Scientific's Financial Advisors" and "The Merger, Opinions of Core Scientific's Financial Advisors, Opinion of PJT Partners," confirming that PJT Partners rendered a fairness opinion to Core Scientific in connection with the merger. No financial advisor to CoreWeave, the acquirer, is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a stock-for-stock merger, no further detail on the specific exchange ratio or other terms of the stock consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Core Scientific or CoreWeave is identified. The heading referenced in the source material notes "Opinions of Core Scientific's Financial Advisors" in the plural, suggesting more than one advisor to Core Scientific may be involved, but only PJT Partners is named in the facts available, and no financial advisor to CoreWeave, the exchange ratio, or an expected closing date is provided.

This deal involves a strategic review and potential sale process, classified as an M&A transaction in the healthcare sector, involving DarioHealth Corp. (ticker DRIO) as the target/subject company. The disclosed value of the transaction is not stated in the source document, consistent with the fact that this is a review process rather than a signed transaction with agreed terms. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 25, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners is identified as financial advisor to DarioHealth, in a lead capacity. The source material notes that in connection with this review, DarioHealth's Board of Directors established a Special Committee of independent directors and engaged Perella Weinberg Partners as financial advisor to assist with that process. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are advising the company or any potential counterparties in this process. Beyond the engagement of a financial advisor to support a strategic review and potential sale process, no further detail on specific transaction terms, potential acquirers, or structural considerations is provided in the facts block, which is consistent with this being characterized as a review process rather than a definitive agreement. Several material facts are not disclosed in the available record. No transaction value is stated, since no definitive transaction has been announced as of the facts given. No legal advisors are identified, no potential acquirer or counterparty is named, and no expected timeline or outcome for the strategic review is given beyond the pending-regulatory status noted in the September 2025 filing.

Mid Penn Bancorp, Inc. (Nasdaq: MPB), headquartered in Harrisburg, Pennsylvania, agreed to acquire 1st Colonial Bancorp, Inc. (OTCPK: FCOB), the Mount Laurel, New Jersey-based parent of 1st Colonial Community Bank, in a cash-and-stock merger. The deal was announced September 24, 2025 in a Form 8-K that included a joint press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2). The merger agreement was unanimously approved by both companies' boards. Mid Penn Chair, President and CEO Rory G. Ritrievi said the transaction is 'a strategic move to further expand our footprint into the greater Philadelphia metropolitan area, particularly southern New Jersey,' creating 'a more powerful, resilient, and dynamic financial institution.' 1st Colonial President and CEO Robert White said the combination 'will allow for an expansion of our product and service offering, as well as bring greater financial capacity for continued investment in our company and our communities.' Under the terms of the merger agreement, 1st Colonial shareholders could elect to receive either 0.6945 of a share of Mid Penn common stock or $18.50 in cash for each 1st Colonial share, subject to proration so that, in the aggregate, 60% of the consideration was paid in Mid Penn stock and 40% in cash. Based on Mid Penn's closing share price of $30.31 on September 23, 2025, this implied a value of approximately $20.03 per 1st Colonial share and an aggregate transaction value of approximately $101 million. The investor presentation disclosed implied pricing multiples of 1.16x 1st Colonial's tangible book value per share and 11.6x its trailing-twelve-month earnings per share. All outstanding 1st Colonial stock options were to be cashed out at closing. The transaction was structured so that 1st Colonial would merge with and into Mid Penn, followed by the merger of 1st Colonial Community Bank into Mid Penn Bank, and was intended to qualify as a tax-free reorganization for 1st Colonial shareholders receiving Mid Penn stock. Following closing, 1st Colonial shareholders were expected to own approximately 8% of Mid Penn's outstanding common stock. Mid Penn disclosed expected fully phased-in cost savings equal to 40% of 1st Colonial's noninterest expense base, with 80% of those savings phased in during 2026. The company estimated one-time merger-related charges of approximately $12 million pre-tax (about $9.6 million after-tax), to be fully reflected in pro forma tangible book value. Other purchase-accounting marks disclosed in the investor presentation included a gross credit mark of $7.9 million (1.25% of loans held for investment, split evenly between purchase-credit-deteriorated and non-PCD loans), a loan interest-rate write-down of $28.3 million pre-tax (4.5% of loans held for investment, accreted over seven years), a core deposit intangible of $14.3 million (2.5% of non-time deposits, amortized over ten years), and a day-two CECL reserve estimate of $3.9 million. On financial impact, Mid Penn disclosed in the investor presentation approximately 10% EPS accretion in 2026 and approximately 14% EPS accretion in 2027 (full-year 2027 estimated earnings accretion), approximately 6% dilution to tangible book value per share at close with an estimated earnback period of approximately 3.4 years (crossover method), a projected internal rate of return of approximately 24% (assuming a 10.0x terminal P/E multiple and 8.5% minimum TCE/TA), pro forma CET1 of approximately 11.7%, and pro forma TCE ratio of approximately 9.4% excluding a stated CECL double count. The deal was expected to be immediately accretive to Mid Penn's estimated earnings per share. 1st Colonial, founded in 2000, operated three full-service branches and one loan production office in the greater Philadelphia area. As of June 30, 2025, 1st Colonial reported approximately $877 million in total assets, $743 million in total deposits and $640 million (reported as $639 million in the investor presentation) in gross loans, with a 0.93% year-to-date ROAA and 0.52% nonperforming-assets-to-assets ratio. On a pro forma basis combining the two companies as of June 30, 2025, Mid Penn disclosed total assets of more than $7.2 billion, total deposits of approximately $6.2 billion, gross loans of more than $5.4 billion, and more than 60 total branch locations. Concurrently with signing, 1st Colonial President and CEO Robert B. White entered into an employment agreement to become Senior Executive Vice President, Greater Philadelphia Metro Area Market President and Senior Risk Advisor of Mid Penn Bank, and one 1st Colonial-nominated director was to join the Mid Penn board at closing. Keefe, Bruyette & Woods, A Stifel Company, acted as exclusive financial advisor to Mid Penn, and Holland & Knight LLP acted as Mid Penn's legal advisor. Stephens Inc. acted as exclusive financial advisor to 1st Colonial and rendered a fairness opinion to 1st Colonial's board, and Stradley Ronon Stevens & Young, LLP acted as 1st Colonial's legal advisor. Mid Penn filed a Form S-4 registration statement on November 24, 2025 (File No. 333-291759, amended December 18, 2025) to register the shares of Mid Penn common stock issuable in the merger, which included a proxy statement for 1st Colonial and a prospectus for Mid Penn. On February 11, 2026, the companies announced that 1st Colonial shareholders had overwhelmingly approved the merger at a special meeting, with 3,993,902 shares voted in favor against 456 against and zero abstentions, representing over 80% of outstanding shares present at the meeting (over 99% of votes cast were in favor). The transaction closed after the close of business on February 27, 2026. At closing, Mid Penn disclosed the cash-and-stock transaction was valued at approximately $106.1 million, reflecting movement in Mid Penn's stock price between signing and closing (versus the approximately $101 million value disclosed at announcement based on the September 23, 2025 stock price). The consolidated company had approximately $7 billion in total assets and Mid Penn's branch count increased to 62 retail locations. In connection with the merger, Thomas R. Brugger, a former 1st Colonial director, was appointed to the Mid Penn and Mid Penn Bank boards effective as of the merger's effective time. Mid Penn confirmed the same financial and legal advisors served through closing: Keefe, Bruyette & Woods, A Stifel Company for Mid Penn, Holland & Knight LLP as Mid Penn's legal advisor, Stephens Inc. for 1st Colonial (including the fairness opinion), and Stradley Ronon Stevens & Young, LLP as 1st Colonial's legal advisor.

WaterBridge Infrastructure LLC, trading under ticker WBI and operating in the natural resources (produced water midstream) sector, completed its initial public offering of 31,700,000 Class A shares representing limited liability company interests at a public offering price of $20.00 per share, for total gross proceeds of $634 million. The underwriting agreement was entered into on September 16, 2025 with J.P. Morgan Securities LLC and Barclays Capital Inc. acting as representatives of the underwriters, and the offering priced that same day. The underwriting discount was $1.20 per share, or $38,040,000 in aggregate, leaving proceeds to WaterBridge of $18.80 per share before offering expenses. The offering closed on September 18, 2025, the same date the shares began trading on the New York Stock Exchange and NYSE Texas under the symbol WBI. The company received net proceeds of approximately $587.6 million at the initial closing. The underwriters were granted a 30-day option to purchase up to 4,755,000 additional Class A shares at the public offering price; this option was exercised in full on September 18, 2025, with the additional shares expected to generate approximately $89.4 million of further net proceeds, after deducting underwriting discounts and offering expenses. A press release confirming the closing of the option shares was issued on September 22, 2025. Use of proceeds was specific and disclosed in the pricing and closing Form 8-K: the company used approximately $228.2 million of net proceeds from the offering to purchase a portion of the OpCo Units held by Elda River Infrastructure WB LLC, and contributed the remaining net proceeds to its operating subsidiary, WBI Operating LLC (OpCo), in exchange for OpCo Units. OpCo in turn used, or intended to use, the remaining net proceeds to repay outstanding indebtedness of WaterBridge Operating LLC, WaterBridge NDB Operating LLC and Desert Environmental LLC, and for general company purposes, including funding working capital and future growth projects. The filing also discloses that affiliates of underwriters Barclays Capital Inc., Goldman Sachs & Co. LLC, Wells Fargo Securities, LLC and TCBI Securities, Inc. are lenders under the company's existing revolving credit facilities and may receive a portion of the offering proceeds used to repay those borrowings. The IPO was structured around a corporate reorganization (the WaterBridge Combination) completed immediately before the offering closed. As part of that reorganization, WBR Holdings, NDB Holdings, Desert Holdings, Devon WB Holdco and Elda River contributed approximately $80,200 in cash in exchange for an aggregate of 80,190,150 Class B shares (non-economic, one vote per share), issued on a one-for-one basis against each OpCo Unit retained by those holders. Following the offering, Class A shares represented approximately 32.4% and Class B shares approximately 67.6% of total voting power, assuming no exercise of the underwriters' option, with the company's pre-IPO affiliates holding approximately 52.3% of total voting power. The company is a controlled company under NYSE rules, with Five Point-affiliated holders able to designate a majority of the board for as long as they hold at least 40% of outstanding common shares. In connection with the offering, directors, executive officers, the Five Point Members, Devon Holdco, Elda River, GIC and certain of their affiliates signed lock-up agreements restricting sales of Class A shares, and securities convertible into or exchangeable for them, until March 15, 2026, subject to customary exceptions. The company also entered into a registration rights agreement with the Five Point Members, Devon Holdco, Elda River and GIC covering resale of Class A shares issuable upon exchange of OpCo Units, and a tax receivable agreement, disclosed via a Form 8-K/A filed September 24, 2025, with OpCo and the TRA holders. As this was a first-time listing, there is no prior closing price against which to measure an offering discount or premium; the $20.00 IPO price was negotiated between the company and underwriter representatives rather than set relative to existing trading. Legal counsel is disclosed in the prospectus: Latham & Watkins LLP, Houston, Texas, passed on the validity of the Class A shares for the company, while Gibson, Dunn & Crutcher LLP, Houston, Texas, advised the underwriters. Deloitte & Touche LLP audited the financial statements of WaterBridge Equity Finance LLC, WaterBridge NDB Operating LLC and the WaterBridge Infrastructure LLC balance sheet, and Weaver and Tidwell, LLP audited Desert Environmental LLC's financial statements.

CaliberCos Inc. (Nasdaq: CWD), a diversified real estate and digital asset management platform, announced on September 17, 2025 that it had closed a $15.9 million private placement of perpetual convertible preferred stock and, separately, activated an at-the-market (ATM) equity program, as disclosed in a Form 8-K and accompanying press release filed that day, along with a Form 424B5 prospectus supplement. In the preferred stock component, Caliber entered into a securities purchase agreement on September 11, 2025 with Mast Hill Fund, L.P., an institutional investor, for the sale of 15,868 shares of newly designated Series B Preferred Stock at a purchase price of $1,000 per share, generating gross proceeds of $15,868,000. The Series B Preferred Stock is convertible at the holder's option into Class A common stock at a conversion price of $250.00 per share, carries no dividend or interest payments, and has no voting rights except as required by law. In liquidation, the Series B ranks senior to Caliber's Class A and Class B common stock, junior to the company's Series A and Series AA Preferred Stock, and pari passu with other preferred stock of substantially similar rights and preferences. Because the preferred shares were sold directly to a single institutional investor in reliance on the Section 4(a)(2) exemption rather than registered and offered to the public, this component is an unregistered private placement rather than an underwritten public offering, and no underwriters or bookrunners are identified in connection with it. In the ATM component, Caliber entered into an At-The-Market Offering Agreement on September 17, 2025 with R.F. Lafferty & Co., Inc. and The Benchmark Company, LLC as exclusive sales agents, under which the company may sell up to an aggregate of $10,333,203 of Class A common stock from time to time, drawing on its existing $50 million shelf registration statement (Form S-3, effective June 25, 2024). Per the September 17, 2025 prospectus supplement (Form 424B5), the sales agents are entitled to a commission of up to 3.0% of the gross sales price per share sold, are deemed statutory underwriters for purposes of the Securities Act, and Caliber agreed to indemnify them against certain liabilities. The prospectus supplement notes that the last reported sale price of CWD common stock on Nasdaq on September 15, 2025 (the trading day before the agreement date) was $7.45 per share; because sales under an ATM program are made at prevailing market prices rather than at a single negotiated offering price, no fixed offering price or premium/discount to that reference price is disclosed. The press release states that Lafferty & Co. is serving as lead sales agent with Benchmark Company acting as co-manager, slightly refining the 'co-lead' characterization in earlier disclosure. Caliber stated in the prospectus supplement that it intends to use the majority of net proceeds from the ATM program for the acquisition of digital assets, starting with Chainlink (LINK) tokens, as part of its newly launched Digital Asset Treasury strategy, with the balance allocated to working capital and general corporate purposes for its core real estate operating business. No specific use-of-proceeds breakdown was disclosed for the Series B Preferred Stock proceeds beyond the general description of strengthening the balance sheet and funding the company's strategy. The company's Form 10-Q for the quarter ended September 30, 2025, filed November 13, 2025, discloses that during the three months ended September 30, 2025 Caliber issued 886,437 shares of Class A common stock under its ATM program for net proceeds of $5.9 million. No over-allotment or greenshoe option is disclosed in connection with either the preferred stock sale or the ATM program; ATM programs of this type do not typically include a greenshoe. No closing 8-K, settlement confirmation, or cumulative total of shares/dollars sold under the full $10,333,203 ATM capacity beyond the Q3 figure has been identified, and the overall dilution impact as a percentage of total shares outstanding is not disclosed in the filings reviewed.

Atlanticus Holdings Corporation (NASDAQ: ATLC), a financial services company that enables credit access for near-prime and underserved consumers, acquired Mercury Financial LLC, a data- and tech-centric credit card platform that provides credit cards to near-prime consumers in the United States through programs issued by First Bank & Trust, Brookings, SD under a Visa license. The transaction was structured as a Membership Interest Purchase Agreement, dated September 11, 2025, under which Mercury Finance Acquisitions, LLC, a newly formed Atlanticus subsidiary, purchased all of the outstanding equity interests of Mercury from Mercury Financial Intermediate LLC. The agreement, press release, and investor presentation were disclosed in a Form 8-K filed September 17, 2025 (Items 1.01 and 7.01), and the acquisition closed the same day it was signed, September 11, 2025, as confirmed by a subsequent Form 8-K/A filed November 28, 2025 containing Mercury's audited and interim financial statements and pro forma combined financial information. Consideration for the acquisition was announced as an approximately $162 million cash Initial Purchase Price, funded from cash on hand, subject to a post-closing true-up for Mercury's adjusted net asset value against a target level and other customary adjustments. The underlying purchase agreement sets the pre-adjustment base price at $201,600,000, which nets down after adjustments to the disclosed $162 million figure. Per the pro forma financial statements filed with the 8-K/A, the acquisition's final total purchase consideration, as allocated for accounting purposes, was $206.5 million, comprising $159.8 million of cash consideration, $6.7 million of direct acquisition-related costs, and $40.0 million representing the estimated fair value of contingent earn-out consideration. In addition to the upfront payment, the seller may receive earn-out payments for up to three years following closing equal to 75% of the amount by which Mercury's managed receivables charge-offs come in below agreed-upon levels. Atlanticus purchased a buy-side representations and warranties insurance policy that serves as the primary remedy for breaches of representations and warranties, subject to policy limits, exclusions and deductibles. The acquisition added approximately 1.3 million credit card accounts and $3.2 billion in credit card receivables to Atlanticus, bringing the company's total serviced accounts to over 5 million and total managed receivables to over $6 billion. Jeff Howard, President and CEO of Atlanticus, said the company was "pleased to add the technology and near prime expertise of Mercury to expand our reach, advance our growth efforts, and leverage the scale that the combined companies create to bring a best-in-class product offering at the lowest possible cost to an even broader consumer segment," adding that, having purchased over $6 billion in credit card receivables portfolios historically, Atlanticus was "highly confident" in its ability to create value through optimization of the $3.2 billion Mercury portfolio. The companies cited expected value creation through portfolio optimization, cost synergies, and increased originations on behalf of bank partners, as well as growth from new marketing channels and product expansion, though no specific synergy dollar figure, percentage of cost base, or phase-in timeline was disclosed. Per unaudited pro forma financial statements filed with the SEC, prepared as if the acquisition had occurred January 1, 2024 and accounted for as an asset acquisition under ASC 805-50 (not a business combination), the combined company's pro forma total revenue and other income for the nine months ended September 30, 2025 was approximately $1.89 billion, versus $1.23 billion for Atlanticus on a standalone basis, with pro forma net income attributable to common shareholders of $37.5 million (versus $79.0 million standalone) and pro forma basic/diluted EPS of $2.48/$1.95 (versus standalone $5.22/$4.21). For the year ended December 31, 2024, pro forma total revenue and other income was approximately $2.37 billion versus $1.31 billion standalone, with pro forma net income attributable to common shareholders of $112.6 million (versus $87.4 million standalone) and pro forma basic/diluted EPS of $7.64/$5.99 (versus standalone $5.92/$4.77). Pro forma adjustments included reversing amortization of Mercury's historical debt issuance costs following a fair-value reset of assumed debt, replacing Mercury's CECL credit-loss provisioning with fair-value loan accounting consistent with Atlanticus's policy, conforming Mercury's capitalized marketing costs to Atlanticus's expense-as-incurred policy, and recording amortization of acquired intangible assets (developed technology valued at $27.0 million and assembled workforce valued at $5.4 million, both with five-year useful lives). As part of the purchase price allocation, Atlanticus recorded $3.0 billion of acquired loans at fair value and assumed $2.8 billion of notes payable, net. Guggenheim Securities, LLC served as financial advisor and Troutman Pepper Locke and Willkie Farr & Gallagher served as legal counsel to Atlanticus in the transaction. Deutsche Bank Securities served as financial advisor to the seller, and Mayer Brown LLP served as legal counsel to the special committee of the board of the seller. Colin M. Adams of Uzzi & Lall served as the Special Committee of Mercury's Board of Directors, which approved the transaction. In connection with the acquisition, Mercury entered into restrictive covenant agreements with the seller and an indirect equityholder restricting solicitation of Mercury employees post-closing. No termination fee is disclosed in the publicly filed exhibits (schedules to the purchase agreement were omitted pursuant to Item 601(a)(5) of Regulation S-K), and no proxy statement, tender offer document, or shareholder vote was required or filed, consistent with a private, all-cash membership-interest purchase that did not require Atlanticus or Mercury shareholder approval.

This transaction is an initial public offering (IPO) by Black Rock Coffee Bar, Inc. (ticker BRCB), a consumer-retail sector company. The offering falls under the equity capital markets (ECM) product group and carries a disclosed value of $294,117,640. The deal is currently in pending regulatory status. This summary draws on four source documents: an SEC EDGAR filing of unknown form type published on September 15, 2025, a Form 8-K published September 16, 2025, and two separate Form 424B4 filings, both published September 15, 2025. The IPO involved a large underwriting syndicate with differentiated lead roles. J.P. Morgan, Jefferies, and Morgan Stanley are each named as lead underwriters in a lead capacity, per the source sentence listing the syndicate order of J.P. Morgan, Jefferies, Morgan Stanley, Baird, Stifel, William Blair, and Raymond James. Baird, Stifel, William Blair, and Raymond James are also named as underwriters, in non-lead roles within that same syndicate. Legal counsel is split between the issuer and the underwriters. Latham & Watkins LLP passed upon the validity of the shares of Class A common stock offered, serving as legal advisor to the issuer, Black Rock Coffee Bar. Kirkland & Ellis LLP acted as counsel for the underwriters in connection with certain legal matters related to the offering. As an IPO, this transaction involves Black Rock Coffee Bar offering Class A common stock to the public for the first time, but the facts block does not disclose the number of shares offered, the per-share offering price, or the resulting post-IPO ownership or market capitalization beyond the aggregate disclosed proceeds figure. Several material facts remain undisclosed. No expected pricing or listing date beyond the filing dates in mid-September 2025 is given. The per-share offering price and total share count are not disclosed, and no detail is provided on any over-allotment option granted to the underwriting syndicate.

This deal is a cash-and-stock acquisition in which Skyward Specialty Insurance Group, Inc. (ticker SKWD), a company in the financial institutions group (FIG) sector, is the acquirer of Apollo Group Holdings Limited, the target. The transaction is classified under the M&A product group, with a disclosed value of $555,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on September 8, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Barclays acted as financial advisor to Skyward Specialty, the acquirer, and also provided committed financing for the transaction, with no lead designation specified. On the target side, Evercore acted as lead financial advisor to Apollo, with Howden Capital Markets & Advisory serving as an additional financial advisor to Apollo without a lead designation. Legal counsel was also disclosed for both sides. RPC acted as legal counsel to Skyward Specialty, the acquirer. Willkie Farr & Gallagher LLP acted as legal counsel to Apollo, the target. Beyond the cash-and-stock characterization of the consideration and the disclosed $555,000,000 deal value, the facts block does not specify the precise split between the cash and stock components. Several facts are not disclosed in the source material. The facts block does not give the specific cash/stock split of the consideration, nor does it disclose the amount of committed financing provided by Barclays. No expected closing date is given for the transaction.

City Office REIT, Inc., a real estate company, is the target in a merger transaction. The acquiring party and other transaction parties have not been specified in the available source materials. This is a mergers and acquisitions engagement within the real estate sector. The transaction has been disclosed but the deal value has not been stated in any of the source documents reviewed. The transaction information is sourced from an SEC filing published on September 8, 2025, through the SEC EDGAR system. The specific form type is not identified in the available documentation. The deal is currently pending regulatory approval, indicating that while the transaction has been announced, it has not yet closed and remains subject to regulatory review and clearance. No financial advisors have been identified or extracted for either the target or the acquiring party in connection with this transaction. This represents an unusual situation in which a merger of this scale proceeds without identified financial advisory support, or alternatively, such advisory relationships either have not been publicly disclosed in the source documents available or have not yet been engaged as of the publication date. No legal advisors have been identified in the source materials for either side of the transaction. The specific structure and terms of the merger remain undisclosed in the available documents. No detail regarding the consideration mix, form of consideration, or any other structural features of the transaction has been provided in the source material. Several critical details about this transaction remain unknown or undisclosed. The acquiring party or parties to the merger have not been identified. The deal value, despite being a material transaction, is not stated anywhere in the source documentation. No expected closing date or timing has been provided. The specific form of consideration, whether cash, stock, debt, or some combination, is not disclosed. The roles and identities of any investment banks, financial advisors, or legal counsel advising the parties are not identified. The current status is limited to the statement that the transaction is pending regulatory approval, but no specifics on which regulatory bodies are reviewing the deal or what approvals remain outstanding have been disclosed.

This transaction involves the acquisition of City Office REIT, Inc., a real-estate sector company, by a parent entity affiliated with Elliott Investment Management L.P. The deal is structured as a cash acquisition taking the company private and falls under the M&A product group. The disclosed value of the transaction is not stated in the source document. The facts underlying this summary are drawn from an SEC EDGAR Form DEFM14A filed and published on September 8, 2025. The deal's current status is pending regulatory review. On the financial advisory side, two advisors are identified, both representing the target, City Office REIT. Raymond James & Associates, Inc. served as financial advisor in a lead capacity; on July 23, 2025, in connection with the merger, Raymond James rendered its written opinion to the board as to the fairness, from a financial point of view, of the merger consideration to be received by holders of common stock. JLL Securities LaSalle Securities, LLC, an affiliate of JLL Securities LaSalle Americas, Inc., was also retained by the board to act as its financial advisor in connection with the transactions contemplated by the merger agreement, also in a lead capacity. No legal advisors are listed in the facts block for this transaction. The facts block identifies the transaction as a cash acquisition resulting in a take-private of City Office REIT, but provides no further detail on the specific per-share price, financing sources, or structure of the merger agreement beyond the fact that a fairness opinion was delivered to the board. Several material facts are not disclosed in the available record. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given. No legal advisors are named for either the target or the acquiring parent entity, and no detail on the acquirer's financing or ownership structure beyond its affiliation with Elliott Investment Management L.P. is provided.

Shimmick Corporation, trading under the ticker SHIM on the Nasdaq Capital Market in the industrials (heavy construction) sector, entered into an At The Market Offering Agreement (the "ATM Agreement") with Roth Capital Partners, LLC on September 8, 2025, authorizing the sale of up to $7,800,000 in aggregate offering price of common stock from time to time. The agreement and the offering were disclosed the same day in a Form 8-K (Item 8.01) and in a prospectus supplement on Form 424B5, both filed September 8, 2025, under the company's effective shelf registration statement on Form S-3 (File No. 333-288513), which the SEC declared effective on July 10, 2025. The offering is structured as a continuous "at the market" program under Rule 415, meaning there is no fixed number of shares, no set price, and no minimum or maximum sales price specified in advance; Roth Capital Partners will sell shares at prevailing market prices on a commercially reasonable efforts basis, acting as sales agent or principal, and is not required to sell any specific amount. For illustrative purposes only, the prospectus supplement estimated that, assuming the full $7.8 million were sold at $2.95 per share (the last reported Nasdaq closing price on September 5, 2025, the trading day before the agreement was signed), approximately 2,644,068 shares would be issued, bringing shares outstanding to an estimated 37,959,570 from a base of 35,315,502 shares outstanding as of September 5, 2025 -- an increase of roughly 7.5%. The actual number of shares and prices will vary depending on if and when sales occur under the program. Shimmick will pay Roth Capital Partners a cash commission of up to 3% of the gross sales price per share sold under the ATM Agreement, and will reimburse the sales agent for documented legal fees and costs up to $50,000 in the aggregate, as disclosed in both the prospectus supplement and the company's Form 10-Q filings. There is no greenshoe or over-allotment option disclosed; the program simply terminates once shares totaling $7.8 million in aggregate offering price have been sold, or earlier if either party terminates the ATM Agreement. The prospectus supplement discloses that net proceeds are intended for general corporate purposes, which may include repayment of debt, funding capital expenditures, financing working capital needs, funding operations, or financing potential acquisitions; the company states it has not allocated specific amounts to each use and retains broad discretion. Pending use, proceeds may be invested temporarily or applied to repay short-term debt. On dilution, the prospectus supplement discloses that Shimmick's historical net tangible book value (deficit) as of July 4, 2025 was approximately $(54.8) million, or $(1.56) per share. Assuming the full $7.8 million were sold at the assumed $2.95 per share price and after deducting commissions and estimated offering expenses, the as-adjusted net tangible book value (deficit) would be approximately $(44.3) million, or $(1.26) per share -- an immediate increase of $0.30 per share to existing stockholders and immediate dilution of $4.21 per share to new investors in the offering. This calculation excludes 2,091,283 shares issuable upon exercise of outstanding stock options (weighted-average exercise price $1.26), 2,604,929 shares issuable upon vesting of outstanding restricted stock units, and 2,430,608 additional shares reserved under the company's equity incentive plans. King & Spalding LLP, Atlanta, Georgia, passed on the validity of the shares for Shimmick and provided a legal opinion (Exhibit 5.1 to the September 8, 2025 Form 8-K) confirming the shares, when issued and sold under the ATM Agreement, will be validly issued, fully paid, and non-assessable. Pryor Cashman LLP, New York, New York, served as counsel to Roth Capital Partners, the sales agent, on certain legal matters in connection with the offering, as disclosed in the "Legal Matters" section of the prospectus supplement. Deloitte & Touche LLP served as the independent registered public accounting firm whose audit report is incorporated by reference. As of the company's most recent disclosures reviewed (the Form 10-Q for the quarter ended October 3, 2025, filed November 13, 2025, and the Form 10-Q for the quarter ended April 3, 2026, filed May 15, 2026), both of which describe the ATM Agreement in materially identical, forward-looking terms, there is no disclosure that any shares have actually been sold under the program, and no disclosed dollar amount of proceeds raised to date. The company states it is not obligated to make any sales under the agreement and gives no assurance as to whether, when, or at what price any shares will be sold. No closing date, pricing confirmation, or completion of the $7.8 million program has been identified in the filings reviewed, consistent with the deal's pending-regulatory status; this status reflects that the shelf-registered ATM program remains open and has not been reported as fully sold out, terminated, or otherwise concluded.

Solventum announced on September 2, 2025 that it had completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. for $4.0 billion in cash before customary adjustments. CEO Bryan Hanson described the closing as "an important milestone in Solventum's three-phased transformation plan," with net proceeds of $3.4 billion earmarked primarily to pay down outstanding debt. This record is sourced from an Exhibit 99.1 press release furnished with Solventum's Form 8-K filed September 2, 2025, announcing the completed closing of the divestiture (not merely its signing). Three financial advisors jointly represented Solventum, the seller: Morgan Stanley & Co. LLC, Perella Weinberg Partners and J.P. Morgan Securities LLC, per the release's statement that "Morgan Stanley & Co. LLC, Perella Weinberg Partners and J.P. Morgan Securities LLC served as financial advisors to Solventum, and Cleary Gottlieb Steen & Hamilton served as legal advisor to Solventum." No financial advisor to Thermo Fisher is named in this release, and no single advisor among the three is designated as lead. On the legal side, Cleary Gottlieb Steen & Hamilton represented Solventum; no legal advisor for Thermo Fisher is disclosed in this release. In connection with the closing, Solventum updated its full-year 2025 guidance to reflect partial-year accretion from the divestiture, raising its adjusted EPS range to $5.88-$6.03 from a prior $5.80-$5.95, while leaving organic sales growth and free cash flow guidance unchanged; the company also noted it will provide transitional services and perform certain manufacturing and distribution activities for Thermo Fisher going forward. Not disclosed in the sourced document is any EBITDA or revenue multiple implied by the $4.0 billion price, the identity of Thermo Fisher's financial or legal advisors, or the original signing date of the transaction (only the completed-closing date of September 2, 2025 is given).

Hyperscale Data, Inc., a technology sector company trading on the NYSE American under ticker GPUS, has conducted a series of at-the-market (ATM) common stock offering programs under a shelf registration statement on Form S-3. The first program, documented in a prospectus supplement filed August 29, 2025, authorized the sale of up to $125,000,000 of Class A common stock through sales agent Wilson-Davis & Co., Inc. The closing price of the stock on August 28, 2025, the day before this agreement was signed, was $0.5567 per share. Wilson-Davis was entitled to a commission of 3.0% of the gross sales price on shares sold under this agreement. The Company disclosed that it intended to use a majority of net proceeds from the $125,000,000 Wilson-Davis ATM program to acquire Bitcoin and to further develop its Michigan data facility, with a smaller portion earmarked to acquire XRP and for working capital and general corporate purposes, which may include repayment, refinancing, redemption or repurchase of indebtedness or capital stock. The prospectus supplement states there is no minimum offering amount, so the actual total proceeds and number of shares sold are not fixed in advance and are reported periodically; the specific number of shares sold and gross proceeds realized under this particular $125,000,000 program are not disclosed in the filings reviewed. On December 19, 2025, the Company entered into a new, separate At-the-Market Issuance Sales Agreement with Spartan Capital Securities, LLC for up to $50,000,000 of Class A common stock, documented in a prospectus supplement filed the same day (to a base prospectus dated December 11, 2025, under a new shelf registration, File No. 333-291595). The closing price on December 18, 2025 was $0.2517 per share. Spartan was entitled to a 2.5% commission on gross sales price. The use of proceeds disclosed for this program was materially the same as the prior one: a majority toward Bitcoin acquisition and continued development of the Michigan data facility, with a smaller amount for working capital and general corporate purposes, including potential repayment, refinancing, redemption or repurchase of indebtedness or capital stock (the December prospectus supplement does not mention XRP). An amendment filed January 16, 2026 (Amendment No. 1 to the December 19, 2025 prospectus supplement) disclosed that, as of that date, the Company had sold an aggregate of 20,000,000 shares of Class A common stock for gross proceeds of approximately $5.2 million under the Spartan ATM Sales Agreement, implying an average realized price of roughly $0.26 per share. On January 16, 2026, the Company and Spartan entered into an Amended and Restated ATM Sales Agreement that kept the $50,000,000 aggregate ceiling but added Wilson-Davis & Co., Inc. as a second sales agent alongside Spartan, with Spartan continuing as lead agent and both firms acting as co-agents and deemed underwriters under the Securities Act, entitled to a combined 2.5% commission rate. The stock closed at $0.297 per share on January 16, 2026. The filings do not explain why Spartan was substituted for Wilson-Davis in December 2025 or why Wilson-Davis was re-added in January 2026. The ATM program with Spartan was subsequently increased twice. A prospectus supplement filed June 18, 2026 shows the Company entered into a new ATM Sales Agreement with Spartan (sole agent at that point) for up to $300,000,000 of Class A common stock, with the stock closing at $0.3979 per share on June 17, 2026. A Supplement No. 1 to that prospectus supplement, filed October 13, 2026, disclosed that on October 9, 2026 the Company and Spartan amended the ATM Sales Agreement to reduce the maximum aggregate amount from $300,000,000 to $100,000,000. As of October 9, 2026, the Company had sold an aggregate of 121,827,841 shares of Class A common stock under this agreement for gross proceeds of $49,781,885, leaving approximately $50,218,115 of remaining capacity under the reduced $100,000,000 cap. The stock closed at $0.1569 per share on October 9, 2026. The commission rate under this agreement is 3.0% of gross sales price. Separately, the Company also established an at-the-market program for its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (ticker GPUS PD) with Wilson-Davis dated February 13, 2026, for up to $35.4 million, at a $25.00 per share liquidation preference; this preferred ATM program is distinct from the common stock ATM programs described above and is not part of the $125,000,000 offering referenced in this record. Legal counsel to Hyperscale Data, Inc. in connection with both the August 29, 2025 Wilson-Davis agreement and the December 19, 2025 Spartan agreement is Olshan Frome Wolosky LLP, which issued customary opinions (Exhibit 5.1 to each Form 8-K) stating that the shares to be offered, when issued, delivered and paid for as contemplated by the registration statement and prospectus, would be legally issued, fully paid and nonassessable. No greenshoe or over-allotment option is disclosed in any of these ATM prospectus supplements, consistent with the nature of at-the-market offerings, which are sold incrementally rather than in a single underwritten tranche. No concurrent share repurchase program is disclosed in the documents reviewed. The filings do not disclose the percentage of shares outstanding represented by any of these programs, a company-wide cumulative total of all shares sold under all ATM programs to date, or a precise timetable for full utilization of any of the agreements; each program terminates upon the earlier of full utilization of the authorized dollar amount or termination by either party upon ten days' notice. Settlement for shares sold under these programs occurs through the facilities of The Depository Trust Company, generally on the second trading day following a sale.

Auddia Inc., a technology sector company trading under the ticker AUUD, has announced an at-the-market offering, a type of equity capital markets transaction. The company is issuing shares of common stock with an aggregate offering price of up to $10,000,000. As the issuer in this offering, Auddia is selling its common stock, par value $0.001 per share, into the market through a registered at-the-market mechanism. This transaction was announced on August 22, 2025, based on a filing published to SEC EDGAR on that same date. The source document is an SEC filing, though the specific form type is not identified in the available information. The deal is currently in announced status, meaning the sales agreement has been executed but the offering remains ongoing. Ascendiant Capital Markets, LLC serves as the sales agent for this at-the-market offering, functioning in a lead capacity. According to the sales agreement entered into on August 22, 2025, Ascendiant Capital Markets, LLC acts as the agent responsible for selling the shares of common stock from time to time pursuant to the at-the-market offering structure under Rule 415 of the Securities Act of 1933, as amended. Carroll Legal LLC is serving as legal counsel to Auddia Inc. in this transaction. The firm has provided an opinion relating to the validity of the shares of common stock that may be sold pursuant to the sales agreement, which opinion has been filed as an exhibit to the offering documents. The at-the-market offering permits Auddia to sell up to $10,000,000 in aggregate offering price of its common stock through Ascendiant Capital Markets, LLC as sales agent. The structure is a registered at-the-market offering as defined under Rule 415 of the Securities Act, which allows the issuer to offer and sell shares opportunistically over time at prevailing market prices, rather than through a fixed underwritten offering at a set price. Several material terms and details of this transaction remain undisclosed. The expected closing date or completion timeline for the offering has not been stated. The number of shares to be offered, pricing mechanisms, and the timing and amount of actual sales under the agreement are not specified. No information has been provided regarding any underwriting discounts, commissions, or other compensation arrangements between the company and the sales agent. Additionally, any lock-up restrictions, standstill provisions, or other customary terms of the sales agreement are not detailed in the available information.

NXP Semiconductors N.V. (Nasdaq: NXPI), through its financing subsidiaries NXP B.V., NXP Funding LLC and NXP USA, Inc., executed an underwriting agreement for a public offering of three tranches of senior notes: 500 million dollars of 4.300% Senior Notes due 2028, 300 million dollars of 4.850% Senior Notes due 2032, and 700 million dollars of 5.250% Senior Notes due 2035, for an aggregate 1.5 billion dollars of unsecured debt guaranteed by NXP Semiconductors N.V. This is a debt capital markets transaction, not an M&A deal, used to refinance existing notes. This record is sourced from an 8-K (Item 8.01) that NXP Semiconductors filed with the SEC on August 18, 2025, describing the underwriting agreement executed on August 12, 2025. At the time of filing the offering had been priced and was awaiting settlement, expected to complete on August 19, 2025, subject to customary closing conditions. The underwriting agreement names Barclays Capital Inc. first among the five bank representatives of the underwriting syndicate: "Barclays Capital Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, PNC Capital Markets LLC and UBS Securities LLC, as representatives of the several underwriters named therein." Being listed first in an underwriting agreement typically signals a lead or left-lead role, though the filing does not use an explicit "lead" label for any single bank. No legal advisors are disclosed in this 8-K. On deal structure, the notes are senior unsecured obligations of the issuers, guaranteed by NXP Semiconductors N.V. on a senior unsecured basis, and were offered under an already-effective automatic shelf registration statement on Form S-3ASR. The company stated it intended to use net proceeds to redeem 500 million dollars of outstanding 5.350% senior unsecured notes due 2026 and 750 million dollars of outstanding 3.875% senior unsecured notes due 2026, with excess proceeds held temporarily in cash or short-term securities, or used for general corporate purposes including capital expenditures or short-term debt repayment. Not disclosed in this exhibit: individual underwriting fees or gross spread, the specific allocation of notes among the five representative banks or the broader syndicate, and whether any single bank acted as sole or lead-left bookrunner as opposed to a joint representative role.

TPG Global, LLC, through its TPG Capital private equity platform, and Corpay, Inc. (NYSE: CPAY) completed their acquisition of AvidXchange Holdings, Inc. (Nasdaq: AVDX), a provider of accounts payable automation software and payment solutions, on October 15, 2025. The transaction was structured through Arrow Borrower 2025, Inc. (Parent) and its wholly owned subsidiary Arrow Merger Sub 2025, Inc., which merged into AvidXchange, with AvidXchange surviving as a wholly owned subsidiary of Parent. TPG acquired a majority interest in AvidXchange and Corpay acquired a minority interest. The deal was announced on May 6, 2025, approved by AvidXchange shareholders on September 16, 2025, and closed on October 15, 2025, following regulatory approvals and other customary closing conditions. Under the terms of the merger agreement, each share of AvidXchange common stock was converted into the right to receive $10.00 in cash, without interest. The company's press release announcing the closing stated that the acquisition "established AvidXchange as a private company valued at approximately $2.2 billion." The $10.00 per share price represented a 22% premium to AvidXchange's closing stock price of $8.20 on May 6, 2025 (the last trading day before the deal was announced), a 16% premium to the 90-day volume-weighted average price as of that date, and a 45% premium to the $6.89 closing price on March 12, 2025, the last trading day before media reports of a potential transaction first surfaced, according to the definitive merger proxy statement. The merger consideration was entirely cash; there was no stock component and no condition to closing tied to the availability of Parent's financing. The proxy statement's "Background of the Merger" section discloses an extended sale process. Beginning in August and September 2024, AvidXchange management and its board fielded inbound inquiries from multiple financial sponsors following a stock price decline tied to lowered fiscal 2024 revenue guidance. From September 2024 through April 2025, the company entered confidentiality agreements with ten counterparties, including TPG and Corpay, and held discussions with several other named financial sponsors (referred to in the proxy as Sponsor A through Sponsor G) as well as an unnamed "Strategic Company," none of which ultimately submitted a bid that advanced to signing. TPG's initial non-binding indicative offer, submitted January 31, 2025, was in a range of $12.00 to $13.00 per share in cash; after the company's growth outlook weakened during the first quarter of 2025, TPG's offer was revised downward over several rounds, reaching a "best and final" joint proposal from TPG and Corpay of $10.00 per share on April 29, 2025, which was signed on May 6, 2025. Corpay's participation, including a disclosed equity commitment of $642 million, was described by TPG as essential to sustaining the $10.00 per share price. Barclays Capital Inc., one of AvidXchange's two financial advisors (together with Financial Technology Partners LP and FTP Securities LLC, or "FT Partners"), delivered a fairness opinion to the board dated May 6, 2025, concluding the $10.00 merger consideration was fair, from a financial point of view, to AvidXchange's unaffiliated stockholders, based on the company's internally prepared "Risk-Adjusted Forecasts." Barclays' selected comparable companies analysis applied EV/CY2025E revenue multiples of 3.0x-6.0x and EV/CY2025E Adjusted EBITDA multiples of 13.0x-18.0x, implying equity values per share of $7.68-$13.81 and $6.76-$8.80, respectively; the $10.00 merger price fell within the revenue-based range and above the EBITDA-based range. A selected precedent transactions analysis (including deals such as Paychex/Paycor, Vista/EngageSmart, Thoma Bravo/Coupa, and Corpay/Paymerang) applied EV/LTM revenue multiples of 5.0x-7.5x, implying $11.33-$16.17 per share, placing the merger price below that range; a discounted cash flow analysis produced an implied range of $8.34-$12.88 per share, within which the $10.00 price fell. Financing for the transaction included new committed equity from TPG and Corpay, an equity rollover from certain members of AvidXchange management (including CEO Michael Praeger, Dan Drees, Joel Wilhite and Ryan Stahl) and from Mastercard International Incorporated, plus third-party debt. At closing, AvidXchange and its affiliates entered into a new credit agreement providing a $440.0 million, seven-year term loan facility and a $60.0 million, seven-year revolving credit facility, with Ares Capital Corporation LLC serving as administrative agent and collateral agent; proceeds were used in part to repay and terminate AvidXchange's prior credit facility with KeyBank National Association and certain other outstanding promissory notes. The merger agreement provided for a termination fee of $78.0 million payable by AvidXchange to Parent under specified circumstances (including a change of board recommendation or acceptance of a superior proposal), and a reverse termination fee of $133.0 million payable by Parent to AvidXchange under specified circumstances (including failure to close after conditions were satisfied), guaranteed in part by TPG and Corpay in proportion to their equity commitments. At the September 16, 2025 special meeting, holders of 161,861,694 shares (77.93% of the 207,698,753 shares outstanding as of the August 14, 2025 record date) were present or represented, constituting a quorum. The merger proposal was approved with 160,933,222 votes in favor, 811,814 against, and 116,658 abstaining. At closing, AvidXchange implemented a retention bonus program with an aggregate value of approximately $3.0 million for named executive officers and other key employees, including $1,104,000 to CEO Michael Praeger, $378,000 to Dan Drees, $462,000 to Joel Wilhite, $282,000 to Angelic Gibson, and $190,500 to Ryan Stahl, vesting in three equal annual installments. AvidXchange common stock, which traded under ticker AVDX on the Nasdaq Global Select Market, was suspended from trading prior to the market open on October 15, 2025, and the company subsequently filed to deregister its shares. On the legal advisory side, Latham & Watkins LLP acted as legal advisor to AvidXchange. Davis Polk & Wardwell LLP and Schulte Roth & Zabel LLP acted as legal counsel to TPG. Eversheds Sutherland acted as legal counsel to Corpay. On the financial advisory side, Financial Technology Partners and Barclays acted as financial advisors to AvidXchange; J.P. Morgan Securities LLC, Moelis & Company and RBC Capital Markets acted as financial advisors to TPG; and Goldman Sachs acted as financial advisor to Corpay. Innisfree M&A Incorporated served as proxy solicitor to assist AvidXchange shareholders with voting on the merger. CEO Michael Praeger stated, "We are truly excited to chart the next chapter in AvidXchange's growth trajectory with the support of TPG and Corpay. As a private company, we look forward to building upon our 25+ years of industry leadership by accelerating innovation, delivering new and enhanced solutions to our customers, and creating further opportunities for our team." John Flynn, Partner at TPG, said, "AvidXchange has long been at the forefront of AP automation, continuously innovating to streamline complex corporate payment workflows." Tim Millikin, Partner at TPG, added, "We're excited to join forces with Corpay to partner with Michael and the AvidXchange team to accelerate growth and unlock its long-term potential as a private company." Ron Clarke, Chairman and CEO of Corpay, said, "We're thrilled to be in the game with Mike and his management team, and we see a path to a much higher growth and more profitable company over the midterm." The transaction has closed. No synergy targets, pro forma EPS impact, or combined-company financial projections were disclosed in the filings reviewed, as this was a cash take-private rather than a strategic stock-for-stock combination.

This deal involves AvidXchange Holdings, Inc., a technology-sector company, as the target in a cash merger backed by a sponsor and strategic consortium, namely an affiliate of TPG and Corpay, Inc. (referred to as Arrow Borrower 2025, Inc.). The transaction falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from a DEFM14A filing with the SEC via EDGAR, published August 15, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed in the record: Barclays Capital Inc., which served as financial advisor to the target, AvidXchange, and is designated lead on that side. The source sentence provided is simply the heading "Opinion of Barclays Capital Inc.," indicating Barclays rendered a fairness opinion in connection with the transaction, though the substantive content of that opinion is not included in the facts block. No financial advisor is named for the acquiring consortium (TPG/Corpay affiliate) side. No legal advisors are identified in the facts block for either the target or the acquiring consortium. Beyond classifying the transaction as a cash merger involving a sponsor and strategic consortium, the facts block does not specify the per-share cash price, financing sources, or any other structural terms. A number of material facts are not disclosed in this record. The transaction's dollar value is not stated. No legal advisors are named for either side. No financial advisor is identified for the acquiring consortium, and no expected closing date is given.

ENB Financial Corp., a financial institutions sector company trading under ticker ENBP, is acquiring Cecil Bancorp, Inc. in an all-cash bank acquisition valued at $30,800,000. This is a merger and acquisition transaction within the financial institutions product group. The transaction is currently pending regulatory approval. The transaction details were disclosed in an SEC EDGAR filing published on August 13, 2025. The specific form type is not identified in the available source materials. The deal remains in regulatory review and has not yet closed. Performance Trust Capital Partners, LLC is serving as exclusive financial advisor to ENB Financial Corp., the acquirer. The firm rendered a fairness opinion to the Board of Directors of ENB and is acting as the lead financial advisor on the transaction. On the target side, Hovde Group, LLC is serving as exclusive financial advisor to Cecil Bancorp, Inc. Hovde Group rendered a fairness opinion to Cecil Bancorp's Board of Directors and is acting as lead financial advisor to the target. Bybel Rutledge LLP is serving as legal counsel to ENB Financial Corp. Nelson Mullins Riley & Scarborough LLP is serving as legal counsel to Cecil Bancorp Inc. The transaction is structured as an acquisition for total consideration of $30,800,000 in cash. No additional detail regarding the breakdown of consideration, any earnout provisions, working capital adjustments, or other structural elements has been disclosed in the available source materials. The specific SEC filing form type has not been identified, and the expected closing date for the transaction has not been disclosed. The precise allocation of the purchase price across cash and any other consideration mechanisms, if applicable, remains unspecified. No information has been provided regarding transaction conditions, termination provisions, or the regulatory approval timeline.

This deal is a cash acquisition classified as an M&A transaction in the financial institutions group (FIG) sector, involving Cecil Bancorp, Inc. as target and ENB Financial Corp (ticker ENBP) as acquirer. The disclosed value of the transaction is $30,800,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on August 13, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Hovde Group, LLC served as exclusive financial advisor to Cecil Bancorp, the target, in a lead capacity, and rendered a fairness opinion to Cecil's Board of Directors. Performance Trust Capital Partners, LLC served as exclusive financial advisor to ENB Financial Corp, the acquirer, also in a lead capacity, and similarly rendered a fairness opinion to ENB's Board of Directors. On the legal side, Nelson Mullins Riley & Scarborough LLP served as legal counsel to Cecil Bancorp, the target, while Bybel Rutledge LLP served as legal counsel to ENB Financial Corp, the acquirer. Beyond the cash consideration implied by the cash acquisition subtype, with a disclosed deal value of $30,800,000, no further detail on per-share pricing or other structural terms is provided in the facts block. Several items are not disclosed in the available record. No further structural detail beyond the cash acquisition classification and disclosed value is given, and no expected closing date or further timeline detail beyond the August 2025 filing date and pending-regulatory status is provided.

This is a cash acquisition structured as a take-private, classified under the M&A product group, in which Advent is acquiring Sapiens International Corporation N.V. The disclosed transaction value is $2,500,000,000. The facts block does not specify a sector classification for this record. The facts are sourced from a Form 6-K filed with the SEC via EDGAR, published on August 13, 2025. A 6-K is a filing type used by foreign private issuers, consistent with Sapiens' status as a Netherlands-incorporated company. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity. William Blair & Company, L.L.C. is acting as financial advisor to Sapiens, the target, per the statement "William Blair & Company, L.L.C. is acting as financial advisor to Sapiens, and Latham & Watkins LLP and Meitar Law Offices are acting as legal counsel to Sapiens." On the acquirer side, Citi is acting as financial advisor to Advent, consistent with the language "Citi is acting as financial advisor to Advent, and Kirkland & Ellis LLP and Herzog Fox Neeman are acting as legal counsel to Advent." Legal advisors are disclosed for both sides, each with two firms reflecting the cross-border, Israel-linked nature of the deal. Latham & Watkins LLP and Meitar Law Offices are acting as legal counsel to Sapiens, the target. Kirkland & Ellis LLP and Herzog Fox Neeman are acting as legal counsel to Advent, the acquirer. Beyond the classification of this transaction as a cash acquisition/take-private with a disclosed value of $2,500,000,000, no further detail on the per-share cash consideration or other specific terms is included in the facts provided. Several items are not disclosed in this record: the per-share cash consideration is not specified, the sector classification is not given, and no expected closing date is given beyond the pending-regulatory status.

Hall of Fame Resort & Entertainment Company (NASDAQ/OTC: HOFV), a Canton, Ohio-based resort, entertainment and media company built around the Pro Football Hall of Fame, agreed on May 7, 2025 to be acquired by HOFV Holdings, LLC (Parent) in an all-cash going-private merger. Parent and its merger subsidiary, Omaha Merger Sub, Inc., are affiliates of Industrial Realty Group, LLC (IRG), a real estate investment and development firm whose founder and president, Stuart Lichter, sits on HOFRE's board and whose affiliates had been HOFRE's largest investor and lender since 2020. CH Capital Lending, LLC, an IRG-affiliated entity, signed the merger agreement solely as guarantor of certain of Parent's obligations. The transaction was announced via a Form 8-K filed May 8, 2025, and closed on December 31, 2025, at which point HOFRE became a wholly owned subsidiary of Parent and its common stock was delisted and deregistered. Under the merger agreement, each outstanding share of HOFRE common stock (other than shares owned by HOFRE, by the buyer parties or their affiliates, and dissenting shares) was converted into the right to receive $0.90 in cash, without interest. Outstanding restricted stock units were cancelled and converted into the right to receive cash equal to the number of underlying shares multiplied by the $0.90 merger consideration, and public, private and Series X warrants became exercisable for the same $0.90-per-share cash amount (holders had 30 days after announcement of closing to exercise, though the filings note the $0.90 payout was less than the warrants' exercise prices). HOFRE's 7.00% Series A Cumulative Redeemable Preferred Stock and 7.00% Series C Convertible Preferred Stock were cancelled for no consideration. HOFRE had approximately 6,698,645 shares of common stock outstanding as of March 31, 2025; the definitive proxy statement discloses that HOFRE's net book value per share was approximately $8.50 as of that date, meaning the $0.90 deal price represented a steep discount to book value. The proxy does not disclose a single aggregate dollar figure for total transaction value, so enterprise/equity value is not stated in the filings reviewed. Parent funded the merger consideration through equity financing, per the closing 8-K; no new acquisition debt is disclosed. The transaction's closing was conditioned on more than HOFRE shareholder approval. Per the announcement 8-K and the definitive proxy, closing required (i) Parent's receipt of at least $20 million of "Parent Acquisition Financing," (ii) consummation of a "Lease Restructuring" under which an IRG-affiliated investor that owns HOFRE's waterpark property would enter a new lease for that property and, following certain real estate transfers, the on-site hotel and stadium properties, (iii) consummation of additional project-level financing of not less than $125 million, (iv) receipt of specified third-party consents, and (v) resignations of HOFRE's directors and officers as requested by Parent. The merger agreement set an initial outside date of October 31, 2025, but the deal did not close until December 31, 2025; a series of 8-Ks between July 2025 and November 2025 (each disclosing new debt obligations under Item 2.03) indicate HOFRE continued to rely on interim financing, including loans from IRG, to fund operations while the financing conditions were satisfied. The proxy discloses that, as of its filing date, IRG had provided approximately $13.7 million of interim financing to HOFRE under a promissory note needed to fund payroll, tax obligations, near-term creditor obligations and vendor arrearages, and that this amount would have to be repaid in cash if the merger did not close. The company's board was advised that failure to complete the merger carried a risk of default, foreclosure by the waterpark landlord and other secured creditors on pledged collateral (including HOFRE's interest in the Tom Benson Hall of Fame Stadium entity and other real estate parcels), and potentially bankruptcy or insolvency. The agreement was unanimously approved and recommended by a Special Committee of independent, disinterested directors, and subsequently approved by the full HOFRE board. Wedbush Securities Inc. acted as exclusive financial advisor to the Special Committee and delivered a fairness opinion dated May 7, 2025, concluding that the $0.90 per share price to be received by unaffiliated stockholders was fair from a financial point of view; the proxy notes Wedbush did not perform a discounted cash flow analysis because, absent the merger or another sale or financing transaction, the Special Committee directed Wedbush to assume HOFRE would not continue as a going concern, and that no explicit going-concern or net-book-value-based valuation was used by the purchaser filing parties because book value was viewed as reflecting historical cost rather than current value. Brown Gibbons Lang served as exclusive financial advisor to IRG and its affiliates. Hunton Andrews Kurth LLP served as legal counsel to the Special Committee, and Bryan Cave Leighton Paisner LLP served as legal counsel to IRG. HOFRE's stockholders were restricted from soliciting competing acquisition proposals after May 7, 2025, and the proxy's "Background of the Merger" section describes a years-long history of HOFRE depending on IRG/Lichter-affiliated financing (loan guarantees, promissory notes, preferred stock purchases, and loan purchases/extensions dating back to 2020-2022) rather than describing a competitive sale process or other bidders; it does not identify any alternative acquirer considered. The merger agreement provided termination rights for either party if closing did not occur by the original October 31, 2025 outside date (subject to customary exceptions), for failure to obtain stockholder approval, for uncured breaches, or for a board recommendation change. HOFRE agreed to pay Parent a $1,000,000 termination fee in cash if it terminated to accept a superior proposal or if Parent terminated following a board recommendation change or a material breach of the no-solicitation covenant. HOFRE's stockholders approved adoption of the merger agreement at a reconvened special meeting on September 24, 2025 (initially convened September 16, 2025), with 3,396,118 shares voting for, 733,949 against, and 42,206 abstaining, out of 4,172,273 shares (62.1% of voting power) represented at the meeting, as reported in an 8-K filed September 26, 2025. The merger closed on December 31, 2025: Omaha Merger Sub, Inc. merged with and into HOFRE, HOFRE survived as a wholly owned subsidiary of Parent, HOFRE's charter and bylaws were amended and restated, several directors (Karl L. Holz, Marcus LaMarr Allen, Anthony J. Buzzelli, David Dennis, Mary Owen, and Kimberly K. Schaefer) resigned from the board, and the company requested that OTC Markets suspend trading of its common stock before the open on January 2, 2026, with HOFRE intending to file a Form 15 to deregister its shares and warrants and suspend its SEC reporting obligations.

TaskUs, Inc., a publicly traded provider of outsourced digital services and customer experience solutions trading under ticker TASK, agreed on May 8, 2025 to be taken private by an affiliate of Blackstone together with TaskUs co-founders Bryce Maddock (Chief Executive Officer) and Jaspar Weir (President) in an all-cash transaction. The agreement was disclosed in a Form 8-K filed May 9, 2025 (Item 1.01), with merger vehicle Breeze Merger Corporation to merge with and into TaskUs. Blackstone, through BCP FC Aggregator L.P., and the Maddock and Weir family trusts (the "Continuing Stockholders"), together held approximately 96 percent to 98 percent of the total voting power of TaskUs since its 2021 IPO, making this a controlled-company going-private transaction rather than a competitive sale process. Under the terms of the Agreement and Plan of Merger, TaskUs stockholders other than the Buyer Group were to receive $16.50 in cash per share of Class A and Class B common stock, representing a premium of approximately 26 percent to the company's 30-day volume-weighted average price as of the announcement. TaskUs' financial advisor Evercore Group L.L.C. rendered a fairness opinion to the Special Committee; its selected-transactions analysis referenced an Enterprise Value/LTM Adjusted EBITDA mean and median of 7.6x and 6.8x among comparable BPO transactions (including Concentrix/Webhelp at 11.8x), and its discounted cash flow analyses applied terminal Adjusted EBITDA multiples in ranges such as 4.5x to 5.5x, alongside selected-company benchmark ranges of 5.0x-6.0x EV/2025E Adjusted EBITDA and 4.5x-5.5x EV/2026E Adjusted EBITDA, as disclosed in the DEFM14A. The transaction was structured as all-cash with no financing condition; funds affiliated with BCP FC Aggregator L.P. provided an equity commitment letter, dated May 8, 2025, to fund the full merger consideration, so no new acquisition debt was disclosed. Co-founder and CEO Bryce Maddock said, "The era of AI is upon us, and we are focused on addressing the changes it requires of our business, while helping our clients navigate their own transformations. This strategic transaction will deliver immediate value to stockholders, while enabling TaskUs to make long-term investments to better support both our own business and our clients as we scale and adapt in the AI age." Amit Dixit, Head of Asia Private Equity at Blackstone, said the firm's "continued commitment to TaskUs coupled with our deep expertise in technology services will equip the Company with more flexibility and resources to make the long-term investments in AI capabilities that will be needed to enhance the customer value proposition in the fast-changing environment brought upon by AI." The Special Committee, which was formed March 20, 2025 in response to the Buyer Group's interest in a possible transaction, stated: "With the assistance of leading independent financial and legal advisors, we carefully considered and negotiated the proposed transaction with the Buyer Group. Following our evaluation, we concluded that this transaction is in the best interest of TaskUs and our public stockholders." Evercore Group L.L.C. served as financial advisor and Cravath, Swaine & Moore LLP served as legal counsel to the Special Committee of the TaskUs Board. BofA Securities served as financial advisor and Simpson Thacher & Bartlett LLP served as legal counsel to the Buyer Group (Blackstone, Maddock and Weir). Latham & Watkins LLP served as legal counsel to Bryce Maddock and Jaspar Weir individually. The merger agreement provided for a company termination fee of $39,000,000 payable by TaskUs in specified circumstances, including termination in connection with a superior proposal, and an outside date of December 8, 2025. Innisfree M&A Incorporated was separately engaged as proxy solicitor in connection with the stockholder vote. The transaction did not close. TaskUs held a special meeting of stockholders on October 8, 2025 (after prior adjournments, including one from September 10, 2025) to vote on the Merger Agreement Proposal, and the requisite stockholder approval, which required a majority of votes cast by unaffiliated stockholders in addition to overall majority approval, was not obtained. As a result, on October 9, 2025, Breeze Merger Corporation and TaskUs entered into a mutual agreement to terminate the Merger Agreement, effective immediately, with mutual releases of claims and no termination fee payable by either party, as disclosed in a Form 8-K filed October 9, 2025 (Item 1.02). The related Voting and Support Agreements with BCP FC Aggregator L.P., the Maddock trusts, and the Weir trusts terminated automatically upon termination of the Merger Agreement. TaskUs has continued to operate and file as a public company since the termination, including holding its 2026 Annual Meeting of Stockholders on May 21, 2026 and filing a Form 10-K for fiscal year 2025 and subsequent Form 10-Qs.

Greif, Inc. announced on August 6, 2025 that it had entered into a definitive agreement with Molpus Woodlands Group, acting on behalf of clients, to sell its Soterra land management business, comprising more than 173,000 acres of timberlands across the Southeastern United States, for $462 million. CEO Ole Rosgaard described the sale as aligning with Greif's strategy "to focus our portfolio on opportunities where Greif can be an industry leader." This record is sourced from an Exhibit 99.1 press release furnished with Greif's Form 8-K filed August 7, 2025 (dated August 6, 2025). At announcement, the transaction was a signed definitive agreement pending customary closing conditions, with closing expected shortly before or after Greif's fiscal year end. Perella Weinberg served as exclusive adviser to Greif on the sale, per the release's statement "Perella Weinberg served as exclusive adviser to Greif during the transaction." The word "exclusive" explicitly marks Perella Weinberg as the sole and lead financial adviser on Greif's side; no financial adviser to Molpus Woodlands Group is named in this release. No legal advisors for either party are disclosed in the fetched document. The release states that cash proceeds from the sale will be allocated to debt repayment, and that the timberlands "seamlessly complement" Molpus's existing portfolio, which spans over 1.7 million acres of timberland investments across 15 states, according to Molpus CEO Terrell Winstead's quoted remarks. Not disclosed in the sourced document is any per-acre or EBITDA valuation multiple implied by the $462 million price, the identity of legal counsel to either party, or a precise calendar closing date beyond "shortly before or after the Company's fiscal year end."

This transaction is an equity-and-cash merger in which Western Midstream Partners, LP (ticker WES), an energy-power sector company, is acquiring Aris Water Solutions, Inc. The deal falls under the M&A product group and carries a disclosed value of $2,000,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on August 6, 2025. Financial advisory roles reflect a notable governance detail on the target side. BofA Securities served as financial advisor to WES, the acquirer. For Aris, the target, Citi served as financial advisor, while Houlihan Lokey served separately as financial advisor specifically to Aris's Audit Committee, indicating the audit committee ran a distinct process alongside the company's general advisory relationship with Citi. Legal counsel follows the same structure. Vinson & Elkins LLP served as legal advisor to WES, the acquirer. Gibson, Dunn & Crutcher LLP served as legal advisor to Aris, the target, while Morris, Nichols, Arsht & Tunnell LLP served as legal advisor specifically to Aris's Audit Committee. The facts block confirms this is structured as an equity-and-cash merger with a disclosed value of $2,000,000,000, but does not specify the exact mix or ratio of equity to cash consideration, nor the exchange ratio for any equity component. Several material facts are not disclosed. No expected closing date is given. The specific equity and cash consideration split is not disclosed beyond the general subtype characterization, and no detail is provided on what prompted the Audit Committee's separate advisory engagement beyond the existence of that mandate itself.

Chegg, Inc., a Santa Clara, California-based learning platform trading on the NYSE under ticker CHGG, initiated a strategic review process on February 24, 2025 to explore alternatives, as disclosed in its fourth-quarter and full-year 2024 earnings release filed on Form 8-K. At the time, then-CEO Nathan Schultz stated the company was "launching a strategic review process" to "maximize the future of our business and shareholder value." Chegg retained Goldman Sachs as its financial advisor for the review. On October 27, 2025, Chegg announced that its Board of Directors had unanimously concluded the strategic review without a sale. According to the press release filed as Exhibit 99.01 to the company's Form 8-K dated October 27, 2025, "Chegg, together with its advisor Goldman Sachs, conducted a comprehensive strategic review evaluating a range of potential outcomes, including being acquired, a go-private transaction, and remaining a public standalone company. After thoughtful consideration of multiple proposals, the Board unanimously determined that remaining an independent public company offers the best opportunity to maximize long-term shareholder value." The filing confirms multiple acquisition or go-private proposals were received and evaluated, but no transaction value, bidder identities, or proposal terms were disclosed in the source documents reviewed. No purchase price, enterprise value, exchange ratio, or valuation multiple is applicable or disclosed, because the strategic review concluded with Chegg remaining an independent, publicly traded company rather than being acquired or taken private. There was no merger agreement, tender offer, or proxy statement filed in connection with a transaction. Concurrent with the conclusion of the strategic review, Chegg announced a restructuring intended to strengthen cash flow and refocus the business on what it called the "$40+ billion skilling market." The restructuring plan, disclosed under Item 2.05 of the same Form 8-K, called for a reduction of 388 roles globally, approximately 45% of the company's workforce, and is expected to reduce 2026 non-GAAP expenses by approximately $100 million to $110 million. The company expects to incur restructuring charges of approximately $15 million to $19 million, consisting primarily of cash severance and employee-transition costs, with substantially all charges incurred by the first quarter of 2026 and approximately $12 million to $16 million of the related cash impact occurring in the fourth quarter of 2026. Chegg stated its skilling-focused businesses, built on its existing professional language learning, workplace readiness, and AI-related skills courses, were expected to generate approximately $70 million of revenue in 2025 with double-digit growth expected in 2026. The same Form 8-K disclosed a leadership transition: Executive Chairman Dan Rosensweig reassumed the role of President and Chief Executive Officer effective October 27, 2025, while outgoing CEO Nathan Schultz became an Executive Advisor to the CEO and Board under a transition and separation agreement (filed as Exhibit 10.1) through a separation date of December 31, 2025. Rosensweig's new offer letter (Exhibit 10.2) provided for a base salary of $850,000, a grant of restricted stock units covering 1,650,000 shares, and performance-based restricted stock units covering up to 3,850,000 shares tied to stock-price hurdles over a 36-month period following grant. Board member Richard Sarnoff also resigned effective October 21, 2025, which the filing states was unrelated to any dispute with management. No legal advisors to Chegg or to any potential acquirer were identified in the source filings reviewed. Only the financial advisor, Goldman Sachs, was named in connection with the strategic review. Subsequent filings reviewed through 2026, including the Q3 2025 earnings release (November 10, 2025) and later 8-Ks concerning a convertible notes repurchase (December 2025) and an NYSE minimum share price deficiency notice (July 2026), make no further reference to a pending acquisition or go-private process, consistent with the strategic review having concluded in October 2025 with Chegg remaining independent. Because the review ended without any acquisition, merger, or going-private transaction being consummated or subsequently announced in the filings reviewed, this record reflects a concluded strategic-alternatives process rather than a pending or completed M&A transaction; no purchase price, financing structure, synergies, or closing conditions exist to report for a deal that did not occur.

SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company focused on rare diseases and medical emergencies, agreed to acquire Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on antibody-based cancer therapeutics, in an all-cash tender offer and merger. The deal was announced August 5, 2025 via a definitive merger agreement dated August 4, 2025, filed as Exhibit 2.1 to Y-mAbs' Form 8-K. The transaction has closed: SERB's wholly owned subsidiary Yosemite Merger Sub, Inc. completed its tender offer on September 15, 2025, with approximately 39,827,138 shares (about 87.22% of shares outstanding) validly tendered, and the companies completed a short-form merger under Section 251(h) of the Delaware General Corporation Law on September 16, 2025, with Y-mAbs becoming a wholly owned subsidiary of SERB's acquisition vehicle, Perseus BidCo US, Inc. Y-mAbs shares were delisted from Nasdaq effective September 16, 2025. SERB paid $8.60 per share in cash for all outstanding Y-mAbs common stock, representing an equity value of approximately $412 million as announced and aggregate consideration (including option and restricted stock unit cashouts) of approximately $413 million, which Parent funded through a combination of cash on hand and short-term financing. The offer price represented an approximately 105% premium to Y-mAbs' closing share price of $4.19 on August 4, 2025, the last full trading day before the merger agreement was signed, and an approximately 92% premium to the volume-weighted average price of Y-mAbs shares over the 90 trading days ending August 4, 2025. Y-mAbs' financial advisor, Centerview Partners, performed a discounted cash flow analysis using discount rates of 14.5% to 16.5%, cash flows from July 1, 2025 through December 31, 2050, a terminal decline rate of 20% per year, and credit for approximately $240 million of federal and $194 million of state net operating losses as of December 31, 2024, net of the estimated cost of assumed future equity raises of $75 million in 2026, $50 million in 2027, $100 million in 2028, $100 million in 2029, and $150 million in a later year per management's financing assumptions. Strategic rationale focused on Y-mAbs' lead commercial asset DANYELZA (naxitamab-gqgk), the first FDA-approved treatment for relapsed or refractory high-risk neuroblastoma. SERB CEO Vanessa Wolfeler stated, "High-risk neuroblastoma is not only a rare and devastating pediatric cancer but also one of the most difficult to treat. DANYELZA is recognized as a critical treatment option for patients and expands the treatment pathways available to providers in an outpatient setting. Working together with the team from Y-mAbs, I believe we can continue generating data for this product, expand partnerships to additional oncology centers, and have a positive impact on the lives of more neuroblastoma patients and their families." SERB Chairman Jeremie Urbain said the acquisition "reflects another milestone in the execution of our growth strategy to build a leading global specialty pharma platform" and that "DANYELZA is an excellent strategic fit for SERB as it strengthens our existing rare oncology portfolio." Y-mAbs CEO Michael Rossi said the agreement with SERB "reflects the most attractive option available to Y-mAbs, providing significant, immediate and certain value to our stockholders," following what the Schedule 14D-9 describes as a roughly five-month strategic review in which Y-mAbs or Centerview contacted or held discussions with at least 36 potential counterparties, signed confidentiality agreements with six potential strategic acquirers and five potential RIT investors, and received competing offers from two counterparties (referred to in the filing as Party A through Party H) before SERB emerged as the only party willing to proceed on acceptable terms. The merger agreement provided for a termination fee payable by Y-mAbs of $14.25 million, equal to approximately 3.46% of the implied equity value of the transaction, in the event Y-mAbs terminated to accept a superior proposal or under other specified circumstances. Y-mAbs stockholders holding approximately 16% of outstanding shares signed tender and support agreements committing to tender their shares. Closing was conditioned on a majority of outstanding shares being tendered and expiration or termination of the HSR Act antitrust waiting period; SERB was contractually obligated to commence the tender offer by August 19, 2025, and the companies had targeted a close by the fourth quarter of 2025, though the transaction in fact closed September 16, 2025, ahead of that target. Y-mAbs agreed to pay Centerview an aggregate fee of approximately $9.1 million for its financial advisory services, of which $1.5 million was payable upon delivery of its fairness opinion and the remainder contingent on closing. Y-mAbs retained Centerview Partners as exclusive financial advisor, Cooley LLP as legal counsel, and Joele Frank, Wilkinson Brimmer Katcher as strategic communications advisor. SERB retained Rothschild & Co. as exclusive financial advisor, Freshfields US LLP as legal counsel, and H/Advisors Abernathy as strategic communications advisor. At the effective time, outstanding Y-mAbs stock options with exercise prices below $8.60 were cancelled and converted into the right to receive cash equal to the spread, out-of-the-money options were cancelled for no consideration, and restricted stock units and performance stock units were cancelled and converted into cash based on the $8.60 merger consideration (with PSUs cashed out at maximum share levels). Following the merger, all of Y-mAbs' incumbent directors (Thomas Gad, David N. Gill, Laura J. Hamill, James I. Healy, Michael Rossi, Ashutosh Tyagi and Johan Wedell-Wedellsborg) and several executive officers, including CEO Michael Rossi, resigned in connection with the transaction.

Mifflinburg Bancorp, Inc. (OTCPK: MIFF) and Northumberland Bancorp (OTCPK: NUBC) announced on September 25, 2024 that they had signed a definitive agreement to combine in an all-stock merger of equals, with Northumberland merging into Mifflinburg and Northumberland's subsidiary, The Northumberland National Bank, merging into Mifflinburg Bank and Trust Company. In announcing the deal, Mifflinburg President and CEO Jeffrey Kapsar said, "This combination brings together two community-minded organizations that are unified by a shared vision, values, and a solid approach to the future of banking." Northumberland's then-CEO J. Todd Troxell added, "Two similar community banks, each in existence for more than a century, are coming together in a strategic merger of equals creating a greater expanded footprint in which to compete." The combination was described as the result of discussions between the two management teams dating back to May 2024, followed by a nonbinding letter of intent on July 10, 2024 and an exclusivity agreement entered July 11, 2024. The merger agreement was amended on December 4, 2024 solely to finalize the name of the combined bank as Central Penn Bank & Trust. Under the terms of the merger agreement, each Northumberland shareholder received a fixed exchange ratio of 1.1850 shares of Mifflinburg (later Steele Bancorp) common stock, plus cash in lieu of fractional shares, in a transaction structured as a tax-free reorganization. At signing, the deal was valued at approximately $34.2 million based on Mifflinburg's September 23, 2024 closing stock price, and Northumberland shareholders were expected to own approximately 46% of the combined company. In its fairness opinion analysis for the Northumberland board, financial advisor J. Alden Associates, Inc. calculated an implied transaction value of approximately $34.12 million, or $26.01 per Northumberland share (based on Mifflinburg's September 20, 2024 closing price of $21.95), equal to 71.1% of Northumberland's tangible book value, 17.2 times Northumberland's last-twelve-months earnings, 22.1 times Northumberland's estimated 2025 earnings per share, a core deposit premium of negative 3.00%, and a 24.5% premium to Northumberland's then-current trading price. A relative contribution analysis as of June 30, 2024 showed Northumberland contributing 54.9% of combined total assets, 56.1% of combined deposits, 46.8% of combined tangible common equity, and only 21.4% of combined net income, against Mifflinburg's 78.6% net income contribution, versus the agreed 1.185x exchange ratio. The combined company's board of directors consists of six members from each legacy company. J. Donald Steele, Jr., formerly Northumberland's chairman, became chairman of the combined Steele Bancorp and Central Penn Bank & Trust; Mifflinburg's Richard J. Drzewiecki became vice chairman; Jeffrey Kapsar continued as President and CEO; and Troxell became Senior Executive Vice President, Chief Administrative Officer of the bank and Corporate Secretary of the holding company. At signing, the combined company was projected to have approximately $1.3 billion in total assets, $1.1 billion in total deposits, $850 million in total loans and $93 million of combined shareholders' equity based on year-end 2023 financials. Mifflinburg's board, in approving the deal, considered pro forma projections assuming closing on April 11, 2025 and 50% realization of estimated cost savings in 2025: projected combined net income of approximately $11.5 million in 2025, earnings-per-share accretion to Mifflinburg shareholders of approximately 7.0% in 2025 and 56.3% in 2026, a 2026 return on assets of 1.24% and return on average equity of 15.83%, tangible book value dilution earnback in approximately 2.75 years, and an increase in the combined bank's pro forma Tier 1 leverage ratio from 7.59% at closing to more than 8.0% by the end of 2026. The S-4 pro forma financial statements separately disclose that the combined company expects to realize cost savings approximating 14% of the combined companies' anticipated non-interest expense base, though these savings are excluded from the pro forma financial statements themselves. The merger agreement provided for a termination fee of $1,400,000 payable by either party under specified circumstances, including a competing acquisition proposal. The background-of-the-merger narrative in the S-4 describes only bilateral negotiations between Mifflinburg and Northumberland; Alden's opinion states it "did not and was not asked to contact any other interested parties," indicating no other bidders were solicited or considered. The transaction received shareholder and regulatory approvals and closed on August 1, 2025. At closing, Mifflinburg changed its name to Steele Bancorp, Inc. (OTCID Pink: STLE) and Mifflinburg Bank and Trust Company was renamed Central Penn Bank & Trust. Northumberland shareholders received an aggregate of approximately 1.55 million shares of Steele common stock plus cash for fractional shares. Following completion, the combined company reported total assets of approximately $1.34 billion, deposits of approximately $1.16 billion and loans of approximately $904 million, operating 13 banking offices across Centre, Northumberland, Snyder and Union counties, Pennsylvania. On the financial advisory side, J. Alden Associates, Inc. (Alden Investment Group) served as exclusive financial advisor to Northumberland and delivered a fairness opinion dated September 23, 2024 to Northumberland's board that the conversion ratio was fair, from a financial point of view, to Northumberland shareholders. The Kafafian Group, Inc. served as financial advisor to Mifflinburg and also delivered a written fairness opinion to Mifflinburg's board that the merger consideration was fair to Mifflinburg shareholders from a financial point of view, a detail confirmed in the merger agreement's representations that is not disclosed in the previously available source summary. Legal counsel to Northumberland was Mette, Evans & Woodside; legal counsel to Mifflinburg was Stevens & Lee.

Array Digital Infrastructure, Inc. (then trading as NYSE: USM, formerly United States Cellular Corporation) and its majority owner Telephone and Data Systems, Inc. (TDS) announced the successful closing of the divestiture of UScellular's wireless operations and select spectrum assets to T-Mobile US, Inc. Total consideration received at closing was $4.3 billion after adjustments, comprising $2.6 billion in cash proceeds and approximately $1.7 billion in debt assumed by T-Mobile through an exchange offer to UScellular's debtholders. The deal is in the telecommunications sector (SIC 4812). This entry is sourced from an 8-K exhibit (Exhibit 99.2) filed jointly in connection with Array/UScellular and TDS filings, dated August 1, 2025, the day of closing. In connection with the closing, Douglas W. Chambers, previously UScellular's CFO and Treasurer, was named interim President and CEO of the surviving company, which changed its NYSE ticker from USM to AD effective August 12, 2025. Array retained approximately 4,400 owned towers, noncontrolling investment interests, and spectrum holdings, which the release describes as the fifth largest tower business in the United States. As part of the deal, T-Mobile entered into a 15-year Master License Agreement to be a long-term tenant on a minimum of 2,015 incremental towers owned by Array, extending lease terms for roughly 600 towers where T-Mobile was already a tenant. On financial advisory, Citigroup Global Markets Inc. served as lead financial advisor, and Centerview Partners LLC served as financial advisor, to TDS; TD Securities (USA) LLC and Wells Fargo also served as financial advisors to TDS. PJT Partners LP served as financial advisor to the independent directors of UScellular. On legal advisory, Sidley Austin LLP served as lead legal advisor to TDS, Cravath, Swaine & Moore LLP served as legal advisor to UScellular's independent directors, and Clifford Chance LLP and Wilkinson Barker Knauer, LLP served as legal regulatory advisors to both UScellular and TDS. What is not disclosed: the release notes the $4.3 billion total consideration is subject to final adjustment approximately 180 days after closing, so the figure recorded is subject to post-closing true-up; the release also does not break out advisor fees or specify how the retained spectrum (separately sold later to AT&T, Verizon, and T-Mobile in follow-on transactions) was valued within this initial divestiture.

This transaction is a cash and stock acquisition in which Palo Alto Networks Inc (ticker PANW), a tech sector company, is acquiring CyberArk. The deal is classified under the M&A product group and carries a disclosed value of $25,000,000,000. The transaction is currently in pending regulatory status. This summary is sourced from an SEC EDGAR Form 6-K filed and published on July 30, 2025. On the financial advisory side, J.P. Morgan Securities LLC is acting as financial advisor to Palo Alto Networks, the acquirer, in a lead role. Qatalyst Partners is acting as financial advisor to CyberArk, the target, also in a lead capacity. Legal and regulatory counsel involved multiple firms on each side. For Palo Alto Networks, Wachtell, Lipton, Rosen & Katz is acting as legal counsel, with Arnold & Porter Kaye Scholer LLP acting separately as regulatory counsel. For CyberArk, Latham & Watkins LLP and Meitar Law Offices are both acting as legal counsel, the latter likely reflecting CyberArk's Israeli nexus. Beyond confirming the transaction is structured as a cash and stock acquisition with a disclosed aggregate value of $25,000,000,000, the facts block does not specify the precise cash-to-stock ratio, the exchange ratio for the stock component, or any other deal-specific structural terms. Several material facts are not disclosed in the available record. No expected closing date is given. The specific split between cash and stock consideration is not disclosed beyond the general subtype characterization. No detail is provided on what regulatory approvals remain outstanding, notable given that Arnold & Porter Kaye Scholer LLP's role is specifically regulatory counsel, suggesting antitrust or other regulatory review is a live consideration.

BIG 5 SPORTING GOODS Corporation (Nasdaq: BGFV), a western United States sporting goods retailer in the consumer-retail sector, agreed on June 29, 2025 to be acquired by a partnership comprised of Worldwide Golf and Capitol Hill Group, structured through Worldwide Sports Group Holdings LLC (Parent) and its merger subsidiary WSG Merger LLC, with Worldwide Golf Group LLC acting as guarantor. The transaction was announced via a joint press release and a Form 8-K filed June 30, 2025, and the merger closed on October 2, 2025, after which Big 5 common stock was delisted from Nasdaq and the company became a private, wholly owned subsidiary of Parent. Under the merger agreement, each share of Big 5 common stock was converted into the right to receive $1.45 per share in cash, a price the company said represented a premium of approximately 36 percent to Big 5's 60-day volume-weighted average price at the time of announcement. Big 5 described the deal as valued at approximately $112.7 million in enterprise value, which included the assumption of approximately $71.4 million in credit line borrowings outstanding as of June 29, 2025. Outstanding stock options, restricted stock units and restricted shares were cashed out based on the same $1.45 per share Merger Consideration (net of exercise price, where applicable). Moelis & Company LLC's financial analysis, disclosed in the definitive merger proxy, included a discounted cash flow analysis using a 17.00 percent to 21.00 percent discount rate range and terminal EBITDA multiples of 4.0x to 6.0x, which implied a standalone value deficit of negative $4.04 to negative $3.69 per share for Big 5 common stock, compared with the $1.45 per share Merger Consideration; Moelis also reviewed trading multiples of selected sporting goods and micro-cap specialty retailers (medians of roughly 4.8x and 5.9x TEV/NTM EBITDA, respectively) against Big 5's own trading multiples (around 4.5x to 5.7x over various historical periods). Steven G. Miller, Big 5's Chairman, President and Chief Executive Officer, said the transaction "marks an exciting new chapter for Big 5 that allows the Company to carry on its legacy of serving customers with quality sporting goods at an exceptional value while maximizing value for our stockholders." Theodore Shin, Chief Executive Officer of Capitol Hill Group, said "We are thrilled to support the next stage of the company's evolution. Big 5 has built an impressive foundation as a leading bricks and mortar sporting goods retailer. We also admire the deep history and culture of the company, and look forward to carrying that forward into the future." The companies described the acquisition as combining Capitol Hill Group's financial resources with Worldwide Golf's specialty retail expertise to give Big 5 long-term capital and strategic support to re-energize growth, with Big 5 continuing to operate as an independent company within the Capitol Hill Group portfolio. In Big 5's second-quarter 2025 earnings release, Miller stated the company was "progressing toward an expected closing in the second half of 2025, subject to customary closing conditions and stockholder approval," calling the deal "a compelling opportunity to maximize value for our stockholders while positioning Big 5 for future success." The definitive merger proxy statement (DEFM14A, filed August 8, 2025) disclosed an extended, competitive process leading to the deal. Beginning in November 2024, an unsolicited bidder referred to as Party A proposed $2.14 per share, later reduced through multiple revisions (to $1.26 per share by April 2025, and raised again to $1.60 per share after signing with Worldwide) amid persistent questions about Party A's ability to provide committed debt financing. Separately, Worldwide (through Parent) first proposed $2.40 per share in February 2025, reduced it to $1.30 per share in April 2025 citing the company's rising indebtedness, and ultimately raised its best and final offer to $1.45 per share on April 15, 2025, conditioned on a 45-day exclusivity period. A private investment group referred to as Party D also submitted proposals implying values around $1.03 per share, and a private equity firm referred to as Party C was contacted but declined to engage. The Big 5 board's three-member Transaction Committee (Colleen Brown as chair, Van Honeycutt and Lily Chang) oversaw the process with Moelis & Company as financial advisor and Latham & Watkins LLP as legal counsel. Even after signing with Worldwide, Party A continued submitting proposals as high as $1.60 per share through August 2025, but the company stated that Party A's debt commitment papers carried significant and atypical conditionality and had, by their terms, previously expired, and the record reflects no completed superior proposal from Party A as of the date of the proxy. The merger agreement specified closing conditions including approval by Big 5 stockholders, absence of a material adverse effect, no injunctions prohibiting the merger, and the company's inventory equaling or exceeding an agreed inventory threshold requirement. The agreement set an End Date of November 26, 2025, after which either party could terminate if the merger had not closed. Big 5 could be required to pay Parent a termination fee of $2.0 million under specified circumstances, including a change in the board's recommendation or entry into a superior proposal; Parent would owe Big 5 a $3.0 million termination fee under specified circumstances, including an uncured material breach by Parent or Parent's failure to close when obligated. Moelis is to receive a transaction fee of $3.0 million upon closing, against which $250,000 in previously paid monthly fees may be credited. Big 5 stockholders approved the merger at a September 26, 2025 special meeting, with 12,160,662 shares voted for and 1,965,126 against the merger proposal (out of 14,285,424 shares present, representing about 62.33 percent of the 22,918,921 shares outstanding as of the August 7, 2025 record date). The merger closed October 2, 2025. At closing, Big 5 terminated and fully repaid its existing credit facility with Bank of America, N.A. using merger proceeds, without incurring early termination penalties. Moelis & Company LLC served as financial advisor to Big 5, and Latham & Watkins LLP served as legal advisor to Big 5. On the acquirer side, Skadden, Arps, Slate, Meagher & Flom LLP, Holland & Knight LLP, and Sklar Kirsh LLP served as legal advisors to Capitol Hill Group and its related entities. No financing source, lender identity, or specific debt terms for the acquirer's side of the transaction were disclosed in the filings reviewed, nor was a post-closing capital structure or pro forma ownership breakdown provided, consistent with this being a privately held buyer group rather than a public-company stock-for-stock combination.

Union Pacific Corporation (NYSE: UNP) and Norfolk Southern Corporation (NYSE: NSC) announced an agreement for Union Pacific to acquire Norfolk Southern in a stock-and-cash transaction described by the companies as creating "America's first transcontinental railroad." The deal implies a value for Norfolk Southern of $320 per share and an enterprise value of $85 billion, with the combined enterprise valued at over $250 billion. The transaction is in the railroad sector (SIC 4011). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Norfolk Southern Corporation with the SEC on July 29, 2025, announcing the signing of the merger agreement. A later Norfolk Southern 8-K filed November 6, 2025 confirms the deal remained pending at that time, noting the parties had filed a Form S-4 registration statement (declared effective September 30, 2025), mailed a joint proxy statement/prospectus to shareholders in October 2025, and faced several shareholder lawsuits alleging disclosure deficiencies, which the companies voluntarily addressed through supplemental disclosures without admitting any wrongdoing. The combined railroad is expected to connect over 50,000 route miles across 43 states and roughly 100 ports, and the companies were targeting a close by early 2027, subject to Surface Transportation Board review and approval, in addition to shareholder approval. On financial advisory, Morgan Stanley & Co. LLC and Wells Fargo served as financial advisors to Union Pacific, while BofA Securities served as exclusive financial advisor to Norfolk Southern. On legal advisory, Skadden, Arps, Slate, Meagher & Flom LLP served as legal advisor to Union Pacific on the acquisition, with Covington & Burling LLP providing regulatory legal advice; Wachtell, Lipton, Rosen & Katz served as legal advisor to Norfolk Southern, with Sidley Austin LLP providing regulatory legal advice. The deal structure disclosed: Norfolk Southern shareholders will receive 1.0 Union Pacific common share and $88.82 in cash for each Norfolk Southern share, with Union Pacific issuing approximately 225 million shares representing 27% ownership of the combined company on a fully diluted basis. The agreement includes a $2.5 billion reverse termination fee and is structured without a voting trust; the combined company expects annualized synergies of approximately $2.75 billion and more than $30 billion of potential value creation, with the combined entity headquartered in Omaha and Atlanta remaining a core location. What is not disclosed in the original announcement: the exact timeline for the Surface Transportation Board's regulatory review process beyond a planned application filing within six months, and the final resolution of the shareholder litigation and disclosure claims referenced in the November 2025 supplemental filing.

This deal is an initial public offering by Accelerant Holdings (ticker ARX), the issuer, a company in the financial institutions group (FIG) sector. The transaction is classified under the ECM (equity capital markets) product group, with a disclosed deal value of $723,684,192. The facts block is sourced from a single SEC filing: a 424B4 filed with SEC EDGAR and published on July 25, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, a large syndicate of underwriters is named for the issuer, Accelerant Holdings. Morgan Stanley and Goldman Sachs & Co. LLC are both designated as lead underwriters. The remaining underwriters, named without a lead designation, are BMO Capital Markets, RBC Capital Markets, Wells Fargo Securities, Piper Sandler, William Blair, Raymond James, TD Securities, Citizens Capital Markets, and FT Partners. The source sentence for these roles is simply the underwriter tombstone listing from the prospectus: "Morgan Stanley Goldman Sachs & Co. LLC BMO Capital Markets RBC Capital Markets Wells Fargo Securities Piper Sandler William Blair Raymond James TD Securities Citizens Capital Markets FT Partners." No legal advisors were identified in the facts block for this transaction. Beyond the disclosed IPO size of $723,684,192 and the identity of the underwriting syndicate, the facts block does not provide further detail on the offering's share price, number of shares offered, or use of proceeds. Several facts are not disclosed in the source material. The facts block does not state the IPO price per share or the number of shares sold, nor does it name any legal counsel to the issuer or the underwriters. It also does not specify an expected pricing or closing date beyond the publication date of the prospectus.

CNB Financial Corporation (Nasdaq: CCNE), parent company of CNB Bank, agreed to acquire ESSA Bancorp, Inc. (Nasdaq: ESSA), parent company of ESSA Bank & Trust, in an all-stock merger. The deal was announced on January 10, 2025, in a joint press release and investor presentation filed as exhibits to current reports on Form 8-K by both companies, following execution of an Agreement and Plan of Merger dated January 9, 2025. Under the agreement, ESSA merged with and into CNB, with CNB as the surviving entity, and ESSA Bank & Trust merged with and into CNB Bank immediately thereafter. The transaction closed after the close of business on July 23, 2025, as confirmed in closing-related Forms 8-K filed by both ESSA and CNB on July 24, 2025. Each outstanding share of ESSA common stock was converted into the right to receive 0.8547 of a share of CNB common stock, a fixed exchange ratio. Based on CNB's 10-day volume weighted average stock price of $24.69 as of January 8, 2025, the deal was valued at approximately $21.10 per ESSA share and approximately $214 million in aggregate merger consideration (deal value shown prior to an ESSA ESOP loan paydown). The transaction was structured as a tax-free reorganization for U.S. federal income tax purposes. At signing, CNB's investor presentation indicated pro forma ownership of approximately 72% for CNB shareholders and 28% for ESSA shareholders. The indicative price represented a price-to-tangible-book-value multiple of 0.99x (a pay-to-trade ratio of 96%) and a price-to-LTM GAAP earnings multiple of 12.2x on an ESSA standalone basis, 6.2x including cost savings, and 4.0x on a fully synergized earnings basis (ESSA GAAP 2024 net income plus fully phased-in cost savings, purchase accounting accretion and other merger-related adjustments), per CNB's investor presentation. CNB disclosed 2026E pre-tax cost savings of $20.5 million, equal to 40% of ESSA's projected noninterest expense on a bottoms-up basis, modeled at a 40% annual cost-save phase-in assumption. The presentation also modeled a 6.7% total loan mark (interest rate plus credit mark), with a 6.7% portfolio discount (primarily rate-related) accreted into earnings over six years, and balance sheet repositioning involving the sale or divestiture of approximately $200 million of loans and approximately $100 million of deposits. CNB estimated approximately $27.6 million of one-time pre-tax merger-related charges at closing. CNB projected the merger would be approximately 35% accretive to its 2026 diluted GAAP earnings per share, inclusive of fully phased-in cost synergies, and approximately 14% accretive on a cash diluted EPS basis. Tangible book value per share dilution to CNB at transaction close was projected at approximately 15% on a GAAP crossover basis (shown elsewhere in the presentation as roughly 3% on a different methodology), with an earnback period of approximately 3.3 years under the GAAP cross-over method and approximately 1.7 years under the static cash earnback method. CNB projected a pro forma 2026 return on average tangible common equity of approximately 16%, return on average assets of approximately 1.3%, and an efficiency ratio of approximately 56%. The pro forma balance sheet at close was projected to have a tangible common equity to tangible assets ratio of approximately 7.7%, a Common Equity Tier 1 capital ratio of approximately 10.7%, and a loan-to-deposit ratio of approximately 89%, with roughly 140 basis points of annual CET1 capital generation excluding asset growth. The combined company was expected to have approximately $8 billion in total assets (CNB's closing press release later cited consolidated assets in excess of $8.0 billion), $7 billion in total deposits, and $6 billion in total loans, with CNB Bank's branch count rising to 78 offices across Pennsylvania, Ohio, New York and Virginia, including ESSA's 20 community offices in the Lehigh Valley, Greater Pocono, Scranton/Wilkes-Barre and suburban Philadelphia areas. The combined Pennsylvania deposit franchise was expected to rank in the state's top 10, and CNB said the deal expanded its footprint into eastern Pennsylvania and the Greater Lehigh Valley without branch overlap. Michael D. Peduzzi, President and CEO of CNB, said: "We are excited to partner with ESSA which shares such a strong banking tradition with CNB. This combination aligns two high performing banks with an exceptional commitment to client-focused services for its customers and financial support to sustain the economic vitality of the communities in which they operate." ESSA President and CEO Gary S. Olson said: "CNB is a powerful partner for our bank that closely mirrors our culture and values, making the transaction a natural fit. CNB's multi-state, multi-brand business model fosters our entrepreneurial spirit, and continues our commitment and presence in eastern Pennsylvania." At closing, Peduzzi added that the merger would "catalyze greater achievement of our strategic asset and profitability growth objectives by embracing these vibrant markets in Northeastern Pennsylvania." Per the terms of the merger agreement, CNB and CNB Bank each appointed three new directors from ESSA: Gary S. Olson (ESSA's President and CEO), Robert C. Selig, Jr. (ESSA's Chairman), and Daniel J. Henning (an ESSA director). Olson also took on a role as strategic advisor to CNB's CEO, and CNB Bank formed an advisory board for the ESSA Bank division. Concurrently with signing, CNB entered into voting agreements with ESSA's directors and certain executive officers obligating them to vote their ESSA shares in favor of the merger, and ESSA entered into reciprocal voting agreements with CNB's directors and certain executive officers favoring the related share issuance. ESSA's definitive merger proxy statement (DEFM14A, filed March 7, 2025) describes a roughly two-year strategic review by ESSA's board before the CNB deal. ESSA's board had maintained a mergers and acquisitions committee and, through its financial advisor, held discussions with one regional bank holding company and six community bank holding companies. Five of those parties declined to proceed. In December 2022, ESSA entered a confidentiality agreement with an unnamed "Company A" that submitted a non-binding indication of interest in January 2023 valuing ESSA shares between $21.06 and $22.60 based on an all-stock exchange ratio; that value fell to between $17.41 and $18.69 amid the regional bank turmoil of early 2023, and discussions were discontinued in August 2023. In March 2024, an unnamed "Company B," a regional bank holding company, submitted a non-binding letter of intent valuing ESSA shares between $21.03 and $21.33 in an all-stock structure, but withdrew its indication of interest at the end of April 2024 to pursue a different acquisition. ESSA's financial advisor, PNC FIG Advisory, then contacted CNB CEO Michael Peduzzi in late July or early August 2024 to gauge interest, leading to direct discussions between Peduzzi and Olson, a mutual confidentiality agreement dated August 13, 2024, and CNB's engagement of Stephens Inc. as its financial advisor. The merger agreement provided for a termination fee of $8.8 million payable by ESSA to CNB under specified circumstances if the merger was not consummated. The deal was unanimously approved by both companies' boards of directors and was subject to approval by the shareholders of both ESSA and CNB as well as customary regulatory approvals; CNB's Form S-4 registration statement (filed February 20, 2025, amended March 3, 2025) served as the vehicle for the joint proxy statement/prospectus. The transaction was expected to close in the third quarter of 2025 and in fact closed on July 23, 2025, consistent with that timeline. On the financial advisory side, PNC FIG Advisory, part of PNC Capital Markets LLC, served as ESSA's exclusive financial advisor and rendered a fairness opinion to ESSA's board of directors. Stephens Inc. served as CNB's exclusive financial advisor, and Piper Sandler & Co rendered a fairness opinion to CNB's board. On the legal side, Luse Gorman, PC served as legal advisor to ESSA, and Hogan Lovells US LLP served as legal advisor to CNB. Upon closing, ESSA Bank & Trust began operating as "ESSA Bank, a division of CNB Bank" within its existing geographic footprint. Holders of ESSA restricted stock awards had their awards automatically vest and exchanged for the merger consideration, while ESSA's performance-based restricted stock units vested at the greater of target or actual performance achievement and were settled in cash, with fractional CNB shares paid out in cash in lieu of issuance, per ESSA's closing Form 8-K.

This transaction is a bank merger, described in the facts as completed in subtype, in which CNB Financial Corporation is acquiring ESSA Bancorp, Inc. The deal is classified within the financial institutions group sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form 8-K filing published on July 24, 2025. Despite the subtype description referencing a completed merger, the status field in the facts provided lists the deal as pending regulatory approval. On the financial advisory side, Piper Sandler & Co rendered a fairness opinion to CNB's board, serving as fairness opinion provider to the acquirer. Separately, Stephens Inc. served as CNB's exclusive financial advisor and is identified as the lead advisor on the acquirer side. On the target side, PNC FIG Advisory, part of PNC Capital Markets LLC, served as ESSA's exclusive financial advisor and rendered a fairness opinion to ESSA's board, and is identified as the lead advisor to ESSA. On the legal side, Luse Gorman, PC served as legal advisor to ESSA, the target, while Hogan Lovells US LLP served as legal advisor to CNB, the acquirer. Beyond confirming that this is a bank merger, no further detail on the specific consideration structure, such as a stock exchange ratio or cash component, is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no detail on the specific merger consideration or exchange ratio is provided. While the subtype notation references the merger as completed, no explicit closing date is given in the facts available, and the status field itself still reflects pending regulatory approval.

ESSA Bancorp, Inc., a financial services sector company, is the target in a merger transaction within the mergers and acquisitions product group. The acquirer is CNB, also operating in the financial services sector. The transaction is structured as a merger. No deal value has been disclosed in the source documents. This briefing is sourced from an SEC EDGAR filing published on July 24, 2025. The specific form type is not identified in the available source material. The transaction is currently pending regulatory approval. On the target side, PNC FIG Advisory, part of PNC Capital Markets LLC, has been retained as ESSA's exclusive financial advisor and has rendered a fairness opinion to ESSA's board of directors. On the acquirer side, two financial advisors have been engaged. Stephens Inc. is serving as CNB's exclusive financial advisor, and has also rendered a fairness opinion to CNB's board. Additionally, Piper Sandler & Co has rendered a separate fairness opinion to CNB's board. ESSA Bancorp is being represented by Luse Gorman, PC as legal counsel. CNB is being represented by Hogan Lovells US LLP as legal counsel. Beyond the engagement of financial and legal advisors, no material terms of the transaction structure have been disclosed. The consideration structure, whether comprised of cash, stock, or some combination, is not specified in the available source documents. No specific merger mechanics, such as the form of consideration or any earnout provisions, have been disclosed. The expected closing date of the transaction has not been provided. Several critical details remain unknown or undisclosed. The transaction value has not been stated. The form type of the SEC filing is not identified. No details regarding the structure of consideration or the ratio of any stock and cash components have been disclosed. An expected closing date has not been announced. These gaps should be clarified through additional filings or public announcements as the transaction progresses through its regulatory approval phase.

This transaction is a bank holding company merger in which ESSA Bancorp, Inc., a company in the financial institutions group (FIG) sector, is the target being acquired by CNB Financial Corporation. The deal is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 24, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Stephens Inc. served as CNB's exclusive financial advisor, the acquirer side, and is designated as lead advisor. Separately, Piper Sandler & Co rendered a fairness opinion to CNB's board, serving in a fairness-opinion-provider capacity on the acquirer side without a lead designation. On the target side, PNC FIG Advisory, part of PNC Capital Markets LLC, served as ESSA's exclusive financial advisor and rendered a fairness opinion to ESSA's board, also designated as lead advisor. Legal counsel was also disclosed for both sides. Hogan Lovells US LLP served as CNB's (the acquirer's) legal advisor. Luse Gorman, PC served as ESSA's (the target's) legal advisor. Beyond the characterization of the deal as a bank holding company merger, the facts block does not disclose further detail on consideration structure, such as whether the merger consideration is cash, stock, or a combination. Several facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not specify the consideration structure (cash, stock, or mixed) for ESSA shareholders, nor does it give an expected closing date.

This record concerns Anebulo Pharmaceuticals, Inc. (ticker ANEB), a healthcare-sector company, acting as both target and issuer in a going-private transaction structured as a reverse stock split. The deal falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an SC 13E3 filing with the SEC via EDGAR, published July 23, 2025. The deal's status is pending regulatory, indicating the going-private process had not yet concluded as of that filing. Only one financial advisor is disclosed: Houlihan Capital, LLC, which served as financial advisor and fairness opinion provider to the company and is designated lead. The source sentence notes that the fairness opinion of Houlihan Capital, LLC, dated July 15, 2025, was made available for inspection and copying at the company's principal executive offices, indicating the opinion addressed the fairness of the reverse stock split transaction to affected stockholders. The only legal advisor disclosed is Blank Rome LLP, serving as counsel to the company. The source sentence is a notice/copy line from the filing listing attorneys Leslie Marlow, Esq. and Melissa Palat Murawsky, Esq. of Blank Rome LLP as recipients of filing copies, indicating the firm's role as counsel in the matter. Beyond classifying the transaction as a going-private reverse stock split, the facts block does not specify the split ratio, the cash-out price for fractional shares, or other mechanical terms of the reverse split. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not specify the reverse stock split ratio or the treatment of stockholders who would be cashed out as a result of the split.

This deal is a cash acquisition in which SS&C Technologies Holdings Inc (ticker SSNC), a company in the tech sector, is acquiring Calastone as the target. The transaction is classified under the M&A product group, with a disclosed deal value of $1,030,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 21, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Barclays served as exclusive financial advisor to Calastone, the target, and is designated as lead advisor in that role. No financial advisor is disclosed for SS&C, the acquirer, in the facts block. Legal counsel, however, was disclosed for both sides. On the target side, both Linklaters and Mishcon De Reya served as legal advisors to Calastone in connection with the transaction. On the acquirer side, SS&C was advised by Davis Polk & Wardwell LLP. Beyond the cash consideration structure implied by the "cash acquisition" subtype and the disclosed $1,030,000,000 value, the facts block provides no further detail on payment mechanics or other specific terms. A number of facts are not disclosed in the source material. No financial advisor is named for SS&C, the acquirer, despite legal counsel being identified for that side. The facts block also does not disclose an expected closing date, and it provides no further breakdown of the cash consideration beyond the aggregate deal value of $1,030,000,000.

This transaction concerns Par Pacific Holdings, Inc. (ticker PARR), a natural-resources sector company, forming a joint venture through a minority equity sale. The deal falls under the M&A product group and carries a disclosed value of $100,000,000. It is currently in pending regulatory status. The facts in this briefing come from an SEC EDGAR Form 8-K filed and published on July 21, 2025. No other source documents are listed in the available record for this transaction. On the financial advisory side, the facts block identifies only one advisor: Lazard served as financial advisor to Par Pacific on this transaction, functioning as the issuer's advisor. No lead or non-lead designation is specified for Lazard's role, and no additional financial advisors are named for any counterparty. No legal advisors are listed in the facts block for this transaction, for either Par Pacific or any other party involved. Beyond identifying the transaction as a joint venture formation involving a minority equity sale with a disclosed value of $100,000,000, the facts block provides no further structural detail, such as the specific equity percentage being sold or governance terms of the joint venture. A significant number of details remain undisclosed. No expected closing date is given. No legal advisors are named for any party. The facts block does not specify the counterparties in the joint venture beyond the issuer itself, nor does it detail what regulatory approvals are pending.

Asbury Automotive Group Inc., a consumer-retail company trading under the ticker ABG, is acquiring an undisclosed target in an all-cash or mixed-consideration merger transaction valued at 1.45 billion dollars. This is a merger and acquisition engagement within the consumer-retail sector. The transaction remains pending regulatory approval as of the most recent available information. The information regarding this deal is sourced from an SEC filing published on July 21, 2025. The specific form type of the SEC filing has not been disclosed in the available materials. The deal is currently in pending regulatory status, meaning it has not yet closed and remains subject to regulatory review and clearance. On the acquirer side, Asbury has assembled a substantial advisory team. Wells Fargo served as the lead arranger for the syndicated mortgage facility supporting the transaction. BofA Securities acts as financial advisor to Asbury. Baker Tilly is serving as the transaction advisory firm to Asbury. Legal counsel to Asbury is provided by two firms: Jones Day and Hill Ward Henderson. On the target side, Stephens Inc. is serving as financial advisor. Legal representation for the target is being provided by Simpson Thacher and WilmerHale. No additional deal structure or financing term details have been disclosed beyond the fact that a syndicated mortgage facility is being arranged by Wells Fargo to support the acquisition. Several material facts remain unknown or undisclosed at this stage. The identity of the target company has not been disclosed. The consideration structure, payment timing, and any conditions precedent to closing have not been specified. The expected closing date or timeline for regulatory approval has not been provided. The specific form type of the SEC filing, such as whether this is a Form 8-K, Form S-4, or other disclosure document, remains unknown. No information has been disclosed regarding earnouts, seller financing, or any other variable or contingent components of consideration.

Wag! Group Co., a business-services company, is the target in a Chapter 11 pre-packaged plan of reorganization and recapitalization transaction. The acquirer in this restructuring is Retriever. This is a restructuring product engagement, specifically structured as a pre-packaged plan, which represents a subset of Chapter 11 bankruptcy proceedings in which a debtor company develops and seeks approval for its reorganization plan prior to filing for bankruptcy protection. No transaction value has been disclosed in the source documentation. This transaction is sourced from an SEC EDGAR filing of unknown form type, published on July 21, 2025. The deal's current status is pending regulatory approval or closure, meaning the Chapter 11 plan has been filed or is in the process of being confirmed but has not yet reached final consummation. On the Wag! side, the company is represented by a multi-disciplinary advisory team. Young Conaway Stargatt & Taylor, LLP serves as restructuring counsel, Latham & Watkins LLP acts as corporate counsel, and Portage Point Partners functions as restructuring advisor. Retriever, the acquiring entity, is represented by two legal counsel firms: The Tuhey Law Firm LLC and Honigman LLP. None of the advisors have been designated as lead or non-lead in the source documentation; instead, each firm's specific functional role has been explicitly stated in the filing materials. The legal advisor breakdown mirrors the financial advisory structure, with Young Conaway Stargatt & Taylor, LLP and Latham & Watkins LLP serving as legal counsel to Wag!, while The Tuhey Law Firm LLC and Honigman LLP serve as legal counsel to Retriever. These designations reflect the specialized requirements of restructuring work, in which separate counsel handle different aspects of the transaction, including bankruptcy law, corporate law, and operational restructuring matters. Regarding deal structure and terms, the transaction is structured as a pre-packaged Chapter 11 plan of reorganization and recapitalization. However, the source documentation does not disclose specific terms such as the consideration mix, equity or debt allocation post-reorganization, asset recovery percentages, or any other detailed structural provisions that would typically be included in a plan of reorganization. Similarly, no information is provided regarding the claims involved, creditor treatment, or the identity of the post-reorganization sponsor or controlling stakeholder. Several material details remain undisclosed or unknown. No transaction value has been stated. The specific expected closing or plan confirmation date is not provided. The detailed terms of reorganization, including how creditors will be treated and what equity structure will emerge from the Chapter 11 process, have not been disclosed in the source filing. Additionally, the exact nature of Retriever's role (whether as acquirer of assets, merger partner, or plan sponsor) is not explicitly clarified in the available documentation.

Artelo Biosciences, Inc., a healthcare sector company trading under ticker ARTL on the Nasdaq Capital Market, entered into an At-The-Market Offering Agreement on July 18, 2025 with R.F. Lafferty & Co., Inc. as exclusive sales agent, under which the company may sell up to an aggregate of $6,500,000 of shares of its common stock, par value $0.001 per share, from time to time at prevailing market prices. The agreement and the related prospectus supplement (Form 424B5) were both filed with the SEC on July 18, 2025, the same day the 8-K announcing the agreement was filed. Under the terms of the sales agreement, Lafferty is entitled to a commission of 2.0% of the gross sales price per share sold, and is deemed an underwriter within the meaning of the Securities Act in connection with those sales, with its compensation treated as underwriting commissions or discounts. Lafferty is not required to sell any specific number or dollar amount of shares and acts on a best-efforts basis. The prospectus supplement notes that, as of the pricing date, the last reported sale price of Artelo common stock on Nasdaq was $15.67 per share (July 17, 2025 close), which was used as an assumed offering price solely for illustrative purposes in the filing's dilution and share-count disclosures; the filing does not state that any shares were actually sold at that price. The prospectus supplement's illustrative dilution table shows that, as of March 31, 2025, Artelo's historical net tangible book value was approximately $(1.4) million, or $(2.44) per share, based on 567,582 shares then outstanding. Assuming the full $6.5 million were sold at $15.67 per share (yielding approximately $6.2 million in estimated net proceeds after commissions and offering expenses), the filing illustrates a pro forma as-adjusted net tangible book value of $4.87 per share, an increase of $7.31 per share for existing stockholders, and dilution of $10.80 per share to new investors at that assumed price. These figures are explicitly labeled illustrative, and the filing states actual results would vary with the real offering price and timing of sales. On use of proceeds, Artelo stated it intends to use net proceeds from the ATM program to advance its product candidates through preclinical and clinical development, including manufacturing, research and technical development, clinical studies, and capital expenditures, as well as for working capital and general corporate purposes. The company also disclosed it may use proceeds for investments in complementary products or technologies, though it had no present commitments or agreements for any such investments as of the filing date. No debt repayment or acquisition-specific use of proceeds was disclosed. R.F. Lafferty & Co., Inc. serves as the sole sales agent to the issuer under the ATM program. Fennemore Craig, P.C. of Reno, Nevada, serves as legal counsel to Artelo and passed on the validity of the shares offered. Ellenoff Grossman & Schole LLP of New York, New York, is disclosed in the prospectus supplement as counsel to Lafferty in connection with the offering. Subsequent SEC filings show modest actual utilization of this ATM program. According to Artelo's Form 10-Q for the quarter ended September 30, 2025, and its Form 10-K for the year ended December 31, 2025, a total of 50,858 shares of common stock were sold under the Sales Agreement during the third quarter of 2025, generating net proceeds of $442,000, all of which occurred during that single quarter (the 10-K's full-year figure for 2025 matches the Q3 figure, indicating no further sales under this particular agreement in the fourth quarter). This represents roughly 6.8% of the $6.5 million maximum authorized under the program. No prospectus supplement, pricing 8-K, or other filing specifies the actual per-share prices at which the 50,858 shares were sold, the gross (as opposed to net) proceeds from those sales, or the specific dates within the third quarter when the sales occurred. There is no free-writing prospectus or formal underwriting agreement associated with this ATM program, consistent with its structure as an agency-basis at-the-market offering rather than a firm-commitment underwritten deal. Artelo separately entered into an underwritten offering with R.F. Lafferty as sole book-running manager in September 2025, but that was a distinct transaction executed under a separate underwriting agreement and is not part of this $6.5 million ATM program. The ATM program itself has not been reported as formally terminated or fully utilized in any filing reviewed.

Solaris Energy Infrastructure, Inc., a technology sector company trading under ticker SEI, is the acquirer in a strategic investment and business partnership transaction valued at 527 million U.S. dollars. The target company is identified as Stratos. This transaction falls within the mergers and acquisitions product group and is classified as a strategic investment and business partnership subtype rather than a traditional acquisition or merger. The transaction details are sourced from an SEC filing published on the EDGAR system on July 18, 2025. The specific form type is not disclosed in the available information. As of the sourcing date, the transaction remains pending regulatory approval, indicating that it has not yet closed and continues to move through the regulatory review process. Wells Fargo served as financial advisor to Solaris Energy Infrastructure and held a lead advisory role on the acquirer side. On the target company side, Goldman Sachs & Co. LLC acted as financial advisor to Stratos, also in a lead capacity. Both financial advisors were instrumental in structuring and advising on the terms of this transaction. Holland & Knight served as legal counsel to Solaris Energy Infrastructure on the acquirer side, while Alston & Bird LLP provided legal counsel to Stratos, the target company. Both legal advisors guided their respective clients through the transaction documentation and regulatory process. The disclosed transaction value is 527 million U.S. dollars. Beyond this aggregate price, no information regarding the consideration structure, mix of cash or equity components, payment timing, or earn-out provisions has been disclosed. The transaction is structured as a strategic investment and business partnership, though the specific mechanics of how this partnership will be implemented and what operational or ownership arrangements will result remain undescribed. Several material details remain either undisclosed or unknown based on the available filing information. No expected closing date has been provided. The consideration structure, including whether payment will be made entirely in cash, entirely in equity, or through some combination, is not specified. The exact form type of the SEC filing is not identified. Additionally, no information is available regarding deal conditions, termination provisions, representations and warranties, indemnification terms, or the nature and scope of the operational partnership itself.

This is an acquisition of a net lease platform in the real-estate sector, in which Starwood Property Trust, Inc. (ticker STWD) is acquiring Fundamental Income Properties, LLC. The product group is M&A, and the disclosed transaction value is $2,200,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on July 16, 2025. The deal's current status is pending regulatory review. Financial advisory roles are disclosed for both sides. On the target side, Wells Fargo and Evercore are both serving as financial advisors to Brookfield Asset Management, the entity identified in the source material in connection with the target, per the statement "Wells Fargo and Evercore are serving as financial advisors to Brookfield Asset Management." On the acquirer side, BofA Securities is serving as the lead, sole financial advisor to Starwood Property Trust, consistent with the language "BofA Securities is serving as sole financial advisor to Starwood Property Trust." No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as an acquisition of a net lease platform with a disclosed value of $2,200,000,000, no further detail on consideration structure, financing sources, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no legal advisors to either side are identified, no detail on consideration structure (cash, stock, or a mix) is provided, and no expected closing date is given beyond the pending-regulatory status.

Portman Ridge Finance Corporation, ticker PTMN, a business development company externally managed by Sierra Crest Investment Management LLC, agreed to acquire Logan Ridge Finance Corporation, ticker LRFC, a business development company externally managed by Mount Logan Management LLC, in an all-stock merger. Both companies are affiliates of the BC Partners Credit platform. The transaction was structured as a two-step merger: Portman Ridge Merger Sub, Inc., a wholly-owned subsidiary of PTMN, merged into LRFC (with LRFC surviving as a PTMN subsidiary), immediately followed by LRFC merging into PTMN, with PTMN as the surviving company. The Agreement and Plan of Merger was signed on January 29, 2025 and disclosed in an 8-K filed February 4, 2025 with the merger agreement attached as Exhibit 2.1. Under the exchange ratio, each share of LRFC common stock was converted into the right to receive 1.500 newly issued shares of PTMN common stock, with cash paid in lieu of fractional shares. Based on share counts as of December 31, 2024, PTMN expected to issue approximately 3,983,847 (approximately 4.0 million) shares to LRFC stockholders, resulting in pro forma ownership of approximately 69.8 percent for existing PTMN stockholders and approximately 30.2 percent for existing LRFC stockholders. As of December 31, 2024, PTMN reported actual net asset value of $19.41 per share and LRFC reported $32.04 per share; on a pro forma basis, after giving effect to approximately $5.3 million of combined estimated transaction expenses and a $1.2 million tax dividend paid by LRFC, the surviving company's pro forma NAV per share was calculated at $19.52 (or $20.00 per share excluding those transaction costs and the tax dividend). The joint proxy statement/prospectus (Form 424(b)(3), filed May 13, 2025) does not disclose an aggregate dollar deal value, equity value, or enterprise value, and no EV/EBITDA, P/E or P/TBV multiple was disclosed; because both parties are BDCs regulated under the Investment Company Act of 1940, valuation was negotiated on a relative-contribution and net-investment-income accretion basis rather than a conventional operating-company multiple. Prior to closing, LRFC was required to pay its stockholders one or more tax distributions to maintain its regulated investment company qualification, estimated at no less than $1.0 million (approximately $0.38 per share, ultimately declared at $0.38 per share on July 14, 2025). Separately, on June 17, 2025, LRFC announced that its investment adviser, Mount Logan Management LLC, agreed to finance an additional, incremental pre-closing cash payment of $0.47 per share to LRFC shareholders of record as of May 6, 2025, contingent on the closing of the merger. LRFC stated that this adviser-funded payment, combined with the $0.38 per share tax distribution and the 1.5x PTMN share exchange ratio, was designed to deliver LRFC shareholders the equivalent of 100 percent of Logan Ridge's net asset value as of March 31, 2025, adjusted for estimated transaction costs. The joint proxy statement describes the strategic rationale considered by each company's special committee, including increased scale, enhanced portfolio diversification, lower pro forma operating expenses, acquisition of a known portfolio with significant overlap, expected accretion to net investment income per share through operational cost synergies, and potential for additional equity research coverage from a larger combined market capitalization. No specific dollar synergy figure, percentage of cost base, or phase-in timeline for cost savings was disclosed in the filings reviewed. During negotiations, Houlihan Lokey (advising the LRFC Special Committee) and Keefe, Bruyette & Woods (advising the PTMN Special Committee) discussed allocating the value of projected net-investment-income synergies between the two companies' stockholders, with the LRFC Special Committee seeking an exchange ratio that would give LRFC stockholders 35-40 percent of the expected merger benefits, while KBW's analysis for PTMN initially favored an implied exchange ratio of 1.58x-1.59x based on PTMN retaining 60 percent of the benefit; the parties ultimately agreed on a 1.500x exchange ratio. The proxy statement's background section describes that the boards of both companies had periodically discussed a potential LRFC/PTMN combination since at least March 2022, when Simpson Thacher & Bartlett LLP (on behalf of BC Partners) sought informal SEC staff guidance on structuring the deal to comply with Rule 17a-8 of the Investment Company Act of 1940, including the use of special committees and a special termination right tied to stockholder dilution; no third-party or competing bidders are described as having been considered. The merger agreement did not disclose a termination fee payable by either party; the agreement specifies that, apart from fee-splitting arrangements described under the termination provisions, each party generally bears its own transaction expenses. The agreement contained a customary "fiduciary out" allowing either special committee to change its recommendation or terminate in favor of a superior proposal, as well as a special committee termination right tied to potential stockholder dilution under Rule 17a-8. Closing was conditioned on, among other things, stockholder approval by both companies, effectiveness of a Form N-14 registration statement, Nasdaq listing authorization for the new PTMN shares, required regulatory approvals, and the new PTMN shares being sold at a price at or above net asset value per share. LRFC shareholders approved the merger at a special meeting held June 20, 2025, with approximately 89.4 percent of voting shareholders in favor; PTMN's special meeting, originally held the same day, was adjourned and reconvened on June 27, 2025 to allow more time for PTMN shareholders to vote on the related share issuance proposal. The merger closed on July 15, 2025, with LRFC merging into PTMN and PTMN continuing as the surviving company. Based on July 11, 2025 financial data, the combined company reported total assets in excess of $600 million. Following the closing, Portman Ridge announced it would rebrand as BCP Investment Corporation and begin trading under the new ticker symbol BCIC, transition its quarterly base distribution to a monthly payment schedule beginning in 2026 while retaining the potential for quarterly supplemental distributions (approximating 50 percent of incremental net investment income above the base), and that the company, its management, its adviser and affiliates intended to purchase up to 20 percent of the company's outstanding common stock over the following 24 months if shares continued trading below 80 percent of NAV. CEO Ted Goldthorpe said at closing, "we look forward to rebranding PTMN as BCP Investment Corporation later this summer, which will better reflect our affiliation with the broader BC Partners Credit Platform," and that the combined company would "leverage the combined company's enhanced scale, further diversified portfolio, cost savings due to lower overall operating expenses, and improved stock trading liquidity to deliver compelling risk-adjusted returns." On the financial advisory side, Houlihan Lokey served as lead financial advisor to the Special Committee of LRFC, and Keefe, Bruyette & Woods, A Stifel Company, served as lead financial advisor to the Special Committee of PTMN. Each special committee received a fairness opinion, dated January 29, 2025, as to the fairness of the 1.500x exchange ratio from a financial point of view. On the legal side, Simpson Thacher & Bartlett LLP served as counsel to PTMN (and BC Partners) with respect to the overall transaction, Dechert LLP served as counsel to LRFC, Skadden, Arps, Slate, Meagher & Flom LLP served as counsel to the Special Committee of LRFC, and Stradley Ronon Stevens & Young, LLP served as counsel to the Special Committee of PTMN.

MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, completed its acquisition of First IC Corporation (OTCEM: FIEB), the holding company for First IC Bank, after the close of business on December 1, 2025. The companies had signed a definitive Agreement and Plan of Reorganization on March 16, 2025, announced publicly on March 17, 2025, under which FIEB merged with and into MCBS, with MCBS as the surviving entity, followed immediately by the merger of First IC Bank into Metro City Bank. Both companies are based in Doraville, Georgia. Chong Chun, Chairman of First IC, said the companies "have been competitors and admirers of the MetroCity franchise for many years and combining our two organizations will create a stronger banking institution for our customers, employees and communities." Nack Paek, MetroCity's Chairman and CEO, said "We too have long competed with and admired the First IC franchise" and that "the combined bank will have the capacity to service our customers better, offer enhanced opportunities for our employees and continue offering excellent returns to our shareholders." At announcement, the transaction was valued at approximately $206 million in aggregate, consisting of 3,384,588 shares of MetroCity common stock and $111,965,213 in cash, or approximately 46% stock and 54% cash. Based on MetroCity's closing stock price of $27.78 on March 14, 2025, the implied purchase price was $22.71 per First IC share, equal to 0.3732 MCBS shares plus a cash component per FIEB share. At closing on December 1, 2025, each FIEB share was converted into 0.3729 MCBS shares plus $12.19 in cash (with cash paid in lieu of fractional shares), and FIEB shareholders received an aggregate of 3,384,381 MCBS shares and approximately $110.6 million in cash; MCBS had approximately 28,818,282 shares outstanding following issuance. At signing, MetroCity estimated pro forma ownership of approximately 88.4% MCBS and 11.6% former FIEB shareholders. First IC stock options were cashed out based on the excess of the per-share cash-equivalent consideration over the exercise price. MetroCity's March 2025 investor presentation disclosed pricing metrics based on its March 14, 2025 closing price: the deal priced at 146% of First IC's tangible book value, 8.3 times First IC's last-twelve-months earnings per share, and 8.9 times First IC's estimated 2025 earnings per share. First IC had approximately $1.2 billion in total assets, $975.6 million in deposits, $984.1 million in net loans and leases, $140.7 million in tangible equity, 0.31% nonperforming assets to total assets, and a 2.10% return on average assets as of December 31, 2024. The pro forma combined company was projected to have approximately $4.8 billion in total assets, $3.7 billion in deposits and $4.1 billion in net loans; upon closing, MetroCity reported approximately $4.8 billion in total assets, $4.0 billion in total loans and $3.6 billion in total deposits, with 30 full-service branches and two loan production offices across Alabama, California, Florida, Georgia, New Jersey, New York, Texas and Virginia. MetroCity disclosed anticipated pre-tax cost savings equal to 37% of First IC's non-interest expense base, phased in at 10% in 2025, 80% in 2026, and 100% thereafter. The company estimated transaction costs of $14.9 million net of tax, a gross credit mark of $12.7 million (1.2% of FIEB's gross loans, with 70%, or $9.6 million, allocated to non-PCD loans and accreted over four years), a CECL reserve for non-PCD loans of $8.9 million, a loan interest rate mark of $10.2 million (1.0% of anticipated gross loans, amortized over four years), elimination of $3.3 million of FIEB's accumulated other comprehensive income, and a core deposit intangible of $18.3 million amortized over 10 years using the sum-of-the-years-digits method. The reorganization agreement separately capped First IC's reimbursable transaction expense allowance at $12.5 million pre-tax, with any shortfall or overage adjusting the cash consideration or permitting a special dividend to FIEB shareholders. MetroCity projected the merger would deliver approximately 26% EPS accretion in the first full year (2026) on a fully phased-in cost-savings basis, with a tangible book value earnback period of approximately 2.4 years and an internal rate of return of approximately 24%. In an illustrative reconciliation using a 9/30/2025 close assumption, MetroCity modeled 2026 estimated pro forma net income of $101.3 million versus $70.8 million MCBS standalone, implying pro forma EPS of $3.48 versus $2.75 standalone, or $0.73 (26.4%) of accretion per share. The same presentation modeled estimated tangible book value dilution of $2.03 per share, or 11.3%, at close, with pro forma tangible book value per share of $15.89 versus $17.92 for MCBS standalone, reflecting $80.3 million of goodwill and core deposit intangibles created against $206.0 million of aggregate merger consideration. On the acquirer side, MetroCity Bankshares engaged Hillworth Bank Partners to serve as its financial advisor and render a fairness opinion to its board of directors, with Hunton Andrews Kurth LLP serving as MetroCity's legal counsel. On the target side, First IC retained Stephens Inc. as its financial advisor to render a fairness opinion to First IC's board, with Alston & Bird LLP serving as First IC's legal counsel. The transaction was structured as a stock-for-stock reorganization intended to qualify under Section 368(a) of the Internal Revenue Code, and MetroCity registered the stock consideration on a Form S-4 (File No. 333-287567) initially filed May 23, 2025, amended June 4, 2025, and declared effective June 6, 2025; MetroCity also filed a final prospectus on Form 424B3 on June 6, 2025. Closing conditions included approval by First IC's shareholders (obtained July 15, 2025), receipt of required regulatory approvals from the Federal Reserve, the FDIC, and the Georgia Department of Banking and Finance without a "Materially Burdensome Regulatory Condition" (received by July 15, 2025, as announced in a joint press release), effectiveness of the S-4, and Nasdaq listing of the shares to be issued. The reorganization agreement provided for a termination fee of $8,239,563 payable by First IC under specified circumstances, and included a stock-price-based collar protection: if MetroCity's average stock price fell below 80% of its pre-signing average and MCBS underperformed the KBW Regional Bank Index by more than 20%, First IC could seek to terminate unless MetroCity elected to increase the merger consideration up to a value of $76,331,936 for the stock component. The agreement would also have permitted termination if the merger was not consummated within one year of signing, subject to extension. The transaction closed on December 1, 2025, roughly on the timeline management originally guided to (fourth quarter 2025). Financial statements of the business acquired and pro forma financial information were to be filed by amendment to the closing Form 8-K within 71 days, consistent with Item 9.01 requirements; MetroCity filed such an amendment (Form 8-K/A) on February 12, 2026, including a pro forma financial statements exhibit.

This deal involves Huntington Bancshares Inc /MD/ (ticker HBAN), a financial-institutions-group (fig) sector company, as the acquirer of Veritex Holdings, Inc., in an all-stock merger. The transaction falls under the M&A product group, and its disclosed value is $1,900,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published July 14, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Multiple financial advisors are disclosed. On the acquirer side, Evercore and Commerce Street Capital, LLC are both serving as financial advisors to Huntington, per the source sentence naming both together, with no lead designation specified for either. On the target side, Keefe, Bruyette & Woods, a Stifel Company, is serving as financial advisor to Veritex, also without a specified lead designation. Legal advisors are disclosed for both sides: Wachtell, Lipton, Rosen & Katz is serving as legal advisor to the acquirer, Huntington, while Simpson Thacher & Bartlett LLP is serving as legal advisor to the target, Veritex. Beyond classifying the transaction as an all-stock merger valued at $1,900,000,000, the facts block does not specify the exchange ratio or the pro forma ownership split between Huntington and Veritex shareholders following the merger. Several facts are not disclosed in this record. No expected closing date is given. The facts block does not specify the exchange ratio for the stock merger, and it does not indicate lead-advisor status for either Evercore or Commerce Street Capital on the Huntington side, or for Keefe, Bruyette & Woods on the Veritex side.

This is a stock-for-stock merger structured as a reverse triangular merger in the energy-power sector, in which Zeo Energy Corp. (ticker ZEO) acquired Heliogen, Inc. The product group is M&A, and the disclosed transaction value is $10,000,000. Unlike most of the deals in this batch, this transaction has already closed. This record draws on an unusually large number of source documents: a form of unknown type published July 11, 2025; an 8-K published May 29, 2025; a document of unknown form published May 29, 2025; two separate 8-K filings with Exhibit 99.1, both published May 29, 2025; an 8-K/A with Exhibit 99.2, published August 12, 2025; an 8-K with Exhibit 2.1, published May 29, 2025; an 8-K published August 11, 2025; and another document of unknown form published May 29, 2025, all filed with the SEC via EDGAR. This volume of filings, spanning the signing in May 2025 through amendments in July and August 2025, reflects the multiple disclosure steps typical of a signed-to-closed merger process. The deal's current status is closed. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity (reflected across duplicate entries in the facts block). Pickering Energy Partners is acting as financial advisor to Heliogen, the target, per the statement "Pickering Energy Partners is acting as financial advisor and Cooley LLP is acting as legal counsel to Heliogen." On the acquirer side, Piper Sandler & Co. is acting as financial advisor to Zeo, consistent with the language "Piper Sandler & Co. is acting as financial advisor and Ellenoff Grossman & Schole LLP is acting as legal counsel to Zeo." Legal advisors are disclosed for both sides: Cooley LLP is acting as legal counsel to Heliogen, the target, while Ellenoff Grossman & Schole LLP is acting as legal counsel to Zeo, the acquirer. Beyond the classification of this transaction as a stock-for-stock, reverse triangular merger with a disclosed value of $10,000,000, no further detail on the specific exchange ratio or other consideration terms is included in the facts provided. The one notable gap in this record is the specific stock exchange ratio used in the merger, which is not given in the facts provided; otherwise, this record is comparatively well-documented, with the deal's closed status and a substantial set of source filings tracking the transaction from signing through closing.

Civista Bancshares, Inc. (NASDAQ: CIVB), parent of Civista Bank and headquartered in Sandusky, Ohio, agreed on July 10, 2025 to acquire The Farmers Savings Bank, a community bank headquartered in Spencer, Ohio, for aggregate consideration of approximately $70.4 million. The transaction was announced jointly with a concurrent underwritten public offering of Civista common shares and was disclosed in a Form 8-K filed July 11, 2025 that attached the Agreement and Plan of Merger (dated July 10, 2025), a joint press release, and related exhibits. Under the merger agreement, Farmers shareholders were to receive $34.925 million in cash and 1,434,491 Civista common shares in the aggregate for all outstanding Farmers shares, implying a consideration mix of approximately 50% cash and 50% stock, with a fixed exchange ratio for the stock portion and fixed cash-per-share for the cash portion. The implied aggregate deal value of $70.4 million was based on Civista's closing share price of $24.72 on July 9, 2025. Consideration was subject to adjustment if Farmers' adjusted shareholders' equity at closing was not equal to $56.0 million, with a dollar-for-dollar downward adjustment to cash consideration if equity came in lower, and (per negotiated merger-agreement terms) fifty cents of additional consideration for each dollar of closing equity above $56.0 million. According to the transaction investor presentation (filed as an exhibit to a Form 8-K/A on July 11, 2025), the deal was valued at 138% of Farmers' tangible book value as of March 31, 2025, and reflected a core deposit premium of 10.6%. Farmers reported total assets of $285 million, gross loans of $107 million, total securities of $161 million, total deposits of $233 million, and total equity of $51 million as of March 31, 2025, with a tangible common equity to tangible assets ratio of 17.9%, a 46% loan-to-deposit ratio, and nonperforming assets (ex-TDRs) of 0.52% of assets. Civista management described Farmers as having "pristine asset quality with $1.5 million in cumulative net loan recoveries over the last 10 years." The combined company was expected to have approximately $4.4 billion in total assets, $3.2 billion in net loans, and $3.5 billion in total deposits based on March 31, 2025 financial data, adding two branches and approximately $183 million in low-cost core deposits in Medina and Lorain Counties, Ohio. Civista disclosed that the acquisition was expected to be approximately 10% accretive to diluted earnings per share once anticipated cost savings were fully phased in (a separate investor presentation slide referenced "high single-digit" EPS accretion). Per the transaction presentation, cost savings were estimated at 30% of Farmers' non-interest expense base, with 75% phased in during 2026 and 100% realized thereafter. One-time, pre-tax transaction and integration expenses were estimated at $4.0 million. The deal involved a gross credit mark of $2.5 million and a loan interest rate mark of $6.0 million, and a core deposit intangible of 3.0% to be amortized over 10 years using the sum-of-years-digits method. Tangible book value dilution at closing was estimated at 4.9%, inclusive of both buyer and seller transaction costs and a CECL "day 2" provision, with an expected earnback period of approximately three years using the cross-over method. Pro forma tangible common equity to tangible assets was expected to be approximately 7.0%. CEO Dennis G. Shaffer said, "We are excited to welcome Farmers Savings Bank into the Civista family. This acquisition not only strengthens our presence in northeast Ohio but also reflects our shared commitment to community banking." Farmers CEO Tom Lee stated the partnership "marks an exciting new chapter for Farmers Savings Bank and the communities we serve" and that "Civista shares our deep commitment to personalized service and community values." Concurrent with the merger announcement, Civista priced an underwritten public offering of 3,294,120 common shares at $21.25 per share (base offering of approximately $70.0 million), with Piper Sandler & Co. acting as sole book-running manager and D.A. Davidson & Co., Hovde Group, LLC, Janney Montgomery Scott LLC, Keefe, Bruyette & Woods (A Stifel Company), and Stephens Inc. serving as co-managers. Net proceeds of approximately $65.5 million (or approximately $75.5 million if underwriters fully exercised their 30-day option) were earmarked for general corporate purposes, including organic growth and future strategic transactions. Piper Sandler & Co. acted as financial advisor to Civista in the merger, and Vorys, Sater, Seymour and Pease LLP served as Civista's legal counsel. Janney Montgomery Scott LLC, retained by Farmers' board on September 19, 2024, acted as Farmers' financial advisor and delivered a fairness opinion to the Farmers board on July 9, 2025 that the merger consideration was fair to Farmers' shareholders from a financial point of view. Dinsmore & Shohl LLP, engaged by Farmers on or about May 13, 2025, served as Farmers' legal counsel. Per the Form S-4 registration statement (filed September 10, 2025, amended September 26, 2025), Farmers had conducted preliminary, informal discussions with another potential acquirer during 2024, but that party withdrew from merger discussions on February 24, 2025 for reasons unrelated to Farmers' asset quality, earnings, or management. Janney then approached two other prospective partners, one of which was Civista (the other indicated it could not pursue a transaction at that time). Civista signed a confidentiality agreement on February 27, 2025 and submitted a non-binding indication of interest on March 28, 2025 valuing the deal at approximately $63.5 million (50% cash/50% stock). A revised indication of interest on April 25, 2025 raised the value to approximately $64.8 million (55% cash/45% stock), which Farmers executed on May 1, 2025. Negotiations over subsequent weeks, including an initial draft merger agreement circulated June 6, 2025, ultimately produced the final $70.4 million transaction signed July 10, 2025, with key shareholders of Farmers separately agreeing to deposit retention and share lock-up agreements, and to vote their shares in favor of the merger. The merger agreement provided for a termination fee of $2,500,000 payable by Farmers to Civista under specified circumstances, including termination in connection with a competing acquisition proposal, as the sole and exclusive remedy available to Civista (absent fraud or willful breach). The transaction closed on November 6, 2025, as confirmed in a Form 8-K filed that day disclosing consummation of the merger of Farmers with and into Civista Bank. At closing, each Farmers common share (500 shares outstanding) was converted into the right to receive $71,086.48 in cash and 2,868.98 Civista common shares, resulting in aggregate consideration of $35,543,239 in cash and approximately 1,434,491 Civista common shares. The closing press release stated the merger added two branches and approximately $236 million in low-cost deposits, with the combined organization having approximately $4.4 billion in total assets, $3.2 billion in net loans, and $3.5 billion in total deposits based on September 30, 2025 data. The system conversion was scheduled for the first quarter of 2026.

This deal is an all-cash acquisition in which TopBuild Corp is the acquirer of Progressive Roofing, with the target also associated with Bow River Capital per the advisor disclosures. No sector classification was provided in the facts block. The transaction is classified under the M&A product group, with a disclosed deal value of $810,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 8, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised the target: Guggenheim Securities and Citizens JMP Securities both acted as financial advisors to Bow River Capital and Progressive Roofing, with no lead designation specified between them. On the acquirer side, RBC acted as financial advisor to TopBuild, also without a lead designation noted. Legal counsel was also disclosed for both sides. Brownstein, Hyatt, Farber, Schrek acted as legal counsel to Bow River Capital and Progressive Roofing, the target side. Jones Day acted as legal counsel to TopBuild, the acquirer. Beyond the all-cash consideration structure implied by the subtype and the disclosed $810,000,000 value, the facts block does not provide further detail on payment mechanics or other specific terms of the acquisition. Several facts are not disclosed in the source material. No lead designation is specified among the financial advisors on either side. The facts block does not state a sector classification for the deal, nor does it provide an expected closing date or any further breakdown of the all-cash consideration beyond the aggregate value of $810,000,000.

This transaction is a bank merger in which Norwood Financial Corp (ticker NWFL) is acquiring PB Bankshares, Inc., with PB Bankshares identified as the target in the financial institutions group (FIG) sector. The deal falls under the M&A product group, and the disclosed transaction value is $54,900,000. The facts block cites three source documents from SEC EDGAR, all published on July 7, 2025: two filings of unspecified form type and one 8-K. The deal's current status is pending regulatory approval. On the financial advisory side, Stephens Inc. served as financial advisor to the target, PB Bankshares (referred to in the source sentence as "Presence"), and rendered a fairness opinion in that capacity; Stephens is identified as the lead advisor on the target side. On the acquirer side, Janney Montgomery Scott LLC served as financial advisor to Norwood Financial and likewise rendered a fairness opinion to Norwood's board, also designated as lead advisor. Legal counsel was also disclosed for both sides. Barley Snyder LLP served as legal counsel to the target (PB Bankshares/"Presence"). On the acquirer side, two firms were named as Norwood Financial's legal counsel: Jones Walker LLP, based in Washington, DC, and Meeks Butera & Israel PLLC. No further detail on the structure of the merger consideration, such as an exchange ratio or cash/stock mix, was provided in the facts block beyond the disclosed aggregate transaction value of $54,900,000. Several items are not disclosed in the source material. The facts block does not specify an expected closing date, nor does it break down the consideration structure (cash, stock, or a combination) beyond the aggregate value. No additional financial advisors beyond Stephens Inc. and Janney Montgomery Scott LLC were identified for either side.

ContextLogic Inc., a consumer-retail company, is the subject of a merger and acquisition transaction structured as a reorganization. The specific identity of the counterparty to this transaction, along with any disclosed deal value, has not been included in the available source material. This briefing is sourced from an SEC filing published on July 3, 2025, accessed through SEC EDGAR. The filing form type has not been identified in the available documentation. The transaction is currently pending regulatory approval, meaning it has not yet closed and remains subject to completion of required regulatory review and clearance. No financial advisors have been identified or extracted in connection with this transaction for either party. This absence may indicate that either no advisors were engaged, or their involvement was not disclosed in the available source documents. No legal advisors have been identified in the available source material for either side of the transaction. The specific structure and material terms of this reorganization have not been disclosed in the source documents reviewed. This includes the form and mix of consideration being offered, any special conditions or staged closing mechanics, and other transaction mechanics that would typically be detailed in merger documentation or proxy filings. Key information gaps remain across several critical dimensions of this deal. The acquiring party or reorganization counterparty is not identified in the source material. The transaction value is entirely undisclosed. No expected closing date or timetable for regulatory approval has been provided. The specific form of consideration, whether cash, stock, or a combination, is not stated. The precise nature of the regulatory approval required and the agencies or jurisdictions involved in that process have not been specified. The SEC filing form type itself could not be determined from the available documentation, which limits understanding of the disclosure context and what additional detail might be available in the full filing text.

Plumas Bancorp, a financial institution trading under the ticker PLBC, is acquiring an unnamed target in a bank merger transaction valued at $61.3 million in disclosed consideration. The transaction falls within the mergers and acquisitions product group and is classified as a bank merger subtype within the financial services sector. As of the sourcing date, the transaction is pending regulatory approval. The transaction is sourced from an SEC EDGAR filing of unknown form type, published on July 2, 2025. The deal remains in pending regulatory status, meaning it has not yet closed and is awaiting required regulatory clearances before completion can occur. On the financial advisory side, Raymond James & Associates, Inc. is serving as financial advisor to Plumas Bancorp in its capacity as acquirer, with lead advisory status. For the target, Performance Trust Capital Partners, LLC is serving as financial advisor and has delivered a fairness opinion to the target's board of directors, also in a lead advisory capacity. Legal counsel representation is as follows: Sheppard, Mullin, Richter & Hampton LLP is serving as legal counsel to Plumas Bancorp on the acquirer side, while Gary Steven Findley & Associates is serving as legal counsel to the target company, identified in the source materials as Cornerstone. The transaction is structured as an acquisition with a total disclosed value of $61.3 million USD. Beyond the aggregate consideration amount, no further detail regarding the consideration mix, payment mechanisms, or deal structure has been disclosed in the available source materials. A number of material facts remain either undisclosed or not yet known. The target company's full legal name does not appear in the sourced material, referred to only as Cornerstone. The specific consideration structure is not disclosed, including whether the $61.3 million represents an all-cash payment, stock consideration, assumed debt, or any combination thereof. No expected closing date or timing for regulatory approval has been provided. The SEC filing form type is unknown and therefore the specific regulatory filing that generated this deal information cannot be precisely identified. These gaps represent information that would typically be material to a complete understanding of the transaction but has not been made available in the sourced document.

This transaction is an asset manager acquisition in which BlackRock, Inc. (ticker BLK), a fig (financial institutions group) sector company, is acquiring HPS Investment Partners. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. This summary is sourced from an SEC EDGAR Form 8-K filed and published on July 1, 2025. The transaction's current status is pending regulatory review. Financial advisory roles on both sides involved multiple firms. For BlackRock, the acquirer, Perella Weinberg Partners LP served as lead financial advisor, while Morgan Stanley & Co. LLC also served as financial advisor in a supporting capacity. For HPS, the target, J.P. Morgan Securities LLC served as lead financial advisor, with Goldman Sachs & Co. LLC, BofA Securities, Inc., Deutsche Bank Securities Inc., BNP Paribas, and RBC Capital Markets acting as co-financial advisors in a non-lead capacity. Legal counsel also broke out by side. For BlackRock, Skadden, Arps, Slate, Meagher & Flom LLP and Clifford Chance LLP acted as legal counsel. For HPS, Fried, Frank, Harris, Shriver & Jacobson LLP served as legal counsel. Beyond identifying this as an acquisition of an asset manager, HPS Investment Partners, by another asset manager, BlackRock, the facts block does not provide detail on the consideration structure, whether cash, stock, or a combination was used, or any integration or governance terms associated with the transaction. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given. No detail on the consideration mix or structure is provided, and no information is given on what regulatory approvals remain pending.

This is a prepackaged Chapter 11 reorganization in the tech sector, with Wolfspeed, Inc. (ticker WOLF) as issuer. The product group is restructuring. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on July 1, 2025. The deal's current status is pending regulatory review. Two financial advisors are identified, both engaged by the company and both serving in a lead, investment-banker capacity. JP Morgan and Perella Weinberg Partners were both engaged as investment bankers, per the source sentence: "Consequently, in February 2025, the Company engaged JP Morgan ('JPM') and Perella Weinberg Partners, as investment bankers, and Latham, as counsel, to assist the Company in this process." This indicates the engagement of both banks dates to February 2025, ahead of the Chapter 11 filing itself. One legal advisor is identified: Latham & Watkins LLP, referred to in the source sentence simply as "Latham," serving as counsel to the issuer, per the same source sentence referenced above. Beyond the classification of this matter as a prepackaged Chapter 11 reorganization, with JP Morgan and Perella Weinberg Partners engaged as investment bankers since February 2025, no further detail on the specific reorganization terms, such as the treatment of existing debt or equity, is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the specific terms of the reorganization plan (such as recovery rates for creditors or equityholders) are not given, and no expected emergence or closing date is given beyond the pending-regulatory status.

This deal is a take-private cash acquisition in which Big 5 Sporting Goods Corp, a company in the consumer-retail sector, is the target being acquired by a partnership comprised of Worldwide Golf and Capitol Hill Group and its related entities. The transaction is classified under the sponsors-coverage product group, with a disclosed deal value of $112,700,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on June 30, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Moelis & Company LLC served as financial advisor to the target, referred to in the source material as "the Company" (Big 5 Sporting Goods), and is designated as lead advisor. No financial advisor is disclosed for the acquiring partnership in the facts block. Legal counsel was disclosed for both sides. On the target side, Latham & Watkins LLP served as legal advisor to the Company. On the acquirer side, three firms, Skadden, Arps, Slate, Meagher & Flom LLP, Holland & Knight LLP, and Sklar Kirsh LLP, served as legal advisors to Capitol Hill Group and its related entities. Beyond the cash consideration implied by the subtype and the disclosed $112,700,000 deal value, the facts block does not provide a per-share purchase price or other specific terms of the acquisition. Several facts are not disclosed in the source material. No financial advisor is named for the acquiring partnership, despite legal counsel being identified for that side. The facts block also does not give a per-share price, nor does it specify an expected closing date for the transaction.

This record concerns a SPAC business combination involving Kodiak Robotics, Inc. and Ares Acquisition Corporation II. The transaction falls under the M&A product group, specifically the SPAC business combination subtype, and its disclosed value is not stated in the source document. The facts are sourced from an S-4 filing with the SEC via EDGAR, published June 30, 2025. The deal's status is pending regulatory, indicating the business combination had not yet closed as of that filing. Only one financial advisor is disclosed: Lincoln International LLC, which is identified in the facts block as providing a fairness opinion on behalf of the sponsor side, and is designated lead. The source sentence is drawn from a consent letter, stating that Lincoln International LLC consented to references to its opinion in the registration statement under the caption "Summary of the Proxy Statement/Prospectus, Fairness Opinion of Lincoln International LLC," and is signed on behalf of Lincoln International LLC. No other financial advisors are named in the facts provided. No legal advisors are identified in the facts block for this transaction. Beyond identifying this as a SPAC business combination, the facts block does not provide detail on the trust account size, redemption terms, PIPE financing, or other structural elements typical of SPAC transactions. A substantial number of facts are not disclosed in this record. The transaction's dollar value is not stated. No legal advisors are named for either the SPAC or Kodiak Robotics. No expected closing date is given, and no detail on the combination's structure beyond "SPAC business combination" is provided.

Brightstar Capital Partners, a middle-market private equity firm, announced on June 30, 2025 the closing of its acquisition of PlayAGS, Inc. (NYSE: AGS), a global gaming supplier of slot machines, table products and interactive gaming content. The transaction, first announced on May 9, 2024, closed after AGS stockholders approved the deal and all required regulatory approvals were received, with AGS stockholders receiving $12.50 per share in cash, valuing the transaction at approximately $1.1 billion, and AGS becoming a privately held company delisted from the NYSE. This extraction is sourced from PlayAGS's 8-K press release exhibit (Exhibit 99.1) filed with the SEC on June 30, 2025, announcing deal completion. On the buy side, Jefferies LLC served as lead financial advisor to Brightstar, with Barclays and Citizens JMP Securities serving as additional financial advisors to Brightstar. On the sell side, Macquarie Capital served as financial advisor to AGS. Legal counsel included Cooley LLP for AGS, and Kirkland & Ellis LLP together with Brownstein Hyatt Farber Schreck for Brightstar. The deal was a straightforward all-cash take-private transaction at $12.50 per AGS share. Over the three years preceding the deal, AGS had more than doubled its global slot unit sales to over 6,100 units, grown online real-money gaming content revenue by over 150%, and increased Table Products revenue by more than 50%, producing three consecutive years of record revenue. AGS CEO David Lopez and Brightstar founder/CEO Andrew Weinberg both framed the deal as positioning AGS to expand into new markets with Brightstar's operational support. The press release does not disclose the specific advisory fees paid to Barclays, Jefferies, Citizens JMP, or Macquarie Capital, nor does it specify the debt versus equity composition of Brightstar's financing for the $1.1 billion purchase price.

An issuer is conducting a debt offering in the debt capital markets product group, with a disclosed size of $150 million in U.S. dollars. The transaction has been announced and represents a primary issuance of debt securities into the capital markets. The issuer and specific sector classification are not identified in the available documentation. This deal is sourced from an SEC filing published on June 27, 2025, via SEC EDGAR. The specific form type is not identified in the available source material. The transaction is in announced status, indicating that the offering has been publicly disclosed but further details regarding closing timeline or final terms may still be outstanding. No financial advisors have been extracted or identified in connection with this offering. This absence of advisor identification may reflect incomplete documentation, advisor information not being disclosed in the available filing, or the possibility that the offering proceeded without formally retained financial advisory support on the capital markets side. No legal advisors have been identified in the available documentation for this transaction. The disclosed transaction size is $150 million. Beyond the aggregate principal amount, no additional structural detail has been disclosed regarding the offering. No information is available on the instrument type (senior notes, subordinated debt, convertible securities, etc.), coupon rate or interest mechanism, maturity date or tenor, call provisions, covenants, security status, or any other material term of the debt securities being offered. The following material details remain undisclosed or unknown: the identity of the issuer and its sector; the specific SEC form type associated with the filing; the intended use of proceeds; the coupon or interest rate; the maturity tenor; whether the notes are senior, subordinated, or convertible; any call, prepayment, or redemption provisions; collateral status; restrictive covenants; underwriting or bookrunning arrangements if any exist; expected closing date; and any tranching or multiple series within the $150 million aggregate.

Bowen Acquisition Corp (NASDAQ: BOWN), a Cayman Islands blank-check company that completed its IPO in July 2023 raising gross proceeds of $69.0 million, agreed on January 18, 2024 to combine with Shenzhen Qianzhi BioTechnology Co. Ltd., a Shenzhen, China-based developer and manufacturer of plant-based, ozonated health and wellness products used in antibacterial, skincare, gynecological and andrological applications. Under the Agreement and Plan of Reorganization, Bowen's merger subsidiary will merge into Qianzhi Group Holding (Cayman) Limited ("NewCo"), the newly formed Cayman Islands parent that now holds Qianzhi, with NewCo surviving as a wholly owned subsidiary of Bowen. CEO Jiangang Luo said "Bowen recognizes Qianzhi BioTech's excellent products, purpose-driven mission and sustainable operations, which improve the well-being of its customers and communities and shape a promising future... We believe that, with the value proposition that Bowen brings, Qianzhi BioTech will have the ability to expand its market and create significant value for stockholders over time." The merger consideration is entirely stock: NewCo shareholders will receive an aggregate of 7,246,377 Bowen ordinary shares, valued at approximately $10.35 per share for an aggregate value of $75,000,000, a portion of which will be held in escrow to secure post-closing indemnification obligations. NewCo shareholders also have a contingent right to receive up to an additional 1,400,000 earnout shares tied to net income milestones for the combined company in the fiscal years ending March 31, 2025 and 2026, or upon a change-of-control event during the earnout period. Bowen's board obtained a fairness opinion from Newbridge Securities, which valued Qianzhi using two methodologies: a comparable public company analysis (applying an average 24.4x 2023/2024E P/E multiple from seven household-goods-chemicals comparables to Qianzhi's net income, yielding an implied enterprise value of $97.1 million and implied equity value of $101.8 million after adding net debt) and a comparable precedent M&A transaction analysis (applying a 20.4x average EV/net income multiple from prior Household Goods Chemicals transactions since 2021, yielding an implied enterprise value of $81.1 million and implied equity value of $85.8 million). Both methods produced implied values above the $75 million merger consideration; Newbridge concluded the consideration was fair, from a financial point of view, to Bowen's shareholders, and the Bowen board unanimously approved the transaction on January 18, 2024. Concurrent with closing, SPAC King Acquisition Inc., an investor unaffiliated with Bowen or Qianzhi, has agreed to purchase 500,000 new Bowen ordinary shares for an aggregate $5.0 million PIPE financing. Based on the S-4/A filed December 12, 2024 and assuming no additional shareholder redemptions, Bowen's public shareholders were expected to retain approximately 39.9% of the combined company ("New Bowen"), Bowen's sponsors and other insiders approximately 12.1% (excluding the PIPE financing), and Qianzhi's shareholders approximately 45.4% (excluding the 1,400,000 earnout shares), with the combined company planned to be renamed "Emerald, Inc." following closing. According to the S-4/A's background-of-the-merger disclosure, Bowen reviewed approximately 20 potential targets, engaged in more detailed discussions with six, and conducted preliminary due diligence on four, including Qianzhi, before selecting Qianzhi; three named alternative candidates (a China-based industrial intelligent-equipment producer, a China-based integrated medical service provider, and a Korea-based AI disaster-prevention company) were considered and dropped due to unresponsiveness, lack of public-company readiness, or listing-strategy uncertainty. Bowen's shareholders approved the business combination, a related name-change proposal (to Emerald, Inc.), and other proposals at an extraordinary general meeting held January 14, 2025 (after a one-day adjournment from January 13), with the Business Combination Proposal passing 7,112,356 votes for versus 229,429 against and 180,042 abstaining. Despite this shareholder approval, the transaction had still not closed as of the company's most recent annual report (Form 10-K filed September 30, 2026), which states that the Company continues to seek to satisfy the remaining conditions to the Closing of the Business Combination. Bowen has repeatedly extended its deadline to complete a business combination through a series of shareholder votes: to April 14, 2025 (with 6,052,095 public shares redeemed at approximately $10.99 per share), to July 14, 2025 (103,432 shares redeemed at approximately $11.07 per share), to December 14, 2025 (16,602 shares redeemed at approximately $11.21 per share), and to June 14, 2026 (54,475 shares redeemed at approximately $11.38 per share), with a further extension proposal (to as late as December 31, 2026) put to shareholders at a meeting noticed for June 11, 2026. Separately, in July 2025 Bowen received a Nasdaq delisting determination, which it appealed; following an August 21, 2025 hearing, Nasdaq notified the company on October 30, 2025 that it would delist Bowen's securities effective at the open of trading on November 3, 2025. The deal remains pending; no closing 8-K or termination notice has been identified. Closing remains subject to customary conditions including Bowen having at least $5,000,001 of net tangible assets after redemptions, Nasdaq listing approval for the shares to be issued, expiration of any HSR Act waiting period, CFIUS approval, and approval of required filings with the China Securities Regulatory Commission (CSRC). All transaction fees and expenses are to be paid by Qianzhi/NewCo under the agreement. On the legal side, Graubard Miller served as U.S. legal advisor to Bowen, with Han Kun Law Offices as Bowen's PRC counsel and Ogier as Bowen's Cayman Islands counsel; Becker & Poliakoff, P.A. served as U.S. legal advisor to Qianzhi, with Jingsh & H Y Leung (Qianhai) Law Firm as Qianzhi's PRC counsel. EarlyBirdCapital, Inc., Bowen's IPO underwriter, also participated as a lender of extension funds to the trust account alongside Qianzhi. No synergy estimates, pro forma combined financial statement figures, or EPS accretion/dilution analysis were identified in the filings reviewed.

Slide Insurance Holdings, Inc., a Tampa, Florida-based property insurer trading under ticker SLDE on the Nasdaq Global Select Market, completed its initial public offering of common stock in the financial services sector. The offering consisted of 24,000,000 shares priced at $17.00 per share, for a total offering size of $408,000,000. Of those shares, 16,666,667 were sold by the company and 7,333,333 were sold by selling stockholders, including certain directors and officers; the company did not receive any proceeds from the shares sold by the selling stockholders. The prospectus, a Form 424B4 filed with the SEC on June 18, 2025 (dated June 17, 2025), disclosed per-share underwriting discounts and commissions of $1.19, implying total underwriting discounts and commissions of $28,560,000 across both the company and selling stockholder shares, and proceeds before expenses to the company of $15.81 per share, or $263,500,005 in aggregate. A closing 8-K filed June 20, 2025 confirmed the IPO was completed that day, with gross proceeds to the company of $283,333,339 from its own 16,666,667 shares before underwriting discounts and offering expenses. The company stated it intended to use the estimated $252.0 million of net proceeds (after underwriting discounts and estimated offering expenses of approximately $11.5 million) to underwrite additional insurance policies, fund the growth of its business, and for general corporate purposes. No specific debt repayment or acquisition use was disclosed. Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as representatives of the underwriters and joint book-running managers. Citizens JMP Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co. served as additional underwriters, with the underwriting table in the prospectus allocating 9,492,857 shares each to Barclays and Morgan Stanley, 1,671,429 shares each to Citizens JMP Securities and Keefe, Bruyette & Woods, and 1,671,428 shares to Piper Sandler. The selling stockholders granted the underwriters a 30-day option to purchase up to an additional 3,600,000 shares to cover over-allotments, which would have brought the maximum offering size to $469,200,000. No subsequent SEC filing discloses whether this over-allotment option was exercised; that detail remains undisclosed. Davis Polk & Wardwell LLP acted as legal counsel to Slide Insurance Holdings, Inc. and certain selling stockholders, passing on the validity of the shares. Skadden, Arps, Slate, Meagher & Flom LLP represented the underwriters. The offering resulted in immediate dilution to new investors. The prospectus disclosed a pro forma net tangible book value of $4.84 per share as of March 31, 2025 (reflecting a stock split and automatic conversion of Series A preferred stock into 51,374,125 shares of common stock), which increased to a pro forma as adjusted net tangible book value of $6.27 per share after the offering, representing immediate dilution of $10.73 per share to new investors purchasing at the $17.00 IPO price. Because Slide Insurance Holdings had no public trading history prior to this offering, the prospectus explicitly notes there was no pre-existing public market for its common stock, so pricing cannot be benchmarked against a prior closing price. The underwriters expected to deliver shares to purchasers on or about June 20, 2025 through the book-entry facilities of the Depository Trust Company, and the closing 8-K confirms the IPO closed on that date, approximately two days after the prospectus was filed. The following details remain undisclosed in the materials reviewed: whether the underwriters' over-allotment option was exercised in whole or in part, the specific allocation of underwriting fees among the five syndicate members individually, any directed share program final take-up beyond the stated 5% reservation, and lock-up agreement terms beyond what is referenced in the prospectus's 'Shares Eligible for Future Sale' section (not independently reviewed in detail here).

This is a senior secured notes offering combined with a tender offer and consent solicitation, classified under the debt capital markets (dcm) product group, in the tech sector, with Unisys Corp (ticker UIS) as issuer. The disclosed transaction value is $700,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on June 17, 2025. The deal's current status is pending regulatory review. No financial advisors were extracted for this deal in the facts block provided. No legal advisors were extracted for this deal either, so counsel to Unisys or to any underwriters involved in the notes offering is not known from this record. Beyond the classification of this transaction as a senior secured notes offering combined with a tender offer and consent solicitation, with a disclosed size of $700,000,000, no further detail on the notes' coupon, maturity, or the specific securities being tendered for or subject to the consent solicitation is included in the facts provided. Several items are not disclosed in this record: no financial advisors or underwriters are identified, no legal advisors are identified, the coupon and maturity of the new senior secured notes are not specified, and no expected closing date is given beyond the pending-regulatory status. This is notably one of the thinner facts blocks in this batch, with no advisor information of any kind.

TTAM Research Institute, a California nonprofit public benefit corporation founded and led by 23andMe co-founder and former CEO Anne Wojcicki, acquired substantially all of the assets of 23andMe Holding Co. for $305.0 million in cash, plus the assumption and payment of certain specified liabilities and cure costs. The transaction was conducted as a sale under Section 363 of the U.S. Bankruptcy Code following 23andMe's Chapter 11 filing in the U.S. Bankruptcy Court for the Eastern District of Missouri on March 23, 2025. The acquired assets include the Personal Genome Service (PGS) and Research Services business lines; the sale excludes the Lemonaid Health telehealth business, which TTAM separately agreed to acquire as a stalking-horse sponsor of a chapter 11 plan for $2.5 million. The $305 million price emerged from a court-supervised competitive bidding process. At the conclusion of an initial auction, the debtors on May 17, 2025 selected Regeneron Pharmaceuticals, Inc. as the successful bidder at $256.0 million in cash, with TTAM as the backup bidder. TTAM then submitted a $305 million bid, and on June 4, 2025 the debtors, TTAM and Regeneron agreed to a further bidding framework starting at TTAM's $305 million offer. Following another round of bidding, the debtors selected TTAM as the winning bidder on June 13, 2025 at $305.0 million in cash, with Regeneron as backup bidder at $151.0 million in cash. The debtors and TTAM signed the Asset Purchase Agreement that same day, and the debtors terminated the Regeneron Asset Purchase Agreement, retaining $15.1 million of Regeneron's earnest deposit to support its back-up bid while releasing the remainder. TTAM was required to post an earnest deposit of $30.5 million in escrow, of which $14.6 million had been deposited as of the June 13 agreement, to be credited against the purchase price at closing or released per the agreement's terms. Mark Jensen, Chair of the Board and a member of the Special Committee of 23andMe's Board of Directors, said the competitive bidding process "resulted in significantly more value to our stakeholders while enhancing critical protections around customer privacy, choice and consent with respect to their genetic data," adding that Wojcicki is "well positioned to advance the Company's founding vision of helping people access, understand and gain health benefits through greater understanding of the human genome." Anne Wojcicki said she was "thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome," and that "the future of healthcare belongs to all of us." As part of the agreement, TTAM made binding commitments on data privacy, including honoring existing policies allowing customers to delete accounts and genetic data and opt out of research in perpetuity, notifying all customers by email at least two business days before closing, restricting transfer of genetic data in any future bankruptcy or change of control to only qualified entities that adopt TTAM's privacy policies, establishing a Consumer Privacy Advisory Board within 90 days of closing, and offering customers two years of free Experian identity theft monitoring. The Bankruptcy Court entered an order on June 27, 2025 authorizing and approving the TTAM Asset Purchase Agreement. The transaction closed on July 14, 2025, at which point 23andMe repaid in full all outstanding indebtedness and terminated all commitments under its Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement with JMB Capital Partners Lending, LLC. The Asset Purchase Agreement had contained termination rights permitting either party to terminate if closing had not occurred by September 1, 2025 (or December 1, 2025 in certain circumstances), or if the Court dismissed or converted the Chapter 11 Cases to Chapter 7 before closing, or if the Court denied approval of the sale; none of those termination triggers occurred given the July 14 closing. The agreement's representations, warranties and pre-closing covenants did not survive closing, and the agreement did not provide for indemnification related to them, consistent with customary terms for a bankruptcy asset sale. Financial advisory and legal roles match those already on file: TD Cowen LLP served as financial advisor to TTAM Research Institute; Moelis & Company LLC served as investment banker to 23andMe and the Special Committee of its Board of Directors; Alvarez & Marsal North America, LLC served as restructuring advisor to 23andMe; and Reevemark and Scale served as communications advisors to 23andMe. Paul, Weiss, Rifkind, Wharton & Garrison LLP and Carmody MacDonald P.C. served as legal counsel to 23andMe, while Skadden, Arps, Slate, Meagher & Flom LLP, Kirkland & Ellis LLP, Arnold & Porter Kaye Scholer LLP, and Quinn Emanuel Urquhart & Sullivan LLP served as legal advisors to TTAM Research Institute. Because this was an all-cash asset sale executed through Section 363 of the Bankruptcy Code rather than a stock-for-stock or equity merger, no exchange ratio, pro forma ownership split, EPS accretion/dilution, synergy targets, or tangible book value metrics were disclosed, and none apply to this transaction structure. No S-4 or merger proxy was filed because TTAM is a private nonprofit acquiring assets, not issuing registered securities. 23andMe's Class A common stock was delisted from Nasdaq (Form 25 filed June 6, 2025) and had been trading on the OTC Pink Market under the symbol MEHCQ; the company's common stockholders' recovery, if any, in the Chapter 11 case was not addressed in these filings.

This deal is a cash acquisition classified as an M&A transaction in the consumer-retail sector, involving FARO Technologies Inc as target and AMETEK Inc (ticker AME) as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from a DEFM14A filing with the SEC, filed via SEC EDGAR and published on June 12, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Barclays Capital Inc. is identified as financial advisor to FARO Technologies, the target, in a lead capacity. The source material references a formal fairness opinion delivered by Barclays Capital Inc. in connection with the transaction. No financial advisor is identified for the acquirer, AMETEK, in the facts provided. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either side of the transaction. Beyond the cash acquisition structure, no further detail on the specific per-share price, financing terms, or other structural provisions is provided in the facts block. Several material facts are not disclosed in the available record. The overall transaction value is not stated in the source document. No acquirer-side financial advisor and no legal advisors for either party are identified. No expected closing date or further timeline detail beyond the June 2025 filing date and pending-regulatory status is given.

Ategrity Specialty Insurance Company Holdings, trading on the New York Stock Exchange under ticker ASIC, priced its initial public offering on June 10, 2025 at $17.00 per share. The base offering consisted of 6,666,667 shares of common stock sold by the company, for gross proceeds of $113,333,339 before underwriting discounts, consistent with the disclosed deal size. The prospectus was filed on Form 424B4 with the SEC on June 11, 2025 and reflects the final, priced terms of the offering rather than a preliminary range. The underwriters were granted a 30-day option to purchase up to 1,000,000 additional shares to cover over-allotments. According to the company's Form 10-Q for the quarter ended June 30, 2025, the IPO closed on June 12, 2025 with the issuance of 7,666,667 shares at $17.00 per share, which equals the base 6,666,667 shares plus the full 1,000,000-share over-allotment, confirming the option was exercised in full. This brought total gross proceeds to approximately $130.3 million. After underwriting discounts and commissions of $8.6 million and other offering expenses of $7.0 million (together $15.6 million), the company received net proceeds of approximately $114.7 million, which were recorded in additional paid-in capital. The underwriting syndicate, as named on the prospectus cover page, consisted of J.P. Morgan Securities LLC and Barclays Capital Inc. as the two largest participants, each allocated 2,666,667 shares in the underwriters' purchase table, followed by Citigroup Global Markets Inc. at 666,667 shares, and TD Securities (USA) LLC and Wells Fargo Securities, LLC at 333,333 shares each (totaling the base 6,666,667 shares before the over-allotment). The underwriting fee was $1.19 per share, equal to $7,933,333.73 on the base offering, with a selling concession to dealers of up to $0.714 per share. Ategrity stated in the prospectus that the principal purposes of the offering were to increase its capitalization and financial flexibility and to create a public market for its common stock, with net proceeds to be used as capital to grow the business, initially invested in fixed income securities, and for other general corporate purposes. The subsequent 10-Q confirmed that net proceeds were used to support growth initiatives, increase statutory capital and surplus of its insurance subsidiaries, and for general corporate purposes; no debt repayment or acquisition financing use was disclosed. Immediately prior to the IPO's effectiveness, Ategrity Specialty Holdings LLC converted from a Delaware LLC into a Nevada corporation and completed a 1-for-10.66 reverse unit split, with all historical share and per-share data retroactively restated. As of March 31, 2025 (the most recent balance sheet date in the prospectus), the company had a historical net tangible book value of $10.56 per share on an as-converted basis; the IPO price of $17.00 per share represented an immediate dilution of $5.84 per share to new investors, with as-adjusted net tangible book value rising to $11.16 per share after the base offering (or $11.26 and $5.74 of dilution if the option were exercised in full). On the base offering, new investors contributed 23.1% of total consideration paid ($113.3 million of $490.1 million) for 14.2% of the 47,066,674 shares outstanding immediately after the offering, while existing securityholders retained 85.8% of shares for 76.9% of consideration paid. Following the full over-allotment exercise, total shares outstanding stood at 48,066,674 as of June 30, 2025. All of the company's directors, officers, and existing owners agreed to 180-day lock-up agreements from the date of the prospectus, subject to customary exceptions. The offering consisted entirely of primary shares sold by the company; no selling stockholder shares were included in the base or over-allotment shares described above. Legal matters for the company in connection with the offering were passed upon by Latham & Watkins LLP (New York, NY), with the validity of the shares passed upon by Brownstein Hyatt Farber Schreck, LLP (Las Vegas, NV), reflecting the company's Nevada incorporation. Skadden, Arps, Slate, Meagher & Flom LLP (New York, NY) represented the underwriters. The consolidated financial statements of Ategrity Specialty Holdings LLC for the years ended December 31, 2024 and 2023 were audited by Ernst & Young LLP. In connection with the IPO's closing, the company also entered into a Shared Services Agreement with Zimmer Financial Services Group LLC (ZFSG), a Stockholders' Agreement among the company, ZFSG, Zimmer Management Services LLC and other signatories, indemnification agreements with directors and officers, and an employment agreement with Justin Cohen, all dated June 10, 2025 and disclosed in a Form 8-K filed June 12, 2025. ZFSG continued to hold majority voting power after the offering, making Ategrity a "controlled company" under NYSE governance rules.

Brown & Brown, Inc., a financial services company trading under ticker BRO, is conducting an equity offering in the financial sector with a disclosed value of 4 billion dollars. This is an equity capital markets transaction and falls within the equity offering subtype. The transaction is currently in pending regulatory status. The information regarding this deal has been sourced from SEC filings published on the SEC EDGAR database. The first filing was published on June 10, 2025, with a subsequent filing published on June 12, 2025. The form type for these filings is not specified in the available documents. The deal remains in pending regulatory status and has not yet closed. The underwriting syndicate for this offering is substantial and multi-tiered. J.P. Morgan and BofA Securities are serving as joint book running managers and are leading the transaction. BMO Capital Markets and Truist Securities are serving as additional book-running managers. The co-managers on the transaction are Wells Fargo Securities, BTIG, Fifth Third Securities, PNC Capital Markets LLC, Morgan Stanley, Citizens Capital Markets, Barclays, Dowling & Partners Securities LLC, Goldman Sachs & Co. LLC, and Raymond James. This represents a broad range of investment banks participating across multiple tiers of the underwriting hierarchy. No legal advisors have been identified or disclosed in the available source materials for this transaction. The transaction is structured as an equity offering with a disclosed aggregate value of 4 billion dollars. However, the specific structural details regarding the composition of this offering, the pricing, the number of shares to be issued, or any other terms and conditions of the equity offering have not been disclosed in the available materials. Several material details regarding this transaction remain undisclosed or unknown. No expected closing date has been provided. The specific consideration structure and pricing parameters for the offering have not been specified. The form type of the SEC filings documenting this transaction is unknown. Additionally, no information has been disclosed regarding any lock-up provisions, share allocation percentages among the underwriters, or other customary equity offering terms.

Brown & Brown, Inc., a financial services sector company trading under ticker BRO, priced a $4.2 billion senior notes offering on June 11, 2025 and closed the sale on June 23, 2025. The notes were issued in six tranches: $400 million of 4.600% senior notes due December 23, 2026; $500 million of 4.700% senior notes due June 23, 2028; $800 million of 4.900% senior notes due June 23, 2030; $500 million of 5.250% senior notes due June 23, 2032; $1.0 billion of 5.550% senior notes due June 23, 2035; and $1.0 billion of 6.250% senior notes due June 23, 2055. Interest on all tranches is payable semi-annually in arrears on June 23 and December 23 of each year, commencing December 23, 2025. The notes were priced at issue prices ranging from 99.697% to 99.994% of face value, with underwriting discounts ranging from 0.300% (2026 notes) to 0.875% (2055 notes). Total proceeds to the company before expenses were approximately $4,167,288,000 after underwriting discounts of $24,700,000 on $4,191,988,000 of gross proceeds (aggregate principal across the six tranches is $4.2 billion). The notes are senior unsecured obligations that rank equally with the company's other senior unsecured indebtedness and were not listed on any securities exchange. They were issued under the company's existing Indenture dated September 18, 2014 with U.S. Bank Trust Company, National Association (as successor trustee), as supplemented by a Sixth Supplemental Indenture dated June 23, 2025. The company intends to use the net proceeds of the notes, together with net proceeds of a concurrent common stock offering (43,137,254 shares priced at $102.00 per share for gross proceeds of approximately $4.3 billion, announced the same day) and cash on hand, to fund the cash consideration payable under its previously announced Agreement and Plan of Merger to acquire RSC Topco, Inc., the holding company for Accession Risk Management Group, Inc., together with Encore Merger Sub, Inc. and Kelso RSC (Investor), L.P. as equityholder representative. Pending application, net proceeds are expected to be invested in investment-grade securities, money market funds, bank deposits or similar short-term instruments. Five of the six tranches (the 2026, 2028, 2030, 2032 and 2055 notes, defined as the "SMR Notes") are subject to a special mandatory redemption feature: if the RSC acquisition is not consummated by the later of March 10, 2026 (extendable to June 10, 2026 under the merger agreement) and five business days after any further extension of the merger agreement's expiration date, or if Brown & Brown notifies the trustee the merger agreement has been terminated, the company must redeem all SMR Notes at 101% of principal plus accrued and unpaid interest. The 2035 notes are not subject to this special mandatory redemption and will remain outstanding regardless of whether the acquisition closes, with proceeds from that tranche to be used for general corporate purposes if the deal falls through. There is no escrow account or security interest securing the special mandatory redemption obligation. Aside from the special mandatory redemption, the company may optionally redeem each series of notes, in whole or in part, prior to a par call date specific to each tranche (ranging from the notes' maturity for the 2026 notes to six months before maturity for the 2055 notes) at a make-whole price equal to the greater of the present value of remaining payments discounted at the Treasury Rate plus a spread ranging from 10 basis points (2026 notes) to 25 basis points (2055 notes), or par, plus accrued interest. On or after the applicable par call date, notes are redeemable at par plus accrued interest. If a Change of Control Triggering Event occurs, the company must offer to repurchase the notes from holders; the prospectus supplement defines "Investment Grade" by reference to Fitch, Moody's and S&P rating thresholds for purposes of that covenant, but no specific issuer or issue credit rating assigned by any rating agency to these notes is disclosed in the filings reviewed. BofA Securities, Inc. and J.P. Morgan Securities LLC acted as lead book-running managers for the notes offering. BMO Capital Markets, Truist Securities, Fifth Third Securities, PNC Capital Markets LLC, US Bancorp, Wells Fargo Securities and Morgan Stanley served as additional book-running managers, and Citizens Capital Markets served as the sole co-manager (Morgan Stanley is an additional book-running manager, not a separate co-manager, per the final prospectus supplement). Holland & Knight LLP, Orlando, Florida, passed on the validity of the notes for Brown & Brown, and Sidley Austin LLP, New York, acted as counsel to the underwriters. The notes offering itself closed on June 23, 2025 and is not contingent on completion of the RSC acquisition; the acquisition was pending regulatory approval as of the pricing date, and the special mandatory redemption mechanics tie five of the six tranches to the outcome of that separate, still-pending transaction. No information was found in the reviewed filings regarding specific credit ratings assigned to the notes by Fitch, Moody's or S&P.

This deal involves Brown & Brown, Inc. (ticker BRO), a financial-institutions-group (fig) sector company, as the acquirer. The transaction is an M&A deal structured as a cash-and-debt-free acquisition, and its disclosed value is $9,825,000,000, making it one of the larger transactions in this batch. The facts are sourced from an 8-K filing with the SEC via EDGAR, published June 10, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. On the acquirer side, BofA Securities and J.P. Morgan Securities acted as financial advisors and also provided committed financing to Brown & Brown, per the source sentence describing both firms' combined advisory and financing role, with no lead designation specified for either. On the target side, Evercore Group L.L.C. is identified as a financial advisor functioning in a broker capacity; the source sentence, drawn from a representations-and-warranties-style disclosure, states that other than Evercore Group L.L.C., there were no brokerage commissions, finders' fees, or similar compensation payable in connection with the transaction based on any arrangement made by or on behalf of the equityholders or the group companies, aside from certain fees that would be paid under a specified contractual section or otherwise borne by the equityholders. The only legal advisor named in the facts block is Skadden, Arps, Slate, Meagher & Flom LLP, which served as legal counsel to Brown & Brown (the acquirer) in the transaction. No legal advisor is identified for the target side. Beyond identifying the transaction as a cash-and-debt-free acquisition valued at $9,825,000,000, with committed financing provided by BofA Securities and J.P. Morgan Securities, the facts block does not detail the specific financing structure (e.g., term loan versus bridge facility) or other terms of the deal. Several facts are not disclosed in this record. No legal advisor is named for the target side. No expected closing date is given, and the facts block does not specify how the committed financing from BofA Securities and J.P. Morgan Securities is structured beyond the general reference to "committed financing."

Sunnova Energy International Inc., an energy and power sector company, is undertaking a Chapter 11 sale process with concurrent asset sales, which constitutes a restructuring transaction. The disclosed value associated with this transaction is $31,000,000 USD. This transaction is sourced from an SEC filing published on the SEC EDGAR database on June 10, 2025. The specific form type is not identified in the available documentation. The deal currently carries a pending-regulatory status, indicating that approvals or clearances remain outstanding. The issuer has assembled a comprehensive advisory team across multiple disciplines. Kirkland & Ellis LLP and Bracewell LLP are serving as legal counsel to the Company, with Kirkland & Ellis taking the lead legal advisory role. Alvarez & Marsal is serving as financial advisor. Moelis & Company LLC is serving as investment banker to the Company. Additionally, C Street Advisory Group has been retained as strategic communications advisor. The legal advisory support is provided by Kirkland & Ellis LLP in a lead capacity and Bracewell LLP, both serving as legal counsel to the issuer throughout the restructuring process. The transaction is structured as a Chapter 11 sale process accompanied by concurrent asset sales. The disclosed transaction value is $31,000,000 USD. No additional details regarding the specific structure of consideration, timing of closings, or mechanics of the asset sales have been disclosed in the available documentation. Several material details remain unknown or undisclosed at this stage. The specific closing timeline has not been provided. The composition of the $31,000,000 in value across the various asset sales and any potential multiple tranches or conditions has not been detailed. The identity of the purchaser or purchasers in this sale process is not disclosed. The exact nature and composition of the assets being sold concurrently with the Chapter 11 process is not specified. Finally, the complete form type of the SEC filing, which could provide additional context regarding disclosure requirements and specificity, is not identified in the available information.

This deal is a senior secured notes private placement combined with a new revolving credit facility, classified under debt capital markets (DCM) in the tech sector, involving Inspired Entertainment, Inc. (ticker INSE) as issuer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on June 9, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Stifel served as financial advisor and exclusive debt financing agent to Inspired Entertainment (the Company), in a lead capacity, reflecting a combined advisory and arranging role on the financing. On the legal side, Davis Polk acted as legal advisor to the Company (Inspired Entertainment), per the same source sentence that names Stifel's role, with no separate legal advisor identified for any other party. Beyond the classification of this transaction as a senior secured notes private placement paired with a new revolving credit facility, no further detail on the notes' principal amount, coupon, tenor, or the revolving facility's size or terms is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document, and no specific terms of the notes (size, coupon, maturity) or the revolving credit facility (commitment size, pricing) are given. No expected closing date or further timeline detail beyond the June 2025 filing date and pending-regulatory status is provided.

374Water Inc., a company trading under ticker SCWO in the industrials sector, entered into an At-The-Market issuance sales agreement on June 6, 2025 with Lake Street Capital Markets, LLC as sales agent, permitting the sale of common stock having an aggregate offering price of up to $15,100,000. The agreement was disclosed in a Form 8-K filed the same day and in a Form 424B5 prospectus supplement, also dated June 6, 2025, filed under the company's existing Form S-3 shelf registration (Registration No. 333-268942), which otherwise registers up to $200,000,000 of securities. The prospectus supplement capped the number of shares issuable under the program at 28,700,000 and noted that, under the Form S-3 "baby shelf" rules (General Instruction I.B.6), the company could not sell securities worth more than one-third of its public float in any 12-month period while that float remained below $75,000,000. This new Lake Street ATM program directly replaced a prior at-the-market facility. A separate 424B5 filed the same day, June 6, 2025, disclosed that 374Water had an existing Open Market Sale Agreement with Jefferies LLC dated December 21, 2022 for up to $100,000,000 of common stock, under which the company had sold approximately $13.8 million of shares as of June 6, 2025. The company and Jefferies mutually terminated that agreement effective June 6, 2025 (reported as Item 1.02 in the same 8-K), and the June 6, 2025 424B5 relating to the Jefferies agreement was filed specifically to terminate that continuous offering; no further sales were to be made under it. Lake Street's compensation was set at up to 3.0% of the gross proceeds of any shares sold under the agreement, and Lake Street was deemed an "underwriter" within the meaning of the Securities Act with respect to that compensation, which was characterized as an underwriting commission or discount. The company agreed to indemnify Lake Street for certain liabilities under the Securities Act and Exchange Act. Lake Street was not required to sell any specific number or dollar amount of shares and could use any method permitted by law to effect sales deemed "at the market" under Rule 415(a)(4), including sales directly on Nasdaq. The prospectus supplement states that the validity of the common stock was passed upon by Cleary Gottlieb Steen & Hamilton LLP, San Francisco, California, counsel to the company, while Sullivan & Worcester LLP, New York, New York, served as counsel to Lake Street. The last reported sale price of 374Water common stock on Nasdaq on June 5, 2025, the day before the agreement and prospectus supplement were dated, was $0.40 per share. The dilution table in the prospectus supplement illustrated a hypothetical sale of the maximum 28,700,000 shares at that $0.40 assumed price, which would have generated approximately $11.5 million in gross proceeds (less than the $15.1 million program cap because of the share-count ceiling) and raised the company's historical net tangible book value per share from $0.08 (as of March 31, 2025) to an as-adjusted $0.13, implying immediate dilution of $0.27 per share to new investors; this was a hypothetical illustration, not an actual pricing. Before the reverse stock split described below, the company had 144,682,963 shares of common stock outstanding as of March 31, 2025. The company stated it intended to use net proceeds from the Lake Street ATM, after deducting Lake Street's commission and offering expenses, for working capital and general corporate purposes; no debt repayment or acquisition use was disclosed. No minimum offering amount, fixed closing date, or firm pricing was specified, consistent with the continuous, at-will nature of an ATM program; actual proceeds would depend on if and when shares were sold and at what market prices. Subsequent periodic filings quantify actual usage of this $15.1 million program before it was superseded. According to the Form 10-Q for the quarter ended June 30, 2025, during the six months ended June 30, 2025 the company sold 1,270,706 shares under the 2025 Sales Agreement for gross proceeds of approximately $477,100 (net proceeds of approximately $332,400 after issuance costs of approximately $144,700, including approximately $49,300 in commissions and sale agent fees), leaving approximately $14.6 million available under the program as of June 30, 2025. The Form 10-Q for the quarter ended September 30, 2025 reported that, cumulatively during the nine months ended September 30, 2025, the company had sold 7,804,130 shares for gross proceeds of approximately $2,103,000 and net proceeds of approximately $1,916,000, leaving approximately $13.1 million available. The Form 10-K for the year ended December 31, 2025 disclosed that, over the full life of this agreement (through its termination), the company sold a cumulative 2,279,180 shares (as adjusted for a subsequent 10-for-1 reverse stock split effective December 26, 2025) for gross proceeds of approximately $9,313,000 and net proceeds of approximately $8,909,000 after issuance costs of approximately $404,000. The 10-K further disclosed that on December 23, 2025 the company entered into a new, separate at-the-market sales agreement with Lake Street for up to $50,000,000, which replaced this $15.1 million agreement; sales under the $15.1 million agreement had terminated by that date. No greenshoe or over-allotment option applied, consistent with the continuous-offering structure of an ATM program, and no concurrent share repurchase was disclosed in connection with this offering. The transaction remains an announced and substantially (though not fully) utilized ATM program that has since been superseded by a new, larger ATM facility; there is no indication in the filings reviewed that this specific $15,100,000 agreement is still active.

Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail company, entered into a definitive agreement on March 6, 2025 to be acquired by an entity affiliated with Sycamore Partners Management, L.P., a New York-based private equity firm specializing in retail, consumer and distribution-related investments. The transaction was disclosed in a Form 8-K filed March 10, 2025 (attaching the Agreement and Plan of Merger as Exhibit 2.1) and in a same-day press release and investor presentation filed under Item 7.01 of an 8-K dated March 6, 2025. The merger closed on August 28, 2025, pursuant to a Form 8-K filed that date, with WBA surviving as a wholly owned subsidiary of Blazing Star Parent, LLC (an affiliate of Sycamore Partners); WBA common stock and its listed notes were delisted from Nasdaq and WBA ceased to be a publicly traded company. Under the terms of the Merger Agreement, WBA stockholders received $11.45 in cash per share (the "Per Share Cash Consideration") plus one non-transferable Divested Asset Proceed Right ("DAP Right") per share, entitling the holder to a share of 70% of net proceeds (up to $3.00 per right, or approximately $2.7 billion in the aggregate) from any future monetization of WBA's debt and equity interests in VillageMD (comprising Village Medical, Summit Health and CityMD). The press release states the total transaction value represents up to $23.7 billion, based on the $11.45 cash consideration plus up to $3.00 per DAP Right, plus net debt, capital leases, the present value of opioid liability and the Everly settlement, less the fair value of all equity investments. The Cash Consideration represented a 29% premium, and the Total Consideration (including the maximum DAP Right value) represented a premium of up to 63%, to WBA's December 9, 2024 closing share price of $8.85, the day before media reports of a potential transaction first surfaced. WBA disclosed that, as the sole lender to VillageMD, it was owed $3.4 billion by VillageMD as of February 28, 2025 (accruing PIK interest at 19% per year), from which DAP Right payouts would ultimately be funded. No EV/EBITDA or other earnings multiple was disclosed in the sources reviewed. Financing was fully committed and the transaction was not subject to a financing condition. According to the definitive proxy statement (DEFM14A) filed June 6, 2025, Parent estimated total funds necessary to complete the merger at approximately $18.8 billion, comprised of $13.33 billion of committed debt financing, $1.25 billion of committed preferred equity financing, and $2.5 billion of equity financing from the Equity Commitment Parties. Separately, WBA's Executive Chairman Stefano Pessina and his holding company, who together owned approximately 17% of WBA's outstanding common stock, entered into voting and reinvestment agreements under which they agreed to vote in favor of the merger and to reinvest all of their cash consideration (plus an incremental cash investment) into the acquiring company, retaining a significant equity stake in the post-merger company and approximately 17% of the DAP Rights. CEO Tim Wentworth said the agreement "provides shareholders premium cash value, with the ability to benefit from additional value creation going forward from monetization of the VillageMD businesses," and that "meaningful value creation will take time, focus and change that is better managed as a private company." Sycamore Managing Director Stefan Kaluzny said the firm has "deep respect for WBA's talented and dedicated team members" and that the transaction "reflects our confidence in WBA's pharmacy-led model and essential role in driving better outcomes for patients, customers and communities." The Merger Agreement included a 35-day go-shop period during which Centerview Partners, as WBA's financial advisor, solicited alternative proposals; the sources reviewed do not identify any competing bidder or superior proposal arising from that process. The Merger Agreement provided for a Company Termination Fee of $158 million (if WBA terminated to accept a superior proposal during the go-shop period or with an exempted person) or $316 million (in certain other specified circumstances, including a Board change of recommendation), and a Parent Termination Fee of $560 million payable by the Sycamore-affiliated Parent entities under specified circumstances, including failure to consummate the transaction or breach of representations and covenants. The deal was approved by WBA stockholders at a Special Meeting held July 11, 2025, as reported in a Form 8-K filed that day. Of 865,560,675 shares outstanding as of the June 6, 2025 record date, 648,219,746 shares (approximately 74.89% of voting power) were represented at the meeting. The Merger Agreement Proposal required both majority approval of outstanding shares and majority approval of shares cast by Unaffiliated Stockholders (holders other than Pessina, John Lederer, and Parent affiliates); it passed with 626,190,387 votes for (of outstanding shares) and 478,357,418 votes for (of the 500,386,777 unaffiliated shares cast), against 20,140,186 and abstentions of 1,889,173 in each tally. A related nonbinding advisory Merger-Related Compensation Proposal also passed. Because Pessina's reinvestment and continuing involvement made certain Sycamore-affiliated parties deemed affiliates of the Company, the transaction was structured and disclosed as a "going-private" transaction under SEC Rule 13e-3, with a Schedule 13E-3 (and amendments) filed by the Company and Sycamore-affiliated parties jointly with the DEFM14A. Legal and financial advisors were identified in the March 6, 2025 press release. Centerview Partners LLC acted as financial advisor to WBA's Board and rendered a fairness opinion dated March 6, 2025 concluding that the Per Share Consideration was fair, from a financial point of view, to WBA stockholders other than Excluded and Dissenting Shares and the SP Investors; Morgan Stanley & Co. LLC also acted as a financial advisor and provided a fairness opinion to the WBA Board. Kirkland & Ellis LLP acted as legal advisor and Ropes & Gray LLP acted as healthcare regulatory counsel to WBA. On the Sycamore Partners side, UBS Investment Bank acted as lead financial advisor, Goldman Sachs and J.P. Morgan acted as co-lead financial advisors, and Citi and Wells Fargo acted as financial advisors; Davis Polk & Wardwell LLP acted as legal counsel and Bass, Berry & Sims PLC acted as healthcare regulatory counsel to Sycamore. Debevoise & Plimpton LLP acted as legal advisor to Stefano Pessina. Innisfree M&A Incorporated, as previously disclosed, served as proxy solicitor for WBA in connection with the Special Meeting. Upon closing on August 28, 2025, WBA repaid and terminated all outstanding amounts under its Three-Year Revolving Credit Agreement (Bank of America, N.A., administrative agent), its Five-Year Revolving Credit Agreement (Wells Fargo Bank, National Association, administrative agent), and a Receivables Financing Agreement (PNC Bank, National Association, as administrative agent and sole swingline lender), releasing related security interests and liens. The company intended to file a Form 15 to terminate SEC registration of its common stock and notes following effectiveness of the Nasdaq Form 25 delisting. No synergy figures, pro forma EPS accretion/dilution, or combined-company financial targets were disclosed in the sources reviewed.

Aveanna Healthcare Holdings Inc., a home care services company trading under ticker AVAH, agreed to acquire Thrive Skilled Pediatric Care, LLC ("Thrive SPC"), a portfolio company backed by growth investment firm Summit Partners. The agreement was announced on April 3, 2025, in a press release attached to a current report on Form 8-K, which disclosed that Aveanna would pay approximately $75.0 million for Thrive SPC, primarily in shares of its common stock, subject to customary purchase price adjustments. The transaction closed on June 2, 2025, roughly two months after signing. Thrive SPC is one of the largest independent providers of pediatric home care, operating 23 locations across seven states: Arizona, Georgia, Kansas, New Mexico, North Carolina, Virginia, and Texas. It primarily provides skilled Private Duty Nursing services, along with Pediatric Therapy, Licensed Health Aide Services, and Certified Nurse Assistant Services. Aveanna said the combination creates an enhanced footprint in states where it already operates while introducing its care model into two new states. Jeff Shaner, Chief Executive Officer of Aveanna, said in the announcement: "Thrive SPC is an exceptional cultural and geographical fit for us and reinforces our strategic mission of remaining the leader in delivering high quality care while bringing unprecedented value and clinical innovation to our payors and stakeholders." Ross Stern, a Managing Director at Summit Partners, said: "We believe Aveanna is an ideal partner for Thrive SPC, given the combined company's shared vision for delivering the highest quality care to patients and innovative and cost-effective solutions to its payors." According to Aveanna's Form 10-Q for the quarter ended June 28, 2025, the company paid approximately $75.7 million in total consideration at closing on June 2, 2025, comprising $15.855 million in cash and $59.838 million in share-based consideration, consisting of 11,184,588 shares of common stock (approximately 11.2 million shares) valued at the opening market price on the closing date. Approximately 1.3 million of the issued shares were placed in escrow for up to 12 months following closing to support indemnification and other obligations under the merger agreement. The shares were issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act. The 10-Q disclosed a preliminary purchase price allocation: total identifiable net assets acquired of $11.515 million (including $5.0 million of license intangibles and $0.54 million of trade name intangibles, net of assumed liabilities such as accrued payroll and other current liabilities), against total consideration of $75.693 million, resulting in preliminary goodwill of $64.178 million. Aveanna stated that goodwill is primarily attributable to expected synergies from the acquisition, though no specific dollar synergy target or phase-in timeline was disclosed. All of the goodwill was allocated to Aveanna's Private Duty Services (PDS) segment. Aveanna explicitly stated that pro forma financial information for the acquisition was not provided because it was not material to the company's consolidated results of operations, and that Thrive's results were not significant for the six-month period ended June 28, 2025. The company also recorded $3.4 million of acquisition-related transaction costs in the second quarter of 2025 ($3.5 million for the six-month period), which were cited as a drag on corporate expenses in that period. Edge Healthcare Partners served as financial advisor to Aveanna, and Bass, Berry & Sims provided legal counsel to Aveanna. Cantor Fitzgerald & Co. served as financial advisor to Thrive SPC, while Ropes & Gray LLP served as Thrive SPC's legal advisor. The transaction has closed. No earnout, exchange ratio, EV/EBITDA multiple, financing-related new debt issuance, or EPS accretion/dilution guidance was disclosed in the filings reviewed. The merger agreement itself (dated April 1, 2025) was not filed as an exhibit to any 8-K reviewed, so its specific termination fee, closing conditions, and other negotiated deal terms beyond the price and advisor disclosures above remain non-public.

This deal involves Inozyme Pharma, Inc., a healthcare-sector company, as the target of an acquisition by BioMarin Pharmaceutical Inc. (ticker BMRN). The transaction is an M&A deal structured as a tender offer, and its disclosed value is $270,000,000. The record draws on a substantial number of SEC EDGAR filings: an SC TO-T published June 2, 2025; a filing of unknown form type published May 16, 2025; two 8-K filings both published May 16, 2025 and an additional 8-K published July 1, 2025; a second unknown-form filing published May 16, 2025; and an SC 14D9 published June 2, 2025. The deal's status is closed, indicating the tender offer was completed. The facts block names two financial advisors, each designated as lead on their respective side. Goldman Sachs & Co. LLC acted as exclusive financial advisor to BioMarin, the acquirer, while Cooley LLP served as BioMarin's legal counsel, per the source language that these two firms were advising the acquirer in tandem. On the target side, Centerview Partners LLC acted as exclusive financial advisor to Inozyme, with Goodwin Procter LLP serving as Inozyme's legal counsel, as stated in the corresponding source sentence. These advisor-role pairings (financial advisor plus legal counsel per side) recur multiple times across the underlying source documents, reflecting that the same relationship was reported in more than one filing. On the legal side, Cooley LLP is confirmed as legal advisor to the acquirer, BioMarin, and Goodwin Procter LLP is confirmed as legal advisor to the target, Inozyme, consistent with the pairings described above. Beyond identifying the transaction as a tender offer with a $270,000,000 disclosed value, the facts block does not provide additional detail on the offer price per share, the proration mechanics, or any other structural terms of the tender offer. Notably absent from the record are details such as the specific per-share tender price, the percentage of shares sought or tendered, and any conditions to closing. Since the deal's status is listed as closed, the disclosed value and advisor roles described above represent the full extent of what the source material provides about how the transaction concluded.

ConnectOne Bancorp, Inc. (Nasdaq: CNOB), parent company of ConnectOne Bank, agreed to acquire The First of Long Island Corporation (Nasdaq: FLIC), parent company of The First National Bank of Long Island, in an all-stock transaction valued at approximately $283.9 million in the aggregate (approximately $12.40 per FLIC share, based on ConnectOne's September 4, 2024 closing price of $23.97). The deal was announced on September 5, 2024, via a definitive Agreement and Plan of Merger dated September 4, 2024, and was completed on June 1-2, 2025, with FLIC merging with and into ConnectOne and First National Bank of Long Island merging into ConnectOne Bank. Frank Sorrentino III, ConnectOne's Chairman and CEO, said the transaction would "bring together two highly complementary, commercially focused banks to create a truly premier New York-metro community bank," adding that it "materially accelerates CNOB's Long Island expansion strategy" and would make ConnectOne "one of the top 5 banks on Long Island, in terms of deposit market share." Chris Becker, CEO of First National Bank of Long Island, said joining ConnectOne "begins the next chapter in The First National Bank of Long Island's story," allowing the combined company to "leverage the strengths, expertise, and resources of both companies to offer our clients the muscle and support of a $14 billion institution." Under the terms of the merger agreement, each share of FLIC common stock was converted into the right to receive 0.5175 shares of ConnectOne common stock, with cash paid in lieu of fractional shares. ConnectOne's September 2024 investor presentation and joint press release disclosed implied pricing multiples of approximately 0.74x FLIC's tangible book value (versus a 1.33x median for comparable nationwide bank M&A deals with deal values between $150 million and $1 billion announced in the prior 12 months), a negative 3.0% core deposit premium, and 10.8x FLIC's 2025 estimated earnings (versus a 12.0x comparable-transaction median). Separately, in its fairness opinion to the FLIC board, Piper Sandler calculated its own implied transaction metrics using FLIC's August 31, 2024 share/RSU count and the September 3, 2024 closing price: an aggregate implied transaction value of approximately $289.3 million, an implied purchase price of $12.64 per FLIC share, 76% of tangible book value per share, 12.9x LTM earnings per share, 15.0x 2024E consensus EPS, 11.0x 2025E consensus EPS, a tangible book premium to core deposits (deposits excluding CDs over $100,000) of negative 2.9%, and a market premium as of September 3, 2024 of negative 0.3%. At closing, ConnectOne shareholders were expected to own approximately 76% of the combined company and FLIC shareholders approximately 23.6% on a fully diluted basis, per the joint proxy statement/prospectus (Form S-4). The combined company, operating under the ConnectOne brand, had approximately $14 billion in total assets, $11 billion in total deposits and $11 billion in total loans at completion, with a pro forma market capitalization of over $1.2 billion based on ConnectOne's September 4, 2024 closing price. First of Long Island, headquartered in Melville, NY, had approximately $4.2 billion of assets, $3.3 billion of loans and $3.4 billion of deposits as of June 30, 2024, operated 40 branches in the New York metropolitan area, and ranked #4 in Nassau County and #5 in Suffolk County in deposit market share among banks with under $100 billion in assets (per S&P Capital IQ Pro data as of June 30, 2023), with approximately 92% of its deposits located in Nassau or Suffolk counties. Pro forma, approximately 30% of the combined company's deposit franchise and approximately 34 branches were expected to be located in the Long Island market, and the FLIC board noted the combined company would hold the 4th and 5th largest deposit market shares in Nassau and Suffolk Counties, respectively. On financial impact, ConnectOne projected the deal would be approximately 36% accretive to its 2025 earnings per share, as adjusted for an illustrative full phase-in of cost savings (9% accretive excluding interest-rate marks, per the investor presentation). Tangible book value per share dilution was projected at approximately 12% (0.5% excluding rate marks), with an earnback period of approximately 2.9 years (0.4 years excluding rate marks). ConnectOne targeted a pro forma 2025 estimated return on average tangible common equity of approximately 14%, a 2025 estimated efficiency ratio of approximately 45%, and 2025 estimated return on average assets of approximately 1.0%, assuming full phase-in of cost savings. The presentation modeled cost savings equal to 35% of FLIC's noninterest expense, phased in 50% in 2025 and 100% thereafter. As part of the transaction, ConnectOne raised approximately $100 million of Tier 2 qualifying subordinated debt prior to closing, with net proceeds downstreamed to ConnectOne Bank as common equity; the merger agreement separately committed ConnectOne to raise up to $200 million in new capital (subordinated debt or a combination of subordinated debt and common equity) if required to obtain necessary regulatory approval, per the joint proxy statement/prospectus. Pro forma capital ratios with the subordinated debt raise were disclosed at approximately 7.9% TCE/TA, 9.8% CET1 and 13.3% total capital ratio. The presentation also disclosed purchase-accounting assumptions including a gross credit mark of approximately $67 million (2.0% of FLIC's loan portfolio), a loan interest rate mark of approximately $198 million (6.1% of the loan portfolio) accreted straight-line over five years, and approximately $38 million of after-tax merger charges fully reflected in tangible book value at closing. The joint proxy statement/prospectus on Form S-4 (filed December 10, 2024, as amended, with a final 424B3 prospectus filed December 31, 2024) disclosed a detailed background of the merger. FLIC, advised by Piper Sandler, had conducted a strategic review beginning in late 2022; in January 2023 Piper Sandler approached 13 financial institution holding companies about a potential sale, five expressed initial interest, and four (including ConnectOne) signed confidentiality agreements. Two parties, ConnectOne and an unnamed "Party B," submitted non-binding indications of interest in February 2023, but market turmoil following the March 2023 regional bank failures caused both to pause. FLIC's CEO Christopher Becker subsequently held exploratory discussions through 2023 and 2024 with ConnectOne and three other unnamed parties referred to in the filing as Party C, Party D and Party E, including a brief due diligence process with Party D in March 2024 that did not proceed due to market conditions. The FLIC board's recommendation noted the company's advisors had reached out to a total of 16 parties over the process. Discussions with ConnectOne re-accelerated in April 2024; on May 22, 2024 ConnectOne submitted a new non-binding indication of interest proposing a potential capital raise of up to $200 million, board seats for up to three FLIC directors, and senior roles for certain FLIC executives, followed by a 60-day mutual exclusivity agreement. The exchange ratio was negotiated between 0.50 and 0.54 ConnectOne shares per FLIC share before the parties agreed on 0.5175 on September 2, 2024. Keefe, Bruyette & Woods (KBW) rendered a fairness opinion to the ConnectOne board, and Piper Sandler rendered a fairness opinion to the FLIC board, both dated September 4, 2024, concluding the exchange ratio was fair, from a financial point of view, to their respective clients. Under the merger agreement, the FLIC board agreed to recommend shareholder approval and not to solicit competing acquisition proposals, subject to a customary fiduciary-out exception for unsolicited superior proposals, and both companies' directors and certain executive officers entered into voting agreements to support the deal. Closing was conditioned on approval by both companies' shareholders, receipt of required regulatory approvals, effectiveness of ConnectOne's Form S-4 registration statement, and Nasdaq listing approval for the shares to be issued. The merger agreement provided that if terminated under certain circumstances in connection with a competing acquisition transaction, FLIC would owe ConnectOne a termination fee of $11,845,000. Following completion, ConnectOne's board was expanded to 15 members; Christopher Becker, former President and CEO of First National Bank of Long Island and FLIC, was appointed Vice Chairman of ConnectOne, and two additional independent FLIC directors, Peter Quick and Ed Haye, joined the ConnectOne board. The merger was structured to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. Keefe, Bruyette & Woods, Inc., A Stifel Company, served as financial advisor to ConnectOne, and Windels Marx Lane & Mittendorf, LLP served as its legal counsel. Piper Sandler & Co. served as financial advisor to First of Long Island, and Luse Gorman PC served as its legal counsel, as confirmed in the September 2024 merger-announcement press release, the joint proxy statement/prospectus, and the June 2025 closing press release.

Duos Technologies Group, Inc., a Florida-incorporated technology sector company trading on the Nasdaq Capital Market under the ticker DUOT, amended its existing at-the-market (ATM) common stock sales agreement with Ascendiant Capital Markets, LLC twice in the spring of 2025 to expand the amount of common stock it may sell through the program. The original At-The-Market Issuance Sales Agreement with Ascendiant dated May 17, 2024 authorized sales of up to $7,500,000 of common stock. A First Amendment, entered into on April 14, 2025 and disclosed in an 8-K filed April 15, 2025, increased the capacity by $8,850,000, bringing total program capacity to $16,350,000; a corresponding prospectus supplement for the $8,850,000 increment was filed the same day, April 14, 2025 (424B5). A Second Amendment, entered into on May 27, 2025 and disclosed in an 8-K filed May 29, 2025, then increased the amount of placement shares available under the agreement by $10,500,000, and the company filed a supplement to the April 14 prospectus supplement on May 28, 2025 covering that $10,500,000 tranche. The offering is structured as an at-the-market program under Rule 415(a)(4), meaning shares are sold incrementally over time through Ascendiant acting as sales agent or principal, rather than in a single priced offering; there is accordingly no single IPO-style "pricing" event, gross proceeds figure, or settlement date for the program as a whole. Ascendiant's compensation is up to 3% of gross proceeds on shares sold under the agreement, and Ascendiant is deemed an "underwriter" under the Securities Act for purposes of that compensation, which is treated as an underwriting discount. The company is not obligated to sell any set number of shares, and sales are made at then-prevailing market prices at times and in amounts the company determines in its discretion. The company disclosed actual utilization of the program in its quarterly reports. During the three months ended March 31, 2025 (prior to either amendment, drawing on the original $7,500,000 tranche), Duos issued 633,683 shares of common stock at a weighted-average price of $6.24 per share through the ATM program, generating gross proceeds of $3,954,940, incurring issuance costs of $137,851, and yielding net proceeds of $3,817,089. During the three months ended June 30, 2025 (following both amendments), the company issued 238,145 shares at a weighted-average price of $7.71 per share, generating gross proceeds of $1,835,874, issuance costs of $55,216, and net proceeds of $1,780,658. The company stated that Q1 2025 ATM gross proceeds were a primary driver of cash provided by financing activities that quarter, partly offset by $1,000,000 in principal repayments on secured promissory notes held by 21 April Fund LP and 21 April Fund Ltd.; those notes had previously required proceeds from the ATM facility to be swept into a blocked account to repay the notes, though the lenders waived that requirement in November 2024, allowing proceeds to be used for general corporate purposes (with amounts still required to be deposited to the blocked account by December 1, 2025). Both prospectus supplements state that net proceeds are intended for general corporate purposes, including working capital, with no minimum offering amount and broad management discretion over use; no acquisition-specific or debt-retirement-specific use of proceeds is designated for either amendment's incremental capacity. Each prospectus supplement also disclosed illustrative dilution. For the April 14, 2025 supplement, based on a December 31, 2024 net tangible book value of $2,440,724 ($0.27 per share) on 8,921,252 shares outstanding, an assumed sale of the full $8,850,000 at $4.69 per share (the last reported sale price on April 11, 2025) would produce pro forma net tangible book value of $10,808,246, or $1.01 per share, a $0.74 per share increase for existing holders and $3.68 per share of immediate dilution to new investors. For the May 28, 2025 supplement, based on a March 31, 2025 net tangible book value of negative $4,360,716 (negative $0.37 per share) on 11,653,905 shares outstanding, an assumed sale of the full $10,500,000 at $8.46 per share (the last reported sale price on May 23, 2025) would produce pro forma net tangible book value of $5,479,284, or $0.42 per share, a $0.79 per share increase for existing holders and $8.04 per share of immediate dilution to new investors. No over-allotment or greenshoe option applies, as is typical for ATM programs; there is no fixed offering size subject to exercise, only the aggregate dollar capacity under the Sales Agreement as amended. Legal counsel to the company was Shutts & Bowen LLP, which delivered opinions as to the validity of the shares issuable under the Sales Agreement (filed as Exhibit 5.1 to both the April 15 and May 29, 2025 8-Ks). Ascendiant Capital Markets was separately represented in connection with the offering by Clyde Snow & Sessions, P.C. of Salt Lake City, Utah, as disclosed in the Legal Matters section of the April 14, 2025 prospectus supplement. The ATM program remains an ongoing, non-firm-commitment facility rather than a completed, discrete transaction; no closing 8-K or final tally of total shares and proceeds raised under the amended capacity has been identified. The deal remains in announced status based on the filings reviewed.

Streamline Health Solutions Inc., a technology sector company, is the target in a merger transaction valued at $37.4 million. The acquirer is MDaudit. This is a mergers and acquisitions transaction classified as a merger subtype within the technology sector. The transaction information is sourced from an SEC filing published on May 29, 2025. The specific form type was not disclosed in the available materials. As of the publication date, the deal remains pending regulatory approval and has not yet closed. On the financial advisory side, Cain Brothers, a division of KeyBanc Capital Markets, served as the exclusive financial advisor to Streamline Health Solutions and rendered a fairness opinion to its Board of Directors in this capacity. No financial advisors to MDaudit were identified in the available materials. Legal representation was split as follows. Goodwin Procter, LLP served as legal counsel to MDaudit, the acquirer. Troutman Pepper Locke LLP served as legal counsel to Streamline Health Solutions, the target. The transaction is structured as a merger with an aggregate disclosed value of $37.4 million. No details regarding the composition of consideration, whether cash, stock, debt, or any combination thereof, have been disclosed. The specific terms, conditions, and mechanics of the transaction structure are not detailed in the available materials. Several material aspects of this transaction remain undisclosed or unknown. The expected closing date has not been provided. The specific consideration structure and any breakdown between cash and equity components is not disclosed. The regulatory bodies whose approval is required and the current status of those approvals remain unspecified. Additionally, the form type of the SEC filing from which this information is sourced was not identified.

GATX Corporation (NYSE: GATX), a railcar, aircraft engine, and tank container leasing company, announced a definitive agreement to acquire approximately 105,000 railcars from Wells Fargo for $4.4 billion through a newly formed joint venture with Brookfield Infrastructure Partners L.P. and its institutional partners. Separately, Brookfield Infrastructure agreed to directly acquire Wells Fargo's rail finance lease portfolio of approximately 23,000 railcars and roughly 440 locomotives. This deal is in the rail transportation leasing sector (SIC 4700). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by GATX Corporation with the SEC on May 29, 2025 (press release dated May 29, 2025, Chicago), announcing the signing of the definitive agreement. The transaction was expected to close in the first quarter of 2026 or sooner, subject to customary closing conditions including required regulatory approvals and clearances. GATX will serve as manager of the railcars in the joint venture as well as the finance lease railcars and locomotives directly owned by Brookfield Infrastructure. On financial advisory, BofA Securities acted as the sole financial advisor to both GATX and Brookfield Infrastructure in this transaction, an unusual single-advisor structure for a large acquiring joint venture. On legal advisory, Mayer Brown served as legal counsel to GATX, and Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to Brookfield Infrastructure. The deal structure disclosed is a joint venture with initial equity ownership split GATX 30% and Brookfield Infrastructure 70%, with GATX holding a series of annual call options that, if exercised, would allow GATX to acquire up to 100% of Brookfield Infrastructure's equity interest in the joint venture over up to 10 years. GATX's initial equity contribution was approximately $400 million, funded through general operating cash flow and financing activity. In addition to partner equity, Wells Fargo Securities, LLC, BofA Securities, MUFG Bank Ltd., and Sumitomo Mitsui Banking Corporation (SMBC) agreed to provide the joint venture with a fully underwritten $3.2 billion 5-year unsecured term loan and a $250 million unsecured revolving credit facility. What is not disclosed: the press release does not state a separate purchase price for the directly-acquired Brookfield Infrastructure finance lease portfolio (23,000 railcars and 440 locomotives) distinct from the $4.4 billion figure tied to the 105,000-railcar operating lease portfolio, and it does not specify the exercise price or schedule for GATX's call options on Brookfield's equity stake.

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing precision therapies for immune-mediated diseases, and ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company in immunology, announced a definitive all-stock merger agreement on February 6, 2025, disclosed in a Form 8-K that included a joint press release. Martin Babler, President, CEO and Chairman of Alumis, said the combination would give Alumis "the financial flexibility and runway to advance an expanded late-stage pipeline, now including lonigutamab, and build commercial capabilities." Bruce Cozadd, Chair of the ACELYRIN Board and a member of its Board Transaction Committee, said the deal was "the culmination of a thorough strategic review process by our Board and management team to determine the best and most value-maximizing path forward for ACELYRIN." Under the original merger agreement, each ACELYRIN share was to be exchanged for 0.4274 shares of Alumis common stock, which would have left Alumis stockholders owning approximately 55% and ACELYRIN stockholders approximately 45% of the combined company on a fully diluted basis. On April 20, 2025, the parties amended the merger agreement to increase the exchange ratio to 0.4814 Alumis shares per ACELYRIN share, after ACELYRIN disclosed that it had received a competing, unsolicited acquisition proposal from Tang Capital Partners (the "Tang Proposal") consisting of $3.00 per share in cash plus a contingent value right tied to 80% of net proceeds from any future out-license or disposition of ACELYRIN's development programs, according to the joint proxy statement/prospectus on Form S-4. Following the amendment, Alumis stockholders were expected to own approximately 52% and ACELYRIN stockholders approximately 48% of the combined company on a fully diluted basis. The S-4 states that the amended exchange ratio represented a premium of approximately 67% relative to the unaffected market-based exchange ratio of ACELYRIN common stock on February 6, 2025. No cash consideration, dollar-denominated enterprise value, or EV/EBITDA-type multiple has been disclosed for the transaction, consistent with its structure as a stock-for-stock exchange between two clinical-stage, pre-revenue biopharmaceutical companies. The companies disclosed a pro forma cash position of approximately $737 million as of December 31, 2024 (Alumis approximately $289 million and ACELYRIN approximately $448 million on a preliminary basis), which they said would provide runway into 2027. No cost synergy dollar figure or phase-in timeline was disclosed; the S-4/joint proxy statement cites only qualitative "cost synergies and operating efficiencies resulting from the elimination of redundant general and administrative costs" as a consideration for the ACELYRIN board, without quantifying the amount. Per the joint proxy statement/prospectus, the Alumis Special Committee retained Morgan Stanley & Co. LLC, which rendered a fairness opinion dated April 20, 2025 concluding the amended exchange ratio was fair, from a financial point of view, to Alumis. ACELYRIN retained Guggenheim Securities, LLC, which rendered a fairness opinion, dated February 6, 2025, as to the fairness of the original exchange ratio to ACELYRIN stockholders. The joint proxy/S-4 also discloses that ACELYRIN, assisted by Guggenheim Securities, contacted 27 strategic parties to assess a potential transaction, and that a separate process previously run by Aquilo Partners had contacted 32 parties regarding a partnership for ACELYRIN's izokibep program; neither process produced an actionable alternative to the Alumis transaction other than the Tang Proposal, which the ACELYRIN board ultimately did not pursue in lieu of the amended Alumis merger. Morgan Stanley & Co. LLC served as financial advisor to Alumis, and Cooley LLP served as its legal counsel. Guggenheim Securities, LLC served as financial advisor to ACELYRIN. ACELYRIN's legal representation included both Fenwick & West LLP, described in the S-4 as ACELYRIN's "recently engaged corporate counsel," and Paul Hastings LLP, identified in the S-4 as "legal counsel to ACELYRIN." Fenwick & West also delivered a tax opinion that the merger would more likely than not qualify as a tax-free "reorganization" under the Internal Revenue Code. The original merger agreement, filed as Exhibit 2.1 to the February 6, 2025 Form 8-K, provided for a $10.0 million termination fee payable by either party under specified circumstances, including termination to accept a superior proposal, and an outside date of July 7, 2025. Alumis stockholders approved the related share-issuance proposal at a special meeting held May 13, 2025, with approximately 88.98% of outstanding shares represented and 41,861,422 votes in favor versus 159,077 against, according to the Form 8-K reporting the vote (Item 5.07). The merger closed on May 21, 2025: ACELYRIN merged with Alumis' wholly owned merger subsidiary and became a wholly owned subsidiary of Alumis, with each ACELYRIN share converted into the right to receive 0.4814 shares of Alumis common stock, per the closing Form 8-K (Item 2.01). ACELYRIN stock options with an exercise price of $18.00 or less were converted into Alumis options at the exchange ratio; options with an exercise price above $18.00 were cancelled without consideration. Outstanding ACELYRIN RSUs and PSUs (with PSUs deemed earned at 100% of target) were converted into Alumis RSUs at the exchange ratio. In connection with the closing, Alumis' board was expanded and Lynn Tetrault was appointed as a new independent director; Henry Gosebruch, who had also been expected to join the board, did not do so after being named CEO of Galapagos. The combined company operates under the Alumis name, led by Alumis' pre-existing executive team, with its headquarters remaining in South San Francisco, California. As permitted under Item 9.01(a)(3) of Form 8-K, audited financial statements of the acquired business and pro forma financial information were to be filed by amendment within 71 days of the closing 8-K's required filing date; this research did not locate or confirm the filing of that amendment.

This transaction involves Alumis Inc. (ticker ALMS), a healthcare-sector company, as the acquirer, with ACELYRIN as the target, in an all-stock merger. The deal falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published May 21, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Guggenheim Securities, LLC served as financial advisor to ACELYRIN (the target), with the source sentence also noting that Fenwick & West LLP and Paul Hastings LLP served as ACELYRIN's legal counsel. On the acquirer side, Morgan Stanley & Co. LLC served as financial advisor to Alumis, with Cooley LLP serving as Alumis's legal counsel, per the corresponding source sentence. Legal advisors are disclosed for both sides. Cooley LLP served as legal counsel to the acquirer, Alumis. On the target side, both Paul Hastings LLP and Fenwick & West LLP served as legal counsel to ACELYRIN, reflecting that the target retained two separate law firms for the transaction. Beyond classifying the transaction as an all-stock merger, the facts block does not specify the exchange ratio, pro forma ownership split, or any other structural terms of the stock consideration. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not clarify the respective roles of ACELYRIN's two legal advisors, Fenwick & West LLP and Paul Hastings LLP, relative to one another.

BeautyHealth is conducting a convertible debt exchange or refinancing transaction with a disclosed size of $250 million USD. This is a debt capital markets product falling under the convertible debt exchange/refinancing subtype. The issuer, BeautyHealth, is managing this transaction with advisory support from multiple firms across financial and legal disciplines. The transaction details are sourced from an SEC EDGAR filing published on May 21, 2025. The specific form type is not disclosed in the available information. The deal is currently in pending-regulatory status, indicating that approvals or clearances are still awaited before the transaction can move forward to closing. Goldman Sachs is serving as the exclusive financial advisor to BeautyHealth on this transaction, taking the lead role in that capacity. Latham & Watkins LLP is serving as transaction counsel to BeautyHealth, providing legal advisory services to the issuer side of the deal. No information has been disclosed regarding the specific structure or terms of the convertible debt exchange or refinancing. This includes whether the transaction involves an exchange of existing convertible securities for new ones, a refinancing of current convertible debt into a new instrument, or another form of convertible restructuring. The consideration structure, pricing, conversion terms, maturity date, coupon or dividend rate, or any other specific financial terms are not provided in the available source material. Additionally, there is no expected closing date disclosed, no information on the size of the existing convertible debt being exchanged or refinanced, and no details regarding whether this is a registered offering, private placement, or other regulatory structure. The reason for the exchange or refinancing and any details about the financial condition or strategic context driving the transaction are likewise not disclosed.

This is a convertible notes exchange and refinancing transaction in the debt capital markets (dcm) product group, involving The Beauty Health Company (referred to in the source material as BeautyHealth) as issuer. The facts block does not specify a sector classification for this record. The disclosed transaction value is $250,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on May 21, 2025. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Goldman Sachs, which served as the lead and exclusive financial advisor to BeautyHealth, the issuer. The source sentence states: "Goldman Sachs is acting as exclusive financial advisor and Latham & Watkins LLP served as transaction counsel to BeautyHealth." One legal advisor is identified: Latham & Watkins LLP served as transaction counsel to BeautyHealth, the issuer, per the same source sentence referenced above. Beyond the classification of this transaction as a convertible notes exchange and refinancing with a disclosed value of $250,000,000, no further detail on the notes' coupon, maturity, conversion price, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the coupon rate, maturity date, and conversion terms of the convertible notes are not specified, and no expected closing date is given beyond the pending-regulatory status.

This deal involves Landsea Homes Corp, a real-estate-sector company, as the target of a cash tender offer followed by a second-step merger, with New Home Co as the acquirer. The transaction falls under the M&A product group, and its disclosed value is $1,200,000,000. The facts are sourced from an SC 14D9 filing with the SEC via EDGAR, published May 13, 2025. The deal's status is pending regulatory, indicating the tender offer process had not yet closed as of that filing. Multiple financial advisors are disclosed. On the target side, Moelis & Company LLC is acting as exclusive financial advisor to Landsea Homes and is designated lead. On the acquirer side, four firms are named as financial advisors to New Home with no lead designation specified individually: Vestra Advisors, J.P. Morgan Securities LLC, RBC Capital Markets, and Wells Fargo, per the source sentence listing "J.P. Morgan Securities LLC, RBC Capital Markets, Vestra Advisors, and Wells Fargo" together as having served as financial advisors to New Home. Legal advisors are disclosed for both sides: Latham & Watkins LLP is acting as legal counsel to the target, Landsea Homes, while Paul, Weiss, Rifkind, Wharton & Garrison LLP is acting as legal counsel to the acquirer, New Home. Beyond describing the transaction as a cash tender offer followed by a second-step merger valued at $1,200,000,000, the facts block does not specify the per-share tender price or the conditions governing the subsequent second-step merger. Several facts are not disclosed in this record. No expected closing date is given. The facts block does not clarify the respective roles of New Home's four financial advisors, Vestra Advisors, J.P. Morgan Securities LLC, RBC Capital Markets, and Wells Fargo, relative to one another beyond their collective listing.

Alchemy Investments Acquisition Corp 1 (Nasdaq, later OTC: ALCY/ALCYF), a special purpose acquisition company focused on data-driven businesses, entered into a definitive business combination agreement on August 22, 2025 to acquire Cartiga, LLC, a litigation finance and legal asset management platform, in an Up-C merger structure. The agreement was announced via a press release and 8-K filed August 25, 2025, following unanimous approval by Alchemy's board on August 19, 2025 and by Cartiga's board of managers. Under the business combination agreement, the new public holding company, to be renamed Cartiga Holdings, Inc. ("New Cartiga"), will acquire all of Cartiga's limited liability company equity interests for an Equity Value of $540,000,000, paid in Merger Consideration consisting of OpCo Units and shares of Class B voting non-economic common stock issued at an implied $10.00 per unit/share. Alchemy will first domesticate from the Cayman Islands to Delaware, after which a merger subsidiary will merge into Cartiga, leaving Cartiga as an operating subsidiary ("OpCo") in an umbrella partnership C-corporation ("Up-C") structure, with Cartiga's existing equity holders retaining their interests as OpCo Units to preserve partnership tax treatment, while Alchemy's existing Class A and Class B ordinary shareholders will hold stock in the Delaware corporate parent. No cash consideration to Cartiga sellers and no new acquisition debt were disclosed in the business combination agreement summary. Closing is subject to customary conditions, including approval by Alchemy's shareholders and Cartiga's members, expiration of the Hart-Scott-Rodino waiting period, Nasdaq's approval of Pubco's initial listing application, and Available Closing Buyer Cash of at least $40,000,000. If Available Closing Buyer Cash falls short of $40,000,000 and Cartiga elects to waive the minimum cash condition, Alchemy's sponsor must forfeit shares on a tiered schedule, for example retaining 3,198,875 shares if cash is between $35,000,000 and $40,000,000, down to 1,700,000 shares if cash is below $5,000,000. The agreement originally provided for termination by either party if closing had not occurred by May 1, 2026, among other customary termination triggers including an uncured material breach, failure to obtain required shareholder or member approvals, or the company entering a definitive agreement for a "Superior Offer" (subject to payment of any required termination fee, the dollar amount of which was not disclosed in the filing). Ancillary agreements executed alongside signing included a Support and Non-Redemption Agreement, a Support Agreement, and Lock-up Agreements restricting Cartiga sellers' post-closing shares for six months or until Pubco's share price reaches $12.00 for 20 of 30 trading days (starting at least 150 days after closing); additional agreements, including an Amended and Restated Registration Rights Agreement, a Tax Receivable Agreement, and an Exchange Agreement, are to be executed at closing. At signing, Alchemy co-CEO Mattia Tomba stated, "At Alchemy, we specialize in unlocking under-explored private-credit opportunities and delivering capital solutions that help companies scale and, when appropriate, access the public markets. We believe Cartiga is exceptionally well situated to capitalize on growing opportunities to invest in the legal services sector, a $300bn+ market representing ~1.4% GDP which has historically been underpenetrated by traditional sources of capital." Cartiga CEO Sam Wathen said, "Accessing the public markets in partnership with Alchemy will position us to leverage our data platform and market distribution to accelerate growth, expand our product suite, and deepen our capital and service-based partnerships with law firms." The press release described the deal as designed to let Cartiga "leverage Cartiga's 20+ year investment track record, proprietary database of over 250,000 individual litigation-linked asset fundings diversified across 8,000+ unique lawyers and law firms, and over $20 million of IT and product development investments since 2020" to use public currency to pursue complementary acquisitions. An Investor Presentation dated October 2025, filed with the SEC on October 30, 2025 under Item 7.01 of Form 8-K, disclosed unaudited Cartiga financial metrics for the nine months ended June 30, 2025: $61,292,000 of revenue, $14,986,000 of EBITDA, $19,230,000 of Adjusted EBITDA, and $5,984,000 of net income. The presentation's EBITDA reconciliation added back $6,202,000 of interest expense and $2,800,000 of depreciation and amortization to net income to reach EBITDA, then added $838,000 of litigation expenses, $2,133,000 of management fees and expenses, $326,000 of severance expenses, $693,000 of strategic expenses, and $254,000 of other items to reach Adjusted EBITDA. The presentation also disclosed that Cartiga has deployed more than $1.6 billion in lifetime originations, participated in matters generating over $20 billion in estimated settlement values, maintains roughly 95 employees, and is backed by over $280 million (elsewhere cited as $250 million+) of committed equity from institutional investors. No pro forma ownership split, exchange ratio, synergy estimate, or EPS accretion/dilution figure was disclosed in any of the filings reviewed. The transaction has not closed. ALCY's registration statement from its 2023 IPO required it to complete a business combination within 36 months of the IPO's May 4, 2023 effectiveness; because the Cartiga combination was not consummated by that May 4, 2026 deadline, Nasdaq suspended trading in ALCY's units, Class A shares, and warrants at the opening of business on May 14, 2026 for noncompliance with Nasdaq Interpretive Material IM-5101-2, and the securities now trade on the OTC Pink Open Market under ALCYF, ALCUF, and ALCWF, as disclosed in Alchemy's DEF 14A filed July 29, 2026. At a general meeting first convened September 1, 2026 and adjourned twice (to September 4 and September 8, 2026), shareholders approved a further extension of Alchemy's deadline to complete a business combination from September 9, 2026 to September 9, 2027, on a month-to-month basis, continuing to pursue the "Proposed Business Combination" with Cartiga; a definitive merger proxy/prospectus on Form S-4 for the Cartiga transaction itself had not yet been declared effective and no shareholder vote on the Business Combination itself has yet occurred. No information was found confirming termination of the Cartiga deal, a closing, or a replacement target, so status remains pending. B. Riley Securities acted as exclusive financial advisor to Cartiga, and Nelson Mullins Riley & Scarborough LLP served as legal counsel to Cartiga. Keefe, Bruyette & Woods, A Stifel Company, acted as exclusive financial advisor to Alchemy, and Loeb & Loeb LLP served as legal counsel to Alchemy.

Nordstrom, Inc. (NYSE: JWN), a Seattle-based multi-line and omnichannel retailer, agreed on December 22, 2024 to be acquired by members of the Nordstrom family (led by co-CEOs Erik and Pete Nordstrom, together with other family members and related trusts, the "Family Group") and El Puerto de Liverpool, S.A.B. de C.V. (BMV: LIVEPOL), a Mexican department-store retailer that already held a passive minority stake in Nordstrom. The transaction was structured as an all-cash going-private merger valued at approximately $6.25 billion on an enterprise basis. The merger closed on May 20, 2025. Under the terms of the Agreement and Plan of Merger, each share of Nordstrom common stock not already held by the Family Group or Liverpool (and not rolled over) was converted into the right to receive $24.25 per share in cash. The merger consideration represented a premium of approximately 42% (42.1% per the proxy statement) over Nordstrom's unaffected closing stock price on March 18, 2024, the last trading day before media speculation about a potential transaction began. The Nordstrom board also declared a special cash dividend of $0.25 per share and a stub-period dividend of $0.1462 per share, both contingent on closing and paid May 27, 2025 to holders of record as of May 19, 2025; outstanding vested options, RSUs and PSUs were cashed out based on a combined reference price of $24.50 per share (merger consideration plus the special dividend). Following the closing, the Nordstrom Family holds a 50.1% ownership stake and Liverpool holds 49.9%, consistent with the ownership split disclosed at signing. The deal was financed through rollover equity contributed by the Family Group and Liverpool, cash commitments from Liverpool, up to $450 million of borrowings under a new $1.2 billion senior secured asset-based revolving credit facility (arranged with Wells Fargo Bank, N.A. as agent) -- of which $450 million was drawn at closing -- and Nordstrom's own cash on hand. Nordstrom's approximately $2.7 billion of existing senior notes and debentures remained outstanding after closing and were secured with new second-priority liens on the company's current assets and first-priority liens on its other assets (excluding real estate). Concurrently with closing, Nordstrom also repaid and terminated its prior revolving credit agreement with Wells Fargo. In fairness analyses prepared for the Special Committee's financial advisors, Centerview Partners' selected public companies analysis, based on department-store peers and Wall Street consensus FY2024 and FY2025 adjusted EBITDA estimates, implied a per-share value range of $14.60 to $21.05 for fiscal 2024 and $17.75 to $25.00 for fiscal 2025, both below or bracketing the $24.25 merger price. Morgan Stanley's comparable company analysis applied a representative AV/EBITDA multiple range of 3.5x to 5.0x to Nordstrom's estimated adjusted EBITDA. Centerview's discounted cash flow analysis used discount rates of 11% to 13% and perpetuity growth rates of 1.5% to 2.5% applied to management's "December Projections." No synergy estimates are disclosed in the sourced materials, consistent with a going-private transaction with no operating combination of two public companies. According to a court declaration by Erik Nordstrom filed in related shareholder litigation, the going-private idea originated with Erik and Pete Nordstrom's own view that the company's next growth phase would be better pursued as a private company; they raised this with the board in February 2024, prompting formation of a three-member Special Committee (Kirsten Green, Amie Thuener O'Toole and Eric Sprunk, as chair) to oversee the process. The Special Committee ran a multi-month solicitation process beginning in 2023-early 2024 that included non-disclosure agreements with seven invitees (including Liverpool, which initially attended only as a passive observer) and outreach to multiple private equity sponsors (referred to in the proxy as "Sponsor E" and "Strategic C," among others) before the Family Group and Liverpool were authorized to pursue a joint proposal as a "Bid Group" in the fall of 2024. Eric Sprunk, the Special Committee chairman, stated the committee "reviewed this proposal against the Company's standalone prospects for growth" and, "following a rigorous and independent evaluation and consultation with outside financial and legal advisors, ... unanimously concluded that this transaction offers greater value for all public shareholders at a significant premium to the unaffected share price." The proxy also discloses that the Nordstrom board assessed that the company's "trading multiple appears range bound based on negative investor sentiment about the retail department store sector." The merger agreement provided for a termination fee payable by Nordstrom to Parent of $85 million if Parent terminated following an adverse recommendation change by the Nordstrom board, or $42.5 million under specified competing-proposal/failure-to-obtain-shareholder-approval circumstances. Parent was required to pay Nordstrom a reverse termination fee of $170 million if Nordstrom terminated due to Parent's material breach or failure to close (or related circumstances), or $100 million if either party terminated due to a below-investment-grade ratings event. The proxy statement's background section also describes earlier negotiating rounds in which the Bid Group's proposals included termination-fee structures expressed as a percentage of equity value (ranging from roughly 2% to 7% of equity value at various points in the negotiation) before the parties settled on the fixed dollar amounts above. Approval required both a two-thirds vote of all outstanding shares and a separate majority-of-the-minority vote of unaffiliated shareholders. At a special shareholder meeting held May 16, 2025, with 142,942,995 shares (approximately 85.47% of shares outstanding) represented, shareholders approved the merger: the two-thirds approval vote passed 142,030,974 for to 770,781 against, and the majority-of-the-minority vote (based on 96,549,953 shares entitled to vote in that sub-class) passed 71,381,079 for to 770,781 against. The merger became effective May 20, 2025 upon filing of Articles of Merger with the Washington Secretary of State. Nordstrom common stock ceased trading and was delisted from the NYSE effective May 21, 2025, and the company subsequently filed to deregister under the Exchange Act. Erik and Pete Nordstrom continue to lead the company as Co-CEOs post-closing. On financial advisors, Morgan Stanley & Co. LLC and Centerview Partners LLC acted as financial advisors to the Special Committee of the Nordstrom board. Moelis & Company LLC acted as financial advisor to the Nordstrom Family. J.P. Morgan Securities LLC acted as financial advisor to Liverpool. On legal advisors, Sidley Austin LLP and Perkins Coie LLP acted as legal counsel to the Special Committee; Wilmer Cutler Pickering Hale and Dorr LLP (WilmerHale), Lane Powell PC and Davis Wright Tremaine LLP acted as legal counsel to the Nordstrom Family; and Simpson Thacher & Bartlett LLP and Galicia Abogados, S.C. acted as legal counsel to Liverpool.

This deal involves TaskUs, Inc. (ticker TASK), a technology-sector company, as the target of a take-private transaction structured as a management buyout with sponsor participation, involving an affiliate of Blackstone together with TaskUs's co-founder and chief executive. The transaction is categorized under the sponsors-coverage product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published May 9, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Evercore Group L.L.C. is serving as financial advisor to the Special Committee of the TaskUs Board of Directors (target side), with the source sentence noting that Cravath, Swaine & Moore LLP is serving as legal counsel to that Special Committee. On the sponsor side, BofA Securities is serving as financial advisor to the Buyer Group, with Simpson Thacher & Bartlett LLP serving as the Buyer Group's legal counsel, per the corresponding source sentence. Legal advisors are disclosed for multiple parties: Cravath, Swaine & Moore LLP is serving as legal counsel to the Special Committee (target side); Simpson Thacher & Bartlett LLP is serving as legal counsel to the Buyer Group (sponsor side); and separately, Latham & Watkins LLP is serving as legal counsel to Bryce Maddock and Jaspar Weir, individuals named in connection with the management buyout, also categorized as sponsor-side counsel in the facts block. Beyond classifying this as a take-private management buyout with sponsor involvement, the facts block does not specify the per-share buyout price or the ownership structure of the post-transaction private company. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not clarify how the Buyer Group, the individuals Bryce Maddock and Jaspar Weir, and the Blackstone affiliate relate to one another in terms of ownership structure.

Accelerate Diagnostics, Inc., a healthcare company, is the target in an asset sale structured as a bankruptcy proceeding. This is a restructuring transaction with a disclosed value of $36,900,000 in U.S. dollars. The transaction was announced and is being tracked through SEC filings. The information regarding this transaction is sourced from an SEC filing published on May 8, 2025, through the SEC EDGAR system. While the specific form type is not identified in the available data, the filing confirms the announced status of the asset sale. No expected closing date or other timeline milestones have been disclosed. Accelerate Diagnostics retained three advisors to represent its interests in the transaction. Fried, Frank, Harris, Shriver & Jacobson LLP serves as legal counsel to the target. On the financial advisory side, Solic Capital is serving as financial advisor, while Perella Weinberg Partners L.P. is acting as restructuring investment banker. No advisors representing the acquirer or other parties to the transaction have been identified in the available source materials. No separate legal advisors beyond Fried, Frank, Harris, Shriver & Jacobson LLP have been disclosed. The legal representation appears to be consolidated under the single counsel identified for Accelerate Diagnostics. The transaction involves an asset sale of Accelerate Diagnostics' assets as part of a bankruptcy process, valued at $36,900,000. Beyond the aggregate disclosed value, no further detail regarding the consideration structure, whether cash or stock or mixed, has been provided. The specific identity of the acquirer or purchaser of the assets has not been disclosed in the available materials. Notable gaps in the public disclosure include the identity of the acquiring party, the expected closing date, the composition of the consideration (cash, stock, other instruments, or a combination thereof), any details regarding which specific assets are being sold, the terms of the bankruptcy sale process, and any additional conditions or milestones that may apply to the transaction. No information regarding potential financing or any debt arrangements related to the asset sale has been provided.

American Integrity Insurance Group, Inc., a Tampa, Florida-based property and casualty insurer trading under ticker AII on the New York Stock Exchange, completed its initial public offering on May 9, 2025. The company sold 6,250,000 shares of common stock and certain selling stockholders sold an additional 625,000 shares, for an aggregate of 6,875,000 shares priced at $16.00 per share, resulting in a total offering size of $110,000,000. Gross proceeds to the company were $100,000,000 and gross proceeds to the selling stockholders were $10,000,000, both before underwriting discounts, commissions and offering expenses. The underwriters were granted a 30-day option to purchase up to 1,031,250 additional shares from the selling stockholders to cover over-allotments. On May 12, 2025 the underwriters notified the company that they had exercised this option in full, and the option shares closed on May 13, 2025. All of the option shares were sold by the selling stockholders, who received additional gross proceeds of $16.5 million before underwriting discounts, commissions and offering expenses; the company did not receive any proceeds from the sale of the option shares. Including the fully exercised option, total gross offering proceeds (company plus selling stockholders) reached $126,500,000. The underwriting discount was $1.12 per share. Before exercise of the option, underwriting discounts and commissions payable by the company and selling stockholders totaled $7,700,000, rising to $8,855,000 assuming full exercise; of that, $700,000 (no exercise) to $1,855,000 (full exercise) was payable by the selling stockholders alone. Proceeds before expenses to the company were $93,000,000 (unaffected by the option, since the company sold no option shares), while proceeds before expenses to the selling stockholders were $9,300,000 with no exercise and $24,645,000 with full exercise. The company separately estimated total offering expenses, excluding underwriting discounts and commissions, at approximately $5,000,000. Keefe, Bruyette & Woods, Inc. and Piper Sandler & Co. acted as joint bookrunning managers and representatives of the underwriters. Per the underwriting agreement's share allocation table, Keefe, Bruyette & Woods and Piper Sandler each committed to purchase 2,406,250 shares; William Blair & Company, L.L.C. committed to 687,500 shares; Citizens JMP Securities, LLC (marketed on the prospectus cover as Citizens Capital Markets) and Raymond James & Associates, Inc. each committed to 515,625 shares; and Oppenheimer & Co. Inc. committed to 343,750 shares, for a total of 6,875,000 shares. The company expects net proceeds of approximately $81.5 million after deducting the underwriting discount and other offering-related expenses, including termination of the Sowell management services agreement and a Restricted Stock Grant Net Settlement. The company intends to use the net proceeds for general corporate purposes, which may include contributing capital to its subsidiary AIICFL to support growth, and to use approximately $3.5 million of net proceeds to satisfy tax withholding and remittance obligations tied to the Restricted Stock Grant Net Settlement (an estimated 427,333 shares of common stock to be issued in that settlement, assuming a 33.8% weighted average tax withholding rate). On a pro forma basis as of December 31, 2024, the company's net tangible book value was $12.11 per share before the offering (on 13,331,828 shares outstanding), increasing to $12.62 per share after the offering. New investors purchasing at the $16.00 IPO price experienced immediate dilution of $3.38 per share, while existing owners saw an immediate increase in net tangible book value of $0.51 per share. After the offering, the company had 19,581,828 shares of common stock outstanding. Substantially all shares not sold in the offering became subject to a 180-day lock-up period under lock-up agreements executed in connection with the offering. In connection with the offering, on May 6, 2025 the company filed an amended and restated certificate of incorporation with the Delaware Secretary of State and its amended and restated bylaws became effective, both approved in advance by the board and stockholders to take effect prior to consummation of the IPO. Legal counsel to the company on the validity of the common stock offered was Haynes and Boone, LLP of Dallas, Texas. Legal counsel to the underwriters was Skadden, Arps, Slate, Meagher & Flom LLP of New York, New York. Certain legal matters relating to descriptions of the company's insurance regulatory environment were passed upon for the company by Meenan, P.A. of Tallahassee, Florida; the prospectus discloses that certain partners of Meenan, P.A. are members of American Integrity Insurance Group, LLC. Because the IPO has been confirmed as completed (priced May 7, 2025, closed May 9, 2025, with the over-allotment option fully exercised and closed May 13, 2025), this deal is no longer pending; the status reflects a closed, completed offering rather than pending regulatory approval. No further use-of-proceeds detail, concurrent share repurchase, or pricing-versus-prior-trading-price comparison is disclosed, since there was no pre-IPO public market for the stock (the $16.00 price was the first public price, not a premium or discount to a prior closing price).

This record describes a cash-and-stock acquisition falling under the M&A product group, involving Endo Inc. and Mallinckrodt plc. The disclosed value of the transaction is not stated in the source document. The source sentence provided references Endo as the party whose financial advisor's opinion is being discussed, consistent with Endo occupying the target role in this record. The facts are sourced from an S-4 filing with the SEC via EDGAR, published May 8, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed: Goldman Sachs & Co. LLC, which served as financial advisor to Endo (the target) and is designated lead. The source sentence is drawn from a consent letter, in which the firm consents to the reference to its opinion letter under the caption "Opinion of Endo's Financial Advisor," and is signed on behalf of Goldman Sachs & Co. LLC. No financial advisor is named for the Mallinckrodt (acquirer) side in the facts provided. No legal advisors are identified in the facts block for either party to this transaction. Beyond classifying this as a cash-and-stock acquisition, the facts block does not specify the mix of cash versus stock consideration, the exchange ratio, or the aggregate or per-share value of the deal. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No legal advisors are named for either side. No financial advisor is identified for Mallinckrodt, and no expected closing date is given.

The Goodyear Tire & Rubber Company announced on May 7, 2025 the completion of its previously announced sale of the Dunlop brand rights covering Europe, North America and Oceania for consumer, commercial and other specialty tires, together with associated intellectual property and inventory, to Japan's Sumitomo Rubber Industries, Ltd. Goodyear said it would use the proceeds to reduce leverage as part of its broader Goodyear Forward transformation plan. This extraction is sourced from Goodyear's 8-K press release exhibit (Exhibit 99.2) filed with the SEC on May 7, 2025, announcing deal completion. The filing confirms the transaction as fully closed rather than merely announced, with gross cash proceeds disclosed at the time of closing. Goldman Sachs & Co. LLC acted as the lead financial advisor to Goodyear, with Barclays Capital Inc. acting as an additional financial advisor to Goodyear on the sell side. The release does not identify any financial advisor to Sumitomo Rubber Industries, the buyer. Cleary Gottlieb Steen & Hamilton LLP served as legal advisor to Goodyear on the transaction; no legal advisor to Sumitomo Rubber Industries is named in this release. Gross cash proceeds at closing totaled $735 million, comprised of $526 million allocated to the Dunlop brand itself, $105 million for a transition support fee, and $104 million for inventory. The divestiture was structured as a straightforward cash sale of brand rights and related assets rather than a sale of an operating subsidiary or business unit with its own financial statements. The press release does not disclose the specific advisory fees paid to either Goldman Sachs or Barclays, the identity of any financial or legal advisor representing Sumitomo Rubber Industries, or the original announcement date of the transaction (only the closing date of May 7, 2025 is given in this exhibit).

This is a cash-and-equity acquisition with an earnout in the fig sector in which TPG Inc. (ticker TPG) is acquiring Peppertree Capital Management, Inc. The product group is M&A, and the disclosed transaction value is $660,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on May 6, 2025. The deal's current status is pending regulatory review. The financial advisory roster on the acquirer side includes four firms: BofA Securities, Goldman Sachs, Houlihan Lokey, and Campbell Lutyens, all identified per the source sentence "BofA Securities, Goldman Sachs, Houlihan Lokey, and Campbell Lutyens acted as financial advisors to TPG," with none of the four individually designated as lead. On the target side, Evercore served as financial advisor to Peppertree, per the statement "Evercore acted as financial advisor to Peppertree," also without a lead designation specified. Legal advisors are disclosed for both sides: Weil, Gotshal & Manges LLP served as TPG's transaction counsel, the acquirer side, while Kirkland & Ellis LLP served as Peppertree's transaction counsel, the target side. Beyond the classification of this transaction as a cash-and-equity acquisition with an earnout, structured with a disclosed value of $660,000,000, no further detail on the specific cash/equity split or the earnout's terms (such as metrics, thresholds, or payout timing) is included in the facts provided. Several items are not disclosed in this record: the precise cash-versus-equity consideration mix is not specified, the structure and targets of the earnout are not detailed, and no expected closing date is given beyond the pending-regulatory status.

This record covers the closing of an acquisition in the industrials sector in which AeroVironment Inc (ticker AVAV) is the acquirer of BlueHalo LLC. The product group is M&A, and the subtype is described as an acquisition closing. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on May 1, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity. RBC Capital Markets served as the lead financial advisor to AeroVironment, the acquirer, per the statement "RBC Capital Markets served as financial advisor and Latham & Watkins LLP served as legal advisor to AeroVironment." On the target side, J.P. Morgan Securities LLC served as the lead financial advisor to Arlington Capital Partners and BlueHalo, consistent with the language "J.P. Morgan Securities LLC served as financial advisor and Goodwin Procter LLP served as legal advisor to Arlington Capital Partners and BlueHalo." Legal advisors are disclosed for both sides: Latham & Watkins LLP served as legal advisor to AeroVironment, the acquirer, while Goodwin Procter LLP served as legal advisor to Arlington Capital Partners and BlueHalo, the target side. Beyond the designation of this record as covering the closing of the acquisition, no further detail on consideration structure, purchase price, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the consideration structure is not specified, and while this record covers the acquisition closing, no additional closing-date detail beyond the pending-regulatory status field is given in the facts provided.

This transaction involves Rocket Companies, Inc. (ticker RKT), a financial-institutions-group (fig) sector company, as the acquirer, in a stock-for-stock merger. The deal falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an S-4 filing with the SEC via EDGAR, published May 1, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed: Goldman Sachs & Co. LLC, which served as financial advisor to the target (Redfin) and is designated lead on that side. The source sentence is drawn from a consent letter referencing Goldman Sachs's opinion, stating that the firm consented to being referenced under the caption "Summary, Opinion of Redfin's Financial Advisor" in the relevant disclosure document, and is signed on behalf of Goldman Sachs & Co. LLC. No financial advisor is named for the acquirer, Rocket Companies, in the facts provided. No legal advisors are identified in the facts block for either the target or the acquirer. Beyond classifying the transaction as a stock-for-stock merger, no further structural detail, such as the exchange ratio, is included in the facts block. A number of material facts are not disclosed in this record. The transaction's dollar value is not stated. No legal advisors are named for either side. No financial advisor is identified for the acquirer side, and no expected closing date is given.

Mid Penn Bancorp, Inc. (NASDAQ: MPB), headquartered in Harrisburg, Pennsylvania, completed its acquisition of William Penn Bancorporation (NASDAQ: WMPN), the Bristol, Pennsylvania-based holding company for William Penn Bank, after the close of business on April 30, 2025. William Penn merged with and into Mid Penn, and William Penn Bank was simultaneously merged into Mid Penn Bank, with Mid Penn Bank as the surviving institution. The transaction was announced on November 1, 2024, when the companies entered into a definitive Agreement and Plan of Merger dated October 31, 2024, and it closed within the timeframe management had targeted of the first half of 2025. The deal was structured as an all-stock transaction. Each share of William Penn common stock was converted into the right to receive 0.426 shares of Mid Penn common stock, with cash paid in lieu of fractional shares. At announcement on November 1, 2024, based on Mid Penn's October 30, 2024 closing stock price of $31.88, the implied value was approximately $13.58 per William Penn share, or approximately $127 million in the aggregate. By the time Piper Sandler rendered its fairness opinion on October 31, 2024, the firm calculated an aggregate implied transaction value of approximately $128.45 million and an implied price of $13.68 per William Penn share, based on 9,208,217 shares outstanding (including restricted stock awards) and 1,264,000 options with a weighted-average exercise price of $11.71. At closing, Mid Penn issued approximately 3,601,407 shares of common stock to William Penn shareholders, plus up to an additional 538,464 shares issuable upon exercise of assumed former William Penn stock options; the completed deal was ultimately described by the company as valued at approximately $120 million. William Penn's options were converted into Mid Penn equivalent options using the same 0.426 exchange ratio, with exercise prices adjusted accordingly. On valuation multiples, Piper Sandler's fairness-opinion analysis calculated the transaction price per share at 102% of William Penn's tangible book value per share, a 1.0% tangible book premium to core deposits (deposits excluding CDs over $100,000), and a 7.3% premium to William Penn's October 29, 2024 closing market price. Price-to-earnings multiples were deemed "not meaningful" (NM, defined as a multiple above 40.0x or below 0.0x) because William Penn's trailing and projected earnings were minimal to negative at the time. In a comparison against a nationwide group of 15 bank and thrift transactions announced between January 1, 2023 and October 29, 2024 with target assets of $500 million to $5.0 billion, the Mid Penn/William Penn deal's 102% price-to-tangible-book multiple compared to a peer-group median of 108% (mean 106%, range 31%-171%), and its 7.3% one-day market premium compared to a median of 39.6% (mean 38.4%) for the precedent group. Piper Sandler's pro forma transaction analysis, assuming a June 30, 2025 close, concluded the merger could be accretive to Mid Penn's estimated earnings per share (excluding one-time transaction costs) for 2025 through 2027, while being dilutive to Mid Penn's estimated tangible book value per share at close and in 2025 and 2026, turning accretive to tangible book value in 2027; no specific accretion/dilution percentages were disclosed in the sections reviewed. The joint proxy statement/prospectus separately disclosed Mid Penn's after-tax estimated merger-related charges of $9.3 million, reflected as an adjustment to the pro forma balance sheet. The pro forma financial statements explicitly excluded any dollar estimate of anticipated cost savings or revenue enhancements; the filing discusses expected cost savings and synergies only in qualitative terms (e.g., consolidating personnel, benefits plans, premises, and systems), without a disclosed dollar figure, percentage of expense base, or phase-in schedule. At announcement, William Penn operated 12 branches across Pennsylvania and New Jersey from its Bristol, PA headquarters, with approximately $812 million in total assets, $465 million in total loans, and $630 million in total deposits as of September 30, 2024. Mid Penn had approximately $5 billion in total assets at announcement. The combined company was expected to have approximately $6.3 billion in total assets, $4.9 billion in total loans, and $5.3 billion in total deposits based on September 30, 2024 data; the actual combined company had approximately $6.3 billion in total assets at closing. Concurrent with the merger announcement, and independent of the merger's completion, Mid Penn also priced a public common stock offering (initially sized at approximately $50 million, later increased to approximately $75 million base amount), ultimately raising approximately $76.5 million of net proceeds through the November 5, 2024 issuance of 2,731,250 shares at $29.50 per share, to support capital levels, commercial real estate concentration ratios, and future growth; the merger's closing was not contingent on completion of the offering. Mid Penn Chair, President and CEO Rory G. Ritrievi said the combination would "bolster Mid Penn's presence in the attractive greater Philadelphia metro area market, aligning with our strategic plan of disciplined growth in the southeastern region of Pennsylvania and the southern region of New Jersey." William Penn Chairman, President and CEO Kenneth J. Stephon said the merger "allows our shareholders to participate in a fabulous long-term growth opportunity while also providing them with immediate value" and would let William Penn "accelerate our growth far more rapidly than we could as an independent company." Upon closing, Stephon joined Mid Penn's and Mid Penn Bank's boards of directors, became Vice Chairman of Mid Penn Bank, and was named Chief Corporate Development Officer of both Mid Penn and Mid Penn Bank under a new three-year employment agreement providing a $400,000 annual base salary, a $900,000 retention bonus payable in three annual installments, and an annual $50,000 deferred-compensation contribution; the joint proxy statement/prospectus separately disclosed a one-time cash bonus of $2,074,776 payable to Stephon immediately prior to closing. William Penn's remaining non-employee directors were offered paid three-year terms on a Mid Penn Bank advisory board. The joint proxy statement/prospectus (Form S-4, File No. 333-284342, declared effective February 7, 2025) disclosed that William Penn ran a multi-party sale process beginning in early 2024: its board, advised by Piper Sandler, rejected an approach from "Company A" at an implied $9.00 per share as inadequate, then had Piper Sandler solicit seven potential acquirers (including Mid Penn) under a confidential information memorandum. Of those, five signed confidentiality agreements, and four (Mid Penn, and "Company B," "Company D," and "Company E") submitted non-binding indications of interest in August 2024, ranging from $10.43 to $12.80 implied value per share; Mid Penn's initial indication implied $11.87 per share at the 0.426 exchange ratio. William Penn's board rejected Company B (whose stock traded at a premium to peers but with a newer, less-experienced management team and no presence in William Penn's market) and Company E (inadequate price), and Company D later withdrew for unrelated reasons, leaving Mid Penn as the remaining bidder; William Penn and Mid Penn signed an exclusivity agreement on September 11, 2024, running to November 4, 2024. Piper Sandler delivered its fairness opinion to William Penn's board and KBW delivered its fairness opinion to Mid Penn's board, both dated October 31, 2024, the date the merger agreement was executed. Piper Sandler's fee for advising William Penn was contingent on closing and equal to 1.25% of the aggregate purchase price (approximately $1.6 million at announcement), with a $250,000 opinion fee credited against that amount. The merger agreement, filed as Exhibit 2.1 to Mid Penn's November 1, 2024 Form 8-K, provided for a termination fee of $4,900,000 payable by William Penn to Mid Penn under certain circumstances, including if William Penn's board changed its recommendation or accepted a superior proposal. Closing conditions included approval by both companies' shareholders, effectiveness of Mid Penn's Form S-4 registration statement, Nasdaq listing approval for the shares to be issued, receipt of required bank regulatory approvals without materially adverse conditions, and customary bring-down of representations and warranties, alongside receipt by each party of a tax opinion that the merger would qualify as a reorganization under Section 368(a) of the Internal Revenue Code. Directors and executive officers of both companies representing approximately 9.2% of William Penn's and 8.9% of Mid Penn's outstanding shares signed affiliate/voting letters agreeing to vote in favor of the transaction. Beginning January 20, 2025, certain purported William Penn shareholders sent demand letters alleging disclosure deficiencies in the Form S-4; neither company believed any resulting demands or litigation would have a material adverse effect on its financial position.

This transaction is an all-stock merger in which Mid Penn Bancorp Inc (ticker MPB), a company in the financial institutions group (FIG) sector, is the acquirer of William Penn Bancorporation, the target. The deal is classified under the M&A product group, with a disclosed value of $120,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on May 1, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Piper Sandler & Co. served as financial advisor to William Penn, the target, rendering a fairness opinion to William Penn's board of directors, and is designated as lead advisor. On the acquirer side, Stephens Inc. served as financial advisor to Mid Penn and is also designated as lead advisor, while Keefe, Bruyette & Woods, a Stifel Company, separately rendered a fairness opinion to Mid Penn's board without a lead designation specified. Legal counsel was also disclosed for both sides. Pillar + Aught served as legal advisor to Mid Penn, the acquirer. Kilpatrick Townsend & Stockton LLP served as legal advisor to William Penn, the target. Beyond the all-stock characterization of the merger and the disclosed $120,000,000 deal value, the facts block does not provide the specific exchange ratio or other detailed terms of the stock consideration. Several facts are not disclosed in the source material. The facts block does not specify the exchange ratio for the all-stock consideration, nor does it give an expected closing date for the transaction.

Enterprise Financial Services Corp (NASDAQ: EFSC), through its wholly-owned subsidiary Enterprise Bank & Trust, agreed to acquire twelve branch offices from First Interstate Bank, the banking subsidiary of First Interstate BancSystem, Inc. (NASDAQ: FIBK). The transaction was announced on April 28, 2025 via a joint press release filed as an exhibit to Form 8-K by both companies, and comprises two separate branch franchises: ten branches in Arizona and two branches in Kansas (Overland Park and Shawnee). Under the purchase and assumption agreement, First Interstate agreed to transfer the branch facilities and associated real estate and fixed assets, approximately $740 million of deposits, and commercially-oriented loans with outstanding balances of roughly $200 million. No purchase price, deposit premium, or other valuation multiple was disclosed in either company's announcement 8-K. Enterprise Bank & Trust CEO James B. Lally said the acquisition would expand the company's presence into "markets with both attractive growth opportunities," and emphasized that Enterprise values "personal connections and trust" in the communities it serves. First Interstate CEO James A. Reuter said the sale would allow First Interstate to "shift capital investment" toward markets where it holds higher market share, consistent with a broader footprint-reorientation strategy the company pursued during 2025 that also included divestitures in Nebraska, outsourcing its consumer credit card product, and discontinuing indirect lending. On a pro forma basis, management said the acquisition would expand Enterprise's Arizona franchise to twelve full-service branches with approximately $1.3 billion of deposits, and its greater Kansas City-area franchise to nine full-service branches with approximately $1.1 billion of deposits. The transaction closed on October 10, 2025, becoming effective at 11:59 p.m. Central time, following all required regulatory approvals. Enterprise disclosed in its closing Form 8-K (filed October 14, 2025) that the final transaction terms at closing involved approximately $645 million of deposits assumed and approximately $300 million of performing loans purchased -- both different from the amounts disclosed at signing ($740 million of deposits and $200 million of loans), reflecting changes in the underlying balances between signing and closing. Enterprise said the completed acquisition brought its pro forma total assets to approximately $17 billion. First Interstate subsequently disclosed in its fourth-quarter 2025 earnings release (Form 8-K filed January 28, 2026) that it recognized a $62.7 million gain on the sale of the Arizona and Kansas branches, recorded in other/noninterest income for the quarter ended December 31, 2025. No purchase price or premium-to-deposits figure that would allow derivation of the sale price has been disclosed in any filing reviewed. No merger proxy, S-4, or tender offer documents were filed in connection with this transaction, consistent with its structure as a branch purchase and assumption agreement rather than a corporate merger; neither company's shareholders were required to vote on the transaction. On the financial advisory side, Keefe, Bruyette and Woods Inc. served as lead financial advisor to First Interstate, and Janney Montgomery Scott LLC served as lead financial advisor to Enterprise. Luse Gorman, PC acted as legal advisor to First Interstate, and Holland and Knight LLP acted as legal advisor to Enterprise.

Enterprise Financial Services Corp (Nasdaq: EFSC), the St. Louis, Missouri-based holding company of Enterprise Bank & Trust, agreed to acquire twelve branch offices from First Interstate Bank, the Billings, Montana-based bank subsidiary of First Interstate BancSystem, Inc. (Nasdaq: FIBK). The transaction was structured as a purchase and assumption agreement, signed April 28, 2025 and announced jointly by both companies that day, rather than a whole-company merger. The acquisition covers two separate franchises: ten branches in Arizona (North Scottsdale, Old Town Scottsdale, Chandler, Maricopa, Casa Grande, Eloy, Coolidge, Globe, Tucson, and Nogales) and two branches in the greater Kansas City area (Overland Park and Shawnee, Kansas). As announced, the purchase and assumption agreement provided for First Interstate Bank to transfer the branch facilities and associated assets to Enterprise Bank & Trust along with approximately $740 million in deposits and roughly $200 million of outstanding loans, described as mostly commercially-oriented. No purchase price, deposit premium, or other valuation metric for the transaction was disclosed in any of the filings reviewed; the agreement was a branch/deposit purchase rather than a stock-for-stock or cash-per-share merger, and the companies did not publish an aggregate deal value, premium percentage, or multiple. James B. Lally, President and CEO of Enterprise Financial Services Corp, said at announcement: "We are pleased to enter into this agreement with First Interstate Bank. This is a unique and strategically-aligned opportunity to expand our access to markets with both attractive growth opportunities and familiarity and to continue to generate long-term value for our shareholders. Since entering the Arizona market nearly fifteen years ago, we have grown our business significantly... In addition, we are also very excited to solidify our presence in Kansas City through this transaction." James A. Reuter, President and CEO of First Interstate BancSystem and First Interstate Bank, stated: "This agreement provides us an opportunity to shift our capital investment and drive growth in areas where we enjoy increased market share, while creating additional capital flexibility." On a pro forma basis at announcement, Enterprise expected the deal to expand its Arizona footprint to twelve full-service branches with approximately $1.3 billion of deposits, and to increase its greater Kansas City presence to nine full-service branches with approximately $1.1 billion of deposits. The transaction closed on October 10, 2025, roughly five and a half months after signing, consistent with the originally guided timeline of "early fourth quarter of 2025." Both companies confirmed the closing in Form 8-K filings dated October 14, 2025. At closing, the actual transferred balances differed from the amounts disclosed at signing: Enterprise Bank & Trust assumed approximately $645 million in deposits and purchased approximately $300 million of performing loans associated with the twelve branches, versus the roughly $740 million in deposits and $200 million in loans originally disclosed in April 2025. Following completion, Enterprise disclosed it had approximately $17 billion in total assets (versus approximately $16.1 billion as of June 30, 2025, per the closing press release), reflecting the added deposits, loans, and real estate. The branches were fully converted to Enterprise Bank & Trust branch offices effective as of 11:59 p.m. Central time on the closing date. At the closing announcement, Lally stated: "We are pleased to announce the completion of the acquisition of twelve First Interstate Bank branches in Arizona and Kansas City. In addition to an enhanced funding profile, the addition of these branches allows us to expand our access to existing markets with attractive growth opportunities. We believe this transaction will help us meet the needs of our new and existing customers while delivering continued long-term value for our stockholders." No synergy dollar figures, cost-base percentage targets, EPS accretion/dilution estimates, tangible book value earnback period, or pro forma leverage figures were disclosed in any of the filings reviewed for this transaction. The filings also do not disclose a termination fee or detailed closing conditions beyond "regulatory approvals and other customary conditions of closing." No merger proxy, S-4, or investor presentation specific to this branch transaction was identified; the deal was announced and closed solely via joint press releases filed as 8-K exhibits by both companies. Janney Montgomery Scott LLC acted as financial advisor and Holland & Knight LLP as legal advisor to Enterprise on the transaction. Keefe, Bruyette and Woods Inc. acted as financial advisor and Luse Gorman, PC as legal advisor to First Interstate. These advisor roles were confirmed in both the April 28, 2025 announcement press release and reiterated for Enterprise in the October 14, 2025 closing press release.

Boeing has completed the sale of portions of its Digital Aviation Solutions business, including its Jeppesen, ForeFlight, AerData and OzRunways assets, to Thoma Bravo in an all-cash transaction valued at $10.55 billion. The deal was announced on April 22, 2025 and closed on October 31, 2025, following regulatory approval and satisfaction of customary closing conditions. The transaction was structured as a membership interest purchase agreement, dated April 22, 2025, among The Boeing Company as seller, JNPR Aero, LLC as the company being sold, and Project Maroon, LLC, a Thoma Bravo acquisition vehicle, as buyer. Under the agreement, the purchase price was defined as $10,550,000,000 plus the target company's cash, adjusted up or down for working capital relative to agreed collars, and reduced by closing-date indebtedness and transaction expenses. The agreement was backed by an equity financing commitment from Thoma Bravo-affiliated funds, with a limited guarantee from Thoma Bravo guarantor entities covering certain of the buyer's payment obligations; no third-party debt financing for the buyer was disclosed in the purchase agreement. Boeing Chief Executive Officer Kelly Ortberg said the transaction was "an important component of our strategy to focus on core businesses, supplement the balance sheet and prioritize the investment grade credit rating." Chris Raymond, president and CEO of Boeing Global Services, said the sale "enables all parts of the digital portfolio to focus on their strengths," adding that Boeing's "commitment to meeting our customers' needs is unwavering as we move forward with our core products and services to support their fleets." Thoma Bravo Managing Partner Holden Spaht said, "with a heritage dating back to the 1930s, Jeppesen has been at the forefront of technological innovation for nearly a century. We are excited to build on this track record and power its next phase of growth." Thoma Bravo Managing Partner Scott Crabill said the business "has been through an impressive growth transformation in recent years and has strong momentum," and that Thoma Bravo would support "the company's standalone growth objectives through strategic investments, operational best practices and a shared commitment to innovation and long-term value creation." Boeing disclosed that it would retain its core digital capabilities that harness aircraft and fleet-specific data to provide commercial and defense customers with fleet maintenance, diagnostics and repair services, including predictive and prognostic maintenance insights, while the divested businesses depart under Thoma Bravo's ownership. Approximately 3,900 employees worldwide worked in Boeing's Digital Aviation Solutions organization at announcement, spanning both the retained and divested portions of the business; the agreement included principles for data sharing and future collaboration between Boeing and the divested business to help ensure continuity of operations. The merger agreement set a termination date of January 17, 2026 (extendable under specified circumstances tied to outstanding regulatory approvals or the pre-closing reorganization), and provided for a termination fee of $844,000,000 payable by the buyer to Boeing if the agreement was terminated under certain buyer-breach or failure-to-close scenarios, with interest and Boeing's collection costs added if not paid promptly; this fee did not come into play because the deal closed. Boeing's financial statements confirm the closing and its financial impact. As of September 30, 2025, the Digital Aviation Solutions assets ($1,473 million) and liabilities ($524 million) being sold, including $810 million of goodwill, $306 million of acquired intangible assets and $160 million of accounts receivable, were classified as held for sale, with the transaction still pending as of that quarter's Form 10-Q. Boeing's Form 10-K for fiscal year 2025 confirms that the sale closed on October 31, 2025 for proceeds of $10,550 million and resulted in a gain of $9,566 million recorded in "Gain on dispositions, net" in Boeing's consolidated statements of operations. Boeing's Global Services segment (BGS) earnings from operations increased by $9,856 million in 2025 compared with 2024, which Boeing attributed primarily to this gain. Citi served as exclusive financial advisor to Boeing and Mayer Brown LLP served as outside legal counsel to Boeing. Kirkland & Ellis LLP served as legal counsel to Thoma Bravo. No separate investor presentation exhibit was filed alongside the merger agreement and press release, and no merger proxy statement was required since the transaction was a private carve-out sale rather than a public-company merger requiring a shareholder vote. Details such as the specific EBITDA or revenue of the divested business, any EV/EBITDA multiple implied by the $10.55 billion price, and the post-closing capital structure of the newly independent company (which has since been operating under the name Jeppesen ForeFlight) are not disclosed in the SEC filings reviewed.

PMGC Holdings Inc., a healthcare sector company trading under the ticker ELAB, is conducting an at-the-market equity issuance with a disclosed aggregate offering price of $100,000,000. An at-the-market offering, or ATM, is an equity capital markets transaction that allows an issuer to sell shares into the public market opportunistically over time, typically at prevailing market prices, rather than in a single block transaction. This transaction type provides issuers with flexibility regarding the timing and volume of share sales while giving them access to capital up to a specified aggregate amount. The transaction was announced on April 24, 2025, based on documentation filed with the SEC on EDGAR. The specific SEC filing form type is not identified in the available sourcing materials. The deal is currently in announced status, though no expected closing date or timeline for share sales under the agreement has been disclosed. On the financial advisory side, Univest Securities, LLC is serving as the sales agent for the offering under the at-the-market issuance sales agreement. Univest is identified as the lead and sole financial advisor on this transaction. The sourcing materials confirm that under the terms of the agreement, PMGC Holdings may issue and sell from time to time shares of its common stock, par value $0.0001 per share, through Univest Securities in its capacity as sales agent or through any sub-agent or other designee that Univest may appoint to assist in the offering. On the legal advisory side, Sichenzia Ross Ference Carmel LLP is providing counsel to PMGC Holdings. The specific scope of their legal work is not detailed beyond their provision of an opinion related to the offering. The transaction structure provides for the issuance of common stock only. The shares are identified as having par value of $0.0001 per share. The maximum aggregate offering price across all shares that may be sold is $100,000,000. The sales agreement permits the sales agent to act through sub-agents or other designees, providing operational flexibility in the execution of share sales. Beyond these structural terms, no additional information regarding the mechanics of the offering, pricing parameters, or conditions to sales has been disclosed. Several material details regarding this offering remain undisclosed. No timeline or expected closing date for the at-the-market agreement has been provided. The specific number of shares to be issued or the anticipated pricing range has not been disclosed. The terms of Univest's compensation as sales agent are not specified in the available materials. Finally, while Sichenzia Ross Ference Carmel LLP is identified as providing legal counsel, the full scope of their engagement and any other legal advisors assisting either party have not been detailed.

This record concerns Global Clean Energy Holdings, Inc., an industrials-sector company that is the issuer in a Chapter 11 restructuring. The transaction is categorized under the restructuring product group, specifically a Chapter 11 restructuring process, and the disclosed value associated with the matter is $100,000,000. The facts are drawn from two SEC EDGAR filings: an 8-K filing published on April 18, 2025, and a second filing of unknown form type also published on April 18, 2025. As of those filings, the matter's status is pending regulatory, indicating the restructuring process had not yet concluded. Multiple financial advisors appear across different constituencies in this matter. On the creditor side, Perella Weinberg Partners is identified as financial advisor to the DIP TL Agent; the source language specifies that the DIP TL Agent and DIP TL Lenders retained a slate of advisors including Latham & Watkins LLP as counsel to the DIP TL Agent, Hunton Andrews Kurth LLP as local counsel to the DIP TL Agent, Perella Weinberg Partners as financial advisor to the DIP TL Agent, and Matthew Crisp as a consultant to the DIP TL Agent and lenders. On the company side, the source states that Kirkland & Ellis is serving as restructuring counsel, Lazard is serving as the investment banker, and Alvarez & Marsal is serving as the financial advisor to the company, with all three listed as company-side advisors (Lazard in an investment banker capacity and Alvarez & Marsal in a financial advisor capacity). No lead-versus-non-lead designation is given for any of these advisors. On the legal side, Hunton Andrews Kurth LLP is named as local counsel to the DIP TL Agent (noted as a "target"-side legal advisor in the record), Latham & Watkins LLP as counsel to the DIP TL Agent, and Kirkland & Ellis as restructuring counsel to the company. Beyond the identification of these advisor roles and the $100,000,000 disclosed value, the facts block does not provide further detail on the structure of the restructuring, such as the treatment of specific creditor classes, equity conversion terms, or a timeline for emergence from Chapter 11. Several items are not disclosed in this record. There is no stated expected timeline for completion of the restructuring, no detail on how the $100,000,000 figure relates to specific debt instruments or facilities, and no information on lead-advisor status among the several financial and legal advisors named. These gaps should be treated as unknown rather than inferred.

TPG Inc., through its TPG Rise Climate Transition Infrastructure strategy, has completed its acquisition of Altus Power, Inc., the largest owner of commercial-scale solar in the United States, in an all-cash transaction that valued the company at approximately $2.2 billion including outstanding debt. The deal was first announced on February 6, 2025, in a current report on Form 8-K that attached the merger agreement and a joint press release, and it closed on April 16, 2025 after Altus Power stockholders approved the transaction and required regulatory clearances were obtained. Under the terms of the Agreement and Plan of Merger, dated as of February 5, 2025, among Altus Power, Avenger Parent, Inc. and Avenger Merger Sub, Inc., each share of Altus Power Class A common stock was converted into the right to receive $5.00 in cash. The $5.00 per-share price represented a 66 percent premium to Altus Power's unaffected closing price on October 15, 2024, the last trading day before the company announced a formal board review of strategic alternatives. The press release described the deal as the ''culmination of a comprehensive review of opportunities available to Altus Power, with the assistance of the Company's financial and legal advisors.'' The transaction was structured as a one-step merger in which Merger Sub merged with and into Altus Power, with Altus Power continuing as the surviving corporation and becoming a wholly owned, privately held subsidiary of Parent. The company's definitive merger proxy (DEFM14A), filed March 13, 2025, states the deal was not subject to a financing condition; TPG's equity commitment was backed by an Equity Commitment Letter, and debt financing was to be provided under a Debt Commitment Letter from Goldman Sachs Asset Management, L.P. and Broad Street Credit Holdings LLC. Specific dollar amounts of the equity and debt commitments were not disclosed in the merger agreement excerpts reviewed. Stockholders representing approximately 40 percent of Altus Power's Class A common stock, including funds managed by Blackstone Credit and Insurance and a subsidiary of CBRE Group, Inc., signed voting and support agreements committing to vote in favor of the merger. Altus Power Chief Executive Officer Gregg Felton called the agreement ''a pivotal moment for Altus Power'' at signing, and upon closing stated that ''the successful close of this transaction marks a pivotal moment for Altus Power, our stockholders, employees and partners.'' Board Chair Christine Detrick said the board ''unanimously approved this transaction'' and that it would ''unlock significant value for our stockholders, customers and employees.'' The companies described the strategic logic as combining ''TPG Rise Climate's investment capabilities with Altus Power's domain expertise in commercial-scale solar'' to scale operations more rapidly and meet rising demand for clean power generation, including for Altus Power's commercial and Community Solar customers. The merger agreement provided for a company termination fee of $60 million payable by Altus Power under specified circumstances, and a reverse termination fee of $70 million payable by Parent under specified circumstances. Moelis & Company LLC, financial advisor to Altus Power, delivered an opinion to the Altus Power board that the $5.00 per share merger consideration was fair, from a financial point of view, to holders of Class A common stock; the opinion explicitly did not address the merits of the merger as compared with any alternative strategies or transactions. The proxy statement's ''Certain Financial Forecasts'' section was referenced but the specific revenue or EBITDA projection figures were not captured from the excerpts reviewed, so those figures are not disclosed here. Required approvals included clearance under the Hart-Scott-Rodino Antitrust Improvements Act, whose waiting period expired on March 10, 2025, and approval from the Federal Energy Regulatory Commission under Section 203 of the Federal Power Act, for which Altus Power and the TPG entities filed an application on February 20, 2025. Altus Power stockholders approved the merger at a special meeting held April 9, 2025. The transaction closed April 16, 2025, at which point Altus Power's Class A common stock (previously NYSE: AMPS) was suspended from trading and the company requested that the NYSE file a Form 25 to delist and deregister the shares; Altus Power also intended to terminate its Class A common stock registration and suspend its Exchange Act reporting obligations, becoming a privately held subsidiary of TPG Rise Climate.

Lyft, Inc., a business-services company trading under the ticker LYFT, is the acquirer in a merger and acquisition transaction with a disclosed value of $197 million. The target of the acquisition is BMW Group and Mercedes-Benz Mobility, entities that together represent the selling side in this transaction. This is a cross-border or multi-stakeholder acquisition involving two major automotive mobility entities being acquired by the ride-sharing platform operator. The transaction details are sourced from an SEC filing published on April 16, 2025, though the specific form type has not been identified in the available documentation. The deal is currently in pending regulatory status, meaning it has been announced and disclosed to the Securities and Exchange Commission but has not yet received all necessary regulatory clearances or closed. On the financial advisory side, Guggenheim Securities, LLC is acting as the lead financial advisor to Lyft, the acquirer. On the target side, Lazard is serving as the lead financial advisor representing both BMW Group and Mercedes-Benz Mobility in the transaction. The choice of these two firms reflects the complexity and scale of the deal, with Guggenheim supporting the buyer's evaluation and transaction execution while Lazard advises the sellers through what appears to be a joint sale process. Baker McKenzie is serving as legal counsel to Lyft and the acquirer side of the transaction. DLA Piper is acting as legal advisor to BMW Group and Mercedes-Benz Mobility on the target side. This pairing of major international law firms underscores the cross-border or multinational character of the deal. Beyond the $197 million disclosed consideration amount, the specific structure of the purchase price, the form of consideration (cash, stock, or a combination), any earn-outs, adjustments, or other deal mechanics have not been disclosed in the available documentation. The transaction status is pending regulatory approval, but no expected closing date or timeline has been provided. The following material terms and facts remain undisclosed or unknown: the specific SEC filing form under which this transaction was disclosed; whether the $197 million represents the full purchase price or is subject to post-closing adjustment; the composition of consideration (cash versus equity or other consideration); any conditions precedent, representations, warranties, or indemnification provisions; the anticipated regulatory approval timeline or expected closing date; and any details about the business operations, assets, or revenue streams being acquired from BMW Group and Mercedes-Benz Mobility by Lyft.

This transaction is a cash acquisition representing the closing of a take-private of SolarWinds Corp, a tech sector company, by Turn/River Capital. The deal falls under the M&A product group and carries a disclosed value of $4,400,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on April 16, 2025. On the financial advisory side, Turn/River, the acquirer, retained a syndicate of advisors: J.P. Morgan, Barclays, Santander, and RBC Capital Markets all acted as financial advisors to Turn/River. For SolarWinds, the target, Goldman Sachs & Co. LLC acted as the lead financial advisor, with Jefferies LLC also acting as a financial advisor in a supporting, non-lead capacity. Legal counsel is split by side. Kirkland & Ellis LLP acted as legal counsel for Turn/River, the acquirer. DLA Piper LLP (US) acted as SolarWinds' legal counsel, the target. The facts block confirms this is a cash acquisition marking the closing of SolarWinds' take-private by Turn/River Capital, with a disclosed aggregate value of $4,400,000,000, but provides no further detail on the per-share price, financing sources for Turn/River's acquisition syndicate, or any other structural terms. Several material facts are not disclosed. No expected closing date beyond the April 16, 2025 filing date is given. The per-share purchase price is not specified beyond the aggregate disclosed value, and no detail is provided on the financing structure backing Turn/River's acquisition syndicate.

This deal involves RadNet, Inc. (ticker RDNT), a healthcare-sector company, as the acquirer of iCAD, Inc., in an all-stock merger. The transaction falls under the M&A product group, and its disclosed value is $103,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published April 15, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed: Piper Sandler & Co., which is serving as financial advisor to iCAD (the target) and is designated lead. The source sentence states that Piper Sandler & Co. is serving as financial advisor to iCAD and Dentons US LLP is serving as iCAD's legal counsel. No financial advisor is named for the acquirer, RadNet, in the facts provided. Legal advisors are disclosed for both sides. Dentons US LLP is serving as iCAD's (the target's) legal counsel, per the same source sentence naming Piper Sandler. On the acquirer side, both Perkins Coie LLP and Reed Smith LLP are serving as legal counsel to RadNet in connection with the transaction, per the source sentence naming both firms together. Beyond classifying the transaction as an all-stock merger valued at $103,000,000, the facts block does not specify the exchange ratio or the pro forma ownership split between RadNet and iCAD shareholders. Several facts are not disclosed in this record. No financial advisor is named for the acquirer, RadNet. No expected closing date is given, and the facts block does not specify the exchange ratio for the stock merger or clarify the respective roles of RadNet's two legal advisors, Perkins Coie LLP and Reed Smith LLP, relative to one another.

This deal involves Paycor HCM, Inc., a technology-sector company, as the target of an all-cash acquisition by Paychex Inc (ticker PAYX). The transaction falls under the M&A product group, and its disclosed value is $4,100,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published April 14, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. J.P. Morgan Securities LLC served as the exclusive financial advisor to Paychex (the acquirer), with the source sentence noting that Davis Polk & Wardwell LLP served as legal advisor to Paychex. On the target side, Goldman Sachs & Co. LLC served as the exclusive financial advisor to Paycor, with Kirkland & Ellis LLP serving as legal advisor to Paycor, per the corresponding source sentence. Legal advisors are disclosed for both sides: Kirkland & Ellis LLP served as legal advisor to the target, Paycor, while Davis Polk & Wardwell LLP served as legal advisor to the acquirer, Paychex. Beyond identifying the transaction as an all-cash acquisition valued at $4,100,000,000, the facts block does not specify the per-share purchase price or any financing arrangements supporting the cash consideration. Several facts are not disclosed in this record. The per-share price is not stated. No expected closing date is given, and the facts block provides no further structural detail beyond the "all-cash acquisition" classification and the aggregate disclosed value.

StoneX Group Inc. (NASDAQ: SNEX), a global financial services network and futures commission merchant (FCM), agreed on April 13, 2025 to acquire R.J. O'Brien (RJO), the oldest independent futures brokerage in the United States, founded in 1914. The deal was announced April 14, 2025 via a Form 8-K that included a press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), with the full Agreement and Plan of Merger filed as Exhibit 2.1. The transaction formally closed on July 31, 2025. Sean O'Connor, StoneX's Executive Vice-Chairman, called the deal "a transformational transaction for StoneX, establishing us as a leading global derivatives clearing firm and reinforcing our position as an integral part of the global market structure across asset classes." Gerry Corcoran, RJO's Chairman and CEO, said the companies were "extraordinarily excited about this partnership between two great companies that each bring over a century of history in the futures industry and complementary capabilities, products, services, and cultures," and he continued on with StoneX in a senior leadership role following closing. StoneX valued the acquisition at approximately $900 million in equity value, financed through a combination of cash and stock. Under the merger agreement (an Agreement and Plan of Merger dated April 13, 2025 among StoneX, merger subsidiary RTS Merger Sub Inc., target parent RTS Investor Corp. -- RJO's holding company -- and Westmoor Trail Partners LLC as equityholder representative), RTS equityholders were entitled to receive $625,000,000 of cash (subject to adjustment based on RTS's tangible book value versus an agreed benchmark) plus shares of StoneX common stock valued at $275,000,000, based on a ten-trading-day volume-weighted average price of StoneX stock subject to a collar of 85% to 115% of $77.50 per share. StoneX also disclosed it would assume up to $143 million of existing RJO debt. At signing, StoneX estimated the stock component at approximately 3.5 million shares. At closing on July 31, 2025, StoneX reported in its Form 8-K (Item 2.01) that it paid RTS equityholders, option holders and SAR holders aggregate consideration of $610,566,926 in cash (subject to post-closing adjustment) plus 3,085,554 shares of StoneX common stock, with fractional shares paid in cash. StoneX stated the final cash purchase price reflected RJO's tangible book value coming in above the agreed benchmark due to strong operating performance, partly offset by RJO's transaction expenses. The merger agreement had also conditioned closing on RTS's tangible book value being not less than $400,000,000 and RTS's subordinated debt not exceeding an agreed limit. RJO generated $766 million in revenue and approximately $170 million in EBITDA during calendar 2024, according to the companies. The acquisition added more than 75,000 client accounts and nearly 300 introducing brokers to StoneX's network, grew StoneX's client float by nearly $6 billion (to over $13 billion combined), and was projected to increase StoneX's cleared listed derivatives volume by 190 million contracts annually. StoneX said the deal would strengthen its position as a leading FCM and expand its institutional-grade execution, clearing, custody and prime brokerage across asset classes, with cross-sell opportunities expected to drive revenue synergies particularly in OTC derivatives, physical commodity trading, and fixed income products. StoneX targeted more than $50 million in annual expense synergies and at least $50 million in one-time capital synergies from consolidating operations; the companies did not disclose a specific phase-in timeline for these synergies. StoneX said the acquisition was expected to enhance its margins, earnings per share, and return on equity, without disclosing a specific accretion/dilution percentage. Financing: Bank of America acted as exclusive financial advisor to StoneX and also provided committed debt financing for the acquisition. In connection with signing, StoneX entered into a commitment letter with Bank of America, N.A. and BofA Securities, Inc. for (i) a senior secured 364-day bridge loan facility of up to $625 million and (ii) a backstop senior secured revolving credit facility of up to $500 million (available only if certain amendments to StoneX's existing credit facilities were not effective by closing). StoneX stated it intended to finance the cash consideration through capital markets transactions rather than draw on the bridge facility to the extent possible. Consistent with that plan, on July 8, 2025 a wholly owned financing subsidiary, StoneX Escrow Issuer LLC, issued $625,000,000 in aggregate principal amount of 6.875% Senior Secured Notes due 2032 under an indenture with The Bank of New York Mellon as trustee, with proceeds held in escrow pending closing. On the July 31, 2025 closing date, the escrow release conditions were satisfied, the escrowed proceeds were used to fund a portion of the cash purchase price and related fees and expenses, and StoneX (as successor to the escrow issuer) assumed the notes, which became guaranteed and secured on a second-priority basis by StoneX's existing credit facility collateral package. Davis Polk & Wardwell LLP served as StoneX's legal counsel. On the target side, Broadhaven Capital Partners acted as exclusive financial advisor to RJO, and Mayer Brown LLP served as RJO's legal advisor. Under the merger agreement, closing was conditioned on, among other things: accuracy of representations and warranties, compliance with covenants, expiration/termination of the HSR Act waiting period and receipt of other antitrust/foreign-investment clearances, receipt of approvals from governmental authorities and financial regulators, absence of any law or order prohibiting the merger, the affirmative vote of holders of a majority of RTS's outstanding Class 1 common stock (concurrently with signing, certain RTS stockholders entered into support agreements agreeing to deliver written consents approving the merger, subject to a time-limited lock-up on the stock consideration), consent of certain StoneX contract counterparties, and the RTS tangible book value and subordinated debt conditions noted above. The agreement could be terminated by mutual consent, by either party if closing did not occur within six months of signing, upon a final non-appealable order prohibiting the merger, for an uncured breach causing a closing-condition failure, or for a material adverse effect on either party; the filings reviewed do not disclose a specific termination fee dollar amount. StoneX also obtained a representation-and-warranty insurance policy in connection with signing. Pro forma condensed combined financial information for the combined company, prepared under SEC Regulation S-X Article 11, was filed as Exhibit 99.4 to a Form 8-K dated June 24, 2025, along with RTS's audited 2024 and reviewed first-quarter 2025 historical financial statements (Exhibits 99.2 and 99.3 to that same filing). The transaction closed on July 31, 2025, making StoneX, in the companies' words, "the largest non-bank Futures Commission Merchant (FCM) in the United States."

This deal involves StoneX Group Inc. (ticker SNEX), a financial-institutions-group (fig) sector company, as the acquirer of R.J. O'Brien (RJO), in a cash-and-stock acquisition. The transaction falls under the M&A product group, and its disclosed value is $900,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published April 14, 2025. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Bank of America is acting as exclusive financial advisor to StoneX (the acquirer) and is also providing committed debt financing for the acquisition, per the source sentence describing Bank of America's dual advisory and financing role. On the target side, Broadhaven Capital Partners is acting as exclusive financial advisor to RJO, with the source sentence noting that Mayer Brown LLP is serving as RJO's legal advisor. Legal advisors are disclosed for both sides: Mayer Brown LLP is serving as legal advisor to the target, RJO, while Davis Polk & Wardwell LLP is serving as StoneX's (the acquirer's) legal counsel, per a separate source sentence confirming Davis Polk's role. Beyond identifying the transaction as a cash-and-stock acquisition valued at $900,000,000, with committed debt financing from Bank of America, the facts block does not specify the exact split between cash and stock consideration or the terms of the debt financing. Several facts are not disclosed in this record. The precise cash/stock consideration mix is not specified. No expected closing date is given, and the facts block does not detail the terms of the committed debt financing beyond identifying Bank of America as its provider.

Nordstrom, Inc. (NYSE: JWN), a major department-store retailer, agreed on December 22, 2024 to be acquired by members of the Nordstrom family (Erik, Pete, Jamie Nordstrom and other family members and related trusts and investment vehicles, the Family Group) together with El Puerto de Liverpool, S.A.B. de C.V. (BMV: LIVEPOL), a Mexican omnichannel retailer, in an all-cash going-private transaction. The agreement was disclosed in a Form 8-K filed with the SEC on December 23, 2024, which attached the Agreement and Plan of Merger as Exhibit 2.1 and a joint press release as Exhibit 99.1. The acquisition vehicles were Nordstrom Holdings, Inc. (formerly Norse Holdings, Inc.), referred to as Parent, and its wholly owned subsidiary Navy Acquisition Co. Inc., referred to as Acquisition Sub. Under the terms of the agreement, Nordstrom shareholders received $24.25 in cash for each share of common stock. The press release describes the transaction as valued at approximately $6.25 billion on an enterprise basis and states the merger consideration represented a premium of approximately 42% to Nordstrom's unaffected closing stock price on March 18, 2024, the last trading day before media speculation about a potential transaction began. The board also declared a special cash dividend of $0.25 per share, contingent on closing, plus a stub-period dividend of $0.1462 per share, both payable to shareholders of record as of May 19, 2025. Following the close, Nordstrom was owned 50.1% by the Nordstrom Family and 49.9% by Liverpool, with the Nordstrom Family holding a majority ownership stake in the company. The Nordstrom board, with Erik and Pete Nordstrom recusing themselves, unanimously approved the transaction based on the unanimous recommendation of a special committee of independent and disinterested directors composed of Kirsten Green, Amie Thuener O'Toole and Eric Sprunk. The special committee was formed in February 2024 in response to interest expressed by Erik and Pete Nordstrom in exploring a possible transaction. Eric Sprunk, special committee chairman, said the committee reviewed the proposal "against the Company's standalone prospects for growth" and, "following a rigorous and independent evaluation and consultation with outside financial and legal advisors," concluded the transaction "offers greater value for all public shareholders at a significant premium to the unaffected share price." Erik Nordstrom, CEO, called the announcement the start of "an exciting new chapter for the business," and Graciano F. Guichard G., Liverpool's executive chairman, said Liverpool was "thrilled to be investing in a company that has meaningfully shaped the industry for nearly 125 years." The press release stated the transaction would be financed through a combination of rollover equity contributed by the Nordstrom Family and Liverpool, cash commitments by Liverpool, up to $450 million in borrowings under a new $1.2 billion asset-based lending (ABL) facility, and company cash on hand. Nordstrom's approximately $2.7 billion of existing senior notes and debentures were expected to remain outstanding, secured following closing by a second lien on current assets and a first lien on other assets (excluding real estate). At closing on May 20, 2025, the company entered into a new ABL credit agreement with Wells Fargo Bank, National Association as agent, providing a $1.2 billion senior secured asset-based revolving facility, and borrowed $450 million under that facility; the company's prior revolving credit agreement, dated May 6, 2022, was repaid in full and terminated. The merger agreement included termination fees: the company would owe Parent $85 million if the agreement were terminated due to an adverse recommendation change by the board or special committee, $42.5 million if terminated by the company to accept a superior proposal (or by either party for failure to obtain shareholder approval following a publicly announced competing proposal that is later consummated), and $100 million if terminated by either party due to a below-investment-grade ratings event. Liverpool and certain Family Group members guaranteed Parent's payment obligations, including these termination fees, on a several basis. Closing was subject to approval by holders of two-thirds of outstanding common stock and, separately, a majority of shares not owned by the Nordstrom Family, Liverpool, or the company's directors and Section 16 officers (a majority-of-the-minority vote), plus customary regulatory approvals. At a special shareholder meeting held May 16, 2025, with 142,942,995 shares present (approximately 85.47% of the 167,234,578 shares outstanding as of the April 7, 2025 record date), shareholders approved the merger: the two-thirds approval vote passed 142,030,974 for to 770,781 against, and the majority-of-the-minority vote (calculated on 96,549,953 shares eligible) passed 71,381,079 for to 770,781 against. A non-binding advisory vote on merger-related executive compensation also passed, 137,006,915 for to 5,509,460 against. The merger closed on May 20, 2025. Nordstrom filed Articles of Merger with the Washington Secretary of State, Acquisition Sub merged into Nordstrom with Nordstrom surviving as a wholly owned subsidiary of Parent, and each outstanding share of Nordstrom common stock (other than rollover and owned shares) was converted into the right to receive $24.25 in cash. Nordstrom common stock ceased trading before the NYSE open on May 21, 2025 and was delisted that day. Erik and Pete Nordstrom became Co-CEOs of the now-private company. Morgan Stanley & Co. LLC and Centerview Partners LLC acted as financial advisors to the special committee of the Nordstrom board. Moelis & Company LLC acted as financial advisor to the Nordstrom Family. J.P. Morgan Securities LLC acted as financial advisor to Liverpool. Innisfree M&A Incorporated served as proxy solicitor for Nordstrom in connection with the special meeting, as previously disclosed. The definitive merger proxy statement is dated April 10, 2025. Not disclosed in the filings reviewed: a per-share or aggregate equity purchase price distinct from the stated $6.25 billion enterprise value; any EV/EBITDA, P/E, or other valuation multiple; the full negotiation background and any other bidders considered (which would typically appear in the "Background of the Merger" section of the definitive proxy, not independently reviewed here); and any post-closing pro forma financial statements.

Globus Medical, Inc., a musculoskeletal technology company trading under ticker GMED, agreed on February 6, 2025 to acquire Nevro Corp., a global medical device company trading under ticker NVRO that makes the HFX spinal cord stimulation platform for chronic pain, in an all-cash transaction. The deal, announced in a joint press release filed as Exhibit 99.1 to a Form 8-K, valued Nevro at approximately $250 million in total equity value, with Nevro shareholders receiving $5.85 in cash for each share of Nevro common stock. This is a cash deal, not a stock deal; the current record's reference to an all-stock structure is incorrect. The $5.85 per-share price represented a 17% premium to Nevro's February 5, 2025 closing price, a 27% premium to Nevro's 90-day volume-weighted average price of $4.61, and a 38% premium to its 30-day VWAP of $4.23, according to the companies' joint press release. Dan Scavilla, President and CEO of Globus Medical, said the transaction "furthers our mission to become the preeminent musculoskeletal technology company in the world by enabling us to expand into new markets for future growth, while gaining access to world-class, differentiated technologies that can provide significant benefit in neuromodulation, enabling technologies, and future implant solutions," adding that Globus's "scale and operational discipline will allow us to optimize Nevro's financial performance to drive enhanced profitability." Nevro CEO and President Kevin Thornal said the company was "thrilled to join Globus Medical as this will allow us to reach more patients globally with clinically proven, innovative products," citing access to "Globus Medical's capabilities, global infrastructure and other resources." The April 3, 2025 closing press release separately noted the acquisition "unlocks a $2 billion market opportunity" in neuromodulation. Nevro's board ran a broad sale process before agreeing to the deal, as described in the "Background of the Merger" section of Nevro's definitive merger proxy (DEFM14A, filed March 10, 2025). After publicly announcing a strategic review in August 2024, BofA Securities contacted 40 potential counterparties (strategic acquirers and financial sponsors); nine signed confidentiality agreements and eight participated in management presentations, referred to in the proxy as Parties A through G. All of the other named bidders ultimately declined to submit a bid or were deemed uncompetitive: a potential merger-of-equals partner (Party B), a large strategic medical device company (Party A), and four financial sponsors (Parties C, D, E and F) all withdrew between September and October 2024, and a later-contacted financial sponsor (Party G) could not provide a competitive proposal versus Globus. Globus's initial non-binding indication of interest, submitted December 4, 2024, offered $200 million in aggregate consideration (about $5.33 per share); Nevro's board rejected this as undervaluing the company. A revised Globus proposal on December 13, 2024 raised the aggregate value to $250 million, and the parties signed a letter of intent on December 20, 2024 before finalizing the $5.85 per-share Merger Agreement on February 6, 2025. BofA Securities, Nevro's financial advisor, delivered a fairness opinion dated February 5, 2025 concluding the merger consideration was fair to Nevro shareholders from a financial point of view, as disclosed in the DEFM14A. BofA Securities' selected publicly traded companies analysis (versus Avanos Medical, Orthofix Medical, Treace Medical Concepts, AngioDynamics and Inogen) applied an EV/2025E Revenue multiple range of 0.46x to 1.23x, implying a per-share equity value range of $5.35 to $12.85, versus the $5.85 deal price and Nevro's $5.13 pre-announcement closing price. A separate historical-average EV/NTM Revenue analysis applied a 0.44x to 0.80x multiple range, implying $5.15 to $8.65 per share. A discounted cash flow analysis, using Nevro management's unaudited projections (revenue growing from $421 million in 2025 to $719 million in 2033, with Adjusted EBITDA turning positive in 2028), applied discount rates of 12.00% to 14.75% and a 2.0%-3.0% perpetuity growth rate, implying $4.65 to $8.00 per share. BofA Securities also cited a 52-week trading range of $3.29 to $17.62 and analyst price targets implying a present value of $3.50 to $6.15 per share. On the financing side, Globus disclosed in its February 6, 2025 press release that it expects the Nevro acquisition to be accretive to its earnings in the second year of operation; on a standalone basis Globus had reaffirmed 2025 guidance of $2.66-$2.69 billion in net sales and $3.40-$3.50 non-GAAP EPS, while pro forma for the transaction (assuming a late-second-quarter 2025 close) it guided to $2.80-$2.90 billion in net sales and $3.10-$3.40 non-GAAP EPS, implying near-term dilution ahead of the anticipated year-two accretion. The merger agreement required Nevro, substantially concurrent with closing, to prepay in full its existing credit facility (dated November 30, 2023, with Wilmington Trust as administrative agent) and separately addressed treatment of Nevro's convertible notes, which became convertible into the cash merger consideration as reference property, and a warrant held by Braidwell Transaction Holdings LLC - Series 4, which was cashed out based on its Black-Scholes value. No new financing or pro forma ownership split is disclosed, consistent with this being a cash (not stock) acquisition. The merger agreement set a termination date of August 6, 2025, extendable to October 6, 2025 under specified conditions. Nevro was required to pay Globus a $15 million termination fee in certain circumstances, including termination to accept a superior proposal, and a separate $10 million fee if Nevro's stockholders voted down the merger; Globus was required to pay Nevro $15 million if Globus breached its obligations in a way that would prevent or materially delay closing. Closing was conditioned on Nevro stockholder approval, HSR Act clearance, and customary representations, warranties and absence of a material adverse effect. Nevro held a special stockholder meeting on April 2, 2025, at which 75.9% of outstanding shares were represented; the merger proposal was approved with 28,350,441 votes for versus 684,453 against and 90,808 abstentions, as reported in Nevro's Form 8-K (Item 5.07) filed April 2, 2025. A related non-binding advisory "golden parachute" compensation proposal did not receive the requisite vote and was not approved. The transaction closed the next day, April 3, 2025, with Palmer Merger Sub, Inc. merging into Nevro, which became a wholly owned subsidiary of Globus Medical; Nevro common stock ceased trading on the NYSE before market open that day. Each outstanding Nevro stock option was cancelled without consideration, each Nevro RSU award was converted into the right to receive cash equal to the merger consideration, and each Nevro performance-based RSU award was cashed out assuming the greater of target or actual performance. This status update (closed April 3, 2025) supersedes the "pending-regulatory" status previously on file; the deal is complete. Globus Medical's financial advisor was Morgan Stanley & Co. LLC and its legal advisor was Wyrick Robbins Yates & Ponton LLP. Nevro's financial advisor was BofA Securities, Inc. and its legal advisor was Latham & Watkins LLP, each confirmed in both the February 6, 2025 announcement press release and the April 3, 2025 closing press release.

This transaction is an acquisition, with the facts noting that the consideration structure is not specified in the excerpt available, in which Globus Medical Inc., trading under the ticker GMED, is acquiring Nevro Corp. The deal is classified within the healthcare sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form 8-K filing published on April 3, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Morgan Stanley & Co. LLC served as financial advisor to Globus Medical, the acquirer, and is identified as the lead advisor on that side. BofA Securities, Inc. served as financial advisor to Nevro Corp., the target, and is likewise identified as the lead advisor for the target. On the legal side, Latham & Watkins LLP served as legal advisor to Nevro Corp., the target, while Wyrick Robbins Yates & Ponton LLP served as legal advisor to Globus Medical, the acquirer. As the facts explicitly note, the consideration structure for this acquisition is not specified in the excerpt available, meaning no detail on whether the transaction involves cash, stock, or a combination of the two is included in the material provided. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and the consideration structure itself is explicitly flagged as not specified in the available excerpt. No expected closing date is given, and no detail on required regulatory approvals is provided in the facts available.

This deal is a cash and stock acquisition classified as an M&A transaction in the healthcare sector, involving Thrive Skilled Pediatric Care LLC (Thrive SPC) as target and Aveanna Healthcare Holdings, Inc. (ticker AVAH) as acquirer. The disclosed value of the transaction is $75,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on April 3, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Cantor Fitzgerald & Co. served as financial advisor to Thrive SPC, the target, in a lead capacity. Edge Healthcare Partners served as financial advisor to Aveanna, the acquirer, also in a lead capacity, with the source material pairing each advisor with its respective legal counsel. On the legal side, Ropes & Gray LLP served as legal advisor to Thrive SPC, the target, while Bass, Berry & Sims provided legal counsel to Aveanna, the acquirer. Beyond the cash and stock consideration structure noted in the deal subtype, with a disclosed value of $75,000,000, no further detail on the specific split between cash and stock components, or other structural terms, is provided in the facts block. Several items are not disclosed in the available record. The precise cash-versus-stock consideration mix is not broken out beyond the general subtype classification, and no expected closing date or further timeline detail beyond the April 2025 filing date and pending-regulatory status is given.

LPL Financial Holdings Inc., a financial services company trading under the ticker LPLA, acquired Commonwealth Financial Network, the largest independently owned wealth management firm in the United States, in an all-cash equity purchase valued at approximately $2.7 billion. The deal was announced on March 31, 2025, through an 8-K disclosing a definitive equity purchase agreement dated March 28, 2025, and closed on August 1, 2025. Under the purchase agreement, LPL Holdings, Inc. (a wholly owned subsidiary of LPL Financial Holdings) acquired 100 percent of the equity of CFN Holding Company, LLC, Commonwealth's parent holding entity, from sellers Gratitude Holdings, Inc. and Odd Couple, Inc. The agreement set a $2,700,000,000 base purchase price in cash, subject to customary post-closing adjustments for cash, indebtedness, net working capital, net regulatory capital, transaction expenses and an escrow amount. LPL valued the deal at approximately 8.0 times Commonwealth's estimated run-rate EBITDA, based on unaudited preliminary Commonwealth financial information for the year ended December 31, 2024. At announcement, Commonwealth supported approximately 2,900 independent financial advisors managing approximately $285 billion in brokerage and advisory assets (about 75 percent advisory, 25 percent brokerage) with roughly $6 billion of client cash sweep balances; by the August 1, 2025 closing, LPL cited approximately 3,000 advisors and $305 billion in assets, based on data as of June 30, 2025. LPL Financial CEO Rich Steinmeier said Commonwealth is "respected throughout our industry as a standard-bearer for service excellence, and their commitment to the success of their Advisors is embedded in all aspects of their business," adding that "LPL's advanced technology, intuitive business solutions and breadth of wealth management offerings unlock boundless potential for Commonwealth Advisors and the clients they serve." Commonwealth founder Joseph Deitch said that after growing the firm over 46 years, "LPL became the logical choice for our next chapter," and he assumed an advisory role to LPL's board of directors upon conversion. Commonwealth CEO Wayne Bloom joined LPL's management committee, retaining his role as Commonwealth CEO, and is partnering with LPL leadership to launch an Office of Advisor Advocacy intended to apply Commonwealth's service model, which J.D. Power ranked #1 in Independent Advisor Satisfaction among financial investment firms for 11 consecutive years at announcement (12 consecutive years by the time of closing). LPL financed the transaction through a combination of corporate cash, new debt and equity, and disclosed it had secured a bridge financing commitment for the majority of the purchase price, to be reduced upon receipt of proceeds from longer-term financing. To preserve capital flexibility, LPL said it would pause share repurchases. The company expected pro forma leverage of roughly 2.25x at closing, above the midpoint of, but within, its stated target range of 1.5x to 2.5x (versus 1.89x at year-end 2024), with a near-term plan to bring leverage back toward the midpoint of that range while maintaining its investment-grade rating. LPL disclosed estimated run-rate EBITDA accretion of approximately $415 million once the acquisition is fully ramped, with Commonwealth's acquired baseline EBITDA estimated at approximately $120 million at close; combined with LPL's trailing-twelve-month EBITDA of approximately $2,111 million at announcement, LPL projected pro forma EBITDA of roughly $2,526 million or more after synergies. The company estimated low-single-digit accretion to run-rate adjusted EPS by the end of 2026, and estimated onboarding and integration costs of approximately $485 million (based on a 90 percent advisor retention assumption), plus approximately $155 million of technology spend to be capitalized and amortized over time. In its third-quarter 2025 earnings release (filed as an 8-K on October 30, 2025), after the deal had closed, LPL raised its estimated run-rate EBITDA accretion to approximately $425 million, reported advisors representing nearly 80 percent of Commonwealth's assets had signed to transition as of that date (tracking toward the 90 percent retention target), and disclosed that purchase accounting required it to treat $419 million of the total purchase price as one-time acquisition costs recognized in the quarter the deal closed, with no change in the amount of cash actually deployed. That quarter's results included a net loss of $30 million, or $0.37 per diluted share, which LPL attributed largely to those one-time Commonwealth acquisition costs; adjusted EPS, which excludes such items, rose 25 percent year-over-year to $5.20. The equity purchase agreement did not disclose a reverse termination fee. It provided for an outside termination date nine months after signing (around late December 2025), automatically extendable by 90 days if all closing conditions other than certain customary ones had been satisfied, reflecting the expectation that the deal would need time to clear regulatory approvals; in the event, the transaction closed within about four months of signing, well inside that outside date. LPL completed the acquisition on August 1, 2025, with LPL Holdings, Inc. acquiring Commonwealth's holding company. Commonwealth is operating as a wholly owned portfolio company and will retain its brand, and LPL said it expects to complete the technology conversion and onboarding of Commonwealth advisors to LPL's platform in the fourth quarter of 2026. Goldman Sachs & Co. LLC served as exclusive financial advisor to Commonwealth, with Ropes & Gray LLP as Commonwealth's legal counsel; Morgan Stanley & Co. LLC served as exclusive financial advisor to LPL, with Allen Overy Shearman Sterling LLP as LPL's legal counsel.

This is a cash acquisition in the fig sector in which LPL Financial Holdings Inc. (ticker LPLA) is acquiring Commonwealth Financial Network. The product group is M&A, and the disclosed transaction value is $2,700,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on March 31, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead and exclusive capacity. Morgan Stanley & Co. LLC is acting as exclusive financial advisor to LPL, the acquirer, per the statement "Morgan Stanley & Co. LLC is acting as exclusive financial advisor to LPL, with Allen Overy Shearman Sterling LLP serving as LPL's legal counsel." On the target side, Goldman Sachs & Co. LLC is acting as exclusive financial advisor to Commonwealth, consistent with the language "Goldman Sachs & Co. LLC is acting as exclusive financial advisor to Commonwealth, with Ropes & Gray LLP serving as Commonwealth's legal counsel." Legal advisors are disclosed for both sides: Allen Overy Shearman Sterling LLP is serving as LPL's legal counsel, the acquirer, while Ropes & Gray LLP is serving as Commonwealth's legal counsel, the target. Beyond the classification of this transaction as a cash acquisition with a disclosed value of $2,700,000,000, no further detail on payment structure, financing sources, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no detail on financing sources for the cash consideration is provided, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a stock-for-stock merger in which Quanterix Corp (ticker QTRX), a healthcare sector company, is acquiring Akoya Biosciences, Inc. The deal is classified under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form S-4 filed and published on March 28, 2025. The transaction's current status is pending regulatory review. Only one financial advisor is named in the facts block: Goldman Sachs & Co. LLC served as financial advisor to the acquirer, Quanterix, in a lead capacity. The source sentence references consent language for Goldman Sachs & Co. LLC's opinion letter under the caption The Merger, Opinion of Quanterix's Financial Advisor, confirming the firm's role was specifically to render a fairness opinion to Quanterix in connection with the merger. No legal advisors are identified in the facts block for either Akoya Biosciences or Quanterix. Beyond confirming the transaction is structured as a stock-for-stock merger, the facts block does not specify the exchange ratio, the treatment of outstanding equity awards or convertible securities, or any other structural terms of the merger agreement. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No financial advisor is named for Akoya Biosciences, the target, and no legal advisors are named for either party. No expected closing date is given, and the specific stock exchange ratio is not disclosed.

Braze, Inc., a technology sector company trading under ticker BRZE, agreed to acquire OfferFit, Inc., a Delaware corporation that provides AI decisioning technology for personalization in CRM marketing, for $325 million in a combination of cash and Braze Class A common stock. The transaction was announced March 27, 2025, in a current report on Form 8-K, following execution of an Agreement and Plan of Merger dated March 26, 2025 among Braze, OfferFit, two Braze merger subsidiaries (Enzyme Merger Sub I, Inc. and Enzyme Merger Sub II, LLC), and WT Representative LLC acting as the sellers' representative. Under the agreement, Braze would acquire all outstanding OfferFit common and preferred stock and all outstanding options and other purchase rights. Bill Magnuson, Braze's cofounder and CEO, said in the announcement that "with Braze's planned acquisition of OfferFit, our complementary products and teams will come together to define the next chapter of the evolution of Customer Engagement with AI," describing a vision in which "reinforcement learning and modern transformer architectures are wielded within the Braze product ecosystem to drive a vision where Agentic AI automatically understands customers in greater depth." George Khachatryan, OfferFit's cofounder and CEO, said OfferFit "replaces the manual work of A/B testing with reinforcement learning agents that autonomously experiment and learn optimal actions," and that the companies, already technology partners, saw clear synergies in joining forces to "leverage Braze's product ecosystem and global scale to enhance the existing OfferFit product, while also augmenting Project Catalyst and BrazeAI overall." The 8-K separately noted the deal would let Braze "more deeply integrate the existing sophisticated, multi-agent approach from OfferFit into its broader platform" alongside its internally developed Project Catalyst AI agent initiative. At signing, Braze disclosed it would issue approximately 3.80 million shares of Class A common stock as part of the consideration, subject to adjustment, with a portion held back in escrows pursuant to the merger agreement. The stock consideration was structured as a private placement exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(b), with resale registration rights to be provided after closing. Shares issued to sellers were subject to a 12-month lock-up, vesting one half at six months, one quarter at nine months, and the final quarter at twelve months post-closing; sellers who held OfferFit preferred stock and were not employees, officers, directors or individual independent contractors of the company were instead subject to a four-week lock-up vesting in equal quarterly installments over that period. The merger agreement contained customary representations, warranties, covenants and post-closing indemnification obligations, and the transaction was expected to close within Braze's fiscal quarter ending July 31, 2025, subject to customary closing conditions. The acquisition closed on June 2, 2025, according to Braze's Form 10-Q for the quarter ended July 31, 2025. At closing, the total preliminary purchase price consideration was $304.0 million, consisting of $195.3 million in cash and $108.7 million in Braze Class A common stock issuances, a figure that differs from the $325 million headline value disclosed at signing (the 10-Q purchase price accounting reflects adjustments, including allocating a portion of replacement award fair value to post-combination compensation expense rather than consideration transferred). Braze recorded estimated fair value of negative $1.9 million of net tangible assets acquired, $66.6 million of identifiable intangible assets, and $239.3 million of goodwill, which the company said is not deductible for tax purposes and is "primarily attributable to expected synergies to the Company's ongoing Artificial Intelligence initiatives." The intangible assets comprised developed technology of $56.7 million (amortized over six years, valued using an excess earnings method), customer relationships of $9.0 million (amortized over six years, valued using the with-and-without method), and trademarks of $0.9 million (amortized over two years, valued using a relief-of-royalty method). Braze also recorded indemnification escrows of $6.0 million and a working capital escrow of $1.3 million within accrued expenses and other current liabilities, both subject to release following post-closing claim and adjustment procedures. In connection with the deal, Braze issued replacement restricted stock awards to OfferFit equity holders with a total fair value of approximately $67.1 million as of the acquisition date, a portion of which was attributed to consideration transferred and the remainder treated as post-combination compensation expense. Acquisition-related costs, expensed as incurred within general and administrative expense, totaled $1.4 million for the quarter and $11.4 million for the six months ended July 31, 2025. OfferFit's post-acquisition results of operations were described by Braze as not material to its consolidated financial statements for the six months ended July 31, 2025. No separate closing 8-K or purchase-price press release was identified beyond this 10-Q disclosure. On the financial advisory side, Goldman Sachs & Co. LLC acted as financial advisor to Braze, while Atlas Technology Group acted as financial advisor to OfferFit. Davis Polk & Wardwell LLP acted as legal advisor to Braze, and Latham & Watkins LLP acted as legal advisor to OfferFit. No merger proxy, S-4, or tender offer filing was identified for this transaction, consistent with its structure as a privately negotiated acquisition of a private company rather than a public-company merger requiring shareholder votes or registered securities. Exchange ratio, per-share pricing, financing sources for the cash portion, termination fee provisions, and any earn-out or contingent consideration terms beyond the described escrows were not disclosed in the filings reviewed.

This deal involves Kestrel Group Ltd (ticker KG), a financial-institutions-group (fig) sector company, as the target, and Maiden Holdings, Ltd. (ticker MHNC) as the acquirer, in a cash-and-stock combination structured as a holding company merger. The transaction falls under the M&A product group, and its disclosed value is $167,500,000. The facts are sourced from two SEC EDGAR filings: a DEFM14A published March 26, 2025, and an 8-K published December 30, 2024. The deal's status is pending regulatory, indicating it had not yet closed as of those filings. This deal has a relatively extensive advisory roster. On the target side, Evercore Group L.L.C. is named as financial advisor to Kestrel in an earlier-stage source sentence describing discussions between Maiden management, representatives of IAP, and representatives of Kestrel, AmTrust, and Evercore regarding a potential business combination; a later source sentence confirms Evercore (the same firm, referenced without "Group L.L.C." in that instance) acting as exclusive financial advisor to Kestrel, designated lead, with Skadden, Arps, Slate, Meagher & Flom LLP acting as Kestrel's legal counsel. On the acquirer side, IAP is named as financial advisor to Maiden, with the source sentence noting Maiden selected IAP because it is a recognized financial advisory firm with substantial experience in similar transactions; a related entry names Insurance Advisory Partners LLC (likely the same firm as "IAP") as exclusive financial advisor to Maiden, designated lead, with Paul, Weiss, Rifkind, Wharton & Garrison LLP acting as Maiden's legal counsel. Multiple legal advisors are disclosed. Skadden, Arps, Slate, Meagher & Flom LLP served as U.S. counsel to Kestrel (the target), as confirmed in two separate source sentences. Paul, Weiss, Rifkind, Wharton & Garrison LLP served as U.S. counsel to Maiden (the acquirer), also confirmed in two separate source sentences. Additionally, Appleby (Bermuda) Limited acted as independent legal counsel to the disinterested members of Maiden's Board of Directors, a distinct governance-focused mandate on the acquirer side. Beyond identifying the transaction as a cash-and-stock holding company merger valued at $167,500,000, the facts block does not specify the precise cash/stock split in the consideration or the exchange ratio for the stock component. Several facts are not disclosed in this record. The precise cash/stock consideration split is not specified. No expected closing date is given, and the facts block does not clarify whether "IAP" and "Insurance Advisory Partners LLC," both named as Maiden's financial advisor, refer to the same entity under two different name renderings.

This is a take-private/leveraged buyout in the business-services sector in which Clearlake Capital Group, L.P. is acquiring Dun & Bradstreet Holdings, Inc. The product group is sponsors-coverage, and the disclosed transaction value is $7,700,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on March 24, 2025. The deal's current status is pending regulatory review. The financial advisory roster on the acquirer side is extensive. Nine firms are named as financial advisors to Clearlake: Morgan Stanley, Goldman Sachs, JP Morgan, Rothschild & Co, Barclays, Citi, Deutsche Bank, Santander, and Wells Fargo, all drawn from the single source sentence "Financial advisors to Clearlake include Morgan Stanley, Goldman Sachs, JP Morgan, Rothschild & Co, Barclays, Citi, Deutsche Bank, Santander, and Wells Fargo." None of these nine is individually designated as lead in the facts provided. On the target side, BofA Securities served as the lead financial advisor to Dun & Bradstreet, per the statement "BofA Securities is serving as financial advisor to Dun & Bradstreet." Legal advisors are disclosed for both sides: Sidley Austin LLP is serving as legal counsel to Clearlake, the acquirer, while Weil, Gotshal & Manges LLP is serving as legal counsel to Dun & Bradstreet, the target. Beyond the classification of this transaction as a take-private/leveraged buyout with a disclosed value of $7,700,000,000, no further detail on per-share pricing, the specific financing structure among the nine advisory banks, or other terms is included in the facts provided. Several items are not disclosed in this record: the per-share consideration is not specified, the facts block does not clarify which of the nine advisors to Clearlake, if any, are providing financing versus pure advisory services, and no expected closing date is given beyond the pending-regulatory status.

TripAdvisor, Inc., a publicly traded technology company trading under the ticker TRIP, is acquiring Liberty TripAdvisor Holdings, Inc., its publicly held affiliate, in an all-stock merger transaction. The deal falls within the mergers and acquisitions product group and represents a consolidation within the technology sector. No deal value has been disclosed in the source materials. This transaction is sourced from an SEC EDGAR filing published on March 24, 2025. The specific form type is not identified in the available documentation. The deal remains in pending regulatory status, indicating that it has not yet received all necessary approvals or closed but is proceeding through the approval process. No financial advisors have been identified or extracted as advising either party to this transaction. This absence of identified financial advisory involvement is notable and may reflect either that such advisors were not engaged, that their roles were not detailed in the available disclosure documents, or that they were not captured in the source material provided. No legal advisors have been identified in the available documentation for either TripAdvisor or Liberty TripAdvisor Holdings in connection with this transaction. The transaction is structured as an all-stock merger, meaning that shareholders of Liberty TripAdvisor Holdings will receive equity consideration from TripAdvisor rather than cash or a mixed consideration package. Beyond the confirmation that the deal is all-stock in nature, no additional structural details have been disclosed regarding exchange ratios, per-share consideration, or any other terms governing the merger consideration. The following material details remain undisclosed or unknown: the specific deal value, the exact exchange ratio or per-share consideration amount, the expected closing date or timeline for regulatory approval, details regarding any financing arrangements, conditions precedent to closing, governance or operational integration plans, and any representations, warranties, or covenants specific to the merger agreement. The form type of the SEC filing has not been identified, which limits understanding of the nature and completeness of disclosure required for this particular filing.

Bowen Acquisition Corp (Nasdaq: BOWN), a Cayman Islands special purpose acquisition company, agreed on January 18, 2024 to acquire Shenzhen Qianzhi BioTechnology Co., Ltd., a Shenzhen, China-based health and wellness biotech company that develops, manufactures and sells ozonated, plant-based personal-care and disinfectant products. The transaction is structured as a merger of Bowen's wholly owned subsidiary, Bowen Merger Sub, with and into Qianzhi Group Holding (Cayman) Limited ("NewCo"), the newly formed Cayman Islands parent of Qianzhi, with NewCo surviving as a wholly owned subsidiary of Bowen. The deal was announced in a press release filed as Exhibit 99.1 to a Form 8-K and further described in a definitive proxy statement/prospectus filed on Form 424B3 on December 18, 2024. "Bowen recognizes Qianzhi BioTech's excellent products, purpose-driven mission and sustainable operations, which improve the well-being of its customers and communities and shape a promising future," said Jiangang Luo, Bowen's Chief Executive Officer, in the announcement. "We are excited to partner with Qianzhi BioTech in this business combination and look forward very much to consummating this transaction. We believe that, with the value proposition that Bowen brings, Qianzhi BioTech will have the ability to expand its market and create significant value for stockholders over time." Under the merger agreement, NewCo shareholders are entitled to receive an aggregate of 7,246,377 Bowen ordinary shares (the "Merger Shares," a portion of which is to be held in escrow for indemnification) plus the right to receive up to an additional 1,400,000 Bowen ordinary shares ("Earnout Shares") if the combined company achieves certain net income milestones for the fiscal years ended March 31, 2025 and 2026, or upon a change of control during the earnout period. The 424B3 proxy states that the "Merger Consideration being paid to Qianzhi" was $75 million. This followed a non-binding letter of intent that had proposed a pre-money equity value for Qianzhi of between $60 million and $80 million, with earnout consideration equal to 20% of that pre-money equity value. Bowen's financial advisor, Newbridge Securities, separately calculated an implied enterprise value for Qianzhi of $97.1 million using a comparable public company analysis (applying an average 24.4x price-to-earnings multiple, derived from 25.5x in 2023 and 23.4x in 2024E among seven selected comparable companies, to the midpoint of Qianzhi's 2023 and 2024E net income of $4.0 million), and, after adding net debt of approximately $4.9 million, an implied equity value of $101.8 million. The proxy notes the comparable companies used in that analysis had considerably larger market capitalizations (ranging from $10.7 billion to $353.4 billion) and 2023 revenues (ranging from $5.5 billion to $81.5 billion) than Qianzhi, which had 2023 revenue of $10.1 million. In connection with the Business Combination Agreement, Bowen also entered into a subscription agreement with investors for a PIPE financing of $5.0 million through the sale of 500,000 Bowen ordinary shares at $10.00 per share. According to the proxy's background section, Bowen reviewed approximately 20 potential targets, engaged in detailed due diligence with four, and ultimately declined to proceed with three other candidates before selecting Qianzhi: a China-based industrial intelligent equipment producer that did not provide requested due diligence information, a China-based integrated medical services provider that lacked PCAOB audit readiness, and a Korea-based AI disaster-prevention company that was leaning toward pursuing its own IPO instead. Bowen was introduced to Qianzhi in September 2023 through Bowen independent director Jun Zhang's personal relationship with Qianzhi's CFO, Liangwen Wang. The proxy discloses that Graubard Miller served as U.S. legal counsel to Bowen, Han Kun Law Offices was engaged on October 19, 2023 "to advise [Bowen] on matters of PRC law and to conduct PRC legal due diligence," Ogier served as Cayman Islands counsel passing on the validity of the Bowen ordinary shares to be issued, Becker & Poliakoff LLP served as U.S. legal counsel to Qianzhi, and Jingsh & H Y Leung served as Qianzhi's PRC legal counsel. Bowen's shareholders approved the business combination with Qianzhi at an extraordinary general meeting held in January 2025. However, more than a year and a half after that vote, the transaction still has not closed. Bowen has held a series of shareholder votes to extend its deadline to complete a business combination -- to April 14, 2025, July 14, 2025, December 14, 2025, and most recently to December 31, 2026 (approved at a June 11, 2026 meeting) -- with public shareholders redeeming shares at each vote. Cumulative redemptions have reduced the trust account from approximately $9.3 million after the January 2025 vote to $2.18 million following the June 2026 extension vote, with only 188,742 public shares remaining outstanding. On July 10, 2026, Nasdaq filed a Form 25-NSE with the SEC to remove Bowen's units, ordinary shares and rights from listing, following a Nasdaq hearing panel's October 2025 decision to delist the securities. Bowen's financial statements for fiscal 2025 and 2024 carried a going-concern qualification from its outside auditor, UHY LLP, and on September 9, 2026 Bowen dismissed UHY and engaged INBERGO CPA LLP as its new independent registered public accounting firm, as disclosed in an 8-K/A filed September 30, 2026. No closing 8-K, termination notice, or other filing confirming consummation of the Qianzhi merger was identified in Bowen's SEC filing history through its most recent 10-Q (filed October 1, 2026). The deal therefore remains pending, though the repeated extensions, heavy shareholder redemptions, Nasdaq delisting, going-concern opinion and auditor change collectively indicate a transaction that has been significantly delayed since shareholder approval in January 2025. Pro forma ownership splits, specific synergy targets, and EPS accretion/dilution figures for the combined company were not disclosed in the filings reviewed.

First Industrial Realty Trust, Inc., a real estate sector company trading under ticker FR, and its operating partnership First Industrial, L.P. closed an amendment and restatement of their senior unsecured revolving credit facility and their unsecured term loan on March 18, 2025, refinancing facilities originally dated July 7, 2021. The transaction was disclosed in a Form 8-K (Items 1.01 and 2.03) filed with the SEC on March 19, 2025, with the actual Fifth Amended and Restated Unsecured Revolving Credit Agreement and Second Amended and Restated Unsecured Term Loan Agreement filed as Exhibits 10.1 and 10.2, respectively. The revolving credit facility, previously a $750.0 million facility under the Fourth Amended and Restated Unsecured Revolving Credit Agreement, was increased to $850.0 million and includes an accordion feature allowing the Operating Partnership to increase total capacity to up to $1.0 billion, subject to lender willingness and customary conditions. Its maturity was extended from July 7, 2025 to March 16, 2029, with two six-month extension options exercisable at the Operating Partnership's election (each requiring a 0.0625% extension fee on revolving commitments), which could push the maturity to 2030 if both options are exercised. As of the filing date the Operating Partnership had $431.0 million outstanding under the facility. The term loan continues at its existing $200.0 million principal amount and was not upsized, though the agreement allows the Operating Partnership to request incremental term loans of up to an aggregate $260.0 million, subject to lender willingness and customary conditions. Its maturity was extended from July 7, 2026 to March 17, 2028, with two one-year extension options at the Operating Partnership's election (each requiring a 0.125% extension fee on principal outstanding). Proceeds of the amended and restated term loan were used to refinance the existing term loan facility, which carried the same outstanding principal amount. Pricing on the revolving facility is set, at the Operating Partnership's option, at (i) base rate plus a margin of 0.00% to 0.40%, (ii) daily SOFR plus a margin of 0.70% to 1.40%, or (iii) term SOFR (one, three or six month) plus a margin of 0.70% to 1.40%, with the margin tied to a grid based on credit ratings and consolidated leverage ratio; based on the company's then-current BBB/Baa2/BBB ratings, the applicable margin was 0.775%. A facility fee of 0.10% to 0.30% of total commitments also applies, again scaled to ratings/leverage. Per the company's press release, initial pricing for the revolving facility was set at SOFR plus 77.5 basis points with a 15 basis point facility fee, reflecting the favorable BBB+/Baa1/BBB+ ratings tier (even though actual ratings were BBB/Baa2/BBB at closing), with that favorable tier maintained as long as consolidated leverage ratio remains below 35.0%; unlike the prior facility, the new revolver's pricing excludes a 10 basis point SOFR credit spread adjustment. The term loan is priced, at the Operating Partnership's option, at (i) base rate plus a margin of 0.00% to 0.60%, (ii) daily SOFR (subject to a 0.10% credit spread adjustment) plus a margin of 0.75% to 1.60%, or (iii) term SOFR (one, three or six month, subject to the same 0.10% adjustment) plus a margin of 0.75% to 1.60%, with the applicable margin at closing equal to 0.85% based on the same BBB/Baa2/BBB ratings and leverage level. Both facilities retain the ability to incorporate a sustainability metric adjustment to the interest rate within one year of closing (extendable by six months), subject to certain conditions. Both facilities are interest-only during their terms, with principal due in full at maturity. Both the revolving facility and term loan are senior unsecured obligations of First Industrial, L.P. as borrower, fully and unconditionally guaranteed by First Industrial Realty Trust, Inc. as parent guarantor; no collateral or secured package is disclosed. Each agreement contains financial maintenance covenants including a minimum fixed charge coverage ratio, a maximum consolidated leverage ratio, a maximum unsecured debt to unencumbered assets ratio, a maximum secured debt to implied capitalization ratio, and a minimum interest expense coverage ratio, alongside customary restrictive covenants (limits on additional indebtedness and liens, restricted payments and investments, mergers/asset sales/affiliate transactions), affirmative covenants including financial reporting, and events of default with cross-default provisions tied to the Operating Partnership's other indebtedness. The filing does not disclose the specific numerical covenant thresholds. Proceeds of the revolving facility are intended for general business purposes, including working capital, closing costs, property acquisitions, construction of new industrial properties, and payment of other debts and obligations. Wells Fargo Securities, LLC, BofA Securities, Inc., PNC Capital Markets LLC and U.S. Bank National Association served as Joint Lead Arrangers and Joint Book Runners on the revolving facility, with Regions Capital Markets, JPMorgan Chase Bank, N.A., Royal Bank of Canada and Fifth Third Bank, National Association serving as additional Joint Lead Arrangers. Wells Fargo Bank, National Association serves as Administrative Agent, with Bank of America, N.A., PNC Bank, National Association and U.S. Bank National Association as Co-Syndication Agents and JPMorgan Chase Bank, N.A., Regions Bank, Royal Bank of Canada and Fifth Third Bank, National Association as Co-Documentation Agents on the revolving facility; Citibank, N.A. also participated in the facility. On the term loan, Wells Fargo Securities, LLC and PNC Capital Markets LLC served as Joint Lead Arrangers and Joint Book Runners, with Fifth Third Bank, National Association, Regions Capital Markets and BofA Securities, Inc. serving as additional Joint Lead Arrangers; Wells Fargo Bank, National Association serves as Administrative Agent, PNC Bank, National Association as Syndication Agent, and Fifth Third Bank, National Association, Regions Bank and Bank of America, N.A. as Co-Documentation Agents, with U.S. Bank National Association and First Independence Bank also participating as lenders. No outside legal advisors are identified in the 8-K; the filing is signed only by the company's internal General Counsel. The transaction has closed: the 8-K was filed under Item 2.03 (Creation of a Direct Financial Obligation), the company's press release is titled "First Industrial Realty Trust Closes $850 Million Unsecured Revolving Credit Facility and $200 Million Unsecured Term Loan," and the filing discloses actual outstanding borrowings under the new revolving facility as of the closing date, which together constitute explicit confirmation of closing rather than a pending or announced-only transaction.

MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, agreed to acquire First IC Corporation (OTCEM: FIEB), the holding company for First IC Bank, in a cash-and-stock transaction announced March 17, 2025 via Form 8-K. Both companies are based in Doraville, Georgia. Under the Agreement and Plan of Reorganization dated March 16, 2025, First IC shareholders were to receive 3,384,588 shares of MetroCity common stock and $111,965,213 in cash in the aggregate, subject to adjustment, representing approximately 46% stock and 54% cash. Based on MetroCity's March 14, 2025 closing price of $27.78 per share, the implied purchase price was $22.71 per First IC share, with an aggregate transaction value of approximately $206 million. Holders of First IC stock options were to be cashed out. Chong Chun, Chairman of First IC Corporation, said, "First IC Corporation and its wholly owned subsidiary, First IC Bank, are thrilled to announce the merger with MetroCity. We have been competitors and admirers of the MetroCity franchise for many years and combining our two organizations will create a stronger banking institution for our customers, employees and communities." Nack Paek, MetroCity's Chairman and CEO, stated, "We too have long competed with and admired the First IC franchise and are excited about combining our two organizations. The combined bank will have the capacity to service our customers better, offer enhanced opportunities for our employees and continue offering excellent returns to our shareholders." The investor presentation filed alongside the announcement described the deal as creating "a $4.8 billion asset franchise while strengthening current markets and expanding to the West Coast." At announcement, First IC had approximately $1.2 billion in total assets, $975 million in total deposits, $993 million in total loans, tangible equity of $140.7 million, non-performing assets of 0.31% of assets, net income of $24.7 million, and ROAA of 2.10% for fiscal 2024. The pro forma combined company was expected to have approximately $4.8 billion in assets, $3.7 billion in deposits, and $4.1 billion in loans across 30 branches (20 MetroCity, 10 First IC) plus two First IC loan production offices. At signing, the implied exchange ratio was 0.3732 MCBS shares per FIEB share, and pro forma ownership was estimated at 88.4% MetroCity / 11.6% First IC. Per the investor presentation's pricing metrics, the deal was valued at 146% of First IC's tangible book value, 8.3x First IC's last-twelve-months earnings per share, and 8.9x First IC's 2025 estimated earnings per share, with a pay-to-trade ratio and an estimated internal rate of return also disclosed in the presentation. MetroCity disclosed anticipated pre-tax cost savings equal to 37% of First IC's non-interest expense base, phased in at 10% in 2025, 80% in 2026, and 100% thereafter. The company estimated approximately $14.9 million in transaction costs, net of tax. Purchase accounting assumptions included a gross credit mark of $12.7 million (1.2% of First IC's gross loans), with 70% allocated to non-PCD loans ($9.6 million) accreted over four years on a straight-line basis, a non-PCD CECL reserve of $8.9 million, a loan interest rate mark of $10.2 million (1.0% of anticipated gross loans at close) amortized over four years, elimination of $3.3 million of First IC's accumulated other comprehensive income, and a core deposit intangible of $18.3 million amortized over ten years using the sum-of-the-years digits method. The transaction was expected to deliver approximately 26% EPS accretion to MetroCity shareholders in the first full year including fully phased-in cost savings (illustrated at 26.4%, or $0.73 per share, versus a $2.75 standalone 2026 estimated EPS), with an estimated tangible book value dilution at close of approximately 11% (shown in the presentation's reconciliation as $2.03 per share, or 11.3%) and a tangible book value earnback period of approximately 2.4 years. On the acquirer side, MetroCity retained Hillworth Bank Partners as financial advisor, which rendered a fairness opinion to MetroCity's board, and was represented by Hunton Andrews Kurth LLP as legal counsel. On the target side, First IC retained Stephens Inc. as financial advisor, which rendered a fairness opinion to First IC's board, and was represented by Alston & Bird LLP as legal counsel. In connection with signing, First IC directors and executive officers holding approximately 25% of First IC's outstanding shares entered into a voting agreement to support the transaction. The merger agreement provided for a termination fee of $8,239,563 payable by First IC under certain circumstances, and included a customary "collar" protection: if MetroCity's average closing stock price over a specified ten-trading-day measurement period fell below 80% of its pre-signing average and MetroCity's stock underperformed the KBW Regional Bank Index by more than 20%, First IC had the right to terminate unless MetroCity elected to increase the merger consideration (up to a cap tied to $76,331,936 of incremental value). First IC was permitted a transaction expense allowance of up to $12.5 million pre-tax, with the aggregate cash consideration adjusted dollar-for-dollar if actual transaction costs varied from that allowance. Closing was conditioned on, among other things, First IC shareholder approval, required regulatory approvals from the Federal Reserve, FDIC, and Georgia Department of Banking and Finance, effectiveness of a Form S-4 registration statement, and Nasdaq listing of the shares to be issued; MetroCity filed the Form S-4 (File No. 333-287567) on May 23, 2025, which the SEC declared effective June 6, 2025. The transaction closed after the close of business on December 1, 2025, as confirmed in a Form 8-K filed December 2, 2025. At closing, each First IC share was converted into the right to receive 0.3729 shares of MetroCity common stock and $12.19 in cash (plus cash in lieu of fractional shares), with First IC shareholders receiving an aggregate of approximately 3,384,381 MetroCity shares and approximately $110.6 million in cash. MetroCity had approximately 28,818,282 shares outstanding following the merger. Immediately after the holding-company merger, First IC Bank merged into Metro City Bank, with Metro City Bank as the surviving bank. Following completion, MetroCity reported approximately $4.8 billion in total assets, $4.0 billion in total loans, and $3.6 billion in total deposits, operating 30 full-service branches and two loan production offices across Alabama, California, Florida, Georgia, New Jersey, New York, Texas, and Virginia. The same financial and legal advisors on both sides were reconfirmed in the closing press release.

Ideanomics, Inc., an industrials sector company, and certain of its subsidiaries, Wireless Advanced Vehicle Electrification LLC, Via Motors International, Inc., Via Motors, Inc., Justly Holdings Inc., Justly Markets LLC, and Timios Holding Corp. (together, the Sellers), filed voluntary Chapter 11 petitions on December 4, 2024 in the United States Bankruptcy Court for the District of Delaware, captioned In re Ideanomics, Inc., et al. Effective the same day, the Sellers entered into an asset purchase agreement (the APA) with Tillou Management and Consulting LLC (the Purchaser), under which the Sellers agreed to sell substantially all of their assets to Tillou pursuant to Section 363 of the Bankruptcy Code, with Tillou acting as stalking-horse purchaser subject to higher and better bids in a court-supervised sale process. The purchase price under the APA was structured as a formula rather than a single stated dollar figure, comprising: (i) the assumption of certain liabilities of the Sellers, including cash payment of cure costs for assumed contracts; (ii) the amount required to pay and satisfy in cash any encumbrances senior to Purchaser's liens on the purchased assets; (iii) the amount required to pay in cash the "Advisor Success Fee," defined in the APA as the success fee and accrued expenses payable to SSG Advisors, LLC under an engagement agreement dated November 7, 2024 among Ideanomics, Wireless Advanced Vehicle Electrification LLC, Via Motors and SSG, as allowed by the Bankruptcy Court; and (iv) a credit bid of the "Credit Bid Amount," defined as the total aggregate amount outstanding of the DIP obligations and secured prepetition obligations owed to Tillou. No aggregate dollar value for the purchase price is disclosed in the filings reviewed. The APA states it does not impose any post-closing indemnification obligations on either the Sellers or the Purchaser, and both parties represented there was no broker, finder or financial advisor owed a fee other than as disclosed (i.e., SSG Advisors on the Sellers' side). In connection with the Chapter 11 filing, the Debtors also entered into a Senior Secured Superpriority Debtor-in-Possession Loan Agreement dated December 4, 2024 with Tillou Management and Consulting LLC as DIP Lender. Tillou was already the holder of Ideanomics' secured debentures (originally sold to YA II PN, Ltd. under an October 25, 2022 purchase agreement and assigned to Tillou on October 29, 2024) and of an amended and restated promissory note dated November 5, 2024. The DIP Credit Agreement provided a new money multiple-draw term loan facility of up to $11,619,000 (of which $6,957,000 was available on an interim basis and the balance upon a final order), bearing interest at 12 percent, alongside a provision converting up to $18,872,350.64 of Tillou's pre-existing claims into DIP loans on a cashless, dollar-for-dollar basis. The DIP facility carried a maturity date that was the earliest of August 5, 2025; consummation of an asset sale with Bankruptcy Court authorization to pay proceeds to the DIP Lender; 45 days after the petition date if a Final DIP Order had not been entered; dismissal or conversion of the Chapter 11 cases; the effective date of a plan of reorganization; or acceleration by the DIP Lender following an event of default. The Bankruptcy Court entered an order on February 26, 2025 authorizing the sale under Section 363 of the Bankruptcy Code. The Sellers consummated the transactions contemplated by the APA on March 7, 2025, completing the disposition of substantially all of the Debtors' assets to Tillou. Proceeds from the sale were used in part to repay the Sellers' obligations under the DIP Credit Agreement, after which that agreement was deemed terminated and its obligations fully satisfied (other than as stated in the sale order). The company disclosed that it expects no proceeds from the sale to be distributed to Ideanomics shareholders. Effective upon closing, Shane McMahon resigned as a Director and Executive Chairman, and the company terminated the employment of CFO Ryan Jenkins; Ideanomics' remaining wind-down operations are managed under a transition services agreement with Tillou and overseen by CEO Alfred P. Poor. Ideanomics stated it was unable to prepare pro forma financial information for the transaction without unreasonable effort or expense, so none was filed. The notices clause of the APA identifies each side's outside counsel: notices to the Sellers were to be copied to Foley & Lardner LLP (Attention: John Simon and Mark Plichta, Detroit, Michigan), and notices to the Purchaser, Tillou Management and Consulting LLC, were to be sent care of and copied to Faegre Drinker Biddle & Reath LLP (Attention: Frank Velocci, Bryan Bloom and Michael Pompeo, Florham Park, New Jersey). The Sellers' financial advisor was SSG Advisors, LLC, under a November 7, 2024 engagement letter, entitled to a success fee payable in cash as part of the purchase price consideration, subject to Bankruptcy Court allowance. The APA was terminable under a number of conditions, including by mutual consent; by either party if closing had not occurred by February 28, 2025; by Purchaser if the Bankruptcy Court did not enter required orders or meet case milestones by specified dates, if a Seller sought dismissal or conversion to Chapter 7, if a trustee or expanded-power examiner was appointed, if a Seller entered an alternative transaction, or if the Sellers materially defaulted under the DIP Credit Agreement; and by either party if a governmental body issued a final order restraining the transaction or if Purchaser was disallowed under Section 363(k) from credit bidding. No separate break-up or termination fee payable by either side is disclosed in the filings reviewed. The transaction has closed; as of the March 13, 2025 Form 8-K, Ideanomics has sold substantially all of its operating assets and remains in wind-down.

This deal is a term loan refinancing and liability management transaction classified under debt capital markets (DCM), involving The E.W. Scripps Company as issuer. The disclosed value of the transaction is $1,300,000,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on March 11, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as financial advisor to the company (E.W. Scripps, the issuer), with no lead/non-lead designation specified. Separately, Moelis & Company LLC served as financial advisor to an ad hoc group of certain initial consenting holders, categorized as creditors, also without a specified lead designation. On the legal side, Simpson Thacher & Bartlett LLP served as counsel to the company (issuer), per the same source sentence naming Perella Weinberg Partners' role, while Davis Polk & Wardwell LLP served as counsel to the ad hoc group of initial consenting holders (creditors). Beyond the classification of this transaction as a term loan refinancing paired with broader liability management, with a disclosed value of $1,300,000,000, no further detail on the specific term loan's pricing, maturity, or amendment terms is provided in the facts block. Several items are not disclosed in the available record. No sector classification is given, and no lead/non-lead designation is specified for either Perella Weinberg Partners or Moelis & Company in their respective advisory roles. No expected closing date or further timeline detail beyond the March 2025 filing date and pending-regulatory status is given.

This matter involves Lands' End, Inc., trading under the ticker LE, undertaking a strategic alternatives review and potential sale process. The deal is classified within the consumer and retail sector, and the disclosed value is not stated in the source document, consistent with the fact that this is described as a review of alternatives rather than a definitive transaction. The matter is sourced from an SEC EDGAR Form 8-K filing published on March 7, 2025. Based on the facts provided, the status of this process is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners serves as Lands' End's financial advisor in connection with this strategic review. No lead designation is specified for this engagement in the facts provided, and no financial advisor to any potential counterparty is named, consistent with the fact that no specific buyer or transaction has been identified. On the legal side, Wachtell, Lipton, Rosen & Katz serves as Lands' End's legal advisor, paired with Perella Weinberg Partners in the same source sentence describing the company's advisory team for this process. Because this is described as a strategic alternatives review and potential sale process rather than a definitive transaction, no deal structure, consideration terms, or counterparty-specific detail is included in the facts available. Several elements remain undisclosed or not yet applicable given the preliminary stage of this process. No specific transaction, counterparty, or value is named, no consideration structure exists to describe, and no expected timeline or outcome for the strategic review is given in the facts available.

Repligen Corporation, a life sciences company trading under ticker RGEN, completed its purchase of 908 Devices Inc's desktop portfolio of four bioprocessing process analytical technology (PAT) devices on March 4, 2025. The transaction was structured as a securities and asset purchase, with Repligen Corporation and its subsidiary Repligen GmbH (together, the purchasers) acquiring 100 percent of the equity interests of 908 Devices GmbH along with certain other assets and liabilities, collectively comprising 908 Devices' entire desktop business. The disposition was disclosed in a Form 8-K filed by 908 Devices Inc (Nasdaq: MASS, CIK 0001555279) on March 4, 2025, reporting Items 1.01, 2.01, 8.01 and 9.01, with the underlying Securities and Asset Purchase Agreement, dated March 4, 2025, attached as Exhibit 2.1. The products acquired include MAVERICK and MAVEN, used for real-time monitoring and control of critical bioprocess parameters, REBEL, an at-line cell culture media analyzer, and ZipChip, a high-resolution sample separations device used in characterization of product quality attributes (the pro forma financial statements also reference a fifth product, Trace C2, as part of the divested desktop commercial-stage analytical technology devices). Olivier Loeillot, President and CEO of Repligen, said: "We are really excited to onboard the 908 bioprocessing team and the four differentiated upstream PAT technologies that are commercialized today. They are the perfect complement to our downstream analytics portfolio and will enable Repligen to further penetrate a broad set of modalities and offer analytics solutions across the entire bioprocess workflow. This asset acquisition is a true win-win for both organizations, and a significant step forward for Repligen as our customers increasingly embed digitization technologies in their production processes." Kevin J. Knopp, CEO and Co-founder of 908 Devices, stated: "Repligen's leadership in commercializing innovative solutions that advance bioprocessing is a great fit for our novel desktop devices and our bioprocessing team. I wish them continued success. Going forward, 908 Devices will continue to advance chemical detection at the point of need with our handheld analytical devices in vital health and safety applications." The purchase price was $70 million in cash, payable by the purchasers for the transferred equity interests and purchased assets, subject to customary adjustment for working capital. A portion of the purchase price is being held in escrow for a period following closing as a source of recovery for possible indemnification claims or negative purchase price adjustments. Per 908 Devices' pro forma disclosure, the upfront payment amounted to $66.0 million net of approximately $4.0 million of transaction costs. 908 Devices estimated a gain on sale of approximately $54.7 million, calculated as total consideration of roughly $67.2 million (the net upfront payment plus a $1.1 million release of cumulative translation adjustment related to 908 Devices GmbH) less net assets transferred of approximately $12.5 million, consisting primarily of accounts receivable, inventory, property and equipment, operating lease right-of-use assets, and intangible assets net of related deferred tax liabilities, offset by assumed liabilities including accounts payable, accrued expenses, deferred revenue and operating lease liabilities. 908 Devices cautioned that this accounting for the gain was preliminary and subject to revision as further analysis of the acquired assets and assumed liabilities was completed. As part of the agreement, 908 Devices and its subsidiaries agreed to a five-year non-compete covering the divested desktop business and an 18-month restriction on soliciting employees who provided services to that business, while the purchasers agreed to an 18-month non-solicitation covenant with respect to 908 Devices' remaining employees. The parties also entered into a transition services agreement under which 908 Devices will provide certain technology, financial and operational transition services to the purchasers through December 31, 2025, a supply agreement under which 908 Devices will continue to supply certain products related to the divested business, and license/sublicense agreements covering intellectual property used in the divested business that was not transferred. Repligen also assumed the lease for the Desktop Business's North Carolina facility and entered into employment agreements with more than fifty employees of 908 Devices who supported that business; 908 Devices expected to terminate its remaining employees who had supported the Desktop Business, anticipated to occur in March 2025. On the financial advisory side, Centerview Partners LLC acted as financial advisor to Repligen Corporation, and Perella Weinberg Partners acted as financial advisor to 908 Devices Inc. On the legal side, Goodwin Procter served as legal counsel to Repligen Corporation, and Paul Hastings LLP served as legal counsel to 908 Devices Inc. 908 Devices' board of directors approved the disposition. Because the sale did not constitute a disposition of substantially all of 908 Devices' assets, stockholder approval was not required under Delaware law in connection with the transaction. No separate financing or regulatory-approval contingency was disclosed in the filings reviewed; the 8-K reflects that the transaction had already closed on the date it was signed (March 4, 2025). Following the close, 908 Devices began presenting the divested Desktop Business as a discontinued operation effective in the first quarter of 2025. On a pro forma basis giving effect to the sale as if it had occurred January 1, 2024, 908 Devices' continuing-operations revenue for fiscal 2024 was $47.7 million (versus $59.6 million historical total revenue) and its pro forma net loss from continuing operations was $40.4 million, or $1.19 per basic and diluted share (versus a $72.2 million historical net loss, or $2.12 per share). For fiscal 2023, pro forma continuing-operations revenue was $38.2 million (versus $50.2 million historical) and the pro forma net loss from continuing operations was $20.7 million, or $0.64 per share (versus a $36.4 million historical net loss, or $1.13 per share). No contingent consideration, earnout, or seller financing tied to the $70 million headline price was disclosed beyond the working-capital adjustment and indemnification escrow referenced above; the specific size and duration of the escrow were not disclosed in the filings reviewed. No EV/EBITDA, revenue, or other valuation multiple for the transaction was disclosed by either company in the filings reviewed.

TKO Group Holdings, Inc., a real-estate sector company trading under ticker TKO, is acquiring a target entity in a merger and acquisition transaction. The deal represents a standard acquisition within the M&A product group. No deal value has been disclosed in the source documents available. The information regarding this transaction is sourced from an SEC filing published on February 28, 2025. The specific form type is not identified in the available data. The transaction is currently pending regulatory approval, indicating that closing has not yet occurred and the deal remains subject to regulatory conditions. TKO's financial advisory team consists of two firms with distinct mandates. Morgan Stanley & Co. LLC served as the lead financial advisor to TKO overall. Additionally, Moelis & Company LLC served as financial advisor to TKO's special committee. On the target side, The Raine Group served as the lead financial advisor to Endeavor, which is the target entity in this acquisition. The legal advisors supporting both parties have also been retained. Skadden, Arps, Slate, Meagher & Flom LLP served as legal advisor to TKO's special committee. Latham & Watkins LLP served as legal advisor to Endeavor on the target side of the transaction. Beyond the advisor and party information, very limited structural or financial detail has been disclosed. The consideration structure, whether it involves cash, stock, debt, or some combination thereof, has not been specified. The deal size and purchase price remain unstated. No information regarding earnouts, working capital adjustments, representations and warranties insurance, or other customary M&A deal mechanics has been disclosed or is available in the source materials. Several critical data points remain unknown or undisclosed at this stage. The target entity name, while referenced as "Endeavor" in advisor language, lacks fuller identification in the filing source itself. No expected closing date or timeline for regulatory approval has been provided. The form type of the SEC filing has not been identified. The transaction structure, consideration mix, and all financial terms remain entirely undisclosed. Given the pending regulatory status, material conditions and milestones ahead of close are similarly not yet known.

TKO Group Holdings, Inc., a real estate sector company trading under the ticker TKO, is the acquirer in an acquisition of an undisclosed target entity. This is a mergers and acquisitions transaction within the real estate sector. The disclosed value of the transaction is not stated in the source document(s). The information regarding this transaction is sourced from an SEC filing published on the SEC EDGAR platform on February 28, 2025. The specific form type is unknown based on the available source material. The deal currently has a pending regulatory status, indicating that it has not yet closed and remains subject to regulatory review or approval. TKO Group Holdings is being advised by two financial advisors. Morgan Stanley & Co. LLC serves as the lead financial advisor to TKO. Additionally, Moelis & Company LLC serves as financial advisor specifically to TKO's special committee. On the target side, The Raine Group serves as the lead financial advisor to Endeavor, which is identified as the target company in this transaction. The legal advisory teams are similarly structured. Skadden, Arps, Slate, Meagher & Flom LLP serves as legal advisor to TKO's special committee. Latham & Watkins LLP serves as legal advisor to the target, Endeavor. No information has been disclosed regarding the deal structure, consideration mix, or specific terms of the transaction. The transaction value is not stated in the source documents. The expected closing date is not disclosed. Whether the transaction will be an all-cash acquisition, an all-stock transaction, or some combination of consideration types is unknown. The source documents do not specify whether this is a merger, asset purchase, stock purchase, or other acquisition structure variant.

reAlpha Tech Corp., a Delaware corporation trading under the ticker AIRE on the Nasdaq Capital Market in the real estate sector, is the issuer in an equity capital markets transaction structured as an amendment to an existing At the Market (ATM) sales agreement rather than a newly launched offering. The underlying ATM Sales Agreement was originally dated December 19, 2024, with A.G.P./Alliance Global Partners acting as sales agent, and was subsequently amended twice, on January 31, 2025 (Amendment No. 1) and February 27, 2025 (Amendment No. 2). Both amendments were disclosed in Form 8-K filings and accompanied by prospectus supplements on Form 424B5 and legal opinions from Mitchell Silberberg & Knupp LLP, counsel to the company. Under the original December 19, 2024 agreement, the company could sell up to $14,275,000 of common stock through A.G.P. at a floor price of $5.00 per share. Amendment No. 1, dated January 31, 2025, reduced the floor price from $5.00 to $3.90 per share while keeping the $14,275,000 aggregate offering cap in place; the related January 31, 2025 prospectus supplement disclosed Nasdaq's last sale price of $1.52 per share as of January 30, 2025, well below the $3.90 floor. Amendment No. 2, dated February 27, 2025, further reduced the floor price from $3.90 to $0.01 per share and, pursuant to Form S-3 Instruction I.B.6 public-float limits, reduced the aggregate offering price the company was eligible to sell under the program from $14,275,000 to $11,700,000; Nasdaq's last sale price at that time was $1.69 per share (February 26, 2025). A.G.P./Alliance Global Partners is compensated with a cash commission of 3.0% of the aggregate gross proceeds from any shares sold under the Sales Agreement, plus reimbursement of certain out-of-pocket expenses including legal fees, per the terms disclosed in the January 31, 2025 Form 8-K. The company stated in both the January 31 and February 27, 2025 prospectus supplements that, during the trailing 12 months through each filing date, it had sold no securities under the ATM program pursuant to Form S-3 General Instruction I.B.6, indicating no shares had yet been issued or proceeds raised under this facility as of the February 27, 2025 amendment. No use-of-proceeds disclosure specific to this ATM program, no greenshoe/over-allotment provision (not applicable to an ATM structure), and no concurrent share repurchase were identified in the available filings. The floor-price reductions triggered anti-dilution adjustments under separate outstanding warrants (the "Follow-On Warrants," issued November 24, 2023 in connection with a prior best-efforts offering with Maxim Group LLC as placement agent). Following Amendment No. 1, the Follow-On Warrants' exercise price was reduced from $5.00 to $3.90 per share and the shares issuable increased to approximately 3,076,924. Following Amendment No. 2, the exercise price was further reduced from $3.90 to $1.44 per share (the warrants' own floor price) and the shares issuable increased to approximately 8,333,336, structured so the aggregate exercise price remained constant. As of February 27, 2025, reAlpha had 46,054,182 shares of common stock outstanding, of which 12,156,461 shares were held by non-affiliates. Mitchell Silberberg & Knupp LLP delivered legal opinions to reAlpha Tech Corp. (Exhibit 5.1) in connection with both the January 31, 2025 and February 27, 2025 amendments, confirming its role as issuer's counsel; no legal advisor to A.G.P./Alliance Global Partners was identified in the available filings. The transaction remains in announced status; no filing identified confirms that any shares have actually been sold, that the ATM program has been terminated, or that the offering has otherwise closed or settled.

Old Second Bancorp, Inc. (Nasdaq: OSBC), a financial institutions sector company headquartered in Aurora, Illinois, agreed to acquire Bancorp Financial, Inc., the Oak Brook, Illinois-based holding company for Evergreen Bank Group, in a cash-and-stock merger. The parties signed an Agreement and Plan of Merger on February 24, 2025, which was disclosed in a Form 8-K filed February 25, 2025 along with a joint press release and investor presentation. The merger closed on July 1, 2025, with Bancorp Financial merging into Old Second and, immediately afterward, Evergreen Bank Group merging into Old Second National Bank, as confirmed in a Form 8-K filed July 1, 2025 reporting completion of the acquisition under Item 2.01. Under the merger agreement, each share of Bancorp Financial common stock was converted into the right to receive 2.5814 shares of Old Second common stock plus $15.93 in cash, with cash paid in lieu of fractional shares. Based on Old Second's February 24, 2025 closing price of $18.08, the per-share consideration was implied at $62.60, and total consideration was approximately 75% stock and 25% cash, for an aggregate transaction value of approximately $197 million as announced. Bancorp Financial's financial advisor, KBW, used a $202.3 million indicative transaction value based on Old Second's February 14, 2025 closing stock price ($18.80) for its fairness-opinion analyses, implying a value of $64.46 per Bancorp Financial share. Keefe, Bruyette & Woods (KBW), financial advisor to Bancorp Financial, calculated implied multiples for the deal in its fairness opinion materials: 19.7 times Bancorp Financial's annualized fourth-quarter 2024 EPS, 16.0 times estimated 2025 EPS, and 10.9 times estimated 2026 EPS. In a separate selected-transactions comparison of recent U.S. whole-bank deals, KBW calculated the Old Second/Bancorp Financial transaction at 1.35 times Bancorp Financial's tangible book value (versus a comparable-group 75th percentile of 1.58x, average of 1.34x, median of 1.29x, and 25th percentile of 1.06x), a core deposit premium of 6.7% (versus a group median of 3.3%), and 35.7 times Bancorp Financial's LTM EPS (versus a group median of 12.2x), reflecting Bancorp Financial's depressed trailing earnings relative to its forward estimates. Old Second disclosed that the combination is expected to deliver approximately 16% EPS accretion to Old Second stockholders in the first full year including fully phased-in cost savings, along with a projected increase in return on average assets of more than 13 basis points and an increase in return on average tangible common equity of more than 267 basis points on a pro forma basis, also assuming fully phased-in cost savings. Old Second said the acquisition would let it deploy excess capital at an estimated internal rate of return above 20%. The companies did not disclose a specific dollar figure or phase-in schedule for merger-related cost savings, nor did they disclose a tangible book value dilution or earnback period for the deal. Strategically, Old Second said the deal would create the second-largest community bank under $10 billion in assets in the Chicago market, with a pro forma company holding approximately $7.1 billion in assets, $6.0 billion in deposits, and $5.2 billion in loans across 56 branches in the Chicago area. James Eccher, Chairman, President and CEO of Old Second, said the transaction "offers a terrific pro forma balance sheet profile by combining the strength of Old Second's funding profile with the yield resiliency of Evergreen's unique asset strategies," adding that management believed "the combined income statement offers significantly less volatility and a stronger earnings profile in all rate environments." Darin Campbell, Chairman, President and CEO of Bancorp Financial, said the merger was "expected to create a stronger banking institution for our customers and communities," citing the combination of Evergreen's FreedomRoad Financial and Performance Finance powersports lending divisions with Old Second's balance sheet. A key strategic driver cited by Old Second was Evergreen's national powersports lending business, which represented approximately 60% of Evergreen's outstanding loan balances across roughly 88,000 accounts with a 2024 portfolio yield of 8.84%, originated through partnerships with original equipment manufacturers and more than 1,000 authorized dealers. The proxy statement/prospectus (Form 424B3 filed May 8, 2025, as supplemented May 15, 2025) that registered the Old Second shares issued in the deal under a Form S-4 (filed April 23, 2025, amended May 6, 2025) disclosed the negotiation background. Old Second CEO James Eccher first contacted Bancorp Financial CEO Darin Campbell in late May 2024. Starting in July 2024, Bancorp Financial's board worked with KBW to evaluate strategic alternatives, including remaining independent; KBW contacted one other Chicago-based financial institution on Bancorp Financial's behalf, but that institution indicated it was not interested in acquiring a company with a consumer lending focus, and no other potential acquirers were solicited. Old Second submitted a non-binding letter of intent on December 10, 2024 at an offered price of $195.0 million (approximately 130% of Bancorp Financial's tangible book value as of September 30, 2024), consisting of about $48.8 million cash and the remainder in stock. After further negotiation, the parties agreed to final terms (the 2.5814 exchange ratio and $15.93 cash per share) in mid-February 2025, and the merger agreement was executed February 24, 2025 following unanimous approval by both boards. The merger agreement provided for a termination fee of $8,500,000 payable by Bancorp Financial to Old Second under certain circumstances, and Bancorp Financial stockholders holding voting agreements, including all Bancorp Financial directors, agreed to vote in favor of the merger. Completion was conditioned on Bancorp Financial stockholder approval, effectiveness of the Form S-4 registration statement, Nasdaq listing approval for the new shares, receipt of required regulatory approvals from the Federal Reserve and the Office of the Comptroller of the Currency, and other customary closing conditions. Bancorp Financial stockholders approved the merger at a special meeting on June 18, 2025, as disclosed in a Form 8-K filed that day, and the deal closed on July 1, 2025. In connection with the closing, Old Second expanded its board by one seat for Darin Campbell and expanded Old Second National Bank's board by two seats for Campbell and Bancorp Financial CFO Jill Voss; Campbell also entered into an employment agreement to serve as EVP of Old Second and President of its National Specialty Lending, FreedomRoad Financial, and Performance Finance units, with an annual base salary of $550,000. On the financial advisory side, Piper Sandler & Co. served as financial advisor to Old Second, and Keefe, Bruyette & Woods, A Stifel Company, served as financial advisor to Bancorp Financial and rendered a fairness opinion, dated February 18, 2025, to Bancorp Financial's board. On the legal side, Nelson Mullins Riley & Scarborough LLP served as counsel to Old Second, and Vedder Price P.C. served as counsel to Bancorp Financial. Following closing, Old Second disclosed pro forma combined financials as of March 31, 2025 of approximately $6.98 billion in assets, $5.95 billion in deposits, and $5.09 billion in loans. Audited Bancorp Financial financial statements and unaudited pro forma condensed combined financial statements for the year ended December 31, 2024 were incorporated into the closing Form 8-K by reference to Old Second's Form S-4 amendment filed May 6, 2025; a further pro forma update covering the six months ended June 30, 2025 was indicated to be filed within 71 days of the closing 8-K.

Chegg, Inc., a learning platform trading under the ticker CHGG, announced on February 24, 2025, in its fourth-quarter and full-year 2024 earnings release filed on Form 8-K, that it was launching a strategic review process to explore alternatives to maximize shareholder value, including being acquired, undertaking a go-private transaction, or remaining as a public standalone company. CEO Nathan Schultz said the company made "two important and connected decisions to maximize the future of our business and shareholder value," tying the review to a concurrent complaint filed against Google LLC and Alphabet Inc. over AI Overviews diverting traffic from Chegg. Chegg retained Goldman Sachs as financial advisor for the strategic review; Susman Godfrey was retained specifically with respect to the Google litigation, not as an advisor on the strategic review itself. On its Q1 2025 earnings call, disclosed in an 8-K exhibit filed May 12, 2025, management reported progress, saying the company had held "dozens of meetings with interested parties, ranging from strategic tech and education companies to private equity firms," and described early indications as positive. On its Q2 2025 earnings call, disclosed in an 8-K exhibit filed August 5, 2025, Chegg said it continued to "engage with a select group of parties" as part of the review, without identifying any party, proposed price, or structure. The strategic review concluded without a sale or go-private transaction. In an 8-K exhibit filed October 27, 2025, Chegg announced that after a year-long review conducted with Goldman Sachs and "after thoughtful consideration of multiple proposals, the Board unanimously determined that remaining an independent public company offers the best opportunity to maximize long-term shareholder value." No acquirer, bidder, purchase price, valuation multiple, or transaction consideration was ever disclosed in connection with the review, and none of the "multiple proposals" referenced were described in the filings reviewed. Concurrent with the conclusion of the review, Chegg announced a leadership change and restructuring. Dan Rosensweig, previously Executive Chairman, reassumed the role of President and CEO effective October 27, 2025, with outgoing CEO Nathan Schultz becoming an Executive Advisor. Chegg also announced a restructuring to reduce its cost structure and redirect investment toward its Busuu language-learning and Skills businesses, which the release said were expected to generate approximately $70 million of revenue in 2025. The restructuring was expected to eliminate 388 roles globally, approximately 45% of the workforce, reduce 2026 non-GAAP expenses by approximately $100 million to $110 million, and result in approximately $15 million to $19 million of charges, mostly cash severance payments. No merger agreement, tender offer, or merger proxy statement (no DEFM14A, PREM14A, S-4, or Schedule TO/14D-9) was ever filed for Chegg in connection with this process, consistent with the review ending in a decision to remain independent rather than in a signed transaction. Subsequent filings show Chegg continuing to operate as a standalone public company: it received an NYSE notice in December 2025 for average share price below $1.00 over 30 trading days, conducted multiple private note repurchases of its 0% convertible senior notes due 2026 through the first half of 2026, and announced on September 1, 2026 that it had repaid the remaining $33.9 million of those notes at maturity, leaving the company with no outstanding debt. No subsequent filing reviewed reopened or restarted a strategic/sale process.

This transaction is a Chapter 11 reorganization plan confirmation in the restructuring product group, with a disclosed transaction value of $2,385,000,000 USD. The specific company and creditor constituencies involved are not identified in the available source material, though the filing references convertible bondholders and an ad hoc group of loyalty noteholders as key stakeholder groups in the proceeding. The information is sourced from an SEC filing published on the SEC EDGAR platform on February 21, 2025. The form type is not specified in the available data. The deal is currently pending regulatory approval or confirmation, as indicated by its pending-regulatory status classification. The company is being advised by a team comprising Davis Polk & Wardwell LLP in the role of restructuring counsel, Alvarez & Marsal serving as restructuring advisor, and Perella Weinberg Partners LP acting as investment banker. All three of these advisors are identified as lead advisors to the company. On the creditor side, multiple advisor teams have been engaged across different constituencies. Paul Hastings LLP is acting as legal counsel and Ducera Partners LLC is acting as financial advisor to the convertible bondholders. Separately, Akin Gump Strauss Hauer & Feld LLP is acting as legal counsel and Evercore is acting as financial advisor to the ad hoc group of loyalty noteholders, indicating that different classes of creditors have retained separate representation. No legal advisors to the company are identified in the source material beyond the financial advisors already noted. The legal representation is specified only for the creditor constituencies. The transaction is structured as a Chapter 11 reorganization plan subject to confirmation, which is the statutory restructuring process under the U.S. Bankruptcy Code. The disclosed transaction value of $2,385,000,000 USD represents the total consideration involved, though the specific composition of that consideration, the treatment of various creditor claims, and the detailed terms of the plan of reorganization are not provided in the available source material. The following material details remain undisclosed or unknown: the identity of the company undergoing reorganization, the specific plan terms and creditor recoveries, the expected confirmation or effective date, the detailed consideration structure, and any equity or debt instruments to be issued as part of the plan. The exact SEC filing form type is also not specified. These gaps would need to be filled by reviewing the actual plan documents filed with the court or the full SEC filing itself.

This transaction is a cash acquisition in which Valvoline Inc. (ticker VVV), an energy-power sector company, is acquiring Breeze Autocare from a private equity seller. The deal is classified under the sponsors-coverage product group and carries a disclosed value of $625,000,000. The transaction is currently in pending regulatory status. This summary is sourced from an SEC EDGAR Form 8-K filed and published on February 20, 2025. No other source documents are referenced in the available facts. On the financial advisory side, Morgan Stanley & Co. LLC is serving as financial advisor to Valvoline Inc., the acquirer, in a lead role. On the sponsor side, Jefferies Group LLC is serving as financial advisor to Breeze Autocare, also in a lead capacity. Legal counsel mirrors this structural split. Squire Patton Boggs (US) LLP is serving as legal advisor to Valvoline Inc., the acquirer, while Kirkland & Ellis LLP is serving as legal advisor for Breeze Autocare, the target being sold by its private equity sponsor. The facts block characterizes this as a cash acquisition from a private equity seller, consistent with its classification under the sponsors-coverage product group, but provides no further detail on the specific structure of the purchase agreement, financing sources for Valvoline, or any contingent consideration elements. Several details remain undisclosed in the available record. No expected closing date is given. The facts block does not name the specific private equity sponsor selling Breeze Autocare beyond referring to it as the sponsor side of the transaction, nor does it provide detail on what regulatory approvals are outstanding under the pending-regulatory status.

This transaction is a subsidiary or asset sale in which AstraZeneca PLC, trading under the ticker AZN, is acquiring FibroGen China from FibroGen. The deal is classified within the healthcare sector, and the disclosed value of the transaction is 160,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on February 20, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, BofA Securities, Inc. is acting as exclusive financial advisor to FibroGen, the seller in this transaction, and is identified as the lead advisor in that capacity. On the legal side, Ropes & Gray LLP is acting as legal advisor to FibroGen, paired with BofA Securities in the same source sentence describing the company's advisory team on this transaction. No financial or legal advisor to AstraZeneca, the acquirer, is identified in the facts provided. Beyond confirming that this is a subsidiary or asset sale with a disclosed value of 160,000,000 dollars, no further detail on the specific assets or subsidiary interests being conveyed, or on any additional consideration structure such as royalties or milestone payments, is included in the facts available. A number of elements of this deal remain undisclosed. No financial or legal advisor to AstraZeneca is named, and no detail is provided on the specific scope of the FibroGen China assets being sold beyond the 160,000,000 dollar disclosed value. The facts also do not specify an expected closing date or what regulatory approvals are required to complete the transaction.

Nikola Corp, an industrials sector company, is the issuer in a Chapter 11 asset sale process, which is a type of restructuring transaction. This represents a formal bankruptcy proceeding in which the company's assets will be sold, typically through an auction process overseen by the bankruptcy court. No transaction value has been disclosed in available source documents. The information regarding this transaction is sourced from an SEC EDGAR filing published on February 19, 2025. The specific form type was not identified in the source material. The deal currently carries a pending regulatory status, indicating that the process remains in motion but has not yet reached completion or closing. On the financial advisory side, Nikola has engaged two advisors. Houlihan Lokey Capital, Inc. serves as the company's investment banker, taking a lead role in the process. M3 Partners has been retained as a financial advisor to the company as well. Both firms are supporting Nikola through the Chapter 11 asset sale process. Nikola's legal representation comprises two firms. Pillsbury Winthrop Shaw Pittman LLP and Potter Anderson & Corroon LLP have both been engaged as legal counsel to the company, providing guidance on the restructuring and asset sale transaction. The deal structure is a Chapter 11 asset sale process, which is the formal subtype within restructuring. However, no specific details regarding the mechanics of the sale, the anticipated auction timeline, reserve prices, or bidding procedures have been disclosed in available source documents. The consideration structure, identity of any bidders or stalking horse offers, and any assumed liabilities or carve-outs have not been stated. Several critical details remain unknown or undisclosed. No transaction value or expected valuation range has been provided. The expected closing date, if any has been determined, is not stated in the available sources. The specific assets to be included in the sale, any going-concern operations to be preserved, and the anticipated timeline for the bankruptcy court approval process have not been disclosed. Additionally, the identity of any potential bidders, the stalking horse bid amount (if one exists), or the expected date of the 363 sale hearing have not been made public based on the available source material.

Profusa, Inc., a California-incorporated clinical-stage and commercial-stage digital health company developing tissue-integrating biosensors for continuous monitoring of patient biochemistry, completed a business combination with NorthView Acquisition Corporation, a special purpose acquisition company (Nasdaq: NVAC). The transaction closed on July 11, 2025, and the combined company was renamed Profusa, Inc., with its common stock beginning trading on Nasdaq under the ticker PFSA on July 14, 2025. The merger agreement and plan of reorganization among NorthView, Profusa, and merger subsidiary NV Profusa Merger Sub Inc. was originally dated November 7, 2022 and was amended, supplemented, and modified over time before closing. NorthView shareholders approved the business combination on June 9, 2025. Under the terms of the merger agreement, each share of Profusa common stock was converted into shares of New Profusa common stock based on an exchange ratio that reflects an equity valuation of Profusa of $155,000,000, as adjusted for the Incentive Equity Value, the Private Placement Value, and the Aggregate Company Incentive Amount, divided by an assumed value of New Profusa common stock of $10.00 per share. The resulting exchange ratio was $0.94, with a Company Reference Share Value of $9.40. Immediately following closing, there were 32,788,877 shares of New Profusa common stock outstanding, no shares of preferred stock outstanding, and 17,404,250 Profusa warrants outstanding. The transaction was accounted for as a reverse capitalization under GAAP, with Profusa treated as the accounting predecessor and New Profusa as the successor SEC registrant. In connection with the closing, the combined company issued a senior secured convertible promissory note to institutional investor Ascent Partners Fund LLC, raising $9,000,000 in net proceeds (a $10,000,000 principal Initial Note at a 10% original issue discount) to fund transaction costs and working capital, under a broader PIPE facility sized up to $22,222,222 in aggregate principal ($20,000,000 aggregate purchase price). The Initial Note matures 18 months from closing, is convertible at the lower of $10.00 per share or 95% of the lowest daily VWAP in the 10 trading days prior to issuance (subject to down-round and most-favored-nation adjustments), and accrues interest at 10% per annum (24% upon default). The note is secured by substantially all assets of New Profusa and Profusa under a security agreement with Ascent as collateral agent, and is further backed by a guaranty from the Profusa parties and their subsidiaries. Certain Profusa and NorthView insiders also agreed to lock-up restrictions of six to twelve months (staged 25%/25%/50%) on Profusa-side shares, and eight months on NorthView sponsor founder shares (with early release tied to a $12.50 trading-price trigger). Ben Hwang, Ph.D., Profusa's Chairman and CEO, said: "In a journey that began over a decade ago, driven by a mission to harness transformative science to positively impact quality of daily living and chronic disease management, we are excited to mark a key milestone of going public and trading on Nasdaq. We believe being a public company better positions us to advance our vision in pioneering tissue-integrating biosensors platform that could function for months at a time, with transformative lower costs, and continuously monitor and transmit body chemistries to smart phone applications..." On the financial advisory side, A.G.P./Alliance Global Partners, I-Bankers Securities, and Dawson James Securities acted as financial advisor to NorthView Acquisition Corp. I-Bankers and Dawson James, which had been engaged under a Business Combination Marketing Agreement tied to NorthView's original IPO, received an aggregate cash fee (the Business Combination Marketing Fee) of $1,500,000 at closing, with a further $500,000 balance deferred, out of a contracted fee equal to 3.68% of NorthView's IPO gross proceeds. HCW acted as Profusa's financial advisor and received a transaction fee of $1,000,000 in cash plus 132,500 warrants to purchase New Profusa common stock at an exercise price of $0.01 per share. On legal advisors, Ellenoff Grossman & Schole LLP acted as legal advisor to Profusa, ArentFox Schiff LLP acted as legal advisor to NorthView Acquisition Corp., and Lucosky Brookman LLP acted as legal advisor to the institutional investor (Ascent Partners Fund LLC) in connection with the secured convertible promissory note. No synergy estimates, cost-saving targets, or EPS accretion/dilution figures are disclosed in the sourced filings; as a going-public reverse-merger transaction between a clinical/commercial-stage biosensor company and a non-operating SPAC shell, such metrics are not applicable in the way they would be for an operating-company-to-operating-company combination. Profusa's unaudited financials as of March 31, 2025 show a net loss of $2.7 million for the quarter (versus $2.4 million a year earlier), cash of less than $0.1 million, and notes and loans payable and interest due of $50.2 million within twelve months, with management disclosing substantial doubt about the company's ability to continue as a going concern absent additional financing. The Tasly-related party convertible debt was repaid in parallel with the closing of the business combination. The transaction has closed; it is not subject to further regulatory approval. The deal record's prior pending-regulatory status reflected an earlier gap in available source material rather than the deal's actual status, which Form 8-K filings confirm as closed as of July 11, 2025.

BranchOut Food Inc., a Nevada-incorporated consumer-retail company trading on the Nasdaq Capital Market under ticker BOF, amended the terms of its existing at-the-market (ATM) equity offering program on February 18, 2025. The underlying ATM Agreement was originally entered into on October 23, 2024 with Alexander Capital, L.P. acting as sales agent, authorizing BranchOut to sell up to $3,000,000 of common stock from time to time through Alexander Capital at prevailing market prices. The First Amendment to the ATM Agreement, dated February 18, 2025, increased the aggregate offering price authorized under the program to up to $5,000,000, an increase of $2,000,000 in remaining issuance capacity. As of February 17, 2025, the day before the amendment, BranchOut had already sold shares under the original ATM Agreement for aggregate gross proceeds of $2,999,995 (1,590,422 shares), effectively exhausting the original $3,000,000 authorization. The prospectus supplement amendment (Amendment No. 1 to the Prospectus Supplement, filed as a 424B5 on February 18, 2025) disclosed that the last reported Nasdaq sale price of BranchOut common stock on February 14, 2025 was $2.42 per share, which was used as the assumed offering price for illustrative calculations in the filing; this is not a fixed or negotiated offering price, since ATM sales occur at prevailing market prices over time rather than in a single priced transaction. Alexander Capital, L.P. is compensated with a cash commission equal to 3.0% of gross proceeds on each sale made under the ATM Agreement. BranchOut also agreed to reimburse Alexander Capital's counsel fees up to $50,000 in connection with establishing the ATM program and up to $3,000 per quarter thereafter, with total estimated offering-establishment expenses (excluding Alexander Capital's commission) of approximately $75,000. Under the Securities Act, Alexander Capital is deemed to be acting in the capacity of an "underwriter," and its commissions are deemed underwriting discounts, though the program is structured as an agency ATM facility rather than a traditional firm-commitment underwritten offering; there is no greenshoe or over-allotment option, consistent with the continuous, uncapped-timing nature of an ATM program. BranchOut stated it intends to use net proceeds from sales under the amended ATM program for working capital and general corporate purposes, including operating expenses and capital expenditures. No debt repayment or acquisition-financing use of proceeds was disclosed. The prospectus supplement amendment included an illustrative dilution analysis. BranchOut's net tangible book value as of September 30, 2024 was approximately $1.525 million, or $0.22 per share. After giving effect to the 1,590,422 shares already sold under the ATM Agreement and the exercise of warrants for 39,747 shares after September 30, 2024, pro forma net tangible book value as of that date was recalculated at $0.51 per share. Assuming a further $2,000,004 of common stock were sold under the amended program at the February 14, 2025 closing price of $2.42 per share (826,448 shares, net offering price of approximately $2.32 per share after commissions and expenses), pro forma as-adjusted net tangible book value was illustrated at approximately $6.3 million, or $0.67 per share, representing an immediate increase of $0.16 per share to existing stockholders and immediate dilution of $1.75 per share to new investors in that illustrative scenario. The filing noted that a $1.00 increase or decrease in the assumed sale price would change dilution to new investors to $2.60 per share or $0.73 per share, respectively. As of February 17, 2025, BranchOut had 8,554,769 shares of common stock outstanding; the filing further disclosed 603,470 shares issuable upon exercise of outstanding stock options (weighted average exercise price $2.39), 108,799 shares reserved under the 2022 Equity Incentive Plan, and 3,422,415 shares issuable upon exercise of outstanding warrants (weighted average exercise price $1.89), none of which are included in the as-adjusted share count. Pachulski Stang Ziehl & Jones LLP, New York, issued the legal opinion as to the validity of the shares on behalf of BranchOut (the issuer) and is identified in the 8-K and 424B5 as issuer's counsel. Sullivan & Worcester, LLP, New York, is identified in the prospectus supplement as counsel to Alexander Capital, L.P. (the sales agent). Because this is a continuous ATM program rather than a single priced offering, there is no discrete pricing date, single gross/net proceeds figure, or settlement date for the program as a whole; proceeds and share counts accumulate over time as individual sales occur under transaction notices, settled on a T+1 basis per sale via book-entry through DTC. The filings do not disclose the total amount ultimately raised under the amended $5,000,000 program, the end date of the ATM facility, or any subsequent termination or completion of the program.

Diamondback Energy, Inc. announced on February 18, 2025 that it had entered into a definitive purchase agreement to acquire certain subsidiaries of Double Eagle IV Midco, LLC in exchange for approximately 6.9 million shares of Diamondback common stock and $3 billion of cash, subject to customary adjustments. The release describes Double Eagle as "the most attractive asset remaining in the Midland Basin," adding approximately 40,000 net acres and 407 estimated gross horizontal drilling locations adjacent to Diamondback's existing core position. This record is sourced from an Exhibit 99.1 press release furnished with Diamondback's Form 8-K filed February 18, 2025. At announcement, the transaction was a signed definitive agreement pending customary closing conditions and regulatory approval, with closing expected on April 1, 2025. TPH&Co, the energy business of Perella Weinberg Partners, served as financial advisor to Diamondback, the acquirer, per the release's statement "TPH&Co, the energy business of Perella Weinberg Partners, is serving as financial advisor to Diamondback." On the seller side, RBC Capital Markets, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC jointly acted as financial advisors to Double Eagle, per "RBC Capital Markets, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as financial advisors to Double Eagle." No lead designation is given among the three Double Eagle advisors, and TPH&Co was Diamondback's sole named advisor. On the legal side, Kirkland & Ellis LLP represented Diamondback, and Vinson & Elkins LLP represented Double Eagle. The release states the transaction is valued at approximately 5.2 times 2025 EBITDA, and that Diamondback separately committed to selling at least $1.5 billion of non-core assets to accelerate debt reduction; Diamondback and Double Eagle also agreed to accelerate development on a portion of Diamondback's non-core southern Midland Basin acreage as part of the deal. Not disclosed in the sourced document is the aggregate dollar value of the 6.9 million Diamondback shares issued as part of the consideration (only the share count and separate $3 billion cash figure are given, with no combined total dollar amount stated), nor Double Eagle's ownership structure beyond its parent entity name.

Asbury Automotive Group, Inc., a consumer-retail sector company trading under ticker ABG, agreed on February 14, 2025 to acquire substantially all of the assets, including real property and businesses, of The Herb Chambers Companies (HCC), the fourteenth-largest privately owned dealership group in the United States by revenue. The agreement was disclosed in a Form 8-K filed February 18, 2025 (Item 1.01) and the transaction closed on July 21, 2025, as confirmed in a subsequent Form 8-K and Form 8-K/A. The assets acquired comprise 33 dealerships, 52 franchises and three collision centers in Massachusetts and Rhode Island; Herb Chambers himself retained ownership of the Mercedes-Benz of Boston dealership in Somerville, Massachusetts, subject to a five-year put right obligating Asbury to purchase it later. David Hult, Asbury's President and CEO, said "HCC is a respected brand with a rich history and reputation for having a customer and team member-focused culture, aligning directly with Asbury's North Star to become the most guest-centric automotive retailer," and on closing added, "Herb redefined the car-buying experience in New England, making 'Herb Chambers' a household name, synonymous with reliability and service." Herb Chambers, the company's founder, stated at signing, "David Hult and the Asbury Automotive Group share our customer-focused philosophy which will remain as the foundation from which they move our great company into the future," and at closing called Asbury "the ideal steward." On Asbury's Q1 2025 earnings call, Hult described the deal as entry into "a strategic part of the country that we have been looking to enter for a long time as part of our disciplined growth strategy," noting the Boston area is "a traditionally resilient market that can weather different economic cycles." At signing, the Purchase and Sale Agreement (filed as Exhibit 2.1 to Asbury's Q1 2025 Form 10-Q) set an aggregate purchase price of approximately $1.34 billion, consisting of $750 million allocated to goodwill ("blue sky") and a real estate purchase price of $528,350,000 plus reimbursable, verifiable construction costs capped at an additional $185.9 million (together described in the 8-K as approximately $590 million for real estate and improvements), with the price for inventory, fixed assets, parts and supplies to be determined at closing. HCC generated $2.9 billion of revenue in 2024 per the announcement press release; the closing press release separately cited $3.2 billion of 2024 revenue and approximately 50,000 new and used vehicles sold, with more than 2,200 employees. At closing on July 21, 2025, Asbury reported an aggregate net purchase price of approximately $1.45 billion: $750 million for goodwill, approximately $610 million for real estate and leasehold improvements, and approximately $85 million for new vehicles, used vehicles, service loaner vehicles, fixed assets, parts and supplies, net of $375 million of non-manufacturer floorplan debt assumed. In the preliminary purchase price allocation disclosed in the Form 8-K/A pro forma financial statements, the $750 million was split between $286.8 million of goodwill and $463.2 million of indefinite-lived franchise rights intangible assets. No EV/EBITDA, P/E or per-share multiple was disclosed for the transaction, consistent with it being an asset purchase from a private company rather than a public-company merger. The transaction was funded through a combination of Asbury's senior credit facility, new mortgage/real estate financing, and cash on hand, with no financing condition under the agreement. In connection with closing, Asbury's subsidiaries borrowed $546,528,750 under a new ten-year Real Estate Credit Agreement with Wells Fargo Bank, N.A. as administrative agent, bearing interest at SOFR plus 2% or, at Asbury's option, a Base Rate plus 1%, repayable in 118 monthly principal payments of $2,277,203 beginning September 1, 2025 with a balloon payment at maturity. Concurrently, Asbury expanded its existing senior credit facility (administered by Bank of America, N.A.) by $750 million under a First Amendment to its Fourth Amended and Restated Credit Agreement dated April 9, 2025. Per the pro forma balance sheet adjustments, financing included $650 million under the revolving credit facility, $546.5 million under the real estate term loan, $598.4 million of incremental new and used vehicle floor plan liabilities, and $46.3 million of cash on hand. As part of its pro forma financial statements, Asbury disclosed estimated "management's adjustments" cost savings consisting of reduced executive compensation (based on historical HCC compensation levels) of $12.0 million for the three months ended March 31, 2025 and $65.6 million for the year ended December 31, 2024, plus one-time transaction costs of $4.7 million in the Q1 2025 period. On a pro forma basis including these adjustments, combined net income was $141.7 million for Q1 2025 and $467.1 million for full-year 2024, with diluted pro forma EPS (after cost savings) of $7.19 for Q1 2025; pro forma combined revenue was $4,830.1 million for Q1 2025 and $19,865.3 million for full-year 2024. The pro forma information also reflects the divestiture of four dealerships (two Lexus and two General Motors stores) required by manufacturers as a condition of the acquisition closing. On the acquirer side, Jones Day and Hill Ward Henderson served as legal counsel to Asbury, Baker Tilly served as transaction advisory firm, and BofA Securities served as financial advisor. For HCC, Stephens Inc. served as financial advisor and WilmerHale served as legal counsel. The Purchase and Sale Agreement required approval of the transaction by certain automotive manufacturers, expiration or termination of the Hart-Scott-Rodino antitrust waiting period, continued accuracy of representations and warranties, assignment of certain leases and key contracts, and absence of a material adverse effect; it was not subject to a financing condition. Asbury deposited $10 million of earnest money into escrow at signing, with an indemnity escrow of $75 million and an adjustment escrow of $2.5 million also established under the agreement. On Asbury's earnings call, Hult confirmed "the asset purchase agreement we have doesn't have a breakup fee for us. It does for the seller," and the original Form 8-K disclosed that in certain circumstances of termination, HCC could be required to pay Asbury a termination fee of $100 million, while in other circumstances Asbury would forfeit its earnest money to HCC. The agreement also specified that closing could not occur before June 16, 2025. The transaction closed on July 21, 2025, completing the acquisition as a business combination under ASC Topic 805. Status is updated from pending regulatory approval to closed based on Asbury's Form 8-K filed July 21, 2025 (Items 1.01, 2.01, 2.03, 7.01) reporting completion of the acquisition, corroborated by the Form 8-K/A filed July 29, 2025 containing HCC's audited financial statements and pro forma combined financial information, and by Asbury's Form 10-Q for the quarter ended June 30, 2025, which states "On July 21, 2025, we completed the acquisition of The Herb Chambers Companies." The company noted the purchase price allocation remained preliminary as of the Q2 2025 10-Q and would be updated in the Form 10-Q for the quarter ending September 30, 2025.

Fold, Inc., a bitcoin financial services company, agreed to become a publicly traded company through a business combination with FTAC Emerald Acquisition Corp. (Nasdaq: EMLD), a special purpose acquisition company sponsored by Cohen Circle. The parties entered into an Agreement and Plan of Merger dated July 24, 2024, filed as Exhibit 2.1 to a Form 8-K filed July 25, 2024. The transaction closed on February 14, 2025, after FTAC Emerald's stockholders approved it at a special meeting held February 13, 2025, at which point the combined company was renamed Fold Holdings, Inc. and began trading on Nasdaq under the symbols "FLD" (common stock) and "FLDDW" (warrants) on or about February 19, 2025. At signing, the transaction implied a pre-money equity valuation for Fold of $365 million. FTAC Emerald's investor presentation, filed as Exhibit 99.1 to the July 24, 2024 Form 8-K, presented an illustrative transaction summary showing a pro forma enterprise value of $381.3 million (implied market capitalization of $493.8 million less $112.5 million of net cash/bitcoin), based on an assumed $10.72 per share price. These figures were explicitly labeled illustrative and subject to change based on actual redemption levels; no restated final valuation was disclosed in the closing 8-K. No EV/EBITDA, P/E, or price-to-tangible-book multiple was disclosed in any filing reviewed. The deal was structured as an all-stock exchange. Under the Agreement and Plan of Merger, each share of Legacy Fold common stock was converted into the right to receive a number of shares of new Fold Holdings common stock equal to a defined exchange ratio; the closing 8-K states this exchange ratio equated to approximately 82.5% of a share of new common stock for each Legacy Fold share (including shares deemed issued on conversion of preferred stock and SAFEs). The merger agreement also contained a bitcoin-price-linked adjustment: if the 60-day volume-weighted average price of bitcoin as of the day before closing was at or above $90,000, the pre-money equity value was to be increased using a formula tied to Fold's bitcoin holdings, as described in the investor presentation footnotes. At signing, the illustrative sources-and-uses schedule showed total sources of $410 million: $365 million of Fold rollover equity, $20 million of cash in trust (assuming 60% redemptions from approximately $50 million held in trust), and $25 million from a PIPE investment, assumed to be raised at the $10.72 estimated share price. Uses included $365 million of equity issued to Fold shareholders, $32.5 million of cash to the balance sheet, and $12.5 million of estimated transaction expenses. At signing, legacy Fold stockholders were expected to own approximately 71.2% of the combined company on a pro forma basis. Actual closing-date mechanics differed from the signing-stage illustration. The closing 8-K discloses that holders of 3,304,183 shares of Emerald Class A common stock (all shares eligible for redemption from the IPO) properly exercised redemption rights, receiving a pro rata portion of the trust account calculated at approximately $11.07 per share, or $36,576,096 in the aggregate. Approximately $14,052,210 was paid from the trust account to cover transaction expenses incurred by Legacy Fold and Emerald, leaving a remaining trust balance of approximately $799,176 released to Fold for general corporate purposes. Following the closing, there were 46,138,876 shares of common stock issued and outstanding. Separately, pursuant to a December 2024 Securities Purchase Agreement, a note held by an existing investor was converted into a new Fold Initial Investor Note convertible into 1,739,130 shares of common stock, and Fold issued the investor warrants exercisable for 869,565 shares at $12.50 per share, 500,000 shares at $0.001 per share, and 869,565 shares at $11.50 per share, in exchange for existing Legacy Fold warrants. Existing Fold stockholders agreed to a six-month lock-up on their shares, subject to early release if the combined company's stock price exceeds $12.00 per share for 20 trading days within any 30 consecutive trading day period ending at least 90 days after closing. Strategic rationale was articulated by both companies' leadership at signing. Will Reeves, CEO of Fold, said the transaction "represents a significant step in Fold's mission to expand access to premium bitcoin financial services and empower individuals to achieve their dreams," adding that "Fold aims to make bitcoin available to everyone -- through accessible, engaging, and useful bitcoin products that are tailored to meet the needs of spenders, earners, and savers." Bracebridge (Brace) Young, Jr., President and CEO of FTAC Emerald, said, "We are excited to partner with Will and his team to bring Fold to the public markets. Fold has aligned its success with the success of its customers, democratizing wealth building with innovative bitcoin financial services while gaining a larger and larger wallet share as the preferred bitcoin savings tool." At closing, Reeves stated the company believes "being a public company better positions us to advance our vision of building a gateway to bitcoin-based financial services and expanding access to wealth creation for Fold's customers." Fold, founded in 2019, was described in the July 2024 press release as having processed over $2 billion in aggregate transaction volume and distributed over $45 million in lifetime bitcoin rewards to customers since inception, with partnerships including Visa, BitGo, and Marqeta, and more than 1,000 bitcoin held in its corporate treasury both before and after the transaction. Upon completion, Fold's management team led by Reeves continued to operate the combined company. The post-closing board added Brace Young (previously CEO of Mariner Investment Group and a Managing Director at Goldman Sachs), Andrew Hohns (an FTAC Emerald director and CEO of Newmarket Capital and its subsidiary Battery Finance, which focus on bitcoin-driven credit and specialty finance), and Jonathan Kirkwood (co-founder and Managing Partner of Ten31, a bitcoin venture capital and private equity platform), joining Reeves on the board. Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acted as exclusive financial advisor, capital markets advisor, and placement agent to Fold. Latham & Watkins LLP acted as legal advisor to Fold. Stevens & Lee PC acted as legal advisor to FTAC Emerald. No termination fee provision was identified in the Agreement and Plan of Merger; SPAC merger agreements of this type typically do not include a cash termination fee comparable to those found in corporate stock/cash mergers. The transaction was announced as unanimously approved by both companies' boards of directors. No Schedule 14A merger proxy (DEFM14A) was identified in Fold/Emerald's EDGAR filing history; the combined company instead registered the new shares via a Form S-4 registration statement (and amendments filed October 2024 through January 2025) that served as the proxy statement/prospectus for the stockholder vote, rather than a traditional merger proxy.

This is a SPAC business combination in the fig sector in which Fold Holdings, Inc. (ticker FLD) is the target combining with FTAC Emerald Acquisition Corp. The product group is sponsors-coverage, consistent with the SPAC structure. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on February 14, 2025. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, which served as the lead financial advisor to Fold in multiple capacities, namely financial advisor, capital markets advisor, and placement agent. The source sentence states: "Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, is acting as exclusive financial advisor, capital markets advisor, and placement agent to Fold." No financial advisor to FTAC Emerald Acquisition Corp is identified in the facts provided. Legal advisors are disclosed for both sides: Latham & Watkins LLP is acting as legal advisor to Fold, the target, while Stevens & Lee PC is acting as legal advisor to FTAC Emerald, the SPAC acquirer. Beyond the classification of this transaction as a SPAC business combination, no further detail on the valuation, PIPE financing, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, no financial advisor to FTAC Emerald is identified, and no expected closing date is given beyond the pending-regulatory status.

This transaction involves a Chapter 11 restructuring triggered by a rejected merger proposal. The deal is classified as a restructuring product within the bankruptcy and reorganization space. The specific sector and company name are not identified in the available source documents, nor has a transaction value been disclosed. The information regarding this transaction is sourced from an SEC EDGAR filing of unknown form type, published on February 12, 2025. The deal is currently in pending regulatory status, indicating that the restructuring process is ongoing but has not yet reached completion or formal confirmation. On the company side, a comprehensive advisory team has been assembled. Davis Polk & Wardwell LLP is serving as the company's restructuring counsel. Alvarez & Marsal is serving as the restructuring advisor. Perella Weinberg Partners LP is acting as the investment banker to the company. The creditor constituencies are represented by multiple specialized advisors. An ad hoc group of loyalty noteholders is being represented by Akin Gump Strauss Hauer & Feld LLP as legal counsel and Evercore as financial advisor. The convertible bondholders are being represented by Paul Hastings LLP as legal counsel and Ducera Partners LLC as financial advisor. The legal advisory structure reflects the multi-party nature of the restructuring. Davis Polk & Wardwell LLP serves as legal counsel to the company on restructuring matters. Akin Gump Strauss Hauer & Feld LLP represents the ad hoc group of loyalty noteholders. Paul Hastings LLP represents the convertible bondholders. This multi-counsel arrangement is typical in complex Chapter 11 cases where different creditor classes retain separate representation. Beyond the advisor engagements noted above, the specific terms of the restructuring remain largely undisclosed in the available source material. No information has been provided regarding the consideration structure, treatment of various creditor classes, proposed plan of reorganization details, or the mechanism by which the rejected merger proposal has triggered the Chapter 11 filing. The timeline to emergence or plan confirmation is not stated. The company name, industry, and total enterprise or claims value are not identified in these filings. No details regarding equity treatment, debt-to-equity conversions, or any new financing contemplated as part of the restructuring have been disclosed.

This transaction is a cash and stock acquisition in which Clearwater Analytics Holdings, Inc., a tech sector company, is acquiring Enfusion, Inc. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this summary are sourced from an SEC EDGAR Form S-4 filed and published on February 11, 2025. The transaction's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Goldman Sachs & Co. LLC served as financial advisor to the target, Enfusion, in a lead capacity, specifically advising the special committee. The source sentence notes consent language referencing Goldman Sachs & Co. LLC's opinion letter under the captions concerning the opinion of the special committee's financial advisor, indicating Goldman Sachs' engagement was tied to a special committee process at Enfusion rather than a general advisory mandate. No legal advisors are identified in the facts block for either Enfusion or Clearwater Analytics. The facts block characterizes this as a cash and stock acquisition, but provides no further detail on the specific mix or ratio of cash to stock consideration, the exchange ratio for any stock component, or other structural terms of the merger agreement. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either party. No expected closing date is given, and the precise cash and stock consideration split is not specified beyond the general characterization of the subtype.

GD Culture Group Ltd, trading under ticker GDC in the business services sector, is conducting an equity capital markets transaction structured as an at-the-market issuance with a disclosed size of $10,000,000 USD. This transaction represents a mechanism by which the issuer can offer and sell shares into the public market in a systematic manner over time, rather than through a traditional underwritten public offering where all shares are sold at a fixed price on a single date. The transaction is sourced from an SEC filing published on February 10, 2025, via SEC EDGAR. The specific form type was not disclosed in the available documentation. The deal is currently in pending regulatory status, indicating that it has been filed but has not yet received final regulatory clearance or completed all required approval steps. On the financial advisory side, Univest Securities, LLC is serving as the sales agent for the issuer in this transaction and holds lead status. According to the source documentation, GD Culture Group Limited entered into an At-The-Market Issuance Sales Agreement with Univest Securities, LLC, establishing the latter as the sales agent responsible for facilitating the offering of shares pursuant to the terms agreed between the parties. Ortoli Rosenstadt LLP is advising the issuer on the legal side of the transaction, as evidenced by their provision of a legal opinion referenced in the filing documentation. With respect to deal structure and terms, the transaction is an at-the-market issuance, meaning it is governed by a sales agreement between the issuer and the sales agent. However, no additional structural details have been disclosed regarding pricing mechanisms, the timing or schedule of share sales, any pricing caps or floors, or the specific terms and conditions under which shares may be sold into the market. Several material details remain undisclosed or unknown at this stage. The expected closing date or timeline for completion of the offering has not been provided. The exact mechanics of how the $10,000,000 will be allocated across tranches or sale periods, if applicable, is not specified. Additionally, the specific regulatory approvals required and their current status beyond the general "pending regulatory" notation are not detailed in the available documentation.

Quikrete Holdings, Inc. completed its acquisition of Summit Materials, Inc. (NYSE: SUM) on February 10, 2025, in an all-cash merger originally valued at approximately $11.5 billion in enterprise value, including debt. Summit's common stock ceased trading on the NYSE and the company became a privately held subsidiary of Quikrete on closing. Under the terms of the Agreement and Plan of Merger, dated November 24, 2024, each share of Summit Class A and Class B common stock was converted into the right to receive $52.50 per share in cash. That price represented an approximately 36 percent premium to Summit's unaffected 90-day volume-weighted average price and an approximately 29 percent premium to Summit's unaffected closing share price of $40.62 on October 23, 2024, the last trading day before Summit's disclosure that it had received a non-binding acquisition proposal. In fairness-opinion work prepared for Summit's board, Morgan Stanley selected a reference range of 11.0x to 13.0x AV/LTM EBITDA (based on a precedent-transaction median of 12.0x), and Evercore separately selected a reference range of 11.0x to 13.0x TEV/LTM Adjusted EBITDA, both applied to Summit's estimated EBITDA. The transaction combines Summit's aggregates, cement and ready-mix concrete businesses with Quikrete's concrete and cement-based products business. Summit Materials President and CEO Anne Noonan said the deal "is a testament to our stellar strategic and financial performance, agile operational and commercial execution, and to the strength and talent of our entire team who have delivered a 34.6% annualized return since we began to develop our Elevate strategy on September 1, 2020," adding that in Quikrete "we have found a strong partner that shares our commitment to safety and innovation." Quikrete CEO Will Magill said the deal "represents a significant milestone in our journey to expand our capabilities and geographic presence," calling Summit "a recognized leader with a highly complementary portfolio of trusted aggregate, cement and ready-mix solutions." Summit Chairman Howard Lance said the board "carefully considered a range of alternatives and determined that this transaction is the best way to maximize value for our shareholders." According to Summit's merger proxy, Quikrete's outreach began in September 2024 and its first written proposal, delivered September 25, 2024, offered $48.00 per share in cash. Summit's board initially determined that offer did not provide sufficient value. Quikrete subsequently raised its proposal to $50.00 per share (mid-October 2024), then $51.50 per share, before Summit's board countered at $52.50 per share, which Quikrete's CEO verbally accepted in mid-November 2024, leading to the signed agreement on November 24, 2024. Summit's largest shareholder, Cementos Argos S.A. (together with affiliates Argos SEM LLC and Valle Cement Investments, Inc.), signed a voting agreement committing to vote its shares in favor of the merger. Quikrete financed the cash consideration with new debt and cash on hand. Concurrently with signing, Quikrete obtained a debt commitment letter for term debt financing of up to $9.2 billion, including up to $6.7 billion in bridge financing, together with a committed asset-based revolving credit facility of up to $1.5 billion. The debt proceeds were earmarked for funding the merger consideration, paying transaction fees and expenses, and repaying Summit's existing credit agreement and bond indebtedness. Receipt of financing was not a condition to Quikrete's obligation to close, and Wells Fargo provided the debt financing commitment. No synergy dollar figure, accretion/dilution estimate, or post-closing leverage ratio was disclosed in the filings reviewed. Closing conditions included approval by a majority of Summit's outstanding shares entitled to vote, expiration of the HSR Act waiting period, approval under the Competition Act (Canada), and other customary regulatory clearances and absence of a legal restraint. At a February 5, 2025 special meeting, holders of 153,789,021 shares (approximately 87.47% of the 175,814,122 shares outstanding as of the December 27, 2024 record date) were present or represented, constituting a quorum, and stockholders approved the merger agreement proposal. The merger agreement specified an outside date of August 24, 2025 (subject to extension for regulatory approvals or a financing marketing period), which was not needed since the deal closed February 10, 2025. The agreement provided for a termination fee of $279,000,000 payable by Summit to Quikrete under specified circumstances, including if Summit's board changed its recommendation or accepted a superior proposal. Wells Fargo served as exclusive financial advisor to Quikrete, with Troutman Pepper Locke LLP (named Troutman Pepper Hamilton Sanders LLP at signing) and Covington & Burling LLP as legal counsel to Quikrete. Morgan Stanley & Co. LLC and Evercore served as financial advisors to Summit, with Davis Polk & Wardwell LLP as Summit's legal advisor.

This transaction is a cash acquisition structured as a take-private of Avid Bioservices by GHO Capital Partners LLP and Ampersand. The deal carries a disclosed value of 1,100,000,000 dollars. Neither a specific target company name field nor sector classification beyond what is embedded in the deal name is included in the facts provided, though the transaction's subtype is explicitly identified as a cash acquisition and take-private. The transaction is sourced from an SEC EDGAR Form 8-K filing published on February 5, 2025. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, William Blair served as buyside financial adviser to GHO and Ampersand, the acquiring parties, and Alvarez & Marsal also served as financial advisor to GHO and Ampersand. In addition to these two financial advisors, the source sentence notes that ClearView Healthcare Partners served as commercial advisor to GHO and Ampersand, rounding out a multi-advisor team on the buy side. No financial advisor to Avid Bioservices, the target, is identified in the facts provided. On the legal side, Ropes & Gray served as legal counsel to GHO and Ampersand, the acquiring side of the transaction. No legal advisor to Avid Bioservices is identified in the available material. Beyond confirming that this is a cash acquisition structured as a take-private with a disclosed value of 1,100,000,000 dollars, no further detail on the specific per-share price or other terms of the cash consideration is included in the facts available. A number of elements of this deal are not disclosed. No financial or legal advisor to Avid Bioservices, the target, is identified, and no expected closing date is given. The facts also do not specify the per-share purchase price or the regulatory approvals required to complete the transaction.

This deal is a take-private merger in which Summit Materials, Inc., a company in the natural-resources sector, is the target being acquired by Quikrete Holdings, Inc. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on February 5, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Wells Fargo is acting as exclusive financial advisor to Quikrete, the acquirer, and is designated as lead advisor. On the target side, both Morgan Stanley & Co. LLC and Evercore are acting as financial advisors to Summit, with no lead designation specified between them. Legal counsel was also disclosed for both sides. On the acquirer side, both Troutman Pepper Locke LLP and Covington & Burling LLP are acting as legal counsel to Quikrete. On the target side, Davis Polk & Wardwell LLP is acting as legal advisor to Summit. Beyond its characterization as a take-private merger, the facts block provides no further detail on the consideration structure, such as whether shareholders are being paid in cash, or on a per-share purchase price. Several facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not specify the consideration structure or a per-share price, nor does it give an expected closing date for the transaction.

This is a take-private/leveraged buyout in the industrials sector in which affiliates of Warburg Pincus and Berkshire Partners are acquiring Triumph Group Inc. The product group is sponsors-coverage, and the disclosed transaction value is $3,000,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on February 3, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity. Goldman Sachs & Co. LLC is serving as exclusive financial advisor to Triumph, the target, per the statement "Goldman Sachs & Co. LLC is serving as exclusive financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to TRIUMPH." On the sponsor side, Lazard is serving as financial advisor to Berkshire Partners and Warburg Pincus, consistent with the language "Lazard is serving as financial advisor and Kirkland & Ellis LLP and Covington & Burling LLP are acting as legal counsel to Berkshire Partners and Warburg Pincus." Legal advisors are disclosed for both sides. Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to Triumph, the target. Kirkland & Ellis LLP and Covington & Burling LLP are both acting as legal counsel to the sponsors, Berkshire Partners and Warburg Pincus. Beyond the classification of this transaction as a take-private/leveraged buyout with a disclosed value of $3,000,000,000, no further detail on the per-share cash consideration, financing structure, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the per-share cash consideration is not specified, no detail on debt financing sources for the buyout is provided, and no expected closing date is given beyond the pending-regulatory status.

This deal is an all-stock merger between the Interpublic Group of Companies, Inc., the target, and Omnicom Group Inc. (ticker OMC), the acquirer, both companies in the tech sector per the facts block's sector classification. The transaction is classified under the M&A product group, and no disclosed deal value is stated in the source documents. The facts block draws on a substantial set of SEC EDGAR filings: a DEFM14A published January 30, 2025; an 8-K published December 9, 2024; two 8-Ks published November 26, 2025; an 8-K with Exhibit 99.2 published December 9, 2024; an unspecified form published January 30, 2025; an 8-K with Exhibit 99.1 published December 9, 2024; and an 8-K with Exhibit 2.1 published December 9, 2024. The deal's current status is closed. On the financial advisory side, PJT Partners served as financial advisor to Omnicom, the acquirer, and is designated as lead advisor in that role. Morgan Stanley served as financial advisor to Interpublic, the target, and is likewise designated as lead advisor. Legal counsel was also disclosed for both parties. Willkie Farr & Gallagher LLP served as legal advisor to Interpublic, the target. Latham & Watkins LLP served as legal advisor to Omnicom, the acquirer. Beyond its classification as an all-stock merger, the facts block does not provide further detail on the exchange ratio or other specific terms of the stock consideration. Several facts are not disclosed in the source material. The disclosed deal value is not stated anywhere in the facts block despite the breadth of filings cited. No further detail is given on the specific stock exchange ratio or other consideration mechanics beyond the "all-stock" characterization. The facts block also does not specify the date on which the deal closed, only that its status is now closed.

Frontier Group Holdings, Inc., parent of Frontier Airlines, submitted an unsolicited proposal on January 7, 2025 to acquire Spirit Airlines, Inc. as an alternative to Spirit's pending Chapter 11 plan of reorganization. Spirit (which later reorganized as Spirit Aviation Holdings, Inc.) had filed for bankruptcy in the U.S. Bankruptcy Court for the Southern District of New York on November 18, 2024. The proposal and the parties' subsequent correspondence were disclosed by Spirit in a Form 8-K filed January 29, 2025 under Item 7.01, which attached eight exhibits consisting of letters exchanged between the companies, two Frontier investor presentations, and related emails. Frontier's letter described the strategic rationale as creating "the country's first, at-scale, low-fare carrier," stating the combined airline would be the fifth largest in the United States, growing to 100 million annual passengers and more than 400 aircraft within a few years, and a top-three carrier at more than half of the top 25 U.S. airports. Frontier's January 28, 2025 presentation to Spirit argued the combination would create "America's first low-cost carrier with sufficient scale to compete with the Big Four." Under the terms of the Proposal, Spirit's stakeholders (senior secured noteholders, convertible noteholders and existing equity interests) would have received $400 million principal amount of new debt issued by Frontier plus 19.0% of Frontier's common equity, which Frontier valued at an aggregate of no less than $2,162 million before synergies, rising to as much as $2,901 million including an assumed $600 million of run-rate synergies. Frontier calculated this against a pro forma combined enterprise value of $18,630 million (applying the 6.5x 2026E EBITDAR multiple used in Spirit's own plan) less pro forma net debt of $9,356 million as of February 28, 2025, implying combined equity value of $9,274 million. Frontier said it had engaged a management consulting firm with aviation expertise that estimated potential revenue synergies of $500 million or more and cost synergies of $100 million or more, together underpinning its assumed $600 million synergy figure, with no phase-in timeline disclosed. The Proposal also required Spirit's consenting creditors to fund a previously announced $350 million equity rights offering, with proceeds used to retire Spirit's debtor-in-possession financing. Frontier's letter disclosed that it had retained Citigroup Global Markets Inc. as financial advisor and Latham & Watkins LLP as legal counsel for the proposal. Spirit's 8-K stated only that its management and board reviewed the proposal "in consultation with the Company's external legal and financial advisors," without naming them in the filed exhibits reviewed. Spirit's board and the advisors to its senior secured noteholders and convertible noteholders rejected the Proposal. In its January 11, 2025 response (Exhibit 99.2), Spirit noted that Frontier's new terms were a material reduction from an agreement in principle reached in the summer and fall of 2024 that would have given Spirit stakeholders 26.5% of the combined company's equity and $580 million of take-back debt, versus the $400 million of debt and 19% equity now proposed, while still requiring creditors to fund a new $350 million equity investment. Spirit's January 29, 2025 Form 8-K disclosed that the company and the noteholder advisors concluded the Proposal "would deliver less in value to the Company's stakeholders than what was contemplated by the Company's existing Plan, is uncertain as to timing and completion, including the need for regulatory and court approvals, and is not actionable considering it would require the NDA Parties to invest $350 million in equity, which they were not willing to do." The filing also noted that, unless waived, the Proposal would have triggered a $35 million break-up fee under Spirit's court-approved equity rights offering backstop agreement. In its final letter to Frontier dated January 28, 2025 (Exhibit 99.8), Spirit stated its board "concluded that continuing to delay our confirmation and emergence process carries too many risks for the Company and its stakeholders and would be irresponsible," and noted its bondholder groups had declined to extend the related non-disclosure agreements. Spirit proceeded with its original, standalone pre-arranged Chapter 11 plan rather than Frontier's proposal. The Bankruptcy Court entered an order confirming that plan on February 20, 2025, and the plan became effective on March 12, 2025, at which point Spirit Aviation Holdings, Inc. became the new parent company of the reorganized airline (per Spirit's Form 8-K15D5 filed March 13, 2025). No subsequent SEC filing by Spirit references a revived Frontier proposal or any Frontier transaction. Based on the filings reviewed, the Frontier proposal to acquire Spirit was rejected and did not proceed; it was not a pending, signed, or regulatory-approval-stage transaction.

Frontier Group Holdings, Inc., a transportation-infrastructure company trading under the ticker ULCC, is pursuing the acquisition of an undisclosed target in a mergers and acquisitions transaction. The specific identity of the target company has not been disclosed in the available source materials. This is a straightforward acquisition structured within the transportation-infrastructure sector. The transaction value has not been stated in the source document or documents reviewed. The information regarding this deal is sourced from an SEC filing published on January 29, 2025, accessed through SEC EDGAR. The specific form type of the filing has not been identified in the available data. The deal is currently pending regulatory approval, indicating that while the transaction has been announced or otherwise disclosed to regulators, it has not yet received all necessary regulatory clearances to proceed to closing. No financial advisors have been extracted or identified as representing either Frontier Group Holdings or the target in connection with this transaction. This stands out as unusual for a material acquisition, and the absence of named financial advisors may indicate either that such advisors have not yet been formally engaged, that their roles have not been publicly disclosed, or that the transaction structure does not require formal financial advisory representation at this stage. No legal advisors have been extracted from the available source materials for this transaction. The deal structure and specific terms of the transaction, including the form of consideration, the valuation, any earnout provisions, assumed liabilities, or other material deal mechanics, have not been disclosed in the source documents reviewed. The key gaps in the information set are significant: the identity of the target company remains undisclosed, the transaction value is not stated, no financial or legal advisors have been identified, the specific SEC filing form type is unknown, no closing date or expected closing timeframe has been provided, the consideration structure and mix (cash, stock, or otherwise) are not disclosed, and the specific regulatory approvals required or expected have not been identified. These represent material information typically available in a more mature disclosure record.

This transaction is a cash and stock acquisition in which Atlas Energy Solutions Inc. (ticker AESI), a natural-resources sector company, is acquiring Moser Energy Systems through Moser Acquisition Inc., with Moser Holdings, LLC as the selling entity. The deal falls under the M&A product group and carries a disclosed value of $220,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on January 27, 2025. Only one financial advisor is named in the facts block: TPH&Co., described as the energy business of Perella Weinberg Partners, is acting as exclusive financial advisor to Moser Holdings, LLC, the target, in a lead capacity. No financial advisor is named for Atlas Energy Solutions, the acquirer. On the legal side, Katten Muchin Rosemann LLP is serving as legal counsel to Moser Holdings, LLC, the target. No legal advisor is named for Atlas Energy Solutions in the facts block. The facts block confirms this is a cash and stock acquisition with a disclosed value of $220,000,000, but provides no further detail on the specific mix or ratio of cash versus stock consideration, nor any other structural terms of the purchase agreement. Several material facts remain undisclosed. No financial or legal advisor is named for Atlas Energy Solutions, the acquirer. No expected closing date is given, and the specific cash and stock consideration split is not disclosed beyond the general subtype characterization.

EMCORE Corporation (Nasdaq: EMKR), a Budd Lake, New Jersey-based provider of inertial navigation products for the aerospace and defense markets, agreed to be acquired by Velocity One Holdings, LP, a newly formed aerospace manufacturing holding company backed by private investment firm Charlesbank Capital Partners. The transaction was announced on November 8, 2024 via a Form 8-K (reporting a Merger Agreement dated November 7, 2024) and a joint press release, and the deal subsequently closed on February 28, 2025. Under the terms of the Agreement and Plan of Merger, each outstanding share of EMCORE common stock (other than excluded and dissenting shares) was converted into the right to receive $3.10 per share in cash, without interest. EMCORE described Velocity One as combining three aerospace and defense manufacturing businesses under one platform: EMCORE, Cartridge Actuated Devices, Inc. (a 50-year veteran designer and manufacturer of energetic devices), and Aerosphere Power, a manufacturer of power system solutions for commercial and military aerospace, military ground vehicles, and UAV applications. John Borduin, CEO of Velocity One, said: "We are excited to bring our playbook to EMCORE, as well as decades of experience operating aerospace and defense manufacturing and engineering businesses and optimizing their efficiency and profitability. EMCORE has excellent technology and offers a large product portfolio." Brandon White, Managing Director at Charlesbank, said the companies saw "a tremendous opportunity to bring together three leading aerospace manufacturing businesses to create a compelling new player in the market." EMCORE CEO Matt Vargas said the merger "underscores our commitment to our domestic and international customer base, including strengthening relationships with and generating synergies across a range of high-priority U.S. and NATO defense programs and industrial partners served by all three companies." According to EMCORE's definitive merger proxy statement (DEFM14A), the $3.10 per share Merger Consideration represented a premium of 41.6% over EMCORE's $2.19 closing stock price on November 6, 2024 (the day before the Board approved the deal), 54.2% over the closing price one week prior, 26.5% over the closing price one month prior, 226.3% over the closing price three months prior, and 156.8% over the 90-calendar-day volume-weighted average price ending September 27, 2024. The deal followed a competitive process: Mobix Labs, Inc. had publicly disclosed a non-binding proposal to acquire EMCORE for $3.80 per share in cash, and earlier (August-September 2024) had submitted letters of intent indicating a $43.0 million aggregate purchase price (approximately $3.38 per share, subject to adjustment). The EMCORE Board, advised by Craig-Hallum Capital Group LLC, ultimately favored the Velocity One/Charlesbank transaction over the higher nominal Mobix bid, citing greater closing certainty because the Guarantor (Charlesbank) and Parent had entered into an equity commitment letter covering the full Aggregate Merger Consideration, whereas Mobix "did not provide sufficient evidence of its ability to finance" its proposal and sought to cap its own breach damages at a $1.5 million reverse termination fee. The Board also noted that Parent had represented the $3.10 price was the maximum it was willing to pay, following arm's-length negotiations. Craig-Hallum rendered a fairness opinion to the EMCORE Board (dated November 7, 2024) that the Merger Consideration was fair, from a financial point of view, to the unaffiliated shareholders. In its comparable public company analysis, benchmarked against AmpliTech Group, KVH Industries, One Stop Systems, Peraso, and Pixelworks, Craig-Hallum derived implied enterprise value reference ranges of $8.0 million to $105.6 million (0.1x-1.2x CY2024E revenue), $8.7 million to $79.9 million (0.1x-0.9x CY2025E revenue), and $7.0 million to $16.6 million (1.4x-3.4x CY2025E adjusted EBITDA), translating to implied per-share value ranges of roughly $0.99-$9.46, $1.07-$7.30, and $0.90-$1.85, respectively. Its discounted cash flow analysis implied enterprise values of $20.5 million to $36.8 million (terminal revenue method, $2.43-$3.97 per share) and $13.9 million to $25.2 million (terminal EBITDA method, $1.78-$3.00 per share). The proxy does not disclose a single specific implied multiple for the actual $3.10 transaction price itself, nor a total aggregate equity or enterprise value for the deal. The transaction was financed through an equity commitment from Charlesbank Equity Fund X, Limited Partnership (the "Guarantor"), which committed to invest or cause to be invested in the equity capital of Parent an aggregate cash amount of up to $37.0 million, solely for the purpose of funding the Merger and other transactions contemplated by the Merger Agreement, including the Merger Consideration, pursuant to an equity commitment letter dated November 7, 2024. No separate debt financing for the acquirer is described in the materials reviewed. The Merger Agreement provided for termination fees: EMCORE would owe Parent a $1.5 million termination fee under specified circumstances (including a change in the Board's recommendation or breach of non-solicitation covenants), while Parent would owe EMCORE a $2.0 million termination fee under specified circumstances (including Parent's breach or failure to close), subject to an aggregate maximum cap referenced in the agreement. On the legal advisory side, Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to EMCORE, and Foley & Lardner LLP served as legal counsel to Velocity One/Parent. On the financial advisory side, Craig-Hallum Capital Group LLC acted as exclusive financial advisor to EMCORE and rendered the fairness opinion, while Skyway Capital Markets, LLC and Launch Point Partners LLC acted as buy-side financial advisors to Velocity One. Alliance Advisors, LLC served as EMCORE's proxy solicitor for the special meeting. EMCORE shareholders approved the Merger Agreement proposal at a virtual special meeting held February 27, 2025, as reported in a Form 8-K filed that same day disclosing the vote results. The Merger closed the next day, February 28, 2025: Merger Sub merged with and into EMCORE, with EMCORE continuing as the surviving corporation and becoming an indirect wholly owned subsidiary of Velocity One Holdings, LP. Outstanding EMCORE restricted stock units and performance-vesting awards were cancelled and converted into lump-sum cash payments based on the $3.10 Merger Consideration (performance awards vesting at 100% of target); there were no outstanding stock options at closing. EMCORE's common stock was suspended from trading and delisted from Nasdaq, and the company's certificate of incorporation and bylaws were amended and restated in connection with the closing. Directors Matthew Vargas, Cletus C. Glasener, Bruce E. Grooms, Jeffrey J. Roncka, and David Rodgers departed the Board as a result of the Merger's completion, not due to any disagreement with the company.

This deal is a Chapter 11 reorganization involving a debt-for-equity exchange, classified as a restructuring transaction in the energy-power sector, involving Vertex Energy Inc. as target/debtor, with funds managed by BlackRock Financial Management Inc. involved as creditors. The disclosed value of the transaction is $320,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on January 22, 2025. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as investment banker to the company (Vertex Energy), with no lead designation specified, alongside Alvarez & Marsal North America, LLC, who served as Chief Restructuring Officer and financial advisor to the company per the same source sentence (though only Perella Weinberg Partners is broken out as a separate structured financial advisor entry). Houlihan Lokey served as financial advisor to an ad hoc group of term loan lenders, categorized as creditors, also without a specified lead designation. On the legal side, Kirkland & Ellis LLP served as restructuring counsel to the company (target), and Bracewell LLP served as restructuring co-counsel to the company, per the same source sentence. Sidley Austin LLP served as legal counsel to the ad hoc group of term loan lenders (creditors). Beyond the Chapter 11 reorganization and debt-for-equity exchange structure, with a disclosed value of $320,000,000, no further detail on the specific equity allocation or treatment of other creditor classes is provided in the facts block. Several items are not disclosed in the available record. While the source sentence references Alvarez & Marsal North America, LLC serving as Chief Restructuring Officer and financial advisor to the company, it is not broken out as a separate structured financial advisor entry beyond Perella Weinberg Partners. No lead designation is specified for any of the named financial advisors, and no expected closing date or further timeline detail beyond the January 2025 filing date and pending-regulatory status is given.

Envoy Medical, Inc., a healthcare company trading on Nasdaq under the ticker COCH, entered into an at-the-market offering agreement to sell up to $15,000,000 of Class A Common Stock. The agreement with the sales agent was dated January 17, 2025, and the transaction was announced the same day the related prospectus supplement was dated, with both the current report on Form 8-K and the Form 424(b)(5) prospectus supplement filed with the SEC on January 21, 2025. Roth Capital Partners, LLC serves as the sole sales agent for the offering. Under the ATM agreement, Envoy Medical will pay Roth Capital Partners a fixed commission of up to 3.0% of the gross sales price per share sold through the facility. Roth Capital Partners is not required to sell any specific number or dollar amount of shares and will act only on a commercially reasonable efforts basis consistent with its normal trading and sales practices; there is no minimum offering amount required to close. The prospectus supplement also discloses that Envoy Medical agreed to reimburse Roth Capital Partners for its legal counsel fees up to $50,000, plus $5,000 per due diligence update session. In connection with sales under the agreement, Roth Capital Partners will be deemed an "underwriter" within the meaning of the Securities Act. Shares will be sold from time to time at prevailing market prices on Nasdaq rather than at a fixed price negotiated in advance, consistent with the at-the-market structure. As of January 16, 2025, Envoy Medical had 21,293,861 shares of Class A Common Stock outstanding, of which approximately 10,702,127 shares were held by non-affiliates. For illustrative purposes only, the prospectus supplement modeled a scenario in which all $15.0 million of shares were sold at $1.50 per share, the last reported Nasdaq closing price on January 16, 2025 (the trading day before the ATM agreement was signed), which would imply roughly 10,000,000 new shares issued, net proceeds of approximately $14.4 million after commissions and estimated offering expenses, and an increase in total shares outstanding to approximately 31,293,861. Because there is no minimum offering amount, the actual number of shares sold, the price at which they are sold, and the resulting gross and net proceeds are not determinable in advance and will depend on market conditions over the life of the ATM program. The prospectus supplement discloses that purchasers in the illustrative $1.50 per share scenario would experience immediate dilution of $1.62 per share, representing the difference between the assumed offering price and Envoy Medical's as-adjusted net tangible book value (deficit) per share as of September 30, 2024 after giving effect to the offering, which the filing states was approximately $(3,499) thousand, or $(0.12) per share, on that pro forma basis. No concurrent share repurchase or buyback was disclosed alongside the offering. Envoy Medical intends to use the net proceeds from the offering for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, clinical trial expenditures, expansion of business development activities, and other general corporate purposes; the filing also notes proceeds may be used to acquire or invest in complementary products, technologies, or businesses, though no specific acquisition or debt repayment use was identified. No greenshoe or over-allotment option applies to this ATM structure, which is standard for at-the-market programs since shares are issued directly into the market over time rather than in a single underwritten tranche. Fredrikson & Byron, P.A. of Minneapolis, Minnesota serves as legal counsel to Envoy Medical and passed upon the validity of the shares offered. Ellenoff Grossman & Schole LLP of New York, New York represents Roth Capital Partners as the sales agent's legal counsel in connection with the offering. Because the ATM program allows sales over an open-ended period at then-prevailing prices, the prospectus supplement does not provide a specific closing date, a fixed number of shares to be sold, or the ultimate aggregate proceeds that will be raised; these depend on the pace and pricing of sales Envoy Medical and Roth Capital Partners choose to execute under the agreement over its term. No subsequent SEC filing confirming the amount actually sold or the program's completion was identified in this review.

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a San Diego-based life science technology company developing next-generation sequencing and spatial multiomics platforms, entered into an Agreement and Plan of Merger on December 22, 2024 with Singular Genomics Parent, LLC and its wholly owned subsidiary Saturn Merger Sub, Inc. Parent and Merger Sub are newly formed entities affiliated with Deerfield Private Design Fund IV, L.P., an investment fund managed by Deerfield Management Company, L.P. that was already a shareholder of the company. The transaction was announced publicly on December 23, 2024 and the merger closed on February 21, 2025, with Singular Genomics becoming a wholly owned subsidiary of the Deerfield-affiliated Parent. Under the terms of the merger agreement, each share of Singular Genomics common stock and Series A Common Stock Equivalent Convertible Preferred Stock (the latter held entirely by Deerfield) not held by Deerfield or other rollover stockholders was cancelled and converted into the right to receive $20.00 in cash per share, without interest. The company's announcement press release stated that the $20.00 per share price represented a 254% premium to the last closing share price prior to the September 12, 2024 public disclosure of Deerfield's initial acquisition proposal. Deerfield and certain other stockholders entered into Rollover Agreements under which their shares, RSUs, or options were contributed to Parent in exchange for equity in Parent rather than cash consideration. With only approximately 2,537,024 shares of common stock outstanding and entitled to vote as of the January 10, 2025 record date, the implied common equity value of the publicly held shares subject to the cash consideration was well under $50 million; the deal's enterprise value is not disclosed in the filings reviewed. The transaction was not subject to a financing condition. Parent secured committed debt financing from Deerfield to fund the merger consideration. At closing, Deerfield Private Design Fund IV entered into a Credit Agreement with Parent and Merger Sub as borrowers, committing to provide a term loan of up to $37.5 million; approximately $37 million of proceeds were deposited with the paying agent to fund payments to stockholders. The loan bears interest at 8%, matures February 20, 2026, and is prepayable at any time. Singular Genomics became a borrower under the Credit Agreement as the surviving corporation. The Singular Genomics Board of Directors formed a special committee composed entirely of independent and disinterested directors to evaluate the company's strategic alternatives. The special committee led negotiations with the assistance of independent financial and legal advisors and unanimously recommended that the board approve the merger agreement, which the full board then did following that recommendation. TD Securities and Houlihan Lokey served as financial advisors to the special committee. Gunderson Dettmer LLP served as legal advisor to Singular Genomics, Richards, Layton & Finger, P.A. served as counsel to the special committee, and Katten Muchin Rosenman LLP served as legal advisor to Deerfield. Andrew ElBardissi, M.D., Partner at Deerfield, said in the announcement press release: "Singular Genomics has developed a state-of-the-art multi-omic spatial biology platform that empowers customers with innovative tools to unlock biological insights and drive breakthroughs in research and medicine. We are proud to support Singular Genomics as they embark on this exciting new chapter, advancing science and serving their customers with excellence." The company stated that becoming a private company would provide Singular Genomics with greater flexibility to continue advancing its business strategy. The merger agreement contained customary termination rights. If terminated by the company under specified circumstances, including entry into a superior proposal or a change in the board's recommendation, the company would owe Parent a termination fee of $1,520,246. The company would also owe this fee if the merger failed to close by the April 22, 2025 Outside Date under certain conditions, if a third-party acquisition proposal for at least 50% of the company's stock or assets was publicly announced and not withdrawn, if stockholders failed to approve the deal, or if the company later entered into or consummated such a third-party proposal within one year of termination. Parent's aggregate monetary liability for willful and material breach or fraud was capped at $2,533,744, a damages cap backstopped by a Limited Guarantee from Deerfield. Separately, Support Agreements were signed concurrently with the merger agreement by stockholders Andrew Spaventa, Eli Glezer, Dalen Meeter, Mike Pellini, and David Barker, who beneficially owned approximately 8.4%, 6.7%, 0.8%, 0.7%, and 1.6%, respectively, of the company's outstanding voting power, committing them to vote in favor of the merger. The merger was approved at a special stockholder meeting held February 19, 2025. Of approximately 2,028,305 shares present or represented by proxy (about 80.0% of shares entitled to vote, constituting a quorum), 2,023,327 shares voted in favor, 3,933 voted against, and 1,045 abstained, representing overwhelming approval. The merger closed two days later, on February 21, 2025. Trading in Singular Genomics common stock was suspended on Nasdaq as of the close of trading that day, the company notified Nasdaq of its intent to delist, and the company indicated it would file a Form 15 to deregister its common stock and suspend its Exchange Act reporting obligations. Following closing, Josh Stahl was appointed Chief Executive Officer of Singular Genomics and joined its board, Jason Myers also joined the board, and Drew Spaventa, the company's co-founder and former CEO and Chairman, remained on the board and took on an additional role as special advisor to the new CEO. The filings reviewed do not disclose an EV/EBITDA, P/E, or other earnings-based valuation multiple for the transaction, nor do they disclose synergy targets, pro forma combined financial projections, or details of the negotiation background (such as other bidders considered) beyond confirming that a special committee process took place; that detail may appear in the DEFM14A proxy statement's "Background of the Merger" section, which was not reviewed as part of this update beyond what is cited above.

This record covers a Chapter 11 recapitalization involving Vroom, Inc., a consumer-retail sector company trading under ticker VRM, as the issuer. The product group is restructuring. The disclosed value is not stated in the source document(s). The facts are sourced from two SEC EDGAR filings: one of unknown form type and an 8-K, both published on January 15, 2025. The deal's current status is pending regulatory review. The advisory roster in this Chapter 11 process spans several roles for the company. Stout Risius Ross, LLC served as the lead financial advisor to the company. Latham & Watkins LLP served as special corporate counsel to the company. Porter Hedges LLP served as bankruptcy counsel to the company. Verita Global served as claims and noticing agent. All of these roles are drawn from a single source sentence: "Porter Hedges LLP served as bankruptcy counsel, Latham & Watkins LLP served as special corporate counsel, Stout Risius Ross, LLC served as financial advisor, and Verita Global served as claims and noticing agent." Separately, on the creditors' side, Wachtell, Lipton, Rosen & Katz and McGuireWoods served as counsel for certain creditors, per the sentence "Wachtell, Lipton, Rosen & Katz and McGuireWoods served as counsel for certain creditors." Legal advisors identified in the facts include Porter Hedges LLP and Latham & Watkins LLP representing the company/target side, and Wachtell, Lipton, Rosen & Katz and McGuireWoods representing certain creditors. Beyond the classification of this matter as a Chapter 11 recapitalization, with Stout Risius Ross as financial advisor and Verita Global handling claims and noticing, no further detail on the specific recapitalization terms, such as debt-for-equity conversion ratios or new capital structure, is included in the facts provided. Several items are not disclosed in this record: the transaction's financial value is not stated, no expected emergence or closing date is given beyond the pending-regulatory status, and the facts block does not specify the particular recapitalization terms beyond the general Chapter 11 process and the advisors involved.

ESSA Bancorp, Inc., a financial services company, is the target in a merger transaction with an acquirer identified as CNB. This is a mergers and acquisitions transaction within the financial services sector, with a disclosed transaction value of $214 million in U.S. dollars. The information regarding this transaction is sourced from an SEC filing published on the SEC EDGAR database on January 10, 2025. The form type is not specified in the available materials. The deal is currently pending regulatory approval, indicating that it has been announced but has not yet closed and remains subject to regulatory conditions. On the acquirer side, Stephens Inc. is serving as CNB's exclusive financial advisor in a lead capacity. Additionally, Piper Sandler & Co has rendered a fairness opinion to CNB's board. For ESSA, the target company, PNC FIG Advisory, which is part of PNC Capital Markets LLC, is serving as the exclusive financial advisor in a lead capacity and also rendered a fairness opinion to ESSA's board of directors. Legal representation has been split accordingly. Hogan Lovells US LLP is serving as the legal advisor to CNB, the acquirer. On the target side, Luse Gorman LLP is serving as ESSA's legal advisor. Beyond the headline transaction value of $214 million and the identities of the parties involved, the specific structure of the consideration being offered, the mix of cash versus stock or other consideration types, and any other material terms governing the merger have not been disclosed in the available materials. Several critical details remain unknown or undisclosed at this stage. No expected closing date has been announced. The form type of the SEC filing from which this information was extracted has not been identified. The specific regulatory bodies whose approvals are required and the anticipated timeline for regulatory clearance are not specified. No details regarding deal conditions, termination rights, or any termination fees or reverse termination fees have been disclosed. The transaction structure beyond the designation as a merger remains unspecified.

CNB Financial Corporation (Nasdaq: CCNE), the parent company of CNB Bank, agreed to acquire ESSA Bancorp, Inc. (Nasdaq: ESSA), the parent company of ESSA Bank & Trust, in an all-stock merger. The deal was announced on January 10, 2025, in a joint press release attached to a Form 8-K filed with the SEC, and the transaction subsequently closed. ESSA merged with and into CNB, and ESSA Bank merged with and into CNB Bank, continuing to operate as ESSA Bank, a division of CNB Bank. Under the Agreement and Plan of Merger dated January 9, 2025, each outstanding share of ESSA common stock is converted into the right to receive a fixed 0.8547 shares of CNB common stock, with no collar or walk-away provision disclosed in the agreement. At signing, the transaction consideration was valued at approximately $214 million in the aggregate, or approximately $21.10 per ESSA share, based on CNB's 10-day volume-weighted average stock price of $24.69 as of January 8, 2025. The merger is structured to be a tax-free exchange for ESSA shareholders for U.S. federal income tax purposes. No separate EV/EBITDA, price-to-earnings, or price-to-tangible-book-value multiple for the transaction was disclosed in the sources reviewed. CNB stated the combined company is expected to have approximately $8 billion in total assets, $7 billion in total deposits, and $6 billion in total loans. CNB projected the merger would be approximately 35% accretive to its diluted earnings per share in 2026, inclusive of fully phased-in cost synergies, with tangible book value per share dilution at transaction close of approximately 15% and an estimated earnback period of approximately 3.3 years. CNB further projected pro forma 2026 return on average tangible common equity of approximately 16% and return on average assets of approximately 1.3%, with an estimated pro forma tangible common equity to tangible asset ratio of approximately 7.7%, a Common Equity Tier 1 ratio of approximately 10.7%, and a loan-to-deposit ratio of approximately 89% at transaction close. No specific dollar figure or percentage for expected cost synergies/savings, nor a phase-in schedule beyond the accretion/dilution figures above, was disclosed in the sources reviewed. CNB President and CEO Michael D. Peduzzi said, "We are excited to partner with ESSA which shares such a strong banking tradition with CNB. This combination aligns two high performing banks with an exceptional commitment to client-focused services for its customers and financial support to sustain the economic vitality of the communities in which they operate." He added that the deal "expands CNB's services to eastern Pennsylvania and the greater Lehigh Valley market without any branch overlap," that the pro forma deposit franchise is expected to rank the combined company in the Top 10 in Pennsylvania and Top 3 in the greater Lehigh Valley, and cited CNB's experience as "a seasoned acquiror" as a factor reducing execution risk. ESSA President and CEO Gary S. Olson said, "CNB is a powerful partner for our bank that closely mirrors our culture and values, making the transaction a natural fit. CNB's multi-state, multi-brand business model fosters our entrepreneurial spirit, and continues our commitment and presence in eastern Pennsylvania." Under the merger agreement, CNB and CNB Bank each agreed to add three ESSA directors to their boards following closing: Gary S. Olson (ESSA's President, CEO and a director), Robert C. Selig Jr. (ESSA's Chairman), and Daniel J. Henning (an ESSA director). Mr. Olson also took on a role as strategic advisor to CNB's CEO, and CNB Bank formed a Board of Advisors for the ESSA Bank division. Headquartered in Stroudsburg, Pennsylvania, ESSA operated 20 community offices across the Lehigh Valley, Greater Pocono, Scranton/Wilkes-Barre, and suburban Philadelphia areas prior to closing. The merger agreement provides for a termination fee of $8,800,000 payable by ESSA to CNB under specified circumstances, including termination in connection with ESSA's board accepting a superior proposal, or if ESSA enters into, or consummates, a definitive agreement for an alternative acquisition proposal within 12 months after CNB terminates the agreement following a willful breach by ESSA connected to a publicly known competing proposal. The agreement states this fee constitutes liquidated damages and is CNB's sole monetary remedy in the specified termination circumstances. No other bidders or negotiation history ahead of signing were disclosed in the sources reviewed (a full merger proxy/prospectus narrative, such as a "Background of the Merger" section, was not independently fetched). The merger was unanimously approved by both companies' boards of directors. ESSA shareholders approved the merger proposal at a Special Meeting held April 15, 2025, with 7,497,798 shares voted for, 535,187 against, 90,852 abstaining, and 732,512 broker non-votes, out of 10,154,664 shares outstanding and 8,856,349 shares represented at the meeting (a quorum). The transaction subsequently closed on July 23, 2025, with CNB confirming completion in a July 24, 2025 press release. On closing, CNB Bank's branch network extended into northeastern Pennsylvania, including the Lehigh Valley, bringing CNB Bank to 78 branches across a four-state footprint (versus 55 branches cited in the January 2025 announcement), with consolidated assets exceeding $8.0 billion post-closing. The deal is stock-for-stock, so no new acquisition debt or separate cash consideration component was disclosed. On the acquirer side, CNB retained Stephens Inc. as its exclusive financial advisor and Hogan Lovells US LLP as its legal advisor; Piper Sandler & Co rendered a fairness opinion to CNB's board. On the target side, ESSA engaged PNC FIG Advisory, part of PNC Capital Markets LLC, as its exclusive financial advisor, which also rendered a fairness opinion to ESSA's board; ESSA's legal advisor was Luse Gorman LLP (referenced as Luse Gorman, PC in the closing press release).

This is a cash-and-unit asset acquisition in the natural-resources sector in which Kimbell Royalty Partners, LP (ticker KRP) is acquiring mineral and royalty interests in the Mabee Ranch from a private seller. The product group is M&A, and the disclosed transaction value is $231,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on January 7, 2025. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead and exclusive capacity. TPH&Co., the energy business of Perella Weinberg Partners, served as exclusive financial advisor to the Seller, per the statement "TPH&Co., the energy business of Perella Weinberg Partners, served as exclusive financial advisor and MLT Aikins LLP and Vinson & Elkins LP served as legal advisor to Seller." On the acquirer side, Citigroup served as exclusive financial advisor to Kimbell, consistent with the language "Citigroup served as exclusive financial advisor and White & Case LLP acted as legal counsel to Kimbell." Legal advisors are disclosed for both sides: MLT Aikins LLP and Vinson & Elkins LP served as legal advisor to the Seller (the target side), while White & Case LLP acted as legal counsel to Kimbell, the acquirer. Beyond the classification of this transaction as a cash-and-unit asset acquisition with a disclosed value of $231,000,000, no further detail on the specific split between cash and unit consideration is included in the facts provided. Several items are not disclosed in this record: the precise cash/unit consideration mix is not specified, and no expected closing date is given beyond the pending-regulatory status.

Lixte Biotechnology Holdings, Inc. is the issuer in an At-the-Market Sales Agreement, which is a registered direct offering product within the equity capital markets space. The company has entered into an arrangement to offer and sell shares of common stock through an agent, with a disclosed aggregate offering price of up to $1,700,000. The stock being offered is common stock with a par value of $0.0001 per share. This transaction was announced on January 6, 2025, as disclosed in an SEC filing published on the same date through SEC EDGAR. The specific form type is not identified in the source materials provided. The deal is currently in announced status, meaning the Sales Agreement has been executed but shares have not yet necessarily been sold under the agreement. WallachBeth Capital, LLC is serving as the agent under the At-the-Market Sales Agreement and is the sole financial advisor on the issuer side. WallachBeth is functioning as the agent through which the company may offer and sell shares from time to time, acting in an agency capacity rather than as a principal. WallachBeth holds lead status as the identified agent on this transaction. TroyGould PC is serving as legal counsel to the issuer and has opined on the legality of the shares being offered. Their opinion letter has been filed as Exhibit 5.1 and incorporated by reference into the Registration Statement, which is standard practice for registered offerings. No legal advisors to any other party are identified in the source materials. Under the terms of the At-the-Market Sales Agreement, Lixte Biotechnology may offer and sell shares of common stock from time to time through WallachBeth Capital, LLC acting as agent. The aggregate offering price of shares that may be sold is capped at $1,700,000. The structure is agent-based rather than a firm commitment underwriting, meaning WallachBeth will facilitate sales on behalf of the company but does not commit to purchase any shares itself. The shares being offered are common stock with a par value of $0.0001 per share. The source materials do not disclose the expected closing date or timeline for completion of the offering. The pricing mechanism for shares sold under this At-the-Market arrangement is not specified. No information is provided regarding any commissions or fees payable to the agent, nor are there any details about any lock-up periods, use of proceeds, or other material terms beyond the basic framework of the Sales Agreement. The specific form type of the SEC filing is not identified in the extracted materials.

Immedica Pharma AB, a Stockholm-based global rare disease company backed by KKR and Impilo, announced on December 30, 2024 a definitive agreement to acquire Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a Radnor, Pennsylvania-based pharmaceutical company focused on seizure disorders, via a cash tender offer followed by a second-step merger. The deal gives Immedica global rights to ZTALMY (ganaxolone) oral suspension, an FDA-approved rare neurology medicine for seizures associated with CDKL5 deficiency disorder, and was structured as an all-cash transaction valuing Marinus at an implied enterprise value of approximately $151 million. This extraction is sourced from Marinus's 8-K exhibit (Exhibit 99.2) filed with the SEC on December 30, 2024, carrying the joint press release announcing the signed merger agreement. The transaction represented the culmination of a strategic alternatives review process Marinus had announced on October 24, 2024. At the time of this filing the tender offer had not yet commenced, and the deal remained subject to customary closing conditions including a majority of outstanding Marinus shares being tendered. Barclays Capital Inc. acted as Marinus's exclusive financial advisor on the sell side, while MTS Health Partners LP acted as Immedica's exclusive financial advisor on the buy side. Each bank held a sole advisory mandate for its respective party. On the legal side, Hogan Lovells LLP served as legal counsel to Marinus, while Gibson, Dunn & Crutcher LLP served as legal counsel to Immedica; Fuchs Patentanwälte Partnerschaft mbB separately served as intellectual property counsel to Immedica on the transaction. Under the terms of the agreement, Immedica, through a wholly owned subsidiary, was to commence a cash tender offer for all outstanding Marinus common stock at $0.55 per share, representing a 48% premium to Marinus's closing price as of December 27, 2024 and a 97% premium to the 30-day volume-weighted average price preceding announcement. The Marinus board unanimously approved the deal and recommended stockholders tender their shares, and each Marinus director and named executive officer undertook to tender their own shares. The transaction was expected to close in the first quarter of 2025. The press release does not disclose specific advisory fees paid to Barclays or MTS Health Partners, nor does it break out any termination fee or financing details for the all-cash tender offer beyond the aggregate enterprise value figure.

This transaction is a comprehensive debt exchange and liability management transaction involving iHeartCommunications, Inc., classified under the restructuring product group. The disclosed value of the transaction is 4,800,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on December 23, 2024. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as financial advisor to an ad hoc group of certain holders of the existing debt, representing the creditor side of this liability management exercise. PJT Partners served as financial advisor to the Company, meaning iHeartCommunications itself, in connection with the transaction. On the legal side, Davis Polk & Wardwell LLP served as counsel to the ad hoc group of creditors, the same group advised by Perella Weinberg Partners, while Simpson Thacher & Bartlett LLP served as counsel to the Company, the same role paired with PJT Partners on the issuer side. Beyond confirming that the transaction is structured as a comprehensive debt exchange and liability management transaction with a disclosed value of 4,800,000,000 dollars, no further detail on the specific notes being exchanged, exchange ratios, or new instrument terms is included in the facts available. A number of elements of this deal are not disclosed in the available material. No detail is provided on the specific series of existing debt being exchanged, the terms of any new instruments issued in the exchange, or an expected closing or settlement date. The facts also do not specify what regulatory or other approvals, if any, remain outstanding.

This deal is a cash acquisition structured as a going-private merger, classified as an M&A transaction in the industrials sector, involving Manitex International, Inc. as target and Tadano Ltd. as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on December 23, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as exclusive financial advisor to Tadano, the acquirer, in a lead capacity. Brown Gibbons Lang & Company served as exclusive financial advisor to Manitex, the target, also in a lead capacity, with each advisor named alongside its respective legal counsel in the source material. On the legal side, Bryan Cave Leighton Paisner LLP served as legal counsel to Manitex, the target, while Sullivan & Cromwell LLP served as legal counsel to Tadano, the acquirer. Beyond the cash consideration and going-private merger structure, no further detail on per-share pricing, financing arrangements, or other structural terms is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document. No expected closing date or further timeline detail beyond the December 2024 filing date and pending-regulatory status is given.

This deal is a cash take-over bid in which Agnico Eagle Mines Ltd (ticker AEM), a company in the natural-resources sector, is the acquirer of O3 Mining Inc., the target. The transaction is classified under the M&A product group, with a disclosed deal value of $204,000,000 (CAD). The facts block is sourced from a single SEC filing: a 6-K filed with SEC EDGAR and published on December 23, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, three firms are named. Edgehill Advisory Ltd. is acting as financial advisor to Agnico Eagle, the acquirer, and is designated as lead advisor. On the target side, Maxit Capital is acting as financial advisor to O3 Mining and is also designated as lead advisor, while Fort Capital is acting as financial advisor to the Special Committee, providing a fairness opinion in that capacity, without a lead designation specified. Legal counsel was also disclosed extensively. Davies Ward Phillips & Vineberg LLP is acting as legal advisor to Agnico Eagle, the acquirer. On the target side, Bennett Jones LLP is acting as legal advisor to O3 Mining, while Cassels Brock & Blackwell LLP is acting as legal advisor to the Special Committee specifically. Beyond the cash consideration implied by the "cash take-over bid" subtype and the disclosed CAD $204,000,000 value, the facts block does not provide a per-share bid price or other specific terms of the offer. Several facts are not disclosed in the source material. The facts block does not give a per-share bid price, nor does it specify an expected closing date for the take-over bid. It also does not elaborate on the reasons a Special Committee was formed or its specific mandate beyond receiving a fairness opinion from Fort Capital.

This record concerns Container Store Group, Inc., a consumer-retail-sector company, as the target in a Chapter 11 recapitalization structured as a pre-packaged plan of reorganization. The transaction falls under the restructuring product group, and its disclosed value is $40,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published December 23, 2024. The deal's status is pending regulatory, indicating the restructuring process had not yet concluded as of that filing. Financial advisors are disclosed for two separate constituencies. On the creditor side, the ad hoc group of the company's term loan lenders are advised by Paul Hastings LLP, Greenhill & Co. as investment banker (designated lead), and AlixPartners as financial advisor, per the source sentence listing all three advisors to that lender group. On the company side, the Container Store is advised by Latham & Watkins LLP as legal counsel, Houlihan Lokey as investment banker (designated lead), FTI Consulting as financial and communications advisor, and A&G Realty as real estate advisor, per the corresponding source sentence naming the company's full advisory team. On the legal side, Paul Hastings LLP is confirmed as counsel to the ad hoc group of term loan lenders (creditors), and Latham & Watkins LLP is confirmed as counsel to the Container Store (target/company). Beyond describing this as a Chapter 11 recapitalization via pre-packaged plan of reorganization with a disclosed value of $40,000,000, the facts block does not detail the specific terms of the recapitalization, such as how existing debt or equity would be treated under the plan, though the breadth of advisors (including a dedicated real estate advisor, A&G Realty) suggests the company's real estate footprint was a relevant consideration in the process. Several facts are not disclosed in this record. No expected timeline for the pre-packaged plan's confirmation or emergence from Chapter 11 is given. The facts block does not specify what the $40,000,000 figure represents in terms of exit financing, debt reduction, or other categories, and lead-versus-non-lead status is not specified for AlixPartners or FTI Consulting.

This is a convertible notes exchange and private placement, classified under the debt capital markets (dcm) product group, in the tech sector, with MACOM Technology Solutions Holdings, Inc. (ticker MTSI) as issuer. The disclosed transaction value is $288,800,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on December 13, 2024. The deal's current status is pending regulatory review. Two financial advisors are identified, both serving the issuer, without a lead designation specified for either. Barclays Capital Inc. and J. Wood Capital Advisors LLC both acted as MACOM's financial advisors in connection with the transactions, per the source sentence: "J. Wood Capital Advisors LLC and Barclays Capital Inc. acted as MACOM's financial advisors in connection with the Transactions." No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as a convertible notes exchange and private placement with a disclosed value of $288,800,000, no further detail on the notes' coupon, maturity, conversion price, or the structure of the private placement is included in the facts provided. Several items are not disclosed in this record: no legal advisors are identified, the coupon, maturity, and conversion terms of the convertible notes are not specified, and no expected closing date is given beyond the pending-regulatory status.

This record concerns Intevac Inc, an industrials-sector company, in connection with a strategic alternatives review with no specific counterparty named. The product group for this record is sponsors-coverage, reflecting the process-oriented, pre-deal nature of a strategic alternatives review rather than a signed transaction. The disclosed value is not stated in the source document, consistent with the fact that no definitive transaction with a named counterparty has been disclosed. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on December 12, 2024. The current status of this matter is pending regulatory review. Houlihan Lokey Capital, Inc. is identified as the lead financial advisor to Intevac on its strategic alternatives review. The source language states that "Following Intevac's restructuring with an increased focus and improved market conditions for HDD, and the resulting improved pro forma forecasted EBITDA profitability, Houlihan Lokey is actively pursuing strategic alternatives, including discussions with interested parties, for the Company." This indicates Houlihan Lokey's mandate includes actively engaging with interested parties on behalf of Intevac, though no specific counterparty or transaction has been identified in the facts provided. No legal advisors were extracted for this matter in the available facts block. Because this is a strategic alternatives review rather than a signed transaction, there is no disclosed consideration structure, subtype-specific deal term, or named counterparty to describe. Several key items are not disclosed in this record: no specific acquirer, merger partner, or other counterparty has been named, no transaction value is disclosed, no legal advisors are identified, and no expected timeline or closing date is given beyond Houlihan Lokey's stated engagement to pursue discussions with interested parties.

This deal is a credit agreement amendment and noteholder restructuring, classified as a restructuring transaction, involving Trinseo Holding S.r.l. The disclosed value of the transaction is not stated in the source document, and no sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on December 11, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners LP is identified as financial advisor to the creditors, specifically serving the group referred to in the source document as the \'Noteholder Advisors,\' which represents an ad hoc group of Supporting Noteholders. No lead/non-lead designation is specified for Perella Weinberg's role, and no financial advisor is identified for the issuer (Trinseo) side in the facts provided. On the legal side, Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor to the creditors, also as part of the Noteholder Advisors group alongside Perella Weinberg Partners, per the defined term in the source document. No legal advisor is identified for the issuer side. Beyond the classification of this transaction as a credit agreement amendment combined with a noteholder restructuring, no further detail on specific facility terms, amendment provisions, or restructuring mechanics is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document, no sector classification is given, and no financial or legal advisor is identified for the issuer (Trinseo, referred to as 'the Company Parties') side of the transaction. No expected closing date or additional timeline detail beyond the December 2024 filing date and pending-regulatory status is provided.

This transaction is a going-private cash-plus-contingent-value-right merger in which Gen Digital Inc., trading under the ticker GEN, acquired MoneyLion Inc. The deal is classified within the financial institutions group sector, carries a disclosed value of 1,000,000,000 dollars, and, notably among this batch, is marked as closed rather than pending. The transaction is sourced from a substantial series of SEC EDGAR filings spanning several months: Form 8-K filings published December 10, 2024, December 11, 2024, April 10, 2025, and April 17, 2025 (including one specifically citing Exhibit 99.1 from the December 10, 2024 filing), a Form DEFM14A published March 5, 2025, and an additional filing of unknown form type also published March 5, 2025. This sequence of filings, running from the initial announcement through to filings in April 2025, is consistent with the deal's current closed status. On the financial advisory side, Keefe, Bruyette & Woods, Inc., a Stifel Company, is serving as exclusive financial advisor to MoneyLion, the target, and is identified as the lead advisor in that role. Evercore is serving as financial advisor to Gen, the acquirer. Separately, Sodali & Co. is named as MoneyLion's proxy solicitor, assisting stockholders with voting their shares in connection with the special meeting on the transaction, as described in the source material directing stockholders with questions to call Sodali & Co.'s toll-free line. On the legal side, Davis Polk & Wardwell LLP is serving as legal counsel to MoneyLion, the target, and Kirkland & Ellis LLP is serving as legal advisor to Gen Digital, the acquirer, consistent across the multiple source sentences referencing each firm's role. The transaction is structured as a going-private, cash-plus-contingent-value-right merger with a disclosed value of 1,000,000,000 dollars; beyond identifying the inclusion of a contingent value right component alongside cash, no further detail on the specific cash amount per share, the CVR terms, or payout triggers is included in the facts available. Some elements remain undisclosed even for this now-closed transaction. No specific per-share cash amount or detailed CVR payout terms are given, and no breakdown is provided of how much of the 1,000,000,000 dollar disclosed value corresponds to the cash portion versus the contingent value right. The facts confirm the deal has closed but do not specify the exact closing date.

This deal is a partial cash tender offer in which CVR Energy Inc (ticker CVI), a company in the energy-power sector, is the target of an offer by Icahn Enterprises Holdings L.P., an offeror controlled by Icahn. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an SC 14D9 filed with SEC EDGAR and published on December 6, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, TPH&Co., the energy business of Perella Weinberg Partners, is named as the independent financial advisor to the Special Committee of CVR Energy, the target, and is designated as lead advisor. The source material notes that on May 6, 2024, the Special Committee selected TPH&Co. for this role due to its extensive industry experience, knowledge of the refining sector, and independence from the Icahn entities. No financial advisor is disclosed for the offeror (Icahn Enterprises Holdings) in the facts block. Legal counsel was disclosed only for the target side: Potter Anderson & Corroon LLP and Baker Botts L.L.P. both served as legal advisors, with the source material identifying specific attorneys at each firm, Mark A. Morton and Alyssa K. Ronan at Potter Anderson, and Clinton W. Rancher and Joshua Davidson at Baker Botts. No legal advisor is disclosed for the offeror. Beyond the characterization of the offer as a "partial" cash tender offer, the facts block does not specify what percentage or number of shares the tender offer covers, nor the offer price per share. Several facts are not disclosed in the source material. The facts block does not give the tender offer price per share or the percentage of shares being sought in the partial tender offer. No financial or legal advisor is named for the offeror, Icahn Enterprises Holdings. No expected closing or expiration date for the tender offer is given.

ONEOK, Inc. (NYSE: OKE), a Tulsa, Oklahoma-based diversified midstream energy infrastructure company, and EnLink Midstream, LLC (NYSE: ENLC), a Dallas-based midstream services provider, announced on November 25, 2024 that they executed a definitive merger agreement under which ONEOK will acquire all outstanding publicly held common units of EnLink that it does not already own, for $4.3 billion in ONEOK common stock. Each outstanding EnLink common unit not already owned by ONEOK will convert into 0.1412 shares of ONEOK common stock, an exchange ratio derived by dividing EnLink's November 22, 2024 market close price of $15.75 per unit by ONEOK's 10-day volume-weighted average price. This transaction follows ONEOK's October 15, 2024 completed acquisition of Global Infrastructure Partners' entire interest in EnLink for approximately $3.3 billion in cash. This entry is sourced from ONEOK's Exhibit 99.1 press release filed as part of an 8-K on November 25, 2024. The transaction had not yet closed as of this filing; completion was expected in the first quarter of 2025, subject to approval by a majority of outstanding EnLink common units (including those owned by ONEOK) and other customary closing conditions. No ONEOK shareholder vote or further regulatory approval was required, as the Hart-Scott-Rodino waiting period was already satisfied in connection with ONEOK's prior GIP acquisition. Goldman Sachs & Co. LLC served as lead financial advisor to ONEOK, with Barclays and Citi also advising ONEOK. Evercore acted as financial advisor to the EnLink Conflicts Committee, a three-member independent director committee delegated authority by the EnLink board to review, evaluate, negotiate and approve the transaction. Kirkland & Ellis LLP served as ONEOK's legal advisor. Richards, Layton & Finger, P.A. served as legal advisor to the EnLink Conflicts Committee, and Baker Botts L.L.P. served as legal advisor to EnLink. Under the disclosed terms, ONEOK will issue approximately 37.0 million shares in the transaction, representing approximately 6.0% of total ONEOK shares outstanding upon consummation. ONEOK committed to vote its units, representing approximately 44% of outstanding EnLink common units, in favor of the transaction. The deal is structured as a tax-free transaction for unitholders. The release does not disclose any termination fee, the specific fee arrangements for Goldman Sachs, Barclays, Citi, or Evercore, or an implied total enterprise value for EnLink as a whole (the $4.3 billion figure applies only to the publicly held units being acquired, not ONEOK's pre-existing EnLink stake).

This transaction is the formation of a midstream joint venture via a non-controlling equity investment, involving EQT Corp (ticker EQT), a natural-resources sector issuer, and Blackstone Credit & Insurance as the investing acquirer. The deal is classified under the M&A product group, with a disclosed value of $8,800,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on November 25, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, RBC Capital Markets, LLC acted as financial advisor to EQT, the issuer, while Citi acted as financial advisor to Blackstone, the acquiring investor. No lead designation was specified for either advisor in the facts block. Legal counsel was also disclosed for both parties. Kirkland & Ellis LLP is serving as EQT's legal counsel on the transaction, while Milbank LLC is serving as Blackstone's legal counsel on the transaction. Beyond its characterization as a non-controlling equity investment forming a midstream joint venture, the facts block does not disclose further structural detail, such as the percentage equity stake being acquired or the specific midstream assets being contributed to the venture. Several facts are not disclosed in the source material. The facts block does not specify the percentage of equity Blackstone is acquiring in the joint venture, nor does it name the specific midstream assets involved. No expected closing date is given, and no lead/non-lead designation is provided for either RBC Capital Markets or Citi.

EQT Corporation (NYSE: EQT), a Pittsburgh-based vertically integrated natural gas company with production and midstream operations in the Appalachian Basin, announced on November 25, 2024 a $3.5 billion midstream joint venture with funds managed by Blackstone Credit & Insurance (BXCI). The joint venture will consist of EQT's ownership interests in Mountain Valley Pipeline, LLC - Series A, FERC-regulated transmission and storage assets, and the Hammerhead Pipeline, a 1.6 billion cubic feet per day gathering header pipeline connecting Pennsylvania and West Virginia natural gas production to MVP and other transmission systems. This entry is sourced from EQT's Exhibit 99.1 press release filed as part of an 8-K on November 25, 2024. The transaction had not yet closed as of the filing date; it was expected to close in the fourth quarter of 2024, subject to customary closing adjustments and required regulatory approvals and clearances. RBC Capital Markets, LLC acted as financial advisor to EQT, and Citi acted as financial advisor to Blackstone. No lead designation is specified for either advisor, and no additional financial advisors are disclosed on either side. Kirkland & Ellis LLP served as EQT's legal counsel on the transaction, and Milbank LLC served as Blackstone's legal counsel. Under the terms of the agreement, BXCI will provide EQT $3.5 billion of cash consideration in exchange for a non-controlling common equity interest in the joint venture, implying a total JV valuation of approximately $8.8 billion, or roughly 12 times projected EBITDA (derived by dividing projected 2025-2029 average JV free cash flow by a target return, with the EBITDA multiple derived by dividing the JV valuation by projected 2025-2029 average JV EBITDA). EQT stated it plans to use proceeds to pay down its term loan and revolving credit facility and to redeem and tender for senior notes, and that, combined with a separately announced divestiture of non-operated Pennsylvania assets, it expected to exit 2024 with approximately $9 billion of net debt. EQT retains rights to growth projects associated with the contributed assets, including the planned MVP expansion and MVP Southgate project. The release does not disclose the specific governance terms of the joint venture (such as board composition or voting rights for BXCI's non-controlling stake), any termination or break-up fee, or the fee arrangements for RBC, Citi, Kirkland & Ellis, or Milbank. No information is provided about financing conditions for BXCI's $3.5 billion cash contribution.

This deal is an all-stock merger classified as an M&A transaction in the natural-resources sector, involving Piedmont Lithium Inc. as target and Sayona Mining Limited as acquirer. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on November 19, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Morgan Stanley acted as exclusive financial advisor to Sayona, the acquirer, in a lead capacity, while J.P. Morgan acted as exclusive financial advisor to Piedmont, the target, also in a lead capacity. Separately, Canaccord Genuity is identified as equity capital markets advisor to the transaction overall, a distinct role not tied to a specific side in the facts block and without a lead designation. On the legal side, Gibson Dunn served as legal counsel to Piedmont (the target), alongside Thomson Geer and Bennett Jones, also named as legal counsel to Piedmont in the same source sentence though only Gibson Dunn is broken out as a structured legal advisor entry. On the acquirer side, Herbert Smith Freehills served as legal counsel to Sayona, alongside Baker Botts and McCarthy Tétrault named in the same source sentence. Beyond the all-stock consideration structure implied by the merger subtype, no further detail on the specific exchange ratio or other structural terms is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document. While the source sentences reference additional legal counsel (Thomson Geer, Bennett Jones for Piedmont; Baker Botts, McCarthy Tétrault for Sayona), these are not broken out as separate structured legal advisor entries beyond Gibson Dunn and Herbert Smith Freehills. No expected closing date or further timeline detail beyond the November 2024 filing date and pending-regulatory status is given.

This transaction involves CareMax, Inc., a healthcare sector company, and is structured as a Chapter 11 asset sale under a prearranged plan, specifically involving CareMax's management services organization (MSO) business being sold to Revere Medical, an affiliate referred to in parts of the record as ClareMedica. The deal falls under the restructuring product group, and the disclosed value is not stated in the source document. This summary draws on two SEC EDGAR Form 8-K filings, one published on November 18, 2024, and a second published on November 25, 2024, reflecting the staged disclosure typical of a Chapter 11 process. The transaction's current status is pending regulatory review. The advisory roster reflects the multi-constituency nature of a bankruptcy sale process. Piper Sandler & Co. is serving as investment banker to CareMax, the debtor, in a lead role, a mandate referenced twice in the source material. Alvarez & Marsal North America, LLC is also serving as financial advisor to CareMax, likewise in a lead capacity, again referenced in two separate source sentences. On the creditor side, Guggenheim Securities, LLC is serving as financial advisor and investment banker to the current secured lenders, in a lead role. On the buyer side, Raymond James & Associates, Inc. is serving as investment banker to ClareMedica and its affiliates, the acquiring entity associated with Revere Medical, and Ernst & Young LLP is serving as financial advisor to ClareMedica, both in lead roles. Legal counsel also reflects this multi-party structure. Sidley Austin LLP is serving as legal counsel to CareMax, referenced twice in the source material. Ropes & Gray LLP is serving as legal counsel to the current secured lenders, alongside Guggenheim Securities' financial advisory role for that same creditor group. McGuireWoods LLP is serving as legal counsel to ClareMedica, alongside Ernst & Young LLP's financial advisory role for that buyer entity. The facts block identifies this as a Chapter 11 asset sale conducted under a prearranged plan, meaning the sale terms were negotiated with key creditor constituencies before the bankruptcy filing, specifically involving the sale of CareMax's MSO business to Revere Medical and ClareMedica, but it does not disclose the specific purchase price, the treatment of other creditor classes, or the timeline for plan confirmation. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No sector classification is given beyond CareMax's own healthcare designation. No expected plan confirmation or closing date is given, and no detail on the treatment of unsecured creditors or equity holders under the prearranged plan is provided.

This record describes a Chapter 11 pre-arranged restructuring. The facts block does not name a specific target, acquirer, or issuer entity, but based on the product classification this is a restructuring matter with a disclosed value of $795,000,000. The source document is an 8-K filing with the SEC via EDGAR, published November 18, 2024. The matter's status is pending regulatory, meaning the restructuring process had not concluded as of that filing. Multiple financial advisors are disclosed across different constituencies. On what the record labels the issuer side, Alvarez & Marsal served as restructuring advisor and is designated lead, while Perella Weinberg Partners LP acted as investment banker and is also designated lead; the source language states that Davis Polk & Wardwell LLP served as the company's restructuring counsel, Alvarez & Marsal served as restructuring advisor, and Perella Weinberg Partners LP acted as investment banker. On the creditor side, two separate creditor constituencies are represented: Ducera Partners LLC served as financial advisor to the convertible bondholders (lead), with Paul Hastings LLP acting as their legal counsel, while Evercore served as financial advisor to the ad hoc group of loyalty noteholders (lead), with Akin Gump Strauss Hauer & Feld LLP acting as that group's legal counsel. On the legal side, Davis Polk & Wardwell LLP is confirmed as counsel to the issuer/company, Paul Hastings LLP as counsel to the convertible bondholders, and Akin Gump Strauss Hauer & Feld LLP as counsel to the ad hoc group of loyalty noteholders, mirroring the financial advisor pairings described above. Beyond classifying this as a pre-arranged Chapter 11 restructuring with a disclosed value of $795,000,000, the facts block does not specify what that dollar figure represents (e.g., a specific debt tranche, DIP facility, or total claims amount), nor does it describe the treatment of any particular class of creditors. Several items remain undisclosed in the record. The identity of the underlying company undergoing restructuring is not given in the facts block beyond the role labels (issuer, creditors). No expected timeline for emergence from Chapter 11 is provided, and no detail on the plan of reorganization's specific terms is included beyond the disclosed aggregate value.

This transaction is an all-stock merger in which NBT Bancorp Inc. (ticker NBTB) is acquiring Evans Bancorp Inc., both companies operating in the fig (financial institutions group) sector. The deal is classified under the M&A product group, and the disclosed value is not stated in the source document. This summary is sourced from an SEC EDGAR Form DEFM14A filed and published on November 7, 2024. The transaction's current status is pending regulatory review. Only one financial advisor is named in the facts block: Piper Sandler & Co. served as financial advisor to Evans, the target, in a lead capacity. The source sentence is drawn directly from a section heading, Opinion of Piper Sandler & Co., Financial Advisor to Evans, indicating the firm's engagement centered on delivering a fairness opinion in connection with the merger. No legal advisors are identified in the facts block for either Evans Bancorp or NBT Bancorp. Beyond confirming that this is structured as an all-stock merger, the facts block provides no further detail on the exchange ratio, the treatment of outstanding equity awards, or any other structural terms of the merger agreement. Several material facts are not disclosed in the available record. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either party. No financial advisor is identified for NBT Bancorp, the acquirer, and no expected closing date is given.

This deal is a cash acquisition structured as a take-private transaction, classified as an M&A deal in the real-estate sector, involving Retail Opportunity Investments Corp as target and Blackstone Real Estate Partners X as acquirer. The disclosed value of the transaction is $4,000,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on November 6, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, J.P. Morgan acted as exclusive financial advisor to Retail Opportunity Investments Corp (ROIC), the target, in a lead capacity. On the acquirer side, Blackstone was advised by a group of four financial advisors acting collectively: BofA Securities, Morgan Stanley & Co. LLC, Newmark, and Eastdil Secured, none of which carries a specified lead designation in the facts block, per the source sentence naming all four together as Blackstone's financial advisors. On the legal side, Clifford Chance US LLP served as legal counsel to ROIC, the target, while Simpson Thacher & Bartlett LLP served as legal counsel to Blackstone, the acquirer. Beyond the cash consideration and take-private structure, with a disclosed deal value of $4,000,000,000, no further detail on per-share pricing, financing sources, or other structural terms is provided in the facts block. Several items are not disclosed in the available record. No lead designation among Blackstone's four financial advisors (BofA Securities, Morgan Stanley, Newmark, and Eastdil Secured) is specified, so it is not possible to determine from the facts which, if any, held a lead role. No expected closing date or further timeline detail beyond the November 2024 filing date and pending-regulatory status is given.

Air Transport Services Group, Inc. (NASDAQ: ATSG), a global leader in medium widebody freighter aircraft leasing and air transport operations, announced a definitive agreement to be acquired by Stonepeak, an alternative investment firm specializing in infrastructure and real assets, in an all-cash transaction with an enterprise valuation of approximately $3.1 billion. ATSG shareholders were to receive $22.50 per share in cash, a premium of approximately 29.3% over ATSG's closing price the last full trading day prior to announcement. The deal is in the air transportation sector (SIC 4513, air courier services). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Air Transport Services Group, Inc. with the SEC on November 4, 2024, announcing the signing of the Agreement and Plan of Merger with Stonepeak Nile Parent LLC and Stonepeak Nile MergerCo Inc. A later ATSG fourth-quarter 2024 earnings release (filed March 3, 2025) confirms the transaction remained pending at that time, noting ATSG had received stockholder approval on February 10, 2025 and was awaiting U.S. Department of Transportation approval, with closing still targeted for the first half of 2025. The deal included fully committed equity and debt financing from Stonepeak-affiliated funds and was not subject to a financing condition, and it featured a 35-to-50-day "go-shop" period allowing ATSG to solicit competing proposals through December 8 or December 23, 2024. On financial advisory, Goldman Sachs & Co. LLC acted as exclusive financial advisor to ATSG, the target, while Evercore acted as financial advisor to Stonepeak, the acquirer. On legal advisory, Davis Polk & Wardwell LLP and Vorys, Sater, Seymour & Pease LLP acted as legal counsel to ATSG, while Simpson Thacher & Bartlett LLP and Hogan Lovells US LLP acted as legal counsel to Stonepeak. The deal structure disclosed is an all-cash merger at $22.50 per share, unanimously approved by ATSG's board, with the transaction expected to close in the first half of 2025 subject to shareholder and regulatory approvals, including Department of Transportation review given ATSG's airline certificate subsidiaries. What is not disclosed in this initial announcement: the exact amount of committed debt and equity financing from Stonepeak, the termination fee payable under the merger agreement, and (as of this particular filing) the actual closing date, since the transaction remained pending as of the follow-on Q4 2024 earnings release reviewed alongside this announcement.

This deal is a senior secured term loan refinancing by Oportun Financial Corp (ticker OPRT), the issuer, a company in the financial institutions group (FIG) sector. The transaction is classified under the levfin (leveraged finance) product group, with a disclosed value of $235,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on October 29, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Evercore acted as financial advisor to the company, Oportun, on the transaction, with no lead designation specified in the facts block. No other financial advisors were identified. Legal counsel was disclosed for the issuer: both Orrick, Herrington & Sutcliffe LLP and Wilson Sonsini Goodrich & Rosati served as legal advisors to the company, Oportun, on the transaction. No legal advisors were disclosed for any lender or arranger side. Beyond the characterization of the transaction as a senior secured term loan refinancing and the disclosed $235,000,000 value, the facts block does not specify the interest rate, maturity, or other terms of the refinanced term loan, nor does it name the lead arranger or lenders providing the new facility. Several facts are not disclosed in the source material. The facts block does not name the arranger or lenders on the new senior secured term loan, nor does it specify the loan's interest rate, maturity date, or covenant terms. No expected closing date is given.

This deal involves Battalion Oil Corp, a natural-resources sector company trading under ticker BATL, as the target of a going-private cash merger. The disclosed facts do not name the acquiring counterparty in this record, and the product group is classified as M&A. The transaction's disclosed value is not stated in the source document, so the financial size of the deal is not known from the available record. The deal is sourced from a DEFM14A filed with the SEC via EDGAR, published on October 21, 2024. That filing type, a definitive merger proxy statement, is consistent with a going-private transaction that requires a shareholder vote. The deal's current status is pending regulatory review. On the financial advisory side, Houlihan Lokey Capital, Inc. is identified as the lead advisor to Battalion Oil, specifically in the capacity of fairness opinion provider. The source language for this engagement is simply styled as an "Opinion of Houlihan Lokey Capital, Inc.," indicating that the firm's role was to render a fairness opinion in connection with the merger, which is typical of the disclosure found in a DEFM14A. No other financial advisors, on either the target or any acquirer side, are identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block, so legal counsel to either side is not known from this record. Beyond the designation of the transaction as a going-private cash merger, no further structural details, such as the per-share cash consideration, financing sources, or any other terms, are included in the facts provided. Several material items are not disclosed in the available record: the identity of the acquiring party or sponsor is not named, the transaction value is not stated, the specific cash consideration per share is not given, no legal advisors are identified for either side, and no expected closing date or timeline beyond the pending regulatory status is provided.

StoneX Group Inc. issued a Rule 8 announcement under the UK Takeover Code on October 21, 2024, directing its stockholders' attention to disclosure obligations arising from CAB Payments Holdings plc's October 10, 2024 announcement that it had received an unsolicited, non-binding proposal from StoneX relating to a possible offer for CAB Payments' entire issued and to be issued share capital. The announcement states there could be no certainty that a firm offer would be made, nor as to its potential terms. This record is sourced from an Exhibit 99.1 Rule 8 Announcement furnished with StoneX's Form 8-K filed October 21, 2024. A subsequent Form 8-K filed November 8, 2024 (also reviewed) discloses that on November 7, 2024, StoneX announced it was no longer pursuing the transaction and did not intend to make an offer to acquire CAB Payments; the proposal was therefore withdrawn and never became a completed deal. Perella Weinberg UK Limited acted as financial adviser to StoneX on the proposal, per the announcement's statement that "Perella Weinberg UK Limited ('PWP'), which is authorized and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for StoneX in connection with the matters set out in this announcement and for no one else." No financial adviser to CAB Payments is named in this particular filing, and no lead designation applies since PWP was StoneX's sole disclosed adviser in this document. No legal advisors are disclosed in the fetched document for either party. The announcement's substance is procedural, explaining UK Takeover Code Rule 8 disclosure obligations (Opening Position Disclosures and Dealing Disclosures) applicable to StoneX stockholders during the CAB Payments offer period, rather than describing commercial deal terms, since no binding offer had yet been made. Not disclosed in the sourced document is any proposed offer price or valuation for CAB Payments, the identity of CAB Payments' financial or legal advisers, or the reason StoneX ultimately decided, per its November 7, 2024 announcement, not to pursue the transaction.

Sophos, a global cybersecurity company backed by Thoma Bravo, entered into a definitive agreement to acquire Secureworks (NASDAQ: SCWX), a cybersecurity leader built around its Taegis extended detection and response (XDR) platform, in an all-cash transaction valued at approximately 859 million dollars. Secureworks shareholders, including majority holder Dell Technologies (NYSE: DELL), were to receive 8.50 dollars per share in cash, representing a 28 percent premium to the unaffected 90-day volume-weighted average price. The combination was framed as uniting Sophos' managed detection and response and endpoint, network, email and cloud security products with Secureworks' Taegis platform and security operations expertise. This record is drawn from an 8-K exhibit (Exhibit 99.1) that Secureworks filed with the SEC on October 21, 2024, containing the companies' joint press release announcing the signed agreement. At the time of filing the deal was newly announced and pending customary closing conditions, with the companies targeting a close in early 2025. On the acquirer's side, the release groups financial advisory and financing roles together: "Goldman Sachs & Co. LLC., Barclays, BofA Securities, HSBC Securities (USA) Inc. and UBS Investment Bank are acting as financial advisors and providing debt financing for the transaction" to Sophos, indicating Barclays served Sophos in a dual capacity as both an M&A financial advisor and a debt financing source, alongside four peer banks, without specifying which bank held a lead role. On the target's side, Piper Sandler & Company and Morgan Stanley & Co. LLC served as financial advisors to Secureworks. Legal counsel to Sophos was provided by Kirkland & Ellis LLP, while Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal counsel to Secureworks. The release notes that additional information about the merger could be found in Secureworks' Form 8-K filed on the same date, and that Secureworks intended to file an information statement on Schedule 14C with the SEC in connection with the merger, since Dell Technologies' majority ownership position meant stockholder approval could be obtained by written consent rather than a full proxy vote. Not disclosed in this exhibit: the specific allocation of advisory fees or lead roles among the five banks advising Sophos, the amount or terms of the debt financing being arranged, and the actual closing date beyond the general expectation of early 2025.

R1 RCM Inc., a healthcare revenue cycle management technology and services company, entered into an Agreement and Plan of Merger dated July 31, 2024 to be acquired by a buyer group formed by affiliates of private equity firms TowerBrook Capital Partners L.P. and Clayton, Dubilier & Rice, LLC, taking the company private at a merger consideration of $14.30 per share in cash, representing a premium of approximately 29% to R1 RCM's unaffected closing price before existing shareholder New Mountain Capital's interest in a transaction became public. This extraction is sourced from R1 RCM's definitive merger proxy statement on Form DEFM14A filed with the SEC on October 16, 2024, prepared ahead of a special meeting of stockholders held November 14, 2024 to vote on the merger. The proxy's background-of-the-merger narrative traces a months-long process beginning with non-binding proposals from New Mountain (an existing R1 RCM shareholder) in early 2024. Barclays was engaged by R1 RCM's Special Committee of independent directors under a March 28, 2024 engagement letter to act as its financial advisor in evaluating strategic alternatives, including a possible sale of the company, and rendered a fairness opinion to the Special Committee on July 31, 2024. Qatalyst Partners LP also provided a fairness opinion in connection with the transaction. Separately, Centerview Partners LLC acted as financial advisor to TA Associates, an existing R1 RCM shareholder involved in discussions around the transaction. On the legal side, Kirkland & Ellis LLP served as legal advisor to the Company (R1 RCM), while Wachtell, Lipton, Rosen & Katz served as legal advisor to TA Associates during the process; Skadden also appears in the proxy as counsel engaged in the deal discussions. The Merger Consideration was a flat cash amount of $14.30 per share for all outstanding R1 RCM common stock, with the Special Committee's engagement of Barclays specifically tied to evaluating a potential sale of the company following unsolicited interest from New Mountain and, ultimately, the TowerBrook/CD&R consortium. The proxy excerpt reviewed here does not provide a single aggregate transaction value or enterprise value figure for the deal (only the $14.30 per-share price), nor does it disclose the specific fees paid to Barclays, Qatalyst, or Centerview for their respective engagements, or the expected closing date of the transaction.

This is a cash-and-stock acquisition in the industrials sector in which VSE Corp (ticker VSEC) is acquiring Kellstrom Aerospace Group, Inc. The product group is M&A, and the disclosed transaction value is $200,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on October 15, 2024. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side, with both advisors serving in a lead capacity. Perella Weinberg Partners served as exclusive financial advisor to Kellstrom, the target, per the statement "Kirkland & Ellis LLP served as legal counsel and Perella Weinberg Partners served as exclusive financial advisor to Kellstrom." On the acquirer side, Jefferies, LLC acted as exclusive financial advisor to VSE Corporation, consistent with the language "Jones Day served as legal counsel and Jefferies, LLC acted as exclusive financial advisor to VSE Corporation with respect to the Kellstrom acquisition." Legal advisors are disclosed for both sides as well: Jones Day served as legal counsel to VSE Corporation, the acquirer, while Kirkland & Ellis LLP served as legal counsel to Kellstrom, the target. Beyond the classification of this transaction as a cash-and-stock acquisition with a disclosed value of $200,000,000, no further detail on the specific split between cash and stock consideration is included in the facts provided. Several items are not disclosed in this record: the precise cash/stock consideration mix is not specified, and no expected closing date is given beyond the pending-regulatory status.

This deal is a take-private leveraged buyout of The Duckhorn Portfolio, Inc., a company in the consumer-retail sector, by Butterfly Equity. The transaction is classified under the sponsors-coverage product group, and the disclosed deal value is $1,950,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on October 7, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, KKR Capital Markets LLC acted as capital markets advisor to Butterfly (the sponsor), and is designated as the lead advisor in that capacity. On the target side, J.P. Morgan Securities LLC acted as financial advisor to Duckhorn and is likewise designated as lead advisor. Legal counsel was also disclosed for both sides of the transaction. Ropes & Gray LLP acted as legal counsel to Duckhorn, the target. Kirkland & Ellis LLP acted as legal counsel to Butterfly, the sponsor. Beyond the disclosed $1,950,000,000 deal value and its classification as a take-private leveraged buyout, the facts block does not provide further detail on the structure of the transaction, such as the per-share consideration or financing structure of the buyout. A number of facts are not disclosed in the source material. The facts block does not state an expected closing date for the transaction. It also does not break out the financing structure behind the leveraged buyout, such as the mix of equity and debt being used by Butterfly, nor does it name any other advisors beyond KKR Capital Markets, J.P. Morgan Securities, Ropes & Gray, and Kirkland & Ellis.

This transaction is a cash and equity acquisition in which Summit Midstream Corp, trading under the ticker SMC, is acquiring Tall Oak Midstream Operating LLC and related Tall Oak entities, including Tall Oak Midstream III, from Tailwater Capital. The deal is classified within the energy and power sector, and the disclosed value of the transaction is 155,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on October 2, 2024. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, TPH&Co., described in the source material as the energy business of Perella Weinberg Partners, served as exclusive financial advisor to Tailwater Capital, the sponsor and seller in this transaction, and is identified as the lead advisor in that role. Guggenheim Securities, LLC served as financial advisor to Summit, the acquirer, and is likewise identified as the lead advisor for Summit. On the legal side, Locke Lord LLP served as legal advisor to Summit, the acquirer. Kirkland & Ellis LLP served as legal advisor to Tall Oak Midstream and Tailwater Capital, covering both the target entities and the sponsor on the seller side. Beyond confirming that this is a cash and equity acquisition with a disclosed value of 155,000,000 dollars, no further detail on the specific split between the cash and equity components of the consideration is included in the facts available. Several elements of this deal remain undisclosed. No specific breakdown between the cash and equity portions of the 155,000,000 dollar consideration is given, and no expected closing date is provided. The facts also do not specify what regulatory approvals are required to complete the transaction.

This deal is a convertible notes exchange and balance sheet restructuring, classified as a restructuring transaction in the telecom sector, involving EchoStar Corp (ticker ECHO) as issuer. The disclosed value of the transaction is $5,100,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 30, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, two firms are identified, both representing creditor groups: Centerview Partners served as exclusive financial advisor to the ad hoc group of holders of 2025 DISH Convertible Notes, in a lead capacity, and Perella Weinberg Partners served as exclusive financial advisor to the ad hoc group of holders of 2026 DISH Convertible Notes, also in a lead capacity. No financial advisor is identified for EchoStar, the issuer, in the facts provided. On the legal side, Akin Gump Strauss Hauer & Feld LLP served as exclusive legal counsel to the ad hoc group of holders of 2026 DISH Convertible Notes, categorized here under the target designation in the facts block. Paul, Weiss, Rifkind, Wharton & Garrison LLP is referenced in the source sentence as exclusive legal advisor to the ad hoc group of holders of 2025 DISH Convertible Notes, though it is named within the Centerview Partners sentence rather than as a separately structured legal advisor entry. Beyond the convertible notes exchange and balance sheet restructuring, with a disclosed value of $5,100,000,000, split across the 2025 and 2026 DISH Convertible Notes noteholder groups, no further detail on the specific exchange terms or new instrument structure is provided in the facts block. Several items are not disclosed in the available record. No financial advisor is identified for EchoStar (the issuer) itself, and Paul, Weiss, Rifkind, Wharton & Garrison LLP's role as legal advisor to the 2025 noteholder group is referenced in source language but not broken out as a separate structured legal advisor entry. No expected closing date or further timeline detail beyond the September 2024 filing date and pending-regulatory status is given.

This deal is a debt exchange and asset acquisition classified as an M&A transaction, involving EchoStar's video distribution business, DISH DBS (including DISH TV and Sling TV), as the target/divested assets, with DIRECTV and TPG as acquirer parties. The disclosed value of the transaction is not stated in the source document. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 30, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, J.P. Morgan acted as lead financial advisor to EchoStar, the target. On the acquirer side, PJT Partners acted as lead financial advisor to DIRECTV, while BofA Securities, Evercore, LionTree, and Morgan Stanley also provided (non-lead) financial advice to both DIRECTV and TPG per the same source sentence. Separately, Barclays acted as lead financial advisor to TPG, categorized as sponsor in the facts block. On the legal side, White & Case LLP acted as legal counsel to EchoStar, the target, alongside Steptoe & Johnson PLLC named in the same source sentence. Ropes & Gray LLP and Crowell & Moring LLP acted as legal counsel to DIRECTV, the acquirer, alongside HWG LLP named in the same source sentence though not broken out as a separate structured entry. Beyond the debt exchange and asset acquisition structure involving DISH DBS, DISH TV, and Sling TV, no further detail on the specific debt instruments exchanged or the allocation of consideration between DIRECTV and TPG is provided in the facts block. Several items are not disclosed in the available record. The overall transaction value is not stated in the source document. While the source sentences reference Steptoe & Johnson PLLC (counsel alongside White & Case for EchoStar) and HWG LLP (counsel alongside Ropes & Gray and Crowell & Moring for DIRECTV), these are not broken out as separate structured legal advisor entries. No expected closing date or further timeline detail beyond the September 2024 filing date and pending-regulatory status is given.

This deal is a cash acquisition classified as an M&A transaction, involving McGriff Insurance Services LLC as target and Marsh McLennan Agency as acquirer. The disclosed value of the transaction is $7,750,000,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 30, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, two firms are identified as financial advisors (brokers) to the target: Morgan Stanley & Co. LLC and Evercore Group L.L.C. Both are named in a no-other-finder's-fee representation within the merger agreement, which states that no agent, broker, investment banker, or financial advisor other than these two firms is entitled to any commission or fee in connection with the transaction. Neither is given a lead designation in the facts block, and no financial advisor is identified for the acquirer, Marsh McLennan Agency. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either side of the transaction. Beyond the cash consideration implied by the cash acquisition subtype, with a disclosed deal value of $7,750,000,000, no further detail on financing sources or other structural terms is provided in the facts block. Several items are not disclosed in the available record. No lead designation is given for either Morgan Stanley or Evercore in their advisory role to the target, no financial advisor is identified for the acquirer, no sector classification is specified, and no legal advisors for either party are identified. No expected closing date or further timeline detail beyond the September 2024 filing date and pending-regulatory status is given.

Universal Logistics Holdings, Inc. (NASDAQ: ULH) announced its acquisition of Parsec, LLC, Parsec Intermodal of Canada ULC, and OB Leasing, LLC (collectively, "Parsec"), a market-leading provider of terminal management services to Class I, regional, and short-line railroads across North America, for a cash purchase price of $193.6 million, subject to customary post-closing adjustments. The deal is in the trucking and logistics sector (SIC 4213). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Universal Logistics Holdings, Inc. with the SEC on September 30, 2024, announcing that the acquisition had already closed. Parsec, with nearly 2,100 employees, offers terminal services at over 20 rail yards in the U.S. and Canada, including container lift on/off, crane and intermodal equipment repair, drayage, and container/chassis stacking; for the trailing twelve months ended August 31, 2024, Parsec reported total operating revenues of $230.2 million. Parsec was to operate within Universal's contract logistics segment, with the acquisition expected to be immediately accretive and to boost that segment's annualized revenues to over $1 billion. On financial advisory, Livingstone Partners served as exclusive financial advisor to Parsec, the target. No financial advisor to Universal Logistics (the acquirer) is named in this press release. On legal advisory, Dykema Gossett PLLC and Vistula PLC served as Universal's legal advisors on the transaction, while Katz Teller served as Parsec's legal advisor. The deal structure disclosed is a straightforward all-cash acquisition at $193.6 million, already closed as of the press release date, with the purchase price subject to customary post-closing adjustments. What is not disclosed: the press release does not name a financial advisor representing Universal Logistics in the transaction, does not break out the $193.6 million price into components (e.g., working capital adjustments, earnouts), and does not specify an exact closing date beyond the September 30, 2024 announcement date.

Pangaea Logistics Solutions Ltd. (Nasdaq: PANL), a global maritime logistics and dry bulk shipping company, and M.T. Maritime Management (USA) LLC (MTM) announced a definitive agreement for Pangaea to acquire fifteen handy-size dry bulk vessels, currently owned by Strategic Shipping Inc. (SSI), a privately held company managed by MTM, and merge them into Pangaea's existing twenty-six vessel fleet. The vessels were valued at approximately $295 million, inclusive of approximately $102 million of vessel-related financing agreements, for a total net asset value of $193 million. The deal is in the deep sea foreign transportation of freight sector (SIC 4412). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Pangaea Logistics Solutions Ltd. with the SEC on September 24, 2024, announcing the signing of the agreement. The transaction was expected to close in the fourth quarter of 2024, subject to customary closing conditions and shareholder approval. As part of the deal, seven employees from MTM's dry bulk chartering and operations teams were to join Pangaea, including Dan Schildt as Chief Strategy Officer, and SSI was granted the right to designate two new members to Pangaea's board of directors, Christina Tan (CEO of MTM) and Gary Vogel (former CEO of Eagle Bulk Shipping). On financial advisory, DNB Markets, Inc. served as Pangaea's financial advisor for the transaction. No separate financial advisor to SSI or MTM is named in this press release. On legal advisory, Seward & Kissel LLP acted as legal advisor for the transaction (the release does not specify whether this representation was exclusively for Pangaea or for the transaction as a whole). The deal structure disclosed is an all-stock transaction: Pangaea agreed to issue approximately 19.0 million new common shares to SSI's owners, equal to approximately 29% of Pangaea's outstanding common stock upon completion, representing the relative net asset value of SSI's vessels compared to Pangaea's own estimated net asset value of approximately $478 million (about $10.20 per share). Cash consideration was to be limited to net working capital contributions, if any, at closing, and Pangaea agreed to assume responsibility for all current charter commitments associated with the SSI fleet. What is not disclosed: the press release does not name a financial advisor representing SSI or MTM in the transaction, does not specify the exact number of shares to be issued (noting it would be determined at closing based on relative fair net asset values), and does not disclose a termination fee.

Battalion Oil Corporation (NYSE American: BATL), an independent energy company engaged in onshore oil and natural gas production in the United States, announced on September 19, 2024 that it entered into an amendment to its previously disclosed Agreement and Plan of Merger with Fury Resources, Inc., under which Fury (acting as Parent) agreed to acquire all outstanding shares of Battalion common stock for $7.00 per share in cash. Holders of Battalion's preferred stock, including Luminus Management, LLC, Gen IV Investment Opportunities, LLC, and funds and accounts managed by Oaktree Capital Management, L.P., agreed to contribute their preferred shares to Fury in exchange for new Fury preferred shares. This entry is sourced from Battalion's Exhibit 99.1 press release filed as part of an 8-K on September 19, 2024, announcing an amendment to a merger agreement that had been previously disclosed. The transaction had not yet closed as of this filing; it was expected to close in the fourth quarter of 2024, subject to closing conditions including approval of Battalion's stockholders. Houlihan Lokey Capital, Inc. acted as financial advisor to Battalion, and Jefferies LLC acted as financial advisor to Fury Resources (Buyer/Parent). Mayer Brown LLP acted as legal counsel to Battalion, and K&L Gates LLP acted as legal counsel to Fury Resources. The per-share merger consideration of $7.00 in cash was disclosed, but no aggregate transaction value was stated in this release. Fury confirmed it had received capital commitments to fund the transaction, including $200 million in debt commitments from Fortress Credit Corp. and AI Partners Asset Management Co., Ltd., $188 million in total preferred stock commitments (comprising $173 million from the Rollover Stockholders and $15 million from AI Partners Asset Management Co., Ltd.), and $160 million in equity commitments to acquire new Fury common stock. Post-transaction, Fury was expected to have approximately $100 million in cash net of acquisition consideration and fees. Luminus and Oaktree, who collectively own 61.61% of Battalion common stock, had entered into a voting agreement committing 6,254,652 shares (38% of total voting power) in favor of the merger. Because no aggregate transaction value was disclosed and total shares outstanding were not stated in this release, an implied total equity value cannot be calculated from the source text alone. The release also does not disclose a termination fee or the specific allocation of the preferred stock rollover valuation beyond stating it was based on the redemption value of Battalion's existing preferred stock.

This transaction is a cash acquisition in which Progress Software is acquiring ShareFile from Cloud Software Group. The disclosed value of the transaction is 875,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on September 9, 2024. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Citi is serving as the exclusive financial advisor for Progress, the acquirer, on this transaction, and is identified as the lead advisor in that capacity. On the target side, Jefferies LLC and Barclays Capital Inc. are both serving as financial advisors to Cloud Software Group, the seller of ShareFile, reflecting two financial advisors working together for the target in this transaction. On the legal side, DLA Piper LLP (US) is serving as Progress' legal counsel, the acquirer's legal advisor. Kirkland & Ellis LLP is serving as legal counsel to Cloud Software Group, the target/seller side of the transaction. Beyond confirming that this is a cash acquisition with a disclosed value of 875,000,000 dollars, no further detail on the specific payment structure or any adjustment mechanisms tied to the purchase price is included in the facts available. A number of elements of this deal are not disclosed. No expected closing date is given, and no detail is provided on any potential purchase price adjustments or escrow arrangements tied to the 875,000,000 dollar disclosed value. The facts also do not specify what regulatory approvals, if any, are required to complete the transaction.

This is a take-private/go-private transaction in which AssetMark Financial Holdings, Inc., a company in the fig (financial institutions group) sector, is being acquired by funds affiliated with GTCR. The product group for this record is sponsors-coverage, reflecting the private equity sponsor's role as acquirer. The disclosed transaction value is $2,700,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on September 5, 2024. The deal's current status is pending regulatory review. The financial advisory roster on the sponsor side is substantial. UBS Investment Bank and Barclays are each identified as co-lead financial advisors to GTCR, per the statement that "UBS Investment Bank and Barclays served as co-lead financial advisors to GTCR and are providing debt financing support for the transaction," meaning both firms also have a debt financing role alongside their advisory mandate. Jefferies LLC and BofA Securities also served as financial advisors to GTCR in a non-lead capacity, as described in the sentence "BofA Securities and Jefferies LLC also served as financial advisors." On the target side, Morgan Stanley & Co. LLC served as exclusive financial advisor to AssetMark, acting in the lead role, consistent with language stating "Morgan Stanley & Co. LLC served as exclusive financial advisor to AssetMark." Legal counsel is disclosed on both sides. Davis Polk & Wardwell LLP provided legal counsel to AssetMark (the target), paired with Morgan Stanley's advisory role in the same source sentence. On the acquirer side, Kirkland & Ellis LLP provided legal counsel, and Paul Hastings LLP provided regulatory legal counsel specifically, per the statement "Kirkland & Ellis LLP provided legal counsel and Paul Hastings LLP provided regulatory legal counsel." Beyond the classification as a take-private/go-private transaction with a $2.7 billion disclosed value, no further detail on consideration structure (e.g., per-share price), financing sources beyond the debt financing support noted from UBS and Barclays, or other deal terms is included in the facts provided. Several items are not disclosed in this record: the per-share or other specific consideration terms are not given, no expected closing date is stated beyond the pending-regulatory status, and the facts block does not specify which of the sponsor-side banks beyond UBS and Barclays are providing financing versus advisory services only.

This deal is a cash acquisition classified as an M&A transaction in the transportation-infrastructure sector, involving Frontier Group Holdings, Inc. (ticker ULCC) as target and Verizon as acquirer. The disclosed value of the transaction is $20,000,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 5, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, PJT Partners served as financial advisor to the Strategic Review Committee of Frontier's Board of Directors, while Barclays served as financial advisor to Frontier directly, both without a specified lead designation, per a shared source sentence distinguishing the two Frontier-side mandates. On the acquirer side, Centerview Partners LLC and Morgan Stanley & Co. LLC acted as financial advisors to Verizon, also without a specified lead designation, per the same source sentence. On the legal side, Cravath, Swaine & Moore LLP served as legal advisor to Frontier directly, while Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor to the Strategic Review Committee of Frontier's Board, reflecting two distinct legal mandates on the target side. Debevoise & Plimpton LLP acted as legal counsel to Verizon, the acquirer. Beyond the cash consideration implied by the cash acquisition subtype, with a disclosed deal value of $20,000,000,000, no further detail on per-share pricing or financing sources is provided in the facts block. Several items are not disclosed in the available record. No lead designation is specified for any of the financial advisors named (PJT Partners, Barclays, Centerview Partners, or Morgan Stanley), and no expected closing date or further timeline detail beyond the September 2024 filing date and pending-regulatory status is given.

First Majestic Silver Corp. (NYSE: AG; TSX: AG; FSE: FMV), a Vancouver-based primary silver producer, and Gatos Silver, Inc. (NYSE: GATO; TSX: GATO), which holds a 70% interest in the Los Gatos Joint Venture operating the Cerro Los Gatos underground silver mine in Chihuahua, Mexico, announced on September 5, 2024 that they entered into a definitive merger agreement under which First Majestic will acquire all issued and outstanding common shares of Gatos in an all-stock transaction. This entry is sourced from Gatos Silver's Exhibit 99.1 press release filed as part of an 8-K on September 5, 2024. The release describes a signed definitive merger agreement; it does not state the deal had closed, and shareholder and other customary approvals were still pending as of this release. National Bank Financial acted as exclusive financial advisor to First Majestic, with TD Securities separately providing a fairness opinion to First Majestic's board of directors. BofA Securities acted as exclusive financial advisor to Gatos, with GenCap Mining Advisory Ltd. providing a separate fairness opinion to the Special Committee of the Gatos board of directors. Bennett Jones LLP and Dorsey & Whitney LLP acted as legal advisors to First Majestic. White & Case LLP and McCarthy Tetrault LLP acted as legal advisors to Gatos. Under the terms disclosed, Gatos shareholders will receive 2.550 common shares of First Majestic for each Gatos common share held, implying consideration of US$13.49 per Gatos share based on First Majestic's NYSE closing price on September 4, 2024, and a total equity value for Gatos of approximately US$970 million. The exchange ratio represented a 16% premium based on each company's closing prices and 20-day volume-weighted average prices on the NYSE through September 4, 2024. Following completion, existing Gatos shareholders were expected to own approximately 38% of First Majestic shares on a fully diluted basis. The release does not disclose an expected closing date, a termination fee, or the specific approval thresholds required from Gatos or First Majestic shareholders. No separate enterprise value (inclusive of debt or cash) is provided beyond the stated equity value, and the fee arrangements for National Bank Financial, TD Securities, BofA Securities, and GenCap Mining Advisory are not disclosed.

This is a cash-and-share scheme of arrangement acquisition in the natural-resources sector in which Gran Tierra Energy Inc. (ticker GTE) is acquiring i3 Energy plc. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on August 30, 2024. The deal's current status is pending regulatory review. The financial advisory roster reflects the cross-border, UK-scheme structure of this deal. On the acquirer side, Stifel Nicolaus Europe Limited and Eight Capital both served as Joint Financial Advisers to Gran Tierra, per the source sentences identifying each as "(Joint Financial Adviser to Gran Tierra)." On the target side, i3 Energy was advised by three firms: National Bank Financial Inc. served as Financial Adviser; Tudor, Pickering, Holt & Co. Securities, Canada, ULC served in a lead capacity as Financial Adviser; and Zeus Capital Limited served in a lead capacity as Rule 3 Financial Adviser, Nominated Adviser (Nomad), and Joint Broker to i3 Energy. The Rule 3 designation reflects the UK Takeover Code requirement for an independent financial adviser to provide the target board with formal advice. Legal advisors are disclosed for both sides, reflecting multiple jurisdictions. For Gran Tierra, Ashurst LLP acted as UK legal adviser (with Stikeman Elliott LLP as Canadian legal adviser and Gibson, Dunn & Crutcher LLP as US legal adviser also referenced in the same source sentence, though only Ashurst LLP is captured as a discrete legal advisor entry). For i3 Energy, Burness Paull LLP acted as UK legal adviser (with Norton Rose Fulbright Canada LLP as Canadian legal adviser referenced in the same sentence, though only Burness Paull LLP is captured as a discrete entry). Beyond the classification of this transaction as a cash-and-share scheme of arrangement, no further detail on the specific split between cash and share consideration, exchange ratios, or other terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the specific cash/share consideration mix is not given, and no expected closing date is provided beyond the pending-regulatory status.

This transaction involves Tellurian Inc., a company in the natural resources sector, which is the target of a cash acquisition by Woodside Energy Holdings NA LLC and Woodside Energy Group Ltd. The deal is classified as an M&A transaction, structured as a cash acquisition. The disclosed value of the transaction is not stated in the source document, so the financial size of the deal cannot be confirmed from the available record. The deal is sourced from a DEFM14A filing made with the SEC via EDGAR, published on August 27, 2024. The deal's current status is pending regulatory review, meaning it had not yet closed as of the date of the source filing. On the financial advisory side, only one advisor is identified in the record: Lazard Freres & Co. LLC, which acted as financial advisor to the target, Tellurian, and is noted as the lead advisor on that side. According to the source filing, Lazard rendered an oral opinion to Tellurian's board on July 21, 2024, later confirmed in writing, addressing whether the merger consideration payable to holders of Tellurian common stock (excluding excluded and dissenting shares) was fair from a financial point of view to those stockholders. No financial advisor to the acquirer, Woodside, is named in the facts provided. No legal advisors are identified in the source material for either the target or the acquirer, so counsel on either side of the transaction is not disclosed in this record. Beyond the designation of the transaction as a cash acquisition, no further structural detail is provided in the facts block, such as the per-share price, the specific consideration mix, or any contingent payment terms. Several material facts about this deal remain undisclosed in the available record. The transaction's dollar value is not stated. No legal advisors are named for either side. No expected closing date is given, and no additional detail on deal structure beyond "cash acquisition" and "pending regulatory" status is available. Readers should treat these as open gaps rather than assume any particular outcome or valuation.

This deal is an all-stock merger of equals classified as an M&A transaction, involving a target identified in the source material as Arch and an acquirer identified as CONSOL. The disclosed value of the transaction is $5,200,000,000. No sector classification is specified in the facts block, and the formal target/acquirer entity names are not separately broken out beyond these references in the source sentences. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on August 21, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners served as exclusive financial advisor to Arch (the target side), in a lead capacity. Moelis & Company LLC served as exclusive financial advisor to CONSOL (the acquirer side), also in a lead capacity. On the legal side, two firms represented Arch (the target): Latham & Watkins LLP and Gibson, Dunn & Crutcher LLP, both named as legal counsel in the same source sentence as Perella Weinberg Partners' role. Two firms represented CONSOL (the acquirer): Wachtell, Lipton, Rosen & Katz and McGuireWoods LLP, both named as legal counsel in the same source sentence as Moelis & Company's role. Beyond the all-stock consideration structure implied by the merger-of-equals subtype, with a disclosed deal value of $5,200,000,000, no further detail on the specific exchange ratio or governance terms typical of a merger of equals is provided in the facts block. Several items are not disclosed in the available record. The precise corporate names behind 'Arch' and 'CONSOL' as referenced in the source sentences are not confirmed by a separate target/acquirer field, no sector classification is given, and no expected closing date or further timeline detail beyond the August 2024 filing date and pending-regulatory status is provided.

This transaction is a corporate spinoff in which Seaport Entertainment Group Inc. (ticker SEG), a real-estate sector company, is being separated from Howard Hughes Holdings Inc. (ticker HHH), also a real-estate sector company, which serves as the issuer in this transaction. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on August 1, 2024. The transaction's current status is pending regulatory review. Two financial advisors are identified, reflecting separate mandates for the parent company and a special committee. Wells Fargo served as financial advisor to Howard Hughes in a lead capacity. Separately, J.P. Morgan Securities LLC served as financial advisor to the special committee of the company's board of directors, also in a lead role, indicating a distinct governance process overseeing the spinoff on behalf of minority or independent interests. Legal counsel mirrors this structure. Latham and Watkins LLP served as legal advisor to Howard Hughes. Richards, Layton & Finger, P.A. served as legal advisor to the special committee of the company's board of directors. Beyond confirming this is structured as a corporate spinoff of Seaport Entertainment Group from Howard Hughes Holdings, the facts block provides no further detail on the distribution ratio, the tax treatment of the spinoff, or any capitalization or debt allocation between the two resulting entities. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing or distribution date is given. No detail on the spinoff's distribution ratio or capital structure allocation between Howard Hughes and Seaport Entertainment Group is provided.

CBIZ, Inc. announced on July 31, 2024 that it had entered into a definitive agreement to acquire the non-attest business of Marcum LLP in a cash-and-stock transaction valued at approximately $2.3 billion, which the release states would make CBIZ the seventh-largest accounting services provider in the U.S. with combined annual revenue of approximately $2.8 billion. Concurrently with closing, Marcum's attest business is to be acquired separately by Mayer Hoffman McCann P.C., a firm with which CBIZ has had a 25-year administrative service agreement. This record is sourced from an Exhibit 99.1 press release furnished with CBIZ's Form 8-K filed July 31, 2024. At announcement, the deal was a signed definitive agreement pending CBIZ stockholder approval, Marcum partner approval, and other customary closing conditions, with closing expected in the fourth quarter of 2024. Perella Weinberg Partners served as financial advisor to CBIZ, the acquirer, per the release's statement "Perella Weinberg Partners is serving as CBIZ's financial advisor and BakerHostetler is serving as CBIZ's legal advisor for the transaction." Deutsche Bank served as financial advisor to Marcum, the target, per "Deutsche Bank is serving as Marcum's financial advisor and Dechert LLP is serving as Marcum's legal advisor for the transaction." No lead designation is specified for either side since each company retained a single financial advisor. On the legal side, BakerHostetler represented CBIZ and Dechert LLP represented Marcum. Under the terms, approximately half of the consideration was expected to be paid in cash and the remainder in shares of CBIZ common stock; CBIZ CEO Jerry Grisko called it "the most significant transaction in CBIZ's history," projecting the combined company would have more than 10,000 team members and over 135,000 clients, and that the deal would be accretive to adjusted earnings per share by approximately 10% in 2025. Not disclosed in the sourced document is the precise dollar split between cash and stock consideration (only the approximate 50/50 split is given), the financing sources for the cash portion, or whether any regulatory antitrust approval (beyond stockholder and partner approvals) was required to close.

Enstar Group Limited, a Bermuda-based global insurance and reinsurance legacy-acquisition specialist, announced on July 29, 2024 that it had entered into a definitive merger agreement to be acquired by investment firm Sixth Street, with Liberty Strategic Capital, J.C. Flowers & Co. LLC, and other institutional investors participating as co-investors. Enstar shareholders were to receive $338.00 in cash per ordinary share, representing a total equity value of $5.1 billion for the company, which has completed more than 117 legacy insurance acquisitions and portfolios since its 2001 formation. This extraction is sourced from Enstar's 8-K exhibit (Exhibit 99.3) filed with the SEC on July 29, 2024, carrying the press release announcing the signed merger agreement, issued alongside Enstar's separate second-quarter earnings release the same day. The deal remained subject to shareholder and regulatory approval at the time of this filing, with a 35-day go-shop period running through September 2, 2024 permitting Enstar's board to solicit superior proposals. Barclays PLC acted as one of three financial advisors to Sixth Street, the acquirer, alongside Ardea Partners LP and J.P. Morgan Securities LLC; none of the three was designated lead or exclusive advisor in the release. Goldman Sachs & Co. LLC acted as financial advisor to Enstar, the target. On the legal side, Paul, Weiss, Rifkind, Wharton & Garrison LLP and Hogan Lovells US LLP served as legal advisors to Enstar, while Simpson Thacher & Bartlett LLP, Debevoise & Plimpton LLP and Cleary Gottlieb Steen & Hamilton LLP served as legal advisors to Sixth Street. The transaction was fully financed with equity provided by Sixth Street and its co-investors, with Enstar separately agreeing to return approximately $500 million from its own balance sheet to shareholders as part of the total $338.00 per share consideration. The $338.00 price represented a premium of approximately 8.5% to Enstar's 90-day volume-weighted average price and 6.9% to its 60-day VWAP as of the last trading day before announcement. Enstar's board unanimously approved and recommended the deal, and the company was expected to continue operating under the Enstar name post-closing, targeting a mid-2025 close. The press release does not disclose the specific advisory fees paid to Barclays, Ardea Partners, J.P. Morgan, or Goldman Sachs, nor does it specify the individual equity contributions of Sixth Street versus its co-investors (Liberty Strategic Capital, J.C. Flowers & Co., and other institutional investors) within the $5.1 billion transaction.

This record concerns Allegro MicroSystems, Inc. (ticker ALGM), a technology-sector company, as the issuer in a follow-on common stock offering, with proceeds used for a share repurchase from a major shareholder. The transaction falls under the equity capital markets (ecm) product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published July 26, 2024. The deal's status is pending regulatory, indicating the offering had not yet fully concluded as of that filing. Two financial advisors are disclosed, both acting as underwriter representatives for the issuer and both designated lead. Barclays Capital Inc. and Morgan Stanley & Co. LLC are named as representatives of the several underwriters named in a schedule attached to the underlying agreement, per the source sentence: "Barclays Capital Inc. Morgan Stanley & Co. LLC, As Representatives of the several Underwriters named in Schedule I attached hereto." This indicates a broader underwriting syndicate existed beyond these two named representatives, though the other syndicate members are not individually identified in the facts block. No legal advisors are identified in the facts block for this transaction. Beyond describing this as a follow-on common stock offering whose proceeds were used for a share repurchase from a major shareholder, the facts block does not specify the offering size, the share repurchase price, or the identity of the major shareholder involved. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No legal advisors are named for the issuer. The facts block does not identify the other underwriters referenced in "Schedule I" beyond Barclays Capital Inc. and Morgan Stanley & Co. LLC, and no expected closing date is given.

This deal is a take-private, sponsor-to-sponsor buyout classified under the sponsors-coverage product group in the tech sector, involving Instructure Holdings, Inc. as target and investment funds managed by KKR as acquirer. The disclosed value of the transaction is $4,800,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on July 25, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, J.P. Morgan Securities LLC acted as lead financial advisor to Instructure, the target, with Macquarie Capital also serving as a (non-lead) financial advisor to Instructure in the same engagement. On the acquirer side, three firms acted as financial advisors to KKR: Morgan Stanley & Co. LLC, Moelis & Company LLC, and UBS Investment Bank, none of which is given a specific lead designation among the three in the facts block. On the legal side, Kirkland & Ellis LLP served as legal advisor to Instructure, the target, while Simpson Thacher & Bartlett LLP served as legal advisor to KKR, the acquirer. Beyond the take-private, sponsor-to-sponsor structure with a disclosed deal value of $4,800,000,000, no further detail on financing sources, equity contribution, or other structural terms is provided in the facts block. Several items are not disclosed in the available record. No lead designation is specified among KKR's three financial advisors (Morgan Stanley, Moelis, UBS Investment Bank), and no expected closing date or further timeline detail beyond the July 2024 filing date and pending-regulatory status is given.

This deal is a joint venture acquisition classified as an M&A transaction, involving Metronet as target, with T-Mobile and KKR forming the joint venture as acquirer/sponsor. The disclosed value of the transaction is $4,900,000,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on July 24, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Bank Street Group LLC served as financial advisor to Metronet, the target, alongside TD Securities per the same source sentence (though only Bank Street Group is broken out as a structured entry), with no lead designation specified. Citigroup Global Markets Inc. served as T-Mobile's financial advisor, in a lead capacity. For the sponsor side, Barclays and Morgan Stanley & Co. LLC served as lead financial advisors to KKR, with Goldman Sachs, Mizuho, and MUFG also serving as (non-lead) financial advisors to KKR per the source sentence, though only Barclays and Morgan Stanley are broken out as structured entries. Separately, Lazard served as financial advisor to Oak Hill Capital, a role distinct from the other named parties. On the legal side, Wachtell, Lipton, Rosen & Katz served as T-Mobile's legal counsel alongside Davis Wright Tremaine (named in the same source sentence). Simpson Thacher served as KKR's (sponsor) legal advisor. Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal counsel to Metronet, the target, alongside Polsinelli named in the same source sentence. Beyond the joint venture acquisition structure with a disclosed deal value of $4,900,000,000, no further detail on the ownership split within the joint venture or other structural terms is provided in the facts block. Several items are not disclosed in the available record. While the source sentences reference additional advisors (TD Securities for Metronet; Goldman Sachs, Mizuho, and MUFG for KKR; Davis Wright Tremaine and Polsinelli on the legal side), these are not broken out as separate structured advisor entries beyond those named above. No expected closing date or further timeline detail beyond the July 2024 filing date and pending-regulatory status is given.

This transaction is a cash-and-stock acquisition in which Archrock, Inc. (ticker AROC), an energy-power sector company, is acquiring Total Operations and Production Services, LLC (TOPS). The deal falls under the M&A product group and carries a disclosed value of $983,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on July 22, 2024. On the financial advisory side, Evercore is acting as exclusive financial advisor to Archrock, the acquirer, in a lead role. Jefferies LLC is acting as exclusive financial advisor to TOPS, the target, also in a lead capacity. Legal counsel follows the same structural split. Latham & Watkins LLP is acting as legal advisor to Archrock, the acquirer. Vinson & Elkins LLP is acting as legal advisor to TOPS, the target. The facts block confirms this is a cash-and-stock acquisition with a disclosed value of $983,000,000, but does not specify the precise mix or ratio between cash and stock consideration, nor the exchange ratio for any stock component. Several material facts remain undisclosed. No expected closing date is given. The specific cash and stock consideration split is not disclosed beyond the general subtype characterization, and no further detail on financing sources or post-closing governance is provided.

Astra Space, Inc. (Nasdaq: ASTR), the satellite launch and propulsion systems company, completed a take-private transaction in which Apogee Parent, Inc., an entity formed by Astra co-founders and executives Chris Kemp and Dr. Adam London, acquired all outstanding Class A common stock not already owned by it for $0.50 per share in cash. The deal is a going-private merger in the aerospace and space-transportation sector, falling under SIC code 4700 (transportation services). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Astra Space, Inc. with the SEC on July 18, 2024, announcing the successful closing of the transaction. The merger agreement underlying the deal had been previously announced on March 7, 2024. As of the closing, Astra's Class A shares ceased trading and the company intended to deregister with the SEC and delist from Nasdaq, having previously received Nasdaq deficiency notices for non-compliance with minimum bid price and stockholders' equity listing requirements. On the financial advisory side, Houlihan Lokey Capital, Inc. served as financial advisor to the Special Committee of Astra's Board of Directors, which was formed to evaluate the going-private proposal from insiders. Moelis & Company served as financial advisor to Parent (Apogee Parent, Inc.), the acquiring entity controlled by Kemp and London. On the legal side, Freshfields Bruckhaus Deringer US LLP served as the Special Committee's legal counsel, Cozen O'Connor, P.C. served as legal counsel to Astra itself, and Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Parent. The disclosed terms are straightforward: an all-cash take-private at $0.50 per share, with Parent acquiring all Class A shares not already owned by the Kemp/London group. No aggregate dollar value for the transaction was stated in the press release (the fixed per-share price was disclosed, but not total shares outstanding or an aggregate deal size), so no aggregate value has been recorded here. What is not disclosed in this filing: the aggregate transaction value in dollars, the total number of shares being acquired, and any termination fee or financing details. The press release confirms only that the deal had closed as of July 18, 2024, with final SEC deregistration filings still to be made.

Energy Transfer LP (NYSE: ET) and Sunoco LP (NYSE: SUN), both Dallas-based energy infrastructure and fuel distribution master limited partnerships under common control (Energy Transfer owns the general partner interest, incentive distribution rights, and approximately 21% of Sunoco's outstanding common units), announced on July 16, 2024 the formation of a joint venture combining their respective crude oil and produced water gathering assets in the Permian Basin. Energy Transfer will serve as operator of the joint venture, holding a 67.5% interest, with Sunoco holding the remaining 32.5% interest, after each party contributes its respective Permian crude oil and produced water gathering assets and operations. This entry is sourced from Sunoco's Exhibit 99.1 press release filed as part of an 8-K on July 18, 2024, describing a joint venture formation with an effective date of July 1, 2024. Given the common-control relationship between the two partnerships, the transaction was structured with separate conflicts/special committee review on each side. Intrepid Partners, LLC served as financial advisor to Energy Transfer's conflicts committee, while Guggenheim Securities, LLC served as financial advisor to Sunoco's special committee. Potter Anderson & Corroon LLP acted as Delaware counsel for Energy Transfer's conflicts committee, and Richards, Layton & Finger, P.A. acted as Delaware counsel for Sunoco's special committee. Vinson & Elkins LLP and Akin Gump Strauss Hauer & Feld LLP also acted as legal counsel to the partnerships on the transaction, though the release does not specify which firm represented which partnership in that broader capacity. The joint venture will operate more than 5,000 miles of crude oil and water gathering pipelines with crude oil storage capacity in excess of 11 million barrels. Energy Transfer's long-haul crude pipeline network transporting crude oil out of the Permian Basin to Nederland, Houston, and Cushing is explicitly excluded from the joint venture. The companies state the transaction is expected to be immediately accretive to distributable cash flow per limited partner unit for both Energy Transfer and Sunoco. The release does not disclose any dollar valuation for the contributed assets, the joint venture as a whole, or either partner's contributed interest. No cash consideration, financing terms, or termination provisions are disclosed. Because this is a related-party asset combination rather than an arm's-length acquisition, no aggregate purchase price or premium analysis applies.

This record covers the formation of a joint venture, classified under the M&A product group. The target in this record is listed as unknown, and the parties involved based on the source language are Energy Transfer and Sunoco, through their respective conflicts committee and special committee. The disclosed value is not stated in the source document(s), and the sector classification is not specified in the facts block. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on July 18, 2024. The deal's current status is pending regulatory review. Two financial advisors are identified, each serving a committee in a lead capacity. Intrepid Partners, LLC served as lead financial advisor to Energy Transfer's conflicts committee, and Guggenheim Securities, LLC served as lead financial advisor to Sunoco's special committee, per the source sentence: "Intrepid Partners, LLC served as financial advisor to Energy Transfer's conflicts committee, while Guggenheim Securities, LLC served as financial advisor to Sunoco's special committee." Several legal advisors are identified, aligned to the two committees and the partnerships generally. Potter Anderson & Corroon LLP acted as Delaware counsel for Energy Transfer's conflicts committee, and Richards, Layton & Finger, P.A. acted as Delaware counsel for Sunoco's special committee, per the source sentence "Potter Anderson & Corroon LLP acted as Delaware counsel for Energy Transfer's conflicts committee, and Richards, Layton & Finger, P.A. acted as Delaware counsel for Sunoco's special committee." Separately, Vinson & Elkins LLP and Akin Gump Strauss Hauer & Feld LLP also acted as legal counsel to the partnerships on the transaction, per the sentence "Vinson & Elkins LLP and Akin Gump Strauss Hauer & Feld LLP also acted as legal counsel to the partnerships on the transaction." Beyond the classification of this matter as a joint venture formation involving Energy Transfer and Sunoco's respective committees, no further detail on the joint venture's structure, ownership split, or contribution terms is included in the facts provided. Several items are not disclosed in this record: the identity of the specific target entity is listed as unknown, the transaction value is not stated, the sector is not specified, the joint venture's ownership and contribution structure is not detailed, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a take-private cash acquisition in which Envestnet, Inc., a company in the business-services sector, is the target being acquired by Bain Capital. The deal is classified under the M&A product group, with a disclosed value of $4,500,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 11, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, four firms, RBC Capital Markets, BMO Capital Markets, Barclays, and Goldman, Sachs & Co. LLC, are described as providing both committed debt financing for the transaction and financial advisory services to Bain Capital, the acquirer, with none of them designated as lead among that group. Separately, J.P. Morgan Securities LLC is named specifically as lead financial advisor to Bain Capital. On the target side, Morgan Stanley & Co. LLC acted as exclusive financial advisor to Envestnet and is designated as lead advisor in that role. Legal counsel was also disclosed for both parties. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal counsel to Envestnet, the target. Ropes & Gray LLP acted as legal counsel to Bain Capital, the acquirer. Beyond the cash consideration implied by the "cash acquisition" subtype and the role of RBC Capital Markets, BMO Capital Markets, Barclays, and Goldman Sachs in providing committed debt financing, the facts block does not disclose the specific amount of debt financing committed or the per-share purchase price. Several facts are not disclosed in the source material. The facts block does not specify the amount of debt financing committed by the four financing banks, nor does it give a per-share price for the cash consideration. No expected closing date is provided.

This deal is a cash tender offer classified as an M&A transaction in the healthcare sector, involving Morphic Holding, Inc. as target and Eli Lilly and Company as acquirer. The disclosed value of the transaction is $3,200,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on July 8, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Centerview Partners LLC acted as exclusive financial advisor to Morphic, the target, in a lead capacity. Evercore Group L.L.C. also provided advice to Morphic, in a non-lead capacity, per a separate source sentence noting its additional advisory role. Citi acted as exclusive financial advisor to Lilly, the acquirer, in a lead capacity. On the legal side, Fenwick & West LLP acted as legal counsel, identified in the facts block under the target designation (Morphic), while Kirkland & Ellis LLP acted as legal counsel to Lilly, the acquirer. Beyond the cash consideration implied by the cash tender offer subtype, with a disclosed deal value of $3,200,000,000, no further detail on the specific per-share tender price or minimum tender condition is provided in the facts block. Several items are not disclosed in the available record. No further structural detail beyond the cash tender offer classification and disclosed value is given, and no expected closing date or further timeline detail beyond the July 2024 filing date and pending-regulatory status is provided.

This record describes an all-stock merger of equals, falling under the M&A product group. While the target entity is listed as unknown in this record's identifying information, the source sentences reference Cedar Fair and "Former Six Flags" as the two parties to the transaction. The disclosed value of the transaction is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published July 1, 2024. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Perella Weinberg Partners served as exclusive financial advisor to Cedar Fair (labeled as the target side in this record), with the source sentence noting that Weil, Gotshal & Manges LLP and Squire Patton Boggs (US) LLP served as legal counsel to Cedar Fair. On the other side, Goldman Sachs & Co. LLC served as exclusive financial advisor to Former Six Flags (labeled as the acquirer side), with Kirkland & Ellis LLP serving as Former Six Flags's legal counsel, per the corresponding source sentence. Legal advisors are disclosed for both sides. Both Squire Patton Boggs (US) LLP and Weil, Gotshal & Manges LLP served as legal counsel to Cedar Fair, reflecting two law firms retained on that side. Kirkland & Ellis LLP served as legal counsel to Former Six Flags. Beyond classifying the transaction as an all-stock merger of equals, the facts block does not specify the exchange ratio, pro forma ownership percentages, or governance terms typically associated with a merger-of-equals structure. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not clarify the respective roles of Cedar Fair's two legal advisors, Weil, Gotshal & Manges LLP and Squire Patton Boggs (US) LLP, relative to one another.

This deal is a tack-on senior secured notes offering classified under debt capital markets (DCM) in the consumer-retail sector, involving B&G Foods, Inc. (ticker BGS) as issuer. The disclosed value of the transaction is $250,000,000. The transaction is sourced from two 8-K filings with the SEC, both filed via SEC EDGAR: one published on June 28, 2024 and a second published on July 15, 2024. The deal's current status is pending regulatory approval. No financial advisors were extracted for this deal in the facts block. This means the facts available do not identify any investment bank, underwriter, or financial advisory firm working on behalf of B&G Foods in connection with this notes offering. Similarly, no legal advisors were identified in the facts block for this transaction. Beyond the classification of this transaction as a tack-on senior secured notes offering with a disclosed value of $250,000,000, no further detail on the notes' coupon, maturity, or the terms of the original notes to which this is a tack-on is provided in the facts block. This is a case where the underlying record is notably thin on advisory detail. No financial advisors and no legal advisors are identified anywhere in the facts block, despite two separate 8-K filings being cited as sources. No expected closing date or further timeline detail beyond the June and July 2024 filing dates and pending-regulatory status is given, and the specific notes terms (coupon, maturity) are not disclosed.

This deal is a stock-and-cash election merger in which SilverBow Resources, Inc., a company in the natural-resources sector, is the target being acquired by Crescent Energy Company. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: a DEFM14A filed with SEC EDGAR and published on June 28, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, four firms are named, two per side, without any lead designations specified. On the acquirer side, Intrepid Partners, LLC served as financial advisor to the Crescent Special Committee, and Jefferies (Jefferies LLC) served as financial advisor to Crescent more broadly. On the target side, Evercore (Evercore Group L.L.C.) and BofA Securities, Inc. both served as financial advisors to SilverBow. No legal advisors were identified in the facts block for this transaction, for either SilverBow or Crescent Energy. Beyond the "stock-and-cash election" characterization of the merger consideration, meaning target shareholders apparently had some form of election between stock and cash consideration, the facts block does not specify the exchange ratio, the cash amount per share, or the mechanics of the election. Several material facts are not disclosed in the source material. The overall deal value is not stated. No legal advisors are identified for either party. The facts block also does not specify the terms of the stock-and-cash election, such as the per-share cash amount or exchange ratio, nor does it give an expected closing date.

This transaction involves BP plc's sale of its 50 percent stake in the BP Bunge Bioenergia joint venture, with Bunge as the counterparty on the other side of the joint venture. The deal is structured as a sale of a joint-venture stake, falls within the energy and power sector, and carries a disclosed value of 800,000,000 dollars. The transaction is sourced from an SEC EDGAR filing, specifically a Form 8-K published on June 24, 2024. As of the information provided, the deal's status is pending regulatory approval. On the financial advisory side, J.P. Morgan is acting as the exclusive financial advisor to Bunge and is identified as the lead advisor on the target side of the transaction. The source language states that J.P. Morgan is acting as exclusive financial advisor to Bunge, which also specifies the legal counsel involved. No financial advisor to BP, the acquirer of the stake, is identified in the facts provided. On the legal side, Tauil & Chequer Advogados, associated with Mayer Brown, is serving as legal counsel to Bunge (the target side of the transaction). No legal advisor is identified for BP in the material provided. Beyond the identification of BP as acquirer of the 50 percent joint-venture stake and Bunge as the counterparty, no further detail on deal structure, such as the form of consideration or any financing arrangements, is included in the facts available. Several elements of this deal are not disclosed in the available material. No expected closing date is given, no outside legal or financial advisor to BP is identified, and no additional structural or financing terms beyond the headline value of 800,000,000 dollars are specified. The current status is pending regulatory approval, with no further detail on the specific regulatory approvals required or an anticipated timeline to completion.

This deal is described as a minority/majority equity investment representing the closing of a previously announced transaction, in which Scholastic Corp (ticker SCHL), a company in the media sector, is the acquirer of 9 Story Media Group, the target. The transaction is classified under the M&A product group, with a disclosed deal value of $182,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on June 21, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, CDX Advisors acted as exclusive financial advisor to Scholastic, the acquirer, and is designated as lead advisor. Barclays acted as exclusive financial advisor to 9 Story, the target, and is likewise designated as lead advisor. Legal counsel on this deal was disclosed extensively, and notably references a seller entity called "ZMC" alongside 9 Story. On the target side, Goodmans LLP served as 9 Story's legal counsel while Sidley Austin LLP served as ZMC's legal counsel. On the acquirer side, three firms, Baker & McKenzie LLP, Dentons Canada LLP, and Mason Hayes & Curran LLP, served as Scholastic's legal counsel in the transaction. Beyond its characterization as a minority/majority equity investment and the closing of a previously announced deal, the facts block does not disclose the specific percentage stake being acquired or other structural terms. Several facts are not disclosed in the source material. The facts block does not specify the exact equity percentage being acquired by Scholastic, despite the "minority/majority" framing, nor does it clarify the relationship between 9 Story and the "ZMC" entity referenced in the legal advisor disclosures. No expected closing date beyond the fact that this filing reflects the closing itself is given, and no further detail on deal mechanics is disclosed.

ANI Pharmaceuticals, Inc., a Nasdaq-listed specialty pharmaceutical company, signed a definitive agreement to acquire Alimera Sciences, Inc., a global ophthalmology-focused pharmaceutical company, to expand ANI's rare disease business. The deal was structured as $5.50 per share in cash at closing plus a non-tradable contingent value right (CVR) worth up to $0.50 per share tied to 2026-2027 net revenue targets for Alimera's commercial products ILUVIEN and YUTIQ. The deal is sourced from a joint press release filed as an 8-K exhibit by ANI Pharmaceuticals on June 21, 2024, announcing the signed agreement, with a closing-confirmation 8-K filed later in September 2024 after the deal completed. Perella Weinberg Partners served as a financial advisor to Alimera, the target, in a non-lead capacity alongside lead advisor Centerview Partners LLC. The release states: "Centerview Partners LLC is acting as lead financial advisor to Alimera, with Perella Weinberg Partners also acting as a financial advisor to Alimera." On the acquirer side, Raymond James & Associates, Inc. is also named as a financial advisor to ANI, though the sentence structure ("is also acting as financial advisor") suggests an additional advisor to ANI's primary deal team not fully captured in the excerpt. Hughes Hubbard & Reed LLP served as legal advisor to ANI, and DLA Piper served as legal advisor to Alimera. The transaction valued Alimera at approximately $381 million in upfront consideration, consistent with the $5.50-per-share cash price before the CVR. The deal was expected to close late in the third quarter of 2024, subject to customary closing conditions including regulatory approvals and Alimera shareholder approval; it subsequently closed, per the separately filed closing 8-K dated September 16, 2024. Not disclosed in the reviewed excerpt: the specific net revenue targets that would trigger CVR payment, the identity and role of ANI's lead financial advisor (if distinct from Raymond James), and the maximum aggregate CVR payout value across all Alimera shares.

This deal is a stock-for-stock arrangement classified as an M&A transaction, involving Strong Global Entertainment Inc. and Fundamental Global Inc. The disclosed value of the transaction is not stated in the source document, and no sector classification is specified in the facts block. The transaction is sourced from an S-4 filing with the SEC, filed via SEC EDGAR and published on June 20, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Intrinsic LLC is identified as financial advisor to the target, Strong Global Entertainment (referred to as SGE in the source material), in a lead capacity. The source sentence references a consent letter from Intrinsic LLC permitting reference to its opinion letter under the heading describing the opinion of SGE's financial advisor in the joint proxy statement/prospectus. No financial advisor is identified for Fundamental Global Inc. in the facts provided. No legal advisors were extracted for this deal in the facts block, so it is not possible to state which law firms, if any, are representing either party. Beyond the stock-for-stock consideration structure noted in the deal subtype, no further detail on the specific exchange ratio or other structural terms is provided in the facts block. Several material facts are not disclosed in the available record. The overall transaction value is not stated in the source document, no sector classification is given, no financial advisor is identified for Fundamental Global Inc., and no legal advisors for either party are identified. No expected closing date or further timeline detail beyond the June 2024 filing date and pending-regulatory status is given.

This deal is a cash divestiture involving Northwestel and Sixty North Unity, with Bell (BCE) referenced as the seller of the relevant business in the advisor disclosures. No sector classification or explicit target/acquirer labeling was provided in the facts block. The transaction is classified under the M&A product group, with a disclosed value of $1,000,000,000 (CAD). The facts block is sourced from a single SEC filing: a 6-K filed with SEC EDGAR and published on June 12, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, TD Securities is acting as financial advisor to Sixty North Unity on the transaction and is designated as lead advisor in that role. RBC Capital Markets is acting as financial advisor to Bell and is also designated as lead advisor. No legal advisors were identified in the facts block for this transaction, for either Sixty North Unity or Bell. Beyond the cash consideration implied by the "cash divestiture" subtype and the disclosed CAD $1,000,000,000 value, the facts block does not provide further detail on the specific assets being divested or other structural terms. Several material facts are not disclosed in the source material. No legal advisors are named for either party. The facts block does not specify a sector classification, nor does it clearly delineate which party is selling Northwestel and which is the acquiring entity beyond naming Sixty North Unity and Bell as the two advised parties. No expected closing date is given.

Cognizant announced on June 10, 2024 that it had signed a definitive agreement to acquire Belcan, LLC, a portfolio company of AE Industrial Partners and a leading global supplier of Engineering Research & Development (ER&D) services, at a purchase price of approximately $1.3 billion in cash and stock. The release describes the deal as establishing a leadership position for Cognizant in the aerospace and defense engineering services market, expanding access to a roughly $190 billion ER&D services market. This record is sourced from an Exhibit 99.1 press release furnished with Cognizant's Form 8-K filed June 10, 2024. At announcement, the transaction was a signed definitive agreement pending regulatory approvals and other closing conditions, with closing anticipated in the quarter ending September 30, 2024. Perella Weinberg Partners served as financial advisor to Cognizant, the acquirer, per the release's statement "Perella Weinberg Partners served as financial advisor and Arnold & Porter served as legal advisor to Cognizant." Jefferies and Solomon Partners both served as financial advisors to Belcan, the target, per "Jefferies and Solomon Partners acted as financial advisors and Kirkland & Ellis served as legal advisor to Belcan." No lead designation is specified among any of the named financial advisors. On the legal side, Arnold & Porter represented Cognizant and Kirkland & Ellis represented Belcan. The total purchase price of approximately $1.29 billion comprised $1.19 billion in cash consideration and a fixed 1.47 million Cognizant shares, valued at $97 million based on Cognizant's closing share price on June 7, 2024; Cognizant said it expects the acquisition to deliver over $100 million in annual revenue synergies within three years and to be accretive to 2026 earnings per share, while remaining broadly neutral to EPS in 2025. Belcan CEO Lance Kwasniewski was expected to continue leading Belcan as an operating unit of Cognizant. Not disclosed in the sourced document is any revenue or EBITDA multiple implied by the $1.29 billion price, the specific regulatory approvals required to close, or how the cash portion of the purchase price would be funded beyond the general description of cash on hand and debt.

This deal is a cash-and-stock merger classified as an M&A transaction in the natural-resources sector, involving Diamond Offshore Drilling, Inc. as target and Noble Corp plc (ticker NE) as acquirer. The disclosed value of the transaction is $600,000,000. The transaction is sourced from two SEC filings via SEC EDGAR: a Form 425 published on June 10, 2024, and an 8-K also published on June 10, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Guggenheim Securities, LLC and TPH&Co. (the energy business of Perella Weinberg Partners) acted as lead financial advisors to Diamond, the target, per the same source sentence naming both firms jointly. On the acquirer side, Morgan Stanley & Co. LLC acted as lead financial advisor to Noble and also provided committed financing, while Wells Fargo Securities and SB1 Markets also advised Noble in a non-lead capacity, per a separate source sentence. On the legal side, Kirkland & Ellis LLP acted as legal advisor to Diamond, the target, while Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor to Noble, the acquirer. Beyond the cash-and-stock merger consideration structure, with a disclosed deal value of $600,000,000, the facts block also notes that Morgan Stanley provided committed financing to Noble in connection with the transaction, though no further detail on the specific cash/stock split or financing terms is provided. Several items are not disclosed in the available record. No further detail on the precise mix between cash and stock consideration is given beyond the general subtype classification, and no expected closing date or further timeline detail beyond the June 2024 filing dates and pending-regulatory status is provided.

This deal is a cash-and-stock acquisition of a controlling stake, involving Beat Capital Partners Limited and Ambac Financial Group, Inc., with Bain Capital also named in the legal advisor disclosures as an affiliated party on the Beat side. The facts block does not explicitly label which entity is the target and which is the acquirer, nor does it provide a sector classification. The transaction is classified under the M&A product group, with a disclosed value of $282,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on June 5, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, UBS Investment Bank served as Ambac's financial advisor, labeled in the facts block as representing the acquirer side, with no lead designation specified. Evercore served as Beat's financial advisor, labeled as representing the target side, also without a lead designation specified. Legal counsel was also disclosed for both sides. Debevoise & Plimpton LLP served as legal counsel to Ambac, the acquirer side. RPC served as legal counsel to Beat and Bain Capital, the target side. Beyond the cash-and-stock characterization of the consideration for the controlling stake and the disclosed $282,000,000 value, the facts block does not specify the split between cash and stock or the percentage of the controlling stake being acquired. Several facts are not disclosed in the source material. The facts block does not clearly state which party, Ambac or Beat, is the target versus the acquirer in conventional M&A terms, nor does it specify the exact cash/stock split of the consideration or the percentage ownership stake involved. No expected closing date is given, and no sector classification is provided.

BD (Becton, Dickinson and Company) and Edwards Lifesciences announced on June 3, 2024 a definitive agreement under which BD will acquire Edwards' Critical Care product group, a global leader in advanced hemodynamic and patient monitoring solutions, for $4.2 billion in cash. Critical Care, which invented the hemodynamic monitoring category and includes the Swan-Ganz pulmonary artery catheter, has approximately 4,500 employees based mostly in Irvine, California, and generated more than $900 million in revenue in 2023. This record is sourced from an Exhibit 99.1 news release furnished with Becton Dickinson's Form 8-K filed June 3, 2024. At announcement, the transaction was a signed definitive agreement subject to customary regulatory reviews and closing conditions, with closing expected before the end of the 2024 calendar year. Perella Weinberg Partners and Citi both acted as financial advisers to BD, the acquirer, per the release's statement "Advisers Perella Weinberg Partners and Citi are acting as financial advisers, and Ropes & Gray, LLP is providing legal counsel to BD." No financial adviser to Edwards Lifesciences is named in this release, and no lead designation is given between Perella Weinberg and Citi. On the legal side, Ropes & Gray, LLP represented BD; no legal adviser for Edwards Lifesciences is disclosed in this release. BD said it expects to fund the all-cash transaction with approximately $1 billion of cash on hand and $3.2 billion of new debt, and that the deal is expected to be immediately accretive to BD's revenue growth, adjusted gross and operating margins, and adjusted earnings per share; Critical Care will operate as a separate business unit within BD's Medical segment, based in Irvine and led by Katie Szyman, reporting to BD Medical segment president Mike Garrison. Not disclosed in the sourced document is any EBITDA or revenue multiple implied by the $4.2 billion price, Edwards Lifesciences' financial or legal advisers on the sale, or the specific regulatory approvals required to close.

This deal involves GTCR acquiring Surmodics Inc, a healthcare-sector company, in a cash acquisition structured as a take-private by a private equity sponsor. The transaction is classified under the M&A product group and carries a disclosed value of $627,000,000. The deal remains in pending regulatory status. The facts underlying this summary come from an SEC EDGAR Form 8-K filed and published on May 29, 2024. No other source documents are referenced in the available record. On the advisory side, Goldman Sachs & Co. LLC served as financial advisor to GTCR, the acquirer, in a lead capacity, working alongside Kirkland & Ellis LLP and Cleary Gottlieb Steen & Hamilton LLP, which together provided legal counsel to GTCR. For Surmodics, the target, Jefferies LLC served as financial advisor in a lead role, while Faegre Drinker Biddle & Reath LLP provided legal counsel to the company. Legal representation breaks down cleanly by side: Kirkland & Ellis LLP and Cleary Gottlieb Steen & Hamilton LLP represented the acquirer, GTCR, while Faegre Drinker Biddle & Reath LLP represented the target, Surmodics. Beyond the cash consideration and the take-private structure implied by the subtype label, the facts block does not provide further detail on the specific per-share price, financing sources, or any contingent consideration elements that may be part of the agreement. A number of details are not disclosed in the available record. No expected closing date is given. No information is provided about financing commitments or termination fees. The facts block also does not specify what approvals are outstanding under the pending-regulatory status.

This is an initial public offering in the fig sector, with Bowhead Specialty Holdings Inc. (ticker BOW) as the issuer. The product group is ecm (equity capital markets). The disclosed transaction value is $128,000,004. The facts are sourced from a 424B4 prospectus filed with the SEC via EDGAR, published on May 24, 2024. A 424B4 is the final prospectus filing type used to document the terms of a completed securities offering, consistent with the IPO subtype of this record. The deal's current status is pending regulatory review. The underwriting syndicate includes several named firms. Morgan Stanley and J.P. Morgan are each identified as joint book-running managers in a lead capacity. RBC Capital Markets and Keefe, Bruyette & Woods, A Stifel Company, are identified as underwriters without a lead designation. The source sentence for all of these entries is drawn from what appears to be the cover page or underwriter listing of the prospectus: "J.P. Morgan Morgan Stanley Keefe, Bruyette & Woods A Stifel Company Citizens JMP RBC Capital Markets Dowling & Partners Securities, LLC Siebert Williams Shank," which also references additional firms, including Citizens, JMP, Dowling & Partners Securities, LLC, and Siebert Williams Shank, though these are not broken out as discrete advisor entries in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as an initial public offering with a disclosed size of $128,000,004, no further detail on the number of shares offered, the offering price per share, or the use of proceeds is included in the facts provided. Several items are not disclosed in this record: no legal advisors are identified for the issuer or the underwriters, the per-share offering price and share count are not specified, and no additional detail beyond the underwriter listing is given regarding the roles of Citizens, JMP, Dowling & Partners Securities, LLC, or Siebert Williams Shank in the syndicate.

This transaction is an at-the-market equity offering by VBI Vaccines Inc., falling under the equity capital markets (ECM) product group. The disclosed value of the offering is $8,468,289. The deal is currently in pending regulatory status. This summary is sourced from an SEC EDGAR Form 8-K filed and published on May 15, 2024. According to the source sentence, on that date VBI Vaccines Inc. entered into an At The Market Offering Agreement, the Sales Agreement, with H.C. Wainwright & Co., LLC, as sales agent. On the financial advisory side, H.C. Wainwright & Co., LLC is identified as the sales agent for the issuer, VBI Vaccines, in a lead capacity for this at-the-market program. No other financial advisors are named in the facts block. Legal representation for the issuer was provided by Stikeman Elliott LLP. The source sentence notes that a copy of the opinion of Stikeman Elliott LLP relating to the legality of the issuance and sale of the shares was attached as Exhibit 5.1 to the Form 8-K, indicating the firm's role was tied to the legal opinion required for the share issuance. As an at-the-market offering, this transaction structure allows the issuer to sell shares incrementally into the market through the sales agent rather than in a single marketed offering. No further detail is given in the facts block on the specific share count, pricing mechanism, or the duration of the sales agreement. Several facts are not disclosed in the available record. No expected closing date or program termination date is given. No sector classification is specified for VBI Vaccines in this facts block. No underwriters or additional financial advisors beyond the sales agent are named, and no further detail on the agreement's specific terms beyond its existence and the disclosed dollar value is provided.

This deal is a notes exchange and liability management transaction classified under debt capital markets (DCM), involving Lions Gate Capital Holdings 1, Inc. as issuer. The disclosed value of the transaction is $383,000,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on May 3, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners LP is identified as financial advisor to the creditors, specifically the noteholders party to the Exchange Agreement. No lead/non-lead designation is specified for this role, and no financial advisor is identified on the issuer side in the facts provided. On the legal side, two advisors are named: White & Case LLP served as legal advisor to the noteholders (creditors), per the same source sentence identifying Perella Weinberg Partners' role, and Wachtell, Lipton, Rosen & Katz served as legal advisor to Lionsgate, the issuer side. Beyond the classification of this transaction as a notes exchange and liability management exercise with a disclosed value of $383,000,000, no further detail on the specific notes involved, exchange ratios, or other structural terms is provided in the facts block. Several items are not disclosed in the available record. No sector classification is given, no financial advisor is identified for the issuer (Lionsgate) side, and lead/non-lead status for Perella Weinberg Partners' role is not specified. No expected closing date or additional timeline detail beyond the May 2024 filing date and pending-regulatory status is provided.

This is a stock-for-stock bank merger in the fig sector in which Southern States Bancshares, Inc. is the acquirer of CBB Bancorp. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an S-4 registration statement filed with the SEC via EDGAR, published on May 2, 2024, consistent with the stock-for-stock structure of this transaction, since an S-4 is used to register the shares issued as merger consideration. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Performance Trust Capital Partners, LLC, which served as the lead financial advisor to CBB Bancorp, the target, and rendered a fairness opinion. The source sentence is drawn from a consent letter: "We hereby consent to the inclusion of our opinion letter, dated February 27, 2024, to the Board of Directors of CBB Bancorp as Annex C to, and to the reference thereto under the captions 'Summary, Opinion of CBB's Financial Advisor,' 'The Merger, Opinion of CBB's Financial Advisor' in, the proxy statement/prospectus relating to the proposed merger of CBB Bancorp and Southern States Bancshares, Inc." This confirms Performance Trust Capital Partners' fairness opinion was dated February 27, 2024. No financial advisor to Southern States Bancshares, the acquirer, is identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as a stock-for-stock bank merger, no further detail on the exchange ratio or other specific consideration terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, no financial advisor to the acquirer is identified, no legal advisors to either side are identified, the exchange ratio is not specified, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a cash acquisition representing the closing of a previously announced deal, in which Vaalco Energy Inc. (ticker EGY), a natural-resources sector company, is acquiring assets or interests from Svenska Petroleum Exploration AB. The deal falls under the M&A product group and carries a disclosed value of $40,200,000. It is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on April 30, 2024. Financial advisory roles were split between the two sides, with the target side notably using two separate advisors. Vaalco, the acquirer, retained Stifel as its sole financial advisor, in a lead role. Svenska Petroleum Exploration AB, the target, retained both Evercore Partners International LLP and GKA Advisors LLP as financial advisers, in a non-lead capacity relative to the sole designation given to Vaalco's advisor. Legal counsel followed the same structural split. Mayer Brown International LLP served as legal counsel to Vaalco, the acquirer. Fieldfisher LLP served as legal counsel to Svenska Petroleum Exploration AB, the target. The facts block identifies this as the closing of a previously announced cash acquisition, but provides no further detail on the specific assets involved, the consideration payment timing, or any post-closing adjustments tied to the $40,200,000 disclosed value. Several material facts remain undisclosed. No expected closing date beyond the filing date is given. No sector classification is provided for Svenska Petroleum Exploration AB in this facts block, and no further detail is given on what prompted the closing characterization or what regulatory approvals, if any, remained outstanding at the time of this filing.

This deal is an asset/product-line acquisition classified as an M&A transaction in the healthcare sector, involving Zoetis's medicated feed additive (MFA) product portfolio as the divested assets and Phibro Animal Health Corp (ticker PAHC) as acquirer. The disclosed value of the transaction is $350,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on April 29, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Guggenheim Securities, LLC acted as exclusive financial advisor to Zoetis, the target/divesting party, in a lead capacity. Citi acted as exclusive financial advisor to Phibro, the acquirer, also in a lead capacity, per the respective source sentences pairing each financial advisor with its legal counsel. On the legal side, Wachtell, Lipton, Rosen & Katz acted as legal advisor to Zoetis, the target, while Kirkland & Ellis LLP acted as legal advisor to Phibro, the acquirer. Beyond the asset/product-line acquisition structure, with a disclosed deal value of $350,000,000, no further detail on which specific products within the MFA portfolio are included or excluded, or other structural terms, is provided in the facts block. Several items are not disclosed in the available record. No further detail on the specific scope of the MFA product portfolio transferred is given beyond the general description, and no expected closing date or further timeline detail beyond the April 2024 filing date and pending-regulatory status is provided.

Rubrik, Inc. priced its initial public offering of 23,500,000 shares of Class A common stock at 32.00 dollars per share, listing on the New York Stock Exchange under the symbol RBRK. Prior to the offering there had been no public market for Rubrik's Class A common stock, and the company disclosed a two-class share structure in which Class A and Class B shares carry identical rights except for voting, conversion and transfer provisions. This record is sourced from the prospectus (Form 424B4) that Rubrik filed with the SEC, dated April 24, 2024, with underwriters expected to deliver shares against payment on April 29, 2024. This document represents the final, priced IPO prospectus rather than a preliminary filing. This is a capital markets underwriting, not an M&A advisory mandate: the cover page of the prospectus lists a syndicate of underwriters led by Goldman Sachs & Co. LLC, with Barclays named second among them, followed by Citigroup, Wells Fargo Securities, Guggenheim Securities, Mizuho, Truist Securities, BMO Capital Markets, Deutsche Bank Securities, KeyBanc Capital Markets, Cantor, CIBC Capital Markets, Capital One Securities, Wedbush Securities and SMBC Nikko. The listing order and typical IPO syndicate conventions indicate Goldman Sachs held the lead left position, with Barclays serving as a senior but non-lead joint bookrunner; the prospectus text available in this excerpt does not explicitly label individual banks' roles beyond listing them on the cover. No legal advisors are disclosed in the excerpted text reviewed for this filing. On deal mechanics, the prospectus states the underwriters had an option to purchase up to an additional 3,525,000 shares if they sold more than 23,500,000 shares, exercisable at the IPO price less underwriting discounts and commissions. Not disclosed in the excerpted text: a precise statement of aggregate gross proceeds (the approximate 752 million dollar figure is derived by multiplying the 23,500,000 share count by the 32.00 dollar offering price rather than appearing as a single verbatim sentence), the explicit designation of which underwriter served as sole lead left bookrunner, and the use of proceeds in detail beyond the cover page terms.

This deal is a restructuring matter involving Express, Inc., structured as a Chapter 11 filing accompanied by a court-supervised sale process to a consortium led by WHP Global, including Simon Property Group, among other parties. The transaction is classified under the restructuring product group, and the disclosed deal value is not stated in the source document. No sector classification was provided in the facts block. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on April 22, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised Express, the target/debtor: Moelis & Company LLC served as investment banker and is designated as the lead advisor in that role, while M3 Partners, LP served as financial advisor without a lead designation specified. No financial advisors were disclosed for the acquiring consortium. Legal counsel was also disclosed: Kirkland & Ellis LLP served as legal counsel to Express. No legal advisors were disclosed for the acquiring consortium in the facts block. Beyond its characterization as a Chapter 11 filing paired with a court-supervised sale process, the facts block provides no further detail on the specific terms of the sale, such as the purchase price or the assets being sold to the consortium. Several material facts are not disclosed in the source material. The overall deal value is not stated. No financial or legal advisors are identified for the acquiring consortium led by WHP Global. The facts block also does not specify an expected closing date or the specific terms of the sale transaction within the Chapter 11 process.

This deal is a stock-for-stock merger in which Capital One Financial Corp (ticker COF), a company in the financial institutions group (FIG) sector, is the acquirer of Discover Financial Services. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an S-4 filed with SEC EDGAR and published on April 19, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, PJT Partners LP served as financial advisor to the target, Discover, and is designated as lead advisor in that role. The source material includes a consent letter in which PJT Partners LP consents to the reference to its opinion letter under the caption "Summary, Opinion of Discover's Financial Advisor" in the relevant filing. No financial advisor is disclosed for Capital One, the acquirer, in the facts block. No legal advisors were identified in the facts block for this transaction, for either Discover or Capital One. Beyond the stock-for-stock characterization of the merger, the facts block does not specify the exchange ratio or other specific terms of the stock consideration. Several material facts are not disclosed in the source material. No financial advisor is named for Capital One, the acquirer, and no legal advisors are identified for either party. The disclosed deal value is not stated, and no expected closing date is given.

This deal is a Section 363 asset sale structured as a Chapter 11 stalking horse agreement, classified as a restructuring transaction, involving Acorda Therapeutics, Inc. as issuer/debtor in connection with assets including Inbrija, Ampyra, and Fampyra, with Merz as the counterparty. The disclosed value of the transaction is $185,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on April 2, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Ducera Partners is named as lead investment banker to Acorda (the issuer), with the source material noting that Acorda is being advised by Ducera Partners and Leerink Partners as investment bankers, alongside Ernst & Young as financial advisor and Baker McKenzie as legal counsel. Separately, Perella Weinberg Partners is identified as lead investment banker to the Senior Convertible Noteholders (creditors), who are also advised by King & Spalding as legal counsel. On the legal side, three firms are named: Baker McKenzie serves as legal counsel to Acorda (issuer), King & Spalding serves as legal counsel to the Senior Convertible Noteholders (creditors), and Freshfields Bruckhaus Deringer US LLP serves as legal counsel to Merz, identified here in the acquirer role, which is also advised by Morgan Stanley as investment banker and Deloitte as financial and tax advisors per the source sentence (though Morgan Stanley and Deloitte are not broken out as separate structured advisor entries in the facts block). Beyond the Section 363 asset sale and stalking horse agreement structure with a disclosed value of $185,000,000, no further detail on the specific consideration mix or additional terms of the stalking horse bid is provided in the facts block. Several items are not disclosed in the available record. While the source sentence references Morgan Stanley and Deloitte advising Merz, they are not listed as separate structured financial advisor entries, so their precise role designation (lead or non-lead) cannot be confirmed from the structured facts. No expected closing date for the Section 363 sale or further timeline detail beyond the April 2024 filing date and pending-regulatory status is provided.

Liberty Media Corporation (Nasdaq: FWONA, FWONK) announced an agreement to acquire Dorna Sports, S.L., the exclusive commercial rights holder to the MotoGP World Championship motorcycle racing series, from private equity firm Bridgepoint and Canada Pension Plan Investment Board (CPP Investments). The transaction reflects an enterprise value for MotoGP of €4.2 billion and an equity value of €3.5 billion, with MotoGP to be attributed to Liberty Media's Formula One Group tracking stock. The filer is classified under SIC 4833 (television broadcasting), reflecting Liberty Media's media and sports rights portfolio. This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Liberty Media Corp with the SEC on April 1, 2024, announcing the signing of the acquisition agreement. Liberty Media will acquire 86% of MotoGP, with MotoGP management retaining approximately 14% of equity in the business; existing debt at MotoGP was expected to remain in place after closing. The acquisition was expected to complete by year-end 2024, subject to competition and foreign investment approvals in multiple jurisdictions. On financial advisory, Goldman Sachs & Co. LLC acted as financial advisor to Liberty Media and was also providing committed debt financing for the transaction, while Moelis & Company LLC acted as financial advisor to Dorna, the target being sold by Bridgepoint and CPP Investments. On legal advisory, O'Melveny & Myers LLP served as legal counsel to Liberty Media, and Latham & Watkins LLP served as legal counsel to Dorna. The deal structure disclosed mixes cash and stock: the equity consideration to sellers is expected to comprise approximately 65% cash, 21% in shares of Series C Liberty Formula One common stock (Nasdaq: FWONK), and 14% retained MotoGP management equity. The cash portion was to be funded with a mix of cash and debt, subject to market conditions, and the FWONK share consideration would be priced on a 20-day volume-weighted average price prior to transaction close; Liberty Media retained an option to deliver additional cash in lieu of FWONK stock at its sole discretion. What is not disclosed: the press release does not provide a specific closing date beyond the year-end 2024 target, does not itemize the exact dollar amount of committed debt financing from Goldman Sachs, and does not specify a termination fee for the transaction.

This deal is a cash acquisition in which PGT Innovations, Inc., a company in the industrials sector, is the target being acquired by MIWD Holding Company LLC (MITER Brands), with Koch Equity Development LLC also involved as a sponsor-side party per the advisor disclosures. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on March 28, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, several firms are named across three distinct roles. On the acquirer side, KeyBanc Capital Markets Inc. and RBC Capital Markets both acted as financial advisors to and provided committed debt financing for MITER Brands, with no lead designation specified. Separately, on the sponsor side, Rothschild & Co US Inc. served as financial advisor to Koch Equity Development LLC. On the target side, Evercore served as exclusive financial advisor to PGTI and is designated as lead advisor. Legal counsel was also extensively disclosed. On the target side, Davis Polk & Wardwell LLP served as legal counsel to PGTI. On the sponsor side, Jones Day served as legal counsel to Koch Equity Development LLC, with Gibson, Dunn & Crutcher LLP serving as its tax counsel. On the acquirer side, Stinson LLP acted as legal counsel and Simpson Thacher & Bartlett LLP acted as debt financing counsel to MITER Brands. Beyond the cash consideration implied by the subtype, the facts block does not disclose a per-share purchase price or the aggregate transaction value. Several facts are not disclosed in the source material. The overall deal value is not stated. The facts block does not give a per-share price, nor does it specify an expected closing date. It also does not detail the size of the committed debt financing provided by KeyBanc Capital Markets and RBC Capital Markets.

This deal is a Chapter 11 pre-arranged restructuring involving Enviva, LLC, a company in the industrials sector, as the issuer/debtor. The transaction is classified under the restructuring product group, with a disclosed value of $1,000,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on March 13, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, two firms advised Enviva, the issuer: Lazard served as investment banker and is designated as lead advisor in that role, while Alvarez & Marsal served as financial advisor, also designated as lead advisor. Separately, on the creditors' side, Evercore Group L.L.C. served as the financial advisor to the Ad Hoc Group of creditors, also designated as lead advisor. Legal counsel was also disclosed for both sides. Vinson & Elkins LLP served as legal counsel to Enviva, the issuer. Davis Polk & Wardwell LLP served as legal advisor to the Ad Hoc Group, the creditors' side. Beyond its characterization as a Chapter 11 pre-arranged restructuring and the disclosed $1,000,000,000 value, the facts block does not specify the particular debt instruments being restructured or the recovery terms for creditors under the arrangement. Several facts are not disclosed in the source material. The facts block does not detail the specific capital structure or debt instruments being addressed in the pre-arranged restructuring, nor does it specify the recovery terms for the Ad Hoc Group or other creditors. No expected timeline for emergence from Chapter 11 is given.

NanoString Technologies, Inc. announced on March 10, 2024 that it had reached an agreement with Patient Square Capital, a health care-focused investment firm, under which Patient Square would serve as the stalking-horse bidder to purchase substantially all assets of NanoString's global business operations as a going concern for $220 million, as part of a Section 363 court-supervised bankruptcy sale process. This follows NanoString's voluntary Chapter 11 filing on February 4, 2024, prompted by an adverse outcome in patent litigation with 10x Genomics over its GeoMx and CosMx spatial biology product lines. This record is sourced from an Exhibit 99.1 press release furnished with NanoString's Form 8-K filed March 12, 2024 (dated March 10, 2024), describing the stalking-horse agreement as "a major step in financial restructuring" within the ongoing Chapter 11 case. At the time of this filing, the transaction was a signed stalking-horse agreement pending Bankruptcy Court approval of bidding procedures (a hearing was scheduled for March 28, 2024) and subject to higher or better competing bids. Perella Weinberg Partners L.P. served as NanoString's restructuring investment banker throughout the Chapter 11 process, per the release's statement "The Company is represented by Willkie Farr & Gallagher LLP as counsel, AlixPartners LLP as restructuring advisor and Perella Weinberg Partners L.P. as restructuring investment banker." On the buy side, Greenhill & Co served as investment banker to Patient Square Capital, per "Patient Square is represented by Kirkland & Ellis LLP as counsel and Greenhill & Co as investment banker." On the legal side, Willkie Farr & Gallagher LLP represented NanoString, while Kirkland & Ellis LLP represented Patient Square Capital. The agreement provided for Bankruptcy Court-approved bidding procedures permitting the submission of higher or otherwise better offers, with the deadline for competing offers requested to be set for April 12, 2024 and a sale-approval hearing requested for April 22, 2024; the transaction remained subject to expiration of the Hart-Scott-Rodino antitrust waiting period. Not disclosed in the sourced document is whether Patient Square's $220 million stalking-horse bid was ultimately the winning bid in the court-supervised auction (a separate April 2024 announcement reviewed separately shows Bruker Corporation, not Patient Square, ultimately acquired the NanoString assets for approximately $392.6 million), nor any outcome of the underlying 10x Genomics patent litigation.

Fortrea Holdings Inc., a Durham, North Carolina-based global contract research organization (CRO), announced on March 11, 2024 that it had signed a definitive agreement to divest its Endpoint Clinical and Fortrea Patient Access businesses, part of its Enabling Services segment, to private equity firm Arsenal Capital Partners. The divestiture was intended to let Fortrea sharpen its strategic focus as a pure-play CRO covering phases 1 through 4 of clinical development, while creating a standalone business for Endpoint's Randomization and Trial Supply Management (RTSM) solutions and Fortrea Patient Access's HUB services and patient support offerings. This extraction is sourced from Fortrea's 8-K exhibit (Exhibit 99.2) filed with the SEC on March 11, 2024, carrying the press release announcing the signed definitive divestiture agreement. The deal was still pending as of this filing, targeted to close in the second quarter of 2024 subject to customary closing conditions, regulatory approvals, and the parties entering into certain services and operating agreements. Barclays served as exclusive financial advisor to Fortrea on the sale, holding a sole advisory mandate for the seller; the press release does not name any financial advisor representing Arsenal Capital Partners, the buyer. On the legal side, Smith Anderson served as legal counsel to Fortrea, while Sidley Austin LLP served as legal counsel to Arsenal. The divested businesses had a long operating history: Endpoint Clinical had supported more than 1,750 clinical trials involving 875,000 patients across 90 countries over more than 15 years, while Fortrea Patient Access had served the biopharmaceutical industry with patient support, product access, affordability and adherence solutions for more than 30 years, supporting over 2.5 million patients and more than 100 unique brands at the time of the announcement. Sam Osman, Fortrea's president of Enabling Services, was to become CEO of the divested businesses alongside Arsenal. The press release does not disclose the purchase price or any financial terms of the divestiture, the advisory fee paid to Barclays, or the identity of any financial advisor representing Arsenal Capital Partners in the transaction.

This deal is a private notes exchange and liability management transaction classified under debt capital markets (DCM), involving Sabre GLBL Inc. as issuer. The disclosed value of the transaction is $43,600,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on March 8, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Perella Weinberg Partners LP served as financial advisor to Sabre (the issuer) on this transaction, with no lead/non-lead designation specified in the facts provided. On the legal side, two firms are named in connection with the issuer side: Davis Polk & Wardwell LLP served as legal counsel to Sabre on the transaction, per the same source sentence naming Perella Weinberg Partners as financial advisor, while Latham & Watkins LLP served as legal counsel to Perella Weinberg Partners LP itself (the financial advisor), a distinct role from counsel to Sabre directly. Beyond the classification of this transaction as a private notes exchange and liability management exercise with a disclosed value of $43,600,000, no further detail on the specific notes involved, exchange terms, or tenor is provided in the facts block. Several items are not disclosed in the available record. No sector classification is given, and no lead/non-lead designation is specified for Perella Weinberg Partners' advisory role. No expected closing date or further timeline detail beyond the March 2024 filing date and pending-regulatory status is given.

This deal involves First Advantage Corp (ticker FA), a technology-sector company, as the acquirer, with Sterling Check Corp as the target. The transaction is an M&A deal structured as a cash-and-stock acquisition, and its disclosed value is $2,200,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published February 29, 2024. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. This deal has an unusually large advisory roster on the acquirer side. J.P. Morgan Securities LLC is named as lead financial advisor to First Advantage. In addition, the source material states that BofA Securities, Inc., Barclays Bank PLC, BMO Capital Markets Corp., Jefferies Finance LLC, and RBC Capital Markets all also served as financial advisors to First Advantage, without individual lead designations beyond J.P. Morgan's. On the target side, Goldman Sachs & Co. LLC and Citigroup Global Markets Inc. acted as financial advisors to Sterling, per the source sentence naming both firms together, with no lead designation specified for either. Legal counsel is also disclosed for both sides: Fried, Frank, Harris, Shriver & Jacobson LLP served as Sterling's (the target's) legal counsel in the transaction, while Simpson Thacher & Bartlett LLP served as First Advantage's (the acquirer's) legal counsel. Beyond identifying the transaction as a cash-and-stock acquisition valued at $2,200,000,000, the facts block does not specify the exact mix of cash versus stock consideration, the per-share price, or any other structural terms. Several facts are not disclosed in the available record. The precise cash/stock consideration split is not specified. No expected closing date is given. The record also does not indicate whether any of the five non-lead financial advisors to First Advantage played differentiated roles (e.g., financing versus advisory) beyond the general "financial advisor" designation.

VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY), a Houston-based independent oil and gas exploration and production company, announced on February 29, 2024 that it entered into a sales and purchase agreement to acquire Svenska Petroleum Exploration AB, a privately held E&P company based in Stockholm, Sweden. Svenska's primary asset is a 27.39% non-operated working interest in the deepwater producing Baobab field in Block CI-40, offshore Cote d'Ivoire in West Africa. This entry is sourced from VAALCO's Exhibit 99.1 press release filed as part of an 8-K on February 29, 2024, announcing the signing of the sales and purchase agreement. The release explicitly marks the announcement as containing inside information. The acquisition had not yet closed as of this filing; closing was expected in the second quarter of 2024, with ultimate timing dependent on final receipt of all necessary approvals. Stifel acted as sole financial advisor to VAALCO. Svenska Petroleum Exploration AB retained Evercore Partners International LLP and GKA Advisors LLP as financial advisers. Mayer Brown International LLP acted as legal counsel to VAALCO. Fieldfisher LLP acted as legal counsel to Svenska (the source text is truncated after naming Fieldfisher but clearly attributes it as Svenska's legal advisor alongside the two named financial advisers). The gross consideration for the acquisition was $66.5 million, subject to customary closing adjustments, with an effective date of October 1, 2023. The purchase price was to be funded partly by a pre-closing dividend of cash on Svenska's own balance sheet to the seller, with the remainder funded from VAALCO's cash on hand, with no issuance of debt or equity. VAALCO estimated net cash due at closing would be in the range of approximately $30 to $40 million, depending on timing. (A later, separate 8-K filed April 30, 2024 confirmed the acquisition had closed, with a net purchase price of $40.2 million fully funded by cash on hand.) The release does not disclose the identity of the seller of Svenska (i.e., Svenska's prior ownership), a termination fee, or the specific fee arrangements for Stifel, Evercore Partners International, GKA Advisors, Mayer Brown, or Fieldfisher. Reserve estimates for the Baobab field interest and other transaction highlights are referenced in the release but are described using non-GAAP reserve metrics not independently verified here.

This transaction involves Rithm Capital Corp. (ticker RITM), a real-estate sector company, in a strategic transaction structured as an external management internalization involving Great Ajax Corp. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are drawn from an SEC EDGAR Form 8-K filed and published on February 27, 2024. The transaction's current status is pending regulatory review. This deal involved three separate sets of financial advisors reflecting its multi-party governance structure. Citi is acting as the exclusive financial advisor to Rithm, the acquirer, in a lead role. BTIG, LLC is acting as exclusive financial advisor to the special committee of the Great Ajax board of directors, also in a lead capacity, representing the company's independent oversight body. Separately, Piper Sandler & Co. is acting as exclusive financial advisor to Great Ajax itself, the target, likewise in a lead role. Legal advisors are correspondingly split three ways. Sidley Austin LLP is serving as legal counsel to Rithm, the acquirer. Sheppard Mullin LLP is acting as legal advisor to the special committee of the Great Ajax board of directors. Mayer Brown LLP is acting as legal advisor to Great Ajax, the target. Beyond identifying this as a strategic transaction involving the internalization of external management, which implies Rithm is bringing Great Ajax's external management function in-house, the facts block provides no further detail on the specific mechanics of the internalization, any consideration paid, or how existing management contracts are being treated. Several material details are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given. No detail is provided on the specific terms of the internalization arrangement or what regulatory approvals remain pending.

This deal is a take-private cash merger classified as an M&A transaction, involving Agiliti, Inc. as target and an affiliate of Thomas H. Lee Partners, L.P. (THL) as acquirer. The disclosed value of the transaction is $2,500,000,000. No sector classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on February 26, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, Centerview Partners LLC acted as exclusive financial advisor to the Special Committee of Agiliti, the target, in a lead capacity. Goldman Sachs & Co. LLC acted as exclusive financial advisor to THL, the acquirer, also in a lead capacity. On the legal side, Weil, Gotshal & Manges LLP acted as legal counsel to the Special Committee of Agiliti, the target, while Ropes & Gray LLP acted as legal counsel to THL, the acquirer. Beyond the cash consideration and take-private structure, with a disclosed deal value of $2,500,000,000, no further detail on per-share pricing or financing sources is provided in the facts block. Several items are not disclosed in the available record. No sector classification is given, and no further structural detail beyond the take-private cash merger classification and disclosed value is provided. No expected closing date or further timeline detail beyond the February 2024 filing date and pending-regulatory status is given.

This record concerns CorEnergy Infrastructure Trust, Inc., a real estate-sector company, which is the target in a Chapter 11 restructuring support agreement involving a debt-for-equity structure. The transaction falls under the restructuring product group, and its disclosed value is $45,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published February 26, 2024. The matter's status is pending regulatory, meaning the restructuring had not concluded as of that filing. Financial advisors are disclosed for two separate constituencies. On the creditor side, the Ad Hoc Group of Noteholders retained Perella Weinberg Partners and TPH&Co. (the energy business of Perella Weinberg Partners) as its investment bankers, alongside Faegre Drinker Biddle & Reath LLP as its legal counsel, per the source sentence describing the Ad Hoc Group's advisory team. On the company side, CorEnergy retained Teneo Capital LLC as its financial advisor and Miller Buckfire as its investment banker, in addition to Husch Blackwell LLP as legal counsel, according to the source language describing CorEnergy's own advisory retentions. No lead-versus-non-lead distinction is specified for any of these advisors in the facts block. On the legal side, Faegre Drinker Biddle & Reath LLP is confirmed as counsel to the Ad Hoc Group of Noteholders (creditors), and Husch Blackwell LLP is confirmed as counsel to CorEnergy (the target/company). Beyond describing this as a Chapter 11 restructuring support agreement involving a debt-for-equity component with a disclosed value of $45,000,000, the facts block does not detail the specific equity allocation, the treatment of existing shareholders, or the terms of any new debt instruments arising from the restructuring. A number of facts are not disclosed here. No expected timeline for completion of the Chapter 11 process is given. The record does not specify what the $45,000,000 figure represents in terms of debt converted, proceeds, or claims. Lead-advisor status among the four financial/investment-banking advisors named is also not indicated.

Trilogy International Partners Inc., a telecommunications holding company (SIC 4812, radiotelephone communications), filed a definitive merger proxy statement (DEFM14A) describing a going-private arrangement under which SG Enterprises II, LLC, a Washington limited liability company controlled by John W. Stanton and Theresa E. Gillespie, will acquire all outstanding common shares of Trilogy not already held by the Purchaser for US$0.07 per share in cash. SG Enterprises already held an aggregate of approximately 19.1% of Trilogy's outstanding common shares prior to the arrangement. This entry is sourced from Trilogy International Partners' DEFM14A proxy statement and management information circular, filed with the SEC on February 21, 2024, in connection with a special meeting of shareholders to vote on the arrangement under section 288 of the Business Corporations Act (British Columbia). A subsequent 8-K exhibit filed by the company on March 25, 2024, confirms that shareholders approved the going-private transaction at the special meeting, indicating the deal proceeded toward closing after this proxy was filed. On financial advisory, Haywood Securities Inc. was engaged as financial advisor to the Special Committee of independent directors formed to evaluate the proposal, and delivered a fairness opinion (the "Fairness Opinion") concluding that the consideration to be received by shareholders was fair, from a financial point of view, to the unaffiliated shareholders. No financial advisor is named as representing the Purchaser (SG Enterprises) in the excerpted sections reviewed. On legal advisory, DuMoulin Black LLP served as legal advisor to the Special Committee, while Blake, Cassels & Graydon LLP ("Blakes") served as legal counsel to the Company (Trilogy) more broadly. The proxy does not name a separate law firm representing the Purchaser in the sections reviewed. The deal structure disclosed is a cash-only going-private arrangement at US$0.07 per common share, arising after the company had already made two prior cash distributions to shareholders (in 2022 and 2023) following earlier asset sales, and was pursuing termination of its public reporting obligations. The Special Committee negotiated the Purchaser up from an earlier lower offer to the final US$0.07 figure before recommending the deal. What is not disclosed, or not confirmed with high confidence from the excerpted text: no aggregate dollar value for the transaction was identified (only the per-share price, which cannot be used as an aggregate value under this schema), no financial advisor was identified for the Purchaser, and no confirmed closing date is recorded here beyond the shareholder approval vote referenced in a later filing.

This transaction is an all-cash divestiture of a subsidiary stake, specifically Truist Insurance Holdings (TIH), sold to an investor group led by Stone Point Capital and including CD&R, or Clayton, Dubilier & Rice. The deal falls under the M&A product group and carries a disclosed value of $15,500,000,000. The transaction is currently in pending regulatory status. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on February 20, 2024. Financial advisory work on the seller side, Truist, involved three firms. Morgan Stanley & Co. LLC served as lead financial advisor to Truist, with Truist Securities and Goldman Sachs & Co. serving as co-advisors in a non-lead capacity. On the buyer side, a large syndicate of financial advisors represented Stone Point and CD&R jointly: J.P. Morgan Securities LLC, BofA Securities, Wells Fargo Securities, Barclays, RBC Capital Markets, Citi, BNP Paribas Securities Corp, Mizuho, TD Securities, Evercore, and UBS Investment Bank all served as financial advisors to the investor group. Legal counsel was more narrowly distributed. Davis Polk & Wardwell LLP served as legal counsel to Truist, the seller. On the buyer side, the two lead sponsors retained separate counsel: Simpson Thacher & Bartlett LLP served as legal counsel to Stone Point, with Paul, Weiss, Rifkind, Wharton & Garrison LLP serving specifically as debt financing counsel to Stone Point, while Debevoise & Plimpton LLP served as legal counsel to CD&R. The facts block confirms this is an all-cash divestiture of a subsidiary stake, meaning Truist is selling an ownership interest in TIH rather than the entire business outright, but it does not specify what percentage stake is being sold or what ownership Truist will retain following the transaction. Several material facts remain undisclosed. No expected closing date is given. The specific percentage of TIH being divested is not disclosed, nor is detail on the post-transaction ownership structure or governance rights retained by Truist as a continuing stakeholder.

This transaction is a take-private cash acquisition in which Patient Square Capital is acquiring Eargo, Inc., a healthcare sector company. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. This summary is sourced from an SEC EDGAR Form 8-K filed and published on February 16, 2024. On the financial advisory side, only one advisor is named: Perella Weinberg Partners LP acted as financial advisor to the special committee of Eargo's board, the target side, though no lead or non-lead designation is given for this role. No financial advisor is named for Patient Square Capital, the acquirer. Legal counsel, by contrast, is more fully documented across three firms. Ropes & Gray LLP acted as legal counsel to Patient Square, the acquirer. On the target side, two firms are named: Davis Polk & Wardwell LLP acted as legal counsel to the special committee, alongside Perella Weinberg's financial advisory role for that same committee, while Freshfields Bruckhaus Deringer LLP acted as legal counsel to the company, Eargo itself, as distinct from the special committee. The facts block confirms this is structured as a take-private cash acquisition, but provides no further detail on the per-share price, financing sources for Patient Square Capital, or any other structural terms of the transaction. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No financial advisor is named for the acquirer, Patient Square Capital. No expected closing date is given, and no detail on the purchase price per share is provided beyond the general cash acquisition characterization.

This record covers a Chapter 11 transaction support agreement in the healthcare sector, with Invitae Corp as issuer. The product group is restructuring. The disclosed value is not stated in the source document(s). The facts are sourced from an 8-K filed with the SEC via EDGAR, published on February 14, 2024. The deal's current status is pending regulatory review. One financial advisor is identified, representing the creditors' side: Perella Weinberg Partners LP, serving as investment banker. The source sentence is drawn from a fee reimbursement provision: "...reasonable and documented fees and expenses when due of the Consenting Stakeholders... including the reasonable and documented fees and expenses of (a) Sullivan & Cromwell LLP, as legal counsel, (b) Hogan Lovells US LLP, as legal counsel, (c) Wollmuth Maher & Deutsch LLP, as legal counsel (d) Perella Weinberg Partners LP, as investment banker... necessary or advisable to represent the interests of the Required Consenting Stakeholders." No lead designation is specified for Perella Weinberg in this capacity. Three legal advisors are identified, all representing the creditors (the Consenting Stakeholders) per the same fee reimbursement provision: Sullivan & Cromwell LLP, Hogan Lovells US LLP, and Wollmuth Maher & Deutsch LLP each served as legal counsel to the Required Consenting Stakeholders. Beyond the classification of this matter as a Chapter 11 transaction support agreement, no further detail on the specific restructuring terms, such as treatment of claims or the capital structure post-emergence, is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, no financial or legal advisor to the company (Invitae) itself, as distinct from the creditors, is identified in the facts provided, the specific terms of the transaction support agreement are not given, and no expected emergence or closing date is given beyond the pending-regulatory status.

This record covers the sale of offshore wind joint venture interests, specifically 50% interests in the South Fork Wind and Revolution Wind projects, to Global Infrastructure Partners. The product group is M&A, and the disclosed transaction value is $1,100,000,000. The facts block does not specify a sector classification for this record, and the seller is identified in context as Eversource, based on the source language. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on February 14, 2024. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Goldman Sachs, engaged by Eversource (the target/seller side) as its financial advisor. The source sentence states: "Eversource has engaged Goldman Sachs as its financial advisor to assist with the transactions and Ropes & Gray LLP serves as its legal counsel." No lead designation is specified, and no financial advisor to Global Infrastructure Partners, the acquirer, is identified in the facts provided. Legal counsel is disclosed for the target/seller side only: Ropes & Gray LLP serves as legal counsel to Eversource. No legal advisor to Global Infrastructure Partners is identified in the facts provided. Beyond the classification of this transaction as a sale of 50% interests in two offshore wind joint ventures with a disclosed value of $1,100,000,000, no further detail on payment structure, timing, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no financial or legal advisor to Global Infrastructure Partners, the acquirer, is identified, the sector classification is not specified, and no expected closing date is given beyond the pending-regulatory status.

This transaction involves Whole Earth Brands, Inc., a consumer-retail-sector company, as the target of a take-private cash acquisition by Ozark Holdings LLC/Sweet Oak Parent, an affiliate entity. The deal is categorized under the sponsors-coverage product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published February 13, 2024. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one per side, both designated lead. Citi is serving as M&A advisor and capital markets advisor to Sweet Oak (the acquirer), with the source sentence also noting that Greenberg Traurig, P.A. is serving as legal counsel to Sweet Oak. On the target side, Jefferies is serving as financial advisor to the Special Committee of Whole Earth Brands, with the source sentence noting that DLA Piper LLP (US) is serving as legal counsel to the Special Committee and the Company. Legal advisors are disclosed for both sides: Greenberg Traurig, P.A. is serving as legal counsel to the acquirer, Sweet Oak, while DLA Piper LLP (US) is serving as legal counsel to the target's Special Committee and the Company itself. Beyond classifying the transaction as a take-private cash acquisition, the facts block does not specify the per-share price or any other structural terms of the deal. Several facts are not disclosed in this record. The transaction's dollar value is not stated. No expected closing date is given, and the facts block does not provide detail beyond the general "take-private / cash acquisition" subtype label regarding how the transaction is structured.

This deal is a majority recapitalization structured as a partnership investment, in which Compass Diversified (CODI) is the acquirer and The Honey Pot Company, LLC is the target. No sector classification was provided in the facts block. The transaction is classified under the M&A product group, with a disclosed value of $380,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on February 1, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, William Blair & Company acted as exclusive financial advisor to Compass Diversified, the acquirer, and is designated as lead advisor. Perella Weinberg Partners served as exclusive financial advisor to The Honey Pot Co., the target, and is likewise designated as lead advisor. Legal counsel was also disclosed for both sides, with an additional party noted for the target's management. On the acquirer side, Ropes & Gray LLP acted as legal counsel to Compass Diversified. On the target side, Winston & Strawn LLP acted as legal counsel to The Honey Pot Co., while Gibson, Dunn & Crutcher LLP separately represented The Honey Pot Co.'s management. Beyond its characterization as a majority recapitalization and partnership investment and the disclosed $380,000,000 value, the facts block does not specify the percentage ownership stake being acquired by Compass Diversified. Several facts are not disclosed in the source material. The facts block does not state the percentage stake Compass Diversified is acquiring in the recapitalization, nor does it specify an expected closing date. It also does not provide a sector classification for the deal.

This transaction is a merger involving a spin-off of non-core assets, with consideration comprising a mix of cash, a contingent value right (CVR), and stock, involving the INBRX-101 asset and Sanofi, acting via Aventis Inc. The deal is classified under the M&A product group and carries a disclosed value of $2,200,000,000. It is currently in pending regulatory status. The facts in this briefing are drawn from an SEC EDGAR Form 8-K filed and published on January 23, 2024. No other source documents are referenced in the available record. On the financial advisory side, Lazard is acting as exclusive financial advisor to Sanofi, the acquirer, in a lead role. Centerview Partners LLC is acting as exclusive financial advisor to Inhibrx, the target, also in a lead capacity. Legal counsel follows the same structural split. Weil, Gotshal & Manges LLP is serving as legal counsel to Sanofi, the acquirer. Paul, Weiss, Rifkind, Wharton and Garrison LLP is serving as legal counsel to Inhibrx, the target. The facts block specifies that the transaction's structure includes a spin-off of non-core assets alongside the core merger, with consideration consisting of a combination of cash, a contingent value right, and stock. However, no further detail is given on the specific allocation among cash, CVR, and stock, the CVR's milestone triggers or payout terms, or the mechanics of the non-core asset spin-off. Several material facts are not disclosed in the available record. No expected closing date is given. The specific breakdown of the cash, CVR, and stock components of consideration is not disclosed beyond their inclusion in the structure. No sector classification is given for either Inhibrx or Sanofi in this facts block, and no detail is provided on what regulatory approvals remain outstanding.

Sunoco LP and NuStar Energy L.P. announced on January 22, 2024 that they had entered into a definitive agreement under which Sunoco would acquire NuStar in an all-equity transaction valued at approximately $7.3 billion, including assumed debt. The deal combined two master limited partnerships in the energy midstream sector: Sunoco's motor fuel distribution and terminalling business with NuStar's roughly 9,500 miles of pipeline and 63 terminal and storage facilities handling crude oil, refined products, renewable fuels, ammonia and specialty liquids across the United States and Mexico. This extraction is sourced from NuStar's 8-K exhibit (Exhibit 99.1) filed with the SEC on January 22, 2024, carrying the joint press release announcing the signed merger agreement. The transaction was unanimously approved by both companies' boards of directors and was pending shareholder and regulatory approval at the time of this filing. Barclays served as the exclusive financial advisor to NuStar, the target, while Truist Securities served as the exclusive financial advisor to Sunoco, the acquirer. Each bank held a sole, lead advisory mandate on its respective side. Truist and Bank of America separately provided committed financing for the transaction, including a $1.6 billion 364-day bridge term loan to refinance certain of NuStar's preferred units, subordinated notes, revolving credit facility and receivables financing agreement. On the legal side, Wachtell, Lipton, Rosen & Katz and Sidley Austin LLP acted as NuStar's legal advisors, while Weil, Gotshal & Manges LLP and Vinson & Elkins LLP acted as Sunoco's legal advisors. Under the terms of the agreement, NuStar common unitholders were to receive 0.400 Sunoco common units for each NuStar common unit held, an all-equity exchange implying a 24% premium based on the 30-day volume-weighted average prices of both companies as of January 19, 2024. The companies expected the deal to be immediately accretive, generate at least $150 million of run-rate synergies by the third year after closing, and achieve a leverage target of 4.0x within 12 to 18 months post-close. The transaction was expected to close in the second quarter of 2024. The press release does not disclose the specific advisory fees paid to Barclays or Truist Securities, nor does it break out NuStar's standalone equity value separate from the combined $7.3 billion enterprise valuation that includes assumed debt.

This transaction is a cash-and-stock acquisition in which BlackRock, Inc. (ticker BLK), a fig (financial institutions group) sector company, is acquiring Global Infrastructure Partners (GIP). The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form 8-K filed and published on January 12, 2024. The transaction's current status is pending regulatory review. On the financial advisory side, Perella Weinberg Partners served as lead financial advisor to BlackRock, the acquirer. Evercore served as lead financial advisor to GIP, the target. Legal counsel was split by side, with each side retaining two firms. For BlackRock, Skadden, Arps, Slate, Meagher & Flom and Fried, Frank, Harris, Shriver & Jacobson LLP both acted as legal counsel. For GIP, Kirkland & Ellis LLP and Debevoise & Plimpton LLP both acted as legal counsel. The facts block confirms this is a cash-and-stock acquisition, but does not specify the precise mix or ratio of cash to stock consideration, the exchange ratio for any stock component, or any other structural terms of the transaction. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given, and the specific cash and stock consideration split is not disclosed beyond the general subtype characterization.

This transaction is a stock-for-stock bank merger in which Eastern Bankshares, Inc. (ticker EBC), a company in the financial institutions group (FIG) sector, is the acquirer of Cambridge Bancorp, the target. The deal is classified under the M&A product group, and the disclosed deal value is not stated in the source document. The facts block is sourced from a single SEC filing: an S-4 filed with SEC EDGAR and published on January 11, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, BofA Securities, Inc. served as financial advisor to Cambridge Bancorp, the target, and is designated as lead advisor. The source material references a consent letter in which BofA Securities consents to the inclusion of its opinion letter, dated September 19, 2023, to the Cambridge board of directors, referenced under the heading "Summary, Opinion of Cambridge's Financial Advisor" in the joint proxy statement/prospectus relating to the merger. No financial advisor is disclosed for Eastern Bankshares, the acquirer, in the facts block. No legal advisors were identified in the facts block for this transaction, for either Cambridge Bancorp or Eastern Bankshares. Beyond the stock-for-stock characterization of the merger, the facts block does not specify the exchange ratio or other specific terms of the stock consideration. Several material facts are not disclosed in the source material. No financial advisor is named for Eastern Bankshares, the acquirer, and no legal advisors are identified for either party. The disclosed deal value is not stated, and no expected closing date is given.

Healthpeak Properties, Inc. and Physicians Realty Trust entered into a definitive merger agreement for an all-stock combination of the two healthcare-focused real estate investment trusts, structured through a series of mergers in which Physicians Realty Trust would merge into a Healthpeak subsidiary (DOC DR Holdco) and a parallel partnership-level merger would combine the companies' operating partnerships. Upon completion, the combined company's portfolio was expected to have a pro forma enterprise value of approximately $21 billion, comprising 753 properties including roughly 40 million square feet of outpatient medical properties and 12 million square feet of lab properties. This extraction is sourced from the joint proxy statement/prospectus on Form DEFM14A filed with the SEC by Physicians Realty Trust on January 11, 2024, detailing the merger background, advisory opinions, and terms following the companies' original announcement in October 2023. Barclays Capital Inc. served as financial advisor to Healthpeak, the acquirer, and delivered a written fairness opinion to the Healthpeak board of directors dated October 29, 2023 regarding the fairness of the exchange ratio to be paid by Healthpeak. BofA Securities, Inc. served as financial advisor to Physicians Realty Trust, the target REIT. On the legal side, Latham & Watkins LLP served as Healthpeak's outside legal advisor throughout the process and rendered a tax opinion to Healthpeak at closing, while Baker & McKenzie LLP served as counsel to Physicians Realty Trust and rendered a corresponding REIT-qualification tax opinion for the Company. Under the terms of the merger agreement, each common share of Physicians Realty Trust was to be converted into the right to receive a fixed exchange ratio of 0.674 of a newly issued share of Healthpeak common stock, making the transaction an all-stock combination rather than involving any cash consideration. Both companies' boards had unanimously approved the merger agreement, and Physicians Realty Trust's board recommended that shareholders approve the transaction. The proxy excerpt reviewed here does not disclose the expected closing date or timeline for the mergers, the specific advisory fees paid to Barclays or BofA Securities, or a standalone equity or enterprise value attributable to Physicians Realty Trust separate from the $21 billion pro forma combined-company figure.

This deal is a prepackaged Chapter 11 balance sheet restructuring, classified as a restructuring transaction in the media sector, involving Audacy, Inc. as issuer/debtor. The disclosed value of the transaction is $1,600,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on January 8, 2024. The deal's current status is pending regulatory approval. On the financial advisory side, PJT Partners acted as lead investment banker to Audacy, the issuer, alongside FTI Consulting, who acted as lead financial advisor to Audacy per a separate, similarly structured source sentence. On the creditor side, Greenhill & Co., LLC acted as lead financial advisor to the DIP financing lenders and the ad hoc group of first lien debtholders, while Evercore Group, LLC acted as lead financial advisor to the ad hoc group of second lien debtholders, reflecting separate advisory mandates across different creditor classes. On the legal side, Latham & Watkins LLP acted as legal counsel to Audacy, the issuer. Gibson, Dunn & Crutcher LLP acted as legal counsel to the DIP financing lenders and ad hoc group of first lien debtholders (creditors), while Akin Gump Strauss Hauer & Feld acted as legal counsel to the ad hoc group of second lien debtholders (also creditors). Beyond the prepackaged Chapter 11 balance sheet restructuring structure, with a disclosed value of $1,600,000,000, no further detail on specific treatment of claims, new capital structure, or plan terms is provided in the facts block. Several items are not disclosed in the available record. No further structural detail on the specific recovery terms for each creditor class or the post-restructuring capital structure is given, and no expected closing date for emergence from Chapter 11 or further timeline detail beyond the January 2024 filing date and pending-regulatory status is provided.

This transaction is an M&A deal in which Forum Energy Technologies, Inc. (ticker FET), classified in the tech sector for purposes of this record, acquires Variperm Energy Services in a cash-and-stock acquisition. The disclosed transaction value is $150,000,000. The target, Variperm, is identified in the sourcing material as an energy services business, while the sector tag applied to the record is tech. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on January 8, 2024. The deal's current status is pending regulatory review. On the financial advisory side, TPH&Co., the energy business of Perella Weinberg Partners, represented Variperm as financial advisor, per language stating that "Variperm was represented by TPH&Co., the energy business of Perella Weinberg Partners, as financial advisor." On the acquirer side, Goldman Sachs & Co. LLC represented Forum Energy Technologies as financial advisor, consistent with the statement that "FET was represented in the transaction by Goldman Sachs & Co. LLC as financial advisor." No lead or non-lead designation is specified for either advisor in the facts provided. Legal counsel is disclosed for both sides. Variperm was represented by Vinson & Elkins LLP and Bennett Jones LLP as legal counsel. Forum Energy Technologies was represented by Gibson, Dunn & Crutcher LLP and Goodmans LLP as legal counsel. The pairing of US and Canadian firms on each side (Vinson & Elkins with Bennett Jones for the target, and Gibson Dunn with Goodmans for the acquirer) reflects the cross-border nature of the deal as described in the source sentences. Beyond the classification of the transaction as a cash-and-stock acquisition and the $150,000,000 disclosed value, no further detail on the specific mix of cash versus stock consideration, financing structure, or other terms is included in the facts provided. Several items are not disclosed in the available record: the precise split between cash and stock consideration is not specified, no expected closing date is given beyond the pending-regulatory status, and no lead designation is assigned to either financial advisor.

This transaction is a cash acquisition in the consumer-retail sector in which Sycamore Partners is acquiring Chico's FAS, Inc. The product group is M&A, and the disclosed transaction value is $1,000,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on January 5, 2024. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side. Solomon Partners, L.P. served as the lead financial advisor to Chico's FAS, per the statement "Solomon Partners, L.P. acted as financial advisor to Chico's FAS." On the acquirer side, UBS Investment Bank served as the lead financial advisor to Sycamore Partners, consistent with the language "UBS Investment Bank acted as financial advisor to Sycamore Partners." Legal advisors are disclosed for both sides as well. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor to Chico's FAS, the target, while Kirkland & Ellis LLP acted as legal advisor to Sycamore Partners, the acquirer. Beyond the classification of this transaction as a cash acquisition with a disclosed value of $1,000,000,000, no further detail on per-share pricing, financing sources, or other structural terms is included in the facts provided. Several items are not disclosed in this record: the per-share cash consideration is not specified, no expected closing date is given beyond the pending-regulatory status, and no detail on financing sources for the acquisition is included.

PNM Resources (NYSE: PNM), an Albuquerque, New Mexico-based energy holding company serving customers through its regulated utilities PNM and TNMP, announced on December 26, 2023 that it entered into an agreement to sell its 50% ownership interest in its renewable joint venture, New Mexico Renewable Development, LLC (NMRD), to Exus North America Holdings, LLC. American Electric Power (AEP), which owns the other 50% of NMRD, is selling its interest in the same transaction. This entry is sourced from PNM Resources' Exhibit 99.1 press release filed as part of an 8-K on December 26, 2023. The sale had not yet closed as of the filing date; it was expected to close in February 2024, subject to regulatory approval by the Federal Energy Regulatory Commission and New Mexico regulatory approvals associated with one of NMRD's projects. The release notes the Hart-Scott-Rodino Antitrust Improvements Act waiting period had already expired. KeyBanc Capital Markets is serving as financial advisor to both PNM Resources and AEP jointly on the sale side; no separate financial advisor is named for buyer Exus North America Holdings, LLC. Foley & Lardner LLP is serving as legal counsel to both PNM Resources and AEP. Under the disclosed terms, PNM Resources and AEP agreed to sell the full NMRD portfolio for approximately $230 million, subject to true-up adjustments at close. PNM Resources' 50% share of the approximate gross proceeds is $115 million, which the company states will support funding of regulated capital investments. The NMRD portfolio includes nine operating solar developments totaling 185 MW and six projects under development with an estimated output of 440 MW. The release does not disclose AEP's specific share of proceeds (though it is presumed to mirror PNM's $115 million given the equal 50/50 ownership split), the purchase agreement's termination provisions, or any financing arrangements by buyer Exus North America Holdings. The release also references a separate, previously announced pending acquisition of PNM Resources itself by Avangrid, Inc., which is a distinct transaction from this NMRD asset sale and is not detailed further in this filing.

This record concerns the sale of a renewable joint venture interest, falling under the M&A product group, involving New Mexico Renewable Development LLC (NMRD) and Exus North America Holdings LLC. The parties referenced in the sourced advisory language are PNM Resources and AEP, who are described as sellers of the interest. The disclosed value of the transaction is $230,000,000. The facts are sourced from an 8-K filing with the SEC via EDGAR, published December 26, 2023. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is disclosed: KeyBanc Capital Markets, which is identified as financial advisor to the target side in the facts block. The source sentence states that KeyBanc Capital Markets is serving as financial advisor and Foley & Lardner LLP is serving as legal counsel to PNM Resources and AEP. No lead designation is specified for KeyBanc, and no financial advisor is named for the buyer side (Exus North America Holdings). The only legal advisor disclosed is Foley & Lardner LLP, serving as legal counsel to PNM Resources and AEP (labeled as the target side in this record), per the same source sentence naming KeyBanc as financial advisor. Beyond describing this as the sale of a renewable joint venture interest valued at $230,000,000, the facts block does not provide further detail on the specific assets, generating capacity, or ownership percentage involved in the joint venture interest being sold. Several facts are not disclosed in this record. No financial or legal advisor is named for the buyer side, Exus North America Holdings. No expected closing date is given, and the facts block does not elaborate on the structure of the joint venture or what percentage interest is changing hands.

Daseke, Inc. (NASDAQ: DSKE), a North American transportation solutions specialist serving challenging industrial end markets, announced a definitive agreement to be acquired by TFI International Inc. (NYSE and TSX: TFII) in an all-cash transaction valuing Daseke at an enterprise value of approximately $1.1 billion. Daseke stockholders were to receive $8.30 per share in cash, representing a 69% premium to the last reported sale price and an 82% premium to the 30-trading-day volume-weighted average price. The deal is in the trucking/transportation sector (SIC 4700). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Daseke, Inc. with the SEC on December 22, 2023, announcing the signing of the definitive merger agreement, which had been unanimously approved by Daseke's board of directors. The transaction was expected to close during the second quarter of 2024, subject to Daseke stockholder approval, regulatory approvals, and other customary closing conditions, and was not subject to any financing condition. Upon closing, Daseke's common stock would no longer be listed on any stock exchange, and Daseke would operate its portfolio of brands as part of TFI International's Truckload segment. On financial advisory, J.P. Morgan Securities LLC served as exclusive financial advisor to Daseke, the target. No financial advisor to TFI International is named in this press release. On legal advisory, Kirkland & Ellis LLP served as Daseke's legal advisor. No legal advisor to TFI International is named in this press release. The deal structure disclosed is a straightforward all-cash acquisition at $8.30 per share, unanimously approved by Daseke's board, not subject to a financing condition, with Daseke's brands to be absorbed into TFI International's Truckload segment post-close. What is not disclosed: the press release does not name any financial or legal advisor representing TFI International (the acquirer) in this transaction, does not break the $1.1 billion enterprise value into separate equity value and net debt components, and does not state a termination fee.

This transaction is a cash-and-stock acquisition in which Aon plc, trading under the ticker AON, is acquiring NFP. The deal is classified within the financial institutions group sector, and the disclosed value of the transaction is 13,400,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on December 20, 2023. Based on the facts provided, the deal's status is pending regulatory approval. The financial advisory roster on this deal is extensive on the target side in particular. Evercore acted as lead financial advisor to NFP, with support from BofA Securities, Inc., Deutsche Bank Securities Inc., Jefferies LLC, and TD Securities, all named as financial advisors to NFP alongside Evercore in a supporting capacity. On the acquirer side, UBS Investment Bank served as the exclusive financial advisor to Aon on the transaction and is identified as the lead advisor in that role, while Citi served as a financial advisor and is advising Aon specifically on the transaction financing. On the legal side, Skadden, Arps, Slate, Meagher & Flom LLP and Ropes & Gray LLP both acted as external legal counsel to NFP, while Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as external legal counsel to NFP's capital sponsors, a distinct constituency from NFP itself. On the acquirer side, Cravath, Swaine & Moore LLP and McDermott Will & Emery LLP both acted as external legal counsel to Aon. Beyond confirming that this is a cash-and-stock acquisition with a disclosed value of 13,400,000,000 dollars, no further detail on the specific mix or ratio between the cash and stock components of the consideration is included in the facts available. Several elements of this deal remain undisclosed. No specific breakdown of the cash-versus-stock consideration mix is given beyond the aggregate disclosed value, and no expected closing date is provided. The facts also do not specify what regulatory approvals are required or the anticipated timeline to completion.

Battalion Oil Corporation (NYSE American: BATL), an independent energy company engaged in the acquisition, production, exploration, and development of onshore oil and natural gas properties in the United States, announced on December 15, 2023 that it entered into an Agreement and Plan of Merger with Fury Resources, Inc., under which Fury (as Buyer/Parent) agreed to acquire all outstanding shares of Battalion common stock for $9.80 per share in cash, representing a total transaction value of approximately $450 million. Preferred stock held by Luminus Management LLC and funds and accounts managed by Oaktree Capital Management, L.P. was to be contributed to Fury in exchange for new Fury preferred shares, or sold to Fury for cash, at a valuation based on the conversion or redemption value of the preferred stock. This entry is sourced from Battalion's Exhibit 99.1 press release filed as part of an 8-K on December 18, 2023, announcing the original signing of the merger agreement. The transaction had not yet closed as of this filing; it was expected to close in the first quarter of 2024, subject to various closing conditions including approval of Battalion's stockholders. (A later amendment to this agreement, announced September 19, 2024, revised the per-share consideration downward to $7.00 per share, reflecting changed terms as the transaction was renegotiated over the intervening months.) Houlihan Lokey Capital, Inc. acted as financial advisor to Battalion, and Jefferies LLC acted as financial advisor to Fury Resources (Buyer/Parent). Mayer Brown LLP acted as legal counsel to Battalion, and K&L Gates LLP acted as legal counsel to Fury Resources. Under the originally disclosed terms, the merger consideration of $9.80 per share in cash implied a total transaction value of approximately $450 million. Fury Resources received debt commitments from Fortress Credit Corp. and AI Partners Asset Management Co., Ltd. to finance a portion of the merger consideration. The Rollover Stockholders (Luminus and Oaktree), who collectively owned 61.61% of Battalion common stock, entered into a voting agreement committing 6,254,652 shares (38% of total voting power) in favor of adopting the merger agreement. The release does not disclose a termination fee, the specific methodology for valuing the preferred stock rollover beyond referencing conversion or redemption value, or fee arrangements for Houlihan Lokey, Jefferies, Mayer Brown, or K&L Gates. As noted above, these original terms were subsequently amended (per a separate, later 8-K), reducing the cash consideration to $7.00 per share; the $450 million transaction value and $9.80 per share figures reflect only the terms as originally announced in this December 2023 filing.

This transaction is a stock-for-stock merger in which Q32 Bio Inc., trading under the ticker QTTB, is combining with Homology Medicines, Inc. The deal is classified within the healthcare sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on December 18, 2023. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Cowen and Company, LLC served as financial advisor to Homology Medicines and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter dated November 15, 2023, addressed to the Board of Directors of Homology Medicines, referencing the inclusion of Cowen's opinion letter as an annex to the proxy statement/prospectus and cited under the headings "Prospectus Summary, Opinion of Homology's Financial Advisor" and "The Merger, Opinion of Homology's Financial Advisor." No financial advisor to Q32 Bio is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a stock-for-stock merger, no further detail on the specific exchange ratio or other terms of the stock consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Q32 Bio or Homology Medicines is identified. No financial advisor to Q32 Bio is named, and no detail on the specific exchange ratio or an expected closing date is provided in the facts available.

Occidental announced on December 11, 2023 that it had entered into a purchase agreement to acquire Midland-based oil and gas producer CrownRock L.P., a joint venture of CrownQuest Operating LLC and Lime Rock Partners, for cash and stock in a transaction valued at approximately $12.0 billion, including the assumption of CrownRock's debt. The release frames the deal as adding approximately 170 thousand barrels of oil equivalent per day of high-margin, lower-decline Permian Basin production in 2024 and roughly 1,700 undeveloped well locations. This record is sourced from an Exhibit 99.1 press release furnished with Occidental's Form 8-K filed December 12, 2023 (dated December 11, 2023). At announcement, the deal was a signed purchase agreement pending customary closing conditions and regulatory approvals, with closing expected in the first quarter of 2024. On the target side, Goldman Sachs & Co. LLC and TPH&Co, the energy business of Perella Weinberg Partners, served as CrownRock's joint-lead financial advisors, per the release's statement "CrownRock's joint-lead financial advisors are Goldman Sachs & Co. LLC and TPH&Co, the energy business of Perella Weinberg Partners." The word "joint-lead" explicitly designates both firms as lead advisors to CrownRock. On the acquirer side, BofA Securities served as Occidental's financial advisor, with an affiliate also providing committed financing, per "Occidental's financial advisor is BofA Securities and an affiliate thereof is providing committed financing." On the legal side, Latham & Watkins LLP represented Occidental and Vinson & Elkins LLP represented CrownRock. Occidental intended to finance the purchase with $9.1 billion of new debt, approximately $1.7 billion of newly issued common equity, and assumption of CrownRock's existing $1.2 billion of debt; the company also announced a 22% increase to its quarterly dividend to $0.22 per share and a planned $4.5-$6.0 billion divestiture program to reduce debt by at least $4.5 billion within 12 months of closing. Not disclosed in the sourced document is the precise split between the cash and stock components paid directly to CrownRock equity holders (only the overall financing plan is described), or any EBITDA multiple implied by the $12.0 billion headline value.

Star Bulk Carriers Corp. (Nasdaq: SBLK) and Eagle Bulk Shipping Inc. (NYSE: EGLE) announced a definitive agreement to combine in an all-stock merger on a Net Asset Value to Net Asset Value (NAV) basis, creating a combined company with a pro forma market capitalization of approximately $2.1 billion. The combination was positioned as creating a global leader in dry bulk shipping with a diversified, scrubber-fitted fleet of 169 owned vessels. The deal is in the deep sea foreign transportation of freight sector (SIC 4412). This entry is sourced from an 8-K exhibit (Exhibit 99.1) filed by Eagle Bulk Shipping Inc. with the SEC on December 11, 2023, announcing the signing of the merger agreement, which was unanimously approved by both companies' boards of directors. The transaction was expected to close in the first half of 2024, subject to approval by Eagle shareholders, applicable regulatory approvals, and other customary closing conditions. The combined company, to be named Star Bulk Carriers Corp., would be headquartered in Athens, Greece, with offices in Stamford, Connecticut, Singapore, Copenhagen, and Limassol; Star Bulk's Petros Pappas would serve as CEO of the combined company. On financial advisory, Houlihan Lokey served as financial advisor to Eagle, the target. No financial advisor to Star Bulk, the acquirer, is named in this press release. On legal advisory, Cravath, Swaine & Moore LLP served as legal counsel to Star Bulk, while Akin Gump Strauss Hauer & Feld LLP served as legal counsel to Eagle and Hogan Lovells US LLP served as legal counsel specifically to the Board of Directors of Eagle. The deal structure disclosed is an all-stock exchange: Eagle shareholders were to receive 2.6211 shares of Star Bulk common stock for each Eagle share owned, representing total consideration of approximately $52.60 per share, a 17% premium to Eagle's closing share price of $44.85 on December 8, 2023. Upon closing, Star Bulk and Eagle shareholders would own approximately 71% and 29% of the combined company, respectively, on a fully diluted basis, and the transaction was expected to generate at least $50 million in annual cost and revenue synergies within 12 to 18 months of closing. What is not disclosed: the press release does not name a financial advisor representing Star Bulk in the transaction, does not specify a termination fee, and does not provide a precise closing date beyond the "first half of 2024" target.

This is a stock-for-stock merger in the healthcare sector in which Standard BioTools Inc. (ticker LAB) is the acquirer of SomaLogic, Inc. The product group is M&A. The disclosed value is not stated in the source document(s). The facts are sourced from an S-4 registration statement filed with the SEC via EDGAR, published on November 14, 2023. An S-4 is the filing type used to register securities issued in connection with a merger, consistent with the stock-for-stock structure of this deal. The current status of the transaction is pending regulatory review. Perella Weinberg Partners L.P. is identified as the lead financial advisor to SomaLogic, the target. The source sentence is a consent letter excerpt stating: "We hereby consent to the inclusion of our opinion dated October 4, 2023 appearing as Annex C to, and the reference to such opinion letter under the headings 'Prospectus Summary, Opinion of SomaLogic's Financial Advisor' and 'The Merger, Opinion of SomaLogic Financial Advisor' in, the Registration Statement on Form S-4 of Standard BioTools Inc. and in the Joint Proxy Statement/Prospectus of Standard BioTools Inc. and SomaLogic, Inc." This confirms Perella Weinberg's role included rendering a fairness opinion to SomaLogic dated October 4, 2023. No financial advisor to Standard BioTools, the acquirer, is identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as a stock-for-stock merger, no further detail on the exchange ratio or other specific consideration terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, no financial advisor to the acquirer is identified, no legal advisors to either side are identified, the exchange ratio is not specified, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a stock-for-stock exchange offer in which Cadeler A/S (ticker CDLR), a transportation-infrastructure sector company, is acquiring Eneti Inc., also classified under the transportation-infrastructure sector. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form SC 14D9 filed and published on November 7, 2023. The transaction's current status is pending regulatory review. Only one financial advisor is named in the facts block: Perella Weinberg Partners LP served as financial advisor to the target, Eneti, in a lead capacity. According to the source sentence, on March 1, 2023, the Eneti board held a meeting to discuss a letter from a Mr. Gleerup dated February 28, 2023, and the engagement of Perella Weinberg Partners LP as Eneti's financial advisor in connection with the potential transaction, indicating the advisory engagement was formalized in early March 2023 in response to shareholder or board-level correspondence. No legal advisors are identified in the facts block for either Eneti or Cadeler A/S. The facts block confirms this is structured as a stock-for-stock exchange offer, but does not specify the exchange ratio or the duration and conditions of the offer. Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either party, and no financial advisor is named for Cadeler A/S, the acquirer. No expected closing date is given, and the specific exchange ratio is not disclosed.

This record concerns a divestiture structured as a cash acquisition, falling under the M&A product group. The disclosed value of the transaction is $111,000,000. The facts block identifies the parties only by role references within the sourced sentences: Chart is referenced as being advised on the sell side, and Arcline Investment Management is referenced as being advised on the buy side (consistent with Fairbanks Morse Defense being a portfolio company of Arcline). The source document is an 8-K filing with the SEC via EDGAR, published October 27, 2023. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Two financial advisors are disclosed, one on each side. Capital One Securities, Inc. served as exclusive financial advisor to Chart and is designated lead on that side, with the source language also noting that Winston & Strawn LLP served as legal counsel to Chart in the same transaction. On the other side, BofA Securities served as financial advisor to Arcline Investment Management, with no lead designation specified. The only legal advisor disclosed in the facts block is Winston & Strawn LLP, serving as counsel to Chart (the target side), per the source sentence pairing Capital One Securities and Winston & Strawn as Chart's financial and legal advisors respectively. No legal counsel is named for the acquirer side (Arcline). Beyond classifying the transaction as a divestiture structured as a cash acquisition valued at $111,000,000, the facts block does not provide further detail such as the specific assets or business lines divested, any earnout or contingent consideration, or financing arrangements. Several items remain undisclosed in this record. No legal advisor is named for the Arcline (acquirer) side. No expected closing date is provided. The facts block also does not elaborate on what specific business or assets changed hands beyond the general labeling of the transaction as a divestiture/cash acquisition.

White Mountains Insurance Group, Ltd., a Bermuda-domiciled financial services holding company listed on the New York Stock Exchange, announced on October 20, 2023 that it had entered into an agreement to acquire a majority stake in Bamboo Ide8 Insurance Services, LLC, a managing general agent focused on the California homeowners insurance market. The transaction is an insurance-sector M&A deal in which White Mountains, the acquirer, agreed to invest approximately $285 million, including primary capital to fund Bamboo's growth, in exchange for approximately 70% of Bamboo's basic shares outstanding. Bamboo, founded in 2018 by insurance executive John Chu, provides homeowners' insurance to over 100,000 California policyholders through a technology-enabled underwriting platform. This record is sourced from Exhibit 99.1, a press release titled White Mountains to Acquire a Majority Stake in Bamboo, attached to a Form 8-K filed by White Mountains Insurance Group, Ltd. with the SEC on October 20, 2023 (filer CIK 0000776867, SIC 6331, fire, marine and casualty insurance). At the time of this announcement the deal was newly signed and pending, with closing targeted for the following year; it is a separate, earlier transaction from White Mountains' subsequent 2025 sale of a controlling interest in Bamboo to CVC Capital Partners. On financial advisors, the press release names two firms split by side of the transaction. Howden Tiger Capital Markets & Advisory acted as financial advisor to White Mountains, the acquirer. Evercore Group, L.L.C. acted as financial advisor to Bamboo and its selling equityholders, i.e., the target side of the deal. The release does not designate either firm as lead financial advisor, and no other financial advisors are named. On the legal side, Cravath, Swaine & Moore LLP provided legal advice to White Mountains, while Willkie Farr & Gallagher LLP provided legal advice to Bamboo and the selling equityholders. Under the terms disclosed, the exact ownership percentage to be acquired by White Mountains and the resulting investment amount were to be determined based on Bamboo unitholder elections made prior to closing, meaning the $285 million and 70% figures are expectations rather than fixed contractual terms. The transaction was expected to close in the first quarter of 2024, subject to regulatory approvals and other customary closing conditions, and was stated not to be subject to a financing condition. The press release does not disclose Bamboo's standalone enterprise value, the cash-versus-stock composition of the consideration (the deal appears to be a primary and/or secondary equity investment rather than a classic cash/stock merger), or the specific regulatory approvals required. John Chu and the existing Bamboo management team were to continue leading the business and retain a significant equity stake, but the size of that retained stake beyond the approximate 30% non-White-Mountains ownership was not specified.

ADT Inc. (NYSE: ADT), a smart home and business security company, circulated a lender presentation describing a proposed 1,400 million dollar Senior Secured Term Loan B facility, with Barclays named as administrative agent, intended to refinance ADT's existing Term Loan B due 2026. The presentation ties this refinancing directly to ADT's prior sale of its commercial security, fire and life safety business to private equity firm GTCR: the document states that "On August 8, 2023, ADT announced the sale of 100% of the commercial business to GTCR for approximately $1.6 billion in an all-cash deal," with net proceeds from that sale used to pay down existing debt, and the new Term Loan B facility completing the capital structure adjustment following the divestiture. This record is sourced from a lender presentation filed as an exhibit to an ADT Form 8-K, describing a transaction connected to the October 2, 2023 closing of the GTCR sale (the presentation itself is dated around that period and references the sale as having closed). At the time of this document, the commercial-business sale had already closed and ADT was in the process of refinancing its remaining Term Loan B due 2026 with a new facility due 2030. Barclays appears in this document in a leveraged finance capacity, not as an M&A financial advisor: the lender presentation lists "Administrative Agent: Barclays" for the proposed 1,400 million dollar Senior Secured Term Loan B facility, and a Barclays managing director is listed among the call participants representing the arranger side. On the underlying M&A transaction (the sale of ADT's commercial business to GTCR), this document does not name Barclays; separate ADT disclosures identify Citi and RBC Capital Markets as financial advisors to ADT on that sale, with Cravath, Swaine & Moore LLP as ADT's legal advisor, none of which involved Barclays in an advisory capacity. No legal advisors are named in connection with the Term Loan B facility itself in this presentation. On deal structure, the presentation describes the new 1,400 million dollar, seven-year Term Loan B as refinancing the existing Term Loan B due 2026, secured by a perfected first-priority security interest in substantially all assets of the borrowers and guarantors, with pro forma first-lien net leverage and total net leverage of approximately 2.5 times and 2.9 times, respectively, based on trailing-twelve-month adjusted EBITDA. Not disclosed in this document: the specific interest rate or pricing terms of the new Term Loan B, the identity of other lenders or arrangers in the syndicate beyond Barclays as administrative agent, and the closing date of the refinancing itself (as distinct from the already-disclosed October 2, 2023 closing of the underlying GTCR sale).

This deal involves Chase Corp, an industrials-sector company, as the target in a cash acquisition. The transaction falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are drawn from an 8-K filing with the SEC via EDGAR, published September 29, 2023. The deal's status is pending regulatory, indicating it had not yet closed as of that filing. Only one financial advisor is identified in the record: Perella Weinberg, which served as financial advisor to Chase (the target) and is designated lead on that side. The source sentence describing this engagement is drawn from a disclosure about potential conflicts of interest, stating that except for its engagement as financial advisor to Chase in connection with the merger, no material relationship existed between Perella Weinberg (or its affiliates) and Chase during the three years prior to the date of Perella Weinberg's fairness opinion for which compensation had been received or was anticipated. No financial advisor is named for the acquirer side in the facts provided. One legal advisor is disclosed: Davis Polk, identified as counsel to the target (Chase). The source sentence notes that, through the evening of July 20, 2023 and into the morning of July 21, 2023, Davis Polk and K&E (an abbreviation appearing in the source text, likely referring to Kirkland & Ellis, though not spelled out in the facts block) finalized the merger agreement, the equity commitment letter, the limited guarantee, and the voting agreements. K&E's specific client role is not spelled out as a separate legal-advisor entry in the facts block. Beyond identifying the transaction as a cash acquisition, the facts block does not provide further detail on the per-share purchase price, financing sources, or other structural terms, though the reference to an "Equity Commitment Letter" and "Limited Guarantee" suggests a sponsor-backed financing structure was involved. Several facts are not disclosed in this record. The overall transaction value is not stated. No financial advisor is named for the acquirer. The precise role and client of "K&E" referenced alongside Davis Polk is not clarified in the facts block, and no expected closing date is given.

This transaction is an all-stock merger in which ExxonMobil Corporation is acquiring Denbury Inc, a natural-resources sector company. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form DEFM14A filed and published on September 29, 2023. The transaction's current status is pending regulatory review. Three financial advisors are identified, all on the target side. PJT Partners LP, TPH & Co., and J.P. Morgan Securities LLC each provided a fairness opinion to Denbury, as reflected in the proxy statement's annexes: Annex D contains the opinion of PJT Partners LP, Annex C contains the opinion of TPH & Co., and Annex B contains the opinion of J.P. Morgan Securities LLC. No lead or non-lead designation is specified among the three, and no financial advisor is named for ExxonMobil, the acquirer. Legal counsel is split by side. Vinson & Elkins, L.L.P. served as legal counsel to Denbury, the target. Davis Polk & Wardwell LLP served as legal counsel to ExxonMobil, the acquirer. The source sentence notes that, as of the date of the proxy statement/prospectus, both firms were of the opinion that the merger would qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code, a tax characterization consistent with the deal's all-stock structure. Beyond confirming the all-stock structure and the tax reorganization opinion referenced by counsel, the facts block does not specify the exchange ratio or the treatment of Denbury's outstanding equity awards. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No financial advisor is named for ExxonMobil. No expected closing date is given, and the specific stock exchange ratio is not disclosed.

This is a cash acquisition classified as an M&A transaction involving Knowles Corporation (NYSE: KN), referred to in the facts block as the Company, in connection with the divestiture of its Consumer MEMS Microphones (CMM) business. The disclosed value of the transaction is $263,000,000. No target, acquirer, or sector field beyond the product classification is specified in the facts block. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on September 18, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, Jefferies LLC was engaged by the Company to assist in the strategic review of the CMM business, a role identified as lead. Separately, J.P. Morgan is named as the exclusive financial advisor to the acquirer, Knowles, also in a lead capacity, with the source language specifically noting that J.P. Morgan served as exclusive financial advisor to Knowles alongside its legal counsel. On the legal side, Foley & Lardner LLP is identified as legal advisor to the acquirer, Knowles, per the same source sentence that names J.P. Morgan as Knowles's exclusive financial advisor. No legal advisor is identified for the Company (the divesting party) in the facts provided. Beyond the cash consideration implied by the cash acquisition subtype and the disclosed $263,000,000 value, no further detail on deal structure, payment terms, or closing mechanics is provided in the facts block. Several items are not disclosed in the available record. The identities of the specific target and acquirer entities beyond \'Knowles\' and \'the Company\' are not separately broken out in structured fields, no sector classification is given, and no legal advisor is named for the Company side of the transaction. No expected closing date or additional timeline detail beyond the September 2023 filing date and pending-regulatory status is provided.

This transaction is a Chapter 11 go-private transaction structured as an asset purchase agreement, in which affiliates of Blue Torch Finance LLC are acquiring AgileThought, Inc. The deal is classified within the business services sector, falls under the restructuring product group, and carries a disclosed value of 22,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on August 31, 2023. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Guggenheim Securities, LLC is serving as investment banker to AgileThought, the target, and is identified as holding lead status in that role. Teneo Capital LLC is serving as financial advisor to AgileThought as well, also identified as holding lead status, indicating two separate lead-designated advisors working alongside each other for the target in this Chapter 11 process. On the acquirer side, FTI Consulting is serving as financial advisor to Blue Torch, the acquiring party. On the legal side, Hughes Hubbard & Reed LLP and Potter Anderson & Corroon LLP are both serving as legal advisor to AgileThought, the target, reflecting two legal advisors on that side. Ropes & Gray LLP is serving as legal advisor to Blue Torch, the acquirer, with the source material noting that Ropes & Gray LLP and FTI Consulting are together serving as legal and financial advisors, respectively, to Blue Torch. Beyond confirming that the transaction is structured as a Chapter 11 go-private asset purchase with a disclosed value of 22,000,000 dollars, no further detail on the specific assets being purchased or the allocation of consideration is included in the facts available. A number of elements of this deal remain undisclosed. No detail is provided on the specific assets covered by the asset purchase agreement, the treatment of specific creditor classes, or an expected date for court approval or closing. The facts also do not specify what, if any, additional regulatory approvals are required.

This deal involves Talaris Therapeutics, Inc. in a stock-for-stock merger. The facts block does not specify which party is the target and which is the acquirer, nor does it name a counterparty company, and no sector classification is provided. The transaction falls under the M&A product group, and the disclosed value is not stated in the source document. The facts block is sourced from a single SEC filing: an S-4 filed with SEC EDGAR and published on August 25, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, Leerink Partners LLC served as financial advisor to the company (Talaris Therapeutics) and is designated as the lead advisor. Leerink's involvement is evidenced by a consent letter referencing its opinion, dated June 22, 2023, delivered to the Talaris board of directors and included as Annex B to the proxy statement/prospectus forming part of Amendment No. 1 to the Form S-4 registration statement. No other financial advisors were identified in the facts block. No legal advisors were identified in the facts block for this transaction, for either Talaris or any counterparty. Beyond the stock-for-stock characterization of the merger consideration, the facts block provides no further detail on the exchange ratio or other specific terms of the transaction. Several material facts are not disclosed in the source material. The facts block does not name the merger counterparty, only referring generically to "the company," nor does it specify a sector or disclosed deal value. No legal advisors are identified for either side, and no expected closing date is given.

This deal is a cash acquisition structured as a take-private by a private equity firm, in which Heritage-Crystal Clean, Inc., a company in the industrials sector, is the target being acquired by J.F. Lehman & Company. The transaction is classified under the M&A product group, with a disclosed deal value of $1,200,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on August 24, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, William Blair & Company served as financial advisor to the target, Heritage-Crystal Clean, with no lead designation specified. The source sentence notes that during the deal's "go-shop" period, at the direction of the company's board of directors, Crystal Clean and representatives of William Blair, acting as financial advisor to the company, engaged with or actively solicited alternative acquisition proposals from 53 potentially interested parties regarding a possible alternative transaction to the merger. No financial advisor is disclosed for J.F. Lehman & Company, the acquirer, in the facts block. No legal advisors were identified in the facts block for this transaction, for either Heritage-Crystal Clean or J.F. Lehman & Company. Beyond the cash consideration implied by the subtype and the disclosed $1,200,000,000 deal value, as well as the existence of a go-shop period during which 53 parties were solicited, the facts block does not provide further detail such as a per-share purchase price or the outcome of the go-shop solicitation. Several facts are not disclosed in the source material. No financial or legal advisor is named for the acquirer, J.F. Lehman & Company, and no legal advisor is named for Heritage-Crystal Clean either. The facts block does not state a per-share price, the outcome of the go-shop process, or an expected closing date.

This is a divestiture structured as a cash acquisition in the tech sector, in which Ingersoll Rand Inc. (ticker IR) is acquiring the Roots business, divested by a seller identified in the source material as Chart. The product group is M&A, and the disclosed transaction value is $300,000,000. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on August 18, 2023. The deal's current status is pending regulatory review. Financial advisory roles are clearly delineated by side. Citi served as financial advisor to Ingersoll Rand, the acquirer, per the statement "Citi served as financial advisor and Simpson Thacher & Bartlett LLP is serving as legal counsel to Ingersoll Rand." On the target/seller side, BofA Securities served as the lead, exclusive financial advisor to Chart, consistent with the language "BofA Securities served as exclusive financial advisor and Winston & Strawn LLP is serving as legal counsel to Chart." Legal advisors are disclosed for both sides: Simpson Thacher & Bartlett LLP is serving as legal counsel to Ingersoll Rand, the acquirer, while Winston & Strawn LLP is serving as legal counsel to Chart, the seller. Beyond the classification of this transaction as a divestiture/cash acquisition with a disclosed value of $300,000,000, no further detail on payment structure, financing sources, or other specific terms is included in the facts provided. Several items are not disclosed in this record: no detail on financing sources for the cash consideration is provided, and no expected closing date is given beyond the pending-regulatory status.

Bruker Corporation and PhenomeX Inc. announced on August 17, 2023 that they had signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction, valuing PhenomeX at a total equity value of approximately $108 million. The release describes the deal as marking "Bruker's entry into functional single-cell biology research solutions," with PhenomeX's Beacon Optofluidic platform and IsoLight/IsoSpark proteomics barcoding products complementing Bruker's spatial biology business. This record is sourced from an Exhibit 99.1 press release furnished with PhenomeX's Form 8-K filed August 17, 2023. At announcement, the transaction was a signed definitive merger agreement structured as a tender offer, not yet closed, and not subject to any financing conditions; closing was expected in the fourth quarter of 2023. Perella Weinberg Partners served as financial advisor to Bruker, the acquirer, per the release's statement "For Bruker, Perella Weinberg Partners acted as financial advisor and Morgan Lewis as legal advisor." William Blair & Company, L.L.C. served as financial advisor to PhenomeX, the target, per "For PhenomeX, William Blair & Company, L.L.C. acted as financial advisor and Freshfields Bruckhaus Deringer LLP as legal advisor." No lead designation is specified for either side since each company retained a single financial advisor. On the legal side, Morgan Lewis represented Bruker and Freshfields Bruckhaus Deringer LLP represented PhenomeX. The transaction was structured as a tender offer for all outstanding PhenomeX shares at $1.00 per share, after which PhenomeX would merge into a wholly owned Bruker subsidiary, with any untendered shares converted into the right to receive the same per-share cash consideration paid in the tender offer. Not disclosed in the sourced document is any revenue or technology-value multiple implied by the $108 million price, the number of PhenomeX instruments or customers that factored into the valuation beyond the "more than 400 instruments" installed-base figure mentioned for context, or the precise date the tender offer was expected to commence.

This transaction involves HF Sinclair Corporation (ticker DINO) acquiring Holly Energy Partners LP, both operating in the energy-power sector. The deal is structured as a cash-and-stock merger effecting a take-private of the publicly traded units of the master limited partnership, and falls under the M&A product group. The disclosed value of the transaction is not stated in the source document. This summary draws on an SEC EDGAR Form 8-K filed and published on August 16, 2023. The deal's current status is pending regulatory review, indicating that closing has not yet occurred as of the facts captured here. On the financial advisory side, Barclays is acting as financial advisor to HF Sinclair, the acquirer. For the target, Intrepid Partners, LLC is acting as financial advisor specifically to the conflicts committee of the board of the ultimate general partner of the partnership, a structure typical of MLP transactions where unitholder and sponsor interests must be separately represented. Legal counsel follows a similar structural split. Vinson & Elkins L.L.P. and Richards, Layton & Finger, P.A. are acting as HF Sinclair's legal advisors on the acquirer side. On the target and conflicts committee side, Gibson, Dunn & Crutcher LLP and Morris, Nichols, Arsht & Tunnell LLP are acting as legal advisors to the conflicts committee of the board of the ultimate general partner of the partnership. The facts block identifies the subtype as a cash-and-stock merger taking private the publicly held units of the MLP, but does not specify the exact mix of cash versus stock consideration, the exchange ratio, or the per-unit price being offered to unitholders. Several key facts are not disclosed in this record. The deal's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is provided. No detail is given on the specific terms of the cash-and-stock split, nor on what regulatory approvals remain outstanding under the pending-regulatory status.

This matter involves United States Steel Corporation undertaking a strategic alternatives review following unsolicited acquisition proposals, with no specific counterparty named in the facts provided. The deal is classified under the sponsors-coverage product group within the industrials sector, and the disclosed value is not stated in the source document, consistent with the fact that no specific transaction or counterparty has been identified at this stage. The matter is sourced from an SEC EDGAR Form 8-K filing published on August 14, 2023. Based on the facts provided, the status of this process is pending regulatory approval. On the financial advisory side, Barclays Capital Inc. and Goldman Sachs & Co. LLC are both serving as financial advisors to U.S. Steel, the company undertaking the strategic review. Both firms are named jointly in the source sentence as serving in this capacity, with no distinction made in the facts between a lead and a non-lead advisor. On the legal side, Milbank LLP and Wachtell, Lipton, Rosen & Katz are both acting as legal advisors to the company. As with the financial advisors, both firms are named together in the source material without a distinction in seniority or role. Because this is described as a strategic alternatives review following unsolicited proposals rather than a definitive transaction, no deal structure, consideration terms, or counterparty-specific detail is included in the facts available. A number of elements remain undisclosed or simply not yet applicable given the stage of this process. No specific counterparty or transaction value is named, no consideration structure exists to describe, and no expected timeline or outcome for the strategic review is given in the facts available.

PowerSchool Holdings, Inc. (NYSE: PWSC), through its subsidiaries PowerSchool Holdings, LLC (formerly Severin Holdings, LLC), Severin Acquisition, LLC and PeopleAdmin, LLC, entered into Incremental Term Facility Amendment No. 5 to its existing First Lien Credit Agreement, incurring an additional 100 million dollars in incremental term loans. The filing states the borrowers expected to use the proceeds of these incremental term loans to finance the company's previously announced acquisition of SchoolMessenger, a K-12 parent and community communications platform, making this a leveraged finance transaction supporting a disclosed but separately-announced M&A deal rather than the M&A announcement itself. This record is sourced from an 8-K that PowerSchool filed with the SEC, dated for the event of July 31, 2023 and filed August 4, 2023, describing the credit agreement amendment and the incremental term loans. At the time of filing, the amendment had already been executed and the incremental loans incurred; this exhibit does not separately restate the terms or closing status of the underlying SchoolMessenger acquisition. Barclays Bank PLC served as administrative agent for the credit facility supporting this financing, a role carried over from the original First Lien Credit Agreement dated August 1, 2018: the amendment was entered into "by and among Holdings, the Borrowers, the subsidiaries of the Company party thereto (the Subsidiary Guarantors), Barclays Bank PLC, as the administrative agent, and the lenders party thereto." No separate M&A financial advisor is named in this filing, since the exhibit concerns only the debt financing mechanics rather than the acquisition agreement itself. No legal advisors are disclosed in this 8-K. On deal structure, the incremental term loans were issued on the same terms as, and are treated as a single fungible class with, the existing term loans under the facility, guaranteed by Holdings, each borrower (other than for its own obligations) and each subsidiary guarantor, with substantially all assets of the borrowers and guarantors pledged as collateral. Not disclosed in this exhibit: the purchase price or any other financial terms of the underlying SchoolMessenger acquisition, the identity of any financial or legal advisor on the SchoolMessenger M&A transaction itself, the interest rate or maturity terms of the new incremental term loans, and the closing date of the SchoolMessenger acquisition.

This transaction is a stock-for-stock reverse merger in which Korro Bio, Inc., trading under the ticker KRRO, is combining with Frequency Therapeutics, Inc. The deal is classified within the healthcare sector, and the disclosed value of the transaction is not stated in the source document. The transaction is sourced from an SEC EDGAR Form S-4 filing published on July 27, 2023. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Cowen and Company, LLC served as financial advisor to Frequency Therapeutics and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter dated July 13, 2023, addressed to the Board of Directors of Frequency, referencing Cowen's opinion letter included as an annex to the proxy statement/prospectus and cited under the headings "Prospectus Summary, Opinion of Frequency's Financial Advisor" and "The Merger, Opinion of Frequency's Financial Advisor." No financial advisor to Korro Bio is identified in the facts provided. No legal advisor is identified for either party in the facts provided for this transaction. Beyond confirming that the transaction is structured as a stock-for-stock reverse merger, no further detail on the specific exchange ratio or other terms of the stock consideration is included in the facts available. Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Korro Bio or Frequency Therapeutics is identified. No financial advisor to Korro Bio is named, and no expected closing date or detail on the specific exchange ratio is provided in the available material.

Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC, issuer entities of Mallinckrodt plc, entered into a Forbearance Agreement dated July 16, 2023 with noteholders beneficially owning over 75% of the outstanding notes under a June 2022 indenture. The agreement was an out-of-court negotiation in which the noteholders (the Forbearing Holders) agreed to temporarily forbear from exercising remedies while the parties worked toward a broader resolution of Mallinckrodt's capital structure. The deal is sourced from an exhibit to Mallinckrodt plc's own 8-K, filed under CIK 0001567892, containing the full executed Forbearance Agreement. This is a primary legal document rather than a press release, and the Perella Weinberg reference appears in the agreement's expense-reimbursement and defined-terms provisions rather than in promotional language. Perella Weinberg Partners LP is named as investment banker to the Forbearing Holders (the ad hoc noteholder group), grouped together with the group's legal counsel as the "Specified Forbearing Holder Advisors" whose fees and expenses the agreement provided for reimbursement of. The operative language reads: "(iv) Perella Weinberg Partners LP (with Paul, Weiss, Landis Rath and Matheson, the 'Specified Forbearing Holder Advisors'), investment banker to the Forbearing Holders, in each case to the extent provided for in the Fee Letters." This confirms Perella Weinberg's role as financial advisor to the creditor group rather than to the company. Paul, Weiss served as lead counsel to the Forbearing Holders, with Landis Rath & Cobb, LLP serving as Delaware counsel and Matheson LLP serving as Irish counsel to the same noteholder group, reflecting Mallinckrodt's Luxembourg/Ireland-linked corporate structure. The reviewed excerpt is a forbearance agreement rather than a definitive restructuring plan, so it does not disclose an aggregate transaction value, exchange ratios, or recovery percentages. The agreement references a prior June 16, 2022 indenture and associated notes but does not restate their principal amount in the portion reviewed. Not disclosed in the reviewed excerpt: the dollar amount of notes subject to the indenture, the duration of the forbearance period, the ultimate restructuring or bankruptcy outcome that followed, and fee amounts payable to Perella Weinberg under the referenced Fee Letters (which were not filed as part of this exhibit).

Denbury Inc. disclosed in a Form 8-K that on July 13, 2023 it had entered into an Agreement and Plan of Merger with Exxon Mobil Corporation and EMPF Corporation, a wholly-owned Exxon Mobil merger subsidiary, under which the merger subsidiary will merge with and into Denbury, leaving Denbury as a wholly owned Exxon Mobil subsidiary. The filing furnishes a joint press release regarding the merger as Exhibit 99.1, but the 8-K body text itself does not restate the transaction's dollar value. This record is sourced from Denbury's Form 8-K filed July 13, 2023 (Item 7.01 Regulation FD Disclosure), which discloses the signing of the merger agreement and the advisor roles connected to it. At the time of this filing, the Denbury/ExxonMobil merger was a newly signed definitive agreement, with ExxonMobil and Denbury expected to file a registration statement and proxy statement/prospectus with the SEC. J.P. Morgan Securities LLC acted as Denbury's lead financial advisor and provided a fairness opinion to its board, per the filing's statement "In connection with the Merger, J.P. Morgan Securities LLC is acting as lead financial advisor to the Company and provided a fairness opinion to the Board of Directors." TPH&Co., the energy business of Perella Weinberg Partners, also acted as a financial advisor to Denbury and separately provided a fairness opinion, per "TPH&Co., the energy business of Perella Weinberg Partners, is acting as financial advisor to the Company and provided a fairness opinion to the Board of Directors." PJT Partners additionally provided a fairness opinion to the board without being described as a transaction financial advisor. J.P. Morgan is explicitly the only advisor designated "lead," with TPH&Co. serving in a secondary, non-lead financial advisor capacity alongside it. On the legal side, Vinson & Elkins LLP served as legal counsel to Denbury; no advisor information for ExxonMobil is disclosed in this filing. The filing notes the merger is subject to Denbury stockholder approval and that a registration statement on Form S-4 would be filed by ExxonMobil containing a joint proxy statement/prospectus, but provides no further deal-structure detail (such as exchange ratio or per-share consideration) in the fetched text. Not disclosed in the sourced document is the transaction's dollar value, exchange ratio, expected closing date, or ExxonMobil's financial or legal advisors, since those details were contained in the furnished Exhibit 99.1 press release rather than the 8-K body text that was fetched.

This transaction is a project financing and joint venture equity investment involving NextDecade Corp, trading under the ticker NEXT, as issuer, with Global Infrastructure Partners, GIC, and Mubadala Investment (and, per the legal advisor detail, TotalEnergies) as participants. The deal is classified under the private capital product group within the energy and power sector, and the disclosed value of the transaction is 18,400,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on July 12, 2023. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, MUFG Bank, Ltd. acted as financial advisor to NextDecade in connection with the debt financing component of the transaction, while Macquarie Capital (USA) Inc. acted as financial advisor to NextDecade in connection with the equity financing component, reflecting a split mandate across the two financing workstreams for the issuer. On the legal side, Latham & Watkins LLP acted as lead outside counsel to NextDecade on the project financing transactions. Separately, a distinct set of legal advisors is identified for the investor group: Kirkland & Ellis LLP acted as legal counsel to GIP, Jones Day acted as legal counsel to TotalEnergies, Sidley Austin LLP acted as legal counsel to GIC, White & Case LLP acted as legal counsel to Mubadala, and Norton Rose Fulbright US LLP acted as legal counsel to the lenders, indicating a broad multi-party advisory structure across the equity investors and the lending group. Beyond confirming that this is structured as a project financing paired with a joint venture equity investment, with a combined disclosed value of 18,400,000,000 dollars split across debt and equity financing components, no further detail on the specific allocation between the debt and equity pieces is included in the facts available. Several elements of this deal remain undisclosed. No specific breakdown between the debt financing and equity financing portions of the 18,400,000,000 dollar disclosed value is given, and no expected closing date is provided. The facts also do not specify what regulatory approvals, if any, remain outstanding for this multi-party project financing.

NextDecade Corporation (NASDAQ: NEXT), a Houston-based LNG and carbon capture development company, announced on July 12, 2023 that it made a positive final investment decision (FID) to construct the first three liquefaction trains (Phase 1) of its 27 million tonnes per annum Rio Grande LNG export facility in Brownsville, Texas. In conjunction with FID, the company closed a joint venture agreement for Phase 1 including approximately $5.9 billion of financial commitments from Global Infrastructure Partners (GIP), GIC, Mubadala Investment Company, and TotalEnergies, alongside $11.6 billion of senior secured non-recourse bank credit facilities and a $700 million senior secured non-recourse private placement notes offering. This entry is sourced from NextDecade's Exhibit 99.1 press release filed as part of an 8-K on July 12, 2023. The transactions described, the joint venture agreement, the credit facilities, and the notes offering, are reported as closed on the date of the release, with RGLNG simultaneously issuing a notice to proceed to Bechtel Energy Inc. to begin EPC construction of Phase 1. MUFG Bank, Ltd. acted as financial advisor to NextDecade in connection with the debt financing, and Macquarie Capital (USA) Inc. acted as financial advisor to NextDecade in connection with the equity financing. No financial advisors are separately named for GIP, GIC, Mubadala, or TotalEnergies in this release. Latham & Watkins LLP acted as lead outside counsel to NextDecade on the project financing transactions. Kirkland & Ellis LLP acted as legal counsel to GIP, Jones Day acted as legal counsel to TotalEnergies, Sidley Austin LLP acted as legal counsel to GIC, White & Case LLP acted as legal counsel to Mubadala, and Norton Rose Fulbright US LLP acted as legal counsel to the lenders. The release describes the overall RGLNG Phase 1 project financing as totaling $18.4 billion, which it characterizes as the largest greenfield energy project financing in U.S. history, comprising the $5.9 billion of Financial Investor and TotalEnergies equity commitments, the $11.6 billion in bank credit facilities ($11.1 billion in construction term loans plus a $500 million working capital facility), and the $700 million private placement notes offering. NextDecade itself committed to invest approximately $283 million in Phase 1, including $125 million of pre-FID capital. Under the joint venture structure, NextDecade will hold equity interests entitling it to up to 20.8% of Phase 1 operating cash flows, with Financial Investors and TotalEnergies entitled to a minimum of 62.5% and 16.7%, respectively. The final EPC cost at notice-to-proceed is approximately $12.0 billion. The release does not disclose the specific fee arrangements for MUFG, Macquarie, or any of the named law firms, nor does it break out individual equity commitment amounts among GIP, GIC, Mubadala, and TotalEnergies beyond their combined $5.9 billion figure. Pricing terms (interest rates, tenors) of the $11.6 billion credit facilities and the $700 million notes are also not disclosed in this release.

This deal is an all-stock plan of arrangement classified as an M&A transaction in the natural-resources sector, involving Rockcliff Metals Corp as target and Hudbay Minerals Inc. (ticker HBM) as acquirer. The disclosed value of the transaction is $13,000,000. The transaction is sourced from a Form 6-K filing with the SEC, filed via SEC EDGAR and published on June 20, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, Haywood Securities Inc. provided a fairness opinion to the Special Committee of Rockcliff, the target, stating that the consideration to be received by Rockcliff shareholders under the arrangement is fair from a financial point of view, with INFOR Financial providing a parallel fairness opinion to the full Board per the same source sentence. Separately, INFOR Financial is also identified as acting as financial advisor to Rockcliff in a lead capacity, while National Bank Financial acted as financial advisor to Hudbay, the acquirer, also in a lead capacity. On the legal side, Peterson McVicar LLP acted as legal counsel to Rockcliff, the target, while Goodmans LLP acted as legal counsel to Hudbay, the acquirer. Beyond the all-stock consideration structure implied by the plan of arrangement subtype, with a disclosed deal value of $13,000,000, no further detail on the specific exchange ratio is provided in the facts block. Several items are not disclosed in the available record. No further structural detail beyond the all-stock plan of arrangement classification and disclosed value is given, and no expected closing date or further timeline detail beyond the June 2023 filing date and pending-regulatory status is provided.

This transaction is a cash-and-stock acquisition in which Nasdaq, Inc., trading under the ticker NDAQ, is acquiring Adenza. The deal is classified within the financial institutions group sector, and the disclosed value of the transaction is 10,500,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on June 12, 2023. According to the facts provided, the deal's status is pending regulatory approval. The financial advisory roster on this deal is extensive. Qatalyst Partners LP is serving as lead financial advisor to Thoma Bravo and Adenza (the target side), with a syndicate of additional advisors supporting in that role, namely Barclays, Citi, Evercore, HSBC Securities (USA) Inc., Jefferies LLC, and Piper Sandler, all named as financial advisors to Thoma Bravo and Adenza alongside Qatalyst. On the acquirer side, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are serving as financial advisors to Nasdaq, with Goldman Sachs & Co. LLC specifically named as serving as lead advisor to Nasdaq. On the legal side, Kirkland & Ellis LLP is serving as legal advisor to Thoma Bravo and Adenza, the target side of the transaction, while Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Nasdaq, the acquirer. Beyond confirming that the transaction is structured as a cash-and-stock acquisition with an aggregate disclosed value of 10,500,000,000 dollars, no further detail on the specific mix or ratio between the cash and stock components is included in the facts available. Several elements of this deal remain undisclosed in the available material. No specific breakdown of the cash-versus-stock consideration mix is given, and no expected closing date is provided. The facts also do not specify which regulatory approvals are required or the anticipated timeline for completion.

This transaction centers on MoneyGram International Inc., a business-services company, which is the target in a take-private acquisition. The deal is structured as a cash acquisition taking the company private, falls under the M&A product group, and its disclosed value is not stated in the source document. The facts are sourced from an 8-K filing with the SEC via EDGAR, published June 1, 2023. As of that filing, the transaction's status is pending regulatory, indicating it had not yet closed. A relatively large advisory roster is disclosed for this deal. BofA Securities, Inc. served as exclusive financial advisor to MoneyGram, the target, and is designated as lead on that side. On the acquirer side, Madison Dearborn Partners (MDP) retained multiple financial advisors: Goldman Sachs & Co. LLC acted as lead financial advisor to MDP, while Deutsche Bank Securities Inc., Barclays, and J.P. Morgan Securities LLC each acted as financial advisors to MDP without a lead designation specified for them individually, per the source sentence naming all four firms together. Legal counsel is also disclosed for both sides. Vinson & Elkins LLP acted as legal counsel to MoneyGram, and Paul Hastings LLP acted as financial services regulatory counsel to MoneyGram, according to the source language. On the acquirer side, Latham & Watkins LLP, Kirkland & Ellis LLP, and Covington & Burling LLP are all named as legal counsel to MDP in the same source sentence that names the financial advisors to MDP. Beyond identifying the transaction as a cash, take-private acquisition, the facts block provides no further detail on the specific per-share price, financing structure, or other terms of the deal. Several key facts are not disclosed in the available record. The overall transaction value is not stated. No expected closing date is given. The facts block also does not specify which, if any, of the three non-lead MDP financial advisors or the three MDP legal advisors played a more senior role relative to the others; they are simply listed together in the source sentence.

This transaction is a divestiture in which RenaissanceRe Holdings Ltd (ticker RNR), a financial institutions group (FIG) sector company, is acquiring a reinsurance business, Validus Re. The deal is classified under the M&A product group as a sale of a reinsurance business, with a disclosed value of $4,500,000,000. The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on May 22, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, both Evercore Group L.L.C. and J.P. Morgan Securities LLC acted as financial advisors on the target side, representing AIG, the seller of the Validus Re business. No lead designation was specified for either advisor in the facts block, and no financial advisors were disclosed on the acquirer side (RenaissanceRe). Legal counsel was disclosed on the target side as well: Wachtell, Lipton, Rosen & Katz and Debevoise & Plimpton LLP both acted as legal counsel for AIG. No legal advisors were identified for RenaissanceRe in the facts block. Beyond the $4,500,000,000 disclosed value and the characterization of the deal as a divestiture or sale of a reinsurance business, no further detail on deal structure, such as whether consideration is cash, stock, or some combination, was provided in the facts block. Several facts are not disclosed in the source material. No financial or legal advisors are named on the acquirer (RenaissanceRe) side of the transaction. The facts block also does not specify an expected closing date, nor does it detail the consideration structure beyond the aggregate value of $4,500,000,000.

Intapp, Inc. (NASDAQ: INTA), a provider of cloud software for the global professional and financial services industry, announced its intention to offer and sell 2,000,000 shares of common stock in an underwritten public offering, with certain selling stockholders concurrently offering an additional 4,250,000 shares in the same offering. The release states the company intended to use net proceeds from its own share sale for working capital and general corporate purposes, while receiving no proceeds from the shares sold by the selling stockholders. This record is sourced from an 8-K exhibit (Exhibit 99.1) that Intapp filed with the SEC on May 19, 2023, announcing the proposed offering. At the time of filing the offering had only been announced as intended and had not yet priced; the release explicitly cautions that "there can be no assurance as to whether or when the Offering may be completed." This is an equity capital markets transaction rather than an M&A advisory mandate: BofA Securities and Barclays acted as joint lead book-running managers for the offering, per the release: "BofA Securities and Barclays are acting as the joint lead book-running managers for the Offering." No other banks or financial advisors are named. No legal advisors are disclosed in this exhibit. On deal mechanics, the release states that certain selling stockholders were expected to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the total shares offered, on the same terms less the underwriting discount, and that the offering was to be made pursuant to an already-effective shelf registration statement filed with the SEC. Not disclosed in this exhibit: the offering price per share, the aggregate dollar size of the offering, the identity of the selling stockholders (only that "certain selling stockholders" intended to sell), and whether or when the offering was ultimately priced and closed, since this release only announces the proposed terms.

This deal is a cash and stock acquisition in which ONEOK, Inc. is the acquirer of Magellan Midstream Partners, L.P., a company in the energy-power sector and the target of the transaction. The deal is classified under the M&A product group, with a disclosed value of $18,800,000,000. The facts block is sourced from a single SEC filing: a Form 425 filed with SEC EDGAR and published on May 15, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, multiple firms are named. Goldman Sachs & Co. LLC is serving as lead financial advisor to ONEOK, the acquirer, with Goldman Sachs Bank USA separately providing fully committed bridge financing; TPH&Co. (the energy business of Perella Weinberg Partners) and BofA Securities also advised ONEOK, without a lead designation. On the target side, Morgan Stanley & Co. LLC is serving as financial advisor to Magellan and is designated as lead advisor. Legal counsel was also disclosed for both sides. Kirkland & Ellis LLP is serving as ONEOK's (the acquirer's) legal advisor. On the target side, both Latham & Watkins LLP and Richards, Layton & Finger, P.A. are acting as Magellan's legal advisors. Beyond the cash-and-stock characterization of the consideration and the disclosed $18,800,000,000 deal value, the facts block does not specify the precise cash/stock split or exchange ratio applicable to Magellan unitholders. Several facts are not disclosed in the source material. The facts block does not give the specific cash amount per unit or the stock exchange ratio that make up the cash-and-stock consideration, nor does it specify an expected closing date. It also does not detail the size of the bridge financing being provided by Goldman Sachs Bank USA.

This record is an M&A transaction structured as a membership interest purchase agreement, involving Percussion Petroleum Operating II LLC and Callon Petroleum Operating Company. The disclosed value is not stated in the source document(s). The facts block does not specify a sector classification for this record, and does not clearly identify which party is the target versus the acquirer beyond the names in the deal's slug. The facts are sourced from an 8-K filed with the SEC via EDGAR, published on May 8, 2023. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Tudor, Pickering, Holt & Co., described as a third-party advisor to the target side. The source sentence is drawn from a defined-term provision in the transaction agreement itself, stating that "'Transaction Expenses' means, with respect to the Company as of the date the determination is being made, without duplication: all fees, costs and expenses (including fees, costs and expenses of third-party advisors (including Tudor, Pickering, Holt & Co.), legal counsel (including Gibson), investment bankers or other representatives) incurred by the Company in connection with the transactions contemplated this Agreement and the Related Agreements." This indicates Tudor, Pickering, Holt & Co.'s role was referenced in the context of reimbursable transaction expenses rather than a standalone advisory announcement. No discrete legal advisor entries are provided in the facts block, though the same source sentence referencing Tudor, Pickering, Holt & Co. also mentions legal counsel "including Gibson" in the context of transaction expenses, without further detail. Beyond the classification of this transaction as a membership interest purchase agreement, no further detail on the purchase price, consideration structure, or other specific terms is included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the sector is not specified, no discrete legal advisor relationship is confirmed beyond the passing reference to "Gibson" in a fee-related defined term, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a cash acquisition in which American Financial Group, Inc., trading under the ticker AFG, is acquiring Crop Risk Services from AIG. The deal is classified within the financial institutions group sector, and the disclosed value of the transaction is 240,000,000 dollars. The transaction is sourced from an SEC EDGAR Form 8-K filing published on May 3, 2023. Based on the facts provided, the deal's status is pending regulatory approval. On the financial advisory side, Evercore Group L.L.C. acted as financial advisor to AIG, the seller in this transaction, with the source material noting that Evercore Group L.L.C. and Sidley Austin LLP acted as financial advisor and legal counsel, respectively, for AIG. No financial advisor to American Financial Group, the acquirer, is identified in the facts provided. On the legal side, Sidley Austin LLP acted as legal counsel for AIG, the seller, paired with Evercore in the same source sentence. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal counsel for AFG, the acquirer. Beyond confirming that this is a cash acquisition with a disclosed value of 240,000,000 dollars, no further detail on the specific payment structure or any adjustment mechanisms is included in the facts available. A number of elements of this deal remain undisclosed. No financial advisor to American Financial Group, the acquirer, is identified, and no expected closing date is given. The facts also do not specify what regulatory approvals are required to complete the transaction beyond the disclosed value of 240,000,000 dollars.

This deal is an asset divestiture structured as a cash acquisition, classified as an M&A transaction in the healthcare sector, involving the Baqsimi product (divested by Lilly) and Amphastar Pharmaceuticals, Inc. (ticker AMPH) as acquirer. The disclosed value of the transaction is $625,000,000. The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on April 24, 2023. The deal's current status is pending regulatory approval. On the financial advisory side, J.P. Morgan Securities LLC acted as financial advisor to Lilly, the target/divesting party, in a lead capacity. Jefferies LLC acted as financial advisor to Amphastar, the acquirer, also in a lead capacity, with each advisor paired with its respective legal counsel in the source material. On the legal side, two firms represented Lilly (the target/divesting party): Kirkland & Ellis LLP and Covington & Burling LLP, both named as legal counsel in the same source sentence as J.P. Morgan's role. Wilson, Sonsini, Goodrich & Rosati, P.C. represented Amphastar, the acquirer, as legal counsel. Beyond the cash consideration for this asset divestiture, with a disclosed deal value of $625,000,000, no further detail on specific terms of the asset transfer beyond it being a product/asset acquisition is provided in the facts block. Several items are not disclosed in the available record. No further structural detail beyond the asset divestiture and cash acquisition classification is given, and no expected closing date or further timeline detail beyond the April 2023 filing date and pending-regulatory status is provided.

This is an all-stock merger of equals, classified under the M&A product group, involving U.S. Data Mining Group, Inc. (USBTC) and Hut 8 Mining Corp. The disclosed value is not stated in the source document(s), and the facts block does not specify a sector classification for this record. The facts are sourced from an S-4 registration statement filed with the SEC via EDGAR, published on April 18, 2023, consistent with the all-stock structure, since an S-4 registers the shares to be issued in the merger. The deal's current status is pending regulatory review. Only one financial advisor is identified in the facts block: Kroll, LLC, operating through its Duff & Phelps Opinions Practice (referred to as Duff & Phelps), which served as the lead, independent financial advisor to Hut 8's board of directors. The source sentence states: "Hut 8 Mining Corp. (the 'Company' or 'Hut 8') has engaged Kroll, LLC ('Duff & Phelps'), operating through its Duff & Phelps Opinions Practice, to serve as an independent financial advisor to the Board of Directors (the 'Board of Directors') of the Company... to provide an opinion... as to the fairness, from a financial point of view, to the Company of the USBTC Exchange Ratio." This confirms Kroll/Duff & Phelps rendered a fairness opinion specifically on the exchange ratio for the USBTC side of the merger. No financial advisor to U.S. Data Mining Group is identified in the facts provided. No legal advisors were extracted for this transaction in the available facts block. Beyond the classification of this transaction as an all-stock merger of equals, the facts confirm that a fairness opinion was rendered on the "USBTC Exchange Ratio," indicating an exchange ratio mechanism was used, though the specific ratio itself is not included in the facts provided. Several items are not disclosed in this record: the transaction value is not stated, the specific exchange ratio is not given, no financial advisor to U.S. Data Mining Group is identified, no legal advisors to either side are identified, and no expected closing date is given beyond the pending-regulatory status.

This transaction is a cash take-private of the publicly held units of GasLog Partners LP (ticker GLOP-PC), a transportation-infrastructure sector company, by GasLog Ltd. The deal falls under the M&A product group, and the disclosed value is not stated in the source document. The facts in this briefing are sourced from an SEC EDGAR Form 6-K filed and published on April 6, 2023. The transaction's current status is pending regulatory review. Financial advisory roles reflect the conflicts committee structure typical of MLP take-private transactions. Evercore is acting as financial advisor to the Conflicts Committee, representing the target's public unitholders, in a lead role. DNB Markets Inc. is acting as financial advisor to GasLog, the acquirer, also in a lead capacity. Legal counsel follows the same split. Richard, Layton & Finger, P.A. is acting as legal counsel to the Conflicts Committee. Cravath, Swaine & Moore LLP, together with Cozen O'Connor (Marshall Islands), is acting as legal counsel to GasLog, the acquirer, the Marshall Islands counsel reflecting GasLog's offshore corporate domicile. The facts block confirms this is structured as a cash take-private of the publicly held units of GasLog Partners LP, but does not specify the per-unit purchase price or the percentage of publicly held units being acquired. Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No expected closing date is given, and the per-unit purchase price is not specified in the available facts.

Ovintiv Inc. announced on April 3, 2023 that it had entered into a definitive purchase agreement to acquire substantially all leasehold interests and related assets of Black Swan Oil & Gas, PetroLegacy Energy and Piedra Resources, portfolio companies of funds managed by EnCap Investments L.P., in a cash-and-stock transaction valued at approximately $4.275 billion. Simultaneously, Ovintiv agreed to divest its entire Bakken asset position for proceeds of approximately $825 million, and announced a 20% increase to its base dividend. This record is sourced from an Exhibit 99.1 news release furnished with Ovintiv's Form 8-K filed April 3, 2023. At announcement, both the Midland Basin acquisition and the Bakken divestiture were signed definitive agreements pending customary closing conditions, with both transactions expected to close by the end of the second quarter of 2023. Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and TPH&Co., the energy business of Perella Weinberg Partners, jointly served as financial advisors to Ovintiv, the acquirer, per the release's statement "Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and TPH&Co., the energy business of Perella Weinberg Partners are serving as financial advisors to Ovintiv." On the seller side, Jefferies LLC served as financial advisor to EnCap specifically "in connection with the Northern Midland Basin transaction," per the release. No lead designation is given among Ovintiv's three financial advisors. On the legal side, Gibson, Dunn & Crutcher LLP, Kirkland & Ellis LLP, and Blake, Cassels & Graydon LLP together served as Ovintiv's legal counsel, while Vinson & Elkins LLP served as EnCap's legal counsel. The acquisition was valued at approximately 2.8 times next-twelve-months Adjusted EBITDA with a 19% NTM free cash flow yield at then-current strip pricing, adding approximately 65,000 net acres and roughly 1,050 net well locations in Martin and Andrews Counties; the effective date of both the acquisition and the Bakken disposition was set as January 1, 2023. Not disclosed in the sourced document is the precise dollar split between the cash and stock components of the $4.275 billion Midland Basin purchase price, or an exact calendar closing date beyond "by the end of the second quarter."